1	be	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	0	_	_	_	_	_	aware.a	Awareness	O
3	that	_	that	_	IN	0	_	_	_	_	_	_	_	O
4	,	_	,	_	,	0	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	0	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	0	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	0	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
12	,	_	,	_	,	0	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	0	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	0	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	0	_	_	_	_	_	_	_	O
20	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	0	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	0	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	0	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	0	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	0	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	0	_	_	_	_	_	_	_	O
4	,	_	,	_	,	0	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	0	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	0	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	0	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
12	,	_	,	_	,	0	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	0	_	_	_	_	_	_	_	S-Entity
14	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	0	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	0	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	0	_	_	_	_	_	effective.a	Usefulness	O
18	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	0	_	_	_	_	_	_	_	O
20	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	0	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	0	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	0	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	0	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	0	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	0	_	_	_	_	_	_	_	O
4	,	_	,	_	,	0	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	0	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	0	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	0	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
12	,	_	,	_	,	0	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	0	_	_	_	_	_	_	_	S-Goods
14	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	0	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	0	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	0	_	_	_	_	_	cost.n	Expensiveness	O
20	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	0	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	0	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	0	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	0	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	0	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	0	_	_	_	_	_	_	_	O
4	,	_	,	_	,	0	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	0	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	0	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	0	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
12	,	_	,	_	,	0	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	0	_	_	_	_	_	_	_	S-Entity
14	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	0	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	0	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	0	_	_	_	_	_	_	_	O
20	effective	_	effective	_	JJ	0	_	_	_	_	_	effective.a	Usefulness	O
21	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	0	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	0	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	0	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	0	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	0	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	0	_	_	_	_	_	_	_	O
4	,	_	,	_	,	0	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	0	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	0	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	0	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
12	,	_	,	_	,	0	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	0	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	0	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	0	_	_	_	_	_	_	_	O
20	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	0	_	_	_	_	_	adult.n	People_by_age	S-Person
23	with	_	with	_	IN	0	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	0	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	0	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	0	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	0	_	_	_	_	_	_	_	O
4	,	_	,	_	,	0	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	0	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	0	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	0	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
12	,	_	,	_	,	0	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	0	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	0	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	0	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	0	_	_	_	_	_	_	_	O
20	effective	_	effective	_	JJ	0	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	0	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	0	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	0	_	_	_	_	_	type.n	Type	S-Subtype
25	2	_	2	_	CD	0	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	0	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	1	_	_	_	_	_	_	_	O
2	,	_	,	_	,	1	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	1	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	1	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	1	_	_	_	_	_	person.n	People	S-Person
7	for	_	for	_	IN	1	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	1	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	1	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	1	_	_	_	_	_	_	_	O
13	,	_	,	_	,	1	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	1	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	1	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	1	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
20	combination	_	combination	_	NN	1	_	_	_	_	_	_	_	O
21	containing	_	contain	_	VBG	1	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
23	that	_	that	_	WDT	1	_	_	_	_	_	_	_	O
24	can	_	can	_	MD	1	_	_	_	_	_	_	_	O
25	be	_	be	_	VB	1	_	_	_	_	_	_	_	O
26	offered	_	offer	_	VBN	1	_	_	_	_	_	_	_	O
27	at	_	at	_	IN	1	_	_	_	_	_	_	_	O
28	first	_	first	_	JJ	1	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
30	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	1	_	_	_	_	_	_	_	O
2	,	_	,	_	,	1	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	1	_	_	_	_	_	_	_	B-Item
4	with	_	with	_	IN	1	_	_	_	_	_	_	_	I-Item
5	any	_	any	_	DT	1	_	_	_	_	_	_	_	I-Item
6	person	_	person	_	NN	1	_	_	_	_	_	_	_	I-Item
7	for	_	for	_	IN	1	_	_	_	_	_	_	_	I-Item
8	whom	_	whom	_	WP	1	_	_	_	_	_	_	_	I-Item
9	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	I-Item
10	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	1	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	1	_	_	_	_	_	consider.v	Categorization	O
13	,	_	,	_	,	1	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	1	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	1	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	1	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
20	combination	_	combination	_	NN	1	_	_	_	_	_	_	_	O
21	containing	_	contain	_	VBG	1	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
23	that	_	that	_	WDT	1	_	_	_	_	_	_	_	O
24	can	_	can	_	MD	1	_	_	_	_	_	_	_	O
25	be	_	be	_	VB	1	_	_	_	_	_	_	_	O
26	offered	_	offer	_	VBN	1	_	_	_	_	_	_	_	O
27	at	_	at	_	IN	1	_	_	_	_	_	_	_	O
28	first	_	first	_	JJ	1	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
30	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	1	_	_	_	_	_	_	_	O
2	,	_	,	_	,	1	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	1	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	1	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	1	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	1	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	1	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	1	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	1	_	_	_	_	_	_	_	O
13	,	_	,	_	,	1	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	1	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	1	_	_	_	_	_	there.adv	Locative_relation	S-Ground
16	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	1	_	_	_	_	_	_	_	B-Ground
18	licensed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	I-Ground
19	unk	_	UNK	_	JJ	1	_	_	_	_	_	_	_	I-Ground
20	combination	_	combination	_	NN	1	_	_	_	_	_	_	_	I-Ground
21	containing	_	contain	_	VBG	1	_	_	_	_	_	_	_	I-Ground
22	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	I-Ground
23	that	_	that	_	WDT	1	_	_	_	_	_	_	_	I-Ground
24	can	_	can	_	MD	1	_	_	_	_	_	_	_	I-Ground
25	be	_	be	_	VB	1	_	_	_	_	_	_	_	I-Ground
26	offered	_	offer	_	VBN	1	_	_	_	_	_	_	_	I-Ground
27	at	_	at	_	IN	1	_	_	_	_	_	_	_	I-Ground
28	first	_	first	_	JJ	1	_	_	_	_	_	_	_	I-Ground
29	intensification	_	UNK	_	NN	1	_	_	_	_	_	_	_	I-Ground
30	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	1	_	_	_	_	_	_	_	O
2	,	_	,	_	,	1	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	1	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	1	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	1	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	1	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	1	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	1	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	1	_	_	_	_	_	_	_	O
13	,	_	,	_	,	1	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	1	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	1	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	1	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	B-Aggregate_property
19	unk	_	UNK	_	JJ	1	_	_	_	_	_	_	_	I-Aggregate_property
20	combination	_	combination	_	NN	1	_	_	_	_	_	combination.n	Aggregate	S-Aggregate
21	containing	_	contain	_	VBG	1	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
23	that	_	that	_	WDT	1	_	_	_	_	_	_	_	O
24	can	_	can	_	MD	1	_	_	_	_	_	_	_	O
25	be	_	be	_	VB	1	_	_	_	_	_	_	_	O
26	offered	_	offer	_	VBN	1	_	_	_	_	_	_	_	O
27	at	_	at	_	IN	1	_	_	_	_	_	_	_	O
28	first	_	first	_	JJ	1	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
30	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	1	_	_	_	_	_	_	_	O
2	,	_	,	_	,	1	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	1	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	1	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	1	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	1	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	1	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	1	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	1	_	_	_	_	_	_	_	O
13	,	_	,	_	,	1	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	1	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	1	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	1	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
20	combination	_	combination	_	NN	1	_	_	_	_	_	_	_	O
21	containing	_	contain	_	VBG	1	_	_	_	_	_	contain.v	Containing	O
22	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	B-Contents
23	that	_	that	_	WDT	1	_	_	_	_	_	_	_	I-Contents
24	can	_	can	_	MD	1	_	_	_	_	_	_	_	I-Contents
25	be	_	be	_	VB	1	_	_	_	_	_	_	_	I-Contents
26	offered	_	offer	_	VBN	1	_	_	_	_	_	_	_	I-Contents
27	at	_	at	_	IN	1	_	_	_	_	_	_	_	I-Contents
28	first	_	first	_	JJ	1	_	_	_	_	_	_	_	I-Contents
29	intensification	_	UNK	_	NN	1	_	_	_	_	_	_	_	I-Contents
30	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	1	_	_	_	_	_	_	_	O
2	,	_	,	_	,	1	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	1	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	1	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	1	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	1	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	1	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	1	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	1	_	_	_	_	_	_	_	O
13	,	_	,	_	,	1	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	1	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	1	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	1	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
20	combination	_	combination	_	NN	1	_	_	_	_	_	_	_	O
21	containing	_	contain	_	VBG	1	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	B-Entity
23	that	_	that	_	WDT	1	_	_	_	_	_	_	_	I-Entity
24	can	_	can	_	MD	1	_	_	_	_	_	can.v	Capability	O
25	be	_	be	_	VB	1	_	_	_	_	_	_	_	B-Event
26	offered	_	offer	_	VBN	1	_	_	_	_	_	_	_	I-Event
27	at	_	at	_	IN	1	_	_	_	_	_	_	_	I-Event
28	first	_	first	_	JJ	1	_	_	_	_	_	_	_	I-Event
29	intensification	_	UNK	_	NN	1	_	_	_	_	_	_	_	I-Event
30	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	1	_	_	_	_	_	_	_	O
2	,	_	,	_	,	1	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	1	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	1	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	1	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	1	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	1	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	1	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	1	_	_	_	_	_	_	_	O
13	,	_	,	_	,	1	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	1	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	1	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	1	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
20	combination	_	combination	_	NN	1	_	_	_	_	_	_	_	O
21	containing	_	contain	_	VBG	1	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
23	that	_	that	_	WDT	1	_	_	_	_	_	_	_	O
24	can	_	can	_	MD	1	_	_	_	_	_	_	_	O
25	be	_	be	_	VB	1	_	_	_	_	_	_	_	O
26	offered	_	offer	_	VBN	1	_	_	_	_	_	_	_	O
27	at	_	at	_	IN	1	_	_	_	_	_	_	_	O
28	first	_	first	_	JJ	1	_	_	_	_	_	first.a	Ordinal_numbers	O
29	intensification	_	UNK	_	NN	1	_	_	_	_	_	_	_	S-Type
30	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	2	_	_	_	_	_	risk.n	Run_risk	O
3	factors	_	factor	_	NNS	2	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
6	conditions	_	condition	_	NNS	2	_	_	_	_	_	_	_	O
7	,	_	,	_	,	2	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	2	_	_	_	_	_	_	_	O
9	increased	_	increase	_	VBN	2	_	_	_	_	_	_	_	O
10	age	_	age	_	NN	2	_	_	_	_	_	_	_	O
11	,	_	,	_	,	2	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	2	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	2	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	2	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	2	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	2	_	_	_	_	_	_	_	O
18	:	_	:	_	:	2	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	2	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	2	_	_	_	_	_	_	_	O
22	'	_	'	_	POS	2	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	2	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	2	_	_	_	_	_	_	_	O
26	characteristics	_	characteristic	_	NNS	2	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	2	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	2	_	_	_	_	_	_	_	O
3	factors	_	factor	_	NNS	2	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	2	_	_	_	_	_	_	_	B-Total
6	conditions	_	condition	_	NNS	2	_	_	_	_	_	_	_	I-Total
7	,	_	,	_	,	2	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	2	_	_	_	_	_	include.v	Inclusion	O
9	increased	_	increase	_	VBN	2	_	_	_	_	_	_	_	B-Part
10	age	_	age	_	NN	2	_	_	_	_	_	_	_	I-Part
11	,	_	,	_	,	2	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	2	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	2	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	2	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	2	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	2	_	_	_	_	_	_	_	O
18	:	_	:	_	:	2	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	2	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	2	_	_	_	_	_	_	_	O
22	'	_	'	_	POS	2	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	2	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	2	_	_	_	_	_	_	_	O
26	characteristics	_	characteristic	_	NNS	2	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	2	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	2	_	_	_	_	_	_	_	O
3	factors	_	factor	_	NNS	2	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
6	conditions	_	condition	_	NNS	2	_	_	_	_	_	_	_	O
7	,	_	,	_	,	2	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	2	_	_	_	_	_	_	_	O
9	increased	_	increase	_	VBN	2	_	_	_	_	_	increase.v	Change_position_on_a_scale	O
10	age	_	age	_	NN	2	_	_	_	_	_	_	_	S-Item
11	,	_	,	_	,	2	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	2	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	2	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	2	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	2	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	2	_	_	_	_	_	_	_	O
18	:	_	:	_	:	2	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	2	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	2	_	_	_	_	_	_	_	O
22	'	_	'	_	POS	2	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	2	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	2	_	_	_	_	_	_	_	O
26	characteristics	_	characteristic	_	NNS	2	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	2	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	2	_	_	_	_	_	_	_	O
3	factors	_	factor	_	NNS	2	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
6	conditions	_	condition	_	NNS	2	_	_	_	_	_	_	_	O
7	,	_	,	_	,	2	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	2	_	_	_	_	_	_	_	O
9	increased	_	increase	_	VBN	2	_	_	_	_	_	_	_	S-Relative_time
10	age	_	age	_	NN	2	_	_	_	_	_	age.n	Calendric_unit	S-Unit
11	,	_	,	_	,	2	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	2	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	2	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	2	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	2	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	2	_	_	_	_	_	_	_	O
18	:	_	:	_	:	2	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	2	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	2	_	_	_	_	_	_	_	O
22	'	_	'	_	POS	2	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	2	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	2	_	_	_	_	_	_	_	O
26	characteristics	_	characteristic	_	NNS	2	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	2	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	2	_	_	_	_	_	_	_	O
3	factors	_	factor	_	NNS	2	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
6	conditions	_	condition	_	NNS	2	_	_	_	_	_	_	_	O
7	,	_	,	_	,	2	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	2	_	_	_	_	_	_	_	O
9	increased	_	increase	_	VBN	2	_	_	_	_	_	_	_	O
10	age	_	age	_	NN	2	_	_	_	_	_	_	_	O
11	,	_	,	_	,	2	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	2	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	2	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	2	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	2	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	2	_	_	_	_	_	_	_	O
18	:	_	:	_	:	2	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	2	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	2	_	_	_	_	_	manufacturer.n	Manufacturing	S-Producer
22	'	_	'	_	POS	2	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	2	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	2	_	_	_	_	_	_	_	O
26	characteristics	_	characteristic	_	NNS	2	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	2	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	2	_	_	_	_	_	_	_	O
3	factors	_	factor	_	NNS	2	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	2	_	_	_	_	_	_	_	O
6	conditions	_	condition	_	NNS	2	_	_	_	_	_	_	_	O
7	,	_	,	_	,	2	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	2	_	_	_	_	_	_	_	O
9	increased	_	increase	_	VBN	2	_	_	_	_	_	_	_	O
10	age	_	age	_	NN	2	_	_	_	_	_	_	_	O
11	,	_	,	_	,	2	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	2	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	2	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	2	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	2	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	2	_	_	_	_	_	_	_	O
18	:	_	:	_	:	2	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	2	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	2	_	_	_	_	_	_	_	O
22	'	_	'	_	POS	2	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	2	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	2	_	_	_	_	_	_	_	S-Entity
26	characteristics	_	characteristic	_	NNS	2	_	_	_	_	_	characteristic.n	Distinctiveness	O
27	for	_	for	_	IN	2	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	2	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	3	_	_	_	_	_	_	_	B-Speaker
2	and	_	and	_	CC	3	_	_	_	_	_	_	_	I-Speaker
3	healthcare	_	UNK	_	NNP	3	_	_	_	_	_	_	_	I-Speaker
4	products	_	product	_	NNS	3	_	_	_	_	_	_	_	I-Speaker
5	regulatory	_	Regulatory	_	NNP	3	_	_	_	_	_	_	_	I-Speaker
6	agency	_	Agency	_	NNP	3	_	_	_	_	_	_	_	I-Speaker
7	(	_	(	_	(	3	_	_	_	_	_	_	_	I-Speaker
8	mhra	_	UNK	_	NNP	3	_	_	_	_	_	_	_	I-Speaker
9	)	_	)	_	)	3	_	_	_	_	_	_	_	I-Speaker
10	guidance	_	guidance	_	NN	3	_	_	_	_	_	_	_	I-Speaker
11	(	_	(	_	(	3	_	_	_	_	_	_	_	I-Speaker
12	2011	_	2011	_	CD	3	_	_	_	_	_	_	_	I-Speaker
13	)	_	)	_	)	3	_	_	_	_	_	_	_	I-Speaker
14	advises	_	advise	_	VBZ	3	_	_	_	_	_	advise.v	Telling	O
15	that	_	that	_	IN	3	_	_	_	_	_	_	_	B-Message
16	unk	_	UNK	_	NNS	3	_	_	_	_	_	_	_	I-Message
17	should	_	should	_	MD	3	_	_	_	_	_	_	_	I-Message
18	review	_	review	_	VB	3	_	_	_	_	_	_	_	I-Message
19	the	_	the	_	DT	3	_	_	_	_	_	_	_	I-Message
20	safety	_	safety	_	NN	3	_	_	_	_	_	_	_	I-Message
21	and	_	and	_	CC	3	_	_	_	_	_	_	_	I-Message
22	efficacy	_	UNK	_	NN	3	_	_	_	_	_	_	_	I-Message
23	of	_	of	_	IN	3	_	_	_	_	_	_	_	I-Message
24	pioglitazone	_	UNK	_	NN	3	_	_	_	_	_	_	_	I-Message
25	in	_	in	_	IN	3	_	_	_	_	_	_	_	I-Message
26	individuals	_	individual	_	NNS	3	_	_	_	_	_	_	_	I-Message
27	after	_	after	_	IN	3	_	_	_	_	_	_	_	I-Message
28	unk	_	UNK	_	CD	3	_	_	_	_	_	_	_	I-Message
29	months	_	month	_	NNS	3	_	_	_	_	_	_	_	I-Message
30	of	_	of	_	IN	3	_	_	_	_	_	_	_	I-Message
31	treatment	_	treatment	_	NN	3	_	_	_	_	_	_	_	I-Message
32	to	_	to	_	TO	3	_	_	_	_	_	_	_	I-Message
33	ensure	_	ensure	_	VB	3	_	_	_	_	_	_	_	I-Message
34	that	_	that	_	IN	3	_	_	_	_	_	_	_	I-Message
35	only	_	only	_	JJ	3	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	3	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	3	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	3	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	3	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	3	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	3	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	3	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	3	_	_	_	_	_	_	_	O
45	'	_	'	_	POS	3	_	_	_	_	_	_	_	O
46	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	3	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	3	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	3	_	_	_	_	_	_	_	O
7	(	_	(	_	(	3	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
9	)	_	)	_	)	3	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	3	_	_	_	_	_	_	_	O
11	(	_	(	_	(	3	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	3	_	_	_	_	_	_	_	O
13	)	_	)	_	)	3	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	3	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	3	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	3	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	3	_	_	_	_	_	safety.n	Being_at_risk	O
21	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	3	_	_	_	_	_	_	_	O
27	after	_	after	_	IN	3	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
29	months	_	month	_	NNS	3	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	3	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	3	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	3	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	3	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	3	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	3	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	3	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	3	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	3	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	3	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	3	_	_	_	_	_	_	_	O
45	'	_	'	_	POS	3	_	_	_	_	_	_	_	O
46	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	3	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	3	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	3	_	_	_	_	_	_	_	O
7	(	_	(	_	(	3	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
9	)	_	)	_	)	3	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	3	_	_	_	_	_	_	_	O
11	(	_	(	_	(	3	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	3	_	_	_	_	_	_	_	O
13	)	_	)	_	)	3	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	3	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	3	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	3	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	3	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	3	_	_	_	_	_	individual.n	People	S-Person
27	after	_	after	_	IN	3	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
29	months	_	month	_	NNS	3	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	3	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	3	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	3	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	3	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	3	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	3	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	3	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	3	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	3	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	3	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	3	_	_	_	_	_	_	_	O
45	'	_	'	_	POS	3	_	_	_	_	_	_	_	O
46	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	3	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	3	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	3	_	_	_	_	_	_	_	O
7	(	_	(	_	(	3	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
9	)	_	)	_	)	3	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	3	_	_	_	_	_	_	_	O
11	(	_	(	_	(	3	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	3	_	_	_	_	_	_	_	O
13	)	_	)	_	)	3	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	3	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	3	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	3	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	3	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	3	_	_	_	_	_	_	_	O
27	after	_	after	_	IN	3	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	3	_	_	_	_	_	_	_	S-Count
29	months	_	month	_	NNS	3	_	_	_	_	_	month.n	Calendric_unit	S-Unit
30	of	_	of	_	IN	3	_	_	_	_	_	_	_	B-Whole
31	treatment	_	treatment	_	NN	3	_	_	_	_	_	_	_	I-Whole
32	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	3	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	3	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	3	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	3	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	3	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	3	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	3	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	3	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	3	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	3	_	_	_	_	_	_	_	O
45	'	_	'	_	POS	3	_	_	_	_	_	_	_	O
46	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	3	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	3	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	3	_	_	_	_	_	_	_	O
7	(	_	(	_	(	3	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
9	)	_	)	_	)	3	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	3	_	_	_	_	_	_	_	O
11	(	_	(	_	(	3	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	3	_	_	_	_	_	_	_	O
13	)	_	)	_	)	3	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	3	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	3	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	3	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	3	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	3	_	_	_	_	_	_	_	O
27	after	_	after	_	IN	3	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
29	months	_	month	_	NNS	3	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	3	_	_	_	_	_	treatment.n	Cure	S-Patient
32	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	3	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	3	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	3	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	3	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	3	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	3	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	3	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	3	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	3	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	3	_	_	_	_	_	_	_	O
45	'	_	'	_	POS	3	_	_	_	_	_	_	_	O
46	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	3	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	3	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	3	_	_	_	_	_	_	_	O
7	(	_	(	_	(	3	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
9	)	_	)	_	)	3	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	3	_	_	_	_	_	_	_	O
11	(	_	(	_	(	3	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	3	_	_	_	_	_	_	_	O
13	)	_	)	_	)	3	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	3	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	3	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	3	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	3	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	3	_	_	_	_	_	_	_	O
27	after	_	after	_	IN	3	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
29	months	_	month	_	NNS	3	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	3	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	3	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	3	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	3	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	3	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	3	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	3	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	3	_	_	_	_	_	_	_	S-Manner
41	continue	_	continue	_	NN	3	_	_	_	_	_	continue.v	Process_continue	O
42	to	_	to	_	TO	3	_	_	_	_	_	_	_	B-Event
43	be	_	be	_	VB	3	_	_	_	_	_	_	_	I-Event
44	treated	_	treat	_	VBN	3	_	_	_	_	_	_	_	I-Event
45	'	_	'	_	POS	3	_	_	_	_	_	_	_	I-Event
46	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	3	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	3	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	3	_	_	_	_	_	_	_	O
7	(	_	(	_	(	3	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
9	)	_	)	_	)	3	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	3	_	_	_	_	_	_	_	O
11	(	_	(	_	(	3	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	3	_	_	_	_	_	_	_	O
13	)	_	)	_	)	3	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	3	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	3	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	3	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	3	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	3	_	_	_	_	_	_	_	O
27	after	_	after	_	IN	3	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
29	months	_	month	_	NNS	3	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	3	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	3	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	3	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	3	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	3	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	3	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	3	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	3	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	3	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	3	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	3	_	_	_	_	_	treat.v	Medical_intervention	O
45	'	_	'	_	POS	3	_	_	_	_	_	_	_	S-Patient
46	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	4	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	4	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	4	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	4	_	_	_	_	_	_	_	O
6	:	_	:	_	:	4	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	4	_	_	_	_	_	_	_	O
8	(	_	(	_	(	4	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	4	_	_	_	_	_	_	_	O
10	)	_	)	_	)	4	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	4	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	4	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
14	)	_	)	_	)	4	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	4	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	4	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	4	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	4	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	4	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	4	_	_	_	_	_	_	_	O
8	(	_	(	_	(	4	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	4	_	_	_	_	_	_	_	O
10	)	_	)	_	)	4	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	4	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	4	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
14	)	_	)	_	)	4	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	5	_	_	_	_	_	last.a	Relative_time	O
2	updated	_	update	_	VBD	5	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	5	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	5	_	_	_	_	_	_	_	O
5	1	_	1	_	CD	5	_	_	_	_	_	_	_	O
6	recommendations	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	6	_	_	_	_	_	_	_	B-Instrument
2	wording	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Instrument
3	used	_	use	_	VBN	6	_	_	_	_	_	use.v	Using	O
4	in	_	in	_	IN	6	_	_	_	_	_	_	_	B-Purpose
5	the	_	the	_	DT	6	_	_	_	_	_	_	_	I-Purpose
6	recommendations	_	UNK	_	NNS	6	_	_	_	_	_	_	_	I-Purpose
7	in	_	in	_	IN	6	_	_	_	_	_	_	_	I-Purpose
8	this	_	this	_	DT	6	_	_	_	_	_	_	_	I-Purpose
9	guideline	_	guideline	_	NN	6	_	_	_	_	_	_	_	I-Purpose
10	(	_	(	_	(	6	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	6	_	_	_	_	_	_	_	O
12	example	_	example	_	NN	6	_	_	_	_	_	_	_	O
13	,	_	,	_	,	6	_	_	_	_	_	_	_	O
14	words	_	word	_	NNS	6	_	_	_	_	_	_	_	O
15	such	_	such	_	JJ	6	_	_	_	_	_	_	_	O
16	as	_	a	_	IN	6	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
18	'	_	'	_	''	6	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NNP	6	_	_	_	_	_	_	_	O
21	'	_	'	_	POS	6	_	_	_	_	_	_	_	O
22	)	_	)	_	)	6	_	_	_	_	_	_	_	O
23	denotes	_	UNK	_	VBZ	6	_	_	_	_	_	_	_	O
24	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
25	certainty	_	certainty	_	NN	6	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	6	_	_	_	_	_	_	_	O
27	which	_	which	_	WDT	6	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
29	recommendation	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	6	_	_	_	_	_	_	_	O
31	made	_	make	_	VBN	6	_	_	_	_	_	_	_	O
32	(	_	(	_	(	6	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
34	strength	_	strength	_	NN	6	_	_	_	_	_	_	_	O
35	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
37	recommendation	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
38	)	_	)	_	)	6	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	6	_	_	_	_	_	_	_	O
2	wording	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
3	used	_	use	_	VBN	6	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	6	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
6	recommendations	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	6	_	_	_	_	_	_	_	O
8	this	_	this	_	DT	6	_	_	_	_	_	_	_	O
9	guideline	_	guideline	_	NN	6	_	_	_	_	_	_	_	O
10	(	_	(	_	(	6	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	6	_	_	_	_	_	_	_	O
12	example	_	example	_	NN	6	_	_	_	_	_	example.n	Instance	S-Instance
13	,	_	,	_	,	6	_	_	_	_	_	_	_	O
14	words	_	word	_	NNS	6	_	_	_	_	_	_	_	O
15	such	_	such	_	JJ	6	_	_	_	_	_	_	_	O
16	as	_	a	_	IN	6	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
18	'	_	'	_	''	6	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NNP	6	_	_	_	_	_	_	_	O
21	'	_	'	_	POS	6	_	_	_	_	_	_	_	O
22	)	_	)	_	)	6	_	_	_	_	_	_	_	O
23	denotes	_	UNK	_	VBZ	6	_	_	_	_	_	_	_	O
24	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
25	certainty	_	certainty	_	NN	6	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	6	_	_	_	_	_	_	_	O
27	which	_	which	_	WDT	6	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
29	recommendation	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	6	_	_	_	_	_	_	_	O
31	made	_	make	_	VBN	6	_	_	_	_	_	_	_	O
32	(	_	(	_	(	6	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
34	strength	_	strength	_	NN	6	_	_	_	_	_	_	_	O
35	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
37	recommendation	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
38	)	_	)	_	)	6	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	6	_	_	_	_	_	_	_	O
2	wording	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
3	used	_	use	_	VBN	6	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	6	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
6	recommendations	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	6	_	_	_	_	_	_	_	O
8	this	_	this	_	DT	6	_	_	_	_	_	_	_	O
9	guideline	_	guideline	_	NN	6	_	_	_	_	_	_	_	O
10	(	_	(	_	(	6	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	6	_	_	_	_	_	_	_	O
12	example	_	example	_	NN	6	_	_	_	_	_	_	_	O
13	,	_	,	_	,	6	_	_	_	_	_	_	_	O
14	words	_	word	_	NNS	6	_	_	_	_	_	_	_	O
15	such	_	such	_	JJ	6	_	_	_	_	_	_	_	O
16	as	_	a	_	IN	6	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
18	'	_	'	_	''	6	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NNP	6	_	_	_	_	_	_	_	O
21	'	_	'	_	POS	6	_	_	_	_	_	_	_	O
22	)	_	)	_	)	6	_	_	_	_	_	_	_	O
23	denotes	_	UNK	_	VBZ	6	_	_	_	_	_	_	_	O
24	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
25	certainty	_	certainty	_	NN	6	_	_	_	_	_	certainty.n	Certainty	O
26	with	_	with	_	IN	6	_	_	_	_	_	_	_	B-Content
27	which	_	which	_	WDT	6	_	_	_	_	_	_	_	I-Content
28	the	_	the	_	DT	6	_	_	_	_	_	_	_	I-Content
29	recommendation	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Content
30	is	_	be	_	VBZ	6	_	_	_	_	_	_	_	I-Content
31	made	_	make	_	VBN	6	_	_	_	_	_	_	_	I-Content
32	(	_	(	_	(	6	_	_	_	_	_	_	_	I-Content
33	the	_	the	_	DT	6	_	_	_	_	_	_	_	I-Content
34	strength	_	strength	_	NN	6	_	_	_	_	_	_	_	I-Content
35	of	_	of	_	IN	6	_	_	_	_	_	_	_	I-Content
36	the	_	the	_	DT	6	_	_	_	_	_	_	_	I-Content
37	recommendation	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Content
38	)	_	)	_	)	6	_	_	_	_	_	_	_	O

1	initial	_	Initial	_	JJ	7	_	_	_	_	_	initial.a	Version_sequence	O
2	drug	_	drug	_	NN	7	_	_	_	_	_	_	_	B-Item
3	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	I-Item

1	initial	_	Initial	_	JJ	7	_	_	_	_	_	_	_	O
2	drug	_	drug	_	NN	7	_	_	_	_	_	_	_	S-Patient
3	treatment	_	treatment	_	NN	7	_	_	_	_	_	treatment.n	Cure	O

1	treatment	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	8	_	_	_	_	_	_	_	O
3	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
4	single	_	single	_	JJ	8	_	_	_	_	_	single.a	Sole_instance	O
5	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	B-Item
6	blood	_	blood	_	NN	8	_	_	_	_	_	_	_	I-Item
7	glucose	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Item
8	lowering	_	lower	_	VBG	8	_	_	_	_	_	_	_	I-Item
9	therapy	_	therapy	_	NN	8	_	_	_	_	_	_	_	I-Item
10	(	_	(	_	(	8	_	_	_	_	_	_	_	I-Item
11	monotherapy	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Item
12	)	_	)	_	)	8	_	_	_	_	_	_	_	I-Item

1	first	_	First	_	NNP	9	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	9	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	9	_	_	_	_	_	_	_	S-Patient
5	treatment	_	treatment	_	NN	9	_	_	_	_	_	treatment.n	Cure	O

1	treatment	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	10	_	_	_	_	_	_	_	O
3	2	_	2	_	CD	10	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
5	blood	_	blood	_	NN	10	_	_	_	_	_	_	_	O
6	glucose	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
7	lowering	_	lower	_	VBG	10	_	_	_	_	_	_	_	O
8	therapies	_	therapy	_	NNS	10	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	10	_	_	_	_	_	_	_	O
10	combination	_	combination	_	NN	10	_	_	_	_	_	_	_	O
11	(	_	(	_	(	10	_	_	_	_	_	_	_	O
12	dual	_	dual	_	JJ	10	_	_	_	_	_	dual.a	Cardinal_numbers	S-Number
13	therapy	_	therapy	_	NN	10	_	_	_	_	_	_	_	S-Entity
14	)	_	)	_	)	10	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	10	_	_	_	_	_	_	_	O
3	2	_	2	_	CD	10	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
5	blood	_	blood	_	NN	10	_	_	_	_	_	_	_	O
6	glucose	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
7	lowering	_	lower	_	VBG	10	_	_	_	_	_	_	_	O
8	therapies	_	therapy	_	NNS	10	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	10	_	_	_	_	_	_	_	O
10	combination	_	combination	_	NN	10	_	_	_	_	_	_	_	O
11	(	_	(	_	(	10	_	_	_	_	_	_	_	O
12	dual	_	dual	_	JJ	10	_	_	_	_	_	_	_	O
13	therapy	_	therapy	_	NN	10	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
14	)	_	)	_	)	10	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	11	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	11	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	11	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	11	_	_	_	_	_	_	_	S-Patient
5	treatment	_	treatment	_	NN	11	_	_	_	_	_	treatment.n	Cure	O

1	treatment	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	12	_	_	_	_	_	_	_	O
3	either	_	either	_	DT	12	_	_	_	_	_	_	_	O
4	3	_	3	_	CD	12	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
6	blood	_	blood	_	NN	12	_	_	_	_	_	_	_	O
7	glucose	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
8	lowering	_	lower	_	VBG	12	_	_	_	_	_	_	_	O
9	therapies	_	therapy	_	NNS	12	_	_	_	_	_	_	_	O
10	in	_	in	_	IN	12	_	_	_	_	_	_	_	O
11	combination	_	combination	_	NN	12	_	_	_	_	_	_	_	O
12	(	_	(	_	(	12	_	_	_	_	_	_	_	O
13	triple	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
14	therapy	_	therapy	_	NN	12	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
15	)	_	)	_	)	12	_	_	_	_	_	_	_	O
16	or	_	or	_	CC	12	_	_	_	_	_	_	_	O
17	any	_	any	_	DT	12	_	_	_	_	_	_	_	O
18	treatment	_	treatment	_	NN	12	_	_	_	_	_	_	_	O
19	combination	_	combination	_	NN	12	_	_	_	_	_	_	_	O
20	containing	_	contain	_	VBG	12	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	12	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	12	_	_	_	_	_	_	_	O
3	either	_	either	_	DT	12	_	_	_	_	_	_	_	O
4	3	_	3	_	CD	12	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
6	blood	_	blood	_	NN	12	_	_	_	_	_	_	_	O
7	glucose	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
8	lowering	_	lower	_	VBG	12	_	_	_	_	_	_	_	O
9	therapies	_	therapy	_	NNS	12	_	_	_	_	_	_	_	O
10	in	_	in	_	IN	12	_	_	_	_	_	_	_	O
11	combination	_	combination	_	NN	12	_	_	_	_	_	_	_	O
12	(	_	(	_	(	12	_	_	_	_	_	_	_	O
13	triple	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
14	therapy	_	therapy	_	NN	12	_	_	_	_	_	_	_	O
15	)	_	)	_	)	12	_	_	_	_	_	_	_	O
16	or	_	or	_	CC	12	_	_	_	_	_	_	_	O
17	any	_	any	_	DT	12	_	_	_	_	_	_	_	O
18	treatment	_	treatment	_	NN	12	_	_	_	_	_	treatment.n	Cure	O
19	combination	_	combination	_	NN	12	_	_	_	_	_	_	_	O
20	containing	_	contain	_	VBG	12	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	12	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	12	_	_	_	_	_	_	_	O
3	either	_	either	_	DT	12	_	_	_	_	_	_	_	O
4	3	_	3	_	CD	12	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
6	blood	_	blood	_	NN	12	_	_	_	_	_	_	_	O
7	glucose	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
8	lowering	_	lower	_	VBG	12	_	_	_	_	_	_	_	O
9	therapies	_	therapy	_	NNS	12	_	_	_	_	_	_	_	O
10	in	_	in	_	IN	12	_	_	_	_	_	_	_	O
11	combination	_	combination	_	NN	12	_	_	_	_	_	_	_	O
12	(	_	(	_	(	12	_	_	_	_	_	_	_	O
13	triple	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
14	therapy	_	therapy	_	NN	12	_	_	_	_	_	_	_	O
15	)	_	)	_	)	12	_	_	_	_	_	_	_	O
16	or	_	or	_	CC	12	_	_	_	_	_	_	_	O
17	any	_	any	_	DT	12	_	_	_	_	_	_	_	O
18	treatment	_	treatment	_	NN	12	_	_	_	_	_	_	_	S-Individuals
19	combination	_	combination	_	NN	12	_	_	_	_	_	combination.n	Aggregate	S-Aggregate
20	containing	_	contain	_	VBG	12	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	12	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	13	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	13	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	13	_	_	_	_	_	_	_	S-Descriptor
4	approach	_	approach	_	NN	13	_	_	_	_	_	approach.n	Means	O
5	to	_	to	_	TO	13	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	13	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	13	_	_	_	_	_	_	_	O
9	is	_	be	_	VBZ	13	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	13	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	13	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	13	_	_	_	_	_	_	_	O
13	needs	_	need	_	NNS	13	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	13	_	_	_	_	_	_	_	O
15	circumstances	_	circumstance	_	NNS	13	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	13	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	13	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	13	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	13	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	13	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
22	,	_	,	_	,	13	_	_	_	_	_	_	_	O
23	taking	_	take	_	VBG	13	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	13	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	13	_	_	_	_	_	_	_	O
26	their	_	their	_	PRP$	13	_	_	_	_	_	_	_	O
27	personal	_	personal	_	JJ	13	_	_	_	_	_	_	_	O
28	preferences	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
29	,	_	,	_	,	13	_	_	_	_	_	_	_	O
30	comorbidities	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
31	,	_	,	_	,	13	_	_	_	_	_	_	_	O
32	risks	_	risk	_	NNS	13	_	_	_	_	_	_	_	O
33	from	_	from	_	IN	13	_	_	_	_	_	_	_	O
34	polypharmacy	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
35	,	_	,	_	,	13	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	13	_	_	_	_	_	_	_	O
37	their	_	their	_	PRP$	13	_	_	_	_	_	_	_	O
38	ability	_	ability	_	NN	13	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	13	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	VB	13	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	13	_	_	_	_	_	_	_	O
42	long-term	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
43	interventions	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
44	because	_	because	_	IN	13	_	_	_	_	_	_	_	O
45	of	_	of	_	IN	13	_	_	_	_	_	_	_	O
46	reduced	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
47	life	_	life	_	NN	13	_	_	_	_	_	_	_	O
48	expectancy	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
49	.	_	.	_	.	13	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	13	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	13	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
4	approach	_	approach	_	NN	13	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	13	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	13	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	13	_	_	_	_	_	_	_	S-Person
9	is	_	be	_	VBZ	13	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	13	_	_	_	_	_	tailor.n	People_by_vocation	O
11	to	_	to	_	TO	13	_	_	_	_	_	_	_	B-Person
12	the	_	the	_	DT	13	_	_	_	_	_	_	_	I-Person
13	needs	_	need	_	NNS	13	_	_	_	_	_	_	_	I-Person
14	and	_	and	_	CC	13	_	_	_	_	_	_	_	I-Person
15	circumstances	_	circumstance	_	NNS	13	_	_	_	_	_	_	_	I-Person
16	of	_	of	_	IN	13	_	_	_	_	_	_	_	I-Person
17	adults	_	adult	_	NNS	13	_	_	_	_	_	_	_	I-Person
18	with	_	with	_	IN	13	_	_	_	_	_	_	_	I-Person
19	type	_	type	_	JJ	13	_	_	_	_	_	_	_	I-Person
20	2	_	2	_	CD	13	_	_	_	_	_	_	_	I-Person
21	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	I-Person
22	,	_	,	_	,	13	_	_	_	_	_	_	_	I-Person
23	taking	_	take	_	VBG	13	_	_	_	_	_	_	_	I-Person
24	into	_	into	_	IN	13	_	_	_	_	_	_	_	I-Person
25	account	_	account	_	NN	13	_	_	_	_	_	_	_	I-Person
26	their	_	their	_	PRP$	13	_	_	_	_	_	_	_	I-Person
27	personal	_	personal	_	JJ	13	_	_	_	_	_	_	_	I-Person
28	preferences	_	UNK	_	NNS	13	_	_	_	_	_	_	_	I-Person
29	,	_	,	_	,	13	_	_	_	_	_	_	_	I-Person
30	comorbidities	_	UNK	_	NNS	13	_	_	_	_	_	_	_	I-Person
31	,	_	,	_	,	13	_	_	_	_	_	_	_	O
32	risks	_	risk	_	NNS	13	_	_	_	_	_	_	_	O
33	from	_	from	_	IN	13	_	_	_	_	_	_	_	O
34	polypharmacy	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
35	,	_	,	_	,	13	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	13	_	_	_	_	_	_	_	O
37	their	_	their	_	PRP$	13	_	_	_	_	_	_	_	O
38	ability	_	ability	_	NN	13	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	13	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	VB	13	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	13	_	_	_	_	_	_	_	O
42	long-term	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
43	interventions	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
44	because	_	because	_	IN	13	_	_	_	_	_	_	_	O
45	of	_	of	_	IN	13	_	_	_	_	_	_	_	O
46	reduced	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
47	life	_	life	_	NN	13	_	_	_	_	_	_	_	O
48	expectancy	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
49	.	_	.	_	.	13	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	13	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	13	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
4	approach	_	approach	_	NN	13	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	13	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	13	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	13	_	_	_	_	_	_	_	O
9	is	_	be	_	VBZ	13	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	13	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	13	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	13	_	_	_	_	_	_	_	O
13	needs	_	need	_	NNS	13	_	_	_	_	_	need.n	Needing	S-Requirement
14	and	_	and	_	CC	13	_	_	_	_	_	_	_	O
15	circumstances	_	circumstance	_	NNS	13	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	13	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	13	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	13	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	13	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	13	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
22	,	_	,	_	,	13	_	_	_	_	_	_	_	O
23	taking	_	take	_	VBG	13	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	13	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	13	_	_	_	_	_	_	_	O
26	their	_	their	_	PRP$	13	_	_	_	_	_	_	_	O
27	personal	_	personal	_	JJ	13	_	_	_	_	_	_	_	O
28	preferences	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
29	,	_	,	_	,	13	_	_	_	_	_	_	_	O
30	comorbidities	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
31	,	_	,	_	,	13	_	_	_	_	_	_	_	O
32	risks	_	risk	_	NNS	13	_	_	_	_	_	_	_	O
33	from	_	from	_	IN	13	_	_	_	_	_	_	_	O
34	polypharmacy	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
35	,	_	,	_	,	13	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	13	_	_	_	_	_	_	_	O
37	their	_	their	_	PRP$	13	_	_	_	_	_	_	_	O
38	ability	_	ability	_	NN	13	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	13	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	VB	13	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	13	_	_	_	_	_	_	_	O
42	long-term	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
43	interventions	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
44	because	_	because	_	IN	13	_	_	_	_	_	_	_	O
45	of	_	of	_	IN	13	_	_	_	_	_	_	_	O
46	reduced	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
47	life	_	life	_	NN	13	_	_	_	_	_	_	_	O
48	expectancy	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
49	.	_	.	_	.	13	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	13	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	13	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
4	approach	_	approach	_	NN	13	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	13	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	13	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	13	_	_	_	_	_	_	_	O
9	is	_	be	_	VBZ	13	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	13	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	13	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	13	_	_	_	_	_	_	_	O
13	needs	_	need	_	NNS	13	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	13	_	_	_	_	_	_	_	O
15	circumstances	_	circumstance	_	NNS	13	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	13	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	13	_	_	_	_	_	adult.n	People_by_age	S-Person
18	with	_	with	_	IN	13	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	13	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	13	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
22	,	_	,	_	,	13	_	_	_	_	_	_	_	O
23	taking	_	take	_	VBG	13	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	13	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	13	_	_	_	_	_	_	_	O
26	their	_	their	_	PRP$	13	_	_	_	_	_	_	_	O
27	personal	_	personal	_	JJ	13	_	_	_	_	_	_	_	O
28	preferences	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
29	,	_	,	_	,	13	_	_	_	_	_	_	_	O
30	comorbidities	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
31	,	_	,	_	,	13	_	_	_	_	_	_	_	O
32	risks	_	risk	_	NNS	13	_	_	_	_	_	_	_	O
33	from	_	from	_	IN	13	_	_	_	_	_	_	_	O
34	polypharmacy	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
35	,	_	,	_	,	13	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	13	_	_	_	_	_	_	_	O
37	their	_	their	_	PRP$	13	_	_	_	_	_	_	_	O
38	ability	_	ability	_	NN	13	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	13	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	VB	13	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	13	_	_	_	_	_	_	_	O
42	long-term	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
43	interventions	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
44	because	_	because	_	IN	13	_	_	_	_	_	_	_	O
45	of	_	of	_	IN	13	_	_	_	_	_	_	_	O
46	reduced	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
47	life	_	life	_	NN	13	_	_	_	_	_	_	_	O
48	expectancy	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
49	.	_	.	_	.	13	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	13	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	13	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
4	approach	_	approach	_	NN	13	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	13	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	13	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	13	_	_	_	_	_	_	_	O
9	is	_	be	_	VBZ	13	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	13	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	13	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	13	_	_	_	_	_	_	_	O
13	needs	_	need	_	NNS	13	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	13	_	_	_	_	_	_	_	O
15	circumstances	_	circumstance	_	NNS	13	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	13	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	13	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	13	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	13	_	_	_	_	_	type.n	Type	S-Subtype
20	2	_	2	_	CD	13	_	_	_	_	_	_	_	B-Category
21	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	I-Category
22	,	_	,	_	,	13	_	_	_	_	_	_	_	O
23	taking	_	take	_	VBG	13	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	13	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	13	_	_	_	_	_	_	_	O
26	their	_	their	_	PRP$	13	_	_	_	_	_	_	_	O
27	personal	_	personal	_	JJ	13	_	_	_	_	_	_	_	O
28	preferences	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
29	,	_	,	_	,	13	_	_	_	_	_	_	_	O
30	comorbidities	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
31	,	_	,	_	,	13	_	_	_	_	_	_	_	O
32	risks	_	risk	_	NNS	13	_	_	_	_	_	_	_	O
33	from	_	from	_	IN	13	_	_	_	_	_	_	_	O
34	polypharmacy	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
35	,	_	,	_	,	13	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	13	_	_	_	_	_	_	_	O
37	their	_	their	_	PRP$	13	_	_	_	_	_	_	_	O
38	ability	_	ability	_	NN	13	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	13	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	VB	13	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	13	_	_	_	_	_	_	_	O
42	long-term	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
43	interventions	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
44	because	_	because	_	IN	13	_	_	_	_	_	_	_	O
45	of	_	of	_	IN	13	_	_	_	_	_	_	_	O
46	reduced	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
47	life	_	life	_	NN	13	_	_	_	_	_	_	_	O
48	expectancy	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
49	.	_	.	_	.	13	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	13	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	13	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
4	approach	_	approach	_	NN	13	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	13	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	13	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	13	_	_	_	_	_	_	_	O
9	is	_	be	_	VBZ	13	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	13	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	13	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	13	_	_	_	_	_	_	_	O
13	needs	_	need	_	NNS	13	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	13	_	_	_	_	_	_	_	O
15	circumstances	_	circumstance	_	NNS	13	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	13	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	13	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	13	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	13	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	13	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
22	,	_	,	_	,	13	_	_	_	_	_	_	_	O
23	taking	_	take	_	VBG	13	_	_	_	_	_	take.v	Taking	O
24	into	_	into	_	IN	13	_	_	_	_	_	_	_	B-Theme
25	account	_	account	_	NN	13	_	_	_	_	_	_	_	I-Theme
26	their	_	their	_	PRP$	13	_	_	_	_	_	_	_	I-Theme
27	personal	_	personal	_	JJ	13	_	_	_	_	_	_	_	I-Theme
28	preferences	_	UNK	_	NNS	13	_	_	_	_	_	_	_	I-Theme
29	,	_	,	_	,	13	_	_	_	_	_	_	_	I-Theme
30	comorbidities	_	UNK	_	NNS	13	_	_	_	_	_	_	_	I-Theme
31	,	_	,	_	,	13	_	_	_	_	_	_	_	I-Theme
32	risks	_	risk	_	NNS	13	_	_	_	_	_	_	_	I-Theme
33	from	_	from	_	IN	13	_	_	_	_	_	_	_	I-Theme
34	polypharmacy	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Theme
35	,	_	,	_	,	13	_	_	_	_	_	_	_	I-Theme
36	and	_	and	_	CC	13	_	_	_	_	_	_	_	I-Theme
37	their	_	their	_	PRP$	13	_	_	_	_	_	_	_	I-Theme
38	ability	_	ability	_	NN	13	_	_	_	_	_	_	_	I-Theme
39	to	_	to	_	TO	13	_	_	_	_	_	_	_	I-Theme
40	benefit	_	benefit	_	VB	13	_	_	_	_	_	_	_	I-Theme
41	from	_	from	_	IN	13	_	_	_	_	_	_	_	I-Theme
42	long-term	_	UNK	_	JJ	13	_	_	_	_	_	_	_	I-Theme
43	interventions	_	UNK	_	NNS	13	_	_	_	_	_	_	_	I-Theme
44	because	_	because	_	IN	13	_	_	_	_	_	_	_	O
45	of	_	of	_	IN	13	_	_	_	_	_	_	_	O
46	reduced	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
47	life	_	life	_	NN	13	_	_	_	_	_	_	_	O
48	expectancy	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
49	.	_	.	_	.	13	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	13	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	13	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
4	approach	_	approach	_	NN	13	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	13	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	13	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	13	_	_	_	_	_	_	_	O
9	is	_	be	_	VBZ	13	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	13	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	13	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	13	_	_	_	_	_	_	_	O
13	needs	_	need	_	NNS	13	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	13	_	_	_	_	_	_	_	O
15	circumstances	_	circumstance	_	NNS	13	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	13	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	13	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	13	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	13	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	13	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
22	,	_	,	_	,	13	_	_	_	_	_	_	_	O
23	taking	_	take	_	VBG	13	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	13	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	13	_	_	_	_	_	account.n	Text	O
26	their	_	their	_	PRP$	13	_	_	_	_	_	_	_	O
27	personal	_	personal	_	JJ	13	_	_	_	_	_	_	_	O
28	preferences	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
29	,	_	,	_	,	13	_	_	_	_	_	_	_	O
30	comorbidities	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
31	,	_	,	_	,	13	_	_	_	_	_	_	_	O
32	risks	_	risk	_	NNS	13	_	_	_	_	_	_	_	O
33	from	_	from	_	IN	13	_	_	_	_	_	_	_	O
34	polypharmacy	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
35	,	_	,	_	,	13	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	13	_	_	_	_	_	_	_	O
37	their	_	their	_	PRP$	13	_	_	_	_	_	_	_	O
38	ability	_	ability	_	NN	13	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	13	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	VB	13	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	13	_	_	_	_	_	_	_	O
42	long-term	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
43	interventions	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
44	because	_	because	_	IN	13	_	_	_	_	_	_	_	O
45	of	_	of	_	IN	13	_	_	_	_	_	_	_	O
46	reduced	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
47	life	_	life	_	NN	13	_	_	_	_	_	_	_	O
48	expectancy	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
49	.	_	.	_	.	13	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	13	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	13	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
4	approach	_	approach	_	NN	13	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	13	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	13	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	13	_	_	_	_	_	_	_	O
9	is	_	be	_	VBZ	13	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	13	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	13	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	13	_	_	_	_	_	_	_	O
13	needs	_	need	_	NNS	13	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	13	_	_	_	_	_	_	_	O
15	circumstances	_	circumstance	_	NNS	13	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	13	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	13	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	13	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	13	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	13	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
22	,	_	,	_	,	13	_	_	_	_	_	_	_	O
23	taking	_	take	_	VBG	13	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	13	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	13	_	_	_	_	_	_	_	O
26	their	_	their	_	PRP$	13	_	_	_	_	_	_	_	O
27	personal	_	personal	_	JJ	13	_	_	_	_	_	_	_	O
28	preferences	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
29	,	_	,	_	,	13	_	_	_	_	_	_	_	O
30	comorbidities	_	UNK	_	NNS	13	_	_	_	_	_	_	_	S-Protagonist
31	,	_	,	_	,	13	_	_	_	_	_	_	_	O
32	risks	_	risk	_	NNS	13	_	_	_	_	_	risk.n	Run_risk	O
33	from	_	from	_	IN	13	_	_	_	_	_	_	_	B-Action
34	polypharmacy	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Action
35	,	_	,	_	,	13	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	13	_	_	_	_	_	_	_	O
37	their	_	their	_	PRP$	13	_	_	_	_	_	_	_	O
38	ability	_	ability	_	NN	13	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	13	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	VB	13	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	13	_	_	_	_	_	_	_	O
42	long-term	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
43	interventions	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
44	because	_	because	_	IN	13	_	_	_	_	_	_	_	O
45	of	_	of	_	IN	13	_	_	_	_	_	_	_	O
46	reduced	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
47	life	_	life	_	NN	13	_	_	_	_	_	_	_	O
48	expectancy	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
49	.	_	.	_	.	13	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	13	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	13	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
4	approach	_	approach	_	NN	13	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	13	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	13	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	13	_	_	_	_	_	_	_	O
9	is	_	be	_	VBZ	13	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	13	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	13	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	13	_	_	_	_	_	_	_	O
13	needs	_	need	_	NNS	13	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	13	_	_	_	_	_	_	_	O
15	circumstances	_	circumstance	_	NNS	13	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	13	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	13	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	13	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	13	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	13	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
22	,	_	,	_	,	13	_	_	_	_	_	_	_	O
23	taking	_	take	_	VBG	13	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	13	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	13	_	_	_	_	_	_	_	O
26	their	_	their	_	PRP$	13	_	_	_	_	_	_	_	O
27	personal	_	personal	_	JJ	13	_	_	_	_	_	_	_	O
28	preferences	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
29	,	_	,	_	,	13	_	_	_	_	_	_	_	O
30	comorbidities	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
31	,	_	,	_	,	13	_	_	_	_	_	_	_	O
32	risks	_	risk	_	NNS	13	_	_	_	_	_	_	_	O
33	from	_	from	_	IN	13	_	_	_	_	_	_	_	O
34	polypharmacy	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
35	,	_	,	_	,	13	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	13	_	_	_	_	_	_	_	O
37	their	_	their	_	PRP$	13	_	_	_	_	_	_	_	S-Entity
38	ability	_	ability	_	NN	13	_	_	_	_	_	ability.n	Capability	O
39	to	_	to	_	TO	13	_	_	_	_	_	_	_	B-Event
40	benefit	_	benefit	_	VB	13	_	_	_	_	_	_	_	I-Event
41	from	_	from	_	IN	13	_	_	_	_	_	_	_	I-Event
42	long-term	_	UNK	_	JJ	13	_	_	_	_	_	_	_	I-Event
43	interventions	_	UNK	_	NNS	13	_	_	_	_	_	_	_	I-Event
44	because	_	because	_	IN	13	_	_	_	_	_	_	_	O
45	of	_	of	_	IN	13	_	_	_	_	_	_	_	O
46	reduced	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
47	life	_	life	_	NN	13	_	_	_	_	_	_	_	O
48	expectancy	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
49	.	_	.	_	.	13	_	_	_	_	_	_	_	O

1	adopt	_	UNK	_	NNP	13	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	13	_	_	_	_	_	_	_	O
3	individualised	_	UNK	_	JJ	13	_	_	_	_	_	_	_	O
4	approach	_	approach	_	NN	13	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	13	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
7	care	_	care	_	NN	13	_	_	_	_	_	_	_	O
8	that	_	that	_	WDT	13	_	_	_	_	_	_	_	O
9	is	_	be	_	VBZ	13	_	_	_	_	_	_	_	O
10	tailored	_	tailor	_	VBN	13	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	13	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	13	_	_	_	_	_	_	_	O
13	needs	_	need	_	NNS	13	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	13	_	_	_	_	_	_	_	O
15	circumstances	_	circumstance	_	NNS	13	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	13	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	13	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	13	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	13	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	13	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
22	,	_	,	_	,	13	_	_	_	_	_	_	_	O
23	taking	_	take	_	VBG	13	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	13	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	13	_	_	_	_	_	_	_	O
26	their	_	their	_	PRP$	13	_	_	_	_	_	_	_	O
27	personal	_	personal	_	JJ	13	_	_	_	_	_	_	_	O
28	preferences	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
29	,	_	,	_	,	13	_	_	_	_	_	_	_	O
30	comorbidities	_	UNK	_	NNS	13	_	_	_	_	_	_	_	O
31	,	_	,	_	,	13	_	_	_	_	_	_	_	O
32	risks	_	risk	_	NNS	13	_	_	_	_	_	_	_	O
33	from	_	from	_	IN	13	_	_	_	_	_	_	_	O
34	polypharmacy	_	UNK	_	NN	13	_	_	_	_	_	_	_	O
35	,	_	,	_	,	13	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	13	_	_	_	_	_	_	_	O
37	their	_	their	_	PRP$	13	_	_	_	_	_	_	_	O
38	ability	_	ability	_	NN	13	_	_	_	_	_	_	_	O
39	to	_	to	_	TO	13	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	VB	13	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	13	_	_	_	_	_	_	_	B-Cause
42	long-term	_	UNK	_	JJ	13	_	_	_	_	_	_	_	I-Cause
43	interventions	_	UNK	_	NNS	13	_	_	_	_	_	_	_	I-Cause
44	because	_	because	_	IN	13	_	_	_	_	_	because.c	Causation	O
45	of	_	of	_	IN	13	_	_	_	_	_	_	_	B-Cause
46	reduced	_	UNK	_	JJ	13	_	_	_	_	_	_	_	I-Cause
47	life	_	life	_	NN	13	_	_	_	_	_	_	_	I-Cause
48	expectancy	_	UNK	_	NN	13	_	_	_	_	_	_	_	I-Cause
49	.	_	.	_	.	13	_	_	_	_	_	_	_	O

1	reassess	_	UNK	_	VB	14	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	14	_	_	_	_	_	_	_	O
3	person	_	person	_	NN	14	_	_	_	_	_	person.n	People	S-Person
4	's	_	's	_	POS	14	_	_	_	_	_	_	_	O
5	needs	_	need	_	NNS	14	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
7	circumstances	_	circumstance	_	NNS	14	_	_	_	_	_	_	_	O
8	at	_	at	_	IN	14	_	_	_	_	_	_	_	O
9	each	_	each	_	DT	14	_	_	_	_	_	_	_	O
10	review	_	review	_	NN	14	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
12	think	_	think	_	VB	14	_	_	_	_	_	_	_	O
13	about	_	about	_	IN	14	_	_	_	_	_	_	_	O
14	whether	_	whether	_	IN	14	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	14	_	_	_	_	_	_	_	O
16	stop	_	stop	_	VB	14	_	_	_	_	_	_	_	O
17	any	_	any	_	DT	14	_	_	_	_	_	_	_	O
18	medicines	_	medicine	_	NNS	14	_	_	_	_	_	_	_	O
19	that	_	that	_	WDT	14	_	_	_	_	_	_	_	O
20	are	_	be	_	VBP	14	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	14	_	_	_	_	_	_	_	O
22	effective	_	effective	_	JJ	14	_	_	_	_	_	_	_	O
23	.	_	.	_	.	14	_	_	_	_	_	_	_	O

1	reassess	_	UNK	_	VB	14	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	14	_	_	_	_	_	_	_	O
3	person	_	person	_	NN	14	_	_	_	_	_	_	_	B-Cognizer
4	's	_	's	_	POS	14	_	_	_	_	_	_	_	I-Cognizer
5	needs	_	need	_	NNS	14	_	_	_	_	_	need.n	Needing	S-Requirement
6	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
7	circumstances	_	circumstance	_	NNS	14	_	_	_	_	_	_	_	O
8	at	_	at	_	IN	14	_	_	_	_	_	_	_	O
9	each	_	each	_	DT	14	_	_	_	_	_	_	_	O
10	review	_	review	_	NN	14	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
12	think	_	think	_	VB	14	_	_	_	_	_	_	_	O
13	about	_	about	_	IN	14	_	_	_	_	_	_	_	O
14	whether	_	whether	_	IN	14	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	14	_	_	_	_	_	_	_	O
16	stop	_	stop	_	VB	14	_	_	_	_	_	_	_	O
17	any	_	any	_	DT	14	_	_	_	_	_	_	_	O
18	medicines	_	medicine	_	NNS	14	_	_	_	_	_	_	_	O
19	that	_	that	_	WDT	14	_	_	_	_	_	_	_	O
20	are	_	be	_	VBP	14	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	14	_	_	_	_	_	_	_	O
22	effective	_	effective	_	JJ	14	_	_	_	_	_	_	_	O
23	.	_	.	_	.	14	_	_	_	_	_	_	_	O

1	reassess	_	UNK	_	VB	14	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	14	_	_	_	_	_	_	_	O
3	person	_	person	_	NN	14	_	_	_	_	_	_	_	O
4	's	_	's	_	POS	14	_	_	_	_	_	_	_	O
5	needs	_	need	_	NNS	14	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
7	circumstances	_	circumstance	_	NNS	14	_	_	_	_	_	_	_	O
8	at	_	at	_	IN	14	_	_	_	_	_	_	_	O
9	each	_	each	_	DT	14	_	_	_	_	_	_	_	O
10	review	_	review	_	NN	14	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
12	think	_	think	_	VB	14	_	_	_	_	_	think.v	Opinion	O
13	about	_	about	_	IN	14	_	_	_	_	_	_	_	B-Opinion
14	whether	_	whether	_	IN	14	_	_	_	_	_	_	_	I-Opinion
15	to	_	to	_	TO	14	_	_	_	_	_	_	_	I-Opinion
16	stop	_	stop	_	VB	14	_	_	_	_	_	_	_	I-Opinion
17	any	_	any	_	DT	14	_	_	_	_	_	_	_	I-Opinion
18	medicines	_	medicine	_	NNS	14	_	_	_	_	_	_	_	I-Opinion
19	that	_	that	_	WDT	14	_	_	_	_	_	_	_	I-Opinion
20	are	_	be	_	VBP	14	_	_	_	_	_	_	_	I-Opinion
21	not	_	not	_	RB	14	_	_	_	_	_	_	_	I-Opinion
22	effective	_	effective	_	JJ	14	_	_	_	_	_	_	_	I-Opinion
23	.	_	.	_	.	14	_	_	_	_	_	_	_	O

1	reassess	_	UNK	_	VB	14	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	14	_	_	_	_	_	_	_	O
3	person	_	person	_	NN	14	_	_	_	_	_	_	_	O
4	's	_	's	_	POS	14	_	_	_	_	_	_	_	O
5	needs	_	need	_	NNS	14	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
7	circumstances	_	circumstance	_	NNS	14	_	_	_	_	_	_	_	O
8	at	_	at	_	IN	14	_	_	_	_	_	_	_	O
9	each	_	each	_	DT	14	_	_	_	_	_	_	_	O
10	review	_	review	_	NN	14	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
12	think	_	think	_	VB	14	_	_	_	_	_	_	_	O
13	about	_	about	_	IN	14	_	_	_	_	_	_	_	O
14	whether	_	whether	_	IN	14	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	14	_	_	_	_	_	_	_	O
16	stop	_	stop	_	VB	14	_	_	_	_	_	stop.v	Preventing_or_letting	O
17	any	_	any	_	DT	14	_	_	_	_	_	_	_	B-Event
18	medicines	_	medicine	_	NNS	14	_	_	_	_	_	_	_	I-Event
19	that	_	that	_	WDT	14	_	_	_	_	_	_	_	I-Event
20	are	_	be	_	VBP	14	_	_	_	_	_	_	_	I-Event
21	not	_	not	_	RB	14	_	_	_	_	_	_	_	I-Event
22	effective	_	effective	_	JJ	14	_	_	_	_	_	_	_	I-Event
23	.	_	.	_	.	14	_	_	_	_	_	_	_	O

1	reassess	_	UNK	_	VB	14	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	14	_	_	_	_	_	_	_	O
3	person	_	person	_	NN	14	_	_	_	_	_	_	_	O
4	's	_	's	_	POS	14	_	_	_	_	_	_	_	O
5	needs	_	need	_	NNS	14	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
7	circumstances	_	circumstance	_	NNS	14	_	_	_	_	_	_	_	O
8	at	_	at	_	IN	14	_	_	_	_	_	_	_	O
9	each	_	each	_	DT	14	_	_	_	_	_	_	_	O
10	review	_	review	_	NN	14	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	14	_	_	_	_	_	_	_	O
12	think	_	think	_	VB	14	_	_	_	_	_	_	_	O
13	about	_	about	_	IN	14	_	_	_	_	_	_	_	O
14	whether	_	whether	_	IN	14	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	14	_	_	_	_	_	_	_	O
16	stop	_	stop	_	VB	14	_	_	_	_	_	_	_	O
17	any	_	any	_	DT	14	_	_	_	_	_	_	_	B-Entity
18	medicines	_	medicine	_	NNS	14	_	_	_	_	_	_	_	I-Entity
19	that	_	that	_	WDT	14	_	_	_	_	_	_	_	I-Entity
20	are	_	be	_	VBP	14	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	14	_	_	_	_	_	_	_	O
22	effective	_	effective	_	JJ	14	_	_	_	_	_	effective.a	Usefulness	O
23	.	_	.	_	.	14	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	15	_	_	_	_	_	_	_	O
2	into	_	into	_	IN	15	_	_	_	_	_	_	_	O
3	account	_	account	_	NN	15	_	_	_	_	_	account.n	Text	O
4	any	_	any	_	DT	15	_	_	_	_	_	_	_	B-Text
5	disabilities	_	disability	_	NNS	15	_	_	_	_	_	_	_	I-Text
6	,	_	,	_	,	15	_	_	_	_	_	_	_	O
7	including	_	include	_	VBG	15	_	_	_	_	_	_	_	O
8	visual	_	visual	_	JJ	15	_	_	_	_	_	_	_	O
9	impairment	_	UNK	_	NN	15	_	_	_	_	_	_	_	O
10	,	_	,	_	,	15	_	_	_	_	_	_	_	O
11	when	_	when	_	WRB	15	_	_	_	_	_	_	_	O
12	planning	_	planning	_	NN	15	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	15	_	_	_	_	_	_	_	O
14	delivering	_	deliver	_	VBG	15	_	_	_	_	_	_	_	O
15	care	_	care	_	NN	15	_	_	_	_	_	_	_	O
16	for	_	for	_	IN	15	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	15	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	15	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	15	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	15	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	15	_	_	_	_	_	_	_	O
22	.	_	.	_	.	15	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	15	_	_	_	_	_	_	_	O
2	into	_	into	_	IN	15	_	_	_	_	_	_	_	O
3	account	_	account	_	NN	15	_	_	_	_	_	_	_	O
4	any	_	any	_	DT	15	_	_	_	_	_	_	_	B-Total
5	disabilities	_	disability	_	NNS	15	_	_	_	_	_	_	_	I-Total
6	,	_	,	_	,	15	_	_	_	_	_	_	_	O
7	including	_	include	_	VBG	15	_	_	_	_	_	include.v	Inclusion	O
8	visual	_	visual	_	JJ	15	_	_	_	_	_	_	_	B-Part
9	impairment	_	UNK	_	NN	15	_	_	_	_	_	_	_	I-Part
10	,	_	,	_	,	15	_	_	_	_	_	_	_	O
11	when	_	when	_	WRB	15	_	_	_	_	_	_	_	O
12	planning	_	planning	_	NN	15	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	15	_	_	_	_	_	_	_	O
14	delivering	_	deliver	_	VBG	15	_	_	_	_	_	_	_	O
15	care	_	care	_	NN	15	_	_	_	_	_	_	_	O
16	for	_	for	_	IN	15	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	15	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	15	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	15	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	15	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	15	_	_	_	_	_	_	_	O
22	.	_	.	_	.	15	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	15	_	_	_	_	_	_	_	O
2	into	_	into	_	IN	15	_	_	_	_	_	_	_	O
3	account	_	account	_	NN	15	_	_	_	_	_	_	_	O
4	any	_	any	_	DT	15	_	_	_	_	_	_	_	O
5	disabilities	_	disability	_	NNS	15	_	_	_	_	_	_	_	O
6	,	_	,	_	,	15	_	_	_	_	_	_	_	O
7	including	_	include	_	VBG	15	_	_	_	_	_	_	_	O
8	visual	_	visual	_	JJ	15	_	_	_	_	_	_	_	O
9	impairment	_	UNK	_	NN	15	_	_	_	_	_	_	_	O
10	,	_	,	_	,	15	_	_	_	_	_	_	_	O
11	when	_	when	_	WRB	15	_	_	_	_	_	_	_	O
12	planning	_	planning	_	NN	15	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	15	_	_	_	_	_	_	_	O
14	delivering	_	deliver	_	VBG	15	_	_	_	_	_	deliver.v	Delivery	O
15	care	_	care	_	NN	15	_	_	_	_	_	_	_	S-Theme
16	for	_	for	_	IN	15	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	15	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	15	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	15	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	15	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	15	_	_	_	_	_	_	_	O
22	.	_	.	_	.	15	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	15	_	_	_	_	_	_	_	O
2	into	_	into	_	IN	15	_	_	_	_	_	_	_	O
3	account	_	account	_	NN	15	_	_	_	_	_	_	_	O
4	any	_	any	_	DT	15	_	_	_	_	_	_	_	O
5	disabilities	_	disability	_	NNS	15	_	_	_	_	_	_	_	O
6	,	_	,	_	,	15	_	_	_	_	_	_	_	O
7	including	_	include	_	VBG	15	_	_	_	_	_	_	_	O
8	visual	_	visual	_	JJ	15	_	_	_	_	_	_	_	O
9	impairment	_	UNK	_	NN	15	_	_	_	_	_	_	_	O
10	,	_	,	_	,	15	_	_	_	_	_	_	_	O
11	when	_	when	_	WRB	15	_	_	_	_	_	_	_	O
12	planning	_	planning	_	NN	15	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	15	_	_	_	_	_	_	_	O
14	delivering	_	deliver	_	VBG	15	_	_	_	_	_	_	_	O
15	care	_	care	_	NN	15	_	_	_	_	_	_	_	O
16	for	_	for	_	IN	15	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	15	_	_	_	_	_	adult.n	People_by_age	S-Person
18	with	_	with	_	IN	15	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	15	_	_	_	_	_	_	_	O
20	2	_	2	_	CD	15	_	_	_	_	_	_	_	O
21	diabetes	_	UNK	_	NNS	15	_	_	_	_	_	_	_	O
22	.	_	.	_	.	15	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	15	_	_	_	_	_	_	_	O
2	into	_	into	_	IN	15	_	_	_	_	_	_	_	O
3	account	_	account	_	NN	15	_	_	_	_	_	_	_	O
4	any	_	any	_	DT	15	_	_	_	_	_	_	_	O
5	disabilities	_	disability	_	NNS	15	_	_	_	_	_	_	_	O
6	,	_	,	_	,	15	_	_	_	_	_	_	_	O
7	including	_	include	_	VBG	15	_	_	_	_	_	_	_	O
8	visual	_	visual	_	JJ	15	_	_	_	_	_	_	_	O
9	impairment	_	UNK	_	NN	15	_	_	_	_	_	_	_	O
10	,	_	,	_	,	15	_	_	_	_	_	_	_	O
11	when	_	when	_	WRB	15	_	_	_	_	_	_	_	O
12	planning	_	planning	_	NN	15	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	15	_	_	_	_	_	_	_	O
14	delivering	_	deliver	_	VBG	15	_	_	_	_	_	_	_	O
15	care	_	care	_	NN	15	_	_	_	_	_	_	_	O
16	for	_	for	_	IN	15	_	_	_	_	_	_	_	O
17	adults	_	adult	_	NNS	15	_	_	_	_	_	_	_	O
18	with	_	with	_	IN	15	_	_	_	_	_	_	_	O
19	type	_	type	_	JJ	15	_	_	_	_	_	type.n	Type	S-Subtype
20	2	_	2	_	CD	15	_	_	_	_	_	_	_	B-Category
21	diabetes	_	UNK	_	NNS	15	_	_	_	_	_	_	_	I-Category
22	.	_	.	_	.	15	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
2	structured	_	UNK	_	JJ	16	_	_	_	_	_	_	_	O
3	education	_	education	_	NN	16	_	_	_	_	_	education.n	Education_teaching	O
4	to	_	to	_	TO	16	_	_	_	_	_	_	_	O
5	adults	_	UNK	_	VB	16	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	16	_	_	_	_	_	_	_	O
7	type	_	type	_	JJ	16	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	16	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	16	_	_	_	_	_	_	_	O
10	and/or	_	and/or	_	VBP	16	_	_	_	_	_	_	_	O
11	their	_	their	_	PRP$	16	_	_	_	_	_	_	_	O
12	family	_	family	_	NN	16	_	_	_	_	_	_	_	O
13	members	_	member	_	NNS	16	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	16	_	_	_	_	_	_	_	O
15	carers	_	UNK	_	NNS	16	_	_	_	_	_	_	_	O
16	(	_	(	_	(	16	_	_	_	_	_	_	_	O
17	as	_	a	_	IN	16	_	_	_	_	_	_	_	O
18	appropriate	_	appropriate	_	NN	16	_	_	_	_	_	_	_	O
19	)	_	)	_	)	16	_	_	_	_	_	_	_	O
20	at	_	at	_	IN	16	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
22	around	_	around	_	IN	16	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
24	time	_	time	_	NN	16	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	16	_	_	_	_	_	_	_	O
26	diagnosis	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
27	,	_	,	_	,	16	_	_	_	_	_	_	_	O
28	with	_	with	_	IN	16	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
2	structured	_	UNK	_	JJ	16	_	_	_	_	_	_	_	O
3	education	_	education	_	NN	16	_	_	_	_	_	_	_	O
4	to	_	to	_	TO	16	_	_	_	_	_	_	_	O
5	adults	_	UNK	_	VB	16	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	16	_	_	_	_	_	_	_	O
7	type	_	type	_	JJ	16	_	_	_	_	_	type.n	Type	S-Subtype
8	2	_	2	_	CD	16	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	16	_	_	_	_	_	_	_	O
10	and/or	_	and/or	_	VBP	16	_	_	_	_	_	_	_	O
11	their	_	their	_	PRP$	16	_	_	_	_	_	_	_	O
12	family	_	family	_	NN	16	_	_	_	_	_	_	_	O
13	members	_	member	_	NNS	16	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	16	_	_	_	_	_	_	_	O
15	carers	_	UNK	_	NNS	16	_	_	_	_	_	_	_	O
16	(	_	(	_	(	16	_	_	_	_	_	_	_	O
17	as	_	a	_	IN	16	_	_	_	_	_	_	_	O
18	appropriate	_	appropriate	_	NN	16	_	_	_	_	_	_	_	O
19	)	_	)	_	)	16	_	_	_	_	_	_	_	O
20	at	_	at	_	IN	16	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
22	around	_	around	_	IN	16	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
24	time	_	time	_	NN	16	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	16	_	_	_	_	_	_	_	O
26	diagnosis	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
27	,	_	,	_	,	16	_	_	_	_	_	_	_	O
28	with	_	with	_	IN	16	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
2	structured	_	UNK	_	JJ	16	_	_	_	_	_	_	_	O
3	education	_	education	_	NN	16	_	_	_	_	_	_	_	O
4	to	_	to	_	TO	16	_	_	_	_	_	_	_	O
5	adults	_	UNK	_	VB	16	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	16	_	_	_	_	_	_	_	O
7	type	_	type	_	JJ	16	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	16	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	16	_	_	_	_	_	_	_	O
10	and/or	_	and/or	_	VBP	16	_	_	_	_	_	_	_	O
11	their	_	their	_	PRP$	16	_	_	_	_	_	_	_	O
12	family	_	family	_	NN	16	_	_	_	_	_	family.n	Kinship	S-Relatives
13	members	_	member	_	NNS	16	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	16	_	_	_	_	_	_	_	O
15	carers	_	UNK	_	NNS	16	_	_	_	_	_	_	_	O
16	(	_	(	_	(	16	_	_	_	_	_	_	_	O
17	as	_	a	_	IN	16	_	_	_	_	_	_	_	O
18	appropriate	_	appropriate	_	NN	16	_	_	_	_	_	_	_	O
19	)	_	)	_	)	16	_	_	_	_	_	_	_	O
20	at	_	at	_	IN	16	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
22	around	_	around	_	IN	16	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
24	time	_	time	_	NN	16	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	16	_	_	_	_	_	_	_	O
26	diagnosis	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
27	,	_	,	_	,	16	_	_	_	_	_	_	_	O
28	with	_	with	_	IN	16	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
2	structured	_	UNK	_	JJ	16	_	_	_	_	_	_	_	O
3	education	_	education	_	NN	16	_	_	_	_	_	_	_	O
4	to	_	to	_	TO	16	_	_	_	_	_	_	_	O
5	adults	_	UNK	_	VB	16	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	16	_	_	_	_	_	_	_	O
7	type	_	type	_	JJ	16	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	16	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	16	_	_	_	_	_	_	_	O
10	and/or	_	and/or	_	VBP	16	_	_	_	_	_	_	_	O
11	their	_	their	_	PRP$	16	_	_	_	_	_	_	_	S-Member
12	family	_	family	_	NN	16	_	_	_	_	_	_	_	S-Group
13	members	_	member	_	NNS	16	_	_	_	_	_	member.n	Membership	S-Member
14	or	_	or	_	CC	16	_	_	_	_	_	_	_	O
15	carers	_	UNK	_	NNS	16	_	_	_	_	_	_	_	O
16	(	_	(	_	(	16	_	_	_	_	_	_	_	O
17	as	_	a	_	IN	16	_	_	_	_	_	_	_	O
18	appropriate	_	appropriate	_	NN	16	_	_	_	_	_	_	_	O
19	)	_	)	_	)	16	_	_	_	_	_	_	_	O
20	at	_	at	_	IN	16	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
22	around	_	around	_	IN	16	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
24	time	_	time	_	NN	16	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	16	_	_	_	_	_	_	_	O
26	diagnosis	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
27	,	_	,	_	,	16	_	_	_	_	_	_	_	O
28	with	_	with	_	IN	16	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
2	structured	_	UNK	_	JJ	16	_	_	_	_	_	_	_	O
3	education	_	education	_	NN	16	_	_	_	_	_	_	_	O
4	to	_	to	_	TO	16	_	_	_	_	_	_	_	O
5	adults	_	UNK	_	VB	16	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	16	_	_	_	_	_	_	_	O
7	type	_	type	_	JJ	16	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	16	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	16	_	_	_	_	_	_	_	O
10	and/or	_	and/or	_	VBP	16	_	_	_	_	_	_	_	O
11	their	_	their	_	PRP$	16	_	_	_	_	_	_	_	O
12	family	_	family	_	NN	16	_	_	_	_	_	_	_	O
13	members	_	member	_	NNS	16	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	16	_	_	_	_	_	_	_	O
15	carers	_	UNK	_	NNS	16	_	_	_	_	_	_	_	O
16	(	_	(	_	(	16	_	_	_	_	_	_	_	O
17	as	_	a	_	IN	16	_	_	_	_	_	_	_	O
18	appropriate	_	appropriate	_	NN	16	_	_	_	_	_	appropriate.a	Suitability	O
19	)	_	)	_	)	16	_	_	_	_	_	_	_	O
20	at	_	at	_	IN	16	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	16	_	_	_	_	_	_	_	O
22	around	_	around	_	IN	16	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	16	_	_	_	_	_	_	_	O
24	time	_	time	_	NN	16	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	16	_	_	_	_	_	_	_	O
26	diagnosis	_	UNK	_	NN	16	_	_	_	_	_	_	_	O
27	,	_	,	_	,	16	_	_	_	_	_	_	_	O
28	with	_	with	_	IN	16	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	17	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	17	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	17	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	17	_	_	_	_	_	_	_	O
6	:	_	:	_	:	17	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	17	_	_	_	_	_	_	_	O
8	(	_	(	_	(	17	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	17	_	_	_	_	_	_	_	O
10	)	_	)	_	)	17	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	17	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	17	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
14	)	_	)	_	)	17	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	17	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	17	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	17	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	17	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	17	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	17	_	_	_	_	_	_	_	O
8	(	_	(	_	(	17	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	17	_	_	_	_	_	_	_	O
10	)	_	)	_	)	17	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	17	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	17	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	17	_	_	_	_	_	_	_	O
14	)	_	)	_	)	17	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	18	_	_	_	_	_	last.a	Relative_time	O
2	updated	_	update	_	VBD	18	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	18	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	18	_	_	_	_	_	_	_	O
5	annual	_	annual	_	JJ	18	_	_	_	_	_	_	_	O
6	reinforcement	_	UNK	_	NN	18	_	_	_	_	_	_	_	O
7	and	_	and	_	CC	18	_	_	_	_	_	_	_	O
8	review	_	review	_	NN	18	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	18	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	18	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	18	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	18	_	_	_	_	_	_	_	O
5	annual	_	annual	_	JJ	18	_	_	_	_	_	annual.a	Frequency	S-Interval
6	reinforcement	_	UNK	_	NN	18	_	_	_	_	_	_	_	S-Event
7	and	_	and	_	CC	18	_	_	_	_	_	_	_	O
8	review	_	review	_	NN	18	_	_	_	_	_	_	_	O

1	explain	_	UNK	_	VB	19	_	_	_	_	_	_	_	O
2	to	_	to	_	TO	19	_	_	_	_	_	_	_	O
3	people	_	people	_	NNS	19	_	_	_	_	_	people.n	People	S-Person
4	and	_	and	_	CC	19	_	_	_	_	_	_	_	O
5	their	_	their	_	PRP$	19	_	_	_	_	_	_	_	O
6	carers	_	UNK	_	NNS	19	_	_	_	_	_	_	_	O
7	that	_	that	_	IN	19	_	_	_	_	_	_	_	O
8	structured	_	UNK	_	JJ	19	_	_	_	_	_	_	_	O
9	education	_	education	_	NN	19	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	19	_	_	_	_	_	_	_	O
11	an	_	an	_	DT	19	_	_	_	_	_	_	_	O
12	integral	_	integral	_	JJ	19	_	_	_	_	_	_	_	O
13	part	_	part	_	NN	19	_	_	_	_	_	_	_	O
14	of	_	of	_	IN	19	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	19	_	_	_	_	_	_	_	O
16	care	_	care	_	NN	19	_	_	_	_	_	_	_	O
17	.	_	.	_	.	19	_	_	_	_	_	_	_	O

1	explain	_	UNK	_	VB	19	_	_	_	_	_	_	_	O
2	to	_	to	_	TO	19	_	_	_	_	_	_	_	O
3	people	_	people	_	NNS	19	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	19	_	_	_	_	_	_	_	O
5	their	_	their	_	PRP$	19	_	_	_	_	_	_	_	O
6	carers	_	UNK	_	NNS	19	_	_	_	_	_	_	_	O
7	that	_	that	_	IN	19	_	_	_	_	_	_	_	O
8	structured	_	UNK	_	JJ	19	_	_	_	_	_	_	_	O
9	education	_	education	_	NN	19	_	_	_	_	_	education.n	Education_teaching	O
10	is	_	be	_	VBZ	19	_	_	_	_	_	_	_	O
11	an	_	an	_	DT	19	_	_	_	_	_	_	_	O
12	integral	_	integral	_	JJ	19	_	_	_	_	_	_	_	O
13	part	_	part	_	NN	19	_	_	_	_	_	_	_	O
14	of	_	of	_	IN	19	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	19	_	_	_	_	_	_	_	O
16	care	_	care	_	NN	19	_	_	_	_	_	_	_	O
17	.	_	.	_	.	19	_	_	_	_	_	_	_	O

1	explain	_	UNK	_	VB	19	_	_	_	_	_	_	_	O
2	to	_	to	_	TO	19	_	_	_	_	_	_	_	O
3	people	_	people	_	NNS	19	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	19	_	_	_	_	_	_	_	O
5	their	_	their	_	PRP$	19	_	_	_	_	_	_	_	O
6	carers	_	UNK	_	NNS	19	_	_	_	_	_	_	_	O
7	that	_	that	_	IN	19	_	_	_	_	_	_	_	O
8	structured	_	UNK	_	JJ	19	_	_	_	_	_	_	_	O
9	education	_	education	_	NN	19	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	19	_	_	_	_	_	_	_	O
11	an	_	an	_	DT	19	_	_	_	_	_	_	_	O
12	integral	_	integral	_	JJ	19	_	_	_	_	_	_	_	S-Part_prop
13	part	_	part	_	NN	19	_	_	_	_	_	part.n	Part_whole	S-Part
14	of	_	of	_	IN	19	_	_	_	_	_	_	_	B-Whole
15	diabetes	_	UNK	_	NNS	19	_	_	_	_	_	_	_	I-Whole
16	care	_	care	_	NN	19	_	_	_	_	_	_	_	I-Whole
17	.	_	.	_	.	19	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	20	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	20	_	_	_	_	_	_	_	O
3	any	_	any	_	DT	20	_	_	_	_	_	_	_	O
4	structured	_	UNK	_	JJ	20	_	_	_	_	_	_	_	O
5	education	_	education	_	NN	20	_	_	_	_	_	education.n	Education_teaching	O
6	programme	_	UNK	_	NN	20	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	20	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	20	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	20	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	20	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	20	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	20	_	_	_	_	_	_	_	O
13	includes	_	include	_	VBZ	20	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	20	_	_	_	_	_	_	_	O
15	following	_	following	_	JJ	20	_	_	_	_	_	_	_	O
16	components	_	component	_	NNS	20	_	_	_	_	_	_	_	O
17	:	_	:	_	:	20	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	20	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	20	_	_	_	_	_	_	_	O
3	any	_	any	_	DT	20	_	_	_	_	_	_	_	O
4	structured	_	UNK	_	JJ	20	_	_	_	_	_	_	_	O
5	education	_	education	_	NN	20	_	_	_	_	_	_	_	O
6	programme	_	UNK	_	NN	20	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	20	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	20	_	_	_	_	_	adult.n	People_by_age	S-Person
9	with	_	with	_	IN	20	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	20	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	20	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	20	_	_	_	_	_	_	_	O
13	includes	_	include	_	VBZ	20	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	20	_	_	_	_	_	_	_	O
15	following	_	following	_	JJ	20	_	_	_	_	_	_	_	O
16	components	_	component	_	NNS	20	_	_	_	_	_	_	_	O
17	:	_	:	_	:	20	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	20	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	20	_	_	_	_	_	_	_	O
3	any	_	any	_	DT	20	_	_	_	_	_	_	_	O
4	structured	_	UNK	_	JJ	20	_	_	_	_	_	_	_	O
5	education	_	education	_	NN	20	_	_	_	_	_	_	_	O
6	programme	_	UNK	_	NN	20	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	20	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	20	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	20	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	20	_	_	_	_	_	type.n	Type	S-Subtype
11	2	_	2	_	CD	20	_	_	_	_	_	_	_	B-Category
12	diabetes	_	UNK	_	NNS	20	_	_	_	_	_	_	_	I-Category
13	includes	_	include	_	VBZ	20	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	20	_	_	_	_	_	_	_	O
15	following	_	following	_	JJ	20	_	_	_	_	_	_	_	O
16	components	_	component	_	NNS	20	_	_	_	_	_	_	_	O
17	:	_	:	_	:	20	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	20	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	20	_	_	_	_	_	_	_	O
3	any	_	any	_	DT	20	_	_	_	_	_	_	_	B-Total
4	structured	_	UNK	_	JJ	20	_	_	_	_	_	_	_	I-Total
5	education	_	education	_	NN	20	_	_	_	_	_	_	_	I-Total
6	programme	_	UNK	_	NN	20	_	_	_	_	_	_	_	I-Total
7	for	_	for	_	IN	20	_	_	_	_	_	_	_	I-Total
8	adults	_	adult	_	NNS	20	_	_	_	_	_	_	_	I-Total
9	with	_	with	_	IN	20	_	_	_	_	_	_	_	I-Total
10	type	_	type	_	JJ	20	_	_	_	_	_	_	_	I-Total
11	2	_	2	_	CD	20	_	_	_	_	_	_	_	I-Total
12	diabetes	_	UNK	_	NNS	20	_	_	_	_	_	_	_	I-Total
13	includes	_	include	_	VBZ	20	_	_	_	_	_	include.v	Inclusion	O
14	the	_	the	_	DT	20	_	_	_	_	_	_	_	B-Part
15	following	_	following	_	JJ	20	_	_	_	_	_	_	_	I-Part
16	components	_	component	_	NNS	20	_	_	_	_	_	_	_	I-Part
17	:	_	:	_	:	20	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	20	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	20	_	_	_	_	_	_	_	O
3	any	_	any	_	DT	20	_	_	_	_	_	_	_	O
4	structured	_	UNK	_	JJ	20	_	_	_	_	_	_	_	O
5	education	_	education	_	NN	20	_	_	_	_	_	_	_	O
6	programme	_	UNK	_	NN	20	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	20	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	20	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	20	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	20	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	20	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	20	_	_	_	_	_	_	_	O
13	includes	_	include	_	VBZ	20	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	20	_	_	_	_	_	_	_	O
15	following	_	following	_	JJ	20	_	_	_	_	_	_	_	O
16	components	_	component	_	NNS	20	_	_	_	_	_	component.n	Ingredients	S-Material
17	:	_	:	_	:	20	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	21	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	21	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	21	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	21	_	_	_	_	_	aim.n	Purpose	S-Goal
5	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	21	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	21	_	_	_	_	_	_	_	S-Goal
8	,	_	,	_	,	21	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	21	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	21	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	21	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	21	_	_	_	_	_	_	_	O
15	family	_	family	_	NN	21	_	_	_	_	_	_	_	O
16	members	_	member	_	NNS	21	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	21	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	21	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	21	_	_	_	_	_	_	_	O
21	attitudes	_	attitude	_	NNS	21	_	_	_	_	_	_	_	O
22	,	_	,	_	,	21	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	21	_	_	_	_	_	_	_	O
24	,	_	,	_	,	21	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	21	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	21	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	21	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	21	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	21	_	_	_	_	_	_	_	O
31	.	_	.	_	.	21	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	21	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	21	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	21	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	21	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	21	_	_	_	_	_	learn.v	Becoming_aware	O
7	objectives	_	objective	_	NNS	21	_	_	_	_	_	_	_	S-Phenomenon
8	,	_	,	_	,	21	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	21	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	21	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	21	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	21	_	_	_	_	_	_	_	O
15	family	_	family	_	NN	21	_	_	_	_	_	_	_	O
16	members	_	member	_	NNS	21	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	21	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	21	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	21	_	_	_	_	_	_	_	O
21	attitudes	_	attitude	_	NNS	21	_	_	_	_	_	_	_	O
22	,	_	,	_	,	21	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	21	_	_	_	_	_	_	_	O
24	,	_	,	_	,	21	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	21	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	21	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	21	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	21	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	21	_	_	_	_	_	_	_	O
31	.	_	.	_	.	21	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	21	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	21	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	21	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	21	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	21	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	21	_	_	_	_	_	objective.n	Purpose	S-Goal
8	,	_	,	_	,	21	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	21	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	21	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	21	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	21	_	_	_	_	_	_	_	O
15	family	_	family	_	NN	21	_	_	_	_	_	_	_	O
16	members	_	member	_	NNS	21	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	21	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	21	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	21	_	_	_	_	_	_	_	O
21	attitudes	_	attitude	_	NNS	21	_	_	_	_	_	_	_	O
22	,	_	,	_	,	21	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	21	_	_	_	_	_	_	_	O
24	,	_	,	_	,	21	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	21	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	21	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	21	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	21	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	21	_	_	_	_	_	_	_	O
31	.	_	.	_	.	21	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	21	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	21	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	21	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	21	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	21	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	21	_	_	_	_	_	_	_	O
8	,	_	,	_	,	21	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	21	_	_	_	_	_	support.v	Taking_sides	O
11	the	_	the	_	DT	21	_	_	_	_	_	_	_	B-Side
12	person	_	person	_	NN	21	_	_	_	_	_	_	_	I-Side
13	and	_	and	_	CC	21	_	_	_	_	_	_	_	I-Side
14	their	_	their	_	PRP$	21	_	_	_	_	_	_	_	I-Side
15	family	_	family	_	NN	21	_	_	_	_	_	_	_	I-Side
16	members	_	member	_	NNS	21	_	_	_	_	_	_	_	I-Side
17	and	_	and	_	CC	21	_	_	_	_	_	_	_	I-Side
18	carers	_	UNK	_	NNS	21	_	_	_	_	_	_	_	I-Side
19	in	_	in	_	IN	21	_	_	_	_	_	_	_	I-Side
20	developing	_	develop	_	VBG	21	_	_	_	_	_	_	_	I-Side
21	attitudes	_	attitude	_	NNS	21	_	_	_	_	_	_	_	I-Side
22	,	_	,	_	,	21	_	_	_	_	_	_	_	I-Side
23	beliefs	_	belief	_	NNS	21	_	_	_	_	_	_	_	I-Side
24	,	_	,	_	,	21	_	_	_	_	_	_	_	I-Side
25	knowledge	_	knowledge	_	NN	21	_	_	_	_	_	_	_	I-Side
26	and	_	and	_	CC	21	_	_	_	_	_	_	_	I-Side
27	skills	_	skill	_	NNS	21	_	_	_	_	_	_	_	I-Side
28	to	_	to	_	TO	21	_	_	_	_	_	_	_	I-Side
29	unk	_	UNK	_	NN	21	_	_	_	_	_	_	_	I-Side
30	diabetes	_	UNK	_	NNS	21	_	_	_	_	_	_	_	I-Side
31	.	_	.	_	.	21	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	21	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	21	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	21	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	21	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	21	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	21	_	_	_	_	_	_	_	O
8	,	_	,	_	,	21	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	21	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	21	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	21	_	_	_	_	_	person.n	People	S-Person
13	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	21	_	_	_	_	_	_	_	O
15	family	_	family	_	NN	21	_	_	_	_	_	_	_	O
16	members	_	member	_	NNS	21	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	21	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	21	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	21	_	_	_	_	_	_	_	O
21	attitudes	_	attitude	_	NNS	21	_	_	_	_	_	_	_	O
22	,	_	,	_	,	21	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	21	_	_	_	_	_	_	_	O
24	,	_	,	_	,	21	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	21	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	21	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	21	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	21	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	21	_	_	_	_	_	_	_	O
31	.	_	.	_	.	21	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	21	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	21	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	21	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	21	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	21	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	21	_	_	_	_	_	_	_	O
8	,	_	,	_	,	21	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	21	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	21	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	21	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	21	_	_	_	_	_	_	_	O
15	family	_	family	_	NN	21	_	_	_	_	_	family.n	Kinship	S-Relatives
16	members	_	member	_	NNS	21	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	21	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	21	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	21	_	_	_	_	_	_	_	O
21	attitudes	_	attitude	_	NNS	21	_	_	_	_	_	_	_	O
22	,	_	,	_	,	21	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	21	_	_	_	_	_	_	_	O
24	,	_	,	_	,	21	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	21	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	21	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	21	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	21	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	21	_	_	_	_	_	_	_	O
31	.	_	.	_	.	21	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	21	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	21	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	21	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	21	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	21	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	21	_	_	_	_	_	_	_	O
8	,	_	,	_	,	21	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	21	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	21	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	21	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	21	_	_	_	_	_	_	_	S-Member
15	family	_	family	_	NN	21	_	_	_	_	_	_	_	S-Group
16	members	_	member	_	NNS	21	_	_	_	_	_	member.n	Membership	S-Member
17	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	21	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	21	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	21	_	_	_	_	_	_	_	O
21	attitudes	_	attitude	_	NNS	21	_	_	_	_	_	_	_	O
22	,	_	,	_	,	21	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	21	_	_	_	_	_	_	_	O
24	,	_	,	_	,	21	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	21	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	21	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	21	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	21	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	21	_	_	_	_	_	_	_	O
31	.	_	.	_	.	21	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	21	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	21	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	21	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	21	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	21	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	21	_	_	_	_	_	_	_	O
8	,	_	,	_	,	21	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	21	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	21	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	21	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	21	_	_	_	_	_	_	_	O
15	family	_	family	_	NN	21	_	_	_	_	_	_	_	O
16	members	_	member	_	NNS	21	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	21	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	21	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	21	_	_	_	_	_	develop.v	Cause_to_make_progress	O
21	attitudes	_	attitude	_	NNS	21	_	_	_	_	_	_	_	S-Project
22	,	_	,	_	,	21	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	21	_	_	_	_	_	_	_	O
24	,	_	,	_	,	21	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	21	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	21	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	21	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	21	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	21	_	_	_	_	_	_	_	O
31	.	_	.	_	.	21	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	21	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	21	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	21	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	21	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	21	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	21	_	_	_	_	_	_	_	O
8	,	_	,	_	,	21	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	21	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	21	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	21	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	21	_	_	_	_	_	_	_	O
15	family	_	family	_	NN	21	_	_	_	_	_	_	_	O
16	members	_	member	_	NNS	21	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	21	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	21	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	21	_	_	_	_	_	_	_	O
21	attitudes	_	attitude	_	NNS	21	_	_	_	_	_	_	_	O
22	,	_	,	_	,	21	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	21	_	_	_	_	_	belief.n	Opinion	O
24	,	_	,	_	,	21	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	21	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	21	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	21	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	21	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	21	_	_	_	_	_	_	_	O
31	.	_	.	_	.	21	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	21	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	21	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	21	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	21	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	21	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	21	_	_	_	_	_	_	_	O
8	,	_	,	_	,	21	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	21	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	21	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	21	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	21	_	_	_	_	_	_	_	O
15	family	_	family	_	NN	21	_	_	_	_	_	_	_	O
16	members	_	member	_	NNS	21	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	21	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	21	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	21	_	_	_	_	_	_	_	O
21	attitudes	_	attitude	_	NNS	21	_	_	_	_	_	_	_	O
22	,	_	,	_	,	21	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	21	_	_	_	_	_	_	_	S-Cognizer
24	,	_	,	_	,	21	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	21	_	_	_	_	_	knowledge.n	Awareness	O
26	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	21	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	21	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	21	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	21	_	_	_	_	_	_	_	O
31	.	_	.	_	.	21	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	21	_	_	_	_	_	_	_	O
2	has	_	have	_	VBZ	21	_	_	_	_	_	_	_	O
3	specific	_	specific	_	JJ	21	_	_	_	_	_	_	_	O
4	aims	_	aim	_	NNS	21	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
6	learning	_	learn	_	VBG	21	_	_	_	_	_	_	_	O
7	objectives	_	objective	_	NNS	21	_	_	_	_	_	_	_	O
8	,	_	,	_	,	21	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
10	supports	_	support	_	VBZ	21	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	21	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	21	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
14	their	_	their	_	PRP$	21	_	_	_	_	_	_	_	O
15	family	_	family	_	NN	21	_	_	_	_	_	_	_	O
16	members	_	member	_	NNS	21	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
18	carers	_	UNK	_	NNS	21	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	21	_	_	_	_	_	_	_	O
20	developing	_	develop	_	VBG	21	_	_	_	_	_	_	_	O
21	attitudes	_	attitude	_	NNS	21	_	_	_	_	_	_	_	O
22	,	_	,	_	,	21	_	_	_	_	_	_	_	O
23	beliefs	_	belief	_	NNS	21	_	_	_	_	_	_	_	O
24	,	_	,	_	,	21	_	_	_	_	_	_	_	O
25	knowledge	_	knowledge	_	NN	21	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	21	_	_	_	_	_	_	_	O
27	skills	_	skill	_	NNS	21	_	_	_	_	_	skill.n	Expertise	S-Protagonist
28	to	_	to	_	TO	21	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	21	_	_	_	_	_	_	_	O
30	diabetes	_	UNK	_	NNS	21	_	_	_	_	_	_	_	O
31	.	_	.	_	.	21	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	22	_	_	_	_	_	_	_	S-Speaker
2	is	_	be	_	VBZ	22	_	_	_	_	_	_	_	O
3	quality	_	quality	_	JJ	22	_	_	_	_	_	_	_	O
4	assured	_	assure	_	VBN	22	_	_	_	_	_	assure.v	Telling	O
5	,	_	,	_	,	22	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	22	_	_	_	_	_	_	_	O
7	reviewed	_	review	_	VBN	22	_	_	_	_	_	_	_	O
8	by	_	by	_	IN	22	_	_	_	_	_	_	_	O
9	trained	_	trained	_	JJ	22	_	_	_	_	_	_	_	O
10	,	_	,	_	,	22	_	_	_	_	_	_	_	O
11	competent	_	competent	_	JJ	22	_	_	_	_	_	_	_	O
12	,	_	,	_	,	22	_	_	_	_	_	_	_	O
13	independent	_	independent	_	JJ	22	_	_	_	_	_	_	_	O
14	assessors	_	UNK	_	NNS	22	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	22	_	_	_	_	_	_	_	O
16	measure	_	measure	_	VBP	22	_	_	_	_	_	_	_	O
17	it	_	it	_	PRP	22	_	_	_	_	_	_	_	O
18	against	_	against	_	IN	22	_	_	_	_	_	_	_	O
19	criteria	_	UNK	_	NNS	22	_	_	_	_	_	_	_	O
20	that	_	that	_	IN	22	_	_	_	_	_	_	_	O
21	ensure	_	ensure	_	VB	22	_	_	_	_	_	_	_	O
22	consistency	_	UNK	_	NN	22	_	_	_	_	_	_	_	O
23	.	_	.	_	.	22	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	22	_	_	_	_	_	_	_	O
2	is	_	be	_	VBZ	22	_	_	_	_	_	_	_	O
3	quality	_	quality	_	JJ	22	_	_	_	_	_	_	_	O
4	assured	_	assure	_	VBN	22	_	_	_	_	_	_	_	O
5	,	_	,	_	,	22	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	22	_	_	_	_	_	_	_	O
7	reviewed	_	review	_	VBN	22	_	_	_	_	_	_	_	O
8	by	_	by	_	IN	22	_	_	_	_	_	_	_	O
9	trained	_	trained	_	JJ	22	_	_	_	_	_	_	_	O
10	,	_	,	_	,	22	_	_	_	_	_	_	_	O
11	competent	_	competent	_	JJ	22	_	_	_	_	_	competent.a	Expertise	O
12	,	_	,	_	,	22	_	_	_	_	_	_	_	O
13	independent	_	independent	_	JJ	22	_	_	_	_	_	_	_	O
14	assessors	_	UNK	_	NNS	22	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	22	_	_	_	_	_	_	_	O
16	measure	_	measure	_	VBP	22	_	_	_	_	_	_	_	O
17	it	_	it	_	PRP	22	_	_	_	_	_	_	_	O
18	against	_	against	_	IN	22	_	_	_	_	_	_	_	O
19	criteria	_	UNK	_	NNS	22	_	_	_	_	_	_	_	O
20	that	_	that	_	IN	22	_	_	_	_	_	_	_	O
21	ensure	_	ensure	_	VB	22	_	_	_	_	_	_	_	O
22	consistency	_	UNK	_	NN	22	_	_	_	_	_	_	_	O
23	.	_	.	_	.	22	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	22	_	_	_	_	_	_	_	O
2	is	_	be	_	VBZ	22	_	_	_	_	_	_	_	O
3	quality	_	quality	_	JJ	22	_	_	_	_	_	_	_	O
4	assured	_	assure	_	VBN	22	_	_	_	_	_	_	_	O
5	,	_	,	_	,	22	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	22	_	_	_	_	_	_	_	O
7	reviewed	_	review	_	VBN	22	_	_	_	_	_	_	_	O
8	by	_	by	_	IN	22	_	_	_	_	_	_	_	O
9	trained	_	trained	_	JJ	22	_	_	_	_	_	_	_	O
10	,	_	,	_	,	22	_	_	_	_	_	_	_	O
11	competent	_	competent	_	JJ	22	_	_	_	_	_	_	_	O
12	,	_	,	_	,	22	_	_	_	_	_	_	_	O
13	independent	_	independent	_	JJ	22	_	_	_	_	_	_	_	B-Object
14	assessors	_	UNK	_	NNS	22	_	_	_	_	_	_	_	I-Object
15	who	_	who	_	WP	22	_	_	_	_	_	_	_	I-Object
16	measure	_	measure	_	VBP	22	_	_	_	_	_	measure.v	Dimension	S-Dimension
17	it	_	it	_	PRP	22	_	_	_	_	_	_	_	S-Object
18	against	_	against	_	IN	22	_	_	_	_	_	_	_	O
19	criteria	_	UNK	_	NNS	22	_	_	_	_	_	_	_	O
20	that	_	that	_	IN	22	_	_	_	_	_	_	_	O
21	ensure	_	ensure	_	VB	22	_	_	_	_	_	_	_	O
22	consistency	_	UNK	_	NN	22	_	_	_	_	_	_	_	O
23	.	_	.	_	.	22	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	VB	23	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	23	_	_	_	_	_	_	_	B-Supplier
3	unk	_	UNK	_	NN	23	_	_	_	_	_	_	_	I-Supplier
4	programme	_	UNK	_	NN	23	_	_	_	_	_	_	_	I-Supplier
5	provides	_	provide	_	VBZ	23	_	_	_	_	_	provide.v	Supply	O
6	the	_	the	_	DT	23	_	_	_	_	_	_	_	B-Theme
7	necessary	_	necessary	_	JJ	23	_	_	_	_	_	_	_	I-Theme
8	resources	_	resource	_	NNS	23	_	_	_	_	_	_	_	I-Theme
9	to	_	to	_	TO	23	_	_	_	_	_	_	_	I-Theme
10	support	_	support	_	VB	23	_	_	_	_	_	_	_	I-Theme
11	the	_	the	_	DT	23	_	_	_	_	_	_	_	I-Theme
12	educators	_	UNK	_	NNS	23	_	_	_	_	_	_	_	I-Theme
13	,	_	,	_	,	23	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	23	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	23	_	_	_	_	_	_	_	O
16	educators	_	UNK	_	NNS	23	_	_	_	_	_	_	_	O
17	are	_	be	_	VBP	23	_	_	_	_	_	_	_	O
18	properly	_	UNK	_	RB	23	_	_	_	_	_	_	_	O
19	trained	_	train	_	VBN	23	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	23	_	_	_	_	_	_	_	O
21	given	_	give	_	VBN	23	_	_	_	_	_	_	_	O
22	time	_	time	_	NN	23	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	23	_	_	_	_	_	_	_	O
24	develop	_	develop	_	VB	23	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	23	_	_	_	_	_	_	_	O
26	maintain	_	maintain	_	VB	23	_	_	_	_	_	_	_	O
27	their	_	their	_	PRP$	23	_	_	_	_	_	_	_	O
28	skills	_	skill	_	NNS	23	_	_	_	_	_	_	_	O
29	.	_	.	_	.	23	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	VB	23	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
4	programme	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
5	provides	_	provide	_	VBZ	23	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
7	necessary	_	necessary	_	JJ	23	_	_	_	_	_	necessary.a	Being_necessary	O
8	resources	_	resource	_	NNS	23	_	_	_	_	_	_	_	S-Requirement
9	to	_	to	_	TO	23	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	23	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
12	educators	_	UNK	_	NNS	23	_	_	_	_	_	_	_	O
13	,	_	,	_	,	23	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	23	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	23	_	_	_	_	_	_	_	O
16	educators	_	UNK	_	NNS	23	_	_	_	_	_	_	_	O
17	are	_	be	_	VBP	23	_	_	_	_	_	_	_	O
18	properly	_	UNK	_	RB	23	_	_	_	_	_	_	_	O
19	trained	_	train	_	VBN	23	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	23	_	_	_	_	_	_	_	O
21	given	_	give	_	VBN	23	_	_	_	_	_	_	_	O
22	time	_	time	_	NN	23	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	23	_	_	_	_	_	_	_	O
24	develop	_	develop	_	VB	23	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	23	_	_	_	_	_	_	_	O
26	maintain	_	maintain	_	VB	23	_	_	_	_	_	_	_	O
27	their	_	their	_	PRP$	23	_	_	_	_	_	_	_	O
28	skills	_	skill	_	NNS	23	_	_	_	_	_	_	_	O
29	.	_	.	_	.	23	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	VB	23	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
4	programme	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
5	provides	_	provide	_	VBZ	23	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
7	necessary	_	necessary	_	JJ	23	_	_	_	_	_	_	_	O
8	resources	_	resource	_	NNS	23	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	23	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	23	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
12	educators	_	UNK	_	NNS	23	_	_	_	_	_	_	_	O
13	,	_	,	_	,	23	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	23	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	23	_	_	_	_	_	_	_	O
16	educators	_	UNK	_	NNS	23	_	_	_	_	_	_	_	S-Student
17	are	_	be	_	VBP	23	_	_	_	_	_	_	_	O
18	properly	_	UNK	_	RB	23	_	_	_	_	_	_	_	S-Manner
19	trained	_	train	_	VBN	23	_	_	_	_	_	train.v	Education_teaching	O
20	and	_	and	_	CC	23	_	_	_	_	_	_	_	O
21	given	_	give	_	VBN	23	_	_	_	_	_	_	_	O
22	time	_	time	_	NN	23	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	23	_	_	_	_	_	_	_	O
24	develop	_	develop	_	VB	23	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	23	_	_	_	_	_	_	_	O
26	maintain	_	maintain	_	VB	23	_	_	_	_	_	_	_	O
27	their	_	their	_	PRP$	23	_	_	_	_	_	_	_	O
28	skills	_	skill	_	NNS	23	_	_	_	_	_	_	_	O
29	.	_	.	_	.	23	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	VB	23	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
4	programme	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
5	provides	_	provide	_	VBZ	23	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
7	necessary	_	necessary	_	JJ	23	_	_	_	_	_	_	_	O
8	resources	_	resource	_	NNS	23	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	23	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	23	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
12	educators	_	UNK	_	NNS	23	_	_	_	_	_	_	_	O
13	,	_	,	_	,	23	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	23	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	23	_	_	_	_	_	_	_	O
16	educators	_	UNK	_	NNS	23	_	_	_	_	_	_	_	S-Agent
17	are	_	be	_	VBP	23	_	_	_	_	_	_	_	O
18	properly	_	UNK	_	RB	23	_	_	_	_	_	_	_	O
19	trained	_	train	_	VBN	23	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	23	_	_	_	_	_	_	_	O
21	given	_	give	_	VBN	23	_	_	_	_	_	_	_	O
22	time	_	time	_	NN	23	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	23	_	_	_	_	_	_	_	O
24	develop	_	develop	_	VB	23	_	_	_	_	_	develop.v	Cause_to_make_progress	O
25	and	_	and	_	CC	23	_	_	_	_	_	_	_	O
26	maintain	_	maintain	_	VB	23	_	_	_	_	_	_	_	O
27	their	_	their	_	PRP$	23	_	_	_	_	_	_	_	B-Project
28	skills	_	skill	_	NNS	23	_	_	_	_	_	_	_	I-Project
29	.	_	.	_	.	23	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	VB	23	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
4	programme	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
5	provides	_	provide	_	VBZ	23	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
7	necessary	_	necessary	_	JJ	23	_	_	_	_	_	_	_	O
8	resources	_	resource	_	NNS	23	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	23	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	23	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
12	educators	_	UNK	_	NNS	23	_	_	_	_	_	_	_	O
13	,	_	,	_	,	23	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	23	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	23	_	_	_	_	_	_	_	O
16	educators	_	UNK	_	NNS	23	_	_	_	_	_	_	_	S-Agent
17	are	_	be	_	VBP	23	_	_	_	_	_	_	_	O
18	properly	_	UNK	_	RB	23	_	_	_	_	_	_	_	O
19	trained	_	train	_	VBN	23	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	23	_	_	_	_	_	_	_	O
21	given	_	give	_	VBN	23	_	_	_	_	_	_	_	O
22	time	_	time	_	NN	23	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	23	_	_	_	_	_	_	_	O
24	develop	_	develop	_	VB	23	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	23	_	_	_	_	_	_	_	O
26	maintain	_	maintain	_	VB	23	_	_	_	_	_	maintain.v	Activity_ongoing	O
27	their	_	their	_	PRP$	23	_	_	_	_	_	_	_	B-Activity
28	skills	_	skill	_	NNS	23	_	_	_	_	_	_	_	I-Activity
29	.	_	.	_	.	23	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	VB	23	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
4	programme	_	UNK	_	NN	23	_	_	_	_	_	_	_	O
5	provides	_	provide	_	VBZ	23	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
7	necessary	_	necessary	_	JJ	23	_	_	_	_	_	_	_	O
8	resources	_	resource	_	NNS	23	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	23	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	23	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	23	_	_	_	_	_	_	_	O
12	educators	_	UNK	_	NNS	23	_	_	_	_	_	_	_	O
13	,	_	,	_	,	23	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	23	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	23	_	_	_	_	_	_	_	O
16	educators	_	UNK	_	NNS	23	_	_	_	_	_	_	_	O
17	are	_	be	_	VBP	23	_	_	_	_	_	_	_	O
18	properly	_	UNK	_	RB	23	_	_	_	_	_	_	_	O
19	trained	_	train	_	VBN	23	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	23	_	_	_	_	_	_	_	O
21	given	_	give	_	VBN	23	_	_	_	_	_	_	_	O
22	time	_	time	_	NN	23	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	23	_	_	_	_	_	_	_	O
24	develop	_	develop	_	VB	23	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	23	_	_	_	_	_	_	_	O
26	maintain	_	maintain	_	VB	23	_	_	_	_	_	_	_	O
27	their	_	their	_	PRP$	23	_	_	_	_	_	_	_	O
28	skills	_	skill	_	NNS	23	_	_	_	_	_	skill.n	Expertise	S-Protagonist
29	.	_	.	_	.	23	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	VB	24	_	_	_	_	_	provide.v	Supply	O
2	an	_	an	_	DT	24	_	_	_	_	_	_	_	B-Theme
3	alternative	_	alternative	_	NN	24	_	_	_	_	_	_	_	I-Theme
4	of	_	of	_	IN	24	_	_	_	_	_	_	_	I-Theme
5	equal	_	equal	_	JJ	24	_	_	_	_	_	_	_	I-Theme
6	standard	_	standard	_	NN	24	_	_	_	_	_	_	_	I-Theme
7	for	_	for	_	IN	24	_	_	_	_	_	_	_	I-Theme
8	a	_	a	_	DT	24	_	_	_	_	_	_	_	I-Theme
9	person	_	person	_	NN	24	_	_	_	_	_	_	_	I-Theme
10	unable	_	unable	_	JJ	24	_	_	_	_	_	_	_	I-Theme
11	or	_	or	_	CC	24	_	_	_	_	_	_	_	I-Theme
12	unwilling	_	UNK	_	JJ	24	_	_	_	_	_	_	_	I-Theme
13	to	_	to	_	TO	24	_	_	_	_	_	_	_	I-Theme
14	participate	_	participate	_	VB	24	_	_	_	_	_	_	_	I-Theme
15	in	_	in	_	IN	24	_	_	_	_	_	_	_	I-Theme
16	group	_	group	_	NN	24	_	_	_	_	_	_	_	I-Theme
17	education	_	education	_	NN	24	_	_	_	_	_	_	_	I-Theme
18	.	_	.	_	.	24	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	VB	24	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	24	_	_	_	_	_	_	_	O
3	alternative	_	alternative	_	NN	24	_	_	_	_	_	alternative.n	Alternatives	O
4	of	_	of	_	IN	24	_	_	_	_	_	_	_	B-Salient_entity
5	equal	_	equal	_	JJ	24	_	_	_	_	_	_	_	I-Salient_entity
6	standard	_	standard	_	NN	24	_	_	_	_	_	_	_	I-Salient_entity
7	for	_	for	_	IN	24	_	_	_	_	_	_	_	I-Salient_entity
8	a	_	a	_	DT	24	_	_	_	_	_	_	_	I-Salient_entity
9	person	_	person	_	NN	24	_	_	_	_	_	_	_	I-Salient_entity
10	unable	_	unable	_	JJ	24	_	_	_	_	_	_	_	I-Salient_entity
11	or	_	or	_	CC	24	_	_	_	_	_	_	_	I-Salient_entity
12	unwilling	_	UNK	_	JJ	24	_	_	_	_	_	_	_	I-Salient_entity
13	to	_	to	_	TO	24	_	_	_	_	_	_	_	I-Salient_entity
14	participate	_	participate	_	VB	24	_	_	_	_	_	_	_	I-Salient_entity
15	in	_	in	_	IN	24	_	_	_	_	_	_	_	I-Salient_entity
16	group	_	group	_	NN	24	_	_	_	_	_	_	_	I-Salient_entity
17	education	_	education	_	NN	24	_	_	_	_	_	_	_	I-Salient_entity
18	.	_	.	_	.	24	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	VB	24	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	24	_	_	_	_	_	_	_	O
3	alternative	_	alternative	_	NN	24	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	24	_	_	_	_	_	_	_	O
5	equal	_	equal	_	JJ	24	_	_	_	_	_	_	_	O
6	standard	_	standard	_	NN	24	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	24	_	_	_	_	_	_	_	O
8	a	_	a	_	DT	24	_	_	_	_	_	_	_	O
9	person	_	person	_	NN	24	_	_	_	_	_	person.n	People	S-Person
10	unable	_	unable	_	JJ	24	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	24	_	_	_	_	_	_	_	O
12	unwilling	_	UNK	_	JJ	24	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	24	_	_	_	_	_	_	_	O
14	participate	_	participate	_	VB	24	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	24	_	_	_	_	_	_	_	O
16	group	_	group	_	NN	24	_	_	_	_	_	_	_	O
17	education	_	education	_	NN	24	_	_	_	_	_	_	_	O
18	.	_	.	_	.	24	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	VB	24	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	24	_	_	_	_	_	_	_	O
3	alternative	_	alternative	_	NN	24	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	24	_	_	_	_	_	_	_	O
5	equal	_	equal	_	JJ	24	_	_	_	_	_	_	_	O
6	standard	_	standard	_	NN	24	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	24	_	_	_	_	_	_	_	O
8	a	_	a	_	DT	24	_	_	_	_	_	_	_	B-Entity
9	person	_	person	_	NN	24	_	_	_	_	_	_	_	I-Entity
10	unable	_	unable	_	JJ	24	_	_	_	_	_	unable.a	Capability	O
11	or	_	or	_	CC	24	_	_	_	_	_	_	_	O
12	unwilling	_	UNK	_	JJ	24	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	24	_	_	_	_	_	_	_	B-Event
14	participate	_	participate	_	VB	24	_	_	_	_	_	_	_	I-Event
15	in	_	in	_	IN	24	_	_	_	_	_	_	_	I-Event
16	group	_	group	_	NN	24	_	_	_	_	_	_	_	I-Event
17	education	_	education	_	NN	24	_	_	_	_	_	_	_	I-Event
18	.	_	.	_	.	24	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	VB	24	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	24	_	_	_	_	_	_	_	O
3	alternative	_	alternative	_	NN	24	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	24	_	_	_	_	_	_	_	O
5	equal	_	equal	_	JJ	24	_	_	_	_	_	_	_	O
6	standard	_	standard	_	NN	24	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	24	_	_	_	_	_	_	_	O
8	a	_	a	_	DT	24	_	_	_	_	_	_	_	O
9	person	_	person	_	NN	24	_	_	_	_	_	_	_	O
10	unable	_	unable	_	JJ	24	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	24	_	_	_	_	_	_	_	O
12	unwilling	_	UNK	_	JJ	24	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	24	_	_	_	_	_	_	_	O
14	participate	_	participate	_	VB	24	_	_	_	_	_	participate.v	Participation	O
15	in	_	in	_	IN	24	_	_	_	_	_	_	_	B-Participant_1
16	group	_	group	_	NN	24	_	_	_	_	_	_	_	I-Participant_1
17	education	_	education	_	NN	24	_	_	_	_	_	_	_	I-Participant_1
18	.	_	.	_	.	24	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	VB	24	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	24	_	_	_	_	_	_	_	O
3	alternative	_	alternative	_	NN	24	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	24	_	_	_	_	_	_	_	O
5	equal	_	equal	_	JJ	24	_	_	_	_	_	_	_	O
6	standard	_	standard	_	NN	24	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	24	_	_	_	_	_	_	_	O
8	a	_	a	_	DT	24	_	_	_	_	_	_	_	O
9	person	_	person	_	NN	24	_	_	_	_	_	_	_	O
10	unable	_	unable	_	JJ	24	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	24	_	_	_	_	_	_	_	O
12	unwilling	_	UNK	_	JJ	24	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	24	_	_	_	_	_	_	_	O
14	participate	_	participate	_	VB	24	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	24	_	_	_	_	_	_	_	O
16	group	_	group	_	NN	24	_	_	_	_	_	group.n	Aggregate	S-Aggregate
17	education	_	education	_	NN	24	_	_	_	_	_	_	_	O
18	.	_	.	_	.	24	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	VB	24	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	24	_	_	_	_	_	_	_	O
3	alternative	_	alternative	_	NN	24	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	24	_	_	_	_	_	_	_	O
5	equal	_	equal	_	JJ	24	_	_	_	_	_	_	_	O
6	standard	_	standard	_	NN	24	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	24	_	_	_	_	_	_	_	O
8	a	_	a	_	DT	24	_	_	_	_	_	_	_	O
9	person	_	person	_	NN	24	_	_	_	_	_	_	_	O
10	unable	_	unable	_	JJ	24	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	24	_	_	_	_	_	_	_	O
12	unwilling	_	UNK	_	JJ	24	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	24	_	_	_	_	_	_	_	O
14	participate	_	participate	_	VB	24	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	24	_	_	_	_	_	_	_	O
16	group	_	group	_	NN	24	_	_	_	_	_	_	_	S-Student
17	education	_	education	_	NN	24	_	_	_	_	_	education.n	Education_teaching	O
18	.	_	.	_	.	24	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	25	_	_	_	_	_	_	_	O
4	members	_	member	_	NNS	25	_	_	_	_	_	member.n	Membership	S-Member
5	of	_	of	_	IN	25	_	_	_	_	_	_	_	B-Group
6	the	_	the	_	DT	25	_	_	_	_	_	_	_	I-Group
7	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	I-Group
8	healthcare	_	healthcare	_	VBP	25	_	_	_	_	_	_	_	O
9	team	_	team	_	NN	25	_	_	_	_	_	_	_	O
10	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	25	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
15	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
16	available	_	available	_	JJ	25	_	_	_	_	_	_	_	O
17	locally	_	locally	_	RB	25	_	_	_	_	_	_	_	O
18	,	_	,	_	,	25	_	_	_	_	_	_	_	O
19	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
20	these	_	these	_	DT	25	_	_	_	_	_	_	_	O
21	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
22	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
23	integrated	_	UNK	_	VBN	25	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
26	rest	_	rest	_	NN	25	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
29	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
30	pathway	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	,	_	,	_	,	25	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
39	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	25	_	_	_	_	_	_	_	O
41	family	_	family	_	NN	25	_	_	_	_	_	_	_	O
42	members	_	member	_	NNS	25	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
44	carers	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
45	(	_	(	_	(	25	_	_	_	_	_	_	_	O
46	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
47	appropriate	_	appropriate	_	NN	25	_	_	_	_	_	_	_	O
48	)	_	)	_	)	25	_	_	_	_	_	_	_	O
49	have	_	have	_	VBP	25	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	25	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	25	_	_	_	_	_	_	_	O
54	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
55	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
56	design	_	design	_	NN	25	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
58	provision	_	provision	_	NN	25	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
60	local	_	local	_	JJ	25	_	_	_	_	_	_	_	O
61	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
62	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	25	_	_	_	_	_	_	_	O
4	members	_	member	_	NNS	25	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
8	healthcare	_	healthcare	_	VBP	25	_	_	_	_	_	_	_	O
9	team	_	team	_	NN	25	_	_	_	_	_	team.n	Aggregate	S-Aggregate
10	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	25	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
15	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
16	available	_	available	_	JJ	25	_	_	_	_	_	_	_	O
17	locally	_	locally	_	RB	25	_	_	_	_	_	_	_	O
18	,	_	,	_	,	25	_	_	_	_	_	_	_	O
19	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
20	these	_	these	_	DT	25	_	_	_	_	_	_	_	O
21	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
22	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
23	integrated	_	UNK	_	VBN	25	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
26	rest	_	rest	_	NN	25	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
29	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
30	pathway	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	,	_	,	_	,	25	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
39	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	25	_	_	_	_	_	_	_	O
41	family	_	family	_	NN	25	_	_	_	_	_	_	_	O
42	members	_	member	_	NNS	25	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
44	carers	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
45	(	_	(	_	(	25	_	_	_	_	_	_	_	O
46	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
47	appropriate	_	appropriate	_	NN	25	_	_	_	_	_	_	_	O
48	)	_	)	_	)	25	_	_	_	_	_	_	_	O
49	have	_	have	_	VBP	25	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	25	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	25	_	_	_	_	_	_	_	O
54	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
55	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
56	design	_	design	_	NN	25	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
58	provision	_	provision	_	NN	25	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
60	local	_	local	_	JJ	25	_	_	_	_	_	_	_	O
61	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
62	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	25	_	_	_	_	_	_	_	B-Protagonist
4	members	_	member	_	NNS	25	_	_	_	_	_	_	_	I-Protagonist
5	of	_	of	_	IN	25	_	_	_	_	_	_	_	I-Protagonist
6	the	_	the	_	DT	25	_	_	_	_	_	_	_	I-Protagonist
7	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	I-Protagonist
8	healthcare	_	healthcare	_	VBP	25	_	_	_	_	_	_	_	I-Protagonist
9	team	_	team	_	NN	25	_	_	_	_	_	_	_	I-Protagonist
10	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	25	_	_	_	_	_	familiar.a	Expertise	O
12	with	_	with	_	IN	25	_	_	_	_	_	_	_	B-Knowledge
13	the	_	the	_	DT	25	_	_	_	_	_	_	_	I-Knowledge
14	unk	_	UNK	_	NN	25	_	_	_	_	_	_	_	I-Knowledge
15	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	I-Knowledge
16	available	_	available	_	JJ	25	_	_	_	_	_	_	_	I-Knowledge
17	locally	_	locally	_	RB	25	_	_	_	_	_	_	_	I-Knowledge
18	,	_	,	_	,	25	_	_	_	_	_	_	_	I-Knowledge
19	that	_	that	_	IN	25	_	_	_	_	_	_	_	I-Knowledge
20	these	_	these	_	DT	25	_	_	_	_	_	_	_	I-Knowledge
21	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	I-Knowledge
22	are	_	be	_	VBP	25	_	_	_	_	_	_	_	I-Knowledge
23	integrated	_	UNK	_	VBN	25	_	_	_	_	_	_	_	I-Knowledge
24	with	_	with	_	IN	25	_	_	_	_	_	_	_	I-Knowledge
25	the	_	the	_	DT	25	_	_	_	_	_	_	_	I-Knowledge
26	rest	_	rest	_	NN	25	_	_	_	_	_	_	_	I-Knowledge
27	of	_	of	_	IN	25	_	_	_	_	_	_	_	I-Knowledge
28	the	_	the	_	DT	25	_	_	_	_	_	_	_	I-Knowledge
29	care	_	care	_	NN	25	_	_	_	_	_	_	_	I-Knowledge
30	pathway	_	UNK	_	NN	25	_	_	_	_	_	_	_	I-Knowledge
31	,	_	,	_	,	25	_	_	_	_	_	_	_	I-Knowledge
32	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
39	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	25	_	_	_	_	_	_	_	O
41	family	_	family	_	NN	25	_	_	_	_	_	_	_	O
42	members	_	member	_	NNS	25	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
44	carers	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
45	(	_	(	_	(	25	_	_	_	_	_	_	_	O
46	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
47	appropriate	_	appropriate	_	NN	25	_	_	_	_	_	_	_	O
48	)	_	)	_	)	25	_	_	_	_	_	_	_	O
49	have	_	have	_	VBP	25	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	25	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	25	_	_	_	_	_	_	_	O
54	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
55	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
56	design	_	design	_	NN	25	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
58	provision	_	provision	_	NN	25	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
60	local	_	local	_	JJ	25	_	_	_	_	_	_	_	O
61	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
62	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	25	_	_	_	_	_	_	_	O
4	members	_	member	_	NNS	25	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
8	healthcare	_	healthcare	_	VBP	25	_	_	_	_	_	_	_	O
9	team	_	team	_	NN	25	_	_	_	_	_	_	_	O
10	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	25	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
15	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
16	available	_	available	_	JJ	25	_	_	_	_	_	_	_	O
17	locally	_	locally	_	RB	25	_	_	_	_	_	_	_	O
18	,	_	,	_	,	25	_	_	_	_	_	_	_	O
19	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
20	these	_	these	_	DT	25	_	_	_	_	_	_	_	O
21	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
22	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
23	integrated	_	UNK	_	VBN	25	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
26	rest	_	rest	_	NN	25	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
29	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
30	pathway	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	,	_	,	_	,	25	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	25	_	_	_	_	_	adult.n	People_by_age	S-Person
35	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
39	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	25	_	_	_	_	_	_	_	O
41	family	_	family	_	NN	25	_	_	_	_	_	_	_	O
42	members	_	member	_	NNS	25	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
44	carers	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
45	(	_	(	_	(	25	_	_	_	_	_	_	_	O
46	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
47	appropriate	_	appropriate	_	NN	25	_	_	_	_	_	_	_	O
48	)	_	)	_	)	25	_	_	_	_	_	_	_	O
49	have	_	have	_	VBP	25	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	25	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	25	_	_	_	_	_	_	_	O
54	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
55	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
56	design	_	design	_	NN	25	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
58	provision	_	provision	_	NN	25	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
60	local	_	local	_	JJ	25	_	_	_	_	_	_	_	O
61	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
62	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	25	_	_	_	_	_	_	_	O
4	members	_	member	_	NNS	25	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
8	healthcare	_	healthcare	_	VBP	25	_	_	_	_	_	_	_	O
9	team	_	team	_	NN	25	_	_	_	_	_	_	_	O
10	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	25	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
15	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
16	available	_	available	_	JJ	25	_	_	_	_	_	_	_	O
17	locally	_	locally	_	RB	25	_	_	_	_	_	_	_	O
18	,	_	,	_	,	25	_	_	_	_	_	_	_	O
19	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
20	these	_	these	_	DT	25	_	_	_	_	_	_	_	O
21	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
22	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
23	integrated	_	UNK	_	VBN	25	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
26	rest	_	rest	_	NN	25	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
29	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
30	pathway	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	,	_	,	_	,	25	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	25	_	_	_	_	_	type.n	Type	S-Subtype
37	2	_	2	_	CD	25	_	_	_	_	_	_	_	B-Category
38	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	I-Category
39	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	25	_	_	_	_	_	_	_	O
41	family	_	family	_	NN	25	_	_	_	_	_	_	_	O
42	members	_	member	_	NNS	25	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
44	carers	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
45	(	_	(	_	(	25	_	_	_	_	_	_	_	O
46	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
47	appropriate	_	appropriate	_	NN	25	_	_	_	_	_	_	_	O
48	)	_	)	_	)	25	_	_	_	_	_	_	_	O
49	have	_	have	_	VBP	25	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	25	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	25	_	_	_	_	_	_	_	O
54	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
55	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
56	design	_	design	_	NN	25	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
58	provision	_	provision	_	NN	25	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
60	local	_	local	_	JJ	25	_	_	_	_	_	_	_	O
61	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
62	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	25	_	_	_	_	_	_	_	O
4	members	_	member	_	NNS	25	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
8	healthcare	_	healthcare	_	VBP	25	_	_	_	_	_	_	_	O
9	team	_	team	_	NN	25	_	_	_	_	_	_	_	O
10	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	25	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
15	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
16	available	_	available	_	JJ	25	_	_	_	_	_	_	_	O
17	locally	_	locally	_	RB	25	_	_	_	_	_	_	_	O
18	,	_	,	_	,	25	_	_	_	_	_	_	_	O
19	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
20	these	_	these	_	DT	25	_	_	_	_	_	_	_	O
21	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
22	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
23	integrated	_	UNK	_	VBN	25	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
26	rest	_	rest	_	NN	25	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
29	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
30	pathway	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	,	_	,	_	,	25	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
39	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	25	_	_	_	_	_	_	_	O
41	family	_	family	_	NN	25	_	_	_	_	_	family.n	Kinship	S-Relatives
42	members	_	member	_	NNS	25	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
44	carers	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
45	(	_	(	_	(	25	_	_	_	_	_	_	_	O
46	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
47	appropriate	_	appropriate	_	NN	25	_	_	_	_	_	_	_	O
48	)	_	)	_	)	25	_	_	_	_	_	_	_	O
49	have	_	have	_	VBP	25	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	25	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	25	_	_	_	_	_	_	_	O
54	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
55	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
56	design	_	design	_	NN	25	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
58	provision	_	provision	_	NN	25	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
60	local	_	local	_	JJ	25	_	_	_	_	_	_	_	O
61	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
62	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	25	_	_	_	_	_	_	_	O
4	members	_	member	_	NNS	25	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
8	healthcare	_	healthcare	_	VBP	25	_	_	_	_	_	_	_	O
9	team	_	team	_	NN	25	_	_	_	_	_	_	_	O
10	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	25	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
15	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
16	available	_	available	_	JJ	25	_	_	_	_	_	_	_	O
17	locally	_	locally	_	RB	25	_	_	_	_	_	_	_	O
18	,	_	,	_	,	25	_	_	_	_	_	_	_	O
19	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
20	these	_	these	_	DT	25	_	_	_	_	_	_	_	O
21	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
22	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
23	integrated	_	UNK	_	VBN	25	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
26	rest	_	rest	_	NN	25	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
29	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
30	pathway	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	,	_	,	_	,	25	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
39	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	25	_	_	_	_	_	_	_	S-Member
41	family	_	family	_	NN	25	_	_	_	_	_	_	_	S-Group
42	members	_	member	_	NNS	25	_	_	_	_	_	member.n	Membership	S-Member
43	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
44	carers	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
45	(	_	(	_	(	25	_	_	_	_	_	_	_	O
46	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
47	appropriate	_	appropriate	_	NN	25	_	_	_	_	_	_	_	O
48	)	_	)	_	)	25	_	_	_	_	_	_	_	O
49	have	_	have	_	VBP	25	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	25	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	25	_	_	_	_	_	_	_	O
54	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
55	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
56	design	_	design	_	NN	25	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
58	provision	_	provision	_	NN	25	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
60	local	_	local	_	JJ	25	_	_	_	_	_	_	_	O
61	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
62	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	25	_	_	_	_	_	_	_	O
4	members	_	member	_	NNS	25	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
8	healthcare	_	healthcare	_	VBP	25	_	_	_	_	_	_	_	O
9	team	_	team	_	NN	25	_	_	_	_	_	_	_	O
10	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	25	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
15	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
16	available	_	available	_	JJ	25	_	_	_	_	_	_	_	O
17	locally	_	locally	_	RB	25	_	_	_	_	_	_	_	O
18	,	_	,	_	,	25	_	_	_	_	_	_	_	O
19	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
20	these	_	these	_	DT	25	_	_	_	_	_	_	_	O
21	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
22	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
23	integrated	_	UNK	_	VBN	25	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
26	rest	_	rest	_	NN	25	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
29	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
30	pathway	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	,	_	,	_	,	25	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
39	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	25	_	_	_	_	_	_	_	O
41	family	_	family	_	NN	25	_	_	_	_	_	_	_	B-Donor
42	members	_	member	_	NNS	25	_	_	_	_	_	_	_	I-Donor
43	or	_	or	_	CC	25	_	_	_	_	_	_	_	I-Donor
44	carers	_	UNK	_	NNS	25	_	_	_	_	_	_	_	I-Donor
45	(	_	(	_	(	25	_	_	_	_	_	_	_	I-Donor
46	as	_	a	_	IN	25	_	_	_	_	_	_	_	I-Donor
47	appropriate	_	appropriate	_	NN	25	_	_	_	_	_	_	_	I-Donor
48	)	_	)	_	)	25	_	_	_	_	_	_	_	I-Donor
49	have	_	have	_	VBP	25	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	25	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	25	_	_	_	_	_	contribute.v	Giving	O
54	to	_	to	_	TO	25	_	_	_	_	_	_	_	B-Theme
55	the	_	the	_	DT	25	_	_	_	_	_	_	_	I-Theme
56	design	_	design	_	NN	25	_	_	_	_	_	_	_	I-Theme
57	and	_	and	_	CC	25	_	_	_	_	_	_	_	I-Theme
58	provision	_	provision	_	NN	25	_	_	_	_	_	_	_	I-Theme
59	of	_	of	_	IN	25	_	_	_	_	_	_	_	I-Theme
60	local	_	local	_	JJ	25	_	_	_	_	_	_	_	I-Theme
61	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	I-Theme
62	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	25	_	_	_	_	_	_	_	O
4	members	_	member	_	NNS	25	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
8	healthcare	_	healthcare	_	VBP	25	_	_	_	_	_	_	_	O
9	team	_	team	_	NN	25	_	_	_	_	_	_	_	O
10	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	25	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
15	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
16	available	_	available	_	JJ	25	_	_	_	_	_	_	_	O
17	locally	_	locally	_	RB	25	_	_	_	_	_	_	_	O
18	,	_	,	_	,	25	_	_	_	_	_	_	_	O
19	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
20	these	_	these	_	DT	25	_	_	_	_	_	_	_	O
21	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
22	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
23	integrated	_	UNK	_	VBN	25	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
26	rest	_	rest	_	NN	25	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
29	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
30	pathway	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	,	_	,	_	,	25	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
39	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	25	_	_	_	_	_	_	_	O
41	family	_	family	_	NN	25	_	_	_	_	_	_	_	O
42	members	_	member	_	NNS	25	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
44	carers	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
45	(	_	(	_	(	25	_	_	_	_	_	_	_	O
46	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
47	appropriate	_	appropriate	_	NN	25	_	_	_	_	_	_	_	O
48	)	_	)	_	)	25	_	_	_	_	_	_	_	O
49	have	_	have	_	VBP	25	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	25	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	25	_	_	_	_	_	_	_	O
54	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
55	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
56	design	_	design	_	NN	25	_	_	_	_	_	design.n	Coming_up_with	O
57	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
58	provision	_	provision	_	NN	25	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	25	_	_	_	_	_	_	_	B-Idea
60	local	_	local	_	JJ	25	_	_	_	_	_	_	_	I-Idea
61	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	I-Idea
62	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	ensure	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
2	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
3	all	_	all	_	DT	25	_	_	_	_	_	_	_	O
4	members	_	member	_	NNS	25	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
8	healthcare	_	healthcare	_	VBP	25	_	_	_	_	_	_	_	O
9	team	_	team	_	NN	25	_	_	_	_	_	_	_	O
10	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
11	familiar	_	familiar	_	JJ	25	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
15	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
16	available	_	available	_	JJ	25	_	_	_	_	_	_	_	O
17	locally	_	locally	_	RB	25	_	_	_	_	_	_	_	O
18	,	_	,	_	,	25	_	_	_	_	_	_	_	O
19	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
20	these	_	these	_	DT	25	_	_	_	_	_	_	_	O
21	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
22	are	_	be	_	VBP	25	_	_	_	_	_	_	_	O
23	integrated	_	UNK	_	VBN	25	_	_	_	_	_	_	_	O
24	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
26	rest	_	rest	_	NN	25	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
29	care	_	care	_	NN	25	_	_	_	_	_	_	_	O
30	pathway	_	UNK	_	NN	25	_	_	_	_	_	_	_	O
31	,	_	,	_	,	25	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
33	that	_	that	_	IN	25	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	25	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	25	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	25	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	25	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
39	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	25	_	_	_	_	_	_	_	O
41	family	_	family	_	NN	25	_	_	_	_	_	_	_	O
42	members	_	member	_	NNS	25	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	25	_	_	_	_	_	_	_	O
44	carers	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
45	(	_	(	_	(	25	_	_	_	_	_	_	_	O
46	as	_	a	_	IN	25	_	_	_	_	_	_	_	O
47	appropriate	_	appropriate	_	NN	25	_	_	_	_	_	_	_	O
48	)	_	)	_	)	25	_	_	_	_	_	_	_	O
49	have	_	have	_	VBP	25	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
51	opportunity	_	opportunity	_	NN	25	_	_	_	_	_	_	_	O
52	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
53	contribute	_	contribute	_	VB	25	_	_	_	_	_	_	_	O
54	to	_	to	_	TO	25	_	_	_	_	_	_	_	O
55	the	_	the	_	DT	25	_	_	_	_	_	_	_	O
56	design	_	design	_	NN	25	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	25	_	_	_	_	_	_	_	O
58	provision	_	provision	_	NN	25	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	25	_	_	_	_	_	_	_	O
60	local	_	local	_	JJ	25	_	_	_	_	_	local.a	Political_locales	S-Locale
61	programmes	_	UNK	_	NNS	25	_	_	_	_	_	_	_	O
62	.	_	.	_	.	25	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	26	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	26	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	26	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	26	_	_	_	_	_	_	_	O
6	:	_	:	_	:	26	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	26	_	_	_	_	_	_	_	O
8	(	_	(	_	(	26	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	26	_	_	_	_	_	_	_	O
10	)	_	)	_	)	26	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	26	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	26	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
14	)	_	)	_	)	26	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	26	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	26	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	26	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	26	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	26	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	26	_	_	_	_	_	_	_	O
8	(	_	(	_	(	26	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	26	_	_	_	_	_	_	_	O
10	)	_	)	_	)	26	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	26	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	26	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	26	_	_	_	_	_	_	_	O
14	)	_	)	_	)	26	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	NNP	27	_	_	_	_	_	provide.v	Supply	O
2	individualised	_	UNK	_	VBD	27	_	_	_	_	_	_	_	B-Theme
3	and	_	and	_	CC	27	_	_	_	_	_	_	_	I-Theme
4	ongoing	_	ongoing	_	JJ	27	_	_	_	_	_	_	_	I-Theme
5	nutritional	_	UNK	_	JJ	27	_	_	_	_	_	_	_	I-Theme
6	advice	_	advice	_	NN	27	_	_	_	_	_	_	_	I-Theme
7	from	_	from	_	IN	27	_	_	_	_	_	_	_	I-Theme
8	a	_	a	_	DT	27	_	_	_	_	_	_	_	I-Theme
9	healthcare	_	healthcare	_	JJ	27	_	_	_	_	_	_	_	I-Theme
10	professional	_	professional	_	NN	27	_	_	_	_	_	_	_	I-Theme
11	with	_	with	_	IN	27	_	_	_	_	_	_	_	I-Theme
12	specific	_	specific	_	JJ	27	_	_	_	_	_	_	_	I-Theme
13	expertise	_	expertise	_	NN	27	_	_	_	_	_	_	_	I-Theme
14	and	_	and	_	CC	27	_	_	_	_	_	_	_	I-Theme
15	competencies	_	UNK	_	NNS	27	_	_	_	_	_	_	_	I-Theme
16	in	_	in	_	IN	27	_	_	_	_	_	_	_	I-Theme
17	nutrition	_	UNK	_	NN	27	_	_	_	_	_	_	_	I-Theme
18	.	_	.	_	.	27	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	NNP	27	_	_	_	_	_	_	_	O
2	individualised	_	UNK	_	VBD	27	_	_	_	_	_	_	_	O
3	and	_	and	_	CC	27	_	_	_	_	_	_	_	O
4	ongoing	_	ongoing	_	JJ	27	_	_	_	_	_	ongoing.a	Process_continue	O
5	nutritional	_	UNK	_	JJ	27	_	_	_	_	_	_	_	B-Event
6	advice	_	advice	_	NN	27	_	_	_	_	_	_	_	I-Event
7	from	_	from	_	IN	27	_	_	_	_	_	_	_	O
8	a	_	a	_	DT	27	_	_	_	_	_	_	_	O
9	healthcare	_	healthcare	_	JJ	27	_	_	_	_	_	_	_	O
10	professional	_	professional	_	NN	27	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	27	_	_	_	_	_	_	_	O
12	specific	_	specific	_	JJ	27	_	_	_	_	_	_	_	O
13	expertise	_	expertise	_	NN	27	_	_	_	_	_	_	_	O
14	and	_	and	_	CC	27	_	_	_	_	_	_	_	O
15	competencies	_	UNK	_	NNS	27	_	_	_	_	_	_	_	O
16	in	_	in	_	IN	27	_	_	_	_	_	_	_	O
17	nutrition	_	UNK	_	NN	27	_	_	_	_	_	_	_	O
18	.	_	.	_	.	27	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	NNP	27	_	_	_	_	_	_	_	O
2	individualised	_	UNK	_	VBD	27	_	_	_	_	_	_	_	O
3	and	_	and	_	CC	27	_	_	_	_	_	_	_	O
4	ongoing	_	ongoing	_	JJ	27	_	_	_	_	_	_	_	O
5	nutritional	_	UNK	_	JJ	27	_	_	_	_	_	_	_	O
6	advice	_	advice	_	NN	27	_	_	_	_	_	_	_	O
7	from	_	from	_	IN	27	_	_	_	_	_	_	_	O
8	a	_	a	_	DT	27	_	_	_	_	_	_	_	O
9	healthcare	_	healthcare	_	JJ	27	_	_	_	_	_	_	_	O
10	professional	_	professional	_	NN	27	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	27	_	_	_	_	_	_	_	O
12	specific	_	specific	_	JJ	27	_	_	_	_	_	_	_	O
13	expertise	_	expertise	_	NN	27	_	_	_	_	_	expertise.n	Expertise	O
14	and	_	and	_	CC	27	_	_	_	_	_	_	_	O
15	competencies	_	UNK	_	NNS	27	_	_	_	_	_	_	_	O
16	in	_	in	_	IN	27	_	_	_	_	_	_	_	O
17	nutrition	_	UNK	_	NN	27	_	_	_	_	_	_	_	O
18	.	_	.	_	.	27	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	NNP	28	_	_	_	_	_	provide.v	Supply	O
2	dietary	_	UNK	_	JJ	28	_	_	_	_	_	_	_	B-Theme
3	advice	_	advice	_	NN	28	_	_	_	_	_	_	_	I-Theme
4	in	_	in	_	IN	28	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	28	_	_	_	_	_	_	_	O
6	form	_	form	_	NN	28	_	_	_	_	_	_	_	O
7	sensitive	_	sensitive	_	NN	28	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	28	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	28	_	_	_	_	_	_	_	O
10	person	_	person	_	NN	28	_	_	_	_	_	_	_	O
11	's	_	's	_	POS	28	_	_	_	_	_	_	_	O
12	needs	_	need	_	NNS	28	_	_	_	_	_	_	_	O
13	,	_	,	_	,	28	_	_	_	_	_	_	_	O
14	culture	_	culture	_	NN	28	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	28	_	_	_	_	_	_	_	O
16	beliefs	_	belief	_	NN	28	_	_	_	_	_	_	_	O
17	,	_	,	_	,	28	_	_	_	_	_	_	_	O
18	being	_	be	_	VBG	28	_	_	_	_	_	_	_	O
19	sensitive	_	sensitive	_	JJ	28	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	28	_	_	_	_	_	_	_	O
21	their	_	their	_	PRP$	28	_	_	_	_	_	_	_	O
22	willingness	_	willingness	_	NN	28	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	28	_	_	_	_	_	_	_	O
24	change	_	change	_	VB	28	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	28	_	_	_	_	_	_	_	O
26	the	_	the	_	DT	28	_	_	_	_	_	_	_	O
27	effects	_	effect	_	NNS	28	_	_	_	_	_	_	_	O
28	on	_	on	_	IN	28	_	_	_	_	_	_	_	O
29	their	_	their	_	PRP$	28	_	_	_	_	_	_	_	O
30	quality	_	quality	_	NN	28	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	28	_	_	_	_	_	_	_	O
32	life	_	life	_	NN	28	_	_	_	_	_	_	_	O
33	.	_	.	_	.	28	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	NNP	28	_	_	_	_	_	_	_	O
2	dietary	_	UNK	_	JJ	28	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	28	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	28	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	28	_	_	_	_	_	_	_	O
6	form	_	form	_	NN	28	_	_	_	_	_	form.n	Type	S-Subtype
7	sensitive	_	sensitive	_	NN	28	_	_	_	_	_	_	_	S-Category
8	to	_	to	_	TO	28	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	28	_	_	_	_	_	_	_	O
10	person	_	person	_	NN	28	_	_	_	_	_	_	_	O
11	's	_	's	_	POS	28	_	_	_	_	_	_	_	O
12	needs	_	need	_	NNS	28	_	_	_	_	_	_	_	O
13	,	_	,	_	,	28	_	_	_	_	_	_	_	O
14	culture	_	culture	_	NN	28	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	28	_	_	_	_	_	_	_	O
16	beliefs	_	belief	_	NN	28	_	_	_	_	_	_	_	O
17	,	_	,	_	,	28	_	_	_	_	_	_	_	O
18	being	_	be	_	VBG	28	_	_	_	_	_	_	_	O
19	sensitive	_	sensitive	_	JJ	28	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	28	_	_	_	_	_	_	_	O
21	their	_	their	_	PRP$	28	_	_	_	_	_	_	_	O
22	willingness	_	willingness	_	NN	28	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	28	_	_	_	_	_	_	_	O
24	change	_	change	_	VB	28	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	28	_	_	_	_	_	_	_	O
26	the	_	the	_	DT	28	_	_	_	_	_	_	_	O
27	effects	_	effect	_	NNS	28	_	_	_	_	_	_	_	O
28	on	_	on	_	IN	28	_	_	_	_	_	_	_	O
29	their	_	their	_	PRP$	28	_	_	_	_	_	_	_	O
30	quality	_	quality	_	NN	28	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	28	_	_	_	_	_	_	_	O
32	life	_	life	_	NN	28	_	_	_	_	_	_	_	O
33	.	_	.	_	.	28	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	NNP	28	_	_	_	_	_	_	_	O
2	dietary	_	UNK	_	JJ	28	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	28	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	28	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	28	_	_	_	_	_	_	_	O
6	form	_	form	_	NN	28	_	_	_	_	_	_	_	O
7	sensitive	_	sensitive	_	NN	28	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	28	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	28	_	_	_	_	_	_	_	O
10	person	_	person	_	NN	28	_	_	_	_	_	person.n	People	S-Person
11	's	_	's	_	POS	28	_	_	_	_	_	_	_	O
12	needs	_	need	_	NNS	28	_	_	_	_	_	_	_	O
13	,	_	,	_	,	28	_	_	_	_	_	_	_	O
14	culture	_	culture	_	NN	28	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	28	_	_	_	_	_	_	_	O
16	beliefs	_	belief	_	NN	28	_	_	_	_	_	_	_	O
17	,	_	,	_	,	28	_	_	_	_	_	_	_	O
18	being	_	be	_	VBG	28	_	_	_	_	_	_	_	O
19	sensitive	_	sensitive	_	JJ	28	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	28	_	_	_	_	_	_	_	O
21	their	_	their	_	PRP$	28	_	_	_	_	_	_	_	O
22	willingness	_	willingness	_	NN	28	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	28	_	_	_	_	_	_	_	O
24	change	_	change	_	VB	28	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	28	_	_	_	_	_	_	_	O
26	the	_	the	_	DT	28	_	_	_	_	_	_	_	O
27	effects	_	effect	_	NNS	28	_	_	_	_	_	_	_	O
28	on	_	on	_	IN	28	_	_	_	_	_	_	_	O
29	their	_	their	_	PRP$	28	_	_	_	_	_	_	_	O
30	quality	_	quality	_	NN	28	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	28	_	_	_	_	_	_	_	O
32	life	_	life	_	NN	28	_	_	_	_	_	_	_	O
33	.	_	.	_	.	28	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	NNP	28	_	_	_	_	_	_	_	O
2	dietary	_	UNK	_	JJ	28	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	28	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	28	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	28	_	_	_	_	_	_	_	O
6	form	_	form	_	NN	28	_	_	_	_	_	_	_	O
7	sensitive	_	sensitive	_	NN	28	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	28	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	28	_	_	_	_	_	_	_	O
10	person	_	person	_	NN	28	_	_	_	_	_	_	_	B-Cognizer
11	's	_	's	_	POS	28	_	_	_	_	_	_	_	I-Cognizer
12	needs	_	need	_	NNS	28	_	_	_	_	_	need.n	Needing	O
13	,	_	,	_	,	28	_	_	_	_	_	_	_	O
14	culture	_	culture	_	NN	28	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	28	_	_	_	_	_	_	_	O
16	beliefs	_	belief	_	NN	28	_	_	_	_	_	_	_	O
17	,	_	,	_	,	28	_	_	_	_	_	_	_	O
18	being	_	be	_	VBG	28	_	_	_	_	_	_	_	O
19	sensitive	_	sensitive	_	JJ	28	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	28	_	_	_	_	_	_	_	O
21	their	_	their	_	PRP$	28	_	_	_	_	_	_	_	O
22	willingness	_	willingness	_	NN	28	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	28	_	_	_	_	_	_	_	O
24	change	_	change	_	VB	28	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	28	_	_	_	_	_	_	_	O
26	the	_	the	_	DT	28	_	_	_	_	_	_	_	O
27	effects	_	effect	_	NNS	28	_	_	_	_	_	_	_	O
28	on	_	on	_	IN	28	_	_	_	_	_	_	_	O
29	their	_	their	_	PRP$	28	_	_	_	_	_	_	_	O
30	quality	_	quality	_	NN	28	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	28	_	_	_	_	_	_	_	O
32	life	_	life	_	NN	28	_	_	_	_	_	_	_	O
33	.	_	.	_	.	28	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	NNP	28	_	_	_	_	_	_	_	O
2	dietary	_	UNK	_	JJ	28	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	28	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	28	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	28	_	_	_	_	_	_	_	O
6	form	_	form	_	NN	28	_	_	_	_	_	_	_	O
7	sensitive	_	sensitive	_	NN	28	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	28	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	28	_	_	_	_	_	_	_	O
10	person	_	person	_	NN	28	_	_	_	_	_	_	_	O
11	's	_	's	_	POS	28	_	_	_	_	_	_	_	O
12	needs	_	need	_	NNS	28	_	_	_	_	_	_	_	O
13	,	_	,	_	,	28	_	_	_	_	_	_	_	O
14	culture	_	culture	_	NN	28	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	28	_	_	_	_	_	_	_	O
16	beliefs	_	belief	_	NN	28	_	_	_	_	_	belief.n	Opinion	O
17	,	_	,	_	,	28	_	_	_	_	_	_	_	O
18	being	_	be	_	VBG	28	_	_	_	_	_	_	_	O
19	sensitive	_	sensitive	_	JJ	28	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	28	_	_	_	_	_	_	_	O
21	their	_	their	_	PRP$	28	_	_	_	_	_	_	_	O
22	willingness	_	willingness	_	NN	28	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	28	_	_	_	_	_	_	_	O
24	change	_	change	_	VB	28	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	28	_	_	_	_	_	_	_	O
26	the	_	the	_	DT	28	_	_	_	_	_	_	_	O
27	effects	_	effect	_	NNS	28	_	_	_	_	_	_	_	O
28	on	_	on	_	IN	28	_	_	_	_	_	_	_	O
29	their	_	their	_	PRP$	28	_	_	_	_	_	_	_	O
30	quality	_	quality	_	NN	28	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	28	_	_	_	_	_	_	_	O
32	life	_	life	_	NN	28	_	_	_	_	_	_	_	O
33	.	_	.	_	.	28	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	NNP	28	_	_	_	_	_	_	_	O
2	dietary	_	UNK	_	JJ	28	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	28	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	28	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	28	_	_	_	_	_	_	_	O
6	form	_	form	_	NN	28	_	_	_	_	_	_	_	O
7	sensitive	_	sensitive	_	NN	28	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	28	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	28	_	_	_	_	_	_	_	O
10	person	_	person	_	NN	28	_	_	_	_	_	_	_	O
11	's	_	's	_	POS	28	_	_	_	_	_	_	_	O
12	needs	_	need	_	NNS	28	_	_	_	_	_	_	_	O
13	,	_	,	_	,	28	_	_	_	_	_	_	_	O
14	culture	_	culture	_	NN	28	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	28	_	_	_	_	_	_	_	O
16	beliefs	_	belief	_	NN	28	_	_	_	_	_	_	_	O
17	,	_	,	_	,	28	_	_	_	_	_	_	_	O
18	being	_	be	_	VBG	28	_	_	_	_	_	_	_	O
19	sensitive	_	sensitive	_	JJ	28	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	28	_	_	_	_	_	_	_	O
21	their	_	their	_	PRP$	28	_	_	_	_	_	_	_	S-Cognizer
22	willingness	_	willingness	_	NN	28	_	_	_	_	_	willingness.n	Willingness	O
23	to	_	to	_	TO	28	_	_	_	_	_	_	_	B-Activity
24	change	_	change	_	VB	28	_	_	_	_	_	_	_	I-Activity
25	and	_	and	_	CC	28	_	_	_	_	_	_	_	I-Activity
26	the	_	the	_	DT	28	_	_	_	_	_	_	_	I-Activity
27	effects	_	effect	_	NNS	28	_	_	_	_	_	_	_	I-Activity
28	on	_	on	_	IN	28	_	_	_	_	_	_	_	I-Activity
29	their	_	their	_	PRP$	28	_	_	_	_	_	_	_	I-Activity
30	quality	_	quality	_	NN	28	_	_	_	_	_	_	_	I-Activity
31	of	_	of	_	IN	28	_	_	_	_	_	_	_	I-Activity
32	life	_	life	_	NN	28	_	_	_	_	_	_	_	I-Activity
33	.	_	.	_	.	28	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	NNP	28	_	_	_	_	_	_	_	O
2	dietary	_	UNK	_	JJ	28	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	28	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	28	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	28	_	_	_	_	_	_	_	O
6	form	_	form	_	NN	28	_	_	_	_	_	_	_	O
7	sensitive	_	sensitive	_	NN	28	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	28	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	28	_	_	_	_	_	_	_	O
10	person	_	person	_	NN	28	_	_	_	_	_	_	_	O
11	's	_	's	_	POS	28	_	_	_	_	_	_	_	O
12	needs	_	need	_	NNS	28	_	_	_	_	_	_	_	O
13	,	_	,	_	,	28	_	_	_	_	_	_	_	O
14	culture	_	culture	_	NN	28	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	28	_	_	_	_	_	_	_	O
16	beliefs	_	belief	_	NN	28	_	_	_	_	_	_	_	O
17	,	_	,	_	,	28	_	_	_	_	_	_	_	O
18	being	_	be	_	VBG	28	_	_	_	_	_	_	_	O
19	sensitive	_	sensitive	_	JJ	28	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	28	_	_	_	_	_	_	_	O
21	their	_	their	_	PRP$	28	_	_	_	_	_	_	_	S-Entity
22	willingness	_	willingness	_	NN	28	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	28	_	_	_	_	_	_	_	O
24	change	_	change	_	VB	28	_	_	_	_	_	change.v	Undergo_change	O
25	and	_	and	_	CC	28	_	_	_	_	_	_	_	O
26	the	_	the	_	DT	28	_	_	_	_	_	_	_	O
27	effects	_	effect	_	NNS	28	_	_	_	_	_	_	_	O
28	on	_	on	_	IN	28	_	_	_	_	_	_	_	O
29	their	_	their	_	PRP$	28	_	_	_	_	_	_	_	O
30	quality	_	quality	_	NN	28	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	28	_	_	_	_	_	_	_	O
32	life	_	life	_	NN	28	_	_	_	_	_	_	_	O
33	.	_	.	_	.	28	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	NNP	28	_	_	_	_	_	_	_	O
2	dietary	_	UNK	_	JJ	28	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	28	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	28	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	28	_	_	_	_	_	_	_	O
6	form	_	form	_	NN	28	_	_	_	_	_	_	_	O
7	sensitive	_	sensitive	_	NN	28	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	28	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	28	_	_	_	_	_	_	_	O
10	person	_	person	_	NN	28	_	_	_	_	_	_	_	O
11	's	_	's	_	POS	28	_	_	_	_	_	_	_	O
12	needs	_	need	_	NNS	28	_	_	_	_	_	_	_	O
13	,	_	,	_	,	28	_	_	_	_	_	_	_	O
14	culture	_	culture	_	NN	28	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	28	_	_	_	_	_	_	_	O
16	beliefs	_	belief	_	NN	28	_	_	_	_	_	_	_	O
17	,	_	,	_	,	28	_	_	_	_	_	_	_	O
18	being	_	be	_	VBG	28	_	_	_	_	_	_	_	O
19	sensitive	_	sensitive	_	JJ	28	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	28	_	_	_	_	_	_	_	O
21	their	_	their	_	PRP$	28	_	_	_	_	_	_	_	O
22	willingness	_	willingness	_	NN	28	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	28	_	_	_	_	_	_	_	O
24	change	_	change	_	VB	28	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	28	_	_	_	_	_	_	_	O
26	the	_	the	_	DT	28	_	_	_	_	_	_	_	O
27	effects	_	effect	_	NNS	28	_	_	_	_	_	effect.n	Objective_influence	O
28	on	_	on	_	IN	28	_	_	_	_	_	_	_	B-Dependent_entity
29	their	_	their	_	PRP$	28	_	_	_	_	_	_	_	I-Dependent_entity
30	quality	_	quality	_	NN	28	_	_	_	_	_	_	_	I-Dependent_entity
31	of	_	of	_	IN	28	_	_	_	_	_	_	_	I-Dependent_entity
32	life	_	life	_	NN	28	_	_	_	_	_	_	_	I-Dependent_entity
33	.	_	.	_	.	28	_	_	_	_	_	_	_	O

1	emphasise	_	UNK	_	NNP	29	_	_	_	_	_	_	_	O
2	advice	_	advice	_	NN	29	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	29	_	_	_	_	_	_	_	O
4	healthy	_	healthy	_	JJ	29	_	_	_	_	_	_	_	O
5	balanced	_	balance	_	VBN	29	_	_	_	_	_	_	_	O
6	eating	_	UNK	_	NN	29	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	29	_	_	_	_	_	_	_	O
8	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
9	applicable	_	applicable	_	JJ	29	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	29	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	29	_	_	_	_	_	_	_	O
12	general	_	general	_	JJ	29	_	_	_	_	_	_	_	S-Aggregate_property
13	population	_	population	_	NN	29	_	_	_	_	_	population.n	Aggregate	S-Aggregate
14	when	_	when	_	WRB	29	_	_	_	_	_	_	_	O
15	providing	_	provide	_	VBG	29	_	_	_	_	_	_	_	O
16	advice	_	advice	_	NN	29	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	29	_	_	_	_	_	_	_	O
18	adults	_	adult	_	NNS	29	_	_	_	_	_	_	_	O
19	with	_	with	_	IN	29	_	_	_	_	_	_	_	O
20	type	_	type	_	JJ	29	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	29	_	_	_	_	_	_	_	O
22	diabetes	_	UNK	_	NNS	29	_	_	_	_	_	_	_	O

1	emphasise	_	UNK	_	NNP	29	_	_	_	_	_	_	_	B-Supplier
2	advice	_	advice	_	NN	29	_	_	_	_	_	_	_	I-Supplier
3	on	_	on	_	IN	29	_	_	_	_	_	_	_	I-Supplier
4	healthy	_	healthy	_	JJ	29	_	_	_	_	_	_	_	I-Supplier
5	balanced	_	balance	_	VBN	29	_	_	_	_	_	_	_	I-Supplier
6	eating	_	UNK	_	NN	29	_	_	_	_	_	_	_	I-Supplier
7	that	_	that	_	WDT	29	_	_	_	_	_	_	_	I-Supplier
8	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	I-Supplier
9	applicable	_	applicable	_	JJ	29	_	_	_	_	_	_	_	I-Supplier
10	to	_	to	_	TO	29	_	_	_	_	_	_	_	I-Supplier
11	the	_	the	_	DT	29	_	_	_	_	_	_	_	I-Supplier
12	general	_	general	_	JJ	29	_	_	_	_	_	_	_	I-Supplier
13	population	_	population	_	NN	29	_	_	_	_	_	_	_	I-Supplier
14	when	_	when	_	WRB	29	_	_	_	_	_	_	_	O
15	providing	_	provide	_	VBG	29	_	_	_	_	_	provide.v	Supply	O
16	advice	_	advice	_	NN	29	_	_	_	_	_	_	_	S-Theme
17	to	_	to	_	TO	29	_	_	_	_	_	_	_	O
18	adults	_	adult	_	NNS	29	_	_	_	_	_	_	_	O
19	with	_	with	_	IN	29	_	_	_	_	_	_	_	O
20	type	_	type	_	JJ	29	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	29	_	_	_	_	_	_	_	O
22	diabetes	_	UNK	_	NNS	29	_	_	_	_	_	_	_	O

1	emphasise	_	UNK	_	NNP	29	_	_	_	_	_	_	_	O
2	advice	_	advice	_	NN	29	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	29	_	_	_	_	_	_	_	O
4	healthy	_	healthy	_	JJ	29	_	_	_	_	_	_	_	O
5	balanced	_	balance	_	VBN	29	_	_	_	_	_	_	_	O
6	eating	_	UNK	_	NN	29	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	29	_	_	_	_	_	_	_	O
8	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
9	applicable	_	applicable	_	JJ	29	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	29	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	29	_	_	_	_	_	_	_	O
12	general	_	general	_	JJ	29	_	_	_	_	_	_	_	O
13	population	_	population	_	NN	29	_	_	_	_	_	_	_	O
14	when	_	when	_	WRB	29	_	_	_	_	_	_	_	O
15	providing	_	provide	_	VBG	29	_	_	_	_	_	_	_	O
16	advice	_	advice	_	NN	29	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	29	_	_	_	_	_	_	_	O
18	adults	_	adult	_	NNS	29	_	_	_	_	_	adult.n	People_by_age	S-Person
19	with	_	with	_	IN	29	_	_	_	_	_	_	_	O
20	type	_	type	_	JJ	29	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	29	_	_	_	_	_	_	_	O
22	diabetes	_	UNK	_	NNS	29	_	_	_	_	_	_	_	O

1	emphasise	_	UNK	_	NNP	29	_	_	_	_	_	_	_	O
2	advice	_	advice	_	NN	29	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	29	_	_	_	_	_	_	_	O
4	healthy	_	healthy	_	JJ	29	_	_	_	_	_	_	_	O
5	balanced	_	balance	_	VBN	29	_	_	_	_	_	_	_	O
6	eating	_	UNK	_	NN	29	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	29	_	_	_	_	_	_	_	O
8	is	_	be	_	VBZ	29	_	_	_	_	_	_	_	O
9	applicable	_	applicable	_	JJ	29	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	29	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	29	_	_	_	_	_	_	_	O
12	general	_	general	_	JJ	29	_	_	_	_	_	_	_	O
13	population	_	population	_	NN	29	_	_	_	_	_	_	_	O
14	when	_	when	_	WRB	29	_	_	_	_	_	_	_	O
15	providing	_	provide	_	VBG	29	_	_	_	_	_	_	_	O
16	advice	_	advice	_	NN	29	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	29	_	_	_	_	_	_	_	O
18	adults	_	adult	_	NNS	29	_	_	_	_	_	_	_	O
19	with	_	with	_	IN	29	_	_	_	_	_	_	_	O
20	type	_	type	_	JJ	29	_	_	_	_	_	type.n	Type	S-Subtype
21	2	_	2	_	CD	29	_	_	_	_	_	_	_	O
22	diabetes	_	UNK	_	NNS	29	_	_	_	_	_	_	_	O

1	encourage	_	UNK	_	VB	30	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
3	,	_	,	_	,	30	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	30	_	_	_	_	_	_	_	S-Descriptor
5	sources	_	source	_	NNS	30	_	_	_	_	_	source.n	Source_of_getting	S-Source
6	of	_	of	_	IN	30	_	_	_	_	_	_	_	O
7	carbohydrate	_	UNK	_	NN	30	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	30	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	30	_	_	_	_	_	_	_	O
10	diet	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
11	,	_	,	_	,	30	_	_	_	_	_	_	_	O
12	such	_	such	_	JJ	30	_	_	_	_	_	_	_	O
13	as	_	a	_	IN	30	_	_	_	_	_	_	_	O
14	fruit	_	fruit	_	NN	30	_	_	_	_	_	_	_	O
15	,	_	,	_	,	30	_	_	_	_	_	_	_	O
16	vegetables	_	vegetable	_	NNS	30	_	_	_	_	_	_	_	O
17	,	_	,	_	,	30	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	NNS	30	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
20	pulses	_	UNK	_	NNS	30	_	_	_	_	_	_	_	O
21	;	_	;	_	:	30	_	_	_	_	_	_	_	O
22	include	_	include	_	VB	30	_	_	_	_	_	_	_	O
23	low-fat	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
24	dairy	_	UNK	_	NN	30	_	_	_	_	_	_	_	O
25	products	_	product	_	NNS	30	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
27	oily	_	UNK	_	RB	30	_	_	_	_	_	_	_	O
28	fish	_	fish	_	JJ	30	_	_	_	_	_	_	_	O
29	;	_	;	_	:	30	_	_	_	_	_	_	_	O
30	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
31	control	_	control	_	VB	30	_	_	_	_	_	_	_	O
32	the	_	the	_	DT	30	_	_	_	_	_	_	_	O
33	intake	_	UNK	_	NN	30	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	30	_	_	_	_	_	_	_	O
35	foods	_	food	_	NNS	30	_	_	_	_	_	_	_	O
36	containing	_	contain	_	VBG	30	_	_	_	_	_	_	_	O
37	saturated	_	UNK	_	VBN	30	_	_	_	_	_	_	_	O
38	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
39	trans	_	UNK	_	NNS	30	_	_	_	_	_	_	_	O
40	fatty	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
41	acids	_	acid	_	NNS	30	_	_	_	_	_	_	_	O
42	.	_	.	_	.	30	_	_	_	_	_	_	_	O

1	encourage	_	UNK	_	VB	30	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
3	,	_	,	_	,	30	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
5	sources	_	source	_	NNS	30	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	30	_	_	_	_	_	_	_	O
7	carbohydrate	_	UNK	_	NN	30	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	30	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	30	_	_	_	_	_	_	_	O
10	diet	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
11	,	_	,	_	,	30	_	_	_	_	_	_	_	O
12	such	_	such	_	JJ	30	_	_	_	_	_	_	_	O
13	as	_	a	_	IN	30	_	_	_	_	_	_	_	O
14	fruit	_	fruit	_	NN	30	_	_	_	_	_	fruit.n	Food	S-Food
15	,	_	,	_	,	30	_	_	_	_	_	_	_	O
16	vegetables	_	vegetable	_	NNS	30	_	_	_	_	_	_	_	O
17	,	_	,	_	,	30	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	NNS	30	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
20	pulses	_	UNK	_	NNS	30	_	_	_	_	_	_	_	O
21	;	_	;	_	:	30	_	_	_	_	_	_	_	O
22	include	_	include	_	VB	30	_	_	_	_	_	_	_	O
23	low-fat	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
24	dairy	_	UNK	_	NN	30	_	_	_	_	_	_	_	O
25	products	_	product	_	NNS	30	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
27	oily	_	UNK	_	RB	30	_	_	_	_	_	_	_	O
28	fish	_	fish	_	JJ	30	_	_	_	_	_	_	_	O
29	;	_	;	_	:	30	_	_	_	_	_	_	_	O
30	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
31	control	_	control	_	VB	30	_	_	_	_	_	_	_	O
32	the	_	the	_	DT	30	_	_	_	_	_	_	_	O
33	intake	_	UNK	_	NN	30	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	30	_	_	_	_	_	_	_	O
35	foods	_	food	_	NNS	30	_	_	_	_	_	_	_	O
36	containing	_	contain	_	VBG	30	_	_	_	_	_	_	_	O
37	saturated	_	UNK	_	VBN	30	_	_	_	_	_	_	_	O
38	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
39	trans	_	UNK	_	NNS	30	_	_	_	_	_	_	_	O
40	fatty	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
41	acids	_	acid	_	NNS	30	_	_	_	_	_	_	_	O
42	.	_	.	_	.	30	_	_	_	_	_	_	_	O

1	encourage	_	UNK	_	VB	30	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
3	,	_	,	_	,	30	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
5	sources	_	source	_	NNS	30	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	30	_	_	_	_	_	_	_	O
7	carbohydrate	_	UNK	_	NN	30	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	30	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	30	_	_	_	_	_	_	_	O
10	diet	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
11	,	_	,	_	,	30	_	_	_	_	_	_	_	O
12	such	_	such	_	JJ	30	_	_	_	_	_	_	_	O
13	as	_	a	_	IN	30	_	_	_	_	_	_	_	O
14	fruit	_	fruit	_	NN	30	_	_	_	_	_	_	_	O
15	,	_	,	_	,	30	_	_	_	_	_	_	_	O
16	vegetables	_	vegetable	_	NNS	30	_	_	_	_	_	vegetable.n	Food	S-Food
17	,	_	,	_	,	30	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	NNS	30	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
20	pulses	_	UNK	_	NNS	30	_	_	_	_	_	_	_	O
21	;	_	;	_	:	30	_	_	_	_	_	_	_	O
22	include	_	include	_	VB	30	_	_	_	_	_	_	_	O
23	low-fat	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
24	dairy	_	UNK	_	NN	30	_	_	_	_	_	_	_	O
25	products	_	product	_	NNS	30	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
27	oily	_	UNK	_	RB	30	_	_	_	_	_	_	_	O
28	fish	_	fish	_	JJ	30	_	_	_	_	_	_	_	O
29	;	_	;	_	:	30	_	_	_	_	_	_	_	O
30	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
31	control	_	control	_	VB	30	_	_	_	_	_	_	_	O
32	the	_	the	_	DT	30	_	_	_	_	_	_	_	O
33	intake	_	UNK	_	NN	30	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	30	_	_	_	_	_	_	_	O
35	foods	_	food	_	NNS	30	_	_	_	_	_	_	_	O
36	containing	_	contain	_	VBG	30	_	_	_	_	_	_	_	O
37	saturated	_	UNK	_	VBN	30	_	_	_	_	_	_	_	O
38	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
39	trans	_	UNK	_	NNS	30	_	_	_	_	_	_	_	O
40	fatty	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
41	acids	_	acid	_	NNS	30	_	_	_	_	_	_	_	O
42	.	_	.	_	.	30	_	_	_	_	_	_	_	O

1	encourage	_	UNK	_	VB	30	_	_	_	_	_	_	_	B-Total
2	unk	_	UNK	_	JJ	30	_	_	_	_	_	_	_	I-Total
3	,	_	,	_	,	30	_	_	_	_	_	_	_	I-Total
4	unk	_	UNK	_	JJ	30	_	_	_	_	_	_	_	I-Total
5	sources	_	source	_	NNS	30	_	_	_	_	_	_	_	I-Total
6	of	_	of	_	IN	30	_	_	_	_	_	_	_	I-Total
7	carbohydrate	_	UNK	_	NN	30	_	_	_	_	_	_	_	I-Total
8	in	_	in	_	IN	30	_	_	_	_	_	_	_	I-Total
9	the	_	the	_	DT	30	_	_	_	_	_	_	_	I-Total
10	diet	_	UNK	_	JJ	30	_	_	_	_	_	_	_	I-Total
11	,	_	,	_	,	30	_	_	_	_	_	_	_	I-Total
12	such	_	such	_	JJ	30	_	_	_	_	_	_	_	I-Total
13	as	_	a	_	IN	30	_	_	_	_	_	_	_	I-Total
14	fruit	_	fruit	_	NN	30	_	_	_	_	_	_	_	I-Total
15	,	_	,	_	,	30	_	_	_	_	_	_	_	I-Total
16	vegetables	_	vegetable	_	NNS	30	_	_	_	_	_	_	_	I-Total
17	,	_	,	_	,	30	_	_	_	_	_	_	_	I-Total
18	unk	_	UNK	_	NNS	30	_	_	_	_	_	_	_	I-Total
19	and	_	and	_	CC	30	_	_	_	_	_	_	_	I-Total
20	pulses	_	UNK	_	NNS	30	_	_	_	_	_	_	_	I-Total
21	;	_	;	_	:	30	_	_	_	_	_	_	_	O
22	include	_	include	_	VB	30	_	_	_	_	_	include.v	Inclusion	O
23	low-fat	_	UNK	_	JJ	30	_	_	_	_	_	_	_	B-Part
24	dairy	_	UNK	_	NN	30	_	_	_	_	_	_	_	I-Part
25	products	_	product	_	NNS	30	_	_	_	_	_	_	_	I-Part
26	and	_	and	_	CC	30	_	_	_	_	_	_	_	I-Part
27	oily	_	UNK	_	RB	30	_	_	_	_	_	_	_	I-Part
28	fish	_	fish	_	JJ	30	_	_	_	_	_	_	_	I-Part
29	;	_	;	_	:	30	_	_	_	_	_	_	_	I-Part
30	and	_	and	_	CC	30	_	_	_	_	_	_	_	I-Part
31	control	_	control	_	VB	30	_	_	_	_	_	_	_	I-Part
32	the	_	the	_	DT	30	_	_	_	_	_	_	_	I-Part
33	intake	_	UNK	_	NN	30	_	_	_	_	_	_	_	I-Part
34	of	_	of	_	IN	30	_	_	_	_	_	_	_	I-Part
35	foods	_	food	_	NNS	30	_	_	_	_	_	_	_	I-Part
36	containing	_	contain	_	VBG	30	_	_	_	_	_	_	_	I-Part
37	saturated	_	UNK	_	VBN	30	_	_	_	_	_	_	_	I-Part
38	and	_	and	_	CC	30	_	_	_	_	_	_	_	I-Part
39	trans	_	UNK	_	NNS	30	_	_	_	_	_	_	_	I-Part
40	fatty	_	UNK	_	JJ	30	_	_	_	_	_	_	_	I-Part
41	acids	_	acid	_	NNS	30	_	_	_	_	_	_	_	I-Part
42	.	_	.	_	.	30	_	_	_	_	_	_	_	O

1	encourage	_	UNK	_	VB	30	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
3	,	_	,	_	,	30	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
5	sources	_	source	_	NNS	30	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	30	_	_	_	_	_	_	_	O
7	carbohydrate	_	UNK	_	NN	30	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	30	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	30	_	_	_	_	_	_	_	O
10	diet	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
11	,	_	,	_	,	30	_	_	_	_	_	_	_	O
12	such	_	such	_	JJ	30	_	_	_	_	_	_	_	O
13	as	_	a	_	IN	30	_	_	_	_	_	_	_	O
14	fruit	_	fruit	_	NN	30	_	_	_	_	_	_	_	O
15	,	_	,	_	,	30	_	_	_	_	_	_	_	O
16	vegetables	_	vegetable	_	NNS	30	_	_	_	_	_	_	_	O
17	,	_	,	_	,	30	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	NNS	30	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
20	pulses	_	UNK	_	NNS	30	_	_	_	_	_	_	_	O
21	;	_	;	_	:	30	_	_	_	_	_	_	_	O
22	include	_	include	_	VB	30	_	_	_	_	_	_	_	O
23	low-fat	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
24	dairy	_	UNK	_	NN	30	_	_	_	_	_	_	_	O
25	products	_	product	_	NNS	30	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
27	oily	_	UNK	_	RB	30	_	_	_	_	_	_	_	S-Degree
28	fish	_	fish	_	JJ	30	_	_	_	_	_	fish.v	Hunting	S-Food
29	;	_	;	_	:	30	_	_	_	_	_	_	_	O
30	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
31	control	_	control	_	VB	30	_	_	_	_	_	_	_	O
32	the	_	the	_	DT	30	_	_	_	_	_	_	_	O
33	intake	_	UNK	_	NN	30	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	30	_	_	_	_	_	_	_	O
35	foods	_	food	_	NNS	30	_	_	_	_	_	_	_	O
36	containing	_	contain	_	VBG	30	_	_	_	_	_	_	_	O
37	saturated	_	UNK	_	VBN	30	_	_	_	_	_	_	_	O
38	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
39	trans	_	UNK	_	NNS	30	_	_	_	_	_	_	_	O
40	fatty	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
41	acids	_	acid	_	NNS	30	_	_	_	_	_	_	_	O
42	.	_	.	_	.	30	_	_	_	_	_	_	_	O

1	encourage	_	UNK	_	VB	30	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
3	,	_	,	_	,	30	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
5	sources	_	source	_	NNS	30	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	30	_	_	_	_	_	_	_	O
7	carbohydrate	_	UNK	_	NN	30	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	30	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	30	_	_	_	_	_	_	_	O
10	diet	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
11	,	_	,	_	,	30	_	_	_	_	_	_	_	O
12	such	_	such	_	JJ	30	_	_	_	_	_	_	_	O
13	as	_	a	_	IN	30	_	_	_	_	_	_	_	O
14	fruit	_	fruit	_	NN	30	_	_	_	_	_	_	_	O
15	,	_	,	_	,	30	_	_	_	_	_	_	_	O
16	vegetables	_	vegetable	_	NNS	30	_	_	_	_	_	_	_	O
17	,	_	,	_	,	30	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	NNS	30	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
20	pulses	_	UNK	_	NNS	30	_	_	_	_	_	_	_	O
21	;	_	;	_	:	30	_	_	_	_	_	_	_	O
22	include	_	include	_	VB	30	_	_	_	_	_	_	_	O
23	low-fat	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
24	dairy	_	UNK	_	NN	30	_	_	_	_	_	_	_	O
25	products	_	product	_	NNS	30	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
27	oily	_	UNK	_	RB	30	_	_	_	_	_	_	_	O
28	fish	_	fish	_	JJ	30	_	_	_	_	_	_	_	O
29	;	_	;	_	:	30	_	_	_	_	_	_	_	O
30	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
31	control	_	control	_	VB	30	_	_	_	_	_	_	_	O
32	the	_	the	_	DT	30	_	_	_	_	_	_	_	O
33	intake	_	UNK	_	NN	30	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	30	_	_	_	_	_	_	_	O
35	foods	_	food	_	NNS	30	_	_	_	_	_	food.n	Food	S-Food
36	containing	_	contain	_	VBG	30	_	_	_	_	_	_	_	O
37	saturated	_	UNK	_	VBN	30	_	_	_	_	_	_	_	O
38	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
39	trans	_	UNK	_	NNS	30	_	_	_	_	_	_	_	O
40	fatty	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
41	acids	_	acid	_	NNS	30	_	_	_	_	_	_	_	O
42	.	_	.	_	.	30	_	_	_	_	_	_	_	O

1	encourage	_	UNK	_	VB	30	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
3	,	_	,	_	,	30	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
5	sources	_	source	_	NNS	30	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	30	_	_	_	_	_	_	_	O
7	carbohydrate	_	UNK	_	NN	30	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	30	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	30	_	_	_	_	_	_	_	O
10	diet	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
11	,	_	,	_	,	30	_	_	_	_	_	_	_	O
12	such	_	such	_	JJ	30	_	_	_	_	_	_	_	O
13	as	_	a	_	IN	30	_	_	_	_	_	_	_	O
14	fruit	_	fruit	_	NN	30	_	_	_	_	_	_	_	O
15	,	_	,	_	,	30	_	_	_	_	_	_	_	O
16	vegetables	_	vegetable	_	NNS	30	_	_	_	_	_	_	_	O
17	,	_	,	_	,	30	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	NNS	30	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
20	pulses	_	UNK	_	NNS	30	_	_	_	_	_	_	_	O
21	;	_	;	_	:	30	_	_	_	_	_	_	_	O
22	include	_	include	_	VB	30	_	_	_	_	_	_	_	O
23	low-fat	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
24	dairy	_	UNK	_	NN	30	_	_	_	_	_	_	_	O
25	products	_	product	_	NNS	30	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
27	oily	_	UNK	_	RB	30	_	_	_	_	_	_	_	O
28	fish	_	fish	_	JJ	30	_	_	_	_	_	_	_	O
29	;	_	;	_	:	30	_	_	_	_	_	_	_	O
30	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
31	control	_	control	_	VB	30	_	_	_	_	_	_	_	O
32	the	_	the	_	DT	30	_	_	_	_	_	_	_	O
33	intake	_	UNK	_	NN	30	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	30	_	_	_	_	_	_	_	O
35	foods	_	food	_	NNS	30	_	_	_	_	_	_	_	O
36	containing	_	contain	_	VBG	30	_	_	_	_	_	_	_	O
37	saturated	_	UNK	_	VBN	30	_	_	_	_	_	_	_	O
38	and	_	and	_	CC	30	_	_	_	_	_	_	_	O
39	trans	_	UNK	_	NNS	30	_	_	_	_	_	_	_	O
40	fatty	_	UNK	_	JJ	30	_	_	_	_	_	_	_	O
41	acids	_	acid	_	NNS	30	_	_	_	_	_	acid.n	Intoxicants	S-Intoxicant
42	.	_	.	_	.	30	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	31	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	31	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	31	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	31	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	31	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	31	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	31	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	31	_	_	_	_	_	_	_	O
9	overweight	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
10	,	_	,	_	,	31	_	_	_	_	_	_	_	O
11	set	_	set	_	VBD	31	_	_	_	_	_	_	_	O
12	an	_	an	_	DT	31	_	_	_	_	_	_	_	O
13	initial	_	initial	_	JJ	31	_	_	_	_	_	_	_	O
14	body	_	body	_	NN	31	_	_	_	_	_	_	_	O
15	weight	_	weight	_	JJ	31	_	_	_	_	_	_	_	O
16	loss	_	loss	_	NN	31	_	_	_	_	_	_	_	O
17	target	_	target	_	NN	31	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	31	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
20	%	_	%	_	NN	31	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	31	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	31	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	31	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	31	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	31	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	31	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	31	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	31	_	_	_	_	_	_	_	O
9	overweight	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
10	,	_	,	_	,	31	_	_	_	_	_	_	_	O
11	set	_	set	_	VBD	31	_	_	_	_	_	_	_	O
12	an	_	an	_	DT	31	_	_	_	_	_	_	_	O
13	initial	_	initial	_	JJ	31	_	_	_	_	_	_	_	O
14	body	_	body	_	NN	31	_	_	_	_	_	_	_	O
15	weight	_	weight	_	JJ	31	_	_	_	_	_	_	_	O
16	loss	_	loss	_	NN	31	_	_	_	_	_	_	_	O
17	target	_	target	_	NN	31	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	31	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
20	%	_	%	_	NN	31	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	31	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	31	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	31	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	31	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	31	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	31	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	31	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	31	_	_	_	_	_	_	_	O
9	overweight	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
10	,	_	,	_	,	31	_	_	_	_	_	_	_	O
11	set	_	set	_	VBD	31	_	_	_	_	_	_	_	O
12	an	_	an	_	DT	31	_	_	_	_	_	_	_	O
13	initial	_	initial	_	JJ	31	_	_	_	_	_	_	_	S-Descriptor
14	body	_	body	_	NN	31	_	_	_	_	_	body.n	Body_parts	S-Body_part
15	weight	_	weight	_	JJ	31	_	_	_	_	_	_	_	O
16	loss	_	loss	_	NN	31	_	_	_	_	_	_	_	O
17	target	_	target	_	NN	31	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	31	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
20	%	_	%	_	NN	31	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	31	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	31	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	31	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	31	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	31	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	31	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	31	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	31	_	_	_	_	_	_	_	O
9	overweight	_	UNK	_	JJ	31	_	_	_	_	_	_	_	O
10	,	_	,	_	,	31	_	_	_	_	_	_	_	O
11	set	_	set	_	VBD	31	_	_	_	_	_	_	_	O
12	an	_	an	_	DT	31	_	_	_	_	_	_	_	O
13	initial	_	initial	_	JJ	31	_	_	_	_	_	_	_	O
14	body	_	body	_	NN	31	_	_	_	_	_	_	_	S-Object
15	weight	_	weight	_	JJ	31	_	_	_	_	_	weight.n	Dimension	S-Dimension
16	loss	_	loss	_	NN	31	_	_	_	_	_	_	_	O
17	target	_	target	_	NN	31	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	31	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	CD	31	_	_	_	_	_	_	_	O
20	%	_	%	_	NN	31	_	_	_	_	_	_	_	O

1	unk	_	UNK	_	NNP	32	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	32	_	_	_	_	_	_	_	O
3	for	_	for	_	IN	32	_	_	_	_	_	_	_	O
4	carbohydrate	_	UNK	_	NN	32	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	32	_	_	_	_	_	_	_	O
6	alcohol	_	alcohol	_	NN	32	_	_	_	_	_	alcohol.n	Intoxicants	S-Intoxicant
7	intake	_	UNK	_	NN	32	_	_	_	_	_	_	_	O
8	,	_	,	_	,	32	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	32	_	_	_	_	_	_	_	O
10	meal	_	meal	_	NN	32	_	_	_	_	_	_	_	O
11	patterns	_	pattern	_	NNS	32	_	_	_	_	_	_	_	O

1	unk	_	UNK	_	NNP	32	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	32	_	_	_	_	_	_	_	O
3	for	_	for	_	IN	32	_	_	_	_	_	_	_	O
4	carbohydrate	_	UNK	_	NN	32	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	32	_	_	_	_	_	_	_	O
6	alcohol	_	alcohol	_	NN	32	_	_	_	_	_	_	_	O
7	intake	_	UNK	_	NN	32	_	_	_	_	_	_	_	O
8	,	_	,	_	,	32	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	32	_	_	_	_	_	_	_	O
10	meal	_	meal	_	NN	32	_	_	_	_	_	_	_	S-Entities
11	patterns	_	pattern	_	NNS	32	_	_	_	_	_	pattern.n	Pattern	O

1	reducing	_	UNK	_	VBG	33	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	33	_	_	_	_	_	_	_	O
3	risk	_	risk	_	NN	33	_	_	_	_	_	risk.n	Run_risk	O
4	of	_	of	_	IN	33	_	_	_	_	_	_	_	B-Asset
5	unk	_	UNK	_	NN	33	_	_	_	_	_	_	_	I-Asset
6	should	_	should	_	MD	33	_	_	_	_	_	_	_	O
7	be	_	be	_	VB	33	_	_	_	_	_	_	_	O
8	a	_	a	_	DT	33	_	_	_	_	_	_	_	O
9	particular	_	particular	_	JJ	33	_	_	_	_	_	_	_	O
10	aim	_	aim	_	NN	33	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	33	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	33	_	_	_	_	_	_	_	O
13	person	_	person	_	NN	33	_	_	_	_	_	_	_	O
14	using	_	use	_	VBG	33	_	_	_	_	_	_	_	O
15	insulin	_	UNK	_	NN	33	_	_	_	_	_	_	_	O
16	or	_	or	_	CC	33	_	_	_	_	_	_	_	O
17	an	_	an	_	DT	33	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	JJ	33	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NN	33	_	_	_	_	_	_	_	O
20	.	_	.	_	.	33	_	_	_	_	_	_	_	O

1	reducing	_	UNK	_	VBG	33	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	33	_	_	_	_	_	_	_	O
3	risk	_	risk	_	NN	33	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	33	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	NN	33	_	_	_	_	_	_	_	O
6	should	_	should	_	MD	33	_	_	_	_	_	_	_	O
7	be	_	be	_	VB	33	_	_	_	_	_	_	_	O
8	a	_	a	_	DT	33	_	_	_	_	_	_	_	O
9	particular	_	particular	_	JJ	33	_	_	_	_	_	_	_	O
10	aim	_	aim	_	NN	33	_	_	_	_	_	aim.n	Purpose	O
11	for	_	for	_	IN	33	_	_	_	_	_	_	_	B-Goal
12	a	_	a	_	DT	33	_	_	_	_	_	_	_	I-Goal
13	person	_	person	_	NN	33	_	_	_	_	_	_	_	I-Goal
14	using	_	use	_	VBG	33	_	_	_	_	_	_	_	I-Goal
15	insulin	_	UNK	_	NN	33	_	_	_	_	_	_	_	I-Goal
16	or	_	or	_	CC	33	_	_	_	_	_	_	_	I-Goal
17	an	_	an	_	DT	33	_	_	_	_	_	_	_	I-Goal
18	insulin	_	UNK	_	JJ	33	_	_	_	_	_	_	_	I-Goal
19	unk	_	UNK	_	NN	33	_	_	_	_	_	_	_	I-Goal
20	.	_	.	_	.	33	_	_	_	_	_	_	_	O

1	reducing	_	UNK	_	VBG	33	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	33	_	_	_	_	_	_	_	O
3	risk	_	risk	_	NN	33	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	33	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	NN	33	_	_	_	_	_	_	_	O
6	should	_	should	_	MD	33	_	_	_	_	_	_	_	O
7	be	_	be	_	VB	33	_	_	_	_	_	_	_	O
8	a	_	a	_	DT	33	_	_	_	_	_	_	_	O
9	particular	_	particular	_	JJ	33	_	_	_	_	_	_	_	O
10	aim	_	aim	_	NN	33	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	33	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	33	_	_	_	_	_	_	_	O
13	person	_	person	_	NN	33	_	_	_	_	_	person.n	People	S-Person
14	using	_	use	_	VBG	33	_	_	_	_	_	_	_	O
15	insulin	_	UNK	_	NN	33	_	_	_	_	_	_	_	O
16	or	_	or	_	CC	33	_	_	_	_	_	_	_	O
17	an	_	an	_	DT	33	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	JJ	33	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NN	33	_	_	_	_	_	_	_	O
20	.	_	.	_	.	33	_	_	_	_	_	_	_	O

1	reducing	_	UNK	_	VBG	33	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	33	_	_	_	_	_	_	_	O
3	risk	_	risk	_	NN	33	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	33	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	NN	33	_	_	_	_	_	_	_	O
6	should	_	should	_	MD	33	_	_	_	_	_	_	_	O
7	be	_	be	_	VB	33	_	_	_	_	_	_	_	O
8	a	_	a	_	DT	33	_	_	_	_	_	_	_	O
9	particular	_	particular	_	JJ	33	_	_	_	_	_	_	_	O
10	aim	_	aim	_	NN	33	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	33	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	33	_	_	_	_	_	_	_	B-Agent
13	person	_	person	_	NN	33	_	_	_	_	_	_	_	I-Agent
14	using	_	use	_	VBG	33	_	_	_	_	_	use.v	Using	O
15	insulin	_	UNK	_	NN	33	_	_	_	_	_	_	_	B-Instrument
16	or	_	or	_	CC	33	_	_	_	_	_	_	_	I-Instrument
17	an	_	an	_	DT	33	_	_	_	_	_	_	_	I-Instrument
18	insulin	_	UNK	_	JJ	33	_	_	_	_	_	_	_	I-Instrument
19	unk	_	UNK	_	NN	33	_	_	_	_	_	_	_	I-Instrument
20	.	_	.	_	.	33	_	_	_	_	_	_	_	O

1	advise	_	UNK	_	NNP	34	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	34	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	34	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	34	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	34	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	34	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	34	_	_	_	_	_	_	_	O
8	limited	_	limit	_	VBD	34	_	_	_	_	_	_	_	O
9	substitution	_	UNK	_	NN	34	_	_	_	_	_	_	_	O
10	of	_	of	_	IN	34	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	34	_	_	_	_	_	_	_	O
12	foods	_	food	_	NNS	34	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	34	_	_	_	_	_	_	_	O
14	other	_	other	_	JJ	34	_	_	_	_	_	_	_	O
15	carbohydrate	_	UNK	_	NN	34	_	_	_	_	_	_	_	O
16	in	_	in	_	IN	34	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	34	_	_	_	_	_	_	_	O
18	meal	_	meal	_	NN	34	_	_	_	_	_	_	_	O
19	plan	_	plan	_	NN	34	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	34	_	_	_	_	_	_	_	O
21	allowable	_	UNK	_	JJ	34	_	_	_	_	_	_	_	O
22	,	_	,	_	,	34	_	_	_	_	_	_	_	O
23	but	_	but	_	CC	34	_	_	_	_	_	_	_	O
24	that	_	that	_	IN	34	_	_	_	_	_	_	_	O
25	they	_	they	_	PRP	34	_	_	_	_	_	_	_	O
26	should	_	should	_	MD	34	_	_	_	_	_	_	_	O
27	take	_	take	_	VB	34	_	_	_	_	_	_	_	O
28	care	_	care	_	NN	34	_	_	_	_	_	_	_	O
29	to	_	to	_	TO	34	_	_	_	_	_	_	_	O
30	avoid	_	avoid	_	VB	34	_	_	_	_	_	_	_	O
31	excess	_	excess	_	JJ	34	_	_	_	_	_	_	_	O
32	energy	_	energy	_	NN	34	_	_	_	_	_	_	_	O
33	intake	_	UNK	_	NN	34	_	_	_	_	_	_	_	O
34	.	_	.	_	.	34	_	_	_	_	_	_	_	O

1	advise	_	UNK	_	NNP	34	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	34	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	34	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	34	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	34	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	34	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	34	_	_	_	_	_	_	_	O
8	limited	_	limit	_	VBD	34	_	_	_	_	_	_	_	O
9	substitution	_	UNK	_	NN	34	_	_	_	_	_	_	_	O
10	of	_	of	_	IN	34	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	34	_	_	_	_	_	_	_	O
12	foods	_	food	_	NNS	34	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	34	_	_	_	_	_	_	_	O
14	other	_	other	_	JJ	34	_	_	_	_	_	_	_	O
15	carbohydrate	_	UNK	_	NN	34	_	_	_	_	_	_	_	O
16	in	_	in	_	IN	34	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	34	_	_	_	_	_	_	_	O
18	meal	_	meal	_	NN	34	_	_	_	_	_	_	_	O
19	plan	_	plan	_	NN	34	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	34	_	_	_	_	_	_	_	O
21	allowable	_	UNK	_	JJ	34	_	_	_	_	_	_	_	O
22	,	_	,	_	,	34	_	_	_	_	_	_	_	O
23	but	_	but	_	CC	34	_	_	_	_	_	_	_	O
24	that	_	that	_	IN	34	_	_	_	_	_	_	_	O
25	they	_	they	_	PRP	34	_	_	_	_	_	_	_	O
26	should	_	should	_	MD	34	_	_	_	_	_	_	_	O
27	take	_	take	_	VB	34	_	_	_	_	_	_	_	O
28	care	_	care	_	NN	34	_	_	_	_	_	_	_	O
29	to	_	to	_	TO	34	_	_	_	_	_	_	_	O
30	avoid	_	avoid	_	VB	34	_	_	_	_	_	_	_	O
31	excess	_	excess	_	JJ	34	_	_	_	_	_	_	_	O
32	energy	_	energy	_	NN	34	_	_	_	_	_	_	_	O
33	intake	_	UNK	_	NN	34	_	_	_	_	_	_	_	O
34	.	_	.	_	.	34	_	_	_	_	_	_	_	O

1	advise	_	UNK	_	NNP	34	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	34	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	34	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	34	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	34	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	34	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	34	_	_	_	_	_	_	_	O
8	limited	_	limit	_	VBD	34	_	_	_	_	_	_	_	O
9	substitution	_	UNK	_	NN	34	_	_	_	_	_	_	_	O
10	of	_	of	_	IN	34	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	34	_	_	_	_	_	_	_	S-Type
12	foods	_	food	_	NNS	34	_	_	_	_	_	food.n	Food	S-Food
13	for	_	for	_	IN	34	_	_	_	_	_	_	_	O
14	other	_	other	_	JJ	34	_	_	_	_	_	_	_	O
15	carbohydrate	_	UNK	_	NN	34	_	_	_	_	_	_	_	O
16	in	_	in	_	IN	34	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	34	_	_	_	_	_	_	_	O
18	meal	_	meal	_	NN	34	_	_	_	_	_	_	_	O
19	plan	_	plan	_	NN	34	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	34	_	_	_	_	_	_	_	O
21	allowable	_	UNK	_	JJ	34	_	_	_	_	_	_	_	O
22	,	_	,	_	,	34	_	_	_	_	_	_	_	O
23	but	_	but	_	CC	34	_	_	_	_	_	_	_	O
24	that	_	that	_	IN	34	_	_	_	_	_	_	_	O
25	they	_	they	_	PRP	34	_	_	_	_	_	_	_	O
26	should	_	should	_	MD	34	_	_	_	_	_	_	_	O
27	take	_	take	_	VB	34	_	_	_	_	_	_	_	O
28	care	_	care	_	NN	34	_	_	_	_	_	_	_	O
29	to	_	to	_	TO	34	_	_	_	_	_	_	_	O
30	avoid	_	avoid	_	VB	34	_	_	_	_	_	_	_	O
31	excess	_	excess	_	JJ	34	_	_	_	_	_	_	_	O
32	energy	_	energy	_	NN	34	_	_	_	_	_	_	_	O
33	intake	_	UNK	_	NN	34	_	_	_	_	_	_	_	O
34	.	_	.	_	.	34	_	_	_	_	_	_	_	O

1	advise	_	UNK	_	NNP	34	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	34	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	34	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	34	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	34	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	34	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	34	_	_	_	_	_	_	_	O
8	limited	_	limit	_	VBD	34	_	_	_	_	_	_	_	O
9	substitution	_	UNK	_	NN	34	_	_	_	_	_	_	_	O
10	of	_	of	_	IN	34	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	34	_	_	_	_	_	_	_	O
12	foods	_	food	_	NNS	34	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	34	_	_	_	_	_	_	_	O
14	other	_	other	_	JJ	34	_	_	_	_	_	other.a	Increment	O
15	carbohydrate	_	UNK	_	NN	34	_	_	_	_	_	_	_	S-Class
16	in	_	in	_	IN	34	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	34	_	_	_	_	_	_	_	O
18	meal	_	meal	_	NN	34	_	_	_	_	_	_	_	O
19	plan	_	plan	_	NN	34	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	34	_	_	_	_	_	_	_	O
21	allowable	_	UNK	_	JJ	34	_	_	_	_	_	_	_	O
22	,	_	,	_	,	34	_	_	_	_	_	_	_	O
23	but	_	but	_	CC	34	_	_	_	_	_	_	_	O
24	that	_	that	_	IN	34	_	_	_	_	_	_	_	O
25	they	_	they	_	PRP	34	_	_	_	_	_	_	_	O
26	should	_	should	_	MD	34	_	_	_	_	_	_	_	O
27	take	_	take	_	VB	34	_	_	_	_	_	_	_	O
28	care	_	care	_	NN	34	_	_	_	_	_	_	_	O
29	to	_	to	_	TO	34	_	_	_	_	_	_	_	O
30	avoid	_	avoid	_	VB	34	_	_	_	_	_	_	_	O
31	excess	_	excess	_	JJ	34	_	_	_	_	_	_	_	O
32	energy	_	energy	_	NN	34	_	_	_	_	_	_	_	O
33	intake	_	UNK	_	NN	34	_	_	_	_	_	_	_	O
34	.	_	.	_	.	34	_	_	_	_	_	_	_	O

1	advise	_	UNK	_	NNP	34	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	34	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	34	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	34	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	34	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	34	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	34	_	_	_	_	_	_	_	O
8	limited	_	limit	_	VBD	34	_	_	_	_	_	_	_	O
9	substitution	_	UNK	_	NN	34	_	_	_	_	_	_	_	O
10	of	_	of	_	IN	34	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	34	_	_	_	_	_	_	_	O
12	foods	_	food	_	NNS	34	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	34	_	_	_	_	_	_	_	O
14	other	_	other	_	JJ	34	_	_	_	_	_	_	_	O
15	carbohydrate	_	UNK	_	NN	34	_	_	_	_	_	_	_	O
16	in	_	in	_	IN	34	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	34	_	_	_	_	_	_	_	O
18	meal	_	meal	_	NN	34	_	_	_	_	_	_	_	S-Goal
19	plan	_	plan	_	NN	34	_	_	_	_	_	plan.n	Purpose	S-Value
20	is	_	be	_	VBZ	34	_	_	_	_	_	_	_	O
21	allowable	_	UNK	_	JJ	34	_	_	_	_	_	_	_	O
22	,	_	,	_	,	34	_	_	_	_	_	_	_	O
23	but	_	but	_	CC	34	_	_	_	_	_	_	_	O
24	that	_	that	_	IN	34	_	_	_	_	_	_	_	O
25	they	_	they	_	PRP	34	_	_	_	_	_	_	_	O
26	should	_	should	_	MD	34	_	_	_	_	_	_	_	O
27	take	_	take	_	VB	34	_	_	_	_	_	_	_	O
28	care	_	care	_	NN	34	_	_	_	_	_	_	_	O
29	to	_	to	_	TO	34	_	_	_	_	_	_	_	O
30	avoid	_	avoid	_	VB	34	_	_	_	_	_	_	_	O
31	excess	_	excess	_	JJ	34	_	_	_	_	_	_	_	O
32	energy	_	energy	_	NN	34	_	_	_	_	_	_	_	O
33	intake	_	UNK	_	NN	34	_	_	_	_	_	_	_	O
34	.	_	.	_	.	34	_	_	_	_	_	_	_	O

1	advise	_	UNK	_	NNP	34	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	34	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	34	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	34	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	34	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	34	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	34	_	_	_	_	_	_	_	O
8	limited	_	limit	_	VBD	34	_	_	_	_	_	_	_	O
9	substitution	_	UNK	_	NN	34	_	_	_	_	_	_	_	O
10	of	_	of	_	IN	34	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	34	_	_	_	_	_	_	_	O
12	foods	_	food	_	NNS	34	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	34	_	_	_	_	_	_	_	O
14	other	_	other	_	JJ	34	_	_	_	_	_	_	_	O
15	carbohydrate	_	UNK	_	NN	34	_	_	_	_	_	_	_	O
16	in	_	in	_	IN	34	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	34	_	_	_	_	_	_	_	O
18	meal	_	meal	_	NN	34	_	_	_	_	_	_	_	O
19	plan	_	plan	_	NN	34	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	34	_	_	_	_	_	_	_	O
21	allowable	_	UNK	_	JJ	34	_	_	_	_	_	_	_	O
22	,	_	,	_	,	34	_	_	_	_	_	_	_	O
23	but	_	but	_	CC	34	_	_	_	_	_	_	_	O
24	that	_	that	_	IN	34	_	_	_	_	_	_	_	O
25	they	_	they	_	PRP	34	_	_	_	_	_	_	_	S-State_of_affairs
26	should	_	should	_	MD	34	_	_	_	_	_	should.v	Desirable_event	O
27	take	_	take	_	VB	34	_	_	_	_	_	_	_	B-State_of_affairs
28	care	_	care	_	NN	34	_	_	_	_	_	_	_	I-State_of_affairs
29	to	_	to	_	TO	34	_	_	_	_	_	_	_	I-State_of_affairs
30	avoid	_	avoid	_	VB	34	_	_	_	_	_	_	_	I-State_of_affairs
31	excess	_	excess	_	JJ	34	_	_	_	_	_	_	_	I-State_of_affairs
32	energy	_	energy	_	NN	34	_	_	_	_	_	_	_	I-State_of_affairs
33	intake	_	UNK	_	NN	34	_	_	_	_	_	_	_	I-State_of_affairs
34	.	_	.	_	.	34	_	_	_	_	_	_	_	O

1	advise	_	UNK	_	NNP	34	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	34	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	34	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	34	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	34	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	34	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	34	_	_	_	_	_	_	_	O
8	limited	_	limit	_	VBD	34	_	_	_	_	_	_	_	O
9	substitution	_	UNK	_	NN	34	_	_	_	_	_	_	_	O
10	of	_	of	_	IN	34	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	JJ	34	_	_	_	_	_	_	_	O
12	foods	_	food	_	NNS	34	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	34	_	_	_	_	_	_	_	O
14	other	_	other	_	JJ	34	_	_	_	_	_	_	_	O
15	carbohydrate	_	UNK	_	NN	34	_	_	_	_	_	_	_	O
16	in	_	in	_	IN	34	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	34	_	_	_	_	_	_	_	O
18	meal	_	meal	_	NN	34	_	_	_	_	_	_	_	O
19	plan	_	plan	_	NN	34	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	34	_	_	_	_	_	_	_	O
21	allowable	_	UNK	_	JJ	34	_	_	_	_	_	_	_	O
22	,	_	,	_	,	34	_	_	_	_	_	_	_	O
23	but	_	but	_	CC	34	_	_	_	_	_	_	_	O
24	that	_	that	_	IN	34	_	_	_	_	_	_	_	O
25	they	_	they	_	PRP	34	_	_	_	_	_	_	_	S-Agent
26	should	_	should	_	MD	34	_	_	_	_	_	_	_	O
27	take	_	take	_	VB	34	_	_	_	_	_	_	_	O
28	care	_	care	_	NN	34	_	_	_	_	_	_	_	O
29	to	_	to	_	TO	34	_	_	_	_	_	_	_	O
30	avoid	_	avoid	_	VB	34	_	_	_	_	_	avoid.v	Avoiding	O
31	excess	_	excess	_	JJ	34	_	_	_	_	_	_	_	B-Undesirable_situation
32	energy	_	energy	_	NN	34	_	_	_	_	_	_	_	I-Undesirable_situation
33	intake	_	UNK	_	NN	34	_	_	_	_	_	_	_	I-Undesirable_situation
34	.	_	.	_	.	34	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	35	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	35	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	35	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	35	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	35	_	_	_	_	_	_	_	O
6	:	_	:	_	:	35	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	35	_	_	_	_	_	_	_	O
8	(	_	(	_	(	35	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
10	)	_	)	_	)	35	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	35	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	35	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	35	_	_	_	_	_	_	_	O
14	)	_	)	_	)	35	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	35	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	35	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	35	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	35	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	35	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	35	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	35	_	_	_	_	_	_	_	O
8	(	_	(	_	(	35	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	35	_	_	_	_	_	_	_	O
10	)	_	)	_	)	35	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	35	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	35	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	35	_	_	_	_	_	_	_	O
14	)	_	)	_	)	35	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	36	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	36	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	36	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	36	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	36	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	36	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	36	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	36	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	36	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	36	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	36	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	36	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	36	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	36	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	36	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	36	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	36	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	36	_	_	_	_	_	_	_	O
19	,	_	,	_	,	36	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	36	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	36	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	36	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	36	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	36	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	36	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	36	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	36	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	36	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	36	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	36	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	36	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	36	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	36	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	36	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	36	_	_	_	_	_	_	_	O
36	.	_	.	_	.	36	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	36	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	36	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	36	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	36	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	36	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	36	_	_	_	_	_	_	_	I-Category
7	are	_	be	_	VBP	36	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	36	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	36	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	36	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	36	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	36	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	36	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	36	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	36	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	36	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	36	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	36	_	_	_	_	_	_	_	O
19	,	_	,	_	,	36	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	36	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	36	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	36	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	36	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	36	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	36	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	36	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	36	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	36	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	36	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	36	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	36	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	36	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	36	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	36	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	36	_	_	_	_	_	_	_	O
36	.	_	.	_	.	36	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	36	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	36	_	_	_	_	_	_	_	B-Information
3	with	_	with	_	IN	36	_	_	_	_	_	_	_	I-Information
4	type	_	type	_	JJ	36	_	_	_	_	_	_	_	I-Information
5	2	_	2	_	CD	36	_	_	_	_	_	_	_	I-Information
6	diabetes	_	UNK	_	NNS	36	_	_	_	_	_	_	_	I-Information
7	are	_	be	_	VBP	36	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	36	_	_	_	_	_	admit.v	Reveal_secret	O
9	to	_	to	_	TO	36	_	_	_	_	_	_	_	B-Information
10	hospital	_	hospital	_	VB	36	_	_	_	_	_	_	_	I-Information
11	as	_	a	_	IN	36	_	_	_	_	_	_	_	I-Information
12	inpatients	_	UNK	_	NNS	36	_	_	_	_	_	_	_	I-Information
13	or	_	or	_	CC	36	_	_	_	_	_	_	_	I-Information
14	to	_	to	_	TO	36	_	_	_	_	_	_	_	I-Information
15	any	_	any	_	DT	36	_	_	_	_	_	_	_	I-Information
16	other	_	other	_	JJ	36	_	_	_	_	_	_	_	I-Information
17	care	_	care	_	NN	36	_	_	_	_	_	_	_	I-Information
18	setting	_	set	_	VBG	36	_	_	_	_	_	_	_	I-Information
19	,	_	,	_	,	36	_	_	_	_	_	_	_	I-Information
20	implement	_	implement	_	VB	36	_	_	_	_	_	_	_	I-Information
21	a	_	a	_	DT	36	_	_	_	_	_	_	_	I-Information
22	meal	_	meal	_	NN	36	_	_	_	_	_	_	_	I-Information
23	planning	_	planning	_	NN	36	_	_	_	_	_	_	_	I-Information
24	system	_	system	_	NN	36	_	_	_	_	_	_	_	I-Information
25	that	_	that	_	WDT	36	_	_	_	_	_	_	_	I-Information
26	provides	_	provide	_	VBZ	36	_	_	_	_	_	_	_	I-Information
27	consistency	_	UNK	_	NN	36	_	_	_	_	_	_	_	I-Information
28	in	_	in	_	IN	36	_	_	_	_	_	_	_	I-Information
29	the	_	the	_	DT	36	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	36	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	36	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	36	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	36	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	36	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	36	_	_	_	_	_	_	_	O
36	.	_	.	_	.	36	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	36	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	36	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	36	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	36	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	36	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	36	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	36	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	36	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	36	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	36	_	_	_	_	_	hospital.n	Buildings	S-Building
11	as	_	a	_	IN	36	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	36	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	36	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	36	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	36	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	36	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	36	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	36	_	_	_	_	_	_	_	O
19	,	_	,	_	,	36	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	36	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	36	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	36	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	36	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	36	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	36	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	36	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	36	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	36	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	36	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	36	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	36	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	36	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	36	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	36	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	36	_	_	_	_	_	_	_	O
36	.	_	.	_	.	36	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	36	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	36	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	36	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	36	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	36	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	36	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	36	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	36	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	36	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	36	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	36	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	36	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	36	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	36	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	36	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	36	_	_	_	_	_	other.a	Increment	O
17	care	_	care	_	NN	36	_	_	_	_	_	_	_	S-Class
18	setting	_	set	_	VBG	36	_	_	_	_	_	_	_	O
19	,	_	,	_	,	36	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	36	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	36	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	36	_	_	_	_	_	_	_	O
23	planning	_	planning	_	NN	36	_	_	_	_	_	_	_	O
24	system	_	system	_	NN	36	_	_	_	_	_	_	_	O
25	that	_	that	_	WDT	36	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	36	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	36	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	36	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	36	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	36	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	36	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	36	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	36	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	36	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	36	_	_	_	_	_	_	_	O
36	.	_	.	_	.	36	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	36	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	36	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	36	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	36	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	36	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	36	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	36	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	36	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	36	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	36	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	36	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	36	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	36	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	36	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	36	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	36	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	36	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	36	_	_	_	_	_	_	_	O
19	,	_	,	_	,	36	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	36	_	_	_	_	_	implement.v	Execute_plan	O
21	a	_	a	_	DT	36	_	_	_	_	_	_	_	B-Plan
22	meal	_	meal	_	NN	36	_	_	_	_	_	_	_	I-Plan
23	planning	_	planning	_	NN	36	_	_	_	_	_	_	_	I-Plan
24	system	_	system	_	NN	36	_	_	_	_	_	_	_	I-Plan
25	that	_	that	_	WDT	36	_	_	_	_	_	_	_	I-Plan
26	provides	_	provide	_	VBZ	36	_	_	_	_	_	_	_	I-Plan
27	consistency	_	UNK	_	NN	36	_	_	_	_	_	_	_	I-Plan
28	in	_	in	_	IN	36	_	_	_	_	_	_	_	I-Plan
29	the	_	the	_	DT	36	_	_	_	_	_	_	_	I-Plan
30	carbohydrate	_	UNK	_	NN	36	_	_	_	_	_	_	_	I-Plan
31	content	_	content	_	NN	36	_	_	_	_	_	_	_	I-Plan
32	of	_	of	_	IN	36	_	_	_	_	_	_	_	I-Plan
33	meals	_	meal	_	NNS	36	_	_	_	_	_	_	_	I-Plan
34	and	_	and	_	CC	36	_	_	_	_	_	_	_	I-Plan
35	snacks	_	UNK	_	NNS	36	_	_	_	_	_	_	_	I-Plan
36	.	_	.	_	.	36	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	36	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	36	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	36	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	36	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	36	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	36	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	36	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	36	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	36	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	36	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	36	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	36	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	36	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	36	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	36	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	36	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	36	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	36	_	_	_	_	_	_	_	O
19	,	_	,	_	,	36	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	36	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	36	_	_	_	_	_	_	_	O
22	meal	_	meal	_	NN	36	_	_	_	_	_	_	_	S-Component_entities
23	planning	_	planning	_	NN	36	_	_	_	_	_	_	_	S-Function
24	system	_	system	_	NN	36	_	_	_	_	_	system.n	System	S-Complex
25	that	_	that	_	WDT	36	_	_	_	_	_	_	_	O
26	provides	_	provide	_	VBZ	36	_	_	_	_	_	_	_	O
27	consistency	_	UNK	_	NN	36	_	_	_	_	_	_	_	O
28	in	_	in	_	IN	36	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	36	_	_	_	_	_	_	_	O
30	carbohydrate	_	UNK	_	NN	36	_	_	_	_	_	_	_	O
31	content	_	content	_	NN	36	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	36	_	_	_	_	_	_	_	O
33	meals	_	meal	_	NNS	36	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	36	_	_	_	_	_	_	_	O
35	snacks	_	UNK	_	NNS	36	_	_	_	_	_	_	_	O
36	.	_	.	_	.	36	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	36	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	36	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	36	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	36	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	36	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	36	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	36	_	_	_	_	_	_	_	O
8	admitted	_	admit	_	VBN	36	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	36	_	_	_	_	_	_	_	O
10	hospital	_	hospital	_	VB	36	_	_	_	_	_	_	_	O
11	as	_	a	_	IN	36	_	_	_	_	_	_	_	O
12	inpatients	_	UNK	_	NNS	36	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	36	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	36	_	_	_	_	_	_	_	O
15	any	_	any	_	DT	36	_	_	_	_	_	_	_	O
16	other	_	other	_	JJ	36	_	_	_	_	_	_	_	O
17	care	_	care	_	NN	36	_	_	_	_	_	_	_	O
18	setting	_	set	_	VBG	36	_	_	_	_	_	_	_	O
19	,	_	,	_	,	36	_	_	_	_	_	_	_	O
20	implement	_	implement	_	VB	36	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	36	_	_	_	_	_	_	_	B-Supplier
22	meal	_	meal	_	NN	36	_	_	_	_	_	_	_	I-Supplier
23	planning	_	planning	_	NN	36	_	_	_	_	_	_	_	I-Supplier
24	system	_	system	_	NN	36	_	_	_	_	_	_	_	I-Supplier
25	that	_	that	_	WDT	36	_	_	_	_	_	_	_	I-Supplier
26	provides	_	provide	_	VBZ	36	_	_	_	_	_	provide.v	Supply	O
27	consistency	_	UNK	_	NN	36	_	_	_	_	_	_	_	B-Theme
28	in	_	in	_	IN	36	_	_	_	_	_	_	_	I-Theme
29	the	_	the	_	DT	36	_	_	_	_	_	_	_	I-Theme
30	carbohydrate	_	UNK	_	NN	36	_	_	_	_	_	_	_	I-Theme
31	content	_	content	_	NN	36	_	_	_	_	_	_	_	I-Theme
32	of	_	of	_	IN	36	_	_	_	_	_	_	_	I-Theme
33	meals	_	meal	_	NNS	36	_	_	_	_	_	_	_	I-Theme
34	and	_	and	_	CC	36	_	_	_	_	_	_	_	I-Theme
35	snacks	_	UNK	_	NNS	36	_	_	_	_	_	_	_	I-Theme
36	.	_	.	_	.	36	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	37	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	37	_	_	_	_	_	_	_	O
4	lifestyle	_	lifestyle	_	JJ	37	_	_	_	_	_	_	_	O
5	advice	_	advice	_	NN	37	_	_	_	_	_	_	_	O
6	,	_	,	_	,	37	_	_	_	_	_	_	_	O
7	see	_	see	_	VBP	37	_	_	_	_	_	see.v	Perception_experience	O
8	the	_	the	_	DT	37	_	_	_	_	_	_	_	B-Phenomenon
9	nice	_	UNK	_	NNP	37	_	_	_	_	_	_	_	I-Phenomenon
10	guidelines	_	guideline	_	NNS	37	_	_	_	_	_	_	_	I-Phenomenon
11	on	_	on	_	IN	37	_	_	_	_	_	_	_	I-Phenomenon
12	:	_	:	_	:	37	_	_	_	_	_	_	_	O
13	preventing	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
14	excess	_	excess	_	JJ	37	_	_	_	_	_	_	_	O
15	weight	_	weight	_	NN	37	_	_	_	_	_	_	_	O
16	gain	_	gain	_	NN	37	_	_	_	_	_	_	_	O
17	,	_	,	_	,	37	_	_	_	_	_	_	_	O
18	weight	_	weight	_	JJ	37	_	_	_	_	_	_	_	O
19	management	_	management	_	NN	37	_	_	_	_	_	_	_	O
20	,	_	,	_	,	37	_	_	_	_	_	_	_	O
21	obesity	_	obesity	_	NN	37	_	_	_	_	_	_	_	O
22	,	_	,	_	,	37	_	_	_	_	_	_	_	O
23	physical	_	physical	_	JJ	37	_	_	_	_	_	_	_	O
24	activity	_	activity	_	NN	37	_	_	_	_	_	_	_	O
25	,	_	,	_	,	37	_	_	_	_	_	_	_	O
26	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
27	:	_	:	_	:	37	_	_	_	_	_	_	_	O
28	brief	_	brief	_	JJ	37	_	_	_	_	_	_	_	O
29	interventions	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
30	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
31	referrals	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
32	,	_	,	_	,	37	_	_	_	_	_	_	_	O
33	stop	_	stop	_	VB	37	_	_	_	_	_	_	_	O
34	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
35	services	_	service	_	NNS	37	_	_	_	_	_	_	_	O
36	,	_	,	_	,	37	_	_	_	_	_	_	_	O
37	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
38	:	_	:	_	:	37	_	_	_	_	_	_	_	O
39	harm	_	harm	_	NN	37	_	_	_	_	_	_	_	O
40	reduction	_	reduction	_	NN	37	_	_	_	_	_	_	_	O
41	,	_	,	_	,	37	_	_	_	_	_	_	_	O
42	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
43	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
44	:	_	:	_	:	37	_	_	_	_	_	_	_	O
45	acute	_	acute	_	NN	37	_	_	_	_	_	_	_	O
46	,	_	,	_	,	37	_	_	_	_	_	_	_	O
47	maternity	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
49	mental	_	mental	_	JJ	37	_	_	_	_	_	_	_	O
50	health	_	health	_	NN	37	_	_	_	_	_	_	_	O
51	services	_	service	_	NNS	37	_	_	_	_	_	_	_	O
52	.	_	.	_	.	37	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	37	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	37	_	_	_	_	_	_	_	O
4	lifestyle	_	lifestyle	_	JJ	37	_	_	_	_	_	_	_	O
5	advice	_	advice	_	NN	37	_	_	_	_	_	_	_	O
6	,	_	,	_	,	37	_	_	_	_	_	_	_	O
7	see	_	see	_	VBP	37	_	_	_	_	_	_	_	O
8	the	_	the	_	DT	37	_	_	_	_	_	_	_	O
9	nice	_	UNK	_	NNP	37	_	_	_	_	_	_	_	O
10	guidelines	_	guideline	_	NNS	37	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	37	_	_	_	_	_	_	_	O
12	:	_	:	_	:	37	_	_	_	_	_	_	_	O
13	preventing	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
14	excess	_	excess	_	JJ	37	_	_	_	_	_	_	_	O
15	weight	_	weight	_	NN	37	_	_	_	_	_	weight.n	Dimension	S-Dimension
16	gain	_	gain	_	NN	37	_	_	_	_	_	_	_	O
17	,	_	,	_	,	37	_	_	_	_	_	_	_	O
18	weight	_	weight	_	JJ	37	_	_	_	_	_	_	_	O
19	management	_	management	_	NN	37	_	_	_	_	_	_	_	O
20	,	_	,	_	,	37	_	_	_	_	_	_	_	O
21	obesity	_	obesity	_	NN	37	_	_	_	_	_	_	_	O
22	,	_	,	_	,	37	_	_	_	_	_	_	_	O
23	physical	_	physical	_	JJ	37	_	_	_	_	_	_	_	O
24	activity	_	activity	_	NN	37	_	_	_	_	_	_	_	O
25	,	_	,	_	,	37	_	_	_	_	_	_	_	O
26	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
27	:	_	:	_	:	37	_	_	_	_	_	_	_	O
28	brief	_	brief	_	JJ	37	_	_	_	_	_	_	_	O
29	interventions	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
30	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
31	referrals	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
32	,	_	,	_	,	37	_	_	_	_	_	_	_	O
33	stop	_	stop	_	VB	37	_	_	_	_	_	_	_	O
34	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
35	services	_	service	_	NNS	37	_	_	_	_	_	_	_	O
36	,	_	,	_	,	37	_	_	_	_	_	_	_	O
37	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
38	:	_	:	_	:	37	_	_	_	_	_	_	_	O
39	harm	_	harm	_	NN	37	_	_	_	_	_	_	_	O
40	reduction	_	reduction	_	NN	37	_	_	_	_	_	_	_	O
41	,	_	,	_	,	37	_	_	_	_	_	_	_	O
42	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
43	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
44	:	_	:	_	:	37	_	_	_	_	_	_	_	O
45	acute	_	acute	_	NN	37	_	_	_	_	_	_	_	O
46	,	_	,	_	,	37	_	_	_	_	_	_	_	O
47	maternity	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
49	mental	_	mental	_	JJ	37	_	_	_	_	_	_	_	O
50	health	_	health	_	NN	37	_	_	_	_	_	_	_	O
51	services	_	service	_	NNS	37	_	_	_	_	_	_	_	O
52	.	_	.	_	.	37	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	37	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	37	_	_	_	_	_	_	_	O
4	lifestyle	_	lifestyle	_	JJ	37	_	_	_	_	_	_	_	O
5	advice	_	advice	_	NN	37	_	_	_	_	_	_	_	O
6	,	_	,	_	,	37	_	_	_	_	_	_	_	O
7	see	_	see	_	VBP	37	_	_	_	_	_	_	_	O
8	the	_	the	_	DT	37	_	_	_	_	_	_	_	O
9	nice	_	UNK	_	NNP	37	_	_	_	_	_	_	_	O
10	guidelines	_	guideline	_	NNS	37	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	37	_	_	_	_	_	_	_	O
12	:	_	:	_	:	37	_	_	_	_	_	_	_	O
13	preventing	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
14	excess	_	excess	_	JJ	37	_	_	_	_	_	_	_	S-Place
15	weight	_	weight	_	NN	37	_	_	_	_	_	_	_	S-Theme
16	gain	_	gain	_	NN	37	_	_	_	_	_	gain.n	Getting	O
17	,	_	,	_	,	37	_	_	_	_	_	_	_	O
18	weight	_	weight	_	JJ	37	_	_	_	_	_	_	_	O
19	management	_	management	_	NN	37	_	_	_	_	_	_	_	O
20	,	_	,	_	,	37	_	_	_	_	_	_	_	O
21	obesity	_	obesity	_	NN	37	_	_	_	_	_	_	_	O
22	,	_	,	_	,	37	_	_	_	_	_	_	_	O
23	physical	_	physical	_	JJ	37	_	_	_	_	_	_	_	O
24	activity	_	activity	_	NN	37	_	_	_	_	_	_	_	O
25	,	_	,	_	,	37	_	_	_	_	_	_	_	O
26	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
27	:	_	:	_	:	37	_	_	_	_	_	_	_	O
28	brief	_	brief	_	JJ	37	_	_	_	_	_	_	_	O
29	interventions	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
30	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
31	referrals	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
32	,	_	,	_	,	37	_	_	_	_	_	_	_	O
33	stop	_	stop	_	VB	37	_	_	_	_	_	_	_	O
34	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
35	services	_	service	_	NNS	37	_	_	_	_	_	_	_	O
36	,	_	,	_	,	37	_	_	_	_	_	_	_	O
37	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
38	:	_	:	_	:	37	_	_	_	_	_	_	_	O
39	harm	_	harm	_	NN	37	_	_	_	_	_	_	_	O
40	reduction	_	reduction	_	NN	37	_	_	_	_	_	_	_	O
41	,	_	,	_	,	37	_	_	_	_	_	_	_	O
42	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
43	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
44	:	_	:	_	:	37	_	_	_	_	_	_	_	O
45	acute	_	acute	_	NN	37	_	_	_	_	_	_	_	O
46	,	_	,	_	,	37	_	_	_	_	_	_	_	O
47	maternity	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
49	mental	_	mental	_	JJ	37	_	_	_	_	_	_	_	O
50	health	_	health	_	NN	37	_	_	_	_	_	_	_	O
51	services	_	service	_	NNS	37	_	_	_	_	_	_	_	O
52	.	_	.	_	.	37	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	37	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	37	_	_	_	_	_	_	_	O
4	lifestyle	_	lifestyle	_	JJ	37	_	_	_	_	_	_	_	O
5	advice	_	advice	_	NN	37	_	_	_	_	_	_	_	O
6	,	_	,	_	,	37	_	_	_	_	_	_	_	O
7	see	_	see	_	VBP	37	_	_	_	_	_	_	_	O
8	the	_	the	_	DT	37	_	_	_	_	_	_	_	O
9	nice	_	UNK	_	NNP	37	_	_	_	_	_	_	_	O
10	guidelines	_	guideline	_	NNS	37	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	37	_	_	_	_	_	_	_	O
12	:	_	:	_	:	37	_	_	_	_	_	_	_	O
13	preventing	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
14	excess	_	excess	_	JJ	37	_	_	_	_	_	_	_	O
15	weight	_	weight	_	NN	37	_	_	_	_	_	_	_	O
16	gain	_	gain	_	NN	37	_	_	_	_	_	_	_	O
17	,	_	,	_	,	37	_	_	_	_	_	_	_	O
18	weight	_	weight	_	JJ	37	_	_	_	_	_	weight.n	Dimension	S-Dimension
19	management	_	management	_	NN	37	_	_	_	_	_	_	_	S-Object
20	,	_	,	_	,	37	_	_	_	_	_	_	_	O
21	obesity	_	obesity	_	NN	37	_	_	_	_	_	_	_	O
22	,	_	,	_	,	37	_	_	_	_	_	_	_	O
23	physical	_	physical	_	JJ	37	_	_	_	_	_	_	_	O
24	activity	_	activity	_	NN	37	_	_	_	_	_	_	_	O
25	,	_	,	_	,	37	_	_	_	_	_	_	_	O
26	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
27	:	_	:	_	:	37	_	_	_	_	_	_	_	O
28	brief	_	brief	_	JJ	37	_	_	_	_	_	_	_	O
29	interventions	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
30	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
31	referrals	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
32	,	_	,	_	,	37	_	_	_	_	_	_	_	O
33	stop	_	stop	_	VB	37	_	_	_	_	_	_	_	O
34	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
35	services	_	service	_	NNS	37	_	_	_	_	_	_	_	O
36	,	_	,	_	,	37	_	_	_	_	_	_	_	O
37	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
38	:	_	:	_	:	37	_	_	_	_	_	_	_	O
39	harm	_	harm	_	NN	37	_	_	_	_	_	_	_	O
40	reduction	_	reduction	_	NN	37	_	_	_	_	_	_	_	O
41	,	_	,	_	,	37	_	_	_	_	_	_	_	O
42	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
43	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
44	:	_	:	_	:	37	_	_	_	_	_	_	_	O
45	acute	_	acute	_	NN	37	_	_	_	_	_	_	_	O
46	,	_	,	_	,	37	_	_	_	_	_	_	_	O
47	maternity	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
49	mental	_	mental	_	JJ	37	_	_	_	_	_	_	_	O
50	health	_	health	_	NN	37	_	_	_	_	_	_	_	O
51	services	_	service	_	NNS	37	_	_	_	_	_	_	_	O
52	.	_	.	_	.	37	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	37	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	37	_	_	_	_	_	_	_	O
4	lifestyle	_	lifestyle	_	JJ	37	_	_	_	_	_	_	_	O
5	advice	_	advice	_	NN	37	_	_	_	_	_	_	_	O
6	,	_	,	_	,	37	_	_	_	_	_	_	_	O
7	see	_	see	_	VBP	37	_	_	_	_	_	_	_	O
8	the	_	the	_	DT	37	_	_	_	_	_	_	_	O
9	nice	_	UNK	_	NNP	37	_	_	_	_	_	_	_	O
10	guidelines	_	guideline	_	NNS	37	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	37	_	_	_	_	_	_	_	O
12	:	_	:	_	:	37	_	_	_	_	_	_	_	O
13	preventing	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
14	excess	_	excess	_	JJ	37	_	_	_	_	_	_	_	O
15	weight	_	weight	_	NN	37	_	_	_	_	_	_	_	O
16	gain	_	gain	_	NN	37	_	_	_	_	_	_	_	O
17	,	_	,	_	,	37	_	_	_	_	_	_	_	O
18	weight	_	weight	_	JJ	37	_	_	_	_	_	_	_	O
19	management	_	management	_	NN	37	_	_	_	_	_	_	_	O
20	,	_	,	_	,	37	_	_	_	_	_	_	_	O
21	obesity	_	obesity	_	NN	37	_	_	_	_	_	_	_	O
22	,	_	,	_	,	37	_	_	_	_	_	_	_	O
23	physical	_	physical	_	JJ	37	_	_	_	_	_	_	_	S-Domain
24	activity	_	activity	_	NN	37	_	_	_	_	_	activity.n	Intentionally_act	O
25	,	_	,	_	,	37	_	_	_	_	_	_	_	O
26	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
27	:	_	:	_	:	37	_	_	_	_	_	_	_	O
28	brief	_	brief	_	JJ	37	_	_	_	_	_	_	_	O
29	interventions	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
30	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
31	referrals	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
32	,	_	,	_	,	37	_	_	_	_	_	_	_	O
33	stop	_	stop	_	VB	37	_	_	_	_	_	_	_	O
34	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
35	services	_	service	_	NNS	37	_	_	_	_	_	_	_	O
36	,	_	,	_	,	37	_	_	_	_	_	_	_	O
37	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
38	:	_	:	_	:	37	_	_	_	_	_	_	_	O
39	harm	_	harm	_	NN	37	_	_	_	_	_	_	_	O
40	reduction	_	reduction	_	NN	37	_	_	_	_	_	_	_	O
41	,	_	,	_	,	37	_	_	_	_	_	_	_	O
42	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
43	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
44	:	_	:	_	:	37	_	_	_	_	_	_	_	O
45	acute	_	acute	_	NN	37	_	_	_	_	_	_	_	O
46	,	_	,	_	,	37	_	_	_	_	_	_	_	O
47	maternity	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
49	mental	_	mental	_	JJ	37	_	_	_	_	_	_	_	O
50	health	_	health	_	NN	37	_	_	_	_	_	_	_	O
51	services	_	service	_	NNS	37	_	_	_	_	_	_	_	O
52	.	_	.	_	.	37	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	37	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	37	_	_	_	_	_	_	_	O
4	lifestyle	_	lifestyle	_	JJ	37	_	_	_	_	_	_	_	O
5	advice	_	advice	_	NN	37	_	_	_	_	_	_	_	O
6	,	_	,	_	,	37	_	_	_	_	_	_	_	O
7	see	_	see	_	VBP	37	_	_	_	_	_	_	_	O
8	the	_	the	_	DT	37	_	_	_	_	_	_	_	O
9	nice	_	UNK	_	NNP	37	_	_	_	_	_	_	_	O
10	guidelines	_	guideline	_	NNS	37	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	37	_	_	_	_	_	_	_	O
12	:	_	:	_	:	37	_	_	_	_	_	_	_	O
13	preventing	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
14	excess	_	excess	_	JJ	37	_	_	_	_	_	_	_	O
15	weight	_	weight	_	NN	37	_	_	_	_	_	_	_	O
16	gain	_	gain	_	NN	37	_	_	_	_	_	_	_	O
17	,	_	,	_	,	37	_	_	_	_	_	_	_	O
18	weight	_	weight	_	JJ	37	_	_	_	_	_	_	_	O
19	management	_	management	_	NN	37	_	_	_	_	_	_	_	O
20	,	_	,	_	,	37	_	_	_	_	_	_	_	O
21	obesity	_	obesity	_	NN	37	_	_	_	_	_	_	_	O
22	,	_	,	_	,	37	_	_	_	_	_	_	_	O
23	physical	_	physical	_	JJ	37	_	_	_	_	_	_	_	O
24	activity	_	activity	_	NN	37	_	_	_	_	_	_	_	O
25	,	_	,	_	,	37	_	_	_	_	_	_	_	O
26	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
27	:	_	:	_	:	37	_	_	_	_	_	_	_	O
28	brief	_	brief	_	JJ	37	_	_	_	_	_	brief.a	Duration_description	O
29	interventions	_	UNK	_	NNS	37	_	_	_	_	_	_	_	B-Eventuality
30	and	_	and	_	CC	37	_	_	_	_	_	_	_	I-Eventuality
31	referrals	_	UNK	_	NNS	37	_	_	_	_	_	_	_	I-Eventuality
32	,	_	,	_	,	37	_	_	_	_	_	_	_	O
33	stop	_	stop	_	VB	37	_	_	_	_	_	_	_	O
34	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
35	services	_	service	_	NNS	37	_	_	_	_	_	_	_	O
36	,	_	,	_	,	37	_	_	_	_	_	_	_	O
37	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
38	:	_	:	_	:	37	_	_	_	_	_	_	_	O
39	harm	_	harm	_	NN	37	_	_	_	_	_	_	_	O
40	reduction	_	reduction	_	NN	37	_	_	_	_	_	_	_	O
41	,	_	,	_	,	37	_	_	_	_	_	_	_	O
42	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
43	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
44	:	_	:	_	:	37	_	_	_	_	_	_	_	O
45	acute	_	acute	_	NN	37	_	_	_	_	_	_	_	O
46	,	_	,	_	,	37	_	_	_	_	_	_	_	O
47	maternity	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
49	mental	_	mental	_	JJ	37	_	_	_	_	_	_	_	O
50	health	_	health	_	NN	37	_	_	_	_	_	_	_	O
51	services	_	service	_	NNS	37	_	_	_	_	_	_	_	O
52	.	_	.	_	.	37	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	37	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	37	_	_	_	_	_	_	_	O
4	lifestyle	_	lifestyle	_	JJ	37	_	_	_	_	_	_	_	O
5	advice	_	advice	_	NN	37	_	_	_	_	_	_	_	O
6	,	_	,	_	,	37	_	_	_	_	_	_	_	O
7	see	_	see	_	VBP	37	_	_	_	_	_	_	_	O
8	the	_	the	_	DT	37	_	_	_	_	_	_	_	O
9	nice	_	UNK	_	NNP	37	_	_	_	_	_	_	_	O
10	guidelines	_	guideline	_	NNS	37	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	37	_	_	_	_	_	_	_	O
12	:	_	:	_	:	37	_	_	_	_	_	_	_	O
13	preventing	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
14	excess	_	excess	_	JJ	37	_	_	_	_	_	_	_	O
15	weight	_	weight	_	NN	37	_	_	_	_	_	_	_	O
16	gain	_	gain	_	NN	37	_	_	_	_	_	_	_	O
17	,	_	,	_	,	37	_	_	_	_	_	_	_	O
18	weight	_	weight	_	JJ	37	_	_	_	_	_	_	_	O
19	management	_	management	_	NN	37	_	_	_	_	_	_	_	O
20	,	_	,	_	,	37	_	_	_	_	_	_	_	O
21	obesity	_	obesity	_	NN	37	_	_	_	_	_	_	_	B-Process
22	,	_	,	_	,	37	_	_	_	_	_	_	_	I-Process
23	physical	_	physical	_	JJ	37	_	_	_	_	_	_	_	I-Process
24	activity	_	activity	_	NN	37	_	_	_	_	_	_	_	I-Process
25	,	_	,	_	,	37	_	_	_	_	_	_	_	I-Process
26	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	I-Process
27	:	_	:	_	:	37	_	_	_	_	_	_	_	I-Process
28	brief	_	brief	_	JJ	37	_	_	_	_	_	_	_	I-Process
29	interventions	_	UNK	_	NNS	37	_	_	_	_	_	_	_	I-Process
30	and	_	and	_	CC	37	_	_	_	_	_	_	_	I-Process
31	referrals	_	UNK	_	NNS	37	_	_	_	_	_	_	_	I-Process
32	,	_	,	_	,	37	_	_	_	_	_	_	_	O
33	stop	_	stop	_	VB	37	_	_	_	_	_	stop.v	Process_stop	O
34	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	B-Process
35	services	_	service	_	NNS	37	_	_	_	_	_	_	_	I-Process
36	,	_	,	_	,	37	_	_	_	_	_	_	_	I-Process
37	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	I-Process
38	:	_	:	_	:	37	_	_	_	_	_	_	_	I-Process
39	harm	_	harm	_	NN	37	_	_	_	_	_	_	_	I-Process
40	reduction	_	reduction	_	NN	37	_	_	_	_	_	_	_	I-Process
41	,	_	,	_	,	37	_	_	_	_	_	_	_	I-Process
42	and	_	and	_	CC	37	_	_	_	_	_	_	_	I-Process
43	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	I-Process
44	:	_	:	_	:	37	_	_	_	_	_	_	_	O
45	acute	_	acute	_	NN	37	_	_	_	_	_	_	_	O
46	,	_	,	_	,	37	_	_	_	_	_	_	_	O
47	maternity	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
49	mental	_	mental	_	JJ	37	_	_	_	_	_	_	_	O
50	health	_	health	_	NN	37	_	_	_	_	_	_	_	O
51	services	_	service	_	NNS	37	_	_	_	_	_	_	_	O
52	.	_	.	_	.	37	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	37	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	37	_	_	_	_	_	_	_	O
4	lifestyle	_	lifestyle	_	JJ	37	_	_	_	_	_	_	_	O
5	advice	_	advice	_	NN	37	_	_	_	_	_	_	_	O
6	,	_	,	_	,	37	_	_	_	_	_	_	_	O
7	see	_	see	_	VBP	37	_	_	_	_	_	_	_	O
8	the	_	the	_	DT	37	_	_	_	_	_	_	_	O
9	nice	_	UNK	_	NNP	37	_	_	_	_	_	_	_	O
10	guidelines	_	guideline	_	NNS	37	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	37	_	_	_	_	_	_	_	O
12	:	_	:	_	:	37	_	_	_	_	_	_	_	O
13	preventing	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
14	excess	_	excess	_	JJ	37	_	_	_	_	_	_	_	O
15	weight	_	weight	_	NN	37	_	_	_	_	_	_	_	O
16	gain	_	gain	_	NN	37	_	_	_	_	_	_	_	O
17	,	_	,	_	,	37	_	_	_	_	_	_	_	O
18	weight	_	weight	_	JJ	37	_	_	_	_	_	_	_	O
19	management	_	management	_	NN	37	_	_	_	_	_	_	_	O
20	,	_	,	_	,	37	_	_	_	_	_	_	_	O
21	obesity	_	obesity	_	NN	37	_	_	_	_	_	_	_	O
22	,	_	,	_	,	37	_	_	_	_	_	_	_	O
23	physical	_	physical	_	JJ	37	_	_	_	_	_	_	_	O
24	activity	_	activity	_	NN	37	_	_	_	_	_	_	_	O
25	,	_	,	_	,	37	_	_	_	_	_	_	_	O
26	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
27	:	_	:	_	:	37	_	_	_	_	_	_	_	O
28	brief	_	brief	_	JJ	37	_	_	_	_	_	_	_	O
29	interventions	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
30	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
31	referrals	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
32	,	_	,	_	,	37	_	_	_	_	_	_	_	O
33	stop	_	stop	_	VB	37	_	_	_	_	_	_	_	O
34	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	S-Domain
35	services	_	service	_	NNS	37	_	_	_	_	_	service.n	Public_services	S-Institution
36	,	_	,	_	,	37	_	_	_	_	_	_	_	O
37	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
38	:	_	:	_	:	37	_	_	_	_	_	_	_	O
39	harm	_	harm	_	NN	37	_	_	_	_	_	_	_	O
40	reduction	_	reduction	_	NN	37	_	_	_	_	_	_	_	O
41	,	_	,	_	,	37	_	_	_	_	_	_	_	O
42	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
43	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
44	:	_	:	_	:	37	_	_	_	_	_	_	_	O
45	acute	_	acute	_	NN	37	_	_	_	_	_	_	_	O
46	,	_	,	_	,	37	_	_	_	_	_	_	_	O
47	maternity	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
49	mental	_	mental	_	JJ	37	_	_	_	_	_	_	_	O
50	health	_	health	_	NN	37	_	_	_	_	_	_	_	O
51	services	_	service	_	NNS	37	_	_	_	_	_	_	_	O
52	.	_	.	_	.	37	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	37	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	37	_	_	_	_	_	_	_	O
4	lifestyle	_	lifestyle	_	JJ	37	_	_	_	_	_	_	_	O
5	advice	_	advice	_	NN	37	_	_	_	_	_	_	_	O
6	,	_	,	_	,	37	_	_	_	_	_	_	_	O
7	see	_	see	_	VBP	37	_	_	_	_	_	_	_	O
8	the	_	the	_	DT	37	_	_	_	_	_	_	_	O
9	nice	_	UNK	_	NNP	37	_	_	_	_	_	_	_	O
10	guidelines	_	guideline	_	NNS	37	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	37	_	_	_	_	_	_	_	O
12	:	_	:	_	:	37	_	_	_	_	_	_	_	O
13	preventing	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
14	excess	_	excess	_	JJ	37	_	_	_	_	_	_	_	O
15	weight	_	weight	_	NN	37	_	_	_	_	_	_	_	O
16	gain	_	gain	_	NN	37	_	_	_	_	_	_	_	O
17	,	_	,	_	,	37	_	_	_	_	_	_	_	O
18	weight	_	weight	_	JJ	37	_	_	_	_	_	_	_	O
19	management	_	management	_	NN	37	_	_	_	_	_	_	_	O
20	,	_	,	_	,	37	_	_	_	_	_	_	_	O
21	obesity	_	obesity	_	NN	37	_	_	_	_	_	_	_	O
22	,	_	,	_	,	37	_	_	_	_	_	_	_	O
23	physical	_	physical	_	JJ	37	_	_	_	_	_	_	_	O
24	activity	_	activity	_	NN	37	_	_	_	_	_	_	_	O
25	,	_	,	_	,	37	_	_	_	_	_	_	_	O
26	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
27	:	_	:	_	:	37	_	_	_	_	_	_	_	O
28	brief	_	brief	_	JJ	37	_	_	_	_	_	_	_	O
29	interventions	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
30	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
31	referrals	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
32	,	_	,	_	,	37	_	_	_	_	_	_	_	O
33	stop	_	stop	_	VB	37	_	_	_	_	_	_	_	O
34	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
35	services	_	service	_	NNS	37	_	_	_	_	_	_	_	O
36	,	_	,	_	,	37	_	_	_	_	_	_	_	O
37	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
38	:	_	:	_	:	37	_	_	_	_	_	_	_	O
39	harm	_	harm	_	NN	37	_	_	_	_	_	_	_	S-Item
40	reduction	_	reduction	_	NN	37	_	_	_	_	_	reduction.n	Cause_change_of_position_on_a_scale	O
41	,	_	,	_	,	37	_	_	_	_	_	_	_	O
42	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
43	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
44	:	_	:	_	:	37	_	_	_	_	_	_	_	O
45	acute	_	acute	_	NN	37	_	_	_	_	_	_	_	O
46	,	_	,	_	,	37	_	_	_	_	_	_	_	O
47	maternity	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
49	mental	_	mental	_	JJ	37	_	_	_	_	_	_	_	O
50	health	_	health	_	NN	37	_	_	_	_	_	_	_	O
51	services	_	service	_	NNS	37	_	_	_	_	_	_	_	O
52	.	_	.	_	.	37	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	37	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	37	_	_	_	_	_	_	_	O
4	lifestyle	_	lifestyle	_	JJ	37	_	_	_	_	_	_	_	O
5	advice	_	advice	_	NN	37	_	_	_	_	_	_	_	O
6	,	_	,	_	,	37	_	_	_	_	_	_	_	O
7	see	_	see	_	VBP	37	_	_	_	_	_	_	_	O
8	the	_	the	_	DT	37	_	_	_	_	_	_	_	O
9	nice	_	UNK	_	NNP	37	_	_	_	_	_	_	_	O
10	guidelines	_	guideline	_	NNS	37	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	37	_	_	_	_	_	_	_	O
12	:	_	:	_	:	37	_	_	_	_	_	_	_	O
13	preventing	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
14	excess	_	excess	_	JJ	37	_	_	_	_	_	_	_	O
15	weight	_	weight	_	NN	37	_	_	_	_	_	_	_	O
16	gain	_	gain	_	NN	37	_	_	_	_	_	_	_	O
17	,	_	,	_	,	37	_	_	_	_	_	_	_	O
18	weight	_	weight	_	JJ	37	_	_	_	_	_	_	_	O
19	management	_	management	_	NN	37	_	_	_	_	_	_	_	O
20	,	_	,	_	,	37	_	_	_	_	_	_	_	O
21	obesity	_	obesity	_	NN	37	_	_	_	_	_	_	_	O
22	,	_	,	_	,	37	_	_	_	_	_	_	_	O
23	physical	_	physical	_	JJ	37	_	_	_	_	_	_	_	O
24	activity	_	activity	_	NN	37	_	_	_	_	_	_	_	O
25	,	_	,	_	,	37	_	_	_	_	_	_	_	O
26	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
27	:	_	:	_	:	37	_	_	_	_	_	_	_	O
28	brief	_	brief	_	JJ	37	_	_	_	_	_	_	_	O
29	interventions	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
30	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
31	referrals	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
32	,	_	,	_	,	37	_	_	_	_	_	_	_	O
33	stop	_	stop	_	VB	37	_	_	_	_	_	_	_	O
34	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
35	services	_	service	_	NNS	37	_	_	_	_	_	_	_	O
36	,	_	,	_	,	37	_	_	_	_	_	_	_	O
37	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
38	:	_	:	_	:	37	_	_	_	_	_	_	_	O
39	harm	_	harm	_	NN	37	_	_	_	_	_	_	_	O
40	reduction	_	reduction	_	NN	37	_	_	_	_	_	_	_	O
41	,	_	,	_	,	37	_	_	_	_	_	_	_	O
42	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
43	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
44	:	_	:	_	:	37	_	_	_	_	_	_	_	O
45	acute	_	acute	_	NN	37	_	_	_	_	_	acute.a	Importance	O
46	,	_	,	_	,	37	_	_	_	_	_	_	_	O
47	maternity	_	UNK	_	NN	37	_	_	_	_	_	_	_	B-Factor
48	and	_	and	_	CC	37	_	_	_	_	_	_	_	I-Factor
49	mental	_	mental	_	JJ	37	_	_	_	_	_	_	_	I-Factor
50	health	_	health	_	NN	37	_	_	_	_	_	_	_	I-Factor
51	services	_	service	_	NNS	37	_	_	_	_	_	_	_	I-Factor
52	.	_	.	_	.	37	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	37	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	37	_	_	_	_	_	_	_	O
4	lifestyle	_	lifestyle	_	JJ	37	_	_	_	_	_	_	_	O
5	advice	_	advice	_	NN	37	_	_	_	_	_	_	_	O
6	,	_	,	_	,	37	_	_	_	_	_	_	_	O
7	see	_	see	_	VBP	37	_	_	_	_	_	_	_	O
8	the	_	the	_	DT	37	_	_	_	_	_	_	_	O
9	nice	_	UNK	_	NNP	37	_	_	_	_	_	_	_	O
10	guidelines	_	guideline	_	NNS	37	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	37	_	_	_	_	_	_	_	O
12	:	_	:	_	:	37	_	_	_	_	_	_	_	O
13	preventing	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
14	excess	_	excess	_	JJ	37	_	_	_	_	_	_	_	O
15	weight	_	weight	_	NN	37	_	_	_	_	_	_	_	O
16	gain	_	gain	_	NN	37	_	_	_	_	_	_	_	O
17	,	_	,	_	,	37	_	_	_	_	_	_	_	O
18	weight	_	weight	_	JJ	37	_	_	_	_	_	_	_	O
19	management	_	management	_	NN	37	_	_	_	_	_	_	_	O
20	,	_	,	_	,	37	_	_	_	_	_	_	_	O
21	obesity	_	obesity	_	NN	37	_	_	_	_	_	_	_	O
22	,	_	,	_	,	37	_	_	_	_	_	_	_	O
23	physical	_	physical	_	JJ	37	_	_	_	_	_	_	_	O
24	activity	_	activity	_	NN	37	_	_	_	_	_	_	_	O
25	,	_	,	_	,	37	_	_	_	_	_	_	_	O
26	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
27	:	_	:	_	:	37	_	_	_	_	_	_	_	O
28	brief	_	brief	_	JJ	37	_	_	_	_	_	_	_	O
29	interventions	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
30	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
31	referrals	_	UNK	_	NNS	37	_	_	_	_	_	_	_	O
32	,	_	,	_	,	37	_	_	_	_	_	_	_	O
33	stop	_	stop	_	VB	37	_	_	_	_	_	_	_	O
34	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
35	services	_	service	_	NNS	37	_	_	_	_	_	_	_	O
36	,	_	,	_	,	37	_	_	_	_	_	_	_	O
37	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
38	:	_	:	_	:	37	_	_	_	_	_	_	_	O
39	harm	_	harm	_	NN	37	_	_	_	_	_	_	_	O
40	reduction	_	reduction	_	NN	37	_	_	_	_	_	_	_	O
41	,	_	,	_	,	37	_	_	_	_	_	_	_	O
42	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
43	smoking	_	smoking	_	NN	37	_	_	_	_	_	_	_	O
44	:	_	:	_	:	37	_	_	_	_	_	_	_	O
45	acute	_	acute	_	NN	37	_	_	_	_	_	_	_	O
46	,	_	,	_	,	37	_	_	_	_	_	_	_	O
47	maternity	_	UNK	_	NN	37	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	37	_	_	_	_	_	_	_	O
49	mental	_	mental	_	JJ	37	_	_	_	_	_	_	_	B-Institution
50	health	_	health	_	NN	37	_	_	_	_	_	_	_	I-Institution
51	services	_	service	_	NNS	37	_	_	_	_	_	service.n	Public_services	O
52	.	_	.	_	.	37	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	38	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	38	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	38	_	_	_	_	_	_	_	O
4	bariatric	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
5	surgery	_	UNK	_	NN	38	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	38	_	_	_	_	_	_	_	O
7	people	_	people	_	NNS	38	_	_	_	_	_	people.n	People	S-Person
8	with	_	with	_	IN	38	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
10	type	_	type	_	NN	38	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	38	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	38	_	_	_	_	_	_	_	O
13	,	_	,	_	,	38	_	_	_	_	_	_	_	O
14	see	_	see	_	VBP	38	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	38	_	_	_	_	_	_	_	O
16	section	_	section	_	NN	38	_	_	_	_	_	_	_	O
17	on	_	on	_	IN	38	_	_	_	_	_	_	_	O
18	bariatric	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
19	surgery	_	UNK	_	NN	38	_	_	_	_	_	_	_	O
20	for	_	for	_	IN	38	_	_	_	_	_	_	_	O
21	people	_	people	_	NNS	38	_	_	_	_	_	_	_	O
22	with	_	with	_	IN	38	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
24	type	_	type	_	NN	38	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	38	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	38	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	38	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	38	_	_	_	_	_	_	_	O
29	nice	_	UNK	_	NNP	38	_	_	_	_	_	_	_	O
30	guideline	_	guideline	_	NN	38	_	_	_	_	_	_	_	O
31	on	_	on	_	IN	38	_	_	_	_	_	_	_	O
32	obesity	_	obesity	_	NN	38	_	_	_	_	_	_	_	O
33	.	_	.	_	.	38	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	38	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	38	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	38	_	_	_	_	_	_	_	O
4	bariatric	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
5	surgery	_	UNK	_	NN	38	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	38	_	_	_	_	_	_	_	O
7	people	_	people	_	NNS	38	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	38	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	JJ	38	_	_	_	_	_	_	_	S-Type_property
10	type	_	type	_	NN	38	_	_	_	_	_	type.n	Type	S-Subtype
11	2	_	2	_	CD	38	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	38	_	_	_	_	_	_	_	O
13	,	_	,	_	,	38	_	_	_	_	_	_	_	O
14	see	_	see	_	VBP	38	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	38	_	_	_	_	_	_	_	O
16	section	_	section	_	NN	38	_	_	_	_	_	_	_	O
17	on	_	on	_	IN	38	_	_	_	_	_	_	_	O
18	bariatric	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
19	surgery	_	UNK	_	NN	38	_	_	_	_	_	_	_	O
20	for	_	for	_	IN	38	_	_	_	_	_	_	_	O
21	people	_	people	_	NNS	38	_	_	_	_	_	_	_	O
22	with	_	with	_	IN	38	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
24	type	_	type	_	NN	38	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	38	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	38	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	38	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	38	_	_	_	_	_	_	_	O
29	nice	_	UNK	_	NNP	38	_	_	_	_	_	_	_	O
30	guideline	_	guideline	_	NN	38	_	_	_	_	_	_	_	O
31	on	_	on	_	IN	38	_	_	_	_	_	_	_	O
32	obesity	_	obesity	_	NN	38	_	_	_	_	_	_	_	O
33	.	_	.	_	.	38	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	38	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	38	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	38	_	_	_	_	_	_	_	O
4	bariatric	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
5	surgery	_	UNK	_	NN	38	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	38	_	_	_	_	_	_	_	O
7	people	_	people	_	NNS	38	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	38	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
10	type	_	type	_	NN	38	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	38	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	38	_	_	_	_	_	_	_	O
13	,	_	,	_	,	38	_	_	_	_	_	_	_	O
14	see	_	see	_	VBP	38	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	38	_	_	_	_	_	_	_	O
16	section	_	section	_	NN	38	_	_	_	_	_	section.n	Part_whole	S-Part
17	on	_	on	_	IN	38	_	_	_	_	_	_	_	B-Whole
18	bariatric	_	UNK	_	JJ	38	_	_	_	_	_	_	_	I-Whole
19	surgery	_	UNK	_	NN	38	_	_	_	_	_	_	_	I-Whole
20	for	_	for	_	IN	38	_	_	_	_	_	_	_	O
21	people	_	people	_	NNS	38	_	_	_	_	_	_	_	O
22	with	_	with	_	IN	38	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
24	type	_	type	_	NN	38	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	38	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	38	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	38	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	38	_	_	_	_	_	_	_	O
29	nice	_	UNK	_	NNP	38	_	_	_	_	_	_	_	O
30	guideline	_	guideline	_	NN	38	_	_	_	_	_	_	_	O
31	on	_	on	_	IN	38	_	_	_	_	_	_	_	O
32	obesity	_	obesity	_	NN	38	_	_	_	_	_	_	_	O
33	.	_	.	_	.	38	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	38	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	38	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	38	_	_	_	_	_	_	_	O
4	bariatric	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
5	surgery	_	UNK	_	NN	38	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	38	_	_	_	_	_	_	_	O
7	people	_	people	_	NNS	38	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	38	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
10	type	_	type	_	NN	38	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	38	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	38	_	_	_	_	_	_	_	O
13	,	_	,	_	,	38	_	_	_	_	_	_	_	O
14	see	_	see	_	VBP	38	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	38	_	_	_	_	_	_	_	O
16	section	_	section	_	NN	38	_	_	_	_	_	_	_	O
17	on	_	on	_	IN	38	_	_	_	_	_	_	_	O
18	bariatric	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
19	surgery	_	UNK	_	NN	38	_	_	_	_	_	_	_	O
20	for	_	for	_	IN	38	_	_	_	_	_	_	_	O
21	people	_	people	_	NNS	38	_	_	_	_	_	people.n	People	S-Person
22	with	_	with	_	IN	38	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
24	type	_	type	_	NN	38	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	38	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	38	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	38	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	38	_	_	_	_	_	_	_	O
29	nice	_	UNK	_	NNP	38	_	_	_	_	_	_	_	O
30	guideline	_	guideline	_	NN	38	_	_	_	_	_	_	_	O
31	on	_	on	_	IN	38	_	_	_	_	_	_	_	O
32	obesity	_	obesity	_	NN	38	_	_	_	_	_	_	_	O
33	.	_	.	_	.	38	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	38	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	38	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	38	_	_	_	_	_	_	_	O
4	bariatric	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
5	surgery	_	UNK	_	NN	38	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	38	_	_	_	_	_	_	_	O
7	people	_	people	_	NNS	38	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	38	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
10	type	_	type	_	NN	38	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	38	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	38	_	_	_	_	_	_	_	O
13	,	_	,	_	,	38	_	_	_	_	_	_	_	O
14	see	_	see	_	VBP	38	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	38	_	_	_	_	_	_	_	O
16	section	_	section	_	NN	38	_	_	_	_	_	_	_	O
17	on	_	on	_	IN	38	_	_	_	_	_	_	_	O
18	bariatric	_	UNK	_	JJ	38	_	_	_	_	_	_	_	O
19	surgery	_	UNK	_	NN	38	_	_	_	_	_	_	_	O
20	for	_	for	_	IN	38	_	_	_	_	_	_	_	O
21	people	_	people	_	NNS	38	_	_	_	_	_	_	_	O
22	with	_	with	_	IN	38	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	JJ	38	_	_	_	_	_	_	_	S-Type_property
24	type	_	type	_	NN	38	_	_	_	_	_	type.n	Type	S-Subtype
25	2	_	2	_	CD	38	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	38	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	38	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	38	_	_	_	_	_	_	_	O
29	nice	_	UNK	_	NNP	38	_	_	_	_	_	_	_	O
30	guideline	_	guideline	_	NN	38	_	_	_	_	_	_	_	O
31	on	_	on	_	IN	38	_	_	_	_	_	_	_	O
32	obesity	_	obesity	_	NN	38	_	_	_	_	_	_	_	O
33	.	_	.	_	.	38	_	_	_	_	_	_	_	O

1	measure	_	UNK	_	NN	39	_	_	_	_	_	_	_	B-Speaker
2	blood	_	blood	_	NN	39	_	_	_	_	_	_	_	I-Speaker
3	pressure	_	pressure	_	NN	39	_	_	_	_	_	pressure.n	Attempt_suasion	O
4	at	_	at	_	IN	39	_	_	_	_	_	_	_	O
5	least	_	least	_	JJS	39	_	_	_	_	_	_	_	O
6	annually	_	annually	_	RB	39	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	39	_	_	_	_	_	_	_	O
8	an	_	an	_	DT	39	_	_	_	_	_	_	_	O
9	adult	_	adult	_	NN	39	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	39	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	39	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	39	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	39	_	_	_	_	_	_	_	O
14	without	_	without	_	IN	39	_	_	_	_	_	_	_	O
15	previously	_	previously	_	RB	39	_	_	_	_	_	_	_	O
16	diagnosed	_	UNK	_	VBN	39	_	_	_	_	_	_	_	O
17	hypertension	_	UNK	_	NN	39	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	39	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	39	_	_	_	_	_	_	_	O
20	disease	_	disease	_	NN	39	_	_	_	_	_	_	_	O

1	measure	_	UNK	_	NN	39	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	39	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	39	_	_	_	_	_	_	_	O
4	at	_	at	_	IN	39	_	_	_	_	_	_	_	O
5	least	_	least	_	JJS	39	_	_	_	_	_	_	_	O
6	annually	_	annually	_	RB	39	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	39	_	_	_	_	_	_	_	O
8	an	_	an	_	DT	39	_	_	_	_	_	_	_	O
9	adult	_	adult	_	NN	39	_	_	_	_	_	adult.n	People_by_age	S-Person
10	with	_	with	_	IN	39	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	39	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	39	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	39	_	_	_	_	_	_	_	O
14	without	_	without	_	IN	39	_	_	_	_	_	_	_	O
15	previously	_	previously	_	RB	39	_	_	_	_	_	_	_	O
16	diagnosed	_	UNK	_	VBN	39	_	_	_	_	_	_	_	O
17	hypertension	_	UNK	_	NN	39	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	39	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	39	_	_	_	_	_	_	_	O
20	disease	_	disease	_	NN	39	_	_	_	_	_	_	_	O

1	measure	_	UNK	_	NN	39	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	39	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	39	_	_	_	_	_	_	_	O
4	at	_	at	_	IN	39	_	_	_	_	_	_	_	O
5	least	_	least	_	JJS	39	_	_	_	_	_	_	_	O
6	annually	_	annually	_	RB	39	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	39	_	_	_	_	_	_	_	O
8	an	_	an	_	DT	39	_	_	_	_	_	_	_	O
9	adult	_	adult	_	NN	39	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	39	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	39	_	_	_	_	_	type.n	Type	S-Subtype
12	2	_	2	_	CD	39	_	_	_	_	_	_	_	B-Category
13	diabetes	_	UNK	_	NNS	39	_	_	_	_	_	_	_	I-Category
14	without	_	without	_	IN	39	_	_	_	_	_	_	_	O
15	previously	_	previously	_	RB	39	_	_	_	_	_	_	_	O
16	diagnosed	_	UNK	_	VBN	39	_	_	_	_	_	_	_	O
17	hypertension	_	UNK	_	NN	39	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	39	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	39	_	_	_	_	_	_	_	O
20	disease	_	disease	_	NN	39	_	_	_	_	_	_	_	O

1	measure	_	UNK	_	NN	39	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	39	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	39	_	_	_	_	_	_	_	O
4	at	_	at	_	IN	39	_	_	_	_	_	_	_	O
5	least	_	least	_	JJS	39	_	_	_	_	_	_	_	O
6	annually	_	annually	_	RB	39	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	39	_	_	_	_	_	_	_	O
8	an	_	an	_	DT	39	_	_	_	_	_	_	_	O
9	adult	_	adult	_	NN	39	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	39	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	39	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	39	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	39	_	_	_	_	_	_	_	O
14	without	_	without	_	IN	39	_	_	_	_	_	_	_	O
15	previously	_	previously	_	RB	39	_	_	_	_	_	_	_	O
16	diagnosed	_	UNK	_	VBN	39	_	_	_	_	_	_	_	O
17	hypertension	_	UNK	_	NN	39	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	39	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	39	_	_	_	_	_	_	_	O
20	disease	_	disease	_	NN	39	_	_	_	_	_	disease.n	Medical_conditions	S-Ailment

1	offer	_	UNK	_	NN	40	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	40	_	_	_	_	_	_	_	O
3	reinforce	_	reinforce	_	VB	40	_	_	_	_	_	reinforce.v	Cause_change_of_strength	O
4	preventive	_	UNK	_	JJ	40	_	_	_	_	_	_	_	B-Patient
5	lifestyle	_	lifestyle	_	JJ	40	_	_	_	_	_	_	_	I-Patient
6	advice	_	advice	_	NN	40	_	_	_	_	_	_	_	I-Patient
7	.	_	.	_	.	40	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	41	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	41	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	41	_	_	_	_	_	adult.n	People_by_age	S-Person
4	with	_	with	_	IN	41	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	41	_	_	_	_	_	_	_	O
6	2	_	2	_	CD	41	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	41	_	_	_	_	_	_	_	O
8	on	_	on	_	IN	41	_	_	_	_	_	_	_	O
9	antihypertensive	_	UNK	_	JJ	41	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	41	_	_	_	_	_	_	_	O
11	treatment	_	treatment	_	NN	41	_	_	_	_	_	_	_	O
12	when	_	when	_	WRB	41	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	VBZ	41	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	41	_	_	_	_	_	_	_	O
15	diagnosed	_	UNK	_	VBN	41	_	_	_	_	_	_	_	O
16	,	_	,	_	,	41	_	_	_	_	_	_	_	O
17	review	_	review	_	VB	41	_	_	_	_	_	_	_	O
18	blood	_	blood	_	NN	41	_	_	_	_	_	_	_	O
19	pressure	_	pressure	_	NN	41	_	_	_	_	_	_	_	O
20	control	_	control	_	NN	41	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	41	_	_	_	_	_	_	_	O
22	medications	_	medication	_	NNS	41	_	_	_	_	_	_	_	O
23	used	_	use	_	VBN	41	_	_	_	_	_	_	_	O
24	.	_	.	_	.	41	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	41	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	41	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	41	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	41	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	41	_	_	_	_	_	type.n	Type	S-Subtype
6	2	_	2	_	CD	41	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	41	_	_	_	_	_	_	_	O
8	on	_	on	_	IN	41	_	_	_	_	_	_	_	O
9	antihypertensive	_	UNK	_	JJ	41	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	41	_	_	_	_	_	_	_	O
11	treatment	_	treatment	_	NN	41	_	_	_	_	_	_	_	O
12	when	_	when	_	WRB	41	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	VBZ	41	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	41	_	_	_	_	_	_	_	O
15	diagnosed	_	UNK	_	VBN	41	_	_	_	_	_	_	_	O
16	,	_	,	_	,	41	_	_	_	_	_	_	_	O
17	review	_	review	_	VB	41	_	_	_	_	_	_	_	O
18	blood	_	blood	_	NN	41	_	_	_	_	_	_	_	O
19	pressure	_	pressure	_	NN	41	_	_	_	_	_	_	_	O
20	control	_	control	_	NN	41	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	41	_	_	_	_	_	_	_	O
22	medications	_	medication	_	NNS	41	_	_	_	_	_	_	_	O
23	used	_	use	_	VBN	41	_	_	_	_	_	_	_	O
24	.	_	.	_	.	41	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	41	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	41	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	41	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	41	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	41	_	_	_	_	_	_	_	O
6	2	_	2	_	CD	41	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	41	_	_	_	_	_	_	_	O
8	on	_	on	_	IN	41	_	_	_	_	_	_	_	O
9	antihypertensive	_	UNK	_	JJ	41	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	41	_	_	_	_	_	_	_	O
11	treatment	_	treatment	_	NN	41	_	_	_	_	_	_	_	O
12	when	_	when	_	WRB	41	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	VBZ	41	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	41	_	_	_	_	_	_	_	O
15	diagnosed	_	UNK	_	VBN	41	_	_	_	_	_	_	_	O
16	,	_	,	_	,	41	_	_	_	_	_	_	_	O
17	review	_	review	_	VB	41	_	_	_	_	_	_	_	O
18	blood	_	blood	_	NN	41	_	_	_	_	_	_	_	S-Speaker
19	pressure	_	pressure	_	NN	41	_	_	_	_	_	pressure.n	Attempt_suasion	O
20	control	_	control	_	NN	41	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	41	_	_	_	_	_	_	_	O
22	medications	_	medication	_	NNS	41	_	_	_	_	_	_	_	O
23	used	_	use	_	VBN	41	_	_	_	_	_	_	_	O
24	.	_	.	_	.	41	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	41	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	41	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	41	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	41	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	41	_	_	_	_	_	_	_	O
6	2	_	2	_	CD	41	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	41	_	_	_	_	_	_	_	O
8	on	_	on	_	IN	41	_	_	_	_	_	_	_	O
9	antihypertensive	_	UNK	_	JJ	41	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	41	_	_	_	_	_	_	_	O
11	treatment	_	treatment	_	NN	41	_	_	_	_	_	_	_	O
12	when	_	when	_	WRB	41	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	VBZ	41	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	41	_	_	_	_	_	_	_	O
15	diagnosed	_	UNK	_	VBN	41	_	_	_	_	_	_	_	O
16	,	_	,	_	,	41	_	_	_	_	_	_	_	O
17	review	_	review	_	VB	41	_	_	_	_	_	_	_	O
18	blood	_	blood	_	NN	41	_	_	_	_	_	_	_	B-Instrument
19	pressure	_	pressure	_	NN	41	_	_	_	_	_	_	_	I-Instrument
20	control	_	control	_	NN	41	_	_	_	_	_	_	_	I-Instrument
21	and	_	and	_	CC	41	_	_	_	_	_	_	_	I-Instrument
22	medications	_	medication	_	NNS	41	_	_	_	_	_	_	_	I-Instrument
23	used	_	use	_	VBN	41	_	_	_	_	_	use.v	Using	O
24	.	_	.	_	.	41	_	_	_	_	_	_	_	O

1	make	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
2	changes	_	change	_	NNS	42	_	_	_	_	_	change.n	Undergo_change	O
3	only	_	only	_	RB	42	_	_	_	_	_	_	_	O
4	if	_	if	_	IN	42	_	_	_	_	_	_	_	O
5	there	_	there	_	EX	42	_	_	_	_	_	_	_	O
6	is	_	be	_	VBZ	42	_	_	_	_	_	_	_	O
7	poor	_	poor	_	JJ	42	_	_	_	_	_	_	_	O
8	control	_	control	_	NN	42	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	42	_	_	_	_	_	_	_	O
10	if	_	if	_	IN	42	_	_	_	_	_	_	_	O
11	current	_	current	_	JJ	42	_	_	_	_	_	_	_	O
12	drug	_	drug	_	NN	42	_	_	_	_	_	_	_	O
13	treatment	_	treatment	_	NN	42	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	42	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	42	_	_	_	_	_	_	_	O
16	appropriate	_	appropriate	_	JJ	42	_	_	_	_	_	_	_	O
17	because	_	because	_	IN	42	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	42	_	_	_	_	_	_	_	O
19	microvascular	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
20	complications	_	UNK	_	NNS	42	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	42	_	_	_	_	_	_	_	O
22	metabolic	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
23	problems	_	problem	_	NNS	42	_	_	_	_	_	_	_	O
24	.	_	.	_	.	42	_	_	_	_	_	_	_	O

1	make	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
2	changes	_	change	_	NNS	42	_	_	_	_	_	_	_	O
3	only	_	only	_	RB	42	_	_	_	_	_	_	_	O
4	if	_	if	_	IN	42	_	_	_	_	_	_	_	O
5	there	_	there	_	EX	42	_	_	_	_	_	there.adv	Locative_relation	S-Ground
6	is	_	be	_	VBZ	42	_	_	_	_	_	_	_	O
7	poor	_	poor	_	JJ	42	_	_	_	_	_	_	_	B-Ground
8	control	_	control	_	NN	42	_	_	_	_	_	_	_	I-Ground
9	or	_	or	_	CC	42	_	_	_	_	_	_	_	O
10	if	_	if	_	IN	42	_	_	_	_	_	_	_	O
11	current	_	current	_	JJ	42	_	_	_	_	_	_	_	O
12	drug	_	drug	_	NN	42	_	_	_	_	_	_	_	O
13	treatment	_	treatment	_	NN	42	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	42	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	42	_	_	_	_	_	_	_	O
16	appropriate	_	appropriate	_	JJ	42	_	_	_	_	_	_	_	O
17	because	_	because	_	IN	42	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	42	_	_	_	_	_	_	_	O
19	microvascular	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
20	complications	_	UNK	_	NNS	42	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	42	_	_	_	_	_	_	_	O
22	metabolic	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
23	problems	_	problem	_	NNS	42	_	_	_	_	_	_	_	O
24	.	_	.	_	.	42	_	_	_	_	_	_	_	O

1	make	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
2	changes	_	change	_	NNS	42	_	_	_	_	_	_	_	O
3	only	_	only	_	RB	42	_	_	_	_	_	_	_	O
4	if	_	if	_	IN	42	_	_	_	_	_	_	_	O
5	there	_	there	_	EX	42	_	_	_	_	_	_	_	O
6	is	_	be	_	VBZ	42	_	_	_	_	_	_	_	O
7	poor	_	poor	_	JJ	42	_	_	_	_	_	_	_	S-Controlling_entity
8	control	_	control	_	NN	42	_	_	_	_	_	control.n	Being_in_control	O
9	or	_	or	_	CC	42	_	_	_	_	_	_	_	O
10	if	_	if	_	IN	42	_	_	_	_	_	_	_	O
11	current	_	current	_	JJ	42	_	_	_	_	_	_	_	O
12	drug	_	drug	_	NN	42	_	_	_	_	_	_	_	O
13	treatment	_	treatment	_	NN	42	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	42	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	42	_	_	_	_	_	_	_	O
16	appropriate	_	appropriate	_	JJ	42	_	_	_	_	_	_	_	O
17	because	_	because	_	IN	42	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	42	_	_	_	_	_	_	_	O
19	microvascular	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
20	complications	_	UNK	_	NNS	42	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	42	_	_	_	_	_	_	_	O
22	metabolic	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
23	problems	_	problem	_	NNS	42	_	_	_	_	_	_	_	O
24	.	_	.	_	.	42	_	_	_	_	_	_	_	O

1	make	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
2	changes	_	change	_	NNS	42	_	_	_	_	_	_	_	O
3	only	_	only	_	RB	42	_	_	_	_	_	_	_	O
4	if	_	if	_	IN	42	_	_	_	_	_	_	_	O
5	there	_	there	_	EX	42	_	_	_	_	_	_	_	O
6	is	_	be	_	VBZ	42	_	_	_	_	_	_	_	O
7	poor	_	poor	_	JJ	42	_	_	_	_	_	_	_	O
8	control	_	control	_	NN	42	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	42	_	_	_	_	_	_	_	O
10	if	_	if	_	IN	42	_	_	_	_	_	_	_	O
11	current	_	current	_	JJ	42	_	_	_	_	_	current.a	Temporal_collocation	O
12	drug	_	drug	_	NN	42	_	_	_	_	_	_	_	B-Trajector_entity
13	treatment	_	treatment	_	NN	42	_	_	_	_	_	_	_	I-Trajector_entity
14	is	_	be	_	VBZ	42	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	42	_	_	_	_	_	_	_	O
16	appropriate	_	appropriate	_	JJ	42	_	_	_	_	_	_	_	O
17	because	_	because	_	IN	42	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	42	_	_	_	_	_	_	_	O
19	microvascular	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
20	complications	_	UNK	_	NNS	42	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	42	_	_	_	_	_	_	_	O
22	metabolic	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
23	problems	_	problem	_	NNS	42	_	_	_	_	_	_	_	O
24	.	_	.	_	.	42	_	_	_	_	_	_	_	O

1	make	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
2	changes	_	change	_	NNS	42	_	_	_	_	_	_	_	O
3	only	_	only	_	RB	42	_	_	_	_	_	_	_	O
4	if	_	if	_	IN	42	_	_	_	_	_	_	_	O
5	there	_	there	_	EX	42	_	_	_	_	_	_	_	O
6	is	_	be	_	VBZ	42	_	_	_	_	_	_	_	O
7	poor	_	poor	_	JJ	42	_	_	_	_	_	_	_	O
8	control	_	control	_	NN	42	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	42	_	_	_	_	_	_	_	O
10	if	_	if	_	IN	42	_	_	_	_	_	_	_	O
11	current	_	current	_	JJ	42	_	_	_	_	_	_	_	O
12	drug	_	drug	_	NN	42	_	_	_	_	_	_	_	S-Patient
13	treatment	_	treatment	_	NN	42	_	_	_	_	_	treatment.n	Cure	O
14	is	_	be	_	VBZ	42	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	42	_	_	_	_	_	_	_	O
16	appropriate	_	appropriate	_	JJ	42	_	_	_	_	_	_	_	O
17	because	_	because	_	IN	42	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	42	_	_	_	_	_	_	_	O
19	microvascular	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
20	complications	_	UNK	_	NNS	42	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	42	_	_	_	_	_	_	_	O
22	metabolic	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
23	problems	_	problem	_	NNS	42	_	_	_	_	_	_	_	O
24	.	_	.	_	.	42	_	_	_	_	_	_	_	O

1	make	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
2	changes	_	change	_	NNS	42	_	_	_	_	_	_	_	O
3	only	_	only	_	RB	42	_	_	_	_	_	_	_	O
4	if	_	if	_	IN	42	_	_	_	_	_	_	_	O
5	there	_	there	_	EX	42	_	_	_	_	_	_	_	O
6	is	_	be	_	VBZ	42	_	_	_	_	_	_	_	O
7	poor	_	poor	_	JJ	42	_	_	_	_	_	_	_	O
8	control	_	control	_	NN	42	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	42	_	_	_	_	_	_	_	O
10	if	_	if	_	IN	42	_	_	_	_	_	_	_	O
11	current	_	current	_	JJ	42	_	_	_	_	_	_	_	B-Evaluee
12	drug	_	drug	_	NN	42	_	_	_	_	_	_	_	I-Evaluee
13	treatment	_	treatment	_	NN	42	_	_	_	_	_	_	_	I-Evaluee
14	is	_	be	_	VBZ	42	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	42	_	_	_	_	_	_	_	O
16	appropriate	_	appropriate	_	JJ	42	_	_	_	_	_	appropriate.a	Suitability	O
17	because	_	because	_	IN	42	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	42	_	_	_	_	_	_	_	O
19	microvascular	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
20	complications	_	UNK	_	NNS	42	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	42	_	_	_	_	_	_	_	O
22	metabolic	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
23	problems	_	problem	_	NNS	42	_	_	_	_	_	_	_	O
24	.	_	.	_	.	42	_	_	_	_	_	_	_	O

1	make	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
2	changes	_	change	_	NNS	42	_	_	_	_	_	_	_	O
3	only	_	only	_	RB	42	_	_	_	_	_	_	_	O
4	if	_	if	_	IN	42	_	_	_	_	_	_	_	O
5	there	_	there	_	EX	42	_	_	_	_	_	_	_	O
6	is	_	be	_	VBZ	42	_	_	_	_	_	_	_	O
7	poor	_	poor	_	JJ	42	_	_	_	_	_	_	_	O
8	control	_	control	_	NN	42	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	42	_	_	_	_	_	_	_	O
10	if	_	if	_	IN	42	_	_	_	_	_	_	_	O
11	current	_	current	_	JJ	42	_	_	_	_	_	_	_	B-Cause
12	drug	_	drug	_	NN	42	_	_	_	_	_	_	_	I-Cause
13	treatment	_	treatment	_	NN	42	_	_	_	_	_	_	_	I-Cause
14	is	_	be	_	VBZ	42	_	_	_	_	_	_	_	I-Cause
15	not	_	not	_	RB	42	_	_	_	_	_	_	_	I-Cause
16	appropriate	_	appropriate	_	JJ	42	_	_	_	_	_	_	_	I-Cause
17	because	_	because	_	IN	42	_	_	_	_	_	because.c	Causation	O
18	of	_	of	_	IN	42	_	_	_	_	_	_	_	B-Effect
19	microvascular	_	UNK	_	JJ	42	_	_	_	_	_	_	_	I-Effect
20	complications	_	UNK	_	NNS	42	_	_	_	_	_	_	_	I-Effect
21	or	_	or	_	CC	42	_	_	_	_	_	_	_	I-Effect
22	metabolic	_	UNK	_	JJ	42	_	_	_	_	_	_	_	I-Effect
23	problems	_	problem	_	NNS	42	_	_	_	_	_	_	_	I-Effect
24	.	_	.	_	.	42	_	_	_	_	_	_	_	O

1	make	_	UNK	_	NNP	42	_	_	_	_	_	_	_	O
2	changes	_	change	_	NNS	42	_	_	_	_	_	_	_	O
3	only	_	only	_	RB	42	_	_	_	_	_	_	_	O
4	if	_	if	_	IN	42	_	_	_	_	_	_	_	O
5	there	_	there	_	EX	42	_	_	_	_	_	_	_	O
6	is	_	be	_	VBZ	42	_	_	_	_	_	_	_	O
7	poor	_	poor	_	JJ	42	_	_	_	_	_	_	_	O
8	control	_	control	_	NN	42	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	42	_	_	_	_	_	_	_	O
10	if	_	if	_	IN	42	_	_	_	_	_	_	_	O
11	current	_	current	_	JJ	42	_	_	_	_	_	_	_	O
12	drug	_	drug	_	NN	42	_	_	_	_	_	_	_	O
13	treatment	_	treatment	_	NN	42	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	42	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	42	_	_	_	_	_	_	_	O
16	appropriate	_	appropriate	_	JJ	42	_	_	_	_	_	_	_	O
17	because	_	because	_	IN	42	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	42	_	_	_	_	_	_	_	O
19	microvascular	_	UNK	_	JJ	42	_	_	_	_	_	_	_	O
20	complications	_	UNK	_	NNS	42	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	42	_	_	_	_	_	_	_	O
22	metabolic	_	UNK	_	JJ	42	_	_	_	_	_	_	_	S-Domain
23	problems	_	problem	_	NNS	42	_	_	_	_	_	problem.n	Predicament	S-Situation
24	.	_	.	_	.	42	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	43	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	43	_	_	_	_	_	pressure.n	Attempt_suasion	O
4	measurements	_	measurement	_	NNS	43	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	43	_	_	_	_	_	_	_	O
6	:	_	:	_	:	43	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	43	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	43	_	_	_	_	_	_	_	O
9	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
11	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	O
16	mmhg	_	UNK	_	JJ	43	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	43	_	_	_	_	_	_	_	O
18	months	_	month	_	NNS	43	_	_	_	_	_	_	_	O
19	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
21	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	O
26	mmhg	_	UNK	_	JJ	43	_	_	_	_	_	_	_	O
27	2	_	2	_	CD	43	_	_	_	_	_	_	_	O
28	months	_	month	_	NNS	43	_	_	_	_	_	_	_	O
29	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
31	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
32	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	43	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	43	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	43	_	_	_	_	_	_	_	O
39	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
40	kidney	_	UNK	_	NN	43	_	_	_	_	_	_	_	O
41	,	_	,	_	,	43	_	_	_	_	_	_	_	O
42	eye	_	eye	_	NN	43	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	43	_	_	_	_	_	_	_	O
44	cerebrovascular	_	UNK	_	JJ	43	_	_	_	_	_	_	_	O
45	damage	_	damage	_	NN	43	_	_	_	_	_	_	_	O
46	.	_	.	_	.	43	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	43	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
4	measurements	_	measurement	_	NNS	43	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	43	_	_	_	_	_	_	_	O
6	:	_	:	_	:	43	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	43	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	43	_	_	_	_	_	month.n	Calendric_unit	S-Unit
9	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
11	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	O
16	mmhg	_	UNK	_	JJ	43	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	43	_	_	_	_	_	_	_	O
18	months	_	month	_	NNS	43	_	_	_	_	_	_	_	O
19	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
21	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	O
26	mmhg	_	UNK	_	JJ	43	_	_	_	_	_	_	_	O
27	2	_	2	_	CD	43	_	_	_	_	_	_	_	O
28	months	_	month	_	NNS	43	_	_	_	_	_	_	_	O
29	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
31	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
32	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	43	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	43	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	43	_	_	_	_	_	_	_	O
39	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
40	kidney	_	UNK	_	NN	43	_	_	_	_	_	_	_	O
41	,	_	,	_	,	43	_	_	_	_	_	_	_	O
42	eye	_	eye	_	NN	43	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	43	_	_	_	_	_	_	_	O
44	cerebrovascular	_	UNK	_	JJ	43	_	_	_	_	_	_	_	O
45	damage	_	damage	_	NN	43	_	_	_	_	_	_	_	O
46	.	_	.	_	.	43	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	43	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
4	measurements	_	measurement	_	NNS	43	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	43	_	_	_	_	_	_	_	O
6	:	_	:	_	:	43	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	43	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	43	_	_	_	_	_	_	_	O
9	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	S-Speaker
11	pressure	_	pressure	_	NN	43	_	_	_	_	_	pressure.n	Attempt_suasion	O
12	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	O
16	mmhg	_	UNK	_	JJ	43	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	43	_	_	_	_	_	_	_	O
18	months	_	month	_	NNS	43	_	_	_	_	_	_	_	O
19	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
21	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	O
26	mmhg	_	UNK	_	JJ	43	_	_	_	_	_	_	_	O
27	2	_	2	_	CD	43	_	_	_	_	_	_	_	O
28	months	_	month	_	NNS	43	_	_	_	_	_	_	_	O
29	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
31	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
32	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	43	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	43	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	43	_	_	_	_	_	_	_	O
39	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
40	kidney	_	UNK	_	NN	43	_	_	_	_	_	_	_	O
41	,	_	,	_	,	43	_	_	_	_	_	_	_	O
42	eye	_	eye	_	NN	43	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	43	_	_	_	_	_	_	_	O
44	cerebrovascular	_	UNK	_	JJ	43	_	_	_	_	_	_	_	O
45	damage	_	damage	_	NN	43	_	_	_	_	_	_	_	O
46	.	_	.	_	.	43	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	43	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
4	measurements	_	measurement	_	NNS	43	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	43	_	_	_	_	_	_	_	O
6	:	_	:	_	:	43	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	43	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	43	_	_	_	_	_	_	_	O
9	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
11	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	B-Relative_time
16	mmhg	_	UNK	_	JJ	43	_	_	_	_	_	_	_	I-Relative_time
17	2	_	2	_	CD	43	_	_	_	_	_	_	_	I-Relative_time
18	months	_	month	_	NNS	43	_	_	_	_	_	month.n	Calendric_unit	S-Unit
19	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
21	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	O
26	mmhg	_	UNK	_	JJ	43	_	_	_	_	_	_	_	O
27	2	_	2	_	CD	43	_	_	_	_	_	_	_	O
28	months	_	month	_	NNS	43	_	_	_	_	_	_	_	O
29	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
31	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
32	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	43	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	43	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	43	_	_	_	_	_	_	_	O
39	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
40	kidney	_	UNK	_	NN	43	_	_	_	_	_	_	_	O
41	,	_	,	_	,	43	_	_	_	_	_	_	_	O
42	eye	_	eye	_	NN	43	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	43	_	_	_	_	_	_	_	O
44	cerebrovascular	_	UNK	_	JJ	43	_	_	_	_	_	_	_	O
45	damage	_	damage	_	NN	43	_	_	_	_	_	_	_	O
46	.	_	.	_	.	43	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	43	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
4	measurements	_	measurement	_	NNS	43	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	43	_	_	_	_	_	_	_	O
6	:	_	:	_	:	43	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	43	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	43	_	_	_	_	_	_	_	O
9	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
11	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	O
16	mmhg	_	UNK	_	JJ	43	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	43	_	_	_	_	_	_	_	O
18	months	_	month	_	NNS	43	_	_	_	_	_	_	_	O
19	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	S-Speaker
21	pressure	_	pressure	_	NN	43	_	_	_	_	_	pressure.n	Attempt_suasion	O
22	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	O
26	mmhg	_	UNK	_	JJ	43	_	_	_	_	_	_	_	O
27	2	_	2	_	CD	43	_	_	_	_	_	_	_	O
28	months	_	month	_	NNS	43	_	_	_	_	_	_	_	O
29	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
31	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
32	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	43	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	43	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	43	_	_	_	_	_	_	_	O
39	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
40	kidney	_	UNK	_	NN	43	_	_	_	_	_	_	_	O
41	,	_	,	_	,	43	_	_	_	_	_	_	_	O
42	eye	_	eye	_	NN	43	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	43	_	_	_	_	_	_	_	O
44	cerebrovascular	_	UNK	_	JJ	43	_	_	_	_	_	_	_	O
45	damage	_	damage	_	NN	43	_	_	_	_	_	_	_	O
46	.	_	.	_	.	43	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	43	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
4	measurements	_	measurement	_	NNS	43	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	43	_	_	_	_	_	_	_	O
6	:	_	:	_	:	43	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	43	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	43	_	_	_	_	_	_	_	O
9	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
11	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	O
16	mmhg	_	UNK	_	JJ	43	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	43	_	_	_	_	_	_	_	O
18	months	_	month	_	NNS	43	_	_	_	_	_	_	_	O
19	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
21	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	B-Relative_time
26	mmhg	_	UNK	_	JJ	43	_	_	_	_	_	_	_	I-Relative_time
27	2	_	2	_	CD	43	_	_	_	_	_	_	_	I-Relative_time
28	months	_	month	_	NNS	43	_	_	_	_	_	month.n	Calendric_unit	S-Unit
29	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
31	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
32	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	43	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	43	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	43	_	_	_	_	_	_	_	O
39	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
40	kidney	_	UNK	_	NN	43	_	_	_	_	_	_	_	O
41	,	_	,	_	,	43	_	_	_	_	_	_	_	O
42	eye	_	eye	_	NN	43	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	43	_	_	_	_	_	_	_	O
44	cerebrovascular	_	UNK	_	JJ	43	_	_	_	_	_	_	_	O
45	damage	_	damage	_	NN	43	_	_	_	_	_	_	_	O
46	.	_	.	_	.	43	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	43	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
4	measurements	_	measurement	_	NNS	43	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	43	_	_	_	_	_	_	_	O
6	:	_	:	_	:	43	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	43	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	43	_	_	_	_	_	_	_	O
9	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
11	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	O
16	mmhg	_	UNK	_	JJ	43	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	43	_	_	_	_	_	_	_	O
18	months	_	month	_	NNS	43	_	_	_	_	_	_	_	O
19	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
21	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	O
26	mmhg	_	UNK	_	JJ	43	_	_	_	_	_	_	_	O
27	2	_	2	_	CD	43	_	_	_	_	_	_	_	O
28	months	_	month	_	NNS	43	_	_	_	_	_	_	_	O
29	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	S-Speaker
31	pressure	_	pressure	_	NN	43	_	_	_	_	_	pressure.n	Attempt_suasion	O
32	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	43	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	43	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	43	_	_	_	_	_	_	_	O
39	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
40	kidney	_	UNK	_	NN	43	_	_	_	_	_	_	_	O
41	,	_	,	_	,	43	_	_	_	_	_	_	_	O
42	eye	_	eye	_	NN	43	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	43	_	_	_	_	_	_	_	O
44	cerebrovascular	_	UNK	_	JJ	43	_	_	_	_	_	_	_	O
45	damage	_	damage	_	NN	43	_	_	_	_	_	_	_	O
46	.	_	.	_	.	43	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	43	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
4	measurements	_	measurement	_	NNS	43	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	43	_	_	_	_	_	_	_	O
6	:	_	:	_	:	43	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	43	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	43	_	_	_	_	_	_	_	O
9	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
11	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	O
16	mmhg	_	UNK	_	JJ	43	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	43	_	_	_	_	_	_	_	O
18	months	_	month	_	NNS	43	_	_	_	_	_	_	_	O
19	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
21	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	O
26	mmhg	_	UNK	_	JJ	43	_	_	_	_	_	_	_	O
27	2	_	2	_	CD	43	_	_	_	_	_	_	_	O
28	months	_	month	_	NNS	43	_	_	_	_	_	_	_	O
29	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
31	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
32	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	43	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	43	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	43	_	_	_	_	_	there.adv	Locative_relation	S-Figure
39	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	B-Ground
40	kidney	_	UNK	_	NN	43	_	_	_	_	_	_	_	I-Ground
41	,	_	,	_	,	43	_	_	_	_	_	_	_	I-Ground
42	eye	_	eye	_	NN	43	_	_	_	_	_	_	_	I-Ground
43	or	_	or	_	CC	43	_	_	_	_	_	_	_	I-Ground
44	cerebrovascular	_	UNK	_	JJ	43	_	_	_	_	_	_	_	I-Ground
45	damage	_	damage	_	NN	43	_	_	_	_	_	_	_	I-Ground
46	.	_	.	_	.	43	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	43	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
4	measurements	_	measurement	_	NNS	43	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	43	_	_	_	_	_	_	_	O
6	:	_	:	_	:	43	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	43	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	43	_	_	_	_	_	_	_	O
9	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
11	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	O
16	mmhg	_	UNK	_	JJ	43	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	43	_	_	_	_	_	_	_	O
18	months	_	month	_	NNS	43	_	_	_	_	_	_	_	O
19	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
21	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	O
26	mmhg	_	UNK	_	JJ	43	_	_	_	_	_	_	_	O
27	2	_	2	_	CD	43	_	_	_	_	_	_	_	O
28	months	_	month	_	NNS	43	_	_	_	_	_	_	_	O
29	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
31	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
32	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	43	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	43	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	43	_	_	_	_	_	_	_	O
39	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
40	kidney	_	UNK	_	NN	43	_	_	_	_	_	_	_	O
41	,	_	,	_	,	43	_	_	_	_	_	_	_	O
42	eye	_	eye	_	NN	43	_	_	_	_	_	eye.n	Body_parts	S-Body_part
43	or	_	or	_	CC	43	_	_	_	_	_	_	_	O
44	cerebrovascular	_	UNK	_	JJ	43	_	_	_	_	_	_	_	O
45	damage	_	damage	_	NN	43	_	_	_	_	_	_	_	O
46	.	_	.	_	.	43	_	_	_	_	_	_	_	O

1	repeat	_	UNK	_	NNP	43	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
4	measurements	_	measurement	_	NNS	43	_	_	_	_	_	_	_	O
5	within	_	within	_	IN	43	_	_	_	_	_	_	_	O
6	:	_	:	_	:	43	_	_	_	_	_	_	_	O
7	1	_	1	_	CD	43	_	_	_	_	_	_	_	O
8	month	_	month	_	NN	43	_	_	_	_	_	_	_	O
9	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
11	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
13	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	O
16	mmhg	_	UNK	_	JJ	43	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	43	_	_	_	_	_	_	_	O
18	months	_	month	_	NNS	43	_	_	_	_	_	_	_	O
19	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
20	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
21	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
23	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
24	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	O
26	mmhg	_	UNK	_	JJ	43	_	_	_	_	_	_	_	O
27	2	_	2	_	CD	43	_	_	_	_	_	_	_	O
28	months	_	month	_	NNS	43	_	_	_	_	_	_	_	O
29	if	_	if	_	IN	43	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	43	_	_	_	_	_	_	_	O
31	pressure	_	pressure	_	NN	43	_	_	_	_	_	_	_	O
32	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
33	higher	_	higher	_	JJR	43	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	43	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	CD	43	_	_	_	_	_	_	_	O
36	mmhg	_	UNK	_	NN	43	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	43	_	_	_	_	_	_	_	O
38	there	_	there	_	EX	43	_	_	_	_	_	_	_	O
39	is	_	be	_	VBZ	43	_	_	_	_	_	_	_	O
40	kidney	_	UNK	_	NN	43	_	_	_	_	_	_	_	O
41	,	_	,	_	,	43	_	_	_	_	_	_	_	O
42	eye	_	eye	_	NN	43	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	43	_	_	_	_	_	_	_	O
44	cerebrovascular	_	UNK	_	JJ	43	_	_	_	_	_	_	_	S-Patient
45	damage	_	damage	_	NN	43	_	_	_	_	_	damage.n	Damaging	O
46	.	_	.	_	.	43	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	NNP	44	_	_	_	_	_	provide.v	Supply	O
2	lifestyle	_	lifestyle	_	JJ	44	_	_	_	_	_	_	_	B-Theme
3	advice	_	advice	_	NN	44	_	_	_	_	_	_	_	I-Theme
4	(	_	(	_	(	44	_	_	_	_	_	_	_	O
5	diet	_	UNK	_	JJ	44	_	_	_	_	_	_	_	B-Theme
6	and	_	and	_	CC	44	_	_	_	_	_	_	_	I-Theme
7	exercise	_	exercise	_	NN	44	_	_	_	_	_	_	_	I-Theme
8	)	_	)	_	)	44	_	_	_	_	_	_	_	O
9	at	_	at	_	IN	44	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	44	_	_	_	_	_	_	_	O
11	same	_	same	_	JJ	44	_	_	_	_	_	_	_	O
12	time	_	time	_	NN	44	_	_	_	_	_	_	_	O
13	.	_	.	_	.	44	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	NNP	44	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	44	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	44	_	_	_	_	_	_	_	O
4	(	_	(	_	(	44	_	_	_	_	_	_	_	O
5	diet	_	UNK	_	JJ	44	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	44	_	_	_	_	_	_	_	O
7	exercise	_	exercise	_	NN	44	_	_	_	_	_	exercise.n	Practice	S-Action
8	)	_	)	_	)	44	_	_	_	_	_	_	_	O
9	at	_	at	_	IN	44	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	44	_	_	_	_	_	_	_	O
11	same	_	same	_	JJ	44	_	_	_	_	_	_	_	O
12	time	_	time	_	NN	44	_	_	_	_	_	_	_	O
13	.	_	.	_	.	44	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	NNP	44	_	_	_	_	_	_	_	B-Figure
2	lifestyle	_	lifestyle	_	JJ	44	_	_	_	_	_	_	_	I-Figure
3	advice	_	advice	_	NN	44	_	_	_	_	_	_	_	I-Figure
4	(	_	(	_	(	44	_	_	_	_	_	_	_	I-Figure
5	diet	_	UNK	_	JJ	44	_	_	_	_	_	_	_	I-Figure
6	and	_	and	_	CC	44	_	_	_	_	_	_	_	I-Figure
7	exercise	_	exercise	_	NN	44	_	_	_	_	_	_	_	I-Figure
8	)	_	)	_	)	44	_	_	_	_	_	_	_	I-Figure
9	at	_	at	_	IN	44	_	_	_	_	_	at.prep	Locative_relation	O
10	the	_	the	_	DT	44	_	_	_	_	_	_	_	B-Ground
11	same	_	same	_	JJ	44	_	_	_	_	_	_	_	I-Ground
12	time	_	time	_	NN	44	_	_	_	_	_	_	_	I-Ground
13	.	_	.	_	.	44	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	NNP	44	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	44	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	44	_	_	_	_	_	_	_	O
4	(	_	(	_	(	44	_	_	_	_	_	_	_	O
5	diet	_	UNK	_	JJ	44	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	44	_	_	_	_	_	_	_	O
7	exercise	_	exercise	_	NN	44	_	_	_	_	_	_	_	O
8	)	_	)	_	)	44	_	_	_	_	_	_	_	O
9	at	_	at	_	IN	44	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	44	_	_	_	_	_	_	_	O
11	same	_	same	_	JJ	44	_	_	_	_	_	same.a	Identicality	O
12	time	_	time	_	NN	44	_	_	_	_	_	_	_	S-Type
13	.	_	.	_	.	44	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	NNP	45	_	_	_	_	_	provide.v	Supply	O
2	lifestyle	_	lifestyle	_	JJ	45	_	_	_	_	_	_	_	B-Theme
3	advice	_	advice	_	NN	45	_	_	_	_	_	_	_	I-Theme
4	(	_	(	_	(	45	_	_	_	_	_	_	_	O
5	see	_	see	_	VB	45	_	_	_	_	_	_	_	O
6	section	_	section	_	NN	45	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	45	_	_	_	_	_	_	_	O
8	this	_	this	_	DT	45	_	_	_	_	_	_	_	O
9	guideline	_	guideline	_	NN	45	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	45	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	45	_	_	_	_	_	_	_	O
12	lifestyle	_	lifestyle	_	JJ	45	_	_	_	_	_	_	_	O
13	interventions	_	UNK	_	NNS	45	_	_	_	_	_	_	_	O
14	section	_	section	_	NN	45	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	45	_	_	_	_	_	_	_	O
16	hypertension	_	UNK	_	NN	45	_	_	_	_	_	_	_	O
17	in	_	in	_	IN	45	_	_	_	_	_	_	_	O
18	adults	_	adult	_	NNS	45	_	_	_	_	_	_	_	O
19	[	_	[	_	JJ	45	_	_	_	_	_	_	_	O
20	nice	_	UNK	_	NNP	45	_	_	_	_	_	_	_	O
21	guideline	_	guideline	_	NN	45	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NNP	45	_	_	_	_	_	_	_	O
23	]	_	]	_	NNP	45	_	_	_	_	_	_	_	O
24	)	_	)	_	)	45	_	_	_	_	_	_	_	O
25	if	_	if	_	IN	45	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	45	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	NNP	45	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	45	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	45	_	_	_	_	_	_	_	O
4	(	_	(	_	(	45	_	_	_	_	_	_	_	O
5	see	_	see	_	VB	45	_	_	_	_	_	_	_	O
6	section	_	section	_	NN	45	_	_	_	_	_	section.n	Part_whole	S-Part
7	in	_	in	_	IN	45	_	_	_	_	_	_	_	O
8	this	_	this	_	DT	45	_	_	_	_	_	_	_	O
9	guideline	_	guideline	_	NN	45	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	45	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	45	_	_	_	_	_	_	_	O
12	lifestyle	_	lifestyle	_	JJ	45	_	_	_	_	_	_	_	O
13	interventions	_	UNK	_	NNS	45	_	_	_	_	_	_	_	O
14	section	_	section	_	NN	45	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	45	_	_	_	_	_	_	_	O
16	hypertension	_	UNK	_	NN	45	_	_	_	_	_	_	_	O
17	in	_	in	_	IN	45	_	_	_	_	_	_	_	O
18	adults	_	adult	_	NNS	45	_	_	_	_	_	_	_	O
19	[	_	[	_	JJ	45	_	_	_	_	_	_	_	O
20	nice	_	UNK	_	NNP	45	_	_	_	_	_	_	_	O
21	guideline	_	guideline	_	NN	45	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NNP	45	_	_	_	_	_	_	_	O
23	]	_	]	_	NNP	45	_	_	_	_	_	_	_	O
24	)	_	)	_	)	45	_	_	_	_	_	_	_	O
25	if	_	if	_	IN	45	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	45	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	NNP	45	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	45	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	45	_	_	_	_	_	_	_	O
4	(	_	(	_	(	45	_	_	_	_	_	_	_	O
5	see	_	see	_	VB	45	_	_	_	_	_	_	_	O
6	section	_	section	_	NN	45	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	45	_	_	_	_	_	_	_	O
8	this	_	this	_	DT	45	_	_	_	_	_	_	_	O
9	guideline	_	guideline	_	NN	45	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	45	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	45	_	_	_	_	_	_	_	O
12	lifestyle	_	lifestyle	_	JJ	45	_	_	_	_	_	_	_	O
13	interventions	_	UNK	_	NNS	45	_	_	_	_	_	_	_	S-Whole
14	section	_	section	_	NN	45	_	_	_	_	_	section.n	Part_whole	S-Part
15	in	_	in	_	IN	45	_	_	_	_	_	_	_	O
16	hypertension	_	UNK	_	NN	45	_	_	_	_	_	_	_	O
17	in	_	in	_	IN	45	_	_	_	_	_	_	_	O
18	adults	_	adult	_	NNS	45	_	_	_	_	_	_	_	O
19	[	_	[	_	JJ	45	_	_	_	_	_	_	_	O
20	nice	_	UNK	_	NNP	45	_	_	_	_	_	_	_	O
21	guideline	_	guideline	_	NN	45	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NNP	45	_	_	_	_	_	_	_	O
23	]	_	]	_	NNP	45	_	_	_	_	_	_	_	O
24	)	_	)	_	)	45	_	_	_	_	_	_	_	O
25	if	_	if	_	IN	45	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	45	_	_	_	_	_	_	_	O

1	provide	_	Provide	_	NNP	45	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	45	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	45	_	_	_	_	_	_	_	O
4	(	_	(	_	(	45	_	_	_	_	_	_	_	O
5	see	_	see	_	VB	45	_	_	_	_	_	_	_	O
6	section	_	section	_	NN	45	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	45	_	_	_	_	_	_	_	O
8	this	_	this	_	DT	45	_	_	_	_	_	_	_	O
9	guideline	_	guideline	_	NN	45	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	45	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	45	_	_	_	_	_	_	_	O
12	lifestyle	_	lifestyle	_	JJ	45	_	_	_	_	_	_	_	O
13	interventions	_	UNK	_	NNS	45	_	_	_	_	_	_	_	O
14	section	_	section	_	NN	45	_	_	_	_	_	_	_	O
15	in	_	in	_	IN	45	_	_	_	_	_	_	_	O
16	hypertension	_	UNK	_	NN	45	_	_	_	_	_	_	_	O
17	in	_	in	_	IN	45	_	_	_	_	_	_	_	O
18	adults	_	adult	_	NNS	45	_	_	_	_	_	adult.n	People_by_age	S-Person
19	[	_	[	_	JJ	45	_	_	_	_	_	_	_	O
20	nice	_	UNK	_	NNP	45	_	_	_	_	_	_	_	O
21	guideline	_	guideline	_	NN	45	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NNP	45	_	_	_	_	_	_	_	O
23	]	_	]	_	NNP	45	_	_	_	_	_	_	_	O
24	)	_	)	_	)	45	_	_	_	_	_	_	_	O
25	if	_	if	_	IN	45	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	45	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	46	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	46	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	46	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	46	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	46	_	_	_	_	_	_	_	O
6	:	_	:	_	:	46	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	46	_	_	_	_	_	_	_	O
8	(	_	(	_	(	46	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	46	_	_	_	_	_	_	_	O
10	)	_	)	_	)	46	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	46	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	46	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	46	_	_	_	_	_	_	_	O
14	)	_	)	_	)	46	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	46	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	46	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	46	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	46	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	46	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	46	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	46	_	_	_	_	_	_	_	O
8	(	_	(	_	(	46	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	46	_	_	_	_	_	_	_	O
10	)	_	)	_	)	46	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	46	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	46	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	46	_	_	_	_	_	_	_	O
14	)	_	)	_	)	46	_	_	_	_	_	_	_	O

1	monitor	_	Monitor	_	NNP	47	_	_	_	_	_	_	_	B-Speaker
2	blood	_	blood	_	NN	47	_	_	_	_	_	_	_	I-Speaker
3	pressure	_	pressure	_	NN	47	_	_	_	_	_	pressure.n	Attempt_suasion	O
4	every	_	every	_	DT	47	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	CD	47	_	_	_	_	_	_	_	O
6	months	_	month	_	NNS	47	_	_	_	_	_	_	_	O
7	,	_	,	_	,	47	_	_	_	_	_	_	_	O
8	and	_	and	_	CC	47	_	_	_	_	_	_	_	O
9	intensify	_	intensify	_	VB	47	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	47	_	_	_	_	_	_	_	O
11	if	_	if	_	IN	47	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	47	_	_	_	_	_	_	_	O
13	person	_	person	_	NN	47	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	47	_	_	_	_	_	_	_	O
15	already	_	already	_	RB	47	_	_	_	_	_	_	_	O
16	on	_	on	_	IN	47	_	_	_	_	_	_	_	O
17	antihypertensive	_	UNK	_	JJ	47	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	47	_	_	_	_	_	_	_	O
19	treatment	_	treatment	_	NN	47	_	_	_	_	_	_	_	O
20	,	_	,	_	,	47	_	_	_	_	_	_	_	O
21	until	_	until	_	IN	47	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	47	_	_	_	_	_	_	_	O
23	blood	_	blood	_	NN	47	_	_	_	_	_	_	_	O
24	pressure	_	pressure	_	NN	47	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	47	_	_	_	_	_	_	_	O
26	consistently	_	consistently	_	RB	47	_	_	_	_	_	_	_	O
27	below	_	below	_	IN	47	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	47	_	_	_	_	_	_	_	O
29	mmhg	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
30	(	_	(	_	(	47	_	_	_	_	_	_	_	O
31	below	_	below	_	IN	47	_	_	_	_	_	_	_	O
32	unk	_	UNK	_	CD	47	_	_	_	_	_	_	_	O
33	mmhg	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
34	if	_	if	_	IN	47	_	_	_	_	_	_	_	O
35	there	_	there	_	EX	47	_	_	_	_	_	_	_	O
36	is	_	be	_	VBZ	47	_	_	_	_	_	_	_	O
37	kidney	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
38	,	_	,	_	,	47	_	_	_	_	_	_	_	O
39	eye	_	eye	_	NN	47	_	_	_	_	_	_	_	O
40	or	_	or	_	CC	47	_	_	_	_	_	_	_	O
41	cerebrovascular	_	UNK	_	JJ	47	_	_	_	_	_	_	_	O
42	damage	_	damage	_	NN	47	_	_	_	_	_	_	_	O
43	)	_	)	_	)	47	_	_	_	_	_	_	_	O
44	.	_	.	_	.	47	_	_	_	_	_	_	_	O

1	monitor	_	Monitor	_	NNP	47	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	47	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	47	_	_	_	_	_	_	_	O
4	every	_	every	_	DT	47	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	CD	47	_	_	_	_	_	_	_	S-Count
6	months	_	month	_	NNS	47	_	_	_	_	_	month.n	Calendric_unit	S-Unit
7	,	_	,	_	,	47	_	_	_	_	_	_	_	O
8	and	_	and	_	CC	47	_	_	_	_	_	_	_	O
9	intensify	_	intensify	_	VB	47	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	47	_	_	_	_	_	_	_	O
11	if	_	if	_	IN	47	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	47	_	_	_	_	_	_	_	O
13	person	_	person	_	NN	47	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	47	_	_	_	_	_	_	_	O
15	already	_	already	_	RB	47	_	_	_	_	_	_	_	O
16	on	_	on	_	IN	47	_	_	_	_	_	_	_	O
17	antihypertensive	_	UNK	_	JJ	47	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	47	_	_	_	_	_	_	_	O
19	treatment	_	treatment	_	NN	47	_	_	_	_	_	_	_	O
20	,	_	,	_	,	47	_	_	_	_	_	_	_	O
21	until	_	until	_	IN	47	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	47	_	_	_	_	_	_	_	O
23	blood	_	blood	_	NN	47	_	_	_	_	_	_	_	O
24	pressure	_	pressure	_	NN	47	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	47	_	_	_	_	_	_	_	O
26	consistently	_	consistently	_	RB	47	_	_	_	_	_	_	_	O
27	below	_	below	_	IN	47	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	47	_	_	_	_	_	_	_	O
29	mmhg	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
30	(	_	(	_	(	47	_	_	_	_	_	_	_	O
31	below	_	below	_	IN	47	_	_	_	_	_	_	_	O
32	unk	_	UNK	_	CD	47	_	_	_	_	_	_	_	O
33	mmhg	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
34	if	_	if	_	IN	47	_	_	_	_	_	_	_	O
35	there	_	there	_	EX	47	_	_	_	_	_	_	_	O
36	is	_	be	_	VBZ	47	_	_	_	_	_	_	_	O
37	kidney	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
38	,	_	,	_	,	47	_	_	_	_	_	_	_	O
39	eye	_	eye	_	NN	47	_	_	_	_	_	_	_	O
40	or	_	or	_	CC	47	_	_	_	_	_	_	_	O
41	cerebrovascular	_	UNK	_	JJ	47	_	_	_	_	_	_	_	O
42	damage	_	damage	_	NN	47	_	_	_	_	_	_	_	O
43	)	_	)	_	)	47	_	_	_	_	_	_	_	O
44	.	_	.	_	.	47	_	_	_	_	_	_	_	O

1	monitor	_	Monitor	_	NNP	47	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	47	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	47	_	_	_	_	_	_	_	O
4	every	_	every	_	DT	47	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	CD	47	_	_	_	_	_	_	_	O
6	months	_	month	_	NNS	47	_	_	_	_	_	_	_	O
7	,	_	,	_	,	47	_	_	_	_	_	_	_	O
8	and	_	and	_	CC	47	_	_	_	_	_	_	_	O
9	intensify	_	intensify	_	VB	47	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	47	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
11	if	_	if	_	IN	47	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	47	_	_	_	_	_	_	_	O
13	person	_	person	_	NN	47	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	47	_	_	_	_	_	_	_	O
15	already	_	already	_	RB	47	_	_	_	_	_	_	_	O
16	on	_	on	_	IN	47	_	_	_	_	_	_	_	O
17	antihypertensive	_	UNK	_	JJ	47	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	47	_	_	_	_	_	_	_	O
19	treatment	_	treatment	_	NN	47	_	_	_	_	_	_	_	O
20	,	_	,	_	,	47	_	_	_	_	_	_	_	O
21	until	_	until	_	IN	47	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	47	_	_	_	_	_	_	_	O
23	blood	_	blood	_	NN	47	_	_	_	_	_	_	_	O
24	pressure	_	pressure	_	NN	47	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	47	_	_	_	_	_	_	_	O
26	consistently	_	consistently	_	RB	47	_	_	_	_	_	_	_	O
27	below	_	below	_	IN	47	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	47	_	_	_	_	_	_	_	O
29	mmhg	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
30	(	_	(	_	(	47	_	_	_	_	_	_	_	O
31	below	_	below	_	IN	47	_	_	_	_	_	_	_	O
32	unk	_	UNK	_	CD	47	_	_	_	_	_	_	_	O
33	mmhg	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
34	if	_	if	_	IN	47	_	_	_	_	_	_	_	O
35	there	_	there	_	EX	47	_	_	_	_	_	_	_	O
36	is	_	be	_	VBZ	47	_	_	_	_	_	_	_	O
37	kidney	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
38	,	_	,	_	,	47	_	_	_	_	_	_	_	O
39	eye	_	eye	_	NN	47	_	_	_	_	_	_	_	O
40	or	_	or	_	CC	47	_	_	_	_	_	_	_	O
41	cerebrovascular	_	UNK	_	JJ	47	_	_	_	_	_	_	_	O
42	damage	_	damage	_	NN	47	_	_	_	_	_	_	_	O
43	)	_	)	_	)	47	_	_	_	_	_	_	_	O
44	.	_	.	_	.	47	_	_	_	_	_	_	_	O

1	monitor	_	Monitor	_	NNP	47	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	47	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	47	_	_	_	_	_	_	_	O
4	every	_	every	_	DT	47	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	CD	47	_	_	_	_	_	_	_	O
6	months	_	month	_	NNS	47	_	_	_	_	_	_	_	O
7	,	_	,	_	,	47	_	_	_	_	_	_	_	O
8	and	_	and	_	CC	47	_	_	_	_	_	_	_	O
9	intensify	_	intensify	_	VB	47	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	47	_	_	_	_	_	_	_	O
11	if	_	if	_	IN	47	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	47	_	_	_	_	_	_	_	O
13	person	_	person	_	NN	47	_	_	_	_	_	person.n	People	S-Person
14	is	_	be	_	VBZ	47	_	_	_	_	_	_	_	O
15	already	_	already	_	RB	47	_	_	_	_	_	_	_	O
16	on	_	on	_	IN	47	_	_	_	_	_	_	_	O
17	antihypertensive	_	UNK	_	JJ	47	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	47	_	_	_	_	_	_	_	O
19	treatment	_	treatment	_	NN	47	_	_	_	_	_	_	_	O
20	,	_	,	_	,	47	_	_	_	_	_	_	_	O
21	until	_	until	_	IN	47	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	47	_	_	_	_	_	_	_	O
23	blood	_	blood	_	NN	47	_	_	_	_	_	_	_	O
24	pressure	_	pressure	_	NN	47	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	47	_	_	_	_	_	_	_	O
26	consistently	_	consistently	_	RB	47	_	_	_	_	_	_	_	O
27	below	_	below	_	IN	47	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	47	_	_	_	_	_	_	_	O
29	mmhg	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
30	(	_	(	_	(	47	_	_	_	_	_	_	_	O
31	below	_	below	_	IN	47	_	_	_	_	_	_	_	O
32	unk	_	UNK	_	CD	47	_	_	_	_	_	_	_	O
33	mmhg	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
34	if	_	if	_	IN	47	_	_	_	_	_	_	_	O
35	there	_	there	_	EX	47	_	_	_	_	_	_	_	O
36	is	_	be	_	VBZ	47	_	_	_	_	_	_	_	O
37	kidney	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
38	,	_	,	_	,	47	_	_	_	_	_	_	_	O
39	eye	_	eye	_	NN	47	_	_	_	_	_	_	_	O
40	or	_	or	_	CC	47	_	_	_	_	_	_	_	O
41	cerebrovascular	_	UNK	_	JJ	47	_	_	_	_	_	_	_	O
42	damage	_	damage	_	NN	47	_	_	_	_	_	_	_	O
43	)	_	)	_	)	47	_	_	_	_	_	_	_	O
44	.	_	.	_	.	47	_	_	_	_	_	_	_	O

1	monitor	_	Monitor	_	NNP	47	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	47	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	47	_	_	_	_	_	_	_	O
4	every	_	every	_	DT	47	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	CD	47	_	_	_	_	_	_	_	O
6	months	_	month	_	NNS	47	_	_	_	_	_	_	_	O
7	,	_	,	_	,	47	_	_	_	_	_	_	_	O
8	and	_	and	_	CC	47	_	_	_	_	_	_	_	O
9	intensify	_	intensify	_	VB	47	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	47	_	_	_	_	_	_	_	O
11	if	_	if	_	IN	47	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	47	_	_	_	_	_	_	_	O
13	person	_	person	_	NN	47	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	47	_	_	_	_	_	_	_	O
15	already	_	already	_	RB	47	_	_	_	_	_	_	_	O
16	on	_	on	_	IN	47	_	_	_	_	_	_	_	O
17	antihypertensive	_	UNK	_	JJ	47	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	47	_	_	_	_	_	_	_	S-Patient
19	treatment	_	treatment	_	NN	47	_	_	_	_	_	treatment.n	Cure	O
20	,	_	,	_	,	47	_	_	_	_	_	_	_	O
21	until	_	until	_	IN	47	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	47	_	_	_	_	_	_	_	O
23	blood	_	blood	_	NN	47	_	_	_	_	_	_	_	O
24	pressure	_	pressure	_	NN	47	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	47	_	_	_	_	_	_	_	O
26	consistently	_	consistently	_	RB	47	_	_	_	_	_	_	_	O
27	below	_	below	_	IN	47	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	47	_	_	_	_	_	_	_	O
29	mmhg	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
30	(	_	(	_	(	47	_	_	_	_	_	_	_	O
31	below	_	below	_	IN	47	_	_	_	_	_	_	_	O
32	unk	_	UNK	_	CD	47	_	_	_	_	_	_	_	O
33	mmhg	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
34	if	_	if	_	IN	47	_	_	_	_	_	_	_	O
35	there	_	there	_	EX	47	_	_	_	_	_	_	_	O
36	is	_	be	_	VBZ	47	_	_	_	_	_	_	_	O
37	kidney	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
38	,	_	,	_	,	47	_	_	_	_	_	_	_	O
39	eye	_	eye	_	NN	47	_	_	_	_	_	_	_	O
40	or	_	or	_	CC	47	_	_	_	_	_	_	_	O
41	cerebrovascular	_	UNK	_	JJ	47	_	_	_	_	_	_	_	O
42	damage	_	damage	_	NN	47	_	_	_	_	_	_	_	O
43	)	_	)	_	)	47	_	_	_	_	_	_	_	O
44	.	_	.	_	.	47	_	_	_	_	_	_	_	O

1	monitor	_	Monitor	_	NNP	47	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	47	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	47	_	_	_	_	_	_	_	O
4	every	_	every	_	DT	47	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	CD	47	_	_	_	_	_	_	_	O
6	months	_	month	_	NNS	47	_	_	_	_	_	_	_	O
7	,	_	,	_	,	47	_	_	_	_	_	_	_	O
8	and	_	and	_	CC	47	_	_	_	_	_	_	_	O
9	intensify	_	intensify	_	VB	47	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	47	_	_	_	_	_	_	_	O
11	if	_	if	_	IN	47	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	47	_	_	_	_	_	_	_	O
13	person	_	person	_	NN	47	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	47	_	_	_	_	_	_	_	O
15	already	_	already	_	RB	47	_	_	_	_	_	_	_	O
16	on	_	on	_	IN	47	_	_	_	_	_	_	_	O
17	antihypertensive	_	UNK	_	JJ	47	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	47	_	_	_	_	_	_	_	O
19	treatment	_	treatment	_	NN	47	_	_	_	_	_	_	_	O
20	,	_	,	_	,	47	_	_	_	_	_	_	_	O
21	until	_	until	_	IN	47	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	47	_	_	_	_	_	_	_	O
23	blood	_	blood	_	NN	47	_	_	_	_	_	_	_	S-Speaker
24	pressure	_	pressure	_	NN	47	_	_	_	_	_	pressure.n	Attempt_suasion	O
25	is	_	be	_	VBZ	47	_	_	_	_	_	_	_	O
26	consistently	_	consistently	_	RB	47	_	_	_	_	_	_	_	O
27	below	_	below	_	IN	47	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	47	_	_	_	_	_	_	_	O
29	mmhg	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
30	(	_	(	_	(	47	_	_	_	_	_	_	_	O
31	below	_	below	_	IN	47	_	_	_	_	_	_	_	O
32	unk	_	UNK	_	CD	47	_	_	_	_	_	_	_	O
33	mmhg	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
34	if	_	if	_	IN	47	_	_	_	_	_	_	_	O
35	there	_	there	_	EX	47	_	_	_	_	_	_	_	O
36	is	_	be	_	VBZ	47	_	_	_	_	_	_	_	O
37	kidney	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
38	,	_	,	_	,	47	_	_	_	_	_	_	_	O
39	eye	_	eye	_	NN	47	_	_	_	_	_	_	_	O
40	or	_	or	_	CC	47	_	_	_	_	_	_	_	O
41	cerebrovascular	_	UNK	_	JJ	47	_	_	_	_	_	_	_	O
42	damage	_	damage	_	NN	47	_	_	_	_	_	_	_	O
43	)	_	)	_	)	47	_	_	_	_	_	_	_	O
44	.	_	.	_	.	47	_	_	_	_	_	_	_	O

1	monitor	_	Monitor	_	NNP	47	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	47	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	47	_	_	_	_	_	_	_	O
4	every	_	every	_	DT	47	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	CD	47	_	_	_	_	_	_	_	O
6	months	_	month	_	NNS	47	_	_	_	_	_	_	_	O
7	,	_	,	_	,	47	_	_	_	_	_	_	_	O
8	and	_	and	_	CC	47	_	_	_	_	_	_	_	O
9	intensify	_	intensify	_	VB	47	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	47	_	_	_	_	_	_	_	O
11	if	_	if	_	IN	47	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	47	_	_	_	_	_	_	_	O
13	person	_	person	_	NN	47	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	47	_	_	_	_	_	_	_	O
15	already	_	already	_	RB	47	_	_	_	_	_	_	_	O
16	on	_	on	_	IN	47	_	_	_	_	_	_	_	O
17	antihypertensive	_	UNK	_	JJ	47	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	47	_	_	_	_	_	_	_	O
19	treatment	_	treatment	_	NN	47	_	_	_	_	_	_	_	O
20	,	_	,	_	,	47	_	_	_	_	_	_	_	O
21	until	_	until	_	IN	47	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	47	_	_	_	_	_	_	_	O
23	blood	_	blood	_	NN	47	_	_	_	_	_	_	_	O
24	pressure	_	pressure	_	NN	47	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	47	_	_	_	_	_	_	_	O
26	consistently	_	consistently	_	RB	47	_	_	_	_	_	_	_	O
27	below	_	below	_	IN	47	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	47	_	_	_	_	_	_	_	O
29	mmhg	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
30	(	_	(	_	(	47	_	_	_	_	_	_	_	O
31	below	_	below	_	IN	47	_	_	_	_	_	_	_	O
32	unk	_	UNK	_	CD	47	_	_	_	_	_	_	_	O
33	mmhg	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
34	if	_	if	_	IN	47	_	_	_	_	_	_	_	O
35	there	_	there	_	EX	47	_	_	_	_	_	there.adv	Locative_relation	S-Figure
36	is	_	be	_	VBZ	47	_	_	_	_	_	_	_	B-Ground
37	kidney	_	UNK	_	NN	47	_	_	_	_	_	_	_	I-Ground
38	,	_	,	_	,	47	_	_	_	_	_	_	_	I-Ground
39	eye	_	eye	_	NN	47	_	_	_	_	_	_	_	I-Ground
40	or	_	or	_	CC	47	_	_	_	_	_	_	_	I-Ground
41	cerebrovascular	_	UNK	_	JJ	47	_	_	_	_	_	_	_	I-Ground
42	damage	_	damage	_	NN	47	_	_	_	_	_	_	_	I-Ground
43	)	_	)	_	)	47	_	_	_	_	_	_	_	I-Ground
44	.	_	.	_	.	47	_	_	_	_	_	_	_	O

1	monitor	_	Monitor	_	NNP	47	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	47	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	47	_	_	_	_	_	_	_	O
4	every	_	every	_	DT	47	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	CD	47	_	_	_	_	_	_	_	O
6	months	_	month	_	NNS	47	_	_	_	_	_	_	_	O
7	,	_	,	_	,	47	_	_	_	_	_	_	_	O
8	and	_	and	_	CC	47	_	_	_	_	_	_	_	O
9	intensify	_	intensify	_	VB	47	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	47	_	_	_	_	_	_	_	O
11	if	_	if	_	IN	47	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	47	_	_	_	_	_	_	_	O
13	person	_	person	_	NN	47	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	47	_	_	_	_	_	_	_	O
15	already	_	already	_	RB	47	_	_	_	_	_	_	_	O
16	on	_	on	_	IN	47	_	_	_	_	_	_	_	O
17	antihypertensive	_	UNK	_	JJ	47	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	47	_	_	_	_	_	_	_	O
19	treatment	_	treatment	_	NN	47	_	_	_	_	_	_	_	O
20	,	_	,	_	,	47	_	_	_	_	_	_	_	O
21	until	_	until	_	IN	47	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	47	_	_	_	_	_	_	_	O
23	blood	_	blood	_	NN	47	_	_	_	_	_	_	_	O
24	pressure	_	pressure	_	NN	47	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	47	_	_	_	_	_	_	_	O
26	consistently	_	consistently	_	RB	47	_	_	_	_	_	_	_	O
27	below	_	below	_	IN	47	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	47	_	_	_	_	_	_	_	O
29	mmhg	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
30	(	_	(	_	(	47	_	_	_	_	_	_	_	O
31	below	_	below	_	IN	47	_	_	_	_	_	_	_	O
32	unk	_	UNK	_	CD	47	_	_	_	_	_	_	_	O
33	mmhg	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
34	if	_	if	_	IN	47	_	_	_	_	_	_	_	O
35	there	_	there	_	EX	47	_	_	_	_	_	_	_	O
36	is	_	be	_	VBZ	47	_	_	_	_	_	_	_	O
37	kidney	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
38	,	_	,	_	,	47	_	_	_	_	_	_	_	O
39	eye	_	eye	_	NN	47	_	_	_	_	_	eye.n	Body_parts	S-Body_part
40	or	_	or	_	CC	47	_	_	_	_	_	_	_	O
41	cerebrovascular	_	UNK	_	JJ	47	_	_	_	_	_	_	_	O
42	damage	_	damage	_	NN	47	_	_	_	_	_	_	_	O
43	)	_	)	_	)	47	_	_	_	_	_	_	_	O
44	.	_	.	_	.	47	_	_	_	_	_	_	_	O

1	monitor	_	Monitor	_	NNP	47	_	_	_	_	_	_	_	O
2	blood	_	blood	_	NN	47	_	_	_	_	_	_	_	O
3	pressure	_	pressure	_	NN	47	_	_	_	_	_	_	_	O
4	every	_	every	_	DT	47	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	CD	47	_	_	_	_	_	_	_	O
6	months	_	month	_	NNS	47	_	_	_	_	_	_	_	O
7	,	_	,	_	,	47	_	_	_	_	_	_	_	O
8	and	_	and	_	CC	47	_	_	_	_	_	_	_	O
9	intensify	_	intensify	_	VB	47	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	47	_	_	_	_	_	_	_	O
11	if	_	if	_	IN	47	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	47	_	_	_	_	_	_	_	O
13	person	_	person	_	NN	47	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	47	_	_	_	_	_	_	_	O
15	already	_	already	_	RB	47	_	_	_	_	_	_	_	O
16	on	_	on	_	IN	47	_	_	_	_	_	_	_	O
17	antihypertensive	_	UNK	_	JJ	47	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	47	_	_	_	_	_	_	_	O
19	treatment	_	treatment	_	NN	47	_	_	_	_	_	_	_	O
20	,	_	,	_	,	47	_	_	_	_	_	_	_	O
21	until	_	until	_	IN	47	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	47	_	_	_	_	_	_	_	O
23	blood	_	blood	_	NN	47	_	_	_	_	_	_	_	O
24	pressure	_	pressure	_	NN	47	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	47	_	_	_	_	_	_	_	O
26	consistently	_	consistently	_	RB	47	_	_	_	_	_	_	_	O
27	below	_	below	_	IN	47	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	47	_	_	_	_	_	_	_	O
29	mmhg	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
30	(	_	(	_	(	47	_	_	_	_	_	_	_	O
31	below	_	below	_	IN	47	_	_	_	_	_	_	_	O
32	unk	_	UNK	_	CD	47	_	_	_	_	_	_	_	O
33	mmhg	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
34	if	_	if	_	IN	47	_	_	_	_	_	_	_	O
35	there	_	there	_	EX	47	_	_	_	_	_	_	_	O
36	is	_	be	_	VBZ	47	_	_	_	_	_	_	_	O
37	kidney	_	UNK	_	NN	47	_	_	_	_	_	_	_	O
38	,	_	,	_	,	47	_	_	_	_	_	_	_	O
39	eye	_	eye	_	NN	47	_	_	_	_	_	_	_	O
40	or	_	or	_	CC	47	_	_	_	_	_	_	_	O
41	cerebrovascular	_	UNK	_	JJ	47	_	_	_	_	_	_	_	S-Patient
42	damage	_	damage	_	NN	47	_	_	_	_	_	damage.n	Damaging	O
43	)	_	)	_	)	47	_	_	_	_	_	_	_	O
44	.	_	.	_	.	47	_	_	_	_	_	_	_	O

1	african	_	African	_	JJ	49	_	_	_	_	_	_	_	O
2	or	_	or	_	CC	49	_	_	_	_	_	_	_	O
3	caribbean	_	Caribbean	_	JJ	49	_	_	_	_	_	_	_	O
4	family	_	family	_	NN	49	_	_	_	_	_	family.n	Kinship	S-Relatives
5	origin	_	origin	_	NN	49	_	_	_	_	_	_	_	O
6	,	_	,	_	,	49	_	_	_	_	_	_	_	O
7	or	_	or	_	CC	49	_	_	_	_	_	_	_	O
8	women	_	woman	_	NNS	49	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	49	_	_	_	_	_	_	_	O
10	whom	_	whom	_	WP	49	_	_	_	_	_	_	_	O
11	there	_	there	_	EX	49	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	49	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	49	_	_	_	_	_	_	_	O
14	possibility	_	possibility	_	NN	49	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	49	_	_	_	_	_	_	_	O
16	becoming	_	become	_	VBG	49	_	_	_	_	_	_	_	O
17	pregnant	_	pregnant	_	NN	49	_	_	_	_	_	_	_	O
18	.	_	.	_	.	49	_	_	_	_	_	_	_	O

1	african	_	African	_	JJ	49	_	_	_	_	_	_	_	B-Origin
2	or	_	or	_	CC	49	_	_	_	_	_	_	_	I-Origin
3	caribbean	_	Caribbean	_	JJ	49	_	_	_	_	_	_	_	I-Origin
4	family	_	family	_	NN	49	_	_	_	_	_	_	_	I-Origin
5	origin	_	origin	_	NN	49	_	_	_	_	_	origin.n	Origin	I-Origin
6	,	_	,	_	,	49	_	_	_	_	_	_	_	O
7	or	_	or	_	CC	49	_	_	_	_	_	_	_	O
8	women	_	woman	_	NNS	49	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	49	_	_	_	_	_	_	_	O
10	whom	_	whom	_	WP	49	_	_	_	_	_	_	_	O
11	there	_	there	_	EX	49	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	49	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	49	_	_	_	_	_	_	_	O
14	possibility	_	possibility	_	NN	49	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	49	_	_	_	_	_	_	_	O
16	becoming	_	become	_	VBG	49	_	_	_	_	_	_	_	O
17	pregnant	_	pregnant	_	NN	49	_	_	_	_	_	_	_	O
18	.	_	.	_	.	49	_	_	_	_	_	_	_	O

1	african	_	African	_	JJ	49	_	_	_	_	_	_	_	O
2	or	_	or	_	CC	49	_	_	_	_	_	_	_	O
3	caribbean	_	Caribbean	_	JJ	49	_	_	_	_	_	_	_	O
4	family	_	family	_	NN	49	_	_	_	_	_	_	_	O
5	origin	_	origin	_	NN	49	_	_	_	_	_	_	_	O
6	,	_	,	_	,	49	_	_	_	_	_	_	_	O
7	or	_	or	_	CC	49	_	_	_	_	_	_	_	O
8	women	_	woman	_	NNS	49	_	_	_	_	_	woman.n	People	S-Person
9	for	_	for	_	IN	49	_	_	_	_	_	_	_	O
10	whom	_	whom	_	WP	49	_	_	_	_	_	_	_	O
11	there	_	there	_	EX	49	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	49	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	49	_	_	_	_	_	_	_	O
14	possibility	_	possibility	_	NN	49	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	49	_	_	_	_	_	_	_	O
16	becoming	_	become	_	VBG	49	_	_	_	_	_	_	_	O
17	pregnant	_	pregnant	_	NN	49	_	_	_	_	_	_	_	O
18	.	_	.	_	.	49	_	_	_	_	_	_	_	O

1	african	_	African	_	JJ	49	_	_	_	_	_	_	_	O
2	or	_	or	_	CC	49	_	_	_	_	_	_	_	O
3	caribbean	_	Caribbean	_	JJ	49	_	_	_	_	_	_	_	O
4	family	_	family	_	NN	49	_	_	_	_	_	_	_	O
5	origin	_	origin	_	NN	49	_	_	_	_	_	_	_	O
6	,	_	,	_	,	49	_	_	_	_	_	_	_	O
7	or	_	or	_	CC	49	_	_	_	_	_	_	_	O
8	women	_	woman	_	NNS	49	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	49	_	_	_	_	_	_	_	O
10	whom	_	whom	_	WP	49	_	_	_	_	_	_	_	O
11	there	_	there	_	EX	49	_	_	_	_	_	there.adv	Locative_relation	S-Ground
12	is	_	be	_	VBZ	49	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	49	_	_	_	_	_	_	_	O
14	possibility	_	possibility	_	NN	49	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	49	_	_	_	_	_	_	_	O
16	becoming	_	become	_	VBG	49	_	_	_	_	_	_	_	O
17	pregnant	_	pregnant	_	NN	49	_	_	_	_	_	_	_	O
18	.	_	.	_	.	49	_	_	_	_	_	_	_	O

1	african	_	African	_	JJ	49	_	_	_	_	_	_	_	O
2	or	_	or	_	CC	49	_	_	_	_	_	_	_	O
3	caribbean	_	Caribbean	_	JJ	49	_	_	_	_	_	_	_	O
4	family	_	family	_	NN	49	_	_	_	_	_	_	_	O
5	origin	_	origin	_	NN	49	_	_	_	_	_	_	_	O
6	,	_	,	_	,	49	_	_	_	_	_	_	_	O
7	or	_	or	_	CC	49	_	_	_	_	_	_	_	O
8	women	_	woman	_	NNS	49	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	49	_	_	_	_	_	_	_	O
10	whom	_	whom	_	WP	49	_	_	_	_	_	_	_	O
11	there	_	there	_	EX	49	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	49	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	49	_	_	_	_	_	_	_	O
14	possibility	_	possibility	_	NN	49	_	_	_	_	_	possibility.n	Alternatives	O
15	of	_	of	_	IN	49	_	_	_	_	_	_	_	B-Salient_entity
16	becoming	_	become	_	VBG	49	_	_	_	_	_	_	_	I-Salient_entity
17	pregnant	_	pregnant	_	NN	49	_	_	_	_	_	_	_	I-Salient_entity
18	.	_	.	_	.	49	_	_	_	_	_	_	_	O

1	african	_	African	_	JJ	49	_	_	_	_	_	_	_	O
2	or	_	or	_	CC	49	_	_	_	_	_	_	_	O
3	caribbean	_	Caribbean	_	JJ	49	_	_	_	_	_	_	_	O
4	family	_	family	_	NN	49	_	_	_	_	_	_	_	O
5	origin	_	origin	_	NN	49	_	_	_	_	_	_	_	O
6	,	_	,	_	,	49	_	_	_	_	_	_	_	O
7	or	_	or	_	CC	49	_	_	_	_	_	_	_	O
8	women	_	woman	_	NNS	49	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	49	_	_	_	_	_	_	_	O
10	whom	_	whom	_	WP	49	_	_	_	_	_	_	_	O
11	there	_	there	_	EX	49	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	49	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	49	_	_	_	_	_	_	_	O
14	possibility	_	possibility	_	NN	49	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	49	_	_	_	_	_	_	_	O
16	becoming	_	become	_	VBG	49	_	_	_	_	_	become.v	Becoming	O
17	pregnant	_	pregnant	_	NN	49	_	_	_	_	_	_	_	S-Final_category
18	.	_	.	_	.	49	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	50	_	_	_	_	_	_	_	O
2	first-line	_	UNK	_	JJ	50	_	_	_	_	_	_	_	O
3	antihypertensive	_	UNK	_	JJ	50	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	S-Patient
5	treatment	_	treatment	_	NN	50	_	_	_	_	_	treatment.n	Cure	O
6	for	_	for	_	IN	50	_	_	_	_	_	_	_	O
7	a	_	a	_	DT	50	_	_	_	_	_	_	_	O
8	person	_	person	_	NN	50	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	50	_	_	_	_	_	_	_	O
10	african	_	African	_	NNP	50	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	50	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	50	_	_	_	_	_	_	_	O
2	first-line	_	UNK	_	JJ	50	_	_	_	_	_	_	_	O
3	antihypertensive	_	UNK	_	JJ	50	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	50	_	_	_	_	_	_	_	O
5	treatment	_	treatment	_	NN	50	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	50	_	_	_	_	_	_	_	O
7	a	_	a	_	DT	50	_	_	_	_	_	_	_	O
8	person	_	person	_	NN	50	_	_	_	_	_	person.n	People	S-Person
9	of	_	of	_	IN	50	_	_	_	_	_	_	_	B-Origin
10	african	_	African	_	NNP	50	_	_	_	_	_	_	_	I-Origin
11	or	_	or	_	CC	50	_	_	_	_	_	_	_	O

1	caribbean	_	Caribbean	_	NNP	51	_	_	_	_	_	_	_	O
2	family	_	family	_	NN	51	_	_	_	_	_	family.n	Kinship	S-Alter
3	origin	_	origin	_	NN	51	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	51	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
6	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
7	ace	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
8	inhibitor	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
9	plus	_	plus	_	CC	51	_	_	_	_	_	_	_	O
10	either	_	either	_	CC	51	_	_	_	_	_	_	_	O
11	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
12	diuretic	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
14	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
15	generic	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
17	blocker	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
18	.	_	.	_	.	51	_	_	_	_	_	_	_	O

1	caribbean	_	Caribbean	_	NNP	51	_	_	_	_	_	_	_	B-Entity
2	family	_	family	_	NN	51	_	_	_	_	_	_	_	I-Entity
3	origin	_	origin	_	NN	51	_	_	_	_	_	origin.n	Origin	S-Origin
4	should	_	should	_	MD	51	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	51	_	_	_	_	_	_	_	O
6	an	_	an	_	DT	51	_	_	_	_	_	_	_	O
7	ace	_	UNK	_	NNP	51	_	_	_	_	_	_	_	O
8	inhibitor	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
9	plus	_	plus	_	CC	51	_	_	_	_	_	_	_	O
10	either	_	either	_	CC	51	_	_	_	_	_	_	_	O
11	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
12	diuretic	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	51	_	_	_	_	_	_	_	O
14	a	_	a	_	DT	51	_	_	_	_	_	_	_	O
15	generic	_	UNK	_	JJ	51	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
17	blocker	_	UNK	_	NN	51	_	_	_	_	_	_	_	O
18	.	_	.	_	.	51	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	52	_	_	_	_	_	_	_	B-State_of_affairs
2	unk	_	UNK	_	JJ	52	_	_	_	_	_	_	_	I-State_of_affairs
3	blocker	_	UNK	_	NN	52	_	_	_	_	_	_	_	I-State_of_affairs
4	should	_	should	_	MD	52	_	_	_	_	_	should.v	Desirable_event	O
5	be	_	be	_	VB	52	_	_	_	_	_	_	_	B-State_of_affairs
6	the	_	the	_	DT	52	_	_	_	_	_	_	_	I-State_of_affairs
7	first-line	_	UNK	_	JJ	52	_	_	_	_	_	_	_	I-State_of_affairs
8	antihypertensive	_	UNK	_	JJ	52	_	_	_	_	_	_	_	I-State_of_affairs
9	drug	_	drug	_	NN	52	_	_	_	_	_	_	_	I-State_of_affairs
10	treatment	_	treatment	_	NN	52	_	_	_	_	_	_	_	I-State_of_affairs
11	for	_	for	_	IN	52	_	_	_	_	_	_	_	I-State_of_affairs
12	a	_	a	_	DT	52	_	_	_	_	_	_	_	I-State_of_affairs
13	woman	_	woman	_	NN	52	_	_	_	_	_	_	_	I-State_of_affairs
14	for	_	for	_	IN	52	_	_	_	_	_	_	_	I-State_of_affairs
15	whom	_	whom	_	WP	52	_	_	_	_	_	_	_	I-State_of_affairs
16	,	_	,	_	,	52	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	52	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	52	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	52	_	_	_	_	_	_	_	O
21	,	_	,	_	,	52	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	52	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	52	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	52	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	52	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	52	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	52	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	52	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	52	_	_	_	_	_	_	_	O
30	her	_	her	_	PRP$	52	_	_	_	_	_	_	_	O
31	becoming	_	become	_	VBG	52	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
33	.	_	.	_	.	52	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	52	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	52	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	52	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	52	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	52	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	52	_	_	_	_	_	_	_	S-Patient
10	treatment	_	treatment	_	NN	52	_	_	_	_	_	treatment.n	Cure	O
11	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	52	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	52	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	52	_	_	_	_	_	_	_	O
16	,	_	,	_	,	52	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	52	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	52	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	52	_	_	_	_	_	_	_	O
21	,	_	,	_	,	52	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	52	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	52	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	52	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	52	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	52	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	52	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	52	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	52	_	_	_	_	_	_	_	O
30	her	_	her	_	PRP$	52	_	_	_	_	_	_	_	O
31	becoming	_	become	_	VBG	52	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
33	.	_	.	_	.	52	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	52	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	52	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	52	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	52	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	52	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	52	_	_	_	_	_	_	_	O
10	treatment	_	treatment	_	NN	52	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	52	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	52	_	_	_	_	_	woman.n	People	S-Person
14	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	52	_	_	_	_	_	_	_	O
16	,	_	,	_	,	52	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	52	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	52	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	52	_	_	_	_	_	_	_	O
21	,	_	,	_	,	52	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	52	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	52	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	52	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	52	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	52	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	52	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	52	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	52	_	_	_	_	_	_	_	O
30	her	_	her	_	PRP$	52	_	_	_	_	_	_	_	O
31	becoming	_	become	_	VBG	52	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
33	.	_	.	_	.	52	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	52	_	_	_	_	_	_	_	B-Event
2	unk	_	UNK	_	JJ	52	_	_	_	_	_	_	_	I-Event
3	blocker	_	UNK	_	NN	52	_	_	_	_	_	_	_	I-Event
4	should	_	should	_	MD	52	_	_	_	_	_	_	_	I-Event
5	be	_	be	_	VB	52	_	_	_	_	_	_	_	I-Event
6	the	_	the	_	DT	52	_	_	_	_	_	_	_	I-Event
7	first-line	_	UNK	_	JJ	52	_	_	_	_	_	_	_	I-Event
8	antihypertensive	_	UNK	_	JJ	52	_	_	_	_	_	_	_	I-Event
9	drug	_	drug	_	NN	52	_	_	_	_	_	_	_	I-Event
10	treatment	_	treatment	_	NN	52	_	_	_	_	_	_	_	I-Event
11	for	_	for	_	IN	52	_	_	_	_	_	_	_	I-Event
12	a	_	a	_	DT	52	_	_	_	_	_	_	_	I-Event
13	woman	_	woman	_	NN	52	_	_	_	_	_	_	_	I-Event
14	for	_	for	_	IN	52	_	_	_	_	_	_	_	I-Event
15	whom	_	whom	_	WP	52	_	_	_	_	_	_	_	I-Event
16	,	_	,	_	,	52	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	52	_	_	_	_	_	after.prep	Time_vector	O
18	an	_	an	_	DT	52	_	_	_	_	_	_	_	B-Landmark_event
19	informed	_	UNK	_	JJ	52	_	_	_	_	_	_	_	I-Landmark_event
20	discussion	_	discussion	_	NN	52	_	_	_	_	_	_	_	I-Landmark_event
21	,	_	,	_	,	52	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	52	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	52	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	52	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	52	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	52	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	52	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	52	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	52	_	_	_	_	_	_	_	O
30	her	_	her	_	PRP$	52	_	_	_	_	_	_	_	O
31	becoming	_	become	_	VBG	52	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
33	.	_	.	_	.	52	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	52	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	52	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	52	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	52	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	52	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	52	_	_	_	_	_	_	_	O
10	treatment	_	treatment	_	NN	52	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	52	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	52	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	52	_	_	_	_	_	_	_	O
16	,	_	,	_	,	52	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	52	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	52	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	52	_	_	_	_	_	_	_	S-Depictive
20	discussion	_	discussion	_	NN	52	_	_	_	_	_	discussion.n	Discussion	O
21	,	_	,	_	,	52	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	52	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	52	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	52	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	52	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	52	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	52	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	52	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	52	_	_	_	_	_	_	_	O
30	her	_	her	_	PRP$	52	_	_	_	_	_	_	_	O
31	becoming	_	become	_	VBG	52	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
33	.	_	.	_	.	52	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	52	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	52	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	52	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	52	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	52	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	52	_	_	_	_	_	_	_	O
10	treatment	_	treatment	_	NN	52	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	52	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	52	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	52	_	_	_	_	_	_	_	O
16	,	_	,	_	,	52	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	52	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	52	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	52	_	_	_	_	_	_	_	O
21	,	_	,	_	,	52	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	52	_	_	_	_	_	_	_	S-Party_1
23	is	_	be	_	VBZ	52	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	52	_	_	_	_	_	agree.v	Make_agreement_on_action	O
25	there	_	there	_	EX	52	_	_	_	_	_	_	_	B-Obligation
26	is	_	be	_	VBZ	52	_	_	_	_	_	_	_	I-Obligation
27	a	_	a	_	DT	52	_	_	_	_	_	_	_	I-Obligation
28	possibility	_	possibility	_	NN	52	_	_	_	_	_	_	_	I-Obligation
29	of	_	of	_	IN	52	_	_	_	_	_	_	_	I-Obligation
30	her	_	her	_	PRP$	52	_	_	_	_	_	_	_	I-Obligation
31	becoming	_	become	_	VBG	52	_	_	_	_	_	_	_	I-Obligation
32	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	I-Obligation
33	.	_	.	_	.	52	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	52	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	52	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	52	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	52	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	52	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	52	_	_	_	_	_	_	_	O
10	treatment	_	treatment	_	NN	52	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	52	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	52	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	52	_	_	_	_	_	_	_	O
16	,	_	,	_	,	52	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	52	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	52	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	52	_	_	_	_	_	_	_	O
21	,	_	,	_	,	52	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	52	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	52	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	52	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	52	_	_	_	_	_	there.adv	Locative_relation	S-Ground
26	is	_	be	_	VBZ	52	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	52	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	52	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	52	_	_	_	_	_	_	_	O
30	her	_	her	_	PRP$	52	_	_	_	_	_	_	_	O
31	becoming	_	become	_	VBG	52	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
33	.	_	.	_	.	52	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	52	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	52	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	52	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	52	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	52	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	52	_	_	_	_	_	_	_	O
10	treatment	_	treatment	_	NN	52	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	52	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	52	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	52	_	_	_	_	_	_	_	O
16	,	_	,	_	,	52	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	52	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	52	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	52	_	_	_	_	_	_	_	O
21	,	_	,	_	,	52	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	52	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	52	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	52	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	52	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	52	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	52	_	_	_	_	_	_	_	O
28	possibility	_	possibility	_	NN	52	_	_	_	_	_	possibility.n	Alternatives	O
29	of	_	of	_	IN	52	_	_	_	_	_	_	_	B-Salient_entity
30	her	_	her	_	PRP$	52	_	_	_	_	_	_	_	I-Salient_entity
31	becoming	_	become	_	VBG	52	_	_	_	_	_	_	_	O
32	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
33	.	_	.	_	.	52	_	_	_	_	_	_	_	O

1	a	_	A	_	DT	52	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
3	blocker	_	UNK	_	NN	52	_	_	_	_	_	_	_	O
4	should	_	should	_	MD	52	_	_	_	_	_	_	_	O
5	be	_	be	_	VB	52	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	52	_	_	_	_	_	_	_	O
7	first-line	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
8	antihypertensive	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
9	drug	_	drug	_	NN	52	_	_	_	_	_	_	_	O
10	treatment	_	treatment	_	NN	52	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	52	_	_	_	_	_	_	_	O
13	woman	_	woman	_	NN	52	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	52	_	_	_	_	_	_	_	O
15	whom	_	whom	_	WP	52	_	_	_	_	_	_	_	O
16	,	_	,	_	,	52	_	_	_	_	_	_	_	O
17	after	_	after	_	IN	52	_	_	_	_	_	_	_	O
18	an	_	an	_	DT	52	_	_	_	_	_	_	_	O
19	informed	_	UNK	_	JJ	52	_	_	_	_	_	_	_	O
20	discussion	_	discussion	_	NN	52	_	_	_	_	_	_	_	O
21	,	_	,	_	,	52	_	_	_	_	_	_	_	O
22	it	_	it	_	PRP	52	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	52	_	_	_	_	_	_	_	O
24	agreed	_	agree	_	VBN	52	_	_	_	_	_	_	_	O
25	there	_	there	_	EX	52	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	52	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	52	_	_	_	_	_	_	_	B-Entity
28	possibility	_	possibility	_	NN	52	_	_	_	_	_	_	_	I-Entity
29	of	_	of	_	IN	52	_	_	_	_	_	_	_	I-Entity
30	her	_	her	_	PRP$	52	_	_	_	_	_	_	_	I-Entity
31	becoming	_	become	_	VBG	52	_	_	_	_	_	become.v	Becoming	O
32	pregnant	_	pregnant	_	JJ	52	_	_	_	_	_	_	_	O
33	.	_	.	_	.	52	_	_	_	_	_	_	_	O

1	do	_	Do	_	NNP	53	_	_	_	_	_	_	_	S-Agent
2	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
3	combine	_	combine	_	VB	53	_	_	_	_	_	combine.v	Cause_to_amalgamate	O
4	an	_	an	_	DT	53	_	_	_	_	_	_	_	B-Whole
5	ace	_	UNK	_	NNP	53	_	_	_	_	_	_	_	I-Whole
6	inhibitor	_	UNK	_	NN	53	_	_	_	_	_	_	_	I-Whole
7	with	_	with	_	IN	53	_	_	_	_	_	_	_	I-Whole
8	an	_	an	_	DT	53	_	_	_	_	_	_	_	I-Whole
9	angiotensin	_	UNK	_	JJ	53	_	_	_	_	_	_	_	I-Whole
10	unk	_	UNK	_	NNP	53	_	_	_	_	_	_	_	I-Whole
11	antagonist	_	UNK	_	NN	53	_	_	_	_	_	_	_	I-Whole
12	to	_	to	_	TO	53	_	_	_	_	_	_	_	I-Whole
13	treat	_	treat	_	VB	53	_	_	_	_	_	_	_	I-Whole
14	hypertension	_	UNK	_	NN	53	_	_	_	_	_	_	_	I-Whole
15	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	do	_	Do	_	NNP	53	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	53	_	_	_	_	_	_	_	O
3	combine	_	combine	_	VB	53	_	_	_	_	_	_	_	O
4	an	_	an	_	DT	53	_	_	_	_	_	_	_	O
5	ace	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
6	inhibitor	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	53	_	_	_	_	_	_	_	O
8	an	_	an	_	DT	53	_	_	_	_	_	_	_	O
9	angiotensin	_	UNK	_	JJ	53	_	_	_	_	_	_	_	O
10	unk	_	UNK	_	NNP	53	_	_	_	_	_	_	_	O
11	antagonist	_	UNK	_	NN	53	_	_	_	_	_	_	_	O
12	to	_	to	_	TO	53	_	_	_	_	_	_	_	O
13	treat	_	treat	_	VB	53	_	_	_	_	_	treat.v	Medical_intervention	O
14	hypertension	_	UNK	_	NN	53	_	_	_	_	_	_	_	S-Patient
15	.	_	.	_	.	53	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	54	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	54	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	54	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	54	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	54	_	_	_	_	_	_	_	O
6	:	_	:	_	:	54	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	54	_	_	_	_	_	_	_	O
8	(	_	(	_	(	54	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	54	_	_	_	_	_	_	_	O
10	)	_	)	_	)	54	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	54	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	54	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	54	_	_	_	_	_	_	_	O
14	)	_	)	_	)	54	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	54	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	54	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	54	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	54	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	54	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	54	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	54	_	_	_	_	_	_	_	O
8	(	_	(	_	(	54	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	54	_	_	_	_	_	_	_	O
10	)	_	)	_	)	54	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	54	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	54	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	54	_	_	_	_	_	_	_	O
14	)	_	)	_	)	54	_	_	_	_	_	_	_	O

1	check	_	UNK	_	NNP	55	_	_	_	_	_	_	_	O
2	for	_	for	_	IN	55	_	_	_	_	_	_	_	O
3	possible	_	possible	_	JJ	55	_	_	_	_	_	possible.a	Likelihood	O
4	adverse	_	UNK	_	JJ	55	_	_	_	_	_	_	_	B-Hypothetical_event
5	effects	_	effect	_	NNS	55	_	_	_	_	_	_	_	I-Hypothetical_event
6	of	_	of	_	IN	55	_	_	_	_	_	_	_	I-Hypothetical_event
7	antihypertensive	_	UNK	_	JJ	55	_	_	_	_	_	_	_	I-Hypothetical_event
8	drug	_	drug	_	NN	55	_	_	_	_	_	_	_	I-Hypothetical_event
9	treatment	_	treatment	_	NN	55	_	_	_	_	_	_	_	I-Hypothetical_event
10	unk	_	UNK	_	NN	55	_	_	_	_	_	_	_	I-Hypothetical_event
11	including	_	include	_	VBG	55	_	_	_	_	_	_	_	I-Hypothetical_event
12	the	_	the	_	DT	55	_	_	_	_	_	_	_	I-Hypothetical_event
13	risks	_	risk	_	NNS	55	_	_	_	_	_	_	_	I-Hypothetical_event
14	from	_	from	_	IN	55	_	_	_	_	_	_	_	I-Hypothetical_event
15	unnecessarily	_	UNK	_	RB	55	_	_	_	_	_	_	_	I-Hypothetical_event
16	low	_	low	_	JJ	55	_	_	_	_	_	_	_	I-Hypothetical_event
17	blood	_	blood	_	NN	55	_	_	_	_	_	_	_	I-Hypothetical_event
18	pressure	_	pressure	_	NN	55	_	_	_	_	_	_	_	I-Hypothetical_event
19	.	_	.	_	.	55	_	_	_	_	_	_	_	O

1	check	_	UNK	_	NNP	55	_	_	_	_	_	_	_	O
2	for	_	for	_	IN	55	_	_	_	_	_	_	_	O
3	possible	_	possible	_	JJ	55	_	_	_	_	_	_	_	O
4	adverse	_	UNK	_	JJ	55	_	_	_	_	_	_	_	O
5	effects	_	effect	_	NNS	55	_	_	_	_	_	effect.n	Objective_influence	O
6	of	_	of	_	IN	55	_	_	_	_	_	_	_	B-Dependent_entity
7	antihypertensive	_	UNK	_	JJ	55	_	_	_	_	_	_	_	I-Dependent_entity
8	drug	_	drug	_	NN	55	_	_	_	_	_	_	_	I-Dependent_entity
9	treatment	_	treatment	_	NN	55	_	_	_	_	_	_	_	I-Dependent_entity
10	unk	_	UNK	_	NN	55	_	_	_	_	_	_	_	I-Dependent_entity
11	including	_	include	_	VBG	55	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	55	_	_	_	_	_	_	_	O
13	risks	_	risk	_	NNS	55	_	_	_	_	_	_	_	O
14	from	_	from	_	IN	55	_	_	_	_	_	_	_	O
15	unnecessarily	_	UNK	_	RB	55	_	_	_	_	_	_	_	O
16	low	_	low	_	JJ	55	_	_	_	_	_	_	_	O
17	blood	_	blood	_	NN	55	_	_	_	_	_	_	_	O
18	pressure	_	pressure	_	NN	55	_	_	_	_	_	_	_	O
19	.	_	.	_	.	55	_	_	_	_	_	_	_	O

1	check	_	UNK	_	NNP	55	_	_	_	_	_	_	_	O
2	for	_	for	_	IN	55	_	_	_	_	_	_	_	O
3	possible	_	possible	_	JJ	55	_	_	_	_	_	_	_	O
4	adverse	_	UNK	_	JJ	55	_	_	_	_	_	_	_	O
5	effects	_	effect	_	NNS	55	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	55	_	_	_	_	_	_	_	O
7	antihypertensive	_	UNK	_	JJ	55	_	_	_	_	_	_	_	O
8	drug	_	drug	_	NN	55	_	_	_	_	_	_	_	S-Patient
9	treatment	_	treatment	_	NN	55	_	_	_	_	_	treatment.n	Cure	O
10	unk	_	UNK	_	NN	55	_	_	_	_	_	_	_	O
11	including	_	include	_	VBG	55	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	55	_	_	_	_	_	_	_	O
13	risks	_	risk	_	NNS	55	_	_	_	_	_	_	_	O
14	from	_	from	_	IN	55	_	_	_	_	_	_	_	O
15	unnecessarily	_	UNK	_	RB	55	_	_	_	_	_	_	_	O
16	low	_	low	_	JJ	55	_	_	_	_	_	_	_	O
17	blood	_	blood	_	NN	55	_	_	_	_	_	_	_	O
18	pressure	_	pressure	_	NN	55	_	_	_	_	_	_	_	O
19	.	_	.	_	.	55	_	_	_	_	_	_	_	O

1	check	_	UNK	_	NNP	55	_	_	_	_	_	_	_	O
2	for	_	for	_	IN	55	_	_	_	_	_	_	_	O
3	possible	_	possible	_	JJ	55	_	_	_	_	_	_	_	O
4	adverse	_	UNK	_	JJ	55	_	_	_	_	_	_	_	B-Total
5	effects	_	effect	_	NNS	55	_	_	_	_	_	_	_	I-Total
6	of	_	of	_	IN	55	_	_	_	_	_	_	_	I-Total
7	antihypertensive	_	UNK	_	JJ	55	_	_	_	_	_	_	_	I-Total
8	drug	_	drug	_	NN	55	_	_	_	_	_	_	_	I-Total
9	treatment	_	treatment	_	NN	55	_	_	_	_	_	_	_	I-Total
10	unk	_	UNK	_	NN	55	_	_	_	_	_	_	_	I-Total
11	including	_	include	_	VBG	55	_	_	_	_	_	include.v	Inclusion	O
12	the	_	the	_	DT	55	_	_	_	_	_	_	_	B-Part
13	risks	_	risk	_	NNS	55	_	_	_	_	_	_	_	I-Part
14	from	_	from	_	IN	55	_	_	_	_	_	_	_	I-Part
15	unnecessarily	_	UNK	_	RB	55	_	_	_	_	_	_	_	I-Part
16	low	_	low	_	JJ	55	_	_	_	_	_	_	_	I-Part
17	blood	_	blood	_	NN	55	_	_	_	_	_	_	_	I-Part
18	pressure	_	pressure	_	NN	55	_	_	_	_	_	_	_	I-Part
19	.	_	.	_	.	55	_	_	_	_	_	_	_	O

1	check	_	UNK	_	NNP	55	_	_	_	_	_	_	_	O
2	for	_	for	_	IN	55	_	_	_	_	_	_	_	O
3	possible	_	possible	_	JJ	55	_	_	_	_	_	_	_	O
4	adverse	_	UNK	_	JJ	55	_	_	_	_	_	_	_	O
5	effects	_	effect	_	NNS	55	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	55	_	_	_	_	_	_	_	O
7	antihypertensive	_	UNK	_	JJ	55	_	_	_	_	_	_	_	O
8	drug	_	drug	_	NN	55	_	_	_	_	_	_	_	O
9	treatment	_	treatment	_	NN	55	_	_	_	_	_	_	_	O
10	unk	_	UNK	_	NN	55	_	_	_	_	_	_	_	O
11	including	_	include	_	VBG	55	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	55	_	_	_	_	_	_	_	O
13	risks	_	risk	_	NNS	55	_	_	_	_	_	risk.n	Daring	O
14	from	_	from	_	IN	55	_	_	_	_	_	_	_	O
15	unnecessarily	_	UNK	_	RB	55	_	_	_	_	_	_	_	O
16	low	_	low	_	JJ	55	_	_	_	_	_	_	_	O
17	blood	_	blood	_	NN	55	_	_	_	_	_	_	_	O
18	pressure	_	pressure	_	NN	55	_	_	_	_	_	_	_	O
19	.	_	.	_	.	55	_	_	_	_	_	_	_	O

1	check	_	UNK	_	NNP	55	_	_	_	_	_	_	_	O
2	for	_	for	_	IN	55	_	_	_	_	_	_	_	O
3	possible	_	possible	_	JJ	55	_	_	_	_	_	_	_	O
4	adverse	_	UNK	_	JJ	55	_	_	_	_	_	_	_	O
5	effects	_	effect	_	NNS	55	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	55	_	_	_	_	_	_	_	O
7	antihypertensive	_	UNK	_	JJ	55	_	_	_	_	_	_	_	O
8	drug	_	drug	_	NN	55	_	_	_	_	_	_	_	O
9	treatment	_	treatment	_	NN	55	_	_	_	_	_	_	_	O
10	unk	_	UNK	_	NN	55	_	_	_	_	_	_	_	O
11	including	_	include	_	VBG	55	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	55	_	_	_	_	_	_	_	O
13	risks	_	risk	_	NNS	55	_	_	_	_	_	_	_	O
14	from	_	from	_	IN	55	_	_	_	_	_	_	_	O
15	unnecessarily	_	UNK	_	RB	55	_	_	_	_	_	_	_	O
16	low	_	low	_	JJ	55	_	_	_	_	_	low.a	Measurable_attributes	O
17	blood	_	blood	_	NN	55	_	_	_	_	_	_	_	B-Entity
18	pressure	_	pressure	_	NN	55	_	_	_	_	_	_	_	I-Entity
19	.	_	.	_	.	55	_	_	_	_	_	_	_	O

1	check	_	UNK	_	NNP	55	_	_	_	_	_	_	_	O
2	for	_	for	_	IN	55	_	_	_	_	_	_	_	O
3	possible	_	possible	_	JJ	55	_	_	_	_	_	_	_	O
4	adverse	_	UNK	_	JJ	55	_	_	_	_	_	_	_	O
5	effects	_	effect	_	NNS	55	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	55	_	_	_	_	_	_	_	O
7	antihypertensive	_	UNK	_	JJ	55	_	_	_	_	_	_	_	O
8	drug	_	drug	_	NN	55	_	_	_	_	_	_	_	O
9	treatment	_	treatment	_	NN	55	_	_	_	_	_	_	_	O
10	unk	_	UNK	_	NN	55	_	_	_	_	_	_	_	O
11	including	_	include	_	VBG	55	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	55	_	_	_	_	_	_	_	O
13	risks	_	risk	_	NNS	55	_	_	_	_	_	_	_	O
14	from	_	from	_	IN	55	_	_	_	_	_	_	_	O
15	unnecessarily	_	UNK	_	RB	55	_	_	_	_	_	_	_	O
16	low	_	low	_	JJ	55	_	_	_	_	_	_	_	O
17	blood	_	blood	_	NN	55	_	_	_	_	_	_	_	S-Speaker
18	pressure	_	pressure	_	NN	55	_	_	_	_	_	pressure.n	Attempt_suasion	O
19	.	_	.	_	.	55	_	_	_	_	_	_	_	O

1	do	_	Do	_	MD	56	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	56	_	_	_	_	_	_	_	O
3	offer	_	offer	_	VB	56	_	_	_	_	_	_	_	O
4	antiplatelet	_	UNK	_	NN	56	_	_	_	_	_	_	_	S-Type
5	therapy	_	therapy	_	NN	56	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
6	(	_	(	_	(	56	_	_	_	_	_	_	_	O
7	aspirin	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
8	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
9	clopidogrel	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
10	)	_	)	_	)	56	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	56	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
17	without	_	without	_	IN	56	_	_	_	_	_	_	_	O
18	cardiovascular	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
19	disease	_	disease	_	NN	56	_	_	_	_	_	_	_	O
20	.	_	.	_	.	56	_	_	_	_	_	_	_	O

1	do	_	Do	_	MD	56	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	56	_	_	_	_	_	_	_	O
3	offer	_	offer	_	VB	56	_	_	_	_	_	_	_	O
4	antiplatelet	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
5	therapy	_	therapy	_	NN	56	_	_	_	_	_	_	_	O
6	(	_	(	_	(	56	_	_	_	_	_	_	_	O
7	aspirin	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
8	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
9	clopidogrel	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
10	)	_	)	_	)	56	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	56	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	56	_	_	_	_	_	adult.n	People_by_age	S-Person
13	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
17	without	_	without	_	IN	56	_	_	_	_	_	_	_	O
18	cardiovascular	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
19	disease	_	disease	_	NN	56	_	_	_	_	_	_	_	O
20	.	_	.	_	.	56	_	_	_	_	_	_	_	O

1	do	_	Do	_	MD	56	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	56	_	_	_	_	_	_	_	O
3	offer	_	offer	_	VB	56	_	_	_	_	_	_	_	O
4	antiplatelet	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
5	therapy	_	therapy	_	NN	56	_	_	_	_	_	_	_	O
6	(	_	(	_	(	56	_	_	_	_	_	_	_	O
7	aspirin	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
8	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
9	clopidogrel	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
10	)	_	)	_	)	56	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	56	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	56	_	_	_	_	_	type.n	Type	S-Subtype
15	2	_	2	_	CD	56	_	_	_	_	_	_	_	B-Category
16	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	I-Category
17	without	_	without	_	IN	56	_	_	_	_	_	_	_	O
18	cardiovascular	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
19	disease	_	disease	_	NN	56	_	_	_	_	_	_	_	O
20	.	_	.	_	.	56	_	_	_	_	_	_	_	O

1	do	_	Do	_	MD	56	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	56	_	_	_	_	_	_	_	O
3	offer	_	offer	_	VB	56	_	_	_	_	_	_	_	O
4	antiplatelet	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
5	therapy	_	therapy	_	NN	56	_	_	_	_	_	_	_	O
6	(	_	(	_	(	56	_	_	_	_	_	_	_	O
7	aspirin	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
8	or	_	or	_	CC	56	_	_	_	_	_	_	_	O
9	clopidogrel	_	UNK	_	NN	56	_	_	_	_	_	_	_	O
10	)	_	)	_	)	56	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	56	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	56	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	56	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	56	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	56	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	56	_	_	_	_	_	_	_	O
17	without	_	without	_	IN	56	_	_	_	_	_	_	_	O
18	cardiovascular	_	UNK	_	JJ	56	_	_	_	_	_	_	_	O
19	disease	_	disease	_	NN	56	_	_	_	_	_	disease.n	Medical_conditions	S-Ailment
20	.	_	.	_	.	56	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	57	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	57	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	57	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	57	_	_	_	_	_	_	_	O
5	primary	_	primary	_	JJ	57	_	_	_	_	_	primary.a	First_rank	O
6	and	_	and	_	CC	57	_	_	_	_	_	_	_	O
7	secondary	_	secondary	_	JJ	57	_	_	_	_	_	_	_	O
8	prevention	_	prevention	_	NN	57	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	57	_	_	_	_	_	_	_	B-Item
10	cardiovascular	_	UNK	_	JJ	57	_	_	_	_	_	_	_	I-Item
11	disease	_	disease	_	NN	57	_	_	_	_	_	_	_	I-Item
12	in	_	in	_	IN	57	_	_	_	_	_	_	_	I-Item
13	adults	_	adult	_	NNS	57	_	_	_	_	_	_	_	I-Item
14	with	_	with	_	IN	57	_	_	_	_	_	_	_	I-Item
15	type	_	type	_	JJ	57	_	_	_	_	_	_	_	I-Item
16	2	_	2	_	CD	57	_	_	_	_	_	_	_	I-Item
17	diabetes	_	UNK	_	NNS	57	_	_	_	_	_	_	_	I-Item
18	,	_	,	_	,	57	_	_	_	_	_	_	_	O
19	see	_	see	_	VBP	57	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	57	_	_	_	_	_	_	_	O
21	nice	_	UNK	_	NNP	57	_	_	_	_	_	_	_	O
22	guidelines	_	guideline	_	NNS	57	_	_	_	_	_	_	_	O
23	on	_	on	_	IN	57	_	_	_	_	_	_	_	O
24	cardiovascular	_	UNK	_	JJ	57	_	_	_	_	_	_	_	O
25	disease	_	disease	_	NN	57	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	57	_	_	_	_	_	_	_	O
27	myocardial	_	UNK	_	JJ	57	_	_	_	_	_	_	_	O
28	infarction	_	UNK	_	NN	57	_	_	_	_	_	_	_	O
29	.	_	.	_	.	57	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	57	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	57	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	57	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	57	_	_	_	_	_	_	_	O
5	primary	_	primary	_	JJ	57	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	57	_	_	_	_	_	_	_	O
7	secondary	_	secondary	_	JJ	57	_	_	_	_	_	_	_	S-Manner
8	prevention	_	prevention	_	NN	57	_	_	_	_	_	prevention.n	Preventing_or_letting	O
9	of	_	of	_	IN	57	_	_	_	_	_	_	_	B-Event
10	cardiovascular	_	UNK	_	JJ	57	_	_	_	_	_	_	_	I-Event
11	disease	_	disease	_	NN	57	_	_	_	_	_	_	_	I-Event
12	in	_	in	_	IN	57	_	_	_	_	_	_	_	I-Event
13	adults	_	adult	_	NNS	57	_	_	_	_	_	_	_	I-Event
14	with	_	with	_	IN	57	_	_	_	_	_	_	_	I-Event
15	type	_	type	_	JJ	57	_	_	_	_	_	_	_	I-Event
16	2	_	2	_	CD	57	_	_	_	_	_	_	_	I-Event
17	diabetes	_	UNK	_	NNS	57	_	_	_	_	_	_	_	I-Event
18	,	_	,	_	,	57	_	_	_	_	_	_	_	O
19	see	_	see	_	VBP	57	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	57	_	_	_	_	_	_	_	O
21	nice	_	UNK	_	NNP	57	_	_	_	_	_	_	_	O
22	guidelines	_	guideline	_	NNS	57	_	_	_	_	_	_	_	O
23	on	_	on	_	IN	57	_	_	_	_	_	_	_	O
24	cardiovascular	_	UNK	_	JJ	57	_	_	_	_	_	_	_	O
25	disease	_	disease	_	NN	57	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	57	_	_	_	_	_	_	_	O
27	myocardial	_	UNK	_	JJ	57	_	_	_	_	_	_	_	O
28	infarction	_	UNK	_	NN	57	_	_	_	_	_	_	_	O
29	.	_	.	_	.	57	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	57	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	57	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	57	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	57	_	_	_	_	_	_	_	O
5	primary	_	primary	_	JJ	57	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	57	_	_	_	_	_	_	_	O
7	secondary	_	secondary	_	JJ	57	_	_	_	_	_	_	_	O
8	prevention	_	prevention	_	NN	57	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	57	_	_	_	_	_	_	_	O
10	cardiovascular	_	UNK	_	JJ	57	_	_	_	_	_	_	_	S-Patient
11	disease	_	disease	_	NN	57	_	_	_	_	_	disease.n	Medical_conditions	S-Ailment
12	in	_	in	_	IN	57	_	_	_	_	_	_	_	O
13	adults	_	adult	_	NNS	57	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	57	_	_	_	_	_	_	_	O
15	type	_	type	_	JJ	57	_	_	_	_	_	_	_	O
16	2	_	2	_	CD	57	_	_	_	_	_	_	_	O
17	diabetes	_	UNK	_	NNS	57	_	_	_	_	_	_	_	O
18	,	_	,	_	,	57	_	_	_	_	_	_	_	O
19	see	_	see	_	VBP	57	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	57	_	_	_	_	_	_	_	O
21	nice	_	UNK	_	NNP	57	_	_	_	_	_	_	_	O
22	guidelines	_	guideline	_	NNS	57	_	_	_	_	_	_	_	O
23	on	_	on	_	IN	57	_	_	_	_	_	_	_	O
24	cardiovascular	_	UNK	_	JJ	57	_	_	_	_	_	_	_	O
25	disease	_	disease	_	NN	57	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	57	_	_	_	_	_	_	_	O
27	myocardial	_	UNK	_	JJ	57	_	_	_	_	_	_	_	O
28	infarction	_	UNK	_	NN	57	_	_	_	_	_	_	_	O
29	.	_	.	_	.	57	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	57	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	57	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	57	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	57	_	_	_	_	_	_	_	O
5	primary	_	primary	_	JJ	57	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	57	_	_	_	_	_	_	_	O
7	secondary	_	secondary	_	JJ	57	_	_	_	_	_	_	_	O
8	prevention	_	prevention	_	NN	57	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	57	_	_	_	_	_	_	_	O
10	cardiovascular	_	UNK	_	JJ	57	_	_	_	_	_	_	_	O
11	disease	_	disease	_	NN	57	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	57	_	_	_	_	_	_	_	O
13	adults	_	adult	_	NNS	57	_	_	_	_	_	adult.n	People_by_age	S-Person
14	with	_	with	_	IN	57	_	_	_	_	_	_	_	O
15	type	_	type	_	JJ	57	_	_	_	_	_	_	_	O
16	2	_	2	_	CD	57	_	_	_	_	_	_	_	O
17	diabetes	_	UNK	_	NNS	57	_	_	_	_	_	_	_	O
18	,	_	,	_	,	57	_	_	_	_	_	_	_	O
19	see	_	see	_	VBP	57	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	57	_	_	_	_	_	_	_	O
21	nice	_	UNK	_	NNP	57	_	_	_	_	_	_	_	O
22	guidelines	_	guideline	_	NNS	57	_	_	_	_	_	_	_	O
23	on	_	on	_	IN	57	_	_	_	_	_	_	_	O
24	cardiovascular	_	UNK	_	JJ	57	_	_	_	_	_	_	_	O
25	disease	_	disease	_	NN	57	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	57	_	_	_	_	_	_	_	O
27	myocardial	_	UNK	_	JJ	57	_	_	_	_	_	_	_	O
28	infarction	_	UNK	_	NN	57	_	_	_	_	_	_	_	O
29	.	_	.	_	.	57	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	57	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	57	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	57	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	57	_	_	_	_	_	_	_	O
5	primary	_	primary	_	JJ	57	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	57	_	_	_	_	_	_	_	O
7	secondary	_	secondary	_	JJ	57	_	_	_	_	_	_	_	O
8	prevention	_	prevention	_	NN	57	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	57	_	_	_	_	_	_	_	O
10	cardiovascular	_	UNK	_	JJ	57	_	_	_	_	_	_	_	O
11	disease	_	disease	_	NN	57	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	57	_	_	_	_	_	_	_	O
13	adults	_	adult	_	NNS	57	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	57	_	_	_	_	_	_	_	O
15	type	_	type	_	JJ	57	_	_	_	_	_	type.n	Type	S-Subtype
16	2	_	2	_	CD	57	_	_	_	_	_	_	_	B-Category
17	diabetes	_	UNK	_	NNS	57	_	_	_	_	_	_	_	I-Category
18	,	_	,	_	,	57	_	_	_	_	_	_	_	O
19	see	_	see	_	VBP	57	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	57	_	_	_	_	_	_	_	O
21	nice	_	UNK	_	NNP	57	_	_	_	_	_	_	_	O
22	guidelines	_	guideline	_	NNS	57	_	_	_	_	_	_	_	O
23	on	_	on	_	IN	57	_	_	_	_	_	_	_	O
24	cardiovascular	_	UNK	_	JJ	57	_	_	_	_	_	_	_	O
25	disease	_	disease	_	NN	57	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	57	_	_	_	_	_	_	_	O
27	myocardial	_	UNK	_	JJ	57	_	_	_	_	_	_	_	O
28	infarction	_	UNK	_	NN	57	_	_	_	_	_	_	_	O
29	.	_	.	_	.	57	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	57	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	57	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	57	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	57	_	_	_	_	_	_	_	O
5	primary	_	primary	_	JJ	57	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	57	_	_	_	_	_	_	_	O
7	secondary	_	secondary	_	JJ	57	_	_	_	_	_	_	_	O
8	prevention	_	prevention	_	NN	57	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	57	_	_	_	_	_	_	_	O
10	cardiovascular	_	UNK	_	JJ	57	_	_	_	_	_	_	_	O
11	disease	_	disease	_	NN	57	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	57	_	_	_	_	_	_	_	O
13	adults	_	adult	_	NNS	57	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	57	_	_	_	_	_	_	_	O
15	type	_	type	_	JJ	57	_	_	_	_	_	_	_	O
16	2	_	2	_	CD	57	_	_	_	_	_	_	_	O
17	diabetes	_	UNK	_	NNS	57	_	_	_	_	_	_	_	O
18	,	_	,	_	,	57	_	_	_	_	_	_	_	O
19	see	_	see	_	VBP	57	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	57	_	_	_	_	_	_	_	O
21	nice	_	UNK	_	NNP	57	_	_	_	_	_	_	_	O
22	guidelines	_	guideline	_	NNS	57	_	_	_	_	_	_	_	O
23	on	_	on	_	IN	57	_	_	_	_	_	_	_	O
24	cardiovascular	_	UNK	_	JJ	57	_	_	_	_	_	_	_	S-Patient
25	disease	_	disease	_	NN	57	_	_	_	_	_	disease.n	Medical_conditions	S-Ailment
26	and	_	and	_	CC	57	_	_	_	_	_	_	_	O
27	myocardial	_	UNK	_	JJ	57	_	_	_	_	_	_	_	O
28	infarction	_	UNK	_	NN	57	_	_	_	_	_	_	_	O
29	.	_	.	_	.	57	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	60	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	60	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	60	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	60	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	60	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	60	_	_	_	_	_	_	_	O
7	,	_	,	_	,	60	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	60	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	60	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	60	_	_	_	_	_	_	_	O
12	:	_	:	_	:	60	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
14	intervals	_	interval	_	NNS	60	_	_	_	_	_	_	_	O
15	(	_	(	_	(	60	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	60	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	60	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	60	_	_	_	_	_	_	_	O
19	needs	_	need	_	NNS	60	_	_	_	_	_	_	_	O
20	)	_	)	_	)	60	_	_	_	_	_	_	_	O
21	,	_	,	_	,	60	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	60	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	60	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	60	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	60	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	60	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	60	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	60	_	_	_	_	_	_	_	O
32	once	_	once	_	IN	60	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	60	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	60	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	60	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	60	_	_	_	_	_	_	_	O
38	glucose	_	UNK	_	NN	60	_	_	_	_	_	_	_	O
39	lowering	_	lower	_	VBG	60	_	_	_	_	_	_	_	O
40	therapy	_	therapy	_	NN	60	_	_	_	_	_	_	_	O
41	are	_	be	_	VBP	60	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	60	_	_	_	_	_	_	_	O
43	.	_	.	_	.	60	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	60	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	60	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	60	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	60	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	60	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	60	_	_	_	_	_	_	_	I-Category
7	,	_	,	_	,	60	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	60	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	60	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	60	_	_	_	_	_	_	_	O
12	:	_	:	_	:	60	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
14	intervals	_	interval	_	NNS	60	_	_	_	_	_	_	_	O
15	(	_	(	_	(	60	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	60	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	60	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	60	_	_	_	_	_	_	_	O
19	needs	_	need	_	NNS	60	_	_	_	_	_	_	_	O
20	)	_	)	_	)	60	_	_	_	_	_	_	_	O
21	,	_	,	_	,	60	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	60	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	60	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	60	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	60	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	60	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	60	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	60	_	_	_	_	_	_	_	O
32	once	_	once	_	IN	60	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	60	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	60	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	60	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	60	_	_	_	_	_	_	_	O
38	glucose	_	UNK	_	NN	60	_	_	_	_	_	_	_	O
39	lowering	_	lower	_	VBG	60	_	_	_	_	_	_	_	O
40	therapy	_	therapy	_	NN	60	_	_	_	_	_	_	_	O
41	are	_	be	_	VBP	60	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	60	_	_	_	_	_	_	_	O
43	.	_	.	_	.	60	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	60	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	60	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	60	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	60	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	60	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	60	_	_	_	_	_	_	_	O
7	,	_	,	_	,	60	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	60	_	_	_	_	_	_	_	S-Rank
9	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	S-Item
10	levels	_	level	_	NNS	60	_	_	_	_	_	level.n	Rank	O
11	at	_	at	_	IN	60	_	_	_	_	_	_	_	O
12	:	_	:	_	:	60	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
14	intervals	_	interval	_	NNS	60	_	_	_	_	_	_	_	O
15	(	_	(	_	(	60	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	60	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	60	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	60	_	_	_	_	_	_	_	O
19	needs	_	need	_	NNS	60	_	_	_	_	_	_	_	O
20	)	_	)	_	)	60	_	_	_	_	_	_	_	O
21	,	_	,	_	,	60	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	60	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	60	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	60	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	60	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	60	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	60	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	60	_	_	_	_	_	_	_	O
32	once	_	once	_	IN	60	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	60	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	60	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	60	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	60	_	_	_	_	_	_	_	O
38	glucose	_	UNK	_	NN	60	_	_	_	_	_	_	_	O
39	lowering	_	lower	_	VBG	60	_	_	_	_	_	_	_	O
40	therapy	_	therapy	_	NN	60	_	_	_	_	_	_	_	O
41	are	_	be	_	VBP	60	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	60	_	_	_	_	_	_	_	O
43	.	_	.	_	.	60	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	60	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	60	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	60	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	60	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	60	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	60	_	_	_	_	_	_	_	O
7	,	_	,	_	,	60	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	60	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	60	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	60	_	_	_	_	_	_	_	O
12	:	_	:	_	:	60	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	60	_	_	_	_	_	_	_	S-Time_span
14	intervals	_	interval	_	NNS	60	_	_	_	_	_	interval.n	Frequency	S-Interval
15	(	_	(	_	(	60	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	60	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	60	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	60	_	_	_	_	_	_	_	O
19	needs	_	need	_	NNS	60	_	_	_	_	_	_	_	O
20	)	_	)	_	)	60	_	_	_	_	_	_	_	O
21	,	_	,	_	,	60	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	60	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	60	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	60	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	60	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	60	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	60	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	60	_	_	_	_	_	_	_	O
32	once	_	once	_	IN	60	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	60	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	60	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	60	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	60	_	_	_	_	_	_	_	O
38	glucose	_	UNK	_	NN	60	_	_	_	_	_	_	_	O
39	lowering	_	lower	_	VBG	60	_	_	_	_	_	_	_	O
40	therapy	_	therapy	_	NN	60	_	_	_	_	_	_	_	O
41	are	_	be	_	VBP	60	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	60	_	_	_	_	_	_	_	O
43	.	_	.	_	.	60	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	60	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	60	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	60	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	60	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	60	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	60	_	_	_	_	_	_	_	O
7	,	_	,	_	,	60	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	60	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	60	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	60	_	_	_	_	_	_	_	O
12	:	_	:	_	:	60	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
14	intervals	_	interval	_	NNS	60	_	_	_	_	_	_	_	O
15	(	_	(	_	(	60	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	60	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	60	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	60	_	_	_	_	_	individual.n	People	O
19	needs	_	need	_	NNS	60	_	_	_	_	_	_	_	S-Person
20	)	_	)	_	)	60	_	_	_	_	_	_	_	O
21	,	_	,	_	,	60	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	60	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	60	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	60	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	60	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	60	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	60	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	60	_	_	_	_	_	_	_	O
32	once	_	once	_	IN	60	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	60	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	60	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	60	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	60	_	_	_	_	_	_	_	O
38	glucose	_	UNK	_	NN	60	_	_	_	_	_	_	_	O
39	lowering	_	lower	_	VBG	60	_	_	_	_	_	_	_	O
40	therapy	_	therapy	_	NN	60	_	_	_	_	_	_	_	O
41	are	_	be	_	VBP	60	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	60	_	_	_	_	_	_	_	O
43	.	_	.	_	.	60	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	60	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	60	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	60	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	60	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	60	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	60	_	_	_	_	_	_	_	O
7	,	_	,	_	,	60	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	60	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	60	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	60	_	_	_	_	_	_	_	O
12	:	_	:	_	:	60	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
14	intervals	_	interval	_	NNS	60	_	_	_	_	_	_	_	O
15	(	_	(	_	(	60	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	60	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	60	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	60	_	_	_	_	_	_	_	S-Cognizer
19	needs	_	need	_	NNS	60	_	_	_	_	_	need.n	Needing	S-Requirement
20	)	_	)	_	)	60	_	_	_	_	_	_	_	O
21	,	_	,	_	,	60	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	60	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	60	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	60	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	60	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	60	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	60	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	60	_	_	_	_	_	_	_	O
32	once	_	once	_	IN	60	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	60	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	60	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	60	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	60	_	_	_	_	_	_	_	O
38	glucose	_	UNK	_	NN	60	_	_	_	_	_	_	_	O
39	lowering	_	lower	_	VBG	60	_	_	_	_	_	_	_	O
40	therapy	_	therapy	_	NN	60	_	_	_	_	_	_	_	O
41	are	_	be	_	VBP	60	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	60	_	_	_	_	_	_	_	O
43	.	_	.	_	.	60	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	60	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	60	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	60	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	60	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	60	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	60	_	_	_	_	_	_	_	O
7	,	_	,	_	,	60	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	60	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	60	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	60	_	_	_	_	_	_	_	O
12	:	_	:	_	:	60	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
14	intervals	_	interval	_	NNS	60	_	_	_	_	_	_	_	O
15	(	_	(	_	(	60	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	60	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	60	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	60	_	_	_	_	_	_	_	O
19	needs	_	need	_	NNS	60	_	_	_	_	_	_	_	O
20	)	_	)	_	)	60	_	_	_	_	_	_	_	O
21	,	_	,	_	,	60	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	60	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	60	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	60	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	60	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	60	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	60	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
30	unk	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	60	_	_	_	_	_	_	_	O
32	once	_	once	_	IN	60	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	60	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	60	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	60	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	60	_	_	_	_	_	_	_	O
38	glucose	_	UNK	_	NN	60	_	_	_	_	_	_	_	O
39	lowering	_	lower	_	VBG	60	_	_	_	_	_	_	_	O
40	therapy	_	therapy	_	NN	60	_	_	_	_	_	_	_	O
41	are	_	be	_	VBP	60	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	60	_	_	_	_	_	_	_	O
43	.	_	.	_	.	60	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	60	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	60	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	60	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	60	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	60	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	60	_	_	_	_	_	_	_	O
7	,	_	,	_	,	60	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	60	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	60	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	60	_	_	_	_	_	_	_	O
12	:	_	:	_	:	60	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
14	intervals	_	interval	_	NNS	60	_	_	_	_	_	_	_	O
15	(	_	(	_	(	60	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	60	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	60	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	60	_	_	_	_	_	_	_	O
19	needs	_	need	_	NNS	60	_	_	_	_	_	_	_	O
20	)	_	)	_	)	60	_	_	_	_	_	_	_	O
21	,	_	,	_	,	60	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	60	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	60	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	60	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	60	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	60	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	60	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	60	_	_	_	_	_	interval.n	Frequency	S-Interval
32	once	_	once	_	IN	60	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	60	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	60	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	60	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	60	_	_	_	_	_	_	_	O
38	glucose	_	UNK	_	NN	60	_	_	_	_	_	_	_	O
39	lowering	_	lower	_	VBG	60	_	_	_	_	_	_	_	O
40	therapy	_	therapy	_	NN	60	_	_	_	_	_	_	_	O
41	are	_	be	_	VBP	60	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	60	_	_	_	_	_	_	_	O
43	.	_	.	_	.	60	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	60	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	60	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	60	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	60	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	60	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	60	_	_	_	_	_	_	_	O
7	,	_	,	_	,	60	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	60	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	60	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	60	_	_	_	_	_	_	_	O
12	:	_	:	_	:	60	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
14	intervals	_	interval	_	NNS	60	_	_	_	_	_	_	_	O
15	(	_	(	_	(	60	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	60	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	60	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	60	_	_	_	_	_	_	_	O
19	needs	_	need	_	NNS	60	_	_	_	_	_	_	_	O
20	)	_	)	_	)	60	_	_	_	_	_	_	_	O
21	,	_	,	_	,	60	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	60	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	60	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	60	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	60	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	60	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	60	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	60	_	_	_	_	_	_	_	O
32	once	_	once	_	IN	60	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	60	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	60	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	60	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	60	_	_	_	_	_	_	_	B-Item
38	glucose	_	UNK	_	NN	60	_	_	_	_	_	_	_	I-Item
39	lowering	_	lower	_	VBG	60	_	_	_	_	_	lower.v	Cause_change_of_position_on_a_scale	O
40	therapy	_	therapy	_	NN	60	_	_	_	_	_	_	_	S-Item
41	are	_	be	_	VBP	60	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	60	_	_	_	_	_	_	_	O
43	.	_	.	_	.	60	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	60	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	60	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	60	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	60	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	60	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	60	_	_	_	_	_	_	_	O
7	,	_	,	_	,	60	_	_	_	_	_	_	_	O
8	measure	_	measure	_	NN	60	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	60	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	60	_	_	_	_	_	_	_	O
12	:	_	:	_	:	60	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
14	intervals	_	interval	_	NNS	60	_	_	_	_	_	_	_	O
15	(	_	(	_	(	60	_	_	_	_	_	_	_	O
16	tailored	_	tailor	_	VBN	60	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	60	_	_	_	_	_	_	_	O
18	individual	_	individual	_	JJ	60	_	_	_	_	_	_	_	O
19	needs	_	need	_	NNS	60	_	_	_	_	_	_	_	O
20	)	_	)	_	)	60	_	_	_	_	_	_	_	O
21	,	_	,	_	,	60	_	_	_	_	_	_	_	O
22	until	_	until	_	IN	60	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	60	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	60	_	_	_	_	_	_	_	O
26	stable	_	stable	_	JJ	60	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	60	_	_	_	_	_	_	_	O
28	unchanging	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	60	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	JJ	60	_	_	_	_	_	_	_	O
31	intervals	_	interval	_	NNS	60	_	_	_	_	_	_	_	O
32	once	_	once	_	IN	60	_	_	_	_	_	_	_	O
33	the	_	the	_	DT	60	_	_	_	_	_	_	_	O
34	hba1c	_	UNK	_	NNP	60	_	_	_	_	_	_	_	O
35	level	_	level	_	NN	60	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	60	_	_	_	_	_	_	_	O
37	blood	_	blood	_	NN	60	_	_	_	_	_	_	_	O
38	glucose	_	UNK	_	NN	60	_	_	_	_	_	_	_	O
39	lowering	_	lower	_	VBG	60	_	_	_	_	_	_	_	O
40	therapy	_	therapy	_	NN	60	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
41	are	_	be	_	VBP	60	_	_	_	_	_	_	_	O
42	stable	_	stable	_	JJ	60	_	_	_	_	_	_	_	O
43	.	_	.	_	.	60	_	_	_	_	_	_	_	O

1	use	_	UNK	_	NNP	61	_	_	_	_	_	_	_	S-Purpose
2	methods	_	method	_	NNS	61	_	_	_	_	_	method.n	Means	S-Means
3	to	_	to	_	TO	61	_	_	_	_	_	_	_	O
4	measure	_	measure	_	VB	61	_	_	_	_	_	_	_	O
5	hba1c	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
6	that	_	that	_	WDT	61	_	_	_	_	_	_	_	O
7	have	_	have	_	VBP	61	_	_	_	_	_	_	_	O
8	been	_	be	_	VBN	61	_	_	_	_	_	_	_	O
9	calibrated	_	UNK	_	VBN	61	_	_	_	_	_	_	_	O
10	according	_	accord	_	VBG	61	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	61	_	_	_	_	_	_	_	O

1	use	_	UNK	_	NNP	61	_	_	_	_	_	_	_	O
2	methods	_	method	_	NNS	61	_	_	_	_	_	_	_	O
3	to	_	to	_	TO	61	_	_	_	_	_	_	_	O
4	measure	_	measure	_	VB	61	_	_	_	_	_	measure.v	Dimension	S-Dimension
5	hba1c	_	UNK	_	NNP	61	_	_	_	_	_	_	_	S-Object
6	that	_	that	_	WDT	61	_	_	_	_	_	_	_	O
7	have	_	have	_	VBP	61	_	_	_	_	_	_	_	O
8	been	_	be	_	VBN	61	_	_	_	_	_	_	_	O
9	calibrated	_	UNK	_	VBN	61	_	_	_	_	_	_	_	O
10	according	_	accord	_	VBG	61	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	61	_	_	_	_	_	_	_	O

1	use	_	UNK	_	NNP	61	_	_	_	_	_	_	_	B-Obligation
2	methods	_	method	_	NNS	61	_	_	_	_	_	_	_	I-Obligation
3	to	_	to	_	TO	61	_	_	_	_	_	_	_	I-Obligation
4	measure	_	measure	_	VB	61	_	_	_	_	_	_	_	I-Obligation
5	hba1c	_	UNK	_	NNP	61	_	_	_	_	_	_	_	I-Obligation
6	that	_	that	_	WDT	61	_	_	_	_	_	_	_	S-Party_1
7	have	_	have	_	VBP	61	_	_	_	_	_	_	_	O
8	been	_	be	_	VBN	61	_	_	_	_	_	_	_	O
9	calibrated	_	UNK	_	VBN	61	_	_	_	_	_	_	_	O
10	according	_	accord	_	VBG	61	_	_	_	_	_	accord.v	Be_in_agreement_on_action	O
11	to	_	to	_	TO	61	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	62	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	62	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	62	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	62	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	62	_	_	_	_	_	_	_	O
6	:	_	:	_	:	62	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	62	_	_	_	_	_	_	_	O
8	(	_	(	_	(	62	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	62	_	_	_	_	_	_	_	O
10	)	_	)	_	)	62	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	62	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	62	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	62	_	_	_	_	_	_	_	O
14	)	_	)	_	)	62	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	62	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	62	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	62	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	62	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	62	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	62	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	62	_	_	_	_	_	_	_	O
8	(	_	(	_	(	62	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	62	_	_	_	_	_	_	_	O
10	)	_	)	_	)	62	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	62	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	62	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	62	_	_	_	_	_	_	_	O
14	)	_	)	_	)	62	_	_	_	_	_	_	_	O

1	investigate	_	UNK	_	NNP	63	_	_	_	_	_	_	_	O
2	unexplained	_	UNK	_	JJ	63	_	_	_	_	_	_	_	O
3	discrepancies	_	UNK	_	NNS	63	_	_	_	_	_	_	_	O
4	between	_	between	_	IN	63	_	_	_	_	_	_	_	O
5	hba1c	_	UNK	_	NNP	63	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	63	_	_	_	_	_	_	_	O
7	other	_	other	_	JJ	63	_	_	_	_	_	other.a	Increment	O
8	glucose	_	UNK	_	NN	63	_	_	_	_	_	_	_	B-Class
9	measurements	_	measurement	_	NNS	63	_	_	_	_	_	_	_	I-Class

1	involve	_	UNK	_	NNP	64	_	_	_	_	_	_	_	S-Descriptor
2	adults	_	adult	_	NNS	64	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	64	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	64	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	64	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	64	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	64	_	_	_	_	_	_	_	O
8	decisions	_	decision	_	NNS	64	_	_	_	_	_	_	_	O
9	about	_	about	_	IN	64	_	_	_	_	_	_	_	O
10	their	_	their	_	PRP$	64	_	_	_	_	_	_	_	O
11	individual	_	individual	_	JJ	64	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	64	_	_	_	_	_	_	_	O
13	target	_	target	_	NN	64	_	_	_	_	_	_	_	O

1	involve	_	UNK	_	NNP	64	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	64	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	64	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	64	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	64	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	64	_	_	_	_	_	_	_	I-Category
7	in	_	in	_	IN	64	_	_	_	_	_	_	_	O
8	decisions	_	decision	_	NNS	64	_	_	_	_	_	_	_	O
9	about	_	about	_	IN	64	_	_	_	_	_	_	_	O
10	their	_	their	_	PRP$	64	_	_	_	_	_	_	_	O
11	individual	_	individual	_	JJ	64	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	64	_	_	_	_	_	_	_	O
13	target	_	target	_	NN	64	_	_	_	_	_	_	_	O

1	involve	_	UNK	_	NNP	64	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	64	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	64	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	64	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	64	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	64	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	64	_	_	_	_	_	_	_	O
8	decisions	_	decision	_	NNS	64	_	_	_	_	_	decision.n	Deciding	O
9	about	_	about	_	IN	64	_	_	_	_	_	_	_	O
10	their	_	their	_	PRP$	64	_	_	_	_	_	_	_	O
11	individual	_	individual	_	JJ	64	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	64	_	_	_	_	_	_	_	O
13	target	_	target	_	NN	64	_	_	_	_	_	_	_	O

1	involve	_	UNK	_	NNP	64	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	64	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	64	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	64	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	64	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	64	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	64	_	_	_	_	_	_	_	O
8	decisions	_	decision	_	NNS	64	_	_	_	_	_	_	_	O
9	about	_	about	_	IN	64	_	_	_	_	_	_	_	O
10	their	_	their	_	PRP$	64	_	_	_	_	_	_	_	O
11	individual	_	individual	_	JJ	64	_	_	_	_	_	individual.n	People	B-Person
12	hba1c	_	UNK	_	NNP	64	_	_	_	_	_	_	_	I-Person
13	target	_	target	_	NN	64	_	_	_	_	_	_	_	I-Person

1	encourage	_	UNK	_	VB	65	_	_	_	_	_	_	_	O
2	them	_	them	_	PRP	65	_	_	_	_	_	_	_	S-Agent
3	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
4	achieve	_	achieve	_	VB	65	_	_	_	_	_	achieve.v	Accomplishment	O
5	the	_	the	_	DT	65	_	_	_	_	_	_	_	B-Goal
6	target	_	target	_	NN	65	_	_	_	_	_	_	_	I-Goal
7	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
8	maintain	_	maintain	_	VB	65	_	_	_	_	_	_	_	O
9	it	_	it	_	PRP	65	_	_	_	_	_	_	_	O
10	unless	_	unless	_	IN	65	_	_	_	_	_	_	_	O
11	any	_	any	_	DT	65	_	_	_	_	_	_	_	O
12	resulting	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
13	adverse	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
14	effects	_	effect	_	NNS	65	_	_	_	_	_	_	_	O
15	(	_	(	_	(	65	_	_	_	_	_	_	_	O
16	including	_	include	_	VBG	65	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	NN	65	_	_	_	_	_	_	_	O
18	)	_	)	_	)	65	_	_	_	_	_	_	_	O
19	,	_	,	_	,	65	_	_	_	_	_	_	_	O
20	or	_	or	_	CC	65	_	_	_	_	_	_	_	O
21	their	_	their	_	PRP$	65	_	_	_	_	_	_	_	O
22	efforts	_	effort	_	NNS	65	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
24	achieve	_	achieve	_	VB	65	_	_	_	_	_	_	_	O
25	their	_	their	_	PRP$	65	_	_	_	_	_	_	_	O
26	target	_	target	_	NN	65	_	_	_	_	_	_	_	O
27	,	_	,	_	,	65	_	_	_	_	_	_	_	O
28	impair	_	UNK	_	VB	65	_	_	_	_	_	_	_	O
29	their	_	their	_	PRP$	65	_	_	_	_	_	_	_	O
30	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
32	life	_	life	_	NN	65	_	_	_	_	_	_	_	O
33	.	_	.	_	.	65	_	_	_	_	_	_	_	O

1	encourage	_	UNK	_	VB	65	_	_	_	_	_	_	_	O
2	them	_	them	_	PRP	65	_	_	_	_	_	_	_	O
3	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
4	achieve	_	achieve	_	VB	65	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
6	target	_	target	_	NN	65	_	_	_	_	_	_	_	O
7	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
8	maintain	_	maintain	_	VB	65	_	_	_	_	_	maintain.v	Activity_ongoing	O
9	it	_	it	_	PRP	65	_	_	_	_	_	_	_	S-Activity
10	unless	_	unless	_	IN	65	_	_	_	_	_	_	_	O
11	any	_	any	_	DT	65	_	_	_	_	_	_	_	O
12	resulting	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
13	adverse	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
14	effects	_	effect	_	NNS	65	_	_	_	_	_	_	_	O
15	(	_	(	_	(	65	_	_	_	_	_	_	_	O
16	including	_	include	_	VBG	65	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	NN	65	_	_	_	_	_	_	_	O
18	)	_	)	_	)	65	_	_	_	_	_	_	_	O
19	,	_	,	_	,	65	_	_	_	_	_	_	_	O
20	or	_	or	_	CC	65	_	_	_	_	_	_	_	O
21	their	_	their	_	PRP$	65	_	_	_	_	_	_	_	O
22	efforts	_	effort	_	NNS	65	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
24	achieve	_	achieve	_	VB	65	_	_	_	_	_	_	_	O
25	their	_	their	_	PRP$	65	_	_	_	_	_	_	_	O
26	target	_	target	_	NN	65	_	_	_	_	_	_	_	O
27	,	_	,	_	,	65	_	_	_	_	_	_	_	O
28	impair	_	UNK	_	VB	65	_	_	_	_	_	_	_	O
29	their	_	their	_	PRP$	65	_	_	_	_	_	_	_	O
30	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
32	life	_	life	_	NN	65	_	_	_	_	_	_	_	O
33	.	_	.	_	.	65	_	_	_	_	_	_	_	O

1	encourage	_	UNK	_	VB	65	_	_	_	_	_	_	_	O
2	them	_	them	_	PRP	65	_	_	_	_	_	_	_	O
3	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
4	achieve	_	achieve	_	VB	65	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
6	target	_	target	_	NN	65	_	_	_	_	_	_	_	O
7	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
8	maintain	_	maintain	_	VB	65	_	_	_	_	_	_	_	O
9	it	_	it	_	PRP	65	_	_	_	_	_	_	_	O
10	unless	_	unless	_	IN	65	_	_	_	_	_	_	_	O
11	any	_	any	_	DT	65	_	_	_	_	_	_	_	O
12	resulting	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
13	adverse	_	UNK	_	JJ	65	_	_	_	_	_	_	_	S-Manner
14	effects	_	effect	_	NNS	65	_	_	_	_	_	effect.n	Objective_influence	O
15	(	_	(	_	(	65	_	_	_	_	_	_	_	O
16	including	_	include	_	VBG	65	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	NN	65	_	_	_	_	_	_	_	O
18	)	_	)	_	)	65	_	_	_	_	_	_	_	O
19	,	_	,	_	,	65	_	_	_	_	_	_	_	O
20	or	_	or	_	CC	65	_	_	_	_	_	_	_	O
21	their	_	their	_	PRP$	65	_	_	_	_	_	_	_	O
22	efforts	_	effort	_	NNS	65	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
24	achieve	_	achieve	_	VB	65	_	_	_	_	_	_	_	O
25	their	_	their	_	PRP$	65	_	_	_	_	_	_	_	O
26	target	_	target	_	NN	65	_	_	_	_	_	_	_	O
27	,	_	,	_	,	65	_	_	_	_	_	_	_	O
28	impair	_	UNK	_	VB	65	_	_	_	_	_	_	_	O
29	their	_	their	_	PRP$	65	_	_	_	_	_	_	_	O
30	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
32	life	_	life	_	NN	65	_	_	_	_	_	_	_	O
33	.	_	.	_	.	65	_	_	_	_	_	_	_	O

1	encourage	_	UNK	_	VB	65	_	_	_	_	_	_	_	O
2	them	_	them	_	PRP	65	_	_	_	_	_	_	_	O
3	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
4	achieve	_	achieve	_	VB	65	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
6	target	_	target	_	NN	65	_	_	_	_	_	_	_	O
7	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
8	maintain	_	maintain	_	VB	65	_	_	_	_	_	_	_	O
9	it	_	it	_	PRP	65	_	_	_	_	_	_	_	O
10	unless	_	unless	_	IN	65	_	_	_	_	_	_	_	O
11	any	_	any	_	DT	65	_	_	_	_	_	_	_	B-Total
12	resulting	_	UNK	_	JJ	65	_	_	_	_	_	_	_	I-Total
13	adverse	_	UNK	_	JJ	65	_	_	_	_	_	_	_	I-Total
14	effects	_	effect	_	NNS	65	_	_	_	_	_	_	_	I-Total
15	(	_	(	_	(	65	_	_	_	_	_	_	_	O
16	including	_	include	_	VBG	65	_	_	_	_	_	include.v	Inclusion	O
17	unk	_	UNK	_	NN	65	_	_	_	_	_	_	_	S-Part
18	)	_	)	_	)	65	_	_	_	_	_	_	_	O
19	,	_	,	_	,	65	_	_	_	_	_	_	_	O
20	or	_	or	_	CC	65	_	_	_	_	_	_	_	O
21	their	_	their	_	PRP$	65	_	_	_	_	_	_	_	O
22	efforts	_	effort	_	NNS	65	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
24	achieve	_	achieve	_	VB	65	_	_	_	_	_	_	_	O
25	their	_	their	_	PRP$	65	_	_	_	_	_	_	_	O
26	target	_	target	_	NN	65	_	_	_	_	_	_	_	O
27	,	_	,	_	,	65	_	_	_	_	_	_	_	O
28	impair	_	UNK	_	VB	65	_	_	_	_	_	_	_	O
29	their	_	their	_	PRP$	65	_	_	_	_	_	_	_	O
30	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
32	life	_	life	_	NN	65	_	_	_	_	_	_	_	O
33	.	_	.	_	.	65	_	_	_	_	_	_	_	O

1	encourage	_	UNK	_	VB	65	_	_	_	_	_	_	_	O
2	them	_	them	_	PRP	65	_	_	_	_	_	_	_	O
3	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
4	achieve	_	achieve	_	VB	65	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
6	target	_	target	_	NN	65	_	_	_	_	_	_	_	O
7	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
8	maintain	_	maintain	_	VB	65	_	_	_	_	_	_	_	O
9	it	_	it	_	PRP	65	_	_	_	_	_	_	_	O
10	unless	_	unless	_	IN	65	_	_	_	_	_	_	_	O
11	any	_	any	_	DT	65	_	_	_	_	_	_	_	O
12	resulting	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
13	adverse	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
14	effects	_	effect	_	NNS	65	_	_	_	_	_	_	_	O
15	(	_	(	_	(	65	_	_	_	_	_	_	_	O
16	including	_	include	_	VBG	65	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	NN	65	_	_	_	_	_	_	_	O
18	)	_	)	_	)	65	_	_	_	_	_	_	_	O
19	,	_	,	_	,	65	_	_	_	_	_	_	_	O
20	or	_	or	_	CC	65	_	_	_	_	_	_	_	O
21	their	_	their	_	PRP$	65	_	_	_	_	_	_	_	S-Agent
22	efforts	_	effort	_	NNS	65	_	_	_	_	_	effort.n	Attempt	O
23	to	_	to	_	TO	65	_	_	_	_	_	_	_	B-Goal
24	achieve	_	achieve	_	VB	65	_	_	_	_	_	_	_	I-Goal
25	their	_	their	_	PRP$	65	_	_	_	_	_	_	_	I-Goal
26	target	_	target	_	NN	65	_	_	_	_	_	_	_	I-Goal
27	,	_	,	_	,	65	_	_	_	_	_	_	_	O
28	impair	_	UNK	_	VB	65	_	_	_	_	_	_	_	O
29	their	_	their	_	PRP$	65	_	_	_	_	_	_	_	O
30	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	65	_	_	_	_	_	_	_	O
32	life	_	life	_	NN	65	_	_	_	_	_	_	_	O
33	.	_	.	_	.	65	_	_	_	_	_	_	_	O

1	encourage	_	UNK	_	VB	65	_	_	_	_	_	_	_	O
2	them	_	them	_	PRP	65	_	_	_	_	_	_	_	O
3	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
4	achieve	_	achieve	_	VB	65	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	65	_	_	_	_	_	_	_	O
6	target	_	target	_	NN	65	_	_	_	_	_	_	_	O
7	and	_	and	_	CC	65	_	_	_	_	_	_	_	O
8	maintain	_	maintain	_	VB	65	_	_	_	_	_	_	_	O
9	it	_	it	_	PRP	65	_	_	_	_	_	_	_	O
10	unless	_	unless	_	IN	65	_	_	_	_	_	_	_	O
11	any	_	any	_	DT	65	_	_	_	_	_	_	_	O
12	resulting	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
13	adverse	_	UNK	_	JJ	65	_	_	_	_	_	_	_	O
14	effects	_	effect	_	NNS	65	_	_	_	_	_	_	_	O
15	(	_	(	_	(	65	_	_	_	_	_	_	_	O
16	including	_	include	_	VBG	65	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	NN	65	_	_	_	_	_	_	_	O
18	)	_	)	_	)	65	_	_	_	_	_	_	_	O
19	,	_	,	_	,	65	_	_	_	_	_	_	_	O
20	or	_	or	_	CC	65	_	_	_	_	_	_	_	O
21	their	_	their	_	PRP$	65	_	_	_	_	_	_	_	S-Agent
22	efforts	_	effort	_	NNS	65	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	65	_	_	_	_	_	_	_	O
24	achieve	_	achieve	_	VB	65	_	_	_	_	_	achieve.v	Accomplishment	O
25	their	_	their	_	PRP$	65	_	_	_	_	_	_	_	B-Goal
26	target	_	target	_	NN	65	_	_	_	_	_	_	_	I-Goal
27	,	_	,	_	,	65	_	_	_	_	_	_	_	O
28	impair	_	UNK	_	VB	65	_	_	_	_	_	_	_	B-Goal
29	their	_	their	_	PRP$	65	_	_	_	_	_	_	_	I-Goal
30	quality	_	quality	_	NN	65	_	_	_	_	_	_	_	I-Goal
31	of	_	of	_	IN	65	_	_	_	_	_	_	_	I-Goal
32	life	_	life	_	NN	65	_	_	_	_	_	_	_	I-Goal
33	.	_	.	_	.	65	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	66	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	66	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	66	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	66	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	66	_	_	_	_	_	_	_	S-Patient
6	treatment	_	treatment	_	NN	66	_	_	_	_	_	treatment.n	Cure	O
7	to	_	to	_	TO	66	_	_	_	_	_	_	_	O
8	support	_	support	_	VB	66	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	66	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	66	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	66	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	66	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	66	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	66	_	_	_	_	_	_	_	O
15	achieve	_	achieve	_	VB	66	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	66	_	_	_	_	_	_	_	O
17	maintain	_	maintain	_	VB	66	_	_	_	_	_	_	_	O
18	their	_	their	_	PRP$	66	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	66	_	_	_	_	_	_	_	O
20	target	_	target	_	NN	66	_	_	_	_	_	_	_	O
21	(	_	(	_	(	66	_	_	_	_	_	_	_	O
22	see	_	see	_	VB	66	_	_	_	_	_	_	_	O
23	section	_	section	_	NN	66	_	_	_	_	_	_	_	O
24	)	_	)	_	)	66	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	66	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	66	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	66	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	66	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	66	_	_	_	_	_	_	_	O
6	treatment	_	treatment	_	NN	66	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	66	_	_	_	_	_	_	_	O
8	support	_	support	_	VB	66	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	66	_	_	_	_	_	adult.n	People_by_age	S-Person
10	with	_	with	_	IN	66	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	66	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	66	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	66	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	66	_	_	_	_	_	_	_	O
15	achieve	_	achieve	_	VB	66	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	66	_	_	_	_	_	_	_	O
17	maintain	_	maintain	_	VB	66	_	_	_	_	_	_	_	O
18	their	_	their	_	PRP$	66	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	66	_	_	_	_	_	_	_	O
20	target	_	target	_	NN	66	_	_	_	_	_	_	_	O
21	(	_	(	_	(	66	_	_	_	_	_	_	_	O
22	see	_	see	_	VB	66	_	_	_	_	_	_	_	O
23	section	_	section	_	NN	66	_	_	_	_	_	_	_	O
24	)	_	)	_	)	66	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	66	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	66	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	66	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	66	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	66	_	_	_	_	_	_	_	O
6	treatment	_	treatment	_	NN	66	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	66	_	_	_	_	_	_	_	O
8	support	_	support	_	VB	66	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	66	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	66	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	66	_	_	_	_	_	type.n	Type	S-Subtype
12	2	_	2	_	CD	66	_	_	_	_	_	_	_	B-Category
13	diabetes	_	UNK	_	NNS	66	_	_	_	_	_	_	_	I-Category
14	to	_	to	_	TO	66	_	_	_	_	_	_	_	O
15	achieve	_	achieve	_	VB	66	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	66	_	_	_	_	_	_	_	O
17	maintain	_	maintain	_	VB	66	_	_	_	_	_	_	_	O
18	their	_	their	_	PRP$	66	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	66	_	_	_	_	_	_	_	O
20	target	_	target	_	NN	66	_	_	_	_	_	_	_	O
21	(	_	(	_	(	66	_	_	_	_	_	_	_	O
22	see	_	see	_	VB	66	_	_	_	_	_	_	_	O
23	section	_	section	_	NN	66	_	_	_	_	_	_	_	O
24	)	_	)	_	)	66	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	66	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	66	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	66	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	66	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	66	_	_	_	_	_	_	_	O
6	treatment	_	treatment	_	NN	66	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	66	_	_	_	_	_	_	_	O
8	support	_	support	_	VB	66	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	66	_	_	_	_	_	_	_	B-Agent
10	with	_	with	_	IN	66	_	_	_	_	_	_	_	I-Agent
11	type	_	type	_	JJ	66	_	_	_	_	_	_	_	I-Agent
12	2	_	2	_	CD	66	_	_	_	_	_	_	_	I-Agent
13	diabetes	_	UNK	_	NNS	66	_	_	_	_	_	_	_	I-Agent
14	to	_	to	_	TO	66	_	_	_	_	_	_	_	O
15	achieve	_	achieve	_	VB	66	_	_	_	_	_	achieve.v	Accomplishment	O
16	and	_	and	_	CC	66	_	_	_	_	_	_	_	O
17	maintain	_	maintain	_	VB	66	_	_	_	_	_	_	_	O
18	their	_	their	_	PRP$	66	_	_	_	_	_	_	_	B-Goal
19	hba1c	_	UNK	_	NNP	66	_	_	_	_	_	_	_	I-Goal
20	target	_	target	_	NN	66	_	_	_	_	_	_	_	I-Goal
21	(	_	(	_	(	66	_	_	_	_	_	_	_	O
22	see	_	see	_	VB	66	_	_	_	_	_	_	_	O
23	section	_	section	_	NN	66	_	_	_	_	_	_	_	O
24	)	_	)	_	)	66	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	66	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	66	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	66	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	66	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	66	_	_	_	_	_	_	_	O
6	treatment	_	treatment	_	NN	66	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	66	_	_	_	_	_	_	_	O
8	support	_	support	_	VB	66	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	66	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	66	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	66	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	66	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	66	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	66	_	_	_	_	_	_	_	O
15	achieve	_	achieve	_	VB	66	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	66	_	_	_	_	_	_	_	O
17	maintain	_	maintain	_	VB	66	_	_	_	_	_	maintain.v	Activity_ongoing	O
18	their	_	their	_	PRP$	66	_	_	_	_	_	_	_	B-Activity
19	hba1c	_	UNK	_	NNP	66	_	_	_	_	_	_	_	I-Activity
20	target	_	target	_	NN	66	_	_	_	_	_	_	_	I-Activity
21	(	_	(	_	(	66	_	_	_	_	_	_	_	O
22	see	_	see	_	VB	66	_	_	_	_	_	_	_	O
23	section	_	section	_	NN	66	_	_	_	_	_	_	_	O
24	)	_	)	_	)	66	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	66	_	_	_	_	_	_	_	O
2	lifestyle	_	lifestyle	_	JJ	66	_	_	_	_	_	_	_	O
3	advice	_	advice	_	NN	66	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	66	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	66	_	_	_	_	_	_	_	O
6	treatment	_	treatment	_	NN	66	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	66	_	_	_	_	_	_	_	O
8	support	_	support	_	VB	66	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	66	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	66	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	66	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	66	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	66	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	66	_	_	_	_	_	_	_	O
15	achieve	_	achieve	_	VB	66	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	66	_	_	_	_	_	_	_	O
17	maintain	_	maintain	_	VB	66	_	_	_	_	_	_	_	O
18	their	_	their	_	PRP$	66	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	66	_	_	_	_	_	_	_	O
20	target	_	target	_	NN	66	_	_	_	_	_	_	_	O
21	(	_	(	_	(	66	_	_	_	_	_	_	_	O
22	see	_	see	_	VB	66	_	_	_	_	_	_	_	O
23	section	_	section	_	NN	66	_	_	_	_	_	section.n	Part_whole	S-Part
24	)	_	)	_	)	66	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	67	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	67	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
7	managed	_	manage	_	VBD	67	_	_	_	_	_	_	_	O
8	either	_	either	_	RB	67	_	_	_	_	_	_	_	O
9	by	_	by	_	IN	67	_	_	_	_	_	_	_	O
10	lifestyle	_	lifestyle	_	NN	67	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
12	diet	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
13	,	_	,	_	,	67	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	67	_	_	_	_	_	_	_	O
16	lifestyle	_	lifestyle	_	JJ	67	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
18	diet	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
19	combined	_	combine	_	VBN	67	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
22	single	_	single	_	JJ	67	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	67	_	_	_	_	_	_	_	O
24	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
25	associated	_	associate	_	VBN	67	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
27	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
28	,	_	,	_	,	67	_	_	_	_	_	_	_	O
29	support	_	support	_	VB	67	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	67	_	_	_	_	_	_	_	O
31	person	_	person	_	NN	67	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	67	_	_	_	_	_	_	_	O
33	aim	_	aim	_	VB	67	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	67	_	_	_	_	_	_	_	O
35	an	_	an	_	DT	67	_	_	_	_	_	_	_	O
36	hba1c	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
37	level	_	level	_	NN	67	_	_	_	_	_	_	_	O
38	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
39	48	_	48	_	CD	67	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
41	(	_	(	_	(	67	_	_	_	_	_	_	_	O
42	%	_	%	_	NN	67	_	_	_	_	_	_	_	O
43	)	_	)	_	)	67	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	67	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	67	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
7	managed	_	manage	_	VBD	67	_	_	_	_	_	_	_	O
8	either	_	either	_	RB	67	_	_	_	_	_	_	_	O
9	by	_	by	_	IN	67	_	_	_	_	_	_	_	O
10	lifestyle	_	lifestyle	_	NN	67	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
12	diet	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
13	,	_	,	_	,	67	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	67	_	_	_	_	_	_	_	O
16	lifestyle	_	lifestyle	_	JJ	67	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
18	diet	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
19	combined	_	combine	_	VBN	67	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
22	single	_	single	_	JJ	67	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	67	_	_	_	_	_	_	_	O
24	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
25	associated	_	associate	_	VBN	67	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
27	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
28	,	_	,	_	,	67	_	_	_	_	_	_	_	O
29	support	_	support	_	VB	67	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	67	_	_	_	_	_	_	_	O
31	person	_	person	_	NN	67	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	67	_	_	_	_	_	_	_	O
33	aim	_	aim	_	VB	67	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	67	_	_	_	_	_	_	_	O
35	an	_	an	_	DT	67	_	_	_	_	_	_	_	O
36	hba1c	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
37	level	_	level	_	NN	67	_	_	_	_	_	_	_	O
38	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
39	48	_	48	_	CD	67	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
41	(	_	(	_	(	67	_	_	_	_	_	_	_	O
42	%	_	%	_	NN	67	_	_	_	_	_	_	_	O
43	)	_	)	_	)	67	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	67	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	B-Agent
3	with	_	with	_	IN	67	_	_	_	_	_	_	_	I-Agent
4	type	_	type	_	JJ	67	_	_	_	_	_	_	_	I-Agent
5	2	_	2	_	CD	67	_	_	_	_	_	_	_	I-Agent
6	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	I-Agent
7	managed	_	manage	_	VBD	67	_	_	_	_	_	manage.v	Success_or_failure	O
8	either	_	either	_	RB	67	_	_	_	_	_	_	_	B-Goal
9	by	_	by	_	IN	67	_	_	_	_	_	_	_	I-Goal
10	lifestyle	_	lifestyle	_	NN	67	_	_	_	_	_	_	_	I-Goal
11	and	_	and	_	CC	67	_	_	_	_	_	_	_	I-Goal
12	diet	_	UNK	_	JJ	67	_	_	_	_	_	_	_	I-Goal
13	,	_	,	_	,	67	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	67	_	_	_	_	_	_	_	O
16	lifestyle	_	lifestyle	_	JJ	67	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
18	diet	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
19	combined	_	combine	_	VBN	67	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
22	single	_	single	_	JJ	67	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	67	_	_	_	_	_	_	_	O
24	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
25	associated	_	associate	_	VBN	67	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
27	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
28	,	_	,	_	,	67	_	_	_	_	_	_	_	O
29	support	_	support	_	VB	67	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	67	_	_	_	_	_	_	_	O
31	person	_	person	_	NN	67	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	67	_	_	_	_	_	_	_	O
33	aim	_	aim	_	VB	67	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	67	_	_	_	_	_	_	_	O
35	an	_	an	_	DT	67	_	_	_	_	_	_	_	O
36	hba1c	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
37	level	_	level	_	NN	67	_	_	_	_	_	_	_	O
38	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
39	48	_	48	_	CD	67	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
41	(	_	(	_	(	67	_	_	_	_	_	_	_	O
42	%	_	%	_	NN	67	_	_	_	_	_	_	_	O
43	)	_	)	_	)	67	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	67	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
7	managed	_	manage	_	VBD	67	_	_	_	_	_	_	_	O
8	either	_	either	_	RB	67	_	_	_	_	_	_	_	O
9	by	_	by	_	IN	67	_	_	_	_	_	_	_	O
10	lifestyle	_	lifestyle	_	NN	67	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
12	diet	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
13	,	_	,	_	,	67	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	67	_	_	_	_	_	_	_	O
16	lifestyle	_	lifestyle	_	JJ	67	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
18	diet	_	UNK	_	JJ	67	_	_	_	_	_	_	_	S-Part_1
19	combined	_	combine	_	VBN	67	_	_	_	_	_	combine.v	Cause_to_amalgamate	O
20	with	_	with	_	IN	67	_	_	_	_	_	_	_	B-Part_2
21	a	_	a	_	DT	67	_	_	_	_	_	_	_	I-Part_2
22	single	_	single	_	JJ	67	_	_	_	_	_	_	_	I-Part_2
23	drug	_	drug	_	NN	67	_	_	_	_	_	_	_	I-Part_2
24	not	_	not	_	RB	67	_	_	_	_	_	_	_	I-Part_2
25	associated	_	associate	_	VBN	67	_	_	_	_	_	_	_	I-Part_2
26	with	_	with	_	IN	67	_	_	_	_	_	_	_	I-Part_2
27	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	I-Part_2
28	,	_	,	_	,	67	_	_	_	_	_	_	_	O
29	support	_	support	_	VB	67	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	67	_	_	_	_	_	_	_	O
31	person	_	person	_	NN	67	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	67	_	_	_	_	_	_	_	O
33	aim	_	aim	_	VB	67	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	67	_	_	_	_	_	_	_	O
35	an	_	an	_	DT	67	_	_	_	_	_	_	_	O
36	hba1c	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
37	level	_	level	_	NN	67	_	_	_	_	_	_	_	O
38	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
39	48	_	48	_	CD	67	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
41	(	_	(	_	(	67	_	_	_	_	_	_	_	O
42	%	_	%	_	NN	67	_	_	_	_	_	_	_	O
43	)	_	)	_	)	67	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	67	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
7	managed	_	manage	_	VBD	67	_	_	_	_	_	_	_	O
8	either	_	either	_	RB	67	_	_	_	_	_	_	_	O
9	by	_	by	_	IN	67	_	_	_	_	_	_	_	O
10	lifestyle	_	lifestyle	_	NN	67	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
12	diet	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
13	,	_	,	_	,	67	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	67	_	_	_	_	_	_	_	O
16	lifestyle	_	lifestyle	_	JJ	67	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
18	diet	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
19	combined	_	combine	_	VBN	67	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
22	single	_	single	_	JJ	67	_	_	_	_	_	single.a	Sole_instance	O
23	drug	_	drug	_	NN	67	_	_	_	_	_	_	_	S-Type
24	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
25	associated	_	associate	_	VBN	67	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
27	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
28	,	_	,	_	,	67	_	_	_	_	_	_	_	O
29	support	_	support	_	VB	67	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	67	_	_	_	_	_	_	_	O
31	person	_	person	_	NN	67	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	67	_	_	_	_	_	_	_	O
33	aim	_	aim	_	VB	67	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	67	_	_	_	_	_	_	_	O
35	an	_	an	_	DT	67	_	_	_	_	_	_	_	O
36	hba1c	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
37	level	_	level	_	NN	67	_	_	_	_	_	_	_	O
38	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
39	48	_	48	_	CD	67	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
41	(	_	(	_	(	67	_	_	_	_	_	_	_	O
42	%	_	%	_	NN	67	_	_	_	_	_	_	_	O
43	)	_	)	_	)	67	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	67	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
7	managed	_	manage	_	VBD	67	_	_	_	_	_	_	_	O
8	either	_	either	_	RB	67	_	_	_	_	_	_	_	O
9	by	_	by	_	IN	67	_	_	_	_	_	_	_	O
10	lifestyle	_	lifestyle	_	NN	67	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
12	diet	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
13	,	_	,	_	,	67	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	67	_	_	_	_	_	_	_	O
16	lifestyle	_	lifestyle	_	JJ	67	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
18	diet	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
19	combined	_	combine	_	VBN	67	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	67	_	_	_	_	_	_	_	B-Partner_1
22	single	_	single	_	JJ	67	_	_	_	_	_	_	_	I-Partner_1
23	drug	_	drug	_	NN	67	_	_	_	_	_	_	_	I-Partner_1
24	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
25	associated	_	associate	_	VBN	67	_	_	_	_	_	associate.v	Collaboration	O
26	with	_	with	_	IN	67	_	_	_	_	_	_	_	B-Undertaking
27	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	I-Undertaking
28	,	_	,	_	,	67	_	_	_	_	_	_	_	O
29	support	_	support	_	VB	67	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	67	_	_	_	_	_	_	_	O
31	person	_	person	_	NN	67	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	67	_	_	_	_	_	_	_	O
33	aim	_	aim	_	VB	67	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	67	_	_	_	_	_	_	_	O
35	an	_	an	_	DT	67	_	_	_	_	_	_	_	O
36	hba1c	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
37	level	_	level	_	NN	67	_	_	_	_	_	_	_	O
38	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
39	48	_	48	_	CD	67	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
41	(	_	(	_	(	67	_	_	_	_	_	_	_	O
42	%	_	%	_	NN	67	_	_	_	_	_	_	_	O
43	)	_	)	_	)	67	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	67	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
7	managed	_	manage	_	VBD	67	_	_	_	_	_	_	_	O
8	either	_	either	_	RB	67	_	_	_	_	_	_	_	O
9	by	_	by	_	IN	67	_	_	_	_	_	_	_	O
10	lifestyle	_	lifestyle	_	NN	67	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
12	diet	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
13	,	_	,	_	,	67	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	67	_	_	_	_	_	_	_	O
16	lifestyle	_	lifestyle	_	JJ	67	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
18	diet	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
19	combined	_	combine	_	VBN	67	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
22	single	_	single	_	JJ	67	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	67	_	_	_	_	_	_	_	O
24	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
25	associated	_	associate	_	VBN	67	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
27	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
28	,	_	,	_	,	67	_	_	_	_	_	_	_	O
29	support	_	support	_	VB	67	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	67	_	_	_	_	_	_	_	O
31	person	_	person	_	NN	67	_	_	_	_	_	person.n	People	S-Person
32	to	_	to	_	TO	67	_	_	_	_	_	_	_	O
33	aim	_	aim	_	VB	67	_	_	_	_	_	_	_	O
34	for	_	for	_	IN	67	_	_	_	_	_	_	_	O
35	an	_	an	_	DT	67	_	_	_	_	_	_	_	O
36	hba1c	_	UNK	_	NNP	67	_	_	_	_	_	_	_	O
37	level	_	level	_	NN	67	_	_	_	_	_	_	_	O
38	of	_	of	_	IN	67	_	_	_	_	_	_	_	O
39	48	_	48	_	CD	67	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
41	(	_	(	_	(	67	_	_	_	_	_	_	_	O
42	%	_	%	_	NN	67	_	_	_	_	_	_	_	O
43	)	_	)	_	)	67	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	67	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	67	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	67	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	67	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	67	_	_	_	_	_	_	_	O
7	managed	_	manage	_	VBD	67	_	_	_	_	_	_	_	O
8	either	_	either	_	RB	67	_	_	_	_	_	_	_	O
9	by	_	by	_	IN	67	_	_	_	_	_	_	_	O
10	lifestyle	_	lifestyle	_	NN	67	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
12	diet	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
13	,	_	,	_	,	67	_	_	_	_	_	_	_	O
14	or	_	or	_	CC	67	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	67	_	_	_	_	_	_	_	O
16	lifestyle	_	lifestyle	_	JJ	67	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	67	_	_	_	_	_	_	_	O
18	diet	_	UNK	_	JJ	67	_	_	_	_	_	_	_	O
19	combined	_	combine	_	VBN	67	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
21	a	_	a	_	DT	67	_	_	_	_	_	_	_	O
22	single	_	single	_	JJ	67	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	67	_	_	_	_	_	_	_	O
24	not	_	not	_	RB	67	_	_	_	_	_	_	_	O
25	associated	_	associate	_	VBN	67	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	67	_	_	_	_	_	_	_	O
27	unk	_	UNK	_	NN	67	_	_	_	_	_	_	_	O
28	,	_	,	_	,	67	_	_	_	_	_	_	_	O
29	support	_	support	_	VB	67	_	_	_	_	_	_	_	O
30	the	_	the	_	DT	67	_	_	_	_	_	_	_	B-Agent
31	person	_	person	_	NN	67	_	_	_	_	_	_	_	I-Agent
32	to	_	to	_	TO	67	_	_	_	_	_	_	_	O
33	aim	_	aim	_	VB	67	_	_	_	_	_	aim.v	Purpose	O
34	for	_	for	_	IN	67	_	_	_	_	_	_	_	B-Goal
35	an	_	an	_	DT	67	_	_	_	_	_	_	_	I-Goal
36	hba1c	_	UNK	_	NNP	67	_	_	_	_	_	_	_	I-Goal
37	level	_	level	_	NN	67	_	_	_	_	_	_	_	I-Goal
38	of	_	of	_	IN	67	_	_	_	_	_	_	_	I-Goal
39	48	_	48	_	CD	67	_	_	_	_	_	_	_	I-Goal
40	unk	_	UNK	_	NNS	67	_	_	_	_	_	_	_	I-Goal
41	(	_	(	_	(	67	_	_	_	_	_	_	_	O
42	%	_	%	_	NN	67	_	_	_	_	_	_	_	O
43	)	_	)	_	)	67	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	68	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	68	_	_	_	_	_	adult.n	People_by_age	S-Person
3	on	_	on	_	IN	68	_	_	_	_	_	_	_	O
4	a	_	a	_	DT	68	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	68	_	_	_	_	_	_	_	O
6	associated	_	associate	_	VBN	68	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	68	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
9	,	_	,	_	,	68	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	68	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	68	_	_	_	_	_	_	_	O
14	aim	_	aim	_	VB	68	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	68	_	_	_	_	_	_	_	O
16	an	_	an	_	DT	68	_	_	_	_	_	_	_	O
17	hba1c	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
18	level	_	level	_	NN	68	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	68	_	_	_	_	_	_	_	O
20	53	_	53	_	CD	68	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
22	(	_	(	_	(	68	_	_	_	_	_	_	_	O
23	%	_	%	_	NN	68	_	_	_	_	_	_	_	O
24	)	_	)	_	)	68	_	_	_	_	_	_	_	O
25	.	_	.	_	.	68	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	68	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	68	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	68	_	_	_	_	_	_	_	O
4	a	_	a	_	DT	68	_	_	_	_	_	_	_	B-Partner_1
5	drug	_	drug	_	NN	68	_	_	_	_	_	_	_	I-Partner_1
6	associated	_	associate	_	VBN	68	_	_	_	_	_	associate.v	Collaboration	O
7	with	_	with	_	IN	68	_	_	_	_	_	_	_	B-Undertaking
8	unk	_	UNK	_	NN	68	_	_	_	_	_	_	_	I-Undertaking
9	,	_	,	_	,	68	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	68	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	68	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	68	_	_	_	_	_	_	_	O
14	aim	_	aim	_	VB	68	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	68	_	_	_	_	_	_	_	O
16	an	_	an	_	DT	68	_	_	_	_	_	_	_	O
17	hba1c	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
18	level	_	level	_	NN	68	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	68	_	_	_	_	_	_	_	O
20	53	_	53	_	CD	68	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
22	(	_	(	_	(	68	_	_	_	_	_	_	_	O
23	%	_	%	_	NN	68	_	_	_	_	_	_	_	O
24	)	_	)	_	)	68	_	_	_	_	_	_	_	O
25	.	_	.	_	.	68	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	68	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	68	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	68	_	_	_	_	_	_	_	O
4	a	_	a	_	DT	68	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	68	_	_	_	_	_	_	_	O
6	associated	_	associate	_	VBN	68	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	68	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
9	,	_	,	_	,	68	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	68	_	_	_	_	_	support.v	Supporting	O
11	the	_	the	_	DT	68	_	_	_	_	_	_	_	B-Supported
12	person	_	person	_	NN	68	_	_	_	_	_	_	_	I-Supported
13	to	_	to	_	TO	68	_	_	_	_	_	_	_	I-Supported
14	aim	_	aim	_	VB	68	_	_	_	_	_	_	_	I-Supported
15	for	_	for	_	IN	68	_	_	_	_	_	_	_	I-Supported
16	an	_	an	_	DT	68	_	_	_	_	_	_	_	I-Supported
17	hba1c	_	UNK	_	NNP	68	_	_	_	_	_	_	_	I-Supported
18	level	_	level	_	NN	68	_	_	_	_	_	_	_	I-Supported
19	of	_	of	_	IN	68	_	_	_	_	_	_	_	I-Supported
20	53	_	53	_	CD	68	_	_	_	_	_	_	_	I-Supported
21	unk	_	UNK	_	NNS	68	_	_	_	_	_	_	_	I-Supported
22	(	_	(	_	(	68	_	_	_	_	_	_	_	O
23	%	_	%	_	NN	68	_	_	_	_	_	_	_	O
24	)	_	)	_	)	68	_	_	_	_	_	_	_	O
25	.	_	.	_	.	68	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	68	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	68	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	68	_	_	_	_	_	_	_	O
4	a	_	a	_	DT	68	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	68	_	_	_	_	_	_	_	O
6	associated	_	associate	_	VBN	68	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	68	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
9	,	_	,	_	,	68	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	68	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	68	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	68	_	_	_	_	_	person.n	People	S-Person
13	to	_	to	_	TO	68	_	_	_	_	_	_	_	O
14	aim	_	aim	_	VB	68	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	68	_	_	_	_	_	_	_	O
16	an	_	an	_	DT	68	_	_	_	_	_	_	_	O
17	hba1c	_	UNK	_	NNP	68	_	_	_	_	_	_	_	O
18	level	_	level	_	NN	68	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	68	_	_	_	_	_	_	_	O
20	53	_	53	_	CD	68	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	NNS	68	_	_	_	_	_	_	_	O
22	(	_	(	_	(	68	_	_	_	_	_	_	_	O
23	%	_	%	_	NN	68	_	_	_	_	_	_	_	O
24	)	_	)	_	)	68	_	_	_	_	_	_	_	O
25	.	_	.	_	.	68	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	68	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	68	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	68	_	_	_	_	_	_	_	O
4	a	_	a	_	DT	68	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	68	_	_	_	_	_	_	_	O
6	associated	_	associate	_	VBN	68	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	68	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NN	68	_	_	_	_	_	_	_	O
9	,	_	,	_	,	68	_	_	_	_	_	_	_	O
10	support	_	support	_	VB	68	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	68	_	_	_	_	_	_	_	B-Agent
12	person	_	person	_	NN	68	_	_	_	_	_	_	_	I-Agent
13	to	_	to	_	TO	68	_	_	_	_	_	_	_	O
14	aim	_	aim	_	VB	68	_	_	_	_	_	aim.v	Purpose	O
15	for	_	for	_	IN	68	_	_	_	_	_	_	_	B-Goal
16	an	_	an	_	DT	68	_	_	_	_	_	_	_	I-Goal
17	hba1c	_	UNK	_	NNP	68	_	_	_	_	_	_	_	I-Goal
18	level	_	level	_	NN	68	_	_	_	_	_	_	_	I-Goal
19	of	_	of	_	IN	68	_	_	_	_	_	_	_	I-Goal
20	53	_	53	_	CD	68	_	_	_	_	_	_	_	I-Goal
21	unk	_	UNK	_	NNS	68	_	_	_	_	_	_	_	I-Goal
22	(	_	(	_	(	68	_	_	_	_	_	_	_	O
23	%	_	%	_	NN	68	_	_	_	_	_	_	_	O
24	)	_	)	_	)	68	_	_	_	_	_	_	_	O
25	.	_	.	_	.	68	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	69	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	69	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	69	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	69	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	69	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
7	,	_	,	_	,	69	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	69	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	69	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	69	_	_	_	_	_	_	_	O
11	are	_	be	_	VBP	69	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	69	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	69	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	69	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	69	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	69	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	69	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	69	_	_	_	_	_	_	_	O
21	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
22	58	_	UNK	_	CD	69	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
24	(	_	(	_	(	69	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	69	_	_	_	_	_	_	_	O
26	)	_	)	_	)	69	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	69	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	69	_	_	_	_	_	_	_	O
29	:	_	:	_	:	69	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	69	_	_	_	_	_	_	_	O
31	advice	_	advice	_	NN	69	_	_	_	_	_	_	_	O
32	about	_	about	_	IN	69	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	69	_	_	_	_	_	_	_	O
34	,	_	,	_	,	69	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	69	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	O
40	treatment	_	treatment	_	NN	69	_	_	_	_	_	_	_	O
41	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	69	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	69	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	69	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	69	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	69	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	69	_	_	_	_	_	_	_	O
49	hba1c	_	UNK	_	NNP	69	_	_	_	_	_	_	_	O
50	level	_	level	_	NN	69	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	69	_	_	_	_	_	_	_	O
52	53	_	53	_	CD	69	_	_	_	_	_	_	_	O
53	unk	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
54	(	_	(	_	(	69	_	_	_	_	_	_	_	O
55	%	_	%	_	NN	69	_	_	_	_	_	_	_	O
56	)	_	)	_	)	69	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
58	intensify	_	intensify	_	JJ	69	_	_	_	_	_	_	_	O
59	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	O
60	treatment	_	treatment	_	NN	69	_	_	_	_	_	_	_	O
61	.	_	.	_	.	69	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	69	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	69	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	69	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	69	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	69	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	69	_	_	_	_	_	_	_	I-Category
7	,	_	,	_	,	69	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	69	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	69	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	69	_	_	_	_	_	_	_	O
11	are	_	be	_	VBP	69	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	69	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	69	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	69	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	69	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	69	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	69	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	69	_	_	_	_	_	_	_	O
21	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
22	58	_	UNK	_	CD	69	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
24	(	_	(	_	(	69	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	69	_	_	_	_	_	_	_	O
26	)	_	)	_	)	69	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	69	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	69	_	_	_	_	_	_	_	O
29	:	_	:	_	:	69	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	69	_	_	_	_	_	_	_	O
31	advice	_	advice	_	NN	69	_	_	_	_	_	_	_	O
32	about	_	about	_	IN	69	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	69	_	_	_	_	_	_	_	O
34	,	_	,	_	,	69	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	69	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	O
40	treatment	_	treatment	_	NN	69	_	_	_	_	_	_	_	O
41	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	69	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	69	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	69	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	69	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	69	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	69	_	_	_	_	_	_	_	O
49	hba1c	_	UNK	_	NNP	69	_	_	_	_	_	_	_	O
50	level	_	level	_	NN	69	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	69	_	_	_	_	_	_	_	O
52	53	_	53	_	CD	69	_	_	_	_	_	_	_	O
53	unk	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
54	(	_	(	_	(	69	_	_	_	_	_	_	_	O
55	%	_	%	_	NN	69	_	_	_	_	_	_	_	O
56	)	_	)	_	)	69	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
58	intensify	_	intensify	_	JJ	69	_	_	_	_	_	_	_	O
59	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	O
60	treatment	_	treatment	_	NN	69	_	_	_	_	_	_	_	O
61	.	_	.	_	.	69	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	69	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	69	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	69	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	69	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	69	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
7	,	_	,	_	,	69	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	69	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	69	_	_	_	_	_	_	_	S-Rank
10	levels	_	level	_	NNS	69	_	_	_	_	_	level.n	Rank	O
11	are	_	be	_	VBP	69	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	69	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	69	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	69	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	69	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	69	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	69	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	69	_	_	_	_	_	_	_	O
21	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
22	58	_	UNK	_	CD	69	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
24	(	_	(	_	(	69	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	69	_	_	_	_	_	_	_	O
26	)	_	)	_	)	69	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	69	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	69	_	_	_	_	_	_	_	O
29	:	_	:	_	:	69	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	69	_	_	_	_	_	_	_	O
31	advice	_	advice	_	NN	69	_	_	_	_	_	_	_	O
32	about	_	about	_	IN	69	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	69	_	_	_	_	_	_	_	O
34	,	_	,	_	,	69	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	69	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	O
40	treatment	_	treatment	_	NN	69	_	_	_	_	_	_	_	O
41	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	69	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	69	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	69	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	69	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	69	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	69	_	_	_	_	_	_	_	O
49	hba1c	_	UNK	_	NNP	69	_	_	_	_	_	_	_	O
50	level	_	level	_	NN	69	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	69	_	_	_	_	_	_	_	O
52	53	_	53	_	CD	69	_	_	_	_	_	_	_	O
53	unk	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
54	(	_	(	_	(	69	_	_	_	_	_	_	_	O
55	%	_	%	_	NN	69	_	_	_	_	_	_	_	O
56	)	_	)	_	)	69	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
58	intensify	_	intensify	_	JJ	69	_	_	_	_	_	_	_	O
59	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	O
60	treatment	_	treatment	_	NN	69	_	_	_	_	_	_	_	O
61	.	_	.	_	.	69	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	69	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	69	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	69	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	69	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	69	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
7	,	_	,	_	,	69	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	69	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	69	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	69	_	_	_	_	_	_	_	O
11	are	_	be	_	VBP	69	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	69	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	69	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	69	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	69	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	69	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	69	_	_	_	_	_	single.a	Sole_instance	O
18	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	S-Type
19	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	69	_	_	_	_	_	_	_	O
21	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
22	58	_	UNK	_	CD	69	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
24	(	_	(	_	(	69	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	69	_	_	_	_	_	_	_	O
26	)	_	)	_	)	69	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	69	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	69	_	_	_	_	_	_	_	O
29	:	_	:	_	:	69	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	69	_	_	_	_	_	_	_	O
31	advice	_	advice	_	NN	69	_	_	_	_	_	_	_	O
32	about	_	about	_	IN	69	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	69	_	_	_	_	_	_	_	O
34	,	_	,	_	,	69	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	69	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	O
40	treatment	_	treatment	_	NN	69	_	_	_	_	_	_	_	O
41	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	69	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	69	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	69	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	69	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	69	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	69	_	_	_	_	_	_	_	O
49	hba1c	_	UNK	_	NNP	69	_	_	_	_	_	_	_	O
50	level	_	level	_	NN	69	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	69	_	_	_	_	_	_	_	O
52	53	_	53	_	CD	69	_	_	_	_	_	_	_	O
53	unk	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
54	(	_	(	_	(	69	_	_	_	_	_	_	_	O
55	%	_	%	_	NN	69	_	_	_	_	_	_	_	O
56	)	_	)	_	)	69	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
58	intensify	_	intensify	_	JJ	69	_	_	_	_	_	_	_	O
59	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	O
60	treatment	_	treatment	_	NN	69	_	_	_	_	_	_	_	O
61	.	_	.	_	.	69	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	69	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	69	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	69	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	69	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	69	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
7	,	_	,	_	,	69	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	69	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	69	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	69	_	_	_	_	_	_	_	O
11	are	_	be	_	VBP	69	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	69	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	69	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	69	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	69	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	69	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	69	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	69	_	_	_	_	_	rise.n	Change_position_on_a_scale	O
21	to	_	to	_	TO	69	_	_	_	_	_	_	_	B-Item
22	58	_	UNK	_	CD	69	_	_	_	_	_	_	_	I-Item
23	unk	_	UNK	_	NNS	69	_	_	_	_	_	_	_	I-Item
24	(	_	(	_	(	69	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	69	_	_	_	_	_	_	_	O
26	)	_	)	_	)	69	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	69	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	69	_	_	_	_	_	_	_	O
29	:	_	:	_	:	69	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	69	_	_	_	_	_	_	_	O
31	advice	_	advice	_	NN	69	_	_	_	_	_	_	_	O
32	about	_	about	_	IN	69	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	69	_	_	_	_	_	_	_	O
34	,	_	,	_	,	69	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	69	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	O
40	treatment	_	treatment	_	NN	69	_	_	_	_	_	_	_	O
41	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	69	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	69	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	69	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	69	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	69	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	69	_	_	_	_	_	_	_	O
49	hba1c	_	UNK	_	NNP	69	_	_	_	_	_	_	_	O
50	level	_	level	_	NN	69	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	69	_	_	_	_	_	_	_	O
52	53	_	53	_	CD	69	_	_	_	_	_	_	_	O
53	unk	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
54	(	_	(	_	(	69	_	_	_	_	_	_	_	O
55	%	_	%	_	NN	69	_	_	_	_	_	_	_	O
56	)	_	)	_	)	69	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
58	intensify	_	intensify	_	JJ	69	_	_	_	_	_	_	_	O
59	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	O
60	treatment	_	treatment	_	NN	69	_	_	_	_	_	_	_	O
61	.	_	.	_	.	69	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	69	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	69	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	69	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	69	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	69	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
7	,	_	,	_	,	69	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	69	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	69	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	69	_	_	_	_	_	_	_	O
11	are	_	be	_	VBP	69	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	69	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	69	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	69	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	69	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	69	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	69	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	69	_	_	_	_	_	_	_	O
21	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
22	58	_	UNK	_	CD	69	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
24	(	_	(	_	(	69	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	69	_	_	_	_	_	_	_	O
26	)	_	)	_	)	69	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	69	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	69	_	_	_	_	_	_	_	O
29	:	_	:	_	:	69	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	69	_	_	_	_	_	reinforce.v	Cause_change_of_strength	O
31	advice	_	advice	_	NN	69	_	_	_	_	_	_	_	S-Patient
32	about	_	about	_	IN	69	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	69	_	_	_	_	_	_	_	O
34	,	_	,	_	,	69	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	69	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	O
40	treatment	_	treatment	_	NN	69	_	_	_	_	_	_	_	O
41	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	69	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	69	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	69	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	69	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	69	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	69	_	_	_	_	_	_	_	O
49	hba1c	_	UNK	_	NNP	69	_	_	_	_	_	_	_	O
50	level	_	level	_	NN	69	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	69	_	_	_	_	_	_	_	O
52	53	_	53	_	CD	69	_	_	_	_	_	_	_	O
53	unk	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
54	(	_	(	_	(	69	_	_	_	_	_	_	_	O
55	%	_	%	_	NN	69	_	_	_	_	_	_	_	O
56	)	_	)	_	)	69	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
58	intensify	_	intensify	_	JJ	69	_	_	_	_	_	_	_	O
59	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	O
60	treatment	_	treatment	_	NN	69	_	_	_	_	_	_	_	O
61	.	_	.	_	.	69	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	69	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	69	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	69	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	69	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	69	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
7	,	_	,	_	,	69	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	69	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	69	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	69	_	_	_	_	_	_	_	O
11	are	_	be	_	VBP	69	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	69	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	69	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	69	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	69	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	69	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	69	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	69	_	_	_	_	_	_	_	O
21	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
22	58	_	UNK	_	CD	69	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
24	(	_	(	_	(	69	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	69	_	_	_	_	_	_	_	O
26	)	_	)	_	)	69	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	69	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	69	_	_	_	_	_	_	_	O
29	:	_	:	_	:	69	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	69	_	_	_	_	_	_	_	O
31	advice	_	advice	_	NN	69	_	_	_	_	_	_	_	O
32	about	_	about	_	IN	69	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	69	_	_	_	_	_	_	_	O
34	,	_	,	_	,	69	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	69	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	S-Patient
40	treatment	_	treatment	_	NN	69	_	_	_	_	_	treatment.n	Cure	O
41	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	69	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	69	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	69	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	69	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	69	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	69	_	_	_	_	_	_	_	O
49	hba1c	_	UNK	_	NNP	69	_	_	_	_	_	_	_	O
50	level	_	level	_	NN	69	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	69	_	_	_	_	_	_	_	O
52	53	_	53	_	CD	69	_	_	_	_	_	_	_	O
53	unk	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
54	(	_	(	_	(	69	_	_	_	_	_	_	_	O
55	%	_	%	_	NN	69	_	_	_	_	_	_	_	O
56	)	_	)	_	)	69	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
58	intensify	_	intensify	_	JJ	69	_	_	_	_	_	_	_	O
59	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	O
60	treatment	_	treatment	_	NN	69	_	_	_	_	_	_	_	O
61	.	_	.	_	.	69	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	69	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	69	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	69	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	69	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	69	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
7	,	_	,	_	,	69	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	69	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	69	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	69	_	_	_	_	_	_	_	O
11	are	_	be	_	VBP	69	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	69	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	69	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	69	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	69	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	69	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	69	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	69	_	_	_	_	_	_	_	O
21	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
22	58	_	UNK	_	CD	69	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
24	(	_	(	_	(	69	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	69	_	_	_	_	_	_	_	O
26	)	_	)	_	)	69	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	69	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	69	_	_	_	_	_	_	_	O
29	:	_	:	_	:	69	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	69	_	_	_	_	_	_	_	O
31	advice	_	advice	_	NN	69	_	_	_	_	_	_	_	O
32	about	_	about	_	IN	69	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	69	_	_	_	_	_	_	_	O
34	,	_	,	_	,	69	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	69	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	O
40	treatment	_	treatment	_	NN	69	_	_	_	_	_	_	_	O
41	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	69	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	69	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	69	_	_	_	_	_	person.n	People	S-Person
45	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	69	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	69	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	69	_	_	_	_	_	_	_	O
49	hba1c	_	UNK	_	NNP	69	_	_	_	_	_	_	_	O
50	level	_	level	_	NN	69	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	69	_	_	_	_	_	_	_	O
52	53	_	53	_	CD	69	_	_	_	_	_	_	_	O
53	unk	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
54	(	_	(	_	(	69	_	_	_	_	_	_	_	O
55	%	_	%	_	NN	69	_	_	_	_	_	_	_	O
56	)	_	)	_	)	69	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
58	intensify	_	intensify	_	JJ	69	_	_	_	_	_	_	_	O
59	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	O
60	treatment	_	treatment	_	NN	69	_	_	_	_	_	_	_	O
61	.	_	.	_	.	69	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	69	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	69	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	69	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	69	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	69	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
7	,	_	,	_	,	69	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	69	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	69	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	69	_	_	_	_	_	_	_	O
11	are	_	be	_	VBP	69	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	69	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	69	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	69	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	69	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	69	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	69	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	69	_	_	_	_	_	_	_	O
21	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
22	58	_	UNK	_	CD	69	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
24	(	_	(	_	(	69	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	69	_	_	_	_	_	_	_	O
26	)	_	)	_	)	69	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	69	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	69	_	_	_	_	_	_	_	O
29	:	_	:	_	:	69	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	69	_	_	_	_	_	_	_	O
31	advice	_	advice	_	NN	69	_	_	_	_	_	_	_	O
32	about	_	about	_	IN	69	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	69	_	_	_	_	_	_	_	O
34	,	_	,	_	,	69	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	69	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	O
40	treatment	_	treatment	_	NN	69	_	_	_	_	_	_	_	O
41	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	69	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	69	_	_	_	_	_	_	_	B-Agent
44	person	_	person	_	NN	69	_	_	_	_	_	_	_	I-Agent
45	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	69	_	_	_	_	_	aim.v	Purpose	O
47	for	_	for	_	IN	69	_	_	_	_	_	_	_	B-Goal
48	an	_	an	_	DT	69	_	_	_	_	_	_	_	I-Goal
49	hba1c	_	UNK	_	NNP	69	_	_	_	_	_	_	_	I-Goal
50	level	_	level	_	NN	69	_	_	_	_	_	_	_	I-Goal
51	of	_	of	_	IN	69	_	_	_	_	_	_	_	I-Goal
52	53	_	53	_	CD	69	_	_	_	_	_	_	_	I-Goal
53	unk	_	UNK	_	NNS	69	_	_	_	_	_	_	_	I-Goal
54	(	_	(	_	(	69	_	_	_	_	_	_	_	I-Goal
55	%	_	%	_	NN	69	_	_	_	_	_	_	_	I-Goal
56	)	_	)	_	)	69	_	_	_	_	_	_	_	I-Goal
57	and	_	and	_	CC	69	_	_	_	_	_	_	_	I-Goal
58	intensify	_	intensify	_	JJ	69	_	_	_	_	_	_	_	I-Goal
59	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	I-Goal
60	treatment	_	treatment	_	NN	69	_	_	_	_	_	_	_	I-Goal
61	.	_	.	_	.	69	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	69	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	69	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	69	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	69	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	69	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
7	,	_	,	_	,	69	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	69	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	69	_	_	_	_	_	_	_	O
10	levels	_	level	_	NNS	69	_	_	_	_	_	_	_	O
11	are	_	be	_	VBP	69	_	_	_	_	_	_	_	O
12	not	_	not	_	RB	69	_	_	_	_	_	_	_	O
13	adequately	_	adequately	_	RB	69	_	_	_	_	_	_	_	O
14	controlled	_	control	_	VBN	69	_	_	_	_	_	_	_	O
15	by	_	by	_	IN	69	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	69	_	_	_	_	_	_	_	O
17	single	_	single	_	JJ	69	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
20	rise	_	rise	_	NN	69	_	_	_	_	_	_	_	O
21	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
22	58	_	UNK	_	CD	69	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
24	(	_	(	_	(	69	_	_	_	_	_	_	_	O
25	%	_	%	_	NN	69	_	_	_	_	_	_	_	O
26	)	_	)	_	)	69	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	69	_	_	_	_	_	_	_	O
28	higher	_	higher	_	JJR	69	_	_	_	_	_	_	_	O
29	:	_	:	_	:	69	_	_	_	_	_	_	_	O
30	reinforce	_	reinforce	_	NN	69	_	_	_	_	_	_	_	O
31	advice	_	advice	_	NN	69	_	_	_	_	_	_	_	O
32	about	_	about	_	IN	69	_	_	_	_	_	_	_	O
33	diet	_	UNK	_	JJ	69	_	_	_	_	_	_	_	O
34	,	_	,	_	,	69	_	_	_	_	_	_	_	O
35	lifestyle	_	lifestyle	_	JJ	69	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
37	adherence	_	UNK	_	NN	69	_	_	_	_	_	_	_	O
38	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
39	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	O
40	treatment	_	treatment	_	NN	69	_	_	_	_	_	_	_	O
41	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
42	support	_	support	_	VB	69	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	69	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	69	_	_	_	_	_	_	_	O
45	to	_	to	_	TO	69	_	_	_	_	_	_	_	O
46	aim	_	aim	_	VB	69	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	69	_	_	_	_	_	_	_	O
48	an	_	an	_	DT	69	_	_	_	_	_	_	_	O
49	hba1c	_	UNK	_	NNP	69	_	_	_	_	_	_	_	O
50	level	_	level	_	NN	69	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	69	_	_	_	_	_	_	_	O
52	53	_	53	_	CD	69	_	_	_	_	_	_	_	O
53	unk	_	UNK	_	NNS	69	_	_	_	_	_	_	_	O
54	(	_	(	_	(	69	_	_	_	_	_	_	_	O
55	%	_	%	_	NN	69	_	_	_	_	_	_	_	O
56	)	_	)	_	)	69	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	69	_	_	_	_	_	_	_	O
58	intensify	_	intensify	_	JJ	69	_	_	_	_	_	_	_	O
59	drug	_	drug	_	NN	69	_	_	_	_	_	_	_	S-Patient
60	treatment	_	treatment	_	NN	69	_	_	_	_	_	treatment.n	Cure	O
61	.	_	.	_	.	69	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	71	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	71	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	71	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	71	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	71	_	_	_	_	_	_	_	O
6	:	_	:	_	:	71	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	71	_	_	_	_	_	_	_	O
8	(	_	(	_	(	71	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	71	_	_	_	_	_	_	_	O
10	)	_	)	_	)	71	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	71	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	71	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	71	_	_	_	_	_	_	_	O
14	)	_	)	_	)	71	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	71	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	71	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	71	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	71	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	71	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	71	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	71	_	_	_	_	_	_	_	O
8	(	_	(	_	(	71	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	71	_	_	_	_	_	_	_	O
10	)	_	)	_	)	71	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	71	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	71	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	71	_	_	_	_	_	_	_	O
14	)	_	)	_	)	71	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	72	_	_	_	_	_	last.a	Relative_time	O
2	updated	_	update	_	VBD	72	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	72	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	72	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	72	_	_	_	_	_	_	_	O
9	,	_	,	_	,	72	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	72	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	72	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	72	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	72	_	_	_	_	_	_	_	O
20	,	_	,	_	,	72	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
27	:	_	:	_	:	72	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	72	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	72	_	_	_	_	_	_	_	O
36	,	_	,	_	,	72	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
39	,	_	,	_	,	72	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	72	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	72	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	72	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	72	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	72	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	72	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	72	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
61	,	_	,	_	,	72	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
64	,	_	,	_	,	72	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	72	_	_	_	_	_	_	_	O
72	,	_	,	_	,	72	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
80	,	_	,	_	,	72	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	72	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	72	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	72	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	72	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	72	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	72	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	72	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	72	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	72	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	72	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	72	_	_	_	_	_	_	_	O
101	,	_	,	_	,	72	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
104	,	_	,	_	,	72	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
109	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	72	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	72	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	72	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	72	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	72	_	_	_	_	_	_	_	O
9	,	_	,	_	,	72	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	72	_	_	_	_	_	particular.a	Idiosyncrasy	O
12	consideration	_	consideration	_	NN	72	_	_	_	_	_	_	_	S-Idiosyncrasy
13	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	72	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	72	_	_	_	_	_	_	_	O
20	,	_	,	_	,	72	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
27	:	_	:	_	:	72	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	72	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	72	_	_	_	_	_	_	_	O
36	,	_	,	_	,	72	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
39	,	_	,	_	,	72	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	72	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	72	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	72	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	72	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	72	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	72	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	72	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
61	,	_	,	_	,	72	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
64	,	_	,	_	,	72	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	72	_	_	_	_	_	_	_	O
72	,	_	,	_	,	72	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
80	,	_	,	_	,	72	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	72	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	72	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	72	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	72	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	72	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	72	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	72	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	72	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	72	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	72	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	72	_	_	_	_	_	_	_	O
101	,	_	,	_	,	72	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
104	,	_	,	_	,	72	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
109	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	72	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	72	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	72	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	72	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	72	_	_	_	_	_	_	_	O
9	,	_	,	_	,	72	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	72	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	72	_	_	_	_	_	consideration.n	Cogitation	O
13	for	_	for	_	IN	72	_	_	_	_	_	_	_	B-Topic
14	people	_	people	_	NNS	72	_	_	_	_	_	_	_	I-Topic
15	who	_	who	_	WP	72	_	_	_	_	_	_	_	I-Topic
16	are	_	be	_	VBP	72	_	_	_	_	_	_	_	I-Topic
17	older	_	older	_	JJR	72	_	_	_	_	_	_	_	I-Topic
18	or	_	or	_	CC	72	_	_	_	_	_	_	_	I-Topic
19	frail	_	frail	_	NN	72	_	_	_	_	_	_	_	I-Topic
20	,	_	,	_	,	72	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
27	:	_	:	_	:	72	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	72	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	72	_	_	_	_	_	_	_	O
36	,	_	,	_	,	72	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
39	,	_	,	_	,	72	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	72	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	72	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	72	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	72	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	72	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	72	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	72	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
61	,	_	,	_	,	72	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
64	,	_	,	_	,	72	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	72	_	_	_	_	_	_	_	O
72	,	_	,	_	,	72	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
80	,	_	,	_	,	72	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	72	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	72	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	72	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	72	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	72	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	72	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	72	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	72	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	72	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	72	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	72	_	_	_	_	_	_	_	O
101	,	_	,	_	,	72	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
104	,	_	,	_	,	72	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
109	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	72	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	72	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	72	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	72	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	72	_	_	_	_	_	_	_	O
9	,	_	,	_	,	72	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	72	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	72	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	72	_	_	_	_	_	people.n	People	S-Person
15	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	72	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	72	_	_	_	_	_	_	_	O
20	,	_	,	_	,	72	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
27	:	_	:	_	:	72	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	72	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	72	_	_	_	_	_	_	_	O
36	,	_	,	_	,	72	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
39	,	_	,	_	,	72	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	72	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	72	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	72	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	72	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	72	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	72	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	72	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
61	,	_	,	_	,	72	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
64	,	_	,	_	,	72	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	72	_	_	_	_	_	_	_	O
72	,	_	,	_	,	72	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
80	,	_	,	_	,	72	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	72	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	72	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	72	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	72	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	72	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	72	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	72	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	72	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	72	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	72	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	72	_	_	_	_	_	_	_	O
101	,	_	,	_	,	72	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
104	,	_	,	_	,	72	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
109	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	72	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	72	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	72	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	72	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	72	_	_	_	_	_	_	_	O
9	,	_	,	_	,	72	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	72	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	72	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	72	_	_	_	_	_	_	_	S-Resisting_entity
16	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	72	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	72	_	_	_	_	_	frail.a	Level_of_force_resistance	O
20	,	_	,	_	,	72	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
27	:	_	:	_	:	72	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	72	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	72	_	_	_	_	_	_	_	O
36	,	_	,	_	,	72	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
39	,	_	,	_	,	72	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	72	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	72	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	72	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	72	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	72	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	72	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	72	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
61	,	_	,	_	,	72	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
64	,	_	,	_	,	72	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	72	_	_	_	_	_	_	_	O
72	,	_	,	_	,	72	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
80	,	_	,	_	,	72	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	72	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	72	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	72	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	72	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	72	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	72	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	72	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	72	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	72	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	72	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	72	_	_	_	_	_	_	_	O
101	,	_	,	_	,	72	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
104	,	_	,	_	,	72	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
109	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	72	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	72	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	72	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	72	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	72	_	_	_	_	_	_	_	O
9	,	_	,	_	,	72	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	72	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	72	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	72	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	72	_	_	_	_	_	_	_	O
20	,	_	,	_	,	72	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	72	_	_	_	_	_	adult.n	People_by_age	S-Person
23	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
27	:	_	:	_	:	72	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	72	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	72	_	_	_	_	_	_	_	O
36	,	_	,	_	,	72	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
39	,	_	,	_	,	72	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	72	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	72	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	72	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	72	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	72	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	72	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	72	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
61	,	_	,	_	,	72	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
64	,	_	,	_	,	72	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	72	_	_	_	_	_	_	_	O
72	,	_	,	_	,	72	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
80	,	_	,	_	,	72	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	72	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	72	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	72	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	72	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	72	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	72	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	72	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	72	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	72	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	72	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	72	_	_	_	_	_	_	_	O
101	,	_	,	_	,	72	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
104	,	_	,	_	,	72	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
109	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	72	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	72	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	72	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	72	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	72	_	_	_	_	_	_	_	O
9	,	_	,	_	,	72	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	72	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	72	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	72	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	72	_	_	_	_	_	_	_	O
20	,	_	,	_	,	72	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	72	_	_	_	_	_	type.n	Type	S-Subtype
25	2	_	2	_	CD	72	_	_	_	_	_	_	_	B-Category
26	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	I-Category
27	:	_	:	_	:	72	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	72	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	72	_	_	_	_	_	_	_	O
36	,	_	,	_	,	72	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
39	,	_	,	_	,	72	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	72	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	72	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	72	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	72	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	72	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	72	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	72	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
61	,	_	,	_	,	72	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
64	,	_	,	_	,	72	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	72	_	_	_	_	_	_	_	O
72	,	_	,	_	,	72	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
80	,	_	,	_	,	72	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	72	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	72	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	72	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	72	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	72	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	72	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	72	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	72	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	72	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	72	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	72	_	_	_	_	_	_	_	O
101	,	_	,	_	,	72	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
104	,	_	,	_	,	72	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
109	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	72	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	72	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	72	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	72	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	72	_	_	_	_	_	_	_	O
9	,	_	,	_	,	72	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	72	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	72	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	72	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	72	_	_	_	_	_	_	_	O
20	,	_	,	_	,	72	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
27	:	_	:	_	:	72	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	72	_	_	_	_	_	_	_	S-Hypothetical_event
29	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	72	_	_	_	_	_	unlikely.a	Likelihood	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	B-Hypothetical_event
32	achieve	_	achieve	_	VB	72	_	_	_	_	_	_	_	I-Hypothetical_event
33	longer-term	_	UNK	_	JJ	72	_	_	_	_	_	_	_	I-Hypothetical_event
34	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	I-Hypothetical_event
35	benefits	_	benefit	_	NNS	72	_	_	_	_	_	_	_	I-Hypothetical_event
36	,	_	,	_	,	72	_	_	_	_	_	_	_	I-Hypothetical_event
37	for	_	for	_	IN	72	_	_	_	_	_	_	_	I-Hypothetical_event
38	example	_	example	_	NN	72	_	_	_	_	_	_	_	I-Hypothetical_event
39	,	_	,	_	,	72	_	_	_	_	_	_	_	I-Hypothetical_event
40	people	_	people	_	NNS	72	_	_	_	_	_	_	_	I-Hypothetical_event
41	with	_	with	_	IN	72	_	_	_	_	_	_	_	I-Hypothetical_event
42	a	_	a	_	DT	72	_	_	_	_	_	_	_	I-Hypothetical_event
43	reduced	_	UNK	_	JJ	72	_	_	_	_	_	_	_	I-Hypothetical_event
44	life	_	life	_	NN	72	_	_	_	_	_	_	_	I-Hypothetical_event
45	expectancy	_	UNK	_	NN	72	_	_	_	_	_	_	_	I-Hypothetical_event
46	for	_	for	_	IN	72	_	_	_	_	_	_	_	I-Hypothetical_event
47	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	I-Hypothetical_event
48	tight	_	UNK	_	JJ	72	_	_	_	_	_	_	_	I-Hypothetical_event
49	blood	_	blood	_	NN	72	_	_	_	_	_	_	_	I-Hypothetical_event
50	glucose	_	UNK	_	VB	72	_	_	_	_	_	_	_	I-Hypothetical_event
51	control	_	control	_	NN	72	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	72	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	72	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	72	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
61	,	_	,	_	,	72	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
64	,	_	,	_	,	72	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	72	_	_	_	_	_	_	_	O
72	,	_	,	_	,	72	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
80	,	_	,	_	,	72	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	72	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	72	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	72	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	72	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	72	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	72	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	72	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	72	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	72	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	72	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	72	_	_	_	_	_	_	_	O
101	,	_	,	_	,	72	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
104	,	_	,	_	,	72	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
109	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	72	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	72	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	72	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	72	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	72	_	_	_	_	_	_	_	O
9	,	_	,	_	,	72	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	72	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	72	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	72	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	72	_	_	_	_	_	_	_	O
20	,	_	,	_	,	72	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
27	:	_	:	_	:	72	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	72	_	_	_	_	_	_	_	S-Agent
29	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	72	_	_	_	_	_	achieve.v	Accomplishment	O
33	longer-term	_	UNK	_	JJ	72	_	_	_	_	_	_	_	B-Goal
34	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	I-Goal
35	benefits	_	benefit	_	NNS	72	_	_	_	_	_	_	_	I-Goal
36	,	_	,	_	,	72	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
39	,	_	,	_	,	72	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	72	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	72	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	72	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	72	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	72	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	72	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	72	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
61	,	_	,	_	,	72	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
64	,	_	,	_	,	72	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	72	_	_	_	_	_	_	_	O
72	,	_	,	_	,	72	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
80	,	_	,	_	,	72	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	72	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	72	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	72	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	72	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	72	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	72	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	72	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	72	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	72	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	72	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	72	_	_	_	_	_	_	_	O
101	,	_	,	_	,	72	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
104	,	_	,	_	,	72	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
109	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	72	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	72	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	72	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	72	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	72	_	_	_	_	_	_	_	O
9	,	_	,	_	,	72	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	72	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	72	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	72	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	72	_	_	_	_	_	_	_	O
20	,	_	,	_	,	72	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
27	:	_	:	_	:	72	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	72	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	72	_	_	_	_	_	_	_	O
36	,	_	,	_	,	72	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	72	_	_	_	_	_	example.n	Instance	S-Instance
39	,	_	,	_	,	72	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	72	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	72	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	72	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	72	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	72	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	72	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	72	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
61	,	_	,	_	,	72	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
64	,	_	,	_	,	72	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	72	_	_	_	_	_	_	_	O
72	,	_	,	_	,	72	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
80	,	_	,	_	,	72	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	72	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	72	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	72	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	72	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	72	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	72	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	72	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	72	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	72	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	72	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	72	_	_	_	_	_	_	_	O
101	,	_	,	_	,	72	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
104	,	_	,	_	,	72	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
109	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	72	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	72	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	72	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	72	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	72	_	_	_	_	_	_	_	O
9	,	_	,	_	,	72	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	72	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	72	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	72	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	72	_	_	_	_	_	_	_	O
20	,	_	,	_	,	72	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
27	:	_	:	_	:	72	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	72	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	72	_	_	_	_	_	_	_	O
36	,	_	,	_	,	72	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
39	,	_	,	_	,	72	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	72	_	_	_	_	_	people.n	People	S-Person
41	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	72	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	72	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	72	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	72	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	72	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	72	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	72	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
61	,	_	,	_	,	72	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
64	,	_	,	_	,	72	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	72	_	_	_	_	_	_	_	O
72	,	_	,	_	,	72	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
80	,	_	,	_	,	72	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	72	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	72	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	72	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	72	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	72	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	72	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	72	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	72	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	72	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	72	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	72	_	_	_	_	_	_	_	O
101	,	_	,	_	,	72	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
104	,	_	,	_	,	72	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
109	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	72	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	72	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	72	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	72	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	72	_	_	_	_	_	_	_	O
9	,	_	,	_	,	72	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	72	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	72	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	72	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	72	_	_	_	_	_	_	_	O
20	,	_	,	_	,	72	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
27	:	_	:	_	:	72	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	72	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	72	_	_	_	_	_	_	_	O
36	,	_	,	_	,	72	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
39	,	_	,	_	,	72	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	72	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	72	_	_	_	_	_	_	_	B-Simulated_entity
50	glucose	_	UNK	_	VB	72	_	_	_	_	_	_	_	I-Simulated_entity
51	control	_	control	_	NN	72	_	_	_	_	_	_	_	I-Simulated_entity
52	poses	_	pose	_	VBZ	72	_	_	_	_	_	pose.v	Posing_as	O
53	a	_	a	_	DT	72	_	_	_	_	_	_	_	B-Simulated_entity
54	high	_	high	_	JJ	72	_	_	_	_	_	_	_	I-Simulated_entity
55	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	I-Simulated_entity
56	of	_	of	_	IN	72	_	_	_	_	_	_	_	I-Simulated_entity
57	the	_	the	_	DT	72	_	_	_	_	_	_	_	I-Simulated_entity
58	consequences	_	consequence	_	NNS	72	_	_	_	_	_	_	_	I-Simulated_entity
59	of	_	of	_	IN	72	_	_	_	_	_	_	_	I-Simulated_entity
60	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	I-Simulated_entity
61	,	_	,	_	,	72	_	_	_	_	_	_	_	I-Simulated_entity
62	for	_	for	_	IN	72	_	_	_	_	_	_	_	I-Simulated_entity
63	example	_	example	_	NN	72	_	_	_	_	_	_	_	I-Simulated_entity
64	,	_	,	_	,	72	_	_	_	_	_	_	_	I-Simulated_entity
65	people	_	people	_	NNS	72	_	_	_	_	_	_	_	I-Simulated_entity
66	who	_	who	_	WP	72	_	_	_	_	_	_	_	I-Simulated_entity
67	are	_	be	_	VBP	72	_	_	_	_	_	_	_	I-Simulated_entity
68	at	_	at	_	IN	72	_	_	_	_	_	_	_	I-Simulated_entity
69	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	I-Simulated_entity
70	of	_	of	_	IN	72	_	_	_	_	_	_	_	I-Simulated_entity
71	falling	_	fall	_	VBG	72	_	_	_	_	_	_	_	I-Simulated_entity
72	,	_	,	_	,	72	_	_	_	_	_	_	_	I-Simulated_entity
73	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
80	,	_	,	_	,	72	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	72	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	72	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	72	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	72	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	72	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	72	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	72	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	72	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	72	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	72	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	72	_	_	_	_	_	_	_	O
101	,	_	,	_	,	72	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
104	,	_	,	_	,	72	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
109	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	72	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	72	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	72	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	72	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	72	_	_	_	_	_	_	_	O
9	,	_	,	_	,	72	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	72	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	72	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	72	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	72	_	_	_	_	_	_	_	O
20	,	_	,	_	,	72	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
27	:	_	:	_	:	72	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	72	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	72	_	_	_	_	_	_	_	O
36	,	_	,	_	,	72	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
39	,	_	,	_	,	72	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	72	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	72	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	72	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	72	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	72	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	72	_	_	_	_	_	high.a	Position_on_a_scale	S-Value
55	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	S-Item
56	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	72	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
61	,	_	,	_	,	72	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
64	,	_	,	_	,	72	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	72	_	_	_	_	_	_	_	O
72	,	_	,	_	,	72	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
80	,	_	,	_	,	72	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	72	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	72	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	72	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	72	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	72	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	72	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	72	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	72	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	72	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	72	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	72	_	_	_	_	_	_	_	O
101	,	_	,	_	,	72	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
104	,	_	,	_	,	72	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
109	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	72	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	72	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	72	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	72	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	72	_	_	_	_	_	_	_	O
9	,	_	,	_	,	72	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	72	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	72	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	72	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	72	_	_	_	_	_	_	_	O
20	,	_	,	_	,	72	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
27	:	_	:	_	:	72	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	72	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	72	_	_	_	_	_	_	_	O
36	,	_	,	_	,	72	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
39	,	_	,	_	,	72	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	72	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	72	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	72	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	72	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	72	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	72	_	_	_	_	_	_	_	S-Bad_outcome
55	risk	_	risk	_	NN	72	_	_	_	_	_	risk.n	Run_risk	O
56	of	_	of	_	IN	72	_	_	_	_	_	_	_	B-Action
57	the	_	the	_	DT	72	_	_	_	_	_	_	_	I-Action
58	consequences	_	consequence	_	NNS	72	_	_	_	_	_	_	_	I-Action
59	of	_	of	_	IN	72	_	_	_	_	_	_	_	I-Action
60	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	I-Action
61	,	_	,	_	,	72	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
64	,	_	,	_	,	72	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	72	_	_	_	_	_	_	_	O
72	,	_	,	_	,	72	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
80	,	_	,	_	,	72	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	72	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	72	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	72	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	72	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	72	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	72	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	72	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	72	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	72	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	72	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	72	_	_	_	_	_	_	_	O
101	,	_	,	_	,	72	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
104	,	_	,	_	,	72	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
109	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	72	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	72	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	72	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	72	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	72	_	_	_	_	_	_	_	O
9	,	_	,	_	,	72	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	72	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	72	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	72	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	72	_	_	_	_	_	_	_	O
20	,	_	,	_	,	72	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
27	:	_	:	_	:	72	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	72	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	72	_	_	_	_	_	_	_	O
36	,	_	,	_	,	72	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
39	,	_	,	_	,	72	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	72	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	72	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	72	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	72	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	72	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	72	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	72	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
61	,	_	,	_	,	72	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	72	_	_	_	_	_	example.n	Instance	S-Instance
64	,	_	,	_	,	72	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	72	_	_	_	_	_	_	_	O
72	,	_	,	_	,	72	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
80	,	_	,	_	,	72	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	72	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	72	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	72	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	72	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	72	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	72	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	72	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	72	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	72	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	72	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	72	_	_	_	_	_	_	_	O
101	,	_	,	_	,	72	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
104	,	_	,	_	,	72	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
109	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	72	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	72	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	72	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	72	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	72	_	_	_	_	_	_	_	O
9	,	_	,	_	,	72	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	72	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	72	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	72	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	72	_	_	_	_	_	_	_	O
20	,	_	,	_	,	72	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
27	:	_	:	_	:	72	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	72	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	72	_	_	_	_	_	_	_	O
36	,	_	,	_	,	72	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
39	,	_	,	_	,	72	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	72	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	72	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	72	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	72	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	72	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	72	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	72	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
61	,	_	,	_	,	72	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
64	,	_	,	_	,	72	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	72	_	_	_	_	_	people.n	People	S-Person
66	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	72	_	_	_	_	_	_	_	O
72	,	_	,	_	,	72	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
80	,	_	,	_	,	72	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	72	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	72	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	72	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	72	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	72	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	72	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	72	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	72	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	72	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	72	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	72	_	_	_	_	_	_	_	O
101	,	_	,	_	,	72	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
104	,	_	,	_	,	72	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
109	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	72	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	72	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	72	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	72	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	72	_	_	_	_	_	_	_	O
9	,	_	,	_	,	72	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	72	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	72	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	72	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	72	_	_	_	_	_	_	_	O
20	,	_	,	_	,	72	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
27	:	_	:	_	:	72	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	72	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	72	_	_	_	_	_	_	_	O
36	,	_	,	_	,	72	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
39	,	_	,	_	,	72	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	72	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	72	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	72	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	72	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	72	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	72	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	72	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
61	,	_	,	_	,	72	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
64	,	_	,	_	,	72	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	72	_	_	_	_	_	_	_	B-Figure
66	who	_	who	_	WP	72	_	_	_	_	_	_	_	I-Figure
67	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	72	_	_	_	_	_	at.prep	Locative_relation	O
69	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	B-Ground
70	of	_	of	_	IN	72	_	_	_	_	_	_	_	I-Ground
71	falling	_	fall	_	VBG	72	_	_	_	_	_	_	_	I-Ground
72	,	_	,	_	,	72	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
80	,	_	,	_	,	72	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	72	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	72	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	72	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	72	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	72	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	72	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	72	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	72	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	72	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	72	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	72	_	_	_	_	_	_	_	O
101	,	_	,	_	,	72	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
104	,	_	,	_	,	72	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
109	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	72	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	72	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	72	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	72	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	72	_	_	_	_	_	_	_	O
9	,	_	,	_	,	72	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	72	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	72	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	72	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	72	_	_	_	_	_	_	_	O
20	,	_	,	_	,	72	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
27	:	_	:	_	:	72	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	72	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	72	_	_	_	_	_	_	_	O
36	,	_	,	_	,	72	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
39	,	_	,	_	,	72	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	72	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	72	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	72	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	72	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	72	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	72	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	72	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
61	,	_	,	_	,	72	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
64	,	_	,	_	,	72	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	72	_	_	_	_	_	_	_	B-Protagonist
66	who	_	who	_	WP	72	_	_	_	_	_	_	_	I-Protagonist
67	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	72	_	_	_	_	_	risk.n	Run_risk	O
70	of	_	of	_	IN	72	_	_	_	_	_	_	_	B-Asset
71	falling	_	fall	_	VBG	72	_	_	_	_	_	_	_	I-Asset
72	,	_	,	_	,	72	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
80	,	_	,	_	,	72	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	72	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	72	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	72	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	72	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	72	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	72	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	72	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	72	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	72	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	72	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	72	_	_	_	_	_	_	_	O
101	,	_	,	_	,	72	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
104	,	_	,	_	,	72	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
109	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	72	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	72	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	72	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	72	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	72	_	_	_	_	_	_	_	O
9	,	_	,	_	,	72	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	72	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	72	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	72	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	72	_	_	_	_	_	_	_	O
20	,	_	,	_	,	72	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
27	:	_	:	_	:	72	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	72	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	72	_	_	_	_	_	_	_	O
36	,	_	,	_	,	72	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
39	,	_	,	_	,	72	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	72	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	72	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	72	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	72	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	72	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	72	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	72	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
61	,	_	,	_	,	72	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
64	,	_	,	_	,	72	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	72	_	_	_	_	_	_	_	O
72	,	_	,	_	,	72	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	72	_	_	_	_	_	people.n	People	S-Person
74	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
80	,	_	,	_	,	72	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	72	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	72	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	72	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	72	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	72	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	72	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	72	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	72	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	72	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	72	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	72	_	_	_	_	_	_	_	O
101	,	_	,	_	,	72	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
104	,	_	,	_	,	72	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
109	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	72	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	72	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	72	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	72	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	72	_	_	_	_	_	_	_	O
9	,	_	,	_	,	72	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	72	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	72	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	72	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	72	_	_	_	_	_	_	_	O
20	,	_	,	_	,	72	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
27	:	_	:	_	:	72	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	72	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	72	_	_	_	_	_	_	_	O
36	,	_	,	_	,	72	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
39	,	_	,	_	,	72	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	72	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	72	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	72	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	72	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	72	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	72	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	72	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
61	,	_	,	_	,	72	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
64	,	_	,	_	,	72	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	72	_	_	_	_	_	_	_	O
72	,	_	,	_	,	72	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
80	,	_	,	_	,	72	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	72	_	_	_	_	_	people.n	People	S-Person
83	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	72	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	72	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	72	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	72	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	72	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	72	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	72	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	72	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	72	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	72	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	72	_	_	_	_	_	_	_	O
101	,	_	,	_	,	72	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
104	,	_	,	_	,	72	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
109	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	72	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	72	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	72	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	72	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	72	_	_	_	_	_	_	_	O
9	,	_	,	_	,	72	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	72	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	72	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	72	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	72	_	_	_	_	_	_	_	O
20	,	_	,	_	,	72	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
27	:	_	:	_	:	72	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	72	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	72	_	_	_	_	_	_	_	O
36	,	_	,	_	,	72	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
39	,	_	,	_	,	72	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	72	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	72	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	72	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	72	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	72	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	72	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	72	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
61	,	_	,	_	,	72	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
64	,	_	,	_	,	72	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	72	_	_	_	_	_	_	_	O
72	,	_	,	_	,	72	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
80	,	_	,	_	,	72	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	72	_	_	_	_	_	_	_	B-Agent
83	who	_	who	_	WP	72	_	_	_	_	_	_	_	I-Agent
84	drive	_	drive	_	VBP	72	_	_	_	_	_	drive.v	Subjective_influence	O
85	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	72	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	72	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	72	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	72	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	72	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	72	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	72	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	72	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	72	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	72	_	_	_	_	_	_	_	O
101	,	_	,	_	,	72	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
104	,	_	,	_	,	72	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
109	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	72	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	72	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	72	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	72	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	72	_	_	_	_	_	_	_	O
9	,	_	,	_	,	72	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	72	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	72	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	72	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	72	_	_	_	_	_	_	_	O
20	,	_	,	_	,	72	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
27	:	_	:	_	:	72	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	72	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	72	_	_	_	_	_	_	_	O
36	,	_	,	_	,	72	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
39	,	_	,	_	,	72	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	72	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	72	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	72	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	72	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	72	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	72	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	72	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
61	,	_	,	_	,	72	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
64	,	_	,	_	,	72	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	72	_	_	_	_	_	_	_	O
72	,	_	,	_	,	72	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
80	,	_	,	_	,	72	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	72	_	_	_	_	_	_	_	B-Operator
83	who	_	who	_	WP	72	_	_	_	_	_	_	_	I-Operator
84	drive	_	drive	_	VBP	72	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	72	_	_	_	_	_	operate.v	Operating_a_system	O
87	machinery	_	machinery	_	NN	72	_	_	_	_	_	_	_	S-System
88	as	_	a	_	IN	72	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	72	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	72	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	72	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	72	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	72	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	72	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	72	_	_	_	_	_	_	_	O
101	,	_	,	_	,	72	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
104	,	_	,	_	,	72	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
109	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	72	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	72	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	72	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	72	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	72	_	_	_	_	_	_	_	O
9	,	_	,	_	,	72	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	72	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	72	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	72	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	72	_	_	_	_	_	_	_	O
20	,	_	,	_	,	72	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
27	:	_	:	_	:	72	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	72	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	72	_	_	_	_	_	_	_	O
36	,	_	,	_	,	72	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
39	,	_	,	_	,	72	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	72	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	72	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	72	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	72	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	72	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	72	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	72	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
61	,	_	,	_	,	72	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
64	,	_	,	_	,	72	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	72	_	_	_	_	_	_	_	O
72	,	_	,	_	,	72	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
80	,	_	,	_	,	72	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	72	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	72	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	72	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	72	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	72	_	_	_	_	_	part.n	Part_whole	S-Part
90	of	_	of	_	IN	72	_	_	_	_	_	_	_	B-Whole
91	their	_	their	_	PRP$	72	_	_	_	_	_	_	_	I-Whole
92	job	_	job	_	NN	72	_	_	_	_	_	_	_	I-Whole
93	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	72	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	72	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	72	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	72	_	_	_	_	_	_	_	O
101	,	_	,	_	,	72	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
104	,	_	,	_	,	72	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
109	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	72	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	72	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	72	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	72	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	72	_	_	_	_	_	_	_	O
9	,	_	,	_	,	72	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	72	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	72	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	72	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	72	_	_	_	_	_	_	_	O
20	,	_	,	_	,	72	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
27	:	_	:	_	:	72	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	72	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	72	_	_	_	_	_	_	_	O
36	,	_	,	_	,	72	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
39	,	_	,	_	,	72	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	72	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	72	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	72	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	72	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	72	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	72	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	72	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
61	,	_	,	_	,	72	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
64	,	_	,	_	,	72	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	72	_	_	_	_	_	_	_	O
72	,	_	,	_	,	72	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
80	,	_	,	_	,	72	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	72	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	72	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	72	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	72	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	72	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	72	_	_	_	_	_	_	_	S-Employee
92	job	_	job	_	NN	72	_	_	_	_	_	job.n	Being_employed	O
93	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	72	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	72	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	72	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	72	_	_	_	_	_	_	_	O
101	,	_	,	_	,	72	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
104	,	_	,	_	,	72	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
109	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	72	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	72	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	72	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	72	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	72	_	_	_	_	_	_	_	O
9	,	_	,	_	,	72	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	72	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	72	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	72	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	72	_	_	_	_	_	_	_	O
20	,	_	,	_	,	72	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
27	:	_	:	_	:	72	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	72	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	72	_	_	_	_	_	_	_	O
36	,	_	,	_	,	72	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
39	,	_	,	_	,	72	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	72	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	72	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	72	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	72	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	72	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	72	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	72	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
61	,	_	,	_	,	72	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
64	,	_	,	_	,	72	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	72	_	_	_	_	_	_	_	O
72	,	_	,	_	,	72	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
80	,	_	,	_	,	72	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	72	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	72	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	72	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	72	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	72	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	72	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	72	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	72	_	_	_	_	_	_	_	B-Evaluee
96	management	_	management	_	NN	72	_	_	_	_	_	_	_	I-Evaluee
97	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	72	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	72	_	_	_	_	_	appropriate.a	Suitability	O
101	,	_	,	_	,	72	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
104	,	_	,	_	,	72	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
109	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	72	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	72	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	72	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	72	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	72	_	_	_	_	_	_	_	O
9	,	_	,	_	,	72	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	72	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	72	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	72	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	72	_	_	_	_	_	_	_	O
20	,	_	,	_	,	72	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
27	:	_	:	_	:	72	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	72	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	72	_	_	_	_	_	_	_	O
36	,	_	,	_	,	72	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
39	,	_	,	_	,	72	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	72	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	72	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	72	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	72	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	72	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	72	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	72	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
61	,	_	,	_	,	72	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
64	,	_	,	_	,	72	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	72	_	_	_	_	_	_	_	O
72	,	_	,	_	,	72	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
80	,	_	,	_	,	72	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	72	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	72	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	72	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	72	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	72	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	72	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	72	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	72	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	72	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	72	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	72	_	_	_	_	_	_	_	O
101	,	_	,	_	,	72	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	72	_	_	_	_	_	example.n	Instance	S-Instance
104	,	_	,	_	,	72	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
109	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	72	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	72	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	72	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	72	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	72	_	_	_	_	_	_	_	O
9	,	_	,	_	,	72	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	72	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	72	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	72	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	72	_	_	_	_	_	_	_	O
20	,	_	,	_	,	72	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
27	:	_	:	_	:	72	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	72	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	72	_	_	_	_	_	_	_	O
36	,	_	,	_	,	72	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
39	,	_	,	_	,	72	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	72	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	72	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	72	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	72	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	72	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	72	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	72	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
61	,	_	,	_	,	72	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
64	,	_	,	_	,	72	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	72	_	_	_	_	_	_	_	O
72	,	_	,	_	,	72	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
80	,	_	,	_	,	72	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	72	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	72	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	72	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	72	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	72	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	72	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	72	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	72	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	72	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	72	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	72	_	_	_	_	_	_	_	O
101	,	_	,	_	,	72	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
104	,	_	,	_	,	72	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	72	_	_	_	_	_	people.n	People	S-Person
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	72	_	_	_	_	_	_	_	O
108	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
109	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	72	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	72	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	72	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	72	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	72	_	_	_	_	_	_	_	O
6	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
7	case-by-case	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
8	basis	_	basis	_	NN	72	_	_	_	_	_	_	_	O
9	,	_	,	_	,	72	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
11	particular	_	particular	_	JJ	72	_	_	_	_	_	_	_	O
12	consideration	_	consideration	_	NN	72	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
14	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
16	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
17	older	_	older	_	JJR	72	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
19	frail	_	frail	_	NN	72	_	_	_	_	_	_	_	O
20	,	_	,	_	,	72	_	_	_	_	_	_	_	O
21	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	72	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	72	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	72	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	72	_	_	_	_	_	_	_	O
27	:	_	:	_	:	72	_	_	_	_	_	_	_	O
28	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
29	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
30	unlikely	_	unlikely	_	JJ	72	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	72	_	_	_	_	_	_	_	O
32	achieve	_	achieve	_	VB	72	_	_	_	_	_	_	_	O
33	longer-term	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
35	benefits	_	benefit	_	NNS	72	_	_	_	_	_	_	_	O
36	,	_	,	_	,	72	_	_	_	_	_	_	_	O
37	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
38	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
39	,	_	,	_	,	72	_	_	_	_	_	_	_	O
40	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
41	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
42	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
43	reduced	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
44	life	_	life	_	NN	72	_	_	_	_	_	_	_	O
45	expectancy	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
46	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
47	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
48	tight	_	UNK	_	JJ	72	_	_	_	_	_	_	_	O
49	blood	_	blood	_	NN	72	_	_	_	_	_	_	_	O
50	glucose	_	UNK	_	VB	72	_	_	_	_	_	_	_	O
51	control	_	control	_	NN	72	_	_	_	_	_	_	_	O
52	poses	_	pose	_	VBZ	72	_	_	_	_	_	_	_	O
53	a	_	a	_	DT	72	_	_	_	_	_	_	_	O
54	high	_	high	_	JJ	72	_	_	_	_	_	_	_	O
55	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
56	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
57	the	_	the	_	DT	72	_	_	_	_	_	_	_	O
58	consequences	_	consequence	_	NNS	72	_	_	_	_	_	_	_	O
59	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
60	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
61	,	_	,	_	,	72	_	_	_	_	_	_	_	O
62	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
63	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
64	,	_	,	_	,	72	_	_	_	_	_	_	_	O
65	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
66	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
67	are	_	be	_	VBP	72	_	_	_	_	_	_	_	O
68	at	_	at	_	IN	72	_	_	_	_	_	_	_	O
69	risk	_	risk	_	NN	72	_	_	_	_	_	_	_	O
70	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
71	falling	_	fall	_	VBG	72	_	_	_	_	_	_	_	O
72	,	_	,	_	,	72	_	_	_	_	_	_	_	O
73	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
74	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
75	have	_	have	_	VBP	72	_	_	_	_	_	_	_	O
76	impaired	_	UNK	_	VBN	72	_	_	_	_	_	_	_	O
77	awareness	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
78	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
79	unk	_	UNK	_	NN	72	_	_	_	_	_	_	_	O
80	,	_	,	_	,	72	_	_	_	_	_	_	_	O
81	and	_	and	_	CC	72	_	_	_	_	_	_	_	O
82	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
83	who	_	who	_	WP	72	_	_	_	_	_	_	_	O
84	drive	_	drive	_	VBP	72	_	_	_	_	_	_	_	O
85	or	_	or	_	CC	72	_	_	_	_	_	_	_	O
86	operate	_	operate	_	VBP	72	_	_	_	_	_	_	_	O
87	machinery	_	machinery	_	NN	72	_	_	_	_	_	_	_	O
88	as	_	a	_	IN	72	_	_	_	_	_	_	_	O
89	part	_	part	_	NN	72	_	_	_	_	_	_	_	O
90	of	_	of	_	IN	72	_	_	_	_	_	_	_	O
91	their	_	their	_	PRP$	72	_	_	_	_	_	_	_	O
92	job	_	job	_	NN	72	_	_	_	_	_	_	_	O
93	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
94	whom	_	whom	_	WP	72	_	_	_	_	_	_	_	O
95	intensive	_	intensive	_	JJ	72	_	_	_	_	_	_	_	O
96	management	_	management	_	NN	72	_	_	_	_	_	_	_	O
97	would	_	would	_	MD	72	_	_	_	_	_	_	_	O
98	not	_	not	_	RB	72	_	_	_	_	_	_	_	O
99	be	_	be	_	VB	72	_	_	_	_	_	_	_	O
100	appropriate	_	appropriate	_	JJ	72	_	_	_	_	_	_	_	O
101	,	_	,	_	,	72	_	_	_	_	_	_	_	O
102	for	_	for	_	IN	72	_	_	_	_	_	_	_	O
103	example	_	example	_	NN	72	_	_	_	_	_	_	_	O
104	,	_	,	_	,	72	_	_	_	_	_	_	_	O
105	people	_	people	_	NNS	72	_	_	_	_	_	_	_	O
106	with	_	with	_	IN	72	_	_	_	_	_	_	_	O
107	significant	_	significant	_	JJ	72	_	_	_	_	_	significant.a	Importance	O
108	comorbidities	_	UNK	_	NNS	72	_	_	_	_	_	_	_	S-Factor
109	.	_	.	_	.	72	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	73	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	73	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	73	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
7	achieve	_	achieve	_	VBP	73	_	_	_	_	_	_	_	O
8	an	_	an	_	DT	73	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
10	level	_	level	_	NN	73	_	_	_	_	_	_	_	O
11	that	_	that	_	WDT	73	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	73	_	_	_	_	_	_	_	O
13	lower	_	lower	_	JJR	73	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	73	_	_	_	_	_	_	_	O
15	their	_	their	_	PRP$	73	_	_	_	_	_	_	_	O
16	target	_	target	_	NN	73	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
18	they	_	they	_	PRP	73	_	_	_	_	_	_	_	O
19	are	_	be	_	VBP	73	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
21	experiencing	_	experience	_	VBG	73	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
23	,	_	,	_	,	73	_	_	_	_	_	_	_	O
24	encourage	_	encourage	_	VB	73	_	_	_	_	_	_	_	O
25	them	_	them	_	PRP	73	_	_	_	_	_	_	_	O
26	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
27	maintain	_	maintain	_	VB	73	_	_	_	_	_	_	_	O
28	it	_	it	_	PRP	73	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	73	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	73	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	73	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	73	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	73	_	_	_	_	_	_	_	I-Category
7	achieve	_	achieve	_	VBP	73	_	_	_	_	_	_	_	O
8	an	_	an	_	DT	73	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
10	level	_	level	_	NN	73	_	_	_	_	_	_	_	O
11	that	_	that	_	WDT	73	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	73	_	_	_	_	_	_	_	O
13	lower	_	lower	_	JJR	73	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	73	_	_	_	_	_	_	_	O
15	their	_	their	_	PRP$	73	_	_	_	_	_	_	_	O
16	target	_	target	_	NN	73	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
18	they	_	they	_	PRP	73	_	_	_	_	_	_	_	O
19	are	_	be	_	VBP	73	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
21	experiencing	_	experience	_	VBG	73	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
23	,	_	,	_	,	73	_	_	_	_	_	_	_	O
24	encourage	_	encourage	_	VB	73	_	_	_	_	_	_	_	O
25	them	_	them	_	PRP	73	_	_	_	_	_	_	_	O
26	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
27	maintain	_	maintain	_	VB	73	_	_	_	_	_	_	_	O
28	it	_	it	_	PRP	73	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	73	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	73	_	_	_	_	_	_	_	B-Agent
3	with	_	with	_	IN	73	_	_	_	_	_	_	_	I-Agent
4	type	_	type	_	JJ	73	_	_	_	_	_	_	_	I-Agent
5	2	_	2	_	CD	73	_	_	_	_	_	_	_	I-Agent
6	diabetes	_	UNK	_	NNS	73	_	_	_	_	_	_	_	I-Agent
7	achieve	_	achieve	_	VBP	73	_	_	_	_	_	achieve.v	Accomplishment	O
8	an	_	an	_	DT	73	_	_	_	_	_	_	_	B-Goal
9	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	I-Goal
10	level	_	level	_	NN	73	_	_	_	_	_	_	_	I-Goal
11	that	_	that	_	WDT	73	_	_	_	_	_	_	_	I-Goal
12	is	_	be	_	VBZ	73	_	_	_	_	_	_	_	I-Goal
13	lower	_	lower	_	JJR	73	_	_	_	_	_	_	_	I-Goal
14	than	_	than	_	IN	73	_	_	_	_	_	_	_	I-Goal
15	their	_	their	_	PRP$	73	_	_	_	_	_	_	_	I-Goal
16	target	_	target	_	NN	73	_	_	_	_	_	_	_	I-Goal
17	and	_	and	_	CC	73	_	_	_	_	_	_	_	I-Goal
18	they	_	they	_	PRP	73	_	_	_	_	_	_	_	I-Goal
19	are	_	be	_	VBP	73	_	_	_	_	_	_	_	I-Goal
20	not	_	not	_	RB	73	_	_	_	_	_	_	_	I-Goal
21	experiencing	_	experience	_	VBG	73	_	_	_	_	_	_	_	I-Goal
22	unk	_	UNK	_	NN	73	_	_	_	_	_	_	_	I-Goal
23	,	_	,	_	,	73	_	_	_	_	_	_	_	O
24	encourage	_	encourage	_	VB	73	_	_	_	_	_	_	_	O
25	them	_	them	_	PRP	73	_	_	_	_	_	_	_	O
26	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
27	maintain	_	maintain	_	VB	73	_	_	_	_	_	_	_	O
28	it	_	it	_	PRP	73	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	73	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	73	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	73	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
7	achieve	_	achieve	_	VBP	73	_	_	_	_	_	_	_	O
8	an	_	an	_	DT	73	_	_	_	_	_	_	_	B-Item
9	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	I-Item
10	level	_	level	_	NN	73	_	_	_	_	_	_	_	I-Item
11	that	_	that	_	WDT	73	_	_	_	_	_	_	_	I-Item
12	is	_	be	_	VBZ	73	_	_	_	_	_	_	_	O
13	lower	_	lower	_	JJR	73	_	_	_	_	_	lower.v	Change_position_on_a_scale	O
14	than	_	than	_	IN	73	_	_	_	_	_	_	_	B-Attribute
15	their	_	their	_	PRP$	73	_	_	_	_	_	_	_	I-Attribute
16	target	_	target	_	NN	73	_	_	_	_	_	_	_	I-Attribute
17	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
18	they	_	they	_	PRP	73	_	_	_	_	_	_	_	O
19	are	_	be	_	VBP	73	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
21	experiencing	_	experience	_	VBG	73	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
23	,	_	,	_	,	73	_	_	_	_	_	_	_	O
24	encourage	_	encourage	_	VB	73	_	_	_	_	_	_	_	O
25	them	_	them	_	PRP	73	_	_	_	_	_	_	_	O
26	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
27	maintain	_	maintain	_	VB	73	_	_	_	_	_	_	_	O
28	it	_	it	_	PRP	73	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	73	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	73	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	73	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
7	achieve	_	achieve	_	VBP	73	_	_	_	_	_	_	_	O
8	an	_	an	_	DT	73	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
10	level	_	level	_	NN	73	_	_	_	_	_	_	_	O
11	that	_	that	_	WDT	73	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	73	_	_	_	_	_	_	_	O
13	lower	_	lower	_	JJR	73	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	73	_	_	_	_	_	_	_	O
15	their	_	their	_	PRP$	73	_	_	_	_	_	_	_	O
16	target	_	target	_	NN	73	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
18	they	_	they	_	PRP	73	_	_	_	_	_	_	_	S-Experiencer
19	are	_	be	_	VBP	73	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
21	experiencing	_	experience	_	VBG	73	_	_	_	_	_	experience.v	Feeling	O
22	unk	_	UNK	_	NN	73	_	_	_	_	_	_	_	S-Emotional_state
23	,	_	,	_	,	73	_	_	_	_	_	_	_	O
24	encourage	_	encourage	_	VB	73	_	_	_	_	_	_	_	O
25	them	_	them	_	PRP	73	_	_	_	_	_	_	_	O
26	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
27	maintain	_	maintain	_	VB	73	_	_	_	_	_	_	_	O
28	it	_	it	_	PRP	73	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	73	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	73	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	73	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
7	achieve	_	achieve	_	VBP	73	_	_	_	_	_	_	_	O
8	an	_	an	_	DT	73	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
10	level	_	level	_	NN	73	_	_	_	_	_	_	_	O
11	that	_	that	_	WDT	73	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	73	_	_	_	_	_	_	_	O
13	lower	_	lower	_	JJR	73	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	73	_	_	_	_	_	_	_	O
15	their	_	their	_	PRP$	73	_	_	_	_	_	_	_	O
16	target	_	target	_	NN	73	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
18	they	_	they	_	PRP	73	_	_	_	_	_	_	_	S-Agent
19	are	_	be	_	VBP	73	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
21	experiencing	_	experience	_	VBG	73	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
23	,	_	,	_	,	73	_	_	_	_	_	_	_	O
24	encourage	_	encourage	_	VB	73	_	_	_	_	_	encourage.v	Subjective_influence	O
25	them	_	them	_	PRP	73	_	_	_	_	_	_	_	S-Situation
26	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
27	maintain	_	maintain	_	VB	73	_	_	_	_	_	_	_	O
28	it	_	it	_	PRP	73	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	73	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	73	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	73	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	73	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	73	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	73	_	_	_	_	_	_	_	O
7	achieve	_	achieve	_	VBP	73	_	_	_	_	_	_	_	O
8	an	_	an	_	DT	73	_	_	_	_	_	_	_	O
9	hba1c	_	UNK	_	NNP	73	_	_	_	_	_	_	_	O
10	level	_	level	_	NN	73	_	_	_	_	_	_	_	O
11	that	_	that	_	WDT	73	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	73	_	_	_	_	_	_	_	O
13	lower	_	lower	_	JJR	73	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	73	_	_	_	_	_	_	_	O
15	their	_	their	_	PRP$	73	_	_	_	_	_	_	_	O
16	target	_	target	_	NN	73	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	73	_	_	_	_	_	_	_	O
18	they	_	they	_	PRP	73	_	_	_	_	_	_	_	O
19	are	_	be	_	VBP	73	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	73	_	_	_	_	_	_	_	O
21	experiencing	_	experience	_	VBG	73	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	73	_	_	_	_	_	_	_	O
23	,	_	,	_	,	73	_	_	_	_	_	_	_	O
24	encourage	_	encourage	_	VB	73	_	_	_	_	_	_	_	O
25	them	_	them	_	PRP	73	_	_	_	_	_	_	_	S-Agent
26	to	_	to	_	TO	73	_	_	_	_	_	_	_	O
27	maintain	_	maintain	_	VB	73	_	_	_	_	_	maintain.v	Activity_ongoing	O
28	it	_	it	_	PRP	73	_	_	_	_	_	_	_	S-Activity

1	be	_	UNK	_	NNP	74	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	74	_	_	_	_	_	aware.a	Awareness	O
3	that	_	that	_	IN	74	_	_	_	_	_	_	_	B-Content
4	there	_	there	_	EX	74	_	_	_	_	_	_	_	I-Content
5	are	_	be	_	VBP	74	_	_	_	_	_	_	_	I-Content
6	other	_	other	_	JJ	74	_	_	_	_	_	_	_	I-Content
7	possible	_	possible	_	JJ	74	_	_	_	_	_	_	_	I-Content
8	reasons	_	reason	_	NNS	74	_	_	_	_	_	_	_	I-Content
9	for	_	for	_	IN	74	_	_	_	_	_	_	_	I-Content
10	a	_	a	_	DT	74	_	_	_	_	_	_	_	I-Content
11	low	_	low	_	JJ	74	_	_	_	_	_	_	_	I-Content
12	hba1c	_	UNK	_	NNP	74	_	_	_	_	_	_	_	I-Content
13	level	_	level	_	NN	74	_	_	_	_	_	_	_	I-Content
14	,	_	,	_	,	74	_	_	_	_	_	_	_	I-Content
15	for	_	for	_	IN	74	_	_	_	_	_	_	_	I-Content
16	example	_	example	_	NN	74	_	_	_	_	_	_	_	I-Content
17	,	_	,	_	,	74	_	_	_	_	_	_	_	I-Content
18	deteriorating	_	deteriorate	_	VBG	74	_	_	_	_	_	_	_	I-Content
19	renal	_	UNK	_	JJ	74	_	_	_	_	_	_	_	I-Content
20	function	_	function	_	NN	74	_	_	_	_	_	_	_	I-Content
21	or	_	or	_	CC	74	_	_	_	_	_	_	_	I-Content
22	sudden	_	sudden	_	JJ	74	_	_	_	_	_	_	_	I-Content
23	weight	_	weight	_	NN	74	_	_	_	_	_	_	_	O
24	loss	_	loss	_	NN	74	_	_	_	_	_	_	_	O
25	.	_	.	_	.	74	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	74	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	74	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	74	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	74	_	_	_	_	_	there.adv	Locative_relation	S-Ground
5	are	_	be	_	VBP	74	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	74	_	_	_	_	_	_	_	O
7	possible	_	possible	_	JJ	74	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	74	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	74	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	74	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	74	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	74	_	_	_	_	_	_	_	O
13	level	_	level	_	NN	74	_	_	_	_	_	_	_	O
14	,	_	,	_	,	74	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	74	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	74	_	_	_	_	_	_	_	O
17	,	_	,	_	,	74	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	74	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	74	_	_	_	_	_	_	_	O
20	function	_	function	_	NN	74	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	74	_	_	_	_	_	_	_	O
22	sudden	_	sudden	_	JJ	74	_	_	_	_	_	_	_	O
23	weight	_	weight	_	NN	74	_	_	_	_	_	_	_	O
24	loss	_	loss	_	NN	74	_	_	_	_	_	_	_	O
25	.	_	.	_	.	74	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	74	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	74	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	74	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	74	_	_	_	_	_	_	_	O
5	are	_	be	_	VBP	74	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	74	_	_	_	_	_	other.a	Increment	O
7	possible	_	possible	_	JJ	74	_	_	_	_	_	_	_	B-Class
8	reasons	_	reason	_	NNS	74	_	_	_	_	_	_	_	I-Class
9	for	_	for	_	IN	74	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	74	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	74	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	74	_	_	_	_	_	_	_	O
13	level	_	level	_	NN	74	_	_	_	_	_	_	_	O
14	,	_	,	_	,	74	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	74	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	74	_	_	_	_	_	_	_	O
17	,	_	,	_	,	74	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	74	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	74	_	_	_	_	_	_	_	O
20	function	_	function	_	NN	74	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	74	_	_	_	_	_	_	_	O
22	sudden	_	sudden	_	JJ	74	_	_	_	_	_	_	_	O
23	weight	_	weight	_	NN	74	_	_	_	_	_	_	_	O
24	loss	_	loss	_	NN	74	_	_	_	_	_	_	_	O
25	.	_	.	_	.	74	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	74	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	74	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	74	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	74	_	_	_	_	_	_	_	O
5	are	_	be	_	VBP	74	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	74	_	_	_	_	_	_	_	O
7	possible	_	possible	_	JJ	74	_	_	_	_	_	possible.a	Likelihood	O
8	reasons	_	reason	_	NNS	74	_	_	_	_	_	_	_	S-Hypothetical_event
9	for	_	for	_	IN	74	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	74	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	74	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	74	_	_	_	_	_	_	_	O
13	level	_	level	_	NN	74	_	_	_	_	_	_	_	O
14	,	_	,	_	,	74	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	74	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	74	_	_	_	_	_	_	_	O
17	,	_	,	_	,	74	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	74	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	74	_	_	_	_	_	_	_	O
20	function	_	function	_	NN	74	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	74	_	_	_	_	_	_	_	O
22	sudden	_	sudden	_	JJ	74	_	_	_	_	_	_	_	O
23	weight	_	weight	_	NN	74	_	_	_	_	_	_	_	O
24	loss	_	loss	_	NN	74	_	_	_	_	_	_	_	O
25	.	_	.	_	.	74	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	74	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	74	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	74	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	74	_	_	_	_	_	_	_	O
5	are	_	be	_	VBP	74	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	74	_	_	_	_	_	_	_	O
7	possible	_	possible	_	JJ	74	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	74	_	_	_	_	_	reason.n	Reason	S-State_of_affairs
9	for	_	for	_	IN	74	_	_	_	_	_	_	_	B-Action
10	a	_	a	_	DT	74	_	_	_	_	_	_	_	I-Action
11	low	_	low	_	JJ	74	_	_	_	_	_	_	_	I-Action
12	hba1c	_	UNK	_	NNP	74	_	_	_	_	_	_	_	I-Action
13	level	_	level	_	NN	74	_	_	_	_	_	_	_	I-Action
14	,	_	,	_	,	74	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	74	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	74	_	_	_	_	_	_	_	O
17	,	_	,	_	,	74	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	74	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	74	_	_	_	_	_	_	_	O
20	function	_	function	_	NN	74	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	74	_	_	_	_	_	_	_	O
22	sudden	_	sudden	_	JJ	74	_	_	_	_	_	_	_	O
23	weight	_	weight	_	NN	74	_	_	_	_	_	_	_	O
24	loss	_	loss	_	NN	74	_	_	_	_	_	_	_	O
25	.	_	.	_	.	74	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	74	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	74	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	74	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	74	_	_	_	_	_	_	_	O
5	are	_	be	_	VBP	74	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	74	_	_	_	_	_	_	_	O
7	possible	_	possible	_	JJ	74	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	74	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	74	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	74	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	74	_	_	_	_	_	low.a	Position_on_a_scale	S-Value
12	hba1c	_	UNK	_	NNP	74	_	_	_	_	_	_	_	B-Item
13	level	_	level	_	NN	74	_	_	_	_	_	_	_	I-Item
14	,	_	,	_	,	74	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	74	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	74	_	_	_	_	_	_	_	O
17	,	_	,	_	,	74	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	74	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	74	_	_	_	_	_	_	_	O
20	function	_	function	_	NN	74	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	74	_	_	_	_	_	_	_	O
22	sudden	_	sudden	_	JJ	74	_	_	_	_	_	_	_	O
23	weight	_	weight	_	NN	74	_	_	_	_	_	_	_	O
24	loss	_	loss	_	NN	74	_	_	_	_	_	_	_	O
25	.	_	.	_	.	74	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	74	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	74	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	74	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	74	_	_	_	_	_	_	_	O
5	are	_	be	_	VBP	74	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	74	_	_	_	_	_	_	_	O
7	possible	_	possible	_	JJ	74	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	74	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	74	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	74	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	74	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	74	_	_	_	_	_	_	_	O
13	level	_	level	_	NN	74	_	_	_	_	_	_	_	O
14	,	_	,	_	,	74	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	74	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	74	_	_	_	_	_	example.n	Instance	S-Instance
17	,	_	,	_	,	74	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	74	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	74	_	_	_	_	_	_	_	O
20	function	_	function	_	NN	74	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	74	_	_	_	_	_	_	_	O
22	sudden	_	sudden	_	JJ	74	_	_	_	_	_	_	_	O
23	weight	_	weight	_	NN	74	_	_	_	_	_	_	_	O
24	loss	_	loss	_	NN	74	_	_	_	_	_	_	_	O
25	.	_	.	_	.	74	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	74	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	74	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	74	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	74	_	_	_	_	_	_	_	O
5	are	_	be	_	VBP	74	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	74	_	_	_	_	_	_	_	O
7	possible	_	possible	_	JJ	74	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	74	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	74	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	74	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	74	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	74	_	_	_	_	_	_	_	O
13	level	_	level	_	NN	74	_	_	_	_	_	_	_	O
14	,	_	,	_	,	74	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	74	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	74	_	_	_	_	_	_	_	O
17	,	_	,	_	,	74	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	74	_	_	_	_	_	deteriorate.v	Improvement_or_decline	O
19	renal	_	UNK	_	JJ	74	_	_	_	_	_	_	_	B-Entity
20	function	_	function	_	NN	74	_	_	_	_	_	_	_	I-Entity
21	or	_	or	_	CC	74	_	_	_	_	_	_	_	I-Entity
22	sudden	_	sudden	_	JJ	74	_	_	_	_	_	_	_	I-Entity
23	weight	_	weight	_	NN	74	_	_	_	_	_	_	_	I-Entity
24	loss	_	loss	_	NN	74	_	_	_	_	_	_	_	I-Entity
25	.	_	.	_	.	74	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	74	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	74	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	74	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	74	_	_	_	_	_	_	_	O
5	are	_	be	_	VBP	74	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	74	_	_	_	_	_	_	_	O
7	possible	_	possible	_	JJ	74	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	74	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	74	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	74	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	74	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	74	_	_	_	_	_	_	_	O
13	level	_	level	_	NN	74	_	_	_	_	_	_	_	O
14	,	_	,	_	,	74	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	74	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	74	_	_	_	_	_	_	_	O
17	,	_	,	_	,	74	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	74	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	74	_	_	_	_	_	_	_	S-Determinant
20	function	_	function	_	NN	74	_	_	_	_	_	function.n	Contingency	O
21	or	_	or	_	CC	74	_	_	_	_	_	_	_	O
22	sudden	_	sudden	_	JJ	74	_	_	_	_	_	_	_	O
23	weight	_	weight	_	NN	74	_	_	_	_	_	_	_	B-Determinant
24	loss	_	loss	_	NN	74	_	_	_	_	_	_	_	I-Determinant
25	.	_	.	_	.	74	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	74	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	74	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	74	_	_	_	_	_	_	_	O
4	there	_	there	_	EX	74	_	_	_	_	_	_	_	O
5	are	_	be	_	VBP	74	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	74	_	_	_	_	_	_	_	O
7	possible	_	possible	_	JJ	74	_	_	_	_	_	_	_	O
8	reasons	_	reason	_	NNS	74	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	74	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	74	_	_	_	_	_	_	_	O
11	low	_	low	_	JJ	74	_	_	_	_	_	_	_	O
12	hba1c	_	UNK	_	NNP	74	_	_	_	_	_	_	_	O
13	level	_	level	_	NN	74	_	_	_	_	_	_	_	O
14	,	_	,	_	,	74	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	74	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	74	_	_	_	_	_	_	_	O
17	,	_	,	_	,	74	_	_	_	_	_	_	_	O
18	deteriorating	_	deteriorate	_	VBG	74	_	_	_	_	_	_	_	O
19	renal	_	UNK	_	JJ	74	_	_	_	_	_	_	_	O
20	function	_	function	_	NN	74	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	74	_	_	_	_	_	_	_	O
22	sudden	_	sudden	_	JJ	74	_	_	_	_	_	_	_	O
23	weight	_	weight	_	NN	74	_	_	_	_	_	weight.n	Dimension	S-Dimension
24	loss	_	loss	_	NN	74	_	_	_	_	_	_	_	O
25	.	_	.	_	.	74	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	75	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	75	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	75	_	_	_	_	_	_	_	O
4	hba1c	_	UNK	_	NNP	75	_	_	_	_	_	_	_	O
5	targets	_	target	_	NNS	75	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	75	_	_	_	_	_	_	_	O
7	women	_	woman	_	NNS	75	_	_	_	_	_	woman.n	People	S-Person
8	with	_	with	_	IN	75	_	_	_	_	_	_	_	O
9	type	_	type	_	JJ	75	_	_	_	_	_	_	_	O
10	2	_	2	_	CD	75	_	_	_	_	_	_	_	O
11	diabetes	_	UNK	_	NNS	75	_	_	_	_	_	_	_	O
12	who	_	who	_	WP	75	_	_	_	_	_	_	_	O
13	are	_	be	_	VBP	75	_	_	_	_	_	_	_	O
14	pregnant	_	pregnant	_	JJ	75	_	_	_	_	_	_	_	O
15	or	_	or	_	CC	75	_	_	_	_	_	_	_	O
16	planning	_	plan	_	VBG	75	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	75	_	_	_	_	_	_	_	O
18	become	_	become	_	VB	75	_	_	_	_	_	_	_	O
19	pregnant	_	pregnant	_	JJ	75	_	_	_	_	_	_	_	O
20	,	_	,	_	,	75	_	_	_	_	_	_	_	O
21	see	_	see	_	VB	75	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	75	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	75	_	_	_	_	_	_	_	O
24	guideline	_	guideline	_	NN	75	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	75	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	75	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	75	_	_	_	_	_	_	_	O
28	pregnancy	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
29	.	_	.	_	.	75	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	75	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	75	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	75	_	_	_	_	_	_	_	O
4	hba1c	_	UNK	_	NNP	75	_	_	_	_	_	_	_	O
5	targets	_	target	_	NNS	75	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	75	_	_	_	_	_	_	_	O
7	women	_	woman	_	NNS	75	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	75	_	_	_	_	_	_	_	O
9	type	_	type	_	JJ	75	_	_	_	_	_	type.n	Type	S-Subtype
10	2	_	2	_	CD	75	_	_	_	_	_	_	_	O
11	diabetes	_	UNK	_	NNS	75	_	_	_	_	_	_	_	O
12	who	_	who	_	WP	75	_	_	_	_	_	_	_	O
13	are	_	be	_	VBP	75	_	_	_	_	_	_	_	O
14	pregnant	_	pregnant	_	JJ	75	_	_	_	_	_	_	_	O
15	or	_	or	_	CC	75	_	_	_	_	_	_	_	O
16	planning	_	plan	_	VBG	75	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	75	_	_	_	_	_	_	_	O
18	become	_	become	_	VB	75	_	_	_	_	_	_	_	O
19	pregnant	_	pregnant	_	JJ	75	_	_	_	_	_	_	_	O
20	,	_	,	_	,	75	_	_	_	_	_	_	_	O
21	see	_	see	_	VB	75	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	75	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	75	_	_	_	_	_	_	_	O
24	guideline	_	guideline	_	NN	75	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	75	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	75	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	75	_	_	_	_	_	_	_	O
28	pregnancy	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
29	.	_	.	_	.	75	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	75	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	75	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	75	_	_	_	_	_	_	_	O
4	hba1c	_	UNK	_	NNP	75	_	_	_	_	_	_	_	O
5	targets	_	target	_	NNS	75	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	75	_	_	_	_	_	_	_	O
7	women	_	woman	_	NNS	75	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	75	_	_	_	_	_	_	_	O
9	type	_	type	_	JJ	75	_	_	_	_	_	_	_	O
10	2	_	2	_	CD	75	_	_	_	_	_	_	_	O
11	diabetes	_	UNK	_	NNS	75	_	_	_	_	_	_	_	O
12	who	_	who	_	WP	75	_	_	_	_	_	_	_	S-Agent
13	are	_	be	_	VBP	75	_	_	_	_	_	_	_	O
14	pregnant	_	pregnant	_	JJ	75	_	_	_	_	_	_	_	O
15	or	_	or	_	CC	75	_	_	_	_	_	_	_	O
16	planning	_	plan	_	VBG	75	_	_	_	_	_	plan.v	Making_arrangements	O
17	to	_	to	_	TO	75	_	_	_	_	_	_	_	B-Event
18	become	_	become	_	VB	75	_	_	_	_	_	_	_	I-Event
19	pregnant	_	pregnant	_	JJ	75	_	_	_	_	_	_	_	I-Event
20	,	_	,	_	,	75	_	_	_	_	_	_	_	O
21	see	_	see	_	VB	75	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	75	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	75	_	_	_	_	_	_	_	O
24	guideline	_	guideline	_	NN	75	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	75	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	75	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	75	_	_	_	_	_	_	_	O
28	pregnancy	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
29	.	_	.	_	.	75	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	75	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	75	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	75	_	_	_	_	_	_	_	O
4	hba1c	_	UNK	_	NNP	75	_	_	_	_	_	_	_	O
5	targets	_	target	_	NNS	75	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	75	_	_	_	_	_	_	_	O
7	women	_	woman	_	NNS	75	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	75	_	_	_	_	_	_	_	O
9	type	_	type	_	JJ	75	_	_	_	_	_	_	_	O
10	2	_	2	_	CD	75	_	_	_	_	_	_	_	O
11	diabetes	_	UNK	_	NNS	75	_	_	_	_	_	_	_	O
12	who	_	who	_	WP	75	_	_	_	_	_	_	_	S-Entity
13	are	_	be	_	VBP	75	_	_	_	_	_	_	_	O
14	pregnant	_	pregnant	_	JJ	75	_	_	_	_	_	_	_	O
15	or	_	or	_	CC	75	_	_	_	_	_	_	_	O
16	planning	_	plan	_	VBG	75	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	75	_	_	_	_	_	_	_	O
18	become	_	become	_	VB	75	_	_	_	_	_	become.v	Becoming	O
19	pregnant	_	pregnant	_	JJ	75	_	_	_	_	_	_	_	S-Final_category
20	,	_	,	_	,	75	_	_	_	_	_	_	_	O
21	see	_	see	_	VB	75	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	75	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	75	_	_	_	_	_	_	_	O
24	guideline	_	guideline	_	NN	75	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	75	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	75	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	75	_	_	_	_	_	_	_	O
28	pregnancy	_	UNK	_	NN	75	_	_	_	_	_	_	_	O
29	.	_	.	_	.	75	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	77	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
3	driver	_	UNK	_	NNP	77	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	77	_	_	_	_	_	_	_	O
5	vehicle	_	Vehicle	_	NNP	77	_	_	_	_	_	vehicle.n	Vehicle	S-Vehicle
6	licensing	_	UNK	_	NNP	77	_	_	_	_	_	_	_	O
7	agency	_	Agency	_	NNP	77	_	_	_	_	_	_	_	O
8	(	_	(	_	(	77	_	_	_	_	_	_	_	O
9	dvla	_	UNK	_	NNP	77	_	_	_	_	_	_	_	O
10	)	_	)	_	)	77	_	_	_	_	_	_	_	O
11	at	_	At	_	IN	77	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	77	_	_	_	_	_	_	_	O
13	glance	_	glance	_	NN	77	_	_	_	_	_	_	_	O
14	guide	_	guide	_	NN	77	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
17	current	_	current	_	JJ	77	_	_	_	_	_	_	_	O
18	medical	_	medical	_	JJ	77	_	_	_	_	_	_	_	O
19	standards	_	standard	_	NNS	77	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
21	fitness	_	fitness	_	NN	77	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
23	drive	_	drive	_	VB	77	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	77	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	77	_	_	_	_	_	_	_	O
26	when	_	when	_	WRB	77	_	_	_	_	_	_	_	O
27	offering	_	offer	_	VBG	77	_	_	_	_	_	_	_	O
28	self-monitoring	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	77	_	_	_	_	_	_	_	O
31	glucose	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
32	levels	_	level	_	NNS	77	_	_	_	_	_	_	_	O
33	for	_	for	_	IN	77	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	77	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	77	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	77	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	77	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	77	_	_	_	_	_	_	_	O
39	.	_	.	_	.	77	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	77	_	_	_	_	_	_	_	B-Figure
2	the	_	the	_	DT	77	_	_	_	_	_	_	_	I-Figure
3	driver	_	UNK	_	NNP	77	_	_	_	_	_	_	_	I-Figure
4	and	_	and	_	CC	77	_	_	_	_	_	_	_	I-Figure
5	vehicle	_	Vehicle	_	NNP	77	_	_	_	_	_	_	_	I-Figure
6	licensing	_	UNK	_	NNP	77	_	_	_	_	_	_	_	I-Figure
7	agency	_	Agency	_	NNP	77	_	_	_	_	_	_	_	I-Figure
8	(	_	(	_	(	77	_	_	_	_	_	_	_	I-Figure
9	dvla	_	UNK	_	NNP	77	_	_	_	_	_	_	_	I-Figure
10	)	_	)	_	)	77	_	_	_	_	_	_	_	I-Figure
11	at	_	At	_	IN	77	_	_	_	_	_	at.prep	Locative_relation	O
12	a	_	a	_	DT	77	_	_	_	_	_	_	_	B-Ground
13	glance	_	glance	_	NN	77	_	_	_	_	_	_	_	I-Ground
14	guide	_	guide	_	NN	77	_	_	_	_	_	_	_	I-Ground
15	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
17	current	_	current	_	JJ	77	_	_	_	_	_	_	_	O
18	medical	_	medical	_	JJ	77	_	_	_	_	_	_	_	O
19	standards	_	standard	_	NNS	77	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
21	fitness	_	fitness	_	NN	77	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
23	drive	_	drive	_	VB	77	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	77	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	77	_	_	_	_	_	_	_	O
26	when	_	when	_	WRB	77	_	_	_	_	_	_	_	O
27	offering	_	offer	_	VBG	77	_	_	_	_	_	_	_	O
28	self-monitoring	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	77	_	_	_	_	_	_	_	O
31	glucose	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
32	levels	_	level	_	NNS	77	_	_	_	_	_	_	_	O
33	for	_	for	_	IN	77	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	77	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	77	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	77	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	77	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	77	_	_	_	_	_	_	_	O
39	.	_	.	_	.	77	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	77	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
3	driver	_	UNK	_	NNP	77	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	77	_	_	_	_	_	_	_	O
5	vehicle	_	Vehicle	_	NNP	77	_	_	_	_	_	_	_	O
6	licensing	_	UNK	_	NNP	77	_	_	_	_	_	_	_	O
7	agency	_	Agency	_	NNP	77	_	_	_	_	_	_	_	O
8	(	_	(	_	(	77	_	_	_	_	_	_	_	O
9	dvla	_	UNK	_	NNP	77	_	_	_	_	_	_	_	O
10	)	_	)	_	)	77	_	_	_	_	_	_	_	O
11	at	_	At	_	IN	77	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	77	_	_	_	_	_	_	_	O
13	glance	_	glance	_	NN	77	_	_	_	_	_	glance.n	Perception_active	O
14	guide	_	guide	_	NN	77	_	_	_	_	_	_	_	S-Phenomenon
15	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
17	current	_	current	_	JJ	77	_	_	_	_	_	_	_	O
18	medical	_	medical	_	JJ	77	_	_	_	_	_	_	_	O
19	standards	_	standard	_	NNS	77	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
21	fitness	_	fitness	_	NN	77	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
23	drive	_	drive	_	VB	77	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	77	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	77	_	_	_	_	_	_	_	O
26	when	_	when	_	WRB	77	_	_	_	_	_	_	_	O
27	offering	_	offer	_	VBG	77	_	_	_	_	_	_	_	O
28	self-monitoring	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	77	_	_	_	_	_	_	_	O
31	glucose	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
32	levels	_	level	_	NNS	77	_	_	_	_	_	_	_	O
33	for	_	for	_	IN	77	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	77	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	77	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	77	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	77	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	77	_	_	_	_	_	_	_	O
39	.	_	.	_	.	77	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	77	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
3	driver	_	UNK	_	NNP	77	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	77	_	_	_	_	_	_	_	O
5	vehicle	_	Vehicle	_	NNP	77	_	_	_	_	_	_	_	O
6	licensing	_	UNK	_	NNP	77	_	_	_	_	_	_	_	O
7	agency	_	Agency	_	NNP	77	_	_	_	_	_	_	_	O
8	(	_	(	_	(	77	_	_	_	_	_	_	_	O
9	dvla	_	UNK	_	NNP	77	_	_	_	_	_	_	_	O
10	)	_	)	_	)	77	_	_	_	_	_	_	_	O
11	at	_	At	_	IN	77	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	77	_	_	_	_	_	_	_	O
13	glance	_	glance	_	NN	77	_	_	_	_	_	_	_	O
14	guide	_	guide	_	NN	77	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
17	current	_	current	_	JJ	77	_	_	_	_	_	current.a	Temporal_collocation	O
18	medical	_	medical	_	JJ	77	_	_	_	_	_	_	_	B-Trajector_entity
19	standards	_	standard	_	NNS	77	_	_	_	_	_	_	_	I-Trajector_entity
20	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
21	fitness	_	fitness	_	NN	77	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
23	drive	_	drive	_	VB	77	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	77	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	77	_	_	_	_	_	_	_	O
26	when	_	when	_	WRB	77	_	_	_	_	_	_	_	O
27	offering	_	offer	_	VBG	77	_	_	_	_	_	_	_	O
28	self-monitoring	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	77	_	_	_	_	_	_	_	O
31	glucose	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
32	levels	_	level	_	NNS	77	_	_	_	_	_	_	_	O
33	for	_	for	_	IN	77	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	77	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	77	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	77	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	77	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	77	_	_	_	_	_	_	_	O
39	.	_	.	_	.	77	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	77	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
3	driver	_	UNK	_	NNP	77	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	77	_	_	_	_	_	_	_	O
5	vehicle	_	Vehicle	_	NNP	77	_	_	_	_	_	_	_	O
6	licensing	_	UNK	_	NNP	77	_	_	_	_	_	_	_	O
7	agency	_	Agency	_	NNP	77	_	_	_	_	_	_	_	O
8	(	_	(	_	(	77	_	_	_	_	_	_	_	O
9	dvla	_	UNK	_	NNP	77	_	_	_	_	_	_	_	O
10	)	_	)	_	)	77	_	_	_	_	_	_	_	O
11	at	_	At	_	IN	77	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	77	_	_	_	_	_	_	_	O
13	glance	_	glance	_	NN	77	_	_	_	_	_	_	_	O
14	guide	_	guide	_	NN	77	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
17	current	_	current	_	JJ	77	_	_	_	_	_	_	_	O
18	medical	_	medical	_	JJ	77	_	_	_	_	_	_	_	O
19	standards	_	standard	_	NNS	77	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
21	fitness	_	fitness	_	NN	77	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
23	drive	_	drive	_	VB	77	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	77	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	77	_	_	_	_	_	account.n	Text	O
26	when	_	when	_	WRB	77	_	_	_	_	_	_	_	O
27	offering	_	offer	_	VBG	77	_	_	_	_	_	_	_	O
28	self-monitoring	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	77	_	_	_	_	_	_	_	O
31	glucose	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
32	levels	_	level	_	NNS	77	_	_	_	_	_	_	_	O
33	for	_	for	_	IN	77	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	77	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	77	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	77	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	77	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	77	_	_	_	_	_	_	_	O
39	.	_	.	_	.	77	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	77	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
3	driver	_	UNK	_	NNP	77	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	77	_	_	_	_	_	_	_	O
5	vehicle	_	Vehicle	_	NNP	77	_	_	_	_	_	_	_	O
6	licensing	_	UNK	_	NNP	77	_	_	_	_	_	_	_	O
7	agency	_	Agency	_	NNP	77	_	_	_	_	_	_	_	O
8	(	_	(	_	(	77	_	_	_	_	_	_	_	O
9	dvla	_	UNK	_	NNP	77	_	_	_	_	_	_	_	O
10	)	_	)	_	)	77	_	_	_	_	_	_	_	O
11	at	_	At	_	IN	77	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	77	_	_	_	_	_	_	_	O
13	glance	_	glance	_	NN	77	_	_	_	_	_	_	_	O
14	guide	_	guide	_	NN	77	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
17	current	_	current	_	JJ	77	_	_	_	_	_	_	_	O
18	medical	_	medical	_	JJ	77	_	_	_	_	_	_	_	O
19	standards	_	standard	_	NNS	77	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
21	fitness	_	fitness	_	NN	77	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
23	drive	_	drive	_	VB	77	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	77	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	77	_	_	_	_	_	_	_	O
26	when	_	when	_	WRB	77	_	_	_	_	_	_	_	O
27	offering	_	offer	_	VBG	77	_	_	_	_	_	_	_	O
28	self-monitoring	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	77	_	_	_	_	_	_	_	O
31	glucose	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
32	levels	_	level	_	NNS	77	_	_	_	_	_	_	_	O
33	for	_	for	_	IN	77	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	77	_	_	_	_	_	adult.n	People_by_age	S-Person
35	with	_	with	_	IN	77	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	77	_	_	_	_	_	_	_	O
37	2	_	2	_	CD	77	_	_	_	_	_	_	_	O
38	diabetes	_	UNK	_	NNS	77	_	_	_	_	_	_	_	O
39	.	_	.	_	.	77	_	_	_	_	_	_	_	O

1	take	_	UNK	_	VB	77	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
3	driver	_	UNK	_	NNP	77	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	77	_	_	_	_	_	_	_	O
5	vehicle	_	Vehicle	_	NNP	77	_	_	_	_	_	_	_	O
6	licensing	_	UNK	_	NNP	77	_	_	_	_	_	_	_	O
7	agency	_	Agency	_	NNP	77	_	_	_	_	_	_	_	O
8	(	_	(	_	(	77	_	_	_	_	_	_	_	O
9	dvla	_	UNK	_	NNP	77	_	_	_	_	_	_	_	O
10	)	_	)	_	)	77	_	_	_	_	_	_	_	O
11	at	_	At	_	IN	77	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	77	_	_	_	_	_	_	_	O
13	glance	_	glance	_	NN	77	_	_	_	_	_	_	_	O
14	guide	_	guide	_	NN	77	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	77	_	_	_	_	_	_	_	O
17	current	_	current	_	JJ	77	_	_	_	_	_	_	_	O
18	medical	_	medical	_	JJ	77	_	_	_	_	_	_	_	O
19	standards	_	standard	_	NNS	77	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
21	fitness	_	fitness	_	NN	77	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	77	_	_	_	_	_	_	_	O
23	drive	_	drive	_	VB	77	_	_	_	_	_	_	_	O
24	into	_	into	_	IN	77	_	_	_	_	_	_	_	O
25	account	_	account	_	NN	77	_	_	_	_	_	_	_	O
26	when	_	when	_	WRB	77	_	_	_	_	_	_	_	O
27	offering	_	offer	_	VBG	77	_	_	_	_	_	_	_	O
28	self-monitoring	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
29	of	_	of	_	IN	77	_	_	_	_	_	_	_	O
30	blood	_	blood	_	NN	77	_	_	_	_	_	_	_	O
31	glucose	_	UNK	_	NN	77	_	_	_	_	_	_	_	O
32	levels	_	level	_	NNS	77	_	_	_	_	_	_	_	O
33	for	_	for	_	IN	77	_	_	_	_	_	_	_	O
34	adults	_	adult	_	NNS	77	_	_	_	_	_	_	_	O
35	with	_	with	_	IN	77	_	_	_	_	_	_	_	O
36	type	_	type	_	JJ	77	_	_	_	_	_	type.n	Type	S-Subtype
37	2	_	2	_	CD	77	_	_	_	_	_	_	_	B-Category
38	diabetes	_	UNK	_	NNS	77	_	_	_	_	_	_	_	I-Category
39	.	_	.	_	.	77	_	_	_	_	_	_	_	O

1	do	_	Do	_	NNP	78	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	78	_	_	_	_	_	_	_	O
3	routinely	_	routinely	_	RB	78	_	_	_	_	_	_	_	O
4	offer	_	offer	_	VBP	78	_	_	_	_	_	_	_	O
5	self-monitoring	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	78	_	_	_	_	_	_	_	O
8	glucose	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
9	levels	_	level	_	NNS	78	_	_	_	_	_	_	_	O
10	for	_	for	_	IN	78	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	78	_	_	_	_	_	adult.n	People_by_age	S-Person
12	with	_	with	_	IN	78	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	78	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	78	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
16	unless	_	unless	_	IN	78	_	_	_	_	_	_	_	O
17	:	_	:	_	:	78	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	78	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
21	on	_	on	_	IN	78	_	_	_	_	_	_	_	O
22	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
23	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
24	there	_	there	_	EX	78	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
26	evidence	_	evidence	_	NN	78	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	JJ	78	_	_	_	_	_	_	_	O
29	episodes	_	episode	_	NNS	78	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
32	person	_	person	_	NN	78	_	_	_	_	_	_	_	O
33	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
34	on	_	on	_	IN	78	_	_	_	_	_	_	_	O
35	oral	_	UNK	_	JJ	78	_	_	_	_	_	_	_	O
36	medication	_	medication	_	NN	78	_	_	_	_	_	_	_	O
37	that	_	that	_	WDT	78	_	_	_	_	_	_	_	O
38	may	_	may	_	MD	78	_	_	_	_	_	_	_	O
39	increase	_	increase	_	VB	78	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	78	_	_	_	_	_	_	_	O
41	risk	_	risk	_	NN	78	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
43	unk	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
44	while	_	while	_	IN	78	_	_	_	_	_	_	_	O
45	driving	_	drive	_	VBG	78	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
47	operating	_	operate	_	VBG	78	_	_	_	_	_	_	_	O
48	machinery	_	machinery	_	NN	78	_	_	_	_	_	_	_	O
49	or	_	or	_	CC	78	_	_	_	_	_	_	_	O

1	do	_	Do	_	NNP	78	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	78	_	_	_	_	_	_	_	O
3	routinely	_	routinely	_	RB	78	_	_	_	_	_	_	_	O
4	offer	_	offer	_	VBP	78	_	_	_	_	_	_	_	O
5	self-monitoring	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	78	_	_	_	_	_	_	_	O
8	glucose	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
9	levels	_	level	_	NNS	78	_	_	_	_	_	_	_	O
10	for	_	for	_	IN	78	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	78	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	78	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	78	_	_	_	_	_	type.n	Type	S-Subtype
14	2	_	2	_	CD	78	_	_	_	_	_	_	_	B-Category
15	diabetes	_	UNK	_	NNS	78	_	_	_	_	_	_	_	I-Category
16	unless	_	unless	_	IN	78	_	_	_	_	_	_	_	O
17	:	_	:	_	:	78	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	78	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
21	on	_	on	_	IN	78	_	_	_	_	_	_	_	O
22	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
23	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
24	there	_	there	_	EX	78	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
26	evidence	_	evidence	_	NN	78	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	JJ	78	_	_	_	_	_	_	_	O
29	episodes	_	episode	_	NNS	78	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
32	person	_	person	_	NN	78	_	_	_	_	_	_	_	O
33	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
34	on	_	on	_	IN	78	_	_	_	_	_	_	_	O
35	oral	_	UNK	_	JJ	78	_	_	_	_	_	_	_	O
36	medication	_	medication	_	NN	78	_	_	_	_	_	_	_	O
37	that	_	that	_	WDT	78	_	_	_	_	_	_	_	O
38	may	_	may	_	MD	78	_	_	_	_	_	_	_	O
39	increase	_	increase	_	VB	78	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	78	_	_	_	_	_	_	_	O
41	risk	_	risk	_	NN	78	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
43	unk	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
44	while	_	while	_	IN	78	_	_	_	_	_	_	_	O
45	driving	_	drive	_	VBG	78	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
47	operating	_	operate	_	VBG	78	_	_	_	_	_	_	_	O
48	machinery	_	machinery	_	NN	78	_	_	_	_	_	_	_	O
49	or	_	or	_	CC	78	_	_	_	_	_	_	_	O

1	do	_	Do	_	NNP	78	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	78	_	_	_	_	_	_	_	O
3	routinely	_	routinely	_	RB	78	_	_	_	_	_	_	_	O
4	offer	_	offer	_	VBP	78	_	_	_	_	_	_	_	O
5	self-monitoring	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	78	_	_	_	_	_	_	_	O
8	glucose	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
9	levels	_	level	_	NNS	78	_	_	_	_	_	_	_	O
10	for	_	for	_	IN	78	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	78	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	78	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	78	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	78	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
16	unless	_	unless	_	IN	78	_	_	_	_	_	_	_	O
17	:	_	:	_	:	78	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	78	_	_	_	_	_	person.n	People	S-Person
20	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
21	on	_	on	_	IN	78	_	_	_	_	_	_	_	O
22	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
23	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
24	there	_	there	_	EX	78	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
26	evidence	_	evidence	_	NN	78	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	JJ	78	_	_	_	_	_	_	_	O
29	episodes	_	episode	_	NNS	78	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
32	person	_	person	_	NN	78	_	_	_	_	_	_	_	O
33	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
34	on	_	on	_	IN	78	_	_	_	_	_	_	_	O
35	oral	_	UNK	_	JJ	78	_	_	_	_	_	_	_	O
36	medication	_	medication	_	NN	78	_	_	_	_	_	_	_	O
37	that	_	that	_	WDT	78	_	_	_	_	_	_	_	O
38	may	_	may	_	MD	78	_	_	_	_	_	_	_	O
39	increase	_	increase	_	VB	78	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	78	_	_	_	_	_	_	_	O
41	risk	_	risk	_	NN	78	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
43	unk	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
44	while	_	while	_	IN	78	_	_	_	_	_	_	_	O
45	driving	_	drive	_	VBG	78	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
47	operating	_	operate	_	VBG	78	_	_	_	_	_	_	_	O
48	machinery	_	machinery	_	NN	78	_	_	_	_	_	_	_	O
49	or	_	or	_	CC	78	_	_	_	_	_	_	_	O

1	do	_	Do	_	NNP	78	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	78	_	_	_	_	_	_	_	O
3	routinely	_	routinely	_	RB	78	_	_	_	_	_	_	_	O
4	offer	_	offer	_	VBP	78	_	_	_	_	_	_	_	O
5	self-monitoring	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	78	_	_	_	_	_	_	_	O
8	glucose	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
9	levels	_	level	_	NNS	78	_	_	_	_	_	_	_	O
10	for	_	for	_	IN	78	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	78	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	78	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	78	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	78	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
16	unless	_	unless	_	IN	78	_	_	_	_	_	_	_	O
17	:	_	:	_	:	78	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	78	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
21	on	_	on	_	IN	78	_	_	_	_	_	_	_	O
22	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
23	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
24	there	_	there	_	EX	78	_	_	_	_	_	there.adv	Locative_relation	S-Ground
25	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
26	evidence	_	evidence	_	NN	78	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	JJ	78	_	_	_	_	_	_	_	O
29	episodes	_	episode	_	NNS	78	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
32	person	_	person	_	NN	78	_	_	_	_	_	_	_	O
33	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
34	on	_	on	_	IN	78	_	_	_	_	_	_	_	O
35	oral	_	UNK	_	JJ	78	_	_	_	_	_	_	_	O
36	medication	_	medication	_	NN	78	_	_	_	_	_	_	_	O
37	that	_	that	_	WDT	78	_	_	_	_	_	_	_	O
38	may	_	may	_	MD	78	_	_	_	_	_	_	_	O
39	increase	_	increase	_	VB	78	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	78	_	_	_	_	_	_	_	O
41	risk	_	risk	_	NN	78	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
43	unk	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
44	while	_	while	_	IN	78	_	_	_	_	_	_	_	O
45	driving	_	drive	_	VBG	78	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
47	operating	_	operate	_	VBG	78	_	_	_	_	_	_	_	O
48	machinery	_	machinery	_	NN	78	_	_	_	_	_	_	_	O
49	or	_	or	_	CC	78	_	_	_	_	_	_	_	O

1	do	_	Do	_	NNP	78	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	78	_	_	_	_	_	_	_	O
3	routinely	_	routinely	_	RB	78	_	_	_	_	_	_	_	O
4	offer	_	offer	_	VBP	78	_	_	_	_	_	_	_	O
5	self-monitoring	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	78	_	_	_	_	_	_	_	O
8	glucose	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
9	levels	_	level	_	NNS	78	_	_	_	_	_	_	_	O
10	for	_	for	_	IN	78	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	78	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	78	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	78	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	78	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
16	unless	_	unless	_	IN	78	_	_	_	_	_	_	_	O
17	:	_	:	_	:	78	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	78	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
21	on	_	on	_	IN	78	_	_	_	_	_	_	_	O
22	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
23	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
24	there	_	there	_	EX	78	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
26	evidence	_	evidence	_	NN	78	_	_	_	_	_	evidence.n	Evidence	O
27	of	_	of	_	IN	78	_	_	_	_	_	_	_	B-Proposition
28	unk	_	UNK	_	JJ	78	_	_	_	_	_	_	_	I-Proposition
29	episodes	_	episode	_	NNS	78	_	_	_	_	_	_	_	I-Proposition
30	or	_	or	_	CC	78	_	_	_	_	_	_	_	I-Proposition
31	the	_	the	_	DT	78	_	_	_	_	_	_	_	I-Proposition
32	person	_	person	_	NN	78	_	_	_	_	_	_	_	I-Proposition
33	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	I-Proposition
34	on	_	on	_	IN	78	_	_	_	_	_	_	_	I-Proposition
35	oral	_	UNK	_	JJ	78	_	_	_	_	_	_	_	I-Proposition
36	medication	_	medication	_	NN	78	_	_	_	_	_	_	_	I-Proposition
37	that	_	that	_	WDT	78	_	_	_	_	_	_	_	I-Proposition
38	may	_	may	_	MD	78	_	_	_	_	_	_	_	I-Proposition
39	increase	_	increase	_	VB	78	_	_	_	_	_	_	_	I-Proposition
40	their	_	their	_	PRP$	78	_	_	_	_	_	_	_	I-Proposition
41	risk	_	risk	_	NN	78	_	_	_	_	_	_	_	I-Proposition
42	of	_	of	_	IN	78	_	_	_	_	_	_	_	I-Proposition
43	unk	_	UNK	_	NN	78	_	_	_	_	_	_	_	I-Proposition
44	while	_	while	_	IN	78	_	_	_	_	_	_	_	I-Proposition
45	driving	_	drive	_	VBG	78	_	_	_	_	_	_	_	I-Proposition
46	or	_	or	_	CC	78	_	_	_	_	_	_	_	I-Proposition
47	operating	_	operate	_	VBG	78	_	_	_	_	_	_	_	O
48	machinery	_	machinery	_	NN	78	_	_	_	_	_	_	_	O
49	or	_	or	_	CC	78	_	_	_	_	_	_	_	O

1	do	_	Do	_	NNP	78	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	78	_	_	_	_	_	_	_	O
3	routinely	_	routinely	_	RB	78	_	_	_	_	_	_	_	O
4	offer	_	offer	_	VBP	78	_	_	_	_	_	_	_	O
5	self-monitoring	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	78	_	_	_	_	_	_	_	O
8	glucose	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
9	levels	_	level	_	NNS	78	_	_	_	_	_	_	_	O
10	for	_	for	_	IN	78	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	78	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	78	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	78	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	78	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
16	unless	_	unless	_	IN	78	_	_	_	_	_	_	_	O
17	:	_	:	_	:	78	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	78	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
21	on	_	on	_	IN	78	_	_	_	_	_	_	_	O
22	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
23	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
24	there	_	there	_	EX	78	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
26	evidence	_	evidence	_	NN	78	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	JJ	78	_	_	_	_	_	_	_	S-Place
29	episodes	_	episode	_	NNS	78	_	_	_	_	_	episode.n	Event	S-Event
30	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
32	person	_	person	_	NN	78	_	_	_	_	_	_	_	O
33	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
34	on	_	on	_	IN	78	_	_	_	_	_	_	_	O
35	oral	_	UNK	_	JJ	78	_	_	_	_	_	_	_	O
36	medication	_	medication	_	NN	78	_	_	_	_	_	_	_	O
37	that	_	that	_	WDT	78	_	_	_	_	_	_	_	O
38	may	_	may	_	MD	78	_	_	_	_	_	_	_	O
39	increase	_	increase	_	VB	78	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	78	_	_	_	_	_	_	_	O
41	risk	_	risk	_	NN	78	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
43	unk	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
44	while	_	while	_	IN	78	_	_	_	_	_	_	_	O
45	driving	_	drive	_	VBG	78	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
47	operating	_	operate	_	VBG	78	_	_	_	_	_	_	_	O
48	machinery	_	machinery	_	NN	78	_	_	_	_	_	_	_	O
49	or	_	or	_	CC	78	_	_	_	_	_	_	_	O

1	do	_	Do	_	NNP	78	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	78	_	_	_	_	_	_	_	O
3	routinely	_	routinely	_	RB	78	_	_	_	_	_	_	_	O
4	offer	_	offer	_	VBP	78	_	_	_	_	_	_	_	O
5	self-monitoring	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	78	_	_	_	_	_	_	_	O
8	glucose	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
9	levels	_	level	_	NNS	78	_	_	_	_	_	_	_	O
10	for	_	for	_	IN	78	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	78	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	78	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	78	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	78	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
16	unless	_	unless	_	IN	78	_	_	_	_	_	_	_	O
17	:	_	:	_	:	78	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	78	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
21	on	_	on	_	IN	78	_	_	_	_	_	_	_	O
22	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
23	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
24	there	_	there	_	EX	78	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
26	evidence	_	evidence	_	NN	78	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	JJ	78	_	_	_	_	_	_	_	O
29	episodes	_	episode	_	NNS	78	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
32	person	_	person	_	NN	78	_	_	_	_	_	person.n	People	S-Person
33	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
34	on	_	on	_	IN	78	_	_	_	_	_	_	_	O
35	oral	_	UNK	_	JJ	78	_	_	_	_	_	_	_	O
36	medication	_	medication	_	NN	78	_	_	_	_	_	_	_	O
37	that	_	that	_	WDT	78	_	_	_	_	_	_	_	O
38	may	_	may	_	MD	78	_	_	_	_	_	_	_	O
39	increase	_	increase	_	VB	78	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	78	_	_	_	_	_	_	_	O
41	risk	_	risk	_	NN	78	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
43	unk	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
44	while	_	while	_	IN	78	_	_	_	_	_	_	_	O
45	driving	_	drive	_	VBG	78	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
47	operating	_	operate	_	VBG	78	_	_	_	_	_	_	_	O
48	machinery	_	machinery	_	NN	78	_	_	_	_	_	_	_	O
49	or	_	or	_	CC	78	_	_	_	_	_	_	_	O

1	do	_	Do	_	NNP	78	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	78	_	_	_	_	_	_	_	O
3	routinely	_	routinely	_	RB	78	_	_	_	_	_	_	_	O
4	offer	_	offer	_	VBP	78	_	_	_	_	_	_	_	O
5	self-monitoring	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	78	_	_	_	_	_	_	_	O
8	glucose	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
9	levels	_	level	_	NNS	78	_	_	_	_	_	_	_	O
10	for	_	for	_	IN	78	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	78	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	78	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	78	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	78	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
16	unless	_	unless	_	IN	78	_	_	_	_	_	_	_	O
17	:	_	:	_	:	78	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	78	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
21	on	_	on	_	IN	78	_	_	_	_	_	_	_	O
22	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
23	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
24	there	_	there	_	EX	78	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
26	evidence	_	evidence	_	NN	78	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	JJ	78	_	_	_	_	_	_	_	O
29	episodes	_	episode	_	NNS	78	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
32	person	_	person	_	NN	78	_	_	_	_	_	_	_	O
33	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
34	on	_	on	_	IN	78	_	_	_	_	_	_	_	O
35	oral	_	UNK	_	JJ	78	_	_	_	_	_	_	_	O
36	medication	_	medication	_	NN	78	_	_	_	_	_	_	_	O
37	that	_	that	_	WDT	78	_	_	_	_	_	_	_	O
38	may	_	may	_	MD	78	_	_	_	_	_	_	_	O
39	increase	_	increase	_	VB	78	_	_	_	_	_	increase.v	Change_position_on_a_scale	O
40	their	_	their	_	PRP$	78	_	_	_	_	_	_	_	B-Item
41	risk	_	risk	_	NN	78	_	_	_	_	_	_	_	I-Item
42	of	_	of	_	IN	78	_	_	_	_	_	_	_	I-Item
43	unk	_	UNK	_	NN	78	_	_	_	_	_	_	_	I-Item
44	while	_	while	_	IN	78	_	_	_	_	_	_	_	O
45	driving	_	drive	_	VBG	78	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
47	operating	_	operate	_	VBG	78	_	_	_	_	_	_	_	O
48	machinery	_	machinery	_	NN	78	_	_	_	_	_	_	_	O
49	or	_	or	_	CC	78	_	_	_	_	_	_	_	O

1	do	_	Do	_	NNP	78	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	78	_	_	_	_	_	_	_	O
3	routinely	_	routinely	_	RB	78	_	_	_	_	_	_	_	O
4	offer	_	offer	_	VBP	78	_	_	_	_	_	_	_	O
5	self-monitoring	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	78	_	_	_	_	_	_	_	O
8	glucose	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
9	levels	_	level	_	NNS	78	_	_	_	_	_	_	_	O
10	for	_	for	_	IN	78	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	78	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	78	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	78	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	78	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
16	unless	_	unless	_	IN	78	_	_	_	_	_	_	_	O
17	:	_	:	_	:	78	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	78	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
21	on	_	on	_	IN	78	_	_	_	_	_	_	_	O
22	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
23	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
24	there	_	there	_	EX	78	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
26	evidence	_	evidence	_	NN	78	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	JJ	78	_	_	_	_	_	_	_	O
29	episodes	_	episode	_	NNS	78	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
32	person	_	person	_	NN	78	_	_	_	_	_	_	_	O
33	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
34	on	_	on	_	IN	78	_	_	_	_	_	_	_	O
35	oral	_	UNK	_	JJ	78	_	_	_	_	_	_	_	O
36	medication	_	medication	_	NN	78	_	_	_	_	_	_	_	O
37	that	_	that	_	WDT	78	_	_	_	_	_	_	_	O
38	may	_	may	_	MD	78	_	_	_	_	_	_	_	O
39	increase	_	increase	_	VB	78	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	78	_	_	_	_	_	_	_	S-Protagonist
41	risk	_	risk	_	NN	78	_	_	_	_	_	risk.n	Run_risk	O
42	of	_	of	_	IN	78	_	_	_	_	_	_	_	B-Action
43	unk	_	UNK	_	NN	78	_	_	_	_	_	_	_	I-Action
44	while	_	while	_	IN	78	_	_	_	_	_	_	_	O
45	driving	_	drive	_	VBG	78	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
47	operating	_	operate	_	VBG	78	_	_	_	_	_	_	_	O
48	machinery	_	machinery	_	NN	78	_	_	_	_	_	_	_	O
49	or	_	or	_	CC	78	_	_	_	_	_	_	_	O

1	do	_	Do	_	NNP	78	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	78	_	_	_	_	_	_	_	O
3	routinely	_	routinely	_	RB	78	_	_	_	_	_	_	_	O
4	offer	_	offer	_	VBP	78	_	_	_	_	_	_	_	O
5	self-monitoring	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	78	_	_	_	_	_	_	_	O
8	glucose	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
9	levels	_	level	_	NNS	78	_	_	_	_	_	_	_	O
10	for	_	for	_	IN	78	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	78	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	78	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	78	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	78	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
16	unless	_	unless	_	IN	78	_	_	_	_	_	_	_	O
17	:	_	:	_	:	78	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	78	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
21	on	_	on	_	IN	78	_	_	_	_	_	_	_	O
22	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
23	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
24	there	_	there	_	EX	78	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
26	evidence	_	evidence	_	NN	78	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	JJ	78	_	_	_	_	_	_	_	O
29	episodes	_	episode	_	NNS	78	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
32	person	_	person	_	NN	78	_	_	_	_	_	_	_	O
33	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
34	on	_	on	_	IN	78	_	_	_	_	_	_	_	O
35	oral	_	UNK	_	JJ	78	_	_	_	_	_	_	_	O
36	medication	_	medication	_	NN	78	_	_	_	_	_	_	_	O
37	that	_	that	_	WDT	78	_	_	_	_	_	_	_	O
38	may	_	may	_	MD	78	_	_	_	_	_	_	_	O
39	increase	_	increase	_	VB	78	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	78	_	_	_	_	_	_	_	O
41	risk	_	risk	_	NN	78	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
43	unk	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
44	while	_	while	_	IN	78	_	_	_	_	_	_	_	O
45	driving	_	drive	_	VBG	78	_	_	_	_	_	drive.v	Operate_vehicle	O
46	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
47	operating	_	operate	_	VBG	78	_	_	_	_	_	_	_	O
48	machinery	_	machinery	_	NN	78	_	_	_	_	_	_	_	S-Vehicle
49	or	_	or	_	CC	78	_	_	_	_	_	_	_	O

1	do	_	Do	_	NNP	78	_	_	_	_	_	_	_	O
2	not	_	not	_	RB	78	_	_	_	_	_	_	_	O
3	routinely	_	routinely	_	RB	78	_	_	_	_	_	_	_	O
4	offer	_	offer	_	VBP	78	_	_	_	_	_	_	_	O
5	self-monitoring	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	78	_	_	_	_	_	_	_	O
8	glucose	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
9	levels	_	level	_	NNS	78	_	_	_	_	_	_	_	O
10	for	_	for	_	IN	78	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	78	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	78	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	78	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	78	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	78	_	_	_	_	_	_	_	O
16	unless	_	unless	_	IN	78	_	_	_	_	_	_	_	O
17	:	_	:	_	:	78	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	78	_	_	_	_	_	_	_	O
20	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
21	on	_	on	_	IN	78	_	_	_	_	_	_	_	O
22	insulin	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
23	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
24	there	_	there	_	EX	78	_	_	_	_	_	_	_	O
25	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
26	evidence	_	evidence	_	NN	78	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	JJ	78	_	_	_	_	_	_	_	O
29	episodes	_	episode	_	NNS	78	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	78	_	_	_	_	_	_	_	O
32	person	_	person	_	NN	78	_	_	_	_	_	_	_	O
33	is	_	be	_	VBZ	78	_	_	_	_	_	_	_	O
34	on	_	on	_	IN	78	_	_	_	_	_	_	_	O
35	oral	_	UNK	_	JJ	78	_	_	_	_	_	_	_	O
36	medication	_	medication	_	NN	78	_	_	_	_	_	_	_	O
37	that	_	that	_	WDT	78	_	_	_	_	_	_	_	O
38	may	_	may	_	MD	78	_	_	_	_	_	_	_	O
39	increase	_	increase	_	VB	78	_	_	_	_	_	_	_	O
40	their	_	their	_	PRP$	78	_	_	_	_	_	_	_	O
41	risk	_	risk	_	NN	78	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	78	_	_	_	_	_	_	_	O
43	unk	_	UNK	_	NN	78	_	_	_	_	_	_	_	O
44	while	_	while	_	IN	78	_	_	_	_	_	_	_	O
45	driving	_	drive	_	VBG	78	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	78	_	_	_	_	_	_	_	O
47	operating	_	operate	_	VBG	78	_	_	_	_	_	operate.v	Operating_a_system	O
48	machinery	_	machinery	_	NN	78	_	_	_	_	_	_	_	S-System
49	or	_	or	_	CC	78	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	79	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	79	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	79	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	79	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	79	_	_	_	_	_	_	_	O
6	:	_	:	_	:	79	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	79	_	_	_	_	_	_	_	O
8	(	_	(	_	(	79	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	79	_	_	_	_	_	_	_	O
10	)	_	)	_	)	79	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	79	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	79	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	79	_	_	_	_	_	_	_	O
14	)	_	)	_	)	79	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	79	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	79	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	79	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	79	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	79	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	79	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	79	_	_	_	_	_	_	_	O
8	(	_	(	_	(	79	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	79	_	_	_	_	_	_	_	O
10	)	_	)	_	)	79	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	79	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	79	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	79	_	_	_	_	_	_	_	O
14	)	_	)	_	)	79	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	80	_	_	_	_	_	last.a	Relative_time	O
2	updated	_	update	_	VBD	80	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	80	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	80	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	80	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	80	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	80	_	_	_	_	_	_	_	O
8	pregnant	_	pregnant	_	JJ	80	_	_	_	_	_	_	_	O
9	,	_	,	_	,	80	_	_	_	_	_	_	_	O
10	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
11	is	_	be	_	VBZ	80	_	_	_	_	_	_	_	O
12	planning	_	plan	_	VBG	80	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
14	become	_	become	_	VB	80	_	_	_	_	_	_	_	O
15	pregnant	_	pregnant	_	JJ	80	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	80	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	80	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	80	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	80	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	80	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	80	_	_	_	_	_	person.n	People	S-Person
7	is	_	be	_	VBZ	80	_	_	_	_	_	_	_	O
8	pregnant	_	pregnant	_	JJ	80	_	_	_	_	_	_	_	O
9	,	_	,	_	,	80	_	_	_	_	_	_	_	O
10	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
11	is	_	be	_	VBZ	80	_	_	_	_	_	_	_	O
12	planning	_	plan	_	VBG	80	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
14	become	_	become	_	VB	80	_	_	_	_	_	_	_	O
15	pregnant	_	pregnant	_	JJ	80	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	80	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	80	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	80	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	80	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	80	_	_	_	_	_	_	_	B-Agent
6	person	_	person	_	NN	80	_	_	_	_	_	_	_	I-Agent
7	is	_	be	_	VBZ	80	_	_	_	_	_	_	_	O
8	pregnant	_	pregnant	_	JJ	80	_	_	_	_	_	_	_	O
9	,	_	,	_	,	80	_	_	_	_	_	_	_	O
10	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
11	is	_	be	_	VBZ	80	_	_	_	_	_	_	_	O
12	planning	_	plan	_	VBG	80	_	_	_	_	_	plan.v	Purpose	O
13	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
14	become	_	become	_	VB	80	_	_	_	_	_	_	_	O
15	pregnant	_	pregnant	_	JJ	80	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	80	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	80	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	80	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	80	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	80	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	80	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	80	_	_	_	_	_	_	_	O
8	pregnant	_	pregnant	_	JJ	80	_	_	_	_	_	_	_	O
9	,	_	,	_	,	80	_	_	_	_	_	_	_	O
10	or	_	or	_	CC	80	_	_	_	_	_	_	_	O
11	is	_	be	_	VBZ	80	_	_	_	_	_	_	_	O
12	planning	_	plan	_	VBG	80	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	80	_	_	_	_	_	_	_	O
14	become	_	become	_	VB	80	_	_	_	_	_	become.v	Becoming	O
15	pregnant	_	pregnant	_	JJ	80	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	81	_	_	_	_	_	_	_	O
2	more	_	more	_	JJR	81	_	_	_	_	_	more.a	Increment	O
3	information	_	information	_	NN	81	_	_	_	_	_	_	_	S-Class
4	,	_	,	_	,	81	_	_	_	_	_	_	_	O
5	see	_	see	_	VBP	81	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	81	_	_	_	_	_	_	_	O
7	nice	_	UNK	_	NNP	81	_	_	_	_	_	_	_	O
8	guideline	_	guideline	_	NN	81	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	81	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	81	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	81	_	_	_	_	_	_	_	O
12	pregnancy	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
13	.	_	.	_	.	81	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	81	_	_	_	_	_	_	_	O
2	more	_	more	_	JJR	81	_	_	_	_	_	_	_	O
3	information	_	information	_	NN	81	_	_	_	_	_	information.n	Information	S-Information
4	,	_	,	_	,	81	_	_	_	_	_	_	_	O
5	see	_	see	_	VBP	81	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	81	_	_	_	_	_	_	_	O
7	nice	_	UNK	_	NNP	81	_	_	_	_	_	_	_	O
8	guideline	_	guideline	_	NN	81	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	81	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	81	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	81	_	_	_	_	_	_	_	O
12	pregnancy	_	UNK	_	NN	81	_	_	_	_	_	_	_	O
13	.	_	.	_	.	81	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	82	_	_	_	_	_	_	_	O
2	short-term	_	short-term	_	JJ	82	_	_	_	_	_	_	_	O
3	self-monitoring	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
5	blood	_	blood	_	NN	82	_	_	_	_	_	_	_	O
6	glucose	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
7	levels	_	level	_	NNS	82	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	82	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	82	_	_	_	_	_	adult.n	People_by_age	S-Person
10	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
14	(	_	(	_	(	82	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	82	_	_	_	_	_	_	_	O
16	review	_	review	_	VB	82	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	82	_	_	_	_	_	_	_	O
18	as	_	a	_	IN	82	_	_	_	_	_	_	_	O
19	necessary	_	necessary	_	JJ	82	_	_	_	_	_	_	_	O
20	)	_	)	_	)	82	_	_	_	_	_	_	_	O
21	:	_	:	_	:	82	_	_	_	_	_	_	_	O
22	when	_	when	_	WRB	82	_	_	_	_	_	_	_	O
23	starting	_	start	_	VBG	82	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	82	_	_	_	_	_	_	_	O
25	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
26	oral	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
28	intravenous	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
29	corticosteroids	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
32	confirm	_	confirm	_	VB	82	_	_	_	_	_	_	_	O
33	suspected	_	suspected	_	JJ	82	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
35	.	_	.	_	.	82	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	82	_	_	_	_	_	_	_	O
2	short-term	_	short-term	_	JJ	82	_	_	_	_	_	_	_	O
3	self-monitoring	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
5	blood	_	blood	_	NN	82	_	_	_	_	_	_	_	O
6	glucose	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
7	levels	_	level	_	NNS	82	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	82	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	82	_	_	_	_	_	type.n	Type	S-Subtype
12	2	_	2	_	CD	82	_	_	_	_	_	_	_	B-Category
13	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	I-Category
14	(	_	(	_	(	82	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	82	_	_	_	_	_	_	_	O
16	review	_	review	_	VB	82	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	82	_	_	_	_	_	_	_	O
18	as	_	a	_	IN	82	_	_	_	_	_	_	_	O
19	necessary	_	necessary	_	JJ	82	_	_	_	_	_	_	_	O
20	)	_	)	_	)	82	_	_	_	_	_	_	_	O
21	:	_	:	_	:	82	_	_	_	_	_	_	_	O
22	when	_	when	_	WRB	82	_	_	_	_	_	_	_	O
23	starting	_	start	_	VBG	82	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	82	_	_	_	_	_	_	_	O
25	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
26	oral	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
28	intravenous	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
29	corticosteroids	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
32	confirm	_	confirm	_	VB	82	_	_	_	_	_	_	_	O
33	suspected	_	suspected	_	JJ	82	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
35	.	_	.	_	.	82	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	82	_	_	_	_	_	_	_	O
2	short-term	_	short-term	_	JJ	82	_	_	_	_	_	_	_	O
3	self-monitoring	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
5	blood	_	blood	_	NN	82	_	_	_	_	_	_	_	O
6	glucose	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
7	levels	_	level	_	NNS	82	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	82	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
14	(	_	(	_	(	82	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	82	_	_	_	_	_	_	_	O
16	review	_	review	_	VB	82	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	82	_	_	_	_	_	_	_	O
18	as	_	a	_	IN	82	_	_	_	_	_	_	_	O
19	necessary	_	necessary	_	JJ	82	_	_	_	_	_	necessary.a	Being_necessary	O
20	)	_	)	_	)	82	_	_	_	_	_	_	_	O
21	:	_	:	_	:	82	_	_	_	_	_	_	_	O
22	when	_	when	_	WRB	82	_	_	_	_	_	_	_	O
23	starting	_	start	_	VBG	82	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	82	_	_	_	_	_	_	_	O
25	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
26	oral	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
28	intravenous	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
29	corticosteroids	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
32	confirm	_	confirm	_	VB	82	_	_	_	_	_	_	_	O
33	suspected	_	suspected	_	JJ	82	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
35	.	_	.	_	.	82	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	82	_	_	_	_	_	_	_	O
2	short-term	_	short-term	_	JJ	82	_	_	_	_	_	_	_	O
3	self-monitoring	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
5	blood	_	blood	_	NN	82	_	_	_	_	_	_	_	O
6	glucose	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
7	levels	_	level	_	NNS	82	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	82	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
14	(	_	(	_	(	82	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	82	_	_	_	_	_	_	_	O
16	review	_	review	_	VB	82	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	82	_	_	_	_	_	_	_	O
18	as	_	a	_	IN	82	_	_	_	_	_	_	_	O
19	necessary	_	necessary	_	JJ	82	_	_	_	_	_	_	_	O
20	)	_	)	_	)	82	_	_	_	_	_	_	_	O
21	:	_	:	_	:	82	_	_	_	_	_	_	_	O
22	when	_	when	_	WRB	82	_	_	_	_	_	_	_	O
23	starting	_	start	_	VBG	82	_	_	_	_	_	start.v	Process_start	O
24	treatment	_	treatment	_	NN	82	_	_	_	_	_	_	_	B-Event
25	with	_	with	_	IN	82	_	_	_	_	_	_	_	I-Event
26	oral	_	UNK	_	JJ	82	_	_	_	_	_	_	_	I-Event
27	or	_	or	_	CC	82	_	_	_	_	_	_	_	I-Event
28	intravenous	_	UNK	_	JJ	82	_	_	_	_	_	_	_	I-Event
29	corticosteroids	_	UNK	_	NNS	82	_	_	_	_	_	_	_	I-Event
30	or	_	or	_	CC	82	_	_	_	_	_	_	_	I-Event
31	to	_	to	_	TO	82	_	_	_	_	_	_	_	I-Event
32	confirm	_	confirm	_	VB	82	_	_	_	_	_	_	_	I-Event
33	suspected	_	suspected	_	JJ	82	_	_	_	_	_	_	_	I-Event
34	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	I-Event
35	.	_	.	_	.	82	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	82	_	_	_	_	_	_	_	O
2	short-term	_	short-term	_	JJ	82	_	_	_	_	_	_	_	O
3	self-monitoring	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
5	blood	_	blood	_	NN	82	_	_	_	_	_	_	_	O
6	glucose	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
7	levels	_	level	_	NNS	82	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	82	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
14	(	_	(	_	(	82	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	82	_	_	_	_	_	_	_	O
16	review	_	review	_	VB	82	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	82	_	_	_	_	_	_	_	O
18	as	_	a	_	IN	82	_	_	_	_	_	_	_	O
19	necessary	_	necessary	_	JJ	82	_	_	_	_	_	_	_	O
20	)	_	)	_	)	82	_	_	_	_	_	_	_	O
21	:	_	:	_	:	82	_	_	_	_	_	_	_	O
22	when	_	when	_	WRB	82	_	_	_	_	_	_	_	O
23	starting	_	start	_	VBG	82	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	82	_	_	_	_	_	treatment.n	Cure	O
25	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
26	oral	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
28	intravenous	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
29	corticosteroids	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
32	confirm	_	confirm	_	VB	82	_	_	_	_	_	_	_	O
33	suspected	_	suspected	_	JJ	82	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
35	.	_	.	_	.	82	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	82	_	_	_	_	_	_	_	O
2	short-term	_	short-term	_	JJ	82	_	_	_	_	_	_	_	O
3	self-monitoring	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
5	blood	_	blood	_	NN	82	_	_	_	_	_	_	_	O
6	glucose	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
7	levels	_	level	_	NNS	82	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	82	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
14	(	_	(	_	(	82	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	82	_	_	_	_	_	_	_	O
16	review	_	review	_	VB	82	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	82	_	_	_	_	_	_	_	O
18	as	_	a	_	IN	82	_	_	_	_	_	_	_	O
19	necessary	_	necessary	_	JJ	82	_	_	_	_	_	_	_	O
20	)	_	)	_	)	82	_	_	_	_	_	_	_	O
21	:	_	:	_	:	82	_	_	_	_	_	_	_	O
22	when	_	when	_	WRB	82	_	_	_	_	_	_	_	O
23	starting	_	start	_	VBG	82	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	82	_	_	_	_	_	_	_	O
25	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
26	oral	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
28	intravenous	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
29	corticosteroids	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
32	confirm	_	confirm	_	VB	82	_	_	_	_	_	confirm.v	Evidence	O
33	suspected	_	suspected	_	JJ	82	_	_	_	_	_	_	_	B-Proposition
34	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	I-Proposition
35	.	_	.	_	.	82	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	82	_	_	_	_	_	_	_	O
2	short-term	_	short-term	_	JJ	82	_	_	_	_	_	_	_	O
3	self-monitoring	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	82	_	_	_	_	_	_	_	O
5	blood	_	blood	_	NN	82	_	_	_	_	_	_	_	O
6	glucose	_	UNK	_	NN	82	_	_	_	_	_	_	_	O
7	levels	_	level	_	NNS	82	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	82	_	_	_	_	_	_	_	O
9	adults	_	adult	_	NNS	82	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
11	type	_	type	_	JJ	82	_	_	_	_	_	_	_	O
12	2	_	2	_	CD	82	_	_	_	_	_	_	_	O
13	diabetes	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
14	(	_	(	_	(	82	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	82	_	_	_	_	_	_	_	O
16	review	_	review	_	VB	82	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	82	_	_	_	_	_	_	_	O
18	as	_	a	_	IN	82	_	_	_	_	_	_	_	O
19	necessary	_	necessary	_	JJ	82	_	_	_	_	_	_	_	O
20	)	_	)	_	)	82	_	_	_	_	_	_	_	O
21	:	_	:	_	:	82	_	_	_	_	_	_	_	O
22	when	_	when	_	WRB	82	_	_	_	_	_	_	_	O
23	starting	_	start	_	VBG	82	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	82	_	_	_	_	_	_	_	O
25	with	_	with	_	IN	82	_	_	_	_	_	_	_	O
26	oral	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
28	intravenous	_	UNK	_	JJ	82	_	_	_	_	_	_	_	O
29	corticosteroids	_	UNK	_	NNS	82	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	82	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	82	_	_	_	_	_	_	_	O
32	confirm	_	confirm	_	VB	82	_	_	_	_	_	_	_	O
33	suspected	_	suspected	_	JJ	82	_	_	_	_	_	suspected.a	Awareness_status	O
34	unk	_	UNK	_	NN	82	_	_	_	_	_	_	_	S-Content
35	.	_	.	_	.	82	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	83	_	_	_	_	_	aware.a	Awareness	O
3	that	_	that	_	IN	83	_	_	_	_	_	_	_	O
4	adults	_	adult	_	NNS	83	_	_	_	_	_	_	_	O
5	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
6	type	_	type	_	JJ	83	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	83	_	_	_	_	_	_	_	O
8	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
9	who	_	who	_	WP	83	_	_	_	_	_	_	_	O
10	have	_	have	_	VBP	83	_	_	_	_	_	_	_	O
11	acute	_	acute	_	VBN	83	_	_	_	_	_	_	_	O
12	unk	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
13	illness	_	illness	_	NN	83	_	_	_	_	_	_	_	O
14	are	_	be	_	VBP	83	_	_	_	_	_	_	_	O
15	at	_	at	_	IN	83	_	_	_	_	_	_	_	O
16	risk	_	risk	_	NN	83	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	83	_	_	_	_	_	_	_	O
18	worsening	_	UNK	_	VBG	83	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NN	83	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	83	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	83	_	_	_	_	_	_	_	O
4	adults	_	adult	_	NNS	83	_	_	_	_	_	adult.n	People_by_age	S-Person
5	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
6	type	_	type	_	JJ	83	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	83	_	_	_	_	_	_	_	O
8	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
9	who	_	who	_	WP	83	_	_	_	_	_	_	_	O
10	have	_	have	_	VBP	83	_	_	_	_	_	_	_	O
11	acute	_	acute	_	VBN	83	_	_	_	_	_	_	_	O
12	unk	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
13	illness	_	illness	_	NN	83	_	_	_	_	_	_	_	O
14	are	_	be	_	VBP	83	_	_	_	_	_	_	_	O
15	at	_	at	_	IN	83	_	_	_	_	_	_	_	O
16	risk	_	risk	_	NN	83	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	83	_	_	_	_	_	_	_	O
18	worsening	_	UNK	_	VBG	83	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NN	83	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	83	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	83	_	_	_	_	_	_	_	O
4	adults	_	adult	_	NNS	83	_	_	_	_	_	_	_	O
5	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
6	type	_	type	_	JJ	83	_	_	_	_	_	type.n	Type	S-Subtype
7	2	_	2	_	CD	83	_	_	_	_	_	_	_	O
8	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
9	who	_	who	_	WP	83	_	_	_	_	_	_	_	O
10	have	_	have	_	VBP	83	_	_	_	_	_	_	_	O
11	acute	_	acute	_	VBN	83	_	_	_	_	_	_	_	O
12	unk	_	UNK	_	JJ	83	_	_	_	_	_	_	_	O
13	illness	_	illness	_	NN	83	_	_	_	_	_	_	_	O
14	are	_	be	_	VBP	83	_	_	_	_	_	_	_	O
15	at	_	at	_	IN	83	_	_	_	_	_	_	_	O
16	risk	_	risk	_	NN	83	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	83	_	_	_	_	_	_	_	O
18	worsening	_	UNK	_	VBG	83	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NN	83	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	83	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	83	_	_	_	_	_	_	_	O
4	adults	_	adult	_	NNS	83	_	_	_	_	_	_	_	O
5	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
6	type	_	type	_	JJ	83	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	83	_	_	_	_	_	_	_	O
8	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
9	who	_	who	_	WP	83	_	_	_	_	_	_	_	O
10	have	_	have	_	VBP	83	_	_	_	_	_	_	_	O
11	acute	_	acute	_	VBN	83	_	_	_	_	_	acute.a	Importance	O
12	unk	_	UNK	_	JJ	83	_	_	_	_	_	_	_	B-Factor
13	illness	_	illness	_	NN	83	_	_	_	_	_	_	_	I-Factor
14	are	_	be	_	VBP	83	_	_	_	_	_	_	_	O
15	at	_	at	_	IN	83	_	_	_	_	_	_	_	O
16	risk	_	risk	_	NN	83	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	83	_	_	_	_	_	_	_	O
18	worsening	_	UNK	_	VBG	83	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NN	83	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	83	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	83	_	_	_	_	_	_	_	O
4	adults	_	adult	_	NNS	83	_	_	_	_	_	_	_	O
5	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
6	type	_	type	_	JJ	83	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	83	_	_	_	_	_	_	_	O
8	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
9	who	_	who	_	WP	83	_	_	_	_	_	_	_	O
10	have	_	have	_	VBP	83	_	_	_	_	_	_	_	O
11	acute	_	acute	_	VBN	83	_	_	_	_	_	_	_	O
12	unk	_	UNK	_	JJ	83	_	_	_	_	_	_	_	S-Cause
13	illness	_	illness	_	NN	83	_	_	_	_	_	illness.n	Medical_conditions	S-Ailment
14	are	_	be	_	VBP	83	_	_	_	_	_	_	_	O
15	at	_	at	_	IN	83	_	_	_	_	_	_	_	O
16	risk	_	risk	_	NN	83	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	83	_	_	_	_	_	_	_	O
18	worsening	_	UNK	_	VBG	83	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NN	83	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	83	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	83	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	83	_	_	_	_	_	_	_	O
4	adults	_	adult	_	NNS	83	_	_	_	_	_	_	_	O
5	with	_	with	_	IN	83	_	_	_	_	_	_	_	O
6	type	_	type	_	JJ	83	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	83	_	_	_	_	_	_	_	O
8	diabetes	_	UNK	_	NNS	83	_	_	_	_	_	_	_	O
9	who	_	who	_	WP	83	_	_	_	_	_	_	_	O
10	have	_	have	_	VBP	83	_	_	_	_	_	_	_	O
11	acute	_	acute	_	VBN	83	_	_	_	_	_	_	_	B-Protagonist
12	unk	_	UNK	_	JJ	83	_	_	_	_	_	_	_	I-Protagonist
13	illness	_	illness	_	NN	83	_	_	_	_	_	_	_	I-Protagonist
14	are	_	be	_	VBP	83	_	_	_	_	_	_	_	O
15	at	_	at	_	IN	83	_	_	_	_	_	_	_	O
16	risk	_	risk	_	NN	83	_	_	_	_	_	risk.n	Run_risk	O
17	of	_	of	_	IN	83	_	_	_	_	_	_	_	O
18	worsening	_	UNK	_	VBG	83	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NN	83	_	_	_	_	_	_	_	O

1	review	_	Review	_	NNP	84	_	_	_	_	_	_	_	S-Treatment
2	treatment	_	treatment	_	NN	84	_	_	_	_	_	treatment.n	Cure	O
3	as	_	a	_	IN	84	_	_	_	_	_	_	_	O
4	necessary	_	necessary	_	JJ	84	_	_	_	_	_	_	_	O
5	.	_	.	_	.	84	_	_	_	_	_	_	_	O

1	review	_	Review	_	NNP	84	_	_	_	_	_	_	_	B-Requirement
2	treatment	_	treatment	_	NN	84	_	_	_	_	_	_	_	I-Requirement
3	as	_	a	_	IN	84	_	_	_	_	_	_	_	O
4	necessary	_	necessary	_	JJ	84	_	_	_	_	_	necessary.a	Being_necessary	O
5	.	_	.	_	.	84	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	85	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	85	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	85	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	85	_	_	_	_	_	_	_	O
8	self-monitoring	_	UNK	_	VBG	85	_	_	_	_	_	_	_	O
9	their	_	their	_	PRP$	85	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	85	_	_	_	_	_	_	_	O
11	glucose	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
12	levels	_	level	_	NNS	85	_	_	_	_	_	_	_	O
13	,	_	,	_	,	85	_	_	_	_	_	_	_	O
14	carry	_	carry	_	VBP	85	_	_	_	_	_	_	_	O
15	out	_	out	_	RP	85	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	85	_	_	_	_	_	_	_	O
17	structured	_	UNK	_	JJ	85	_	_	_	_	_	_	_	O
18	assessment	_	assessment	_	NN	85	_	_	_	_	_	_	_	O
19	at	_	at	_	IN	85	_	_	_	_	_	_	_	O
20	least	_	least	_	JJS	85	_	_	_	_	_	_	_	O
21	annually	_	annually	_	RB	85	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	85	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	85	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	85	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	85	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	85	_	_	_	_	_	_	_	I-Category
7	are	_	be	_	VBP	85	_	_	_	_	_	_	_	O
8	self-monitoring	_	UNK	_	VBG	85	_	_	_	_	_	_	_	O
9	their	_	their	_	PRP$	85	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	85	_	_	_	_	_	_	_	O
11	glucose	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
12	levels	_	level	_	NNS	85	_	_	_	_	_	_	_	O
13	,	_	,	_	,	85	_	_	_	_	_	_	_	O
14	carry	_	carry	_	VBP	85	_	_	_	_	_	_	_	O
15	out	_	out	_	RP	85	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	85	_	_	_	_	_	_	_	O
17	structured	_	UNK	_	JJ	85	_	_	_	_	_	_	_	O
18	assessment	_	assessment	_	NN	85	_	_	_	_	_	_	_	O
19	at	_	at	_	IN	85	_	_	_	_	_	_	_	O
20	least	_	least	_	JJS	85	_	_	_	_	_	_	_	O
21	annually	_	annually	_	RB	85	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	85	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	85	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	85	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	85	_	_	_	_	_	_	_	O
8	self-monitoring	_	UNK	_	VBG	85	_	_	_	_	_	_	_	O
9	their	_	their	_	PRP$	85	_	_	_	_	_	_	_	B-Theme
10	blood	_	blood	_	NN	85	_	_	_	_	_	_	_	I-Theme
11	glucose	_	UNK	_	NN	85	_	_	_	_	_	_	_	I-Theme
12	levels	_	level	_	NNS	85	_	_	_	_	_	_	_	I-Theme
13	,	_	,	_	,	85	_	_	_	_	_	_	_	O
14	carry	_	carry	_	VBP	85	_	_	_	_	_	carry.v	Bringing	O
15	out	_	out	_	RP	85	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	85	_	_	_	_	_	_	_	B-Goal
17	structured	_	UNK	_	JJ	85	_	_	_	_	_	_	_	I-Goal
18	assessment	_	assessment	_	NN	85	_	_	_	_	_	_	_	I-Goal
19	at	_	at	_	IN	85	_	_	_	_	_	_	_	O
20	least	_	least	_	JJS	85	_	_	_	_	_	_	_	O
21	annually	_	annually	_	RB	85	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	85	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	85	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	85	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	85	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	85	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	85	_	_	_	_	_	_	_	O
7	are	_	be	_	VBP	85	_	_	_	_	_	_	_	O
8	self-monitoring	_	UNK	_	VBG	85	_	_	_	_	_	_	_	O
9	their	_	their	_	PRP$	85	_	_	_	_	_	_	_	O
10	blood	_	blood	_	NN	85	_	_	_	_	_	_	_	O
11	glucose	_	UNK	_	NN	85	_	_	_	_	_	_	_	O
12	levels	_	level	_	NNS	85	_	_	_	_	_	_	_	O
13	,	_	,	_	,	85	_	_	_	_	_	_	_	O
14	carry	_	carry	_	VBP	85	_	_	_	_	_	_	_	O
15	out	_	out	_	RP	85	_	_	_	_	_	_	_	O
16	a	_	a	_	DT	85	_	_	_	_	_	_	_	O
17	structured	_	UNK	_	JJ	85	_	_	_	_	_	_	_	O
18	assessment	_	assessment	_	NN	85	_	_	_	_	_	assessment.n	Assessing	S-Assessor
19	at	_	at	_	IN	85	_	_	_	_	_	_	_	O
20	least	_	least	_	JJS	85	_	_	_	_	_	_	_	O
21	annually	_	annually	_	RB	85	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	86	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	86	_	_	_	_	_	assessment.n	Assessing	S-Assessor
3	should	_	should	_	MD	86	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	86	_	_	_	_	_	_	_	O
5	:	_	:	_	:	86	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	86	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	86	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	86	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	86	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	86	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	86	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	86	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	86	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	86	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	86	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	86	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	86	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	86	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	86	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	86	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	86	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	86	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	86	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	86	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	86	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	86	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	86	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	86	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	86	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	86	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	86	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	86	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	86	_	_	_	_	_	_	_	O
52	.	_	.	_	.	86	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	86	_	_	_	_	_	_	_	B-Total
2	assessment	_	assessment	_	NN	86	_	_	_	_	_	_	_	I-Total
3	should	_	should	_	MD	86	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	86	_	_	_	_	_	include.v	Inclusion	O
5	:	_	:	_	:	86	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	86	_	_	_	_	_	_	_	B-Part
7	person	_	person	_	NN	86	_	_	_	_	_	_	_	I-Part
8	's	_	's	_	POS	86	_	_	_	_	_	_	_	I-Part
9	self-monitoring	_	UNK	_	JJ	86	_	_	_	_	_	_	_	I-Part
10	skills	_	skill	_	NNS	86	_	_	_	_	_	_	_	I-Part
11	the	_	the	_	DT	86	_	_	_	_	_	_	_	I-Part
12	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	I-Part
13	and	_	and	_	CC	86	_	_	_	_	_	_	_	I-Part
14	frequency	_	frequency	_	NN	86	_	_	_	_	_	_	_	I-Part
15	of	_	of	_	IN	86	_	_	_	_	_	_	_	I-Part
16	testing	_	test	_	VBG	86	_	_	_	_	_	_	_	I-Part
17	checking	_	check	_	VBG	86	_	_	_	_	_	_	_	I-Part
18	that	_	that	_	IN	86	_	_	_	_	_	_	_	I-Part
19	the	_	the	_	DT	86	_	_	_	_	_	_	_	I-Part
20	person	_	person	_	NN	86	_	_	_	_	_	_	_	I-Part
21	knows	_	know	_	VBZ	86	_	_	_	_	_	_	_	I-Part
22	how	_	how	_	WRB	86	_	_	_	_	_	_	_	I-Part
23	to	_	to	_	TO	86	_	_	_	_	_	_	_	I-Part
24	interpret	_	UNK	_	VB	86	_	_	_	_	_	_	_	I-Part
25	the	_	the	_	DT	86	_	_	_	_	_	_	_	I-Part
26	blood	_	blood	_	NN	86	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	86	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	86	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	86	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	86	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	86	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	86	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	86	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	86	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	86	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	86	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	86	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	86	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	86	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	86	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	86	_	_	_	_	_	_	_	O
52	.	_	.	_	.	86	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	86	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	86	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	86	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	86	_	_	_	_	_	_	_	O
5	:	_	:	_	:	86	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	86	_	_	_	_	_	person.n	People	S-Person
8	's	_	's	_	POS	86	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	86	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	86	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	86	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	86	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	86	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	86	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	86	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	86	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	86	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	86	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	86	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	86	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	86	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	86	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	86	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	86	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	86	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	86	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	86	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	86	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	86	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	86	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	86	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	86	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	86	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	86	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	86	_	_	_	_	_	_	_	O
52	.	_	.	_	.	86	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	86	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	86	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	86	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	86	_	_	_	_	_	_	_	O
5	:	_	:	_	:	86	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	86	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	86	_	_	_	_	_	_	_	S-Knowledge
10	skills	_	skill	_	NNS	86	_	_	_	_	_	skill.n	Expertise	O
11	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	86	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	86	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	86	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	86	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	86	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	86	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	86	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	86	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	86	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	86	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	86	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	86	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	86	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	86	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	86	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	86	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	86	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	86	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	86	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	86	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	86	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	86	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	86	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	86	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	86	_	_	_	_	_	_	_	O
52	.	_	.	_	.	86	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	86	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	86	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	86	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	86	_	_	_	_	_	_	_	O
5	:	_	:	_	:	86	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	86	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	86	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	86	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	86	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	86	_	_	_	_	_	frequency.n	Frequency	O
15	of	_	of	_	IN	86	_	_	_	_	_	_	_	B-Event
16	testing	_	test	_	VBG	86	_	_	_	_	_	_	_	I-Event
17	checking	_	check	_	VBG	86	_	_	_	_	_	_	_	I-Event
18	that	_	that	_	IN	86	_	_	_	_	_	_	_	I-Event
19	the	_	the	_	DT	86	_	_	_	_	_	_	_	I-Event
20	person	_	person	_	NN	86	_	_	_	_	_	_	_	I-Event
21	knows	_	know	_	VBZ	86	_	_	_	_	_	_	_	I-Event
22	how	_	how	_	WRB	86	_	_	_	_	_	_	_	I-Event
23	to	_	to	_	TO	86	_	_	_	_	_	_	_	I-Event
24	interpret	_	UNK	_	VB	86	_	_	_	_	_	_	_	I-Event
25	the	_	the	_	DT	86	_	_	_	_	_	_	_	I-Event
26	blood	_	blood	_	NN	86	_	_	_	_	_	_	_	I-Event
27	glucose	_	UNK	_	JJ	86	_	_	_	_	_	_	_	I-Event
28	results	_	result	_	NNS	86	_	_	_	_	_	_	_	I-Event
29	and	_	and	_	CC	86	_	_	_	_	_	_	_	I-Event
30	what	_	what	_	WP	86	_	_	_	_	_	_	_	I-Event
31	action	_	action	_	NN	86	_	_	_	_	_	_	_	I-Event
32	to	_	to	_	TO	86	_	_	_	_	_	_	_	I-Event
33	take	_	take	_	VB	86	_	_	_	_	_	_	_	I-Event
34	the	_	the	_	DT	86	_	_	_	_	_	_	_	I-Event
35	impact	_	impact	_	NN	86	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	86	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	86	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	86	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	86	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	86	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	86	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	86	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	86	_	_	_	_	_	_	_	O
52	.	_	.	_	.	86	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	86	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	86	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	86	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	86	_	_	_	_	_	_	_	O
5	:	_	:	_	:	86	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	86	_	_	_	_	_	_	_	B-Tester
7	person	_	person	_	NN	86	_	_	_	_	_	_	_	I-Tester
8	's	_	's	_	POS	86	_	_	_	_	_	_	_	I-Tester
9	self-monitoring	_	UNK	_	JJ	86	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	86	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	86	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	86	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	86	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	86	_	_	_	_	_	test.v	Operational_testing	O
17	checking	_	check	_	VBG	86	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	86	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	86	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	86	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	86	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	86	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	86	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	86	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	86	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	86	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	86	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	86	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	86	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	86	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	86	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	86	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	86	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	86	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	86	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	86	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	86	_	_	_	_	_	_	_	O
52	.	_	.	_	.	86	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	86	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	86	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	86	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	86	_	_	_	_	_	_	_	O
5	:	_	:	_	:	86	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	86	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	86	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	86	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	86	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	86	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	86	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	86	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	86	_	_	_	_	_	check.v	Inspecting	O
18	that	_	that	_	IN	86	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	86	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	86	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	86	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	86	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	86	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	86	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	86	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	86	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	86	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	86	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	86	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	86	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	86	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	86	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	86	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	86	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	86	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	86	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	86	_	_	_	_	_	_	_	O
52	.	_	.	_	.	86	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	86	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	86	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	86	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	86	_	_	_	_	_	_	_	O
5	:	_	:	_	:	86	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	86	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	86	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	86	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	86	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	86	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	86	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	86	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	86	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	86	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	86	_	_	_	_	_	person.n	People	S-Person
21	knows	_	know	_	VBZ	86	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	86	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	86	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	86	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	86	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	86	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	86	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	86	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	86	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	86	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	86	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	86	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	86	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	86	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	86	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	86	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	86	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	86	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	86	_	_	_	_	_	_	_	O
52	.	_	.	_	.	86	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	86	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	86	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	86	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	86	_	_	_	_	_	_	_	O
5	:	_	:	_	:	86	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	86	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	86	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	86	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	86	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	86	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	86	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	86	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	86	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	86	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	86	_	_	_	_	_	_	_	B-Cognizer
20	person	_	person	_	NN	86	_	_	_	_	_	_	_	I-Cognizer
21	knows	_	know	_	VBZ	86	_	_	_	_	_	know.v	Awareness	O
22	how	_	how	_	WRB	86	_	_	_	_	_	_	_	B-Content
23	to	_	to	_	TO	86	_	_	_	_	_	_	_	I-Content
24	interpret	_	UNK	_	VB	86	_	_	_	_	_	_	_	I-Content
25	the	_	the	_	DT	86	_	_	_	_	_	_	_	I-Content
26	blood	_	blood	_	NN	86	_	_	_	_	_	_	_	I-Content
27	glucose	_	UNK	_	JJ	86	_	_	_	_	_	_	_	I-Content
28	results	_	result	_	NNS	86	_	_	_	_	_	_	_	I-Content
29	and	_	and	_	CC	86	_	_	_	_	_	_	_	I-Content
30	what	_	what	_	WP	86	_	_	_	_	_	_	_	I-Content
31	action	_	action	_	NN	86	_	_	_	_	_	_	_	I-Content
32	to	_	to	_	TO	86	_	_	_	_	_	_	_	I-Content
33	take	_	take	_	VB	86	_	_	_	_	_	_	_	I-Content
34	the	_	the	_	DT	86	_	_	_	_	_	_	_	I-Content
35	impact	_	impact	_	NN	86	_	_	_	_	_	_	_	I-Content
36	on	_	on	_	IN	86	_	_	_	_	_	_	_	I-Content
37	the	_	the	_	DT	86	_	_	_	_	_	_	_	I-Content
38	person	_	person	_	NN	86	_	_	_	_	_	_	_	I-Content
39	's	_	's	_	POS	86	_	_	_	_	_	_	_	I-Content
40	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	I-Content
41	of	_	of	_	IN	86	_	_	_	_	_	_	_	I-Content
42	life	_	life	_	NN	86	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	86	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	86	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	86	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	86	_	_	_	_	_	_	_	O
52	.	_	.	_	.	86	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	86	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	86	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	86	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	86	_	_	_	_	_	_	_	O
5	:	_	:	_	:	86	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	86	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	86	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	86	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	86	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	86	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	86	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	86	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	86	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	86	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	86	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	86	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	86	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	86	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	86	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	86	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	86	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	86	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	86	_	_	_	_	_	action.n	Intentionally_act	O
32	to	_	to	_	TO	86	_	_	_	_	_	_	_	B-Act
33	take	_	take	_	VB	86	_	_	_	_	_	_	_	I-Act
34	the	_	the	_	DT	86	_	_	_	_	_	_	_	I-Act
35	impact	_	impact	_	NN	86	_	_	_	_	_	_	_	I-Act
36	on	_	on	_	IN	86	_	_	_	_	_	_	_	I-Act
37	the	_	the	_	DT	86	_	_	_	_	_	_	_	I-Act
38	person	_	person	_	NN	86	_	_	_	_	_	_	_	I-Act
39	's	_	's	_	POS	86	_	_	_	_	_	_	_	I-Act
40	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	I-Act
41	of	_	of	_	IN	86	_	_	_	_	_	_	_	I-Act
42	life	_	life	_	NN	86	_	_	_	_	_	_	_	I-Act
43	the	_	the	_	DT	86	_	_	_	_	_	_	_	I-Act
44	continued	_	continued	_	JJ	86	_	_	_	_	_	_	_	I-Act
45	benefit	_	benefit	_	NN	86	_	_	_	_	_	_	_	I-Act
46	to	_	to	_	TO	86	_	_	_	_	_	_	_	I-Act
47	the	_	the	_	DT	86	_	_	_	_	_	_	_	I-Act
48	person	_	person	_	NN	86	_	_	_	_	_	_	_	I-Act
49	the	_	the	_	DT	86	_	_	_	_	_	_	_	I-Act
50	equipment	_	equipment	_	NN	86	_	_	_	_	_	_	_	I-Act
51	used	_	use	_	VBN	86	_	_	_	_	_	_	_	I-Act
52	.	_	.	_	.	86	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	86	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	86	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	86	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	86	_	_	_	_	_	_	_	O
5	:	_	:	_	:	86	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	86	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	86	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	86	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	86	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	86	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	86	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	86	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	86	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	86	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	86	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	86	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	86	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	86	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	86	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	86	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	86	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	86	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	86	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	86	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	86	_	_	_	_	_	impact.n	Objective_influence	O
36	on	_	on	_	IN	86	_	_	_	_	_	_	_	B-Dependent_entity
37	the	_	the	_	DT	86	_	_	_	_	_	_	_	I-Dependent_entity
38	person	_	person	_	NN	86	_	_	_	_	_	_	_	I-Dependent_entity
39	's	_	's	_	POS	86	_	_	_	_	_	_	_	I-Dependent_entity
40	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	I-Dependent_entity
41	of	_	of	_	IN	86	_	_	_	_	_	_	_	I-Dependent_entity
42	life	_	life	_	NN	86	_	_	_	_	_	_	_	I-Dependent_entity
43	the	_	the	_	DT	86	_	_	_	_	_	_	_	I-Dependent_entity
44	continued	_	continued	_	JJ	86	_	_	_	_	_	_	_	I-Dependent_entity
45	benefit	_	benefit	_	NN	86	_	_	_	_	_	_	_	I-Dependent_entity
46	to	_	to	_	TO	86	_	_	_	_	_	_	_	I-Dependent_entity
47	the	_	the	_	DT	86	_	_	_	_	_	_	_	I-Dependent_entity
48	person	_	person	_	NN	86	_	_	_	_	_	_	_	I-Dependent_entity
49	the	_	the	_	DT	86	_	_	_	_	_	_	_	I-Dependent_entity
50	equipment	_	equipment	_	NN	86	_	_	_	_	_	_	_	I-Dependent_entity
51	used	_	use	_	VBN	86	_	_	_	_	_	_	_	I-Dependent_entity
52	.	_	.	_	.	86	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	86	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	86	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	86	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	86	_	_	_	_	_	_	_	O
5	:	_	:	_	:	86	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	86	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	86	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	86	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	86	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	86	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	86	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	86	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	86	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	86	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	86	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	86	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	86	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	86	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	86	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	86	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	86	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	86	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	86	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	86	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	86	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	86	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	86	_	_	_	_	_	person.n	People	S-Person
39	's	_	's	_	POS	86	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	86	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	86	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	86	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	86	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	86	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	86	_	_	_	_	_	_	_	O
52	.	_	.	_	.	86	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	86	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	86	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	86	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	86	_	_	_	_	_	_	_	O
5	:	_	:	_	:	86	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	86	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	86	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	86	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	86	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	86	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	86	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	86	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	86	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	86	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	86	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	86	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	86	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	86	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	86	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	86	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	86	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	86	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	86	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	86	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	86	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	86	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	86	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	86	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	86	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	86	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	86	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	86	_	_	_	_	_	person.n	People	S-Person
49	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	86	_	_	_	_	_	_	_	O
51	used	_	use	_	VBN	86	_	_	_	_	_	_	_	O
52	.	_	.	_	.	86	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	86	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	86	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	86	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	86	_	_	_	_	_	_	_	O
5	:	_	:	_	:	86	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	86	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	86	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	86	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	86	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	86	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	86	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	86	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	86	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	86	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	86	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	86	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	86	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	86	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	86	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	86	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	86	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	86	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	86	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	86	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	86	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	86	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	86	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	86	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	86	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	86	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	86	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	86	_	_	_	_	_	equipment.n	Gizmo	S-Gizmo
51	used	_	use	_	VBN	86	_	_	_	_	_	_	_	O
52	.	_	.	_	.	86	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	86	_	_	_	_	_	_	_	O
2	assessment	_	assessment	_	NN	86	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	86	_	_	_	_	_	_	_	O
4	include	_	include	_	VB	86	_	_	_	_	_	_	_	O
5	:	_	:	_	:	86	_	_	_	_	_	_	_	O
6	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
7	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
8	's	_	's	_	POS	86	_	_	_	_	_	_	_	O
9	self-monitoring	_	UNK	_	JJ	86	_	_	_	_	_	_	_	O
10	skills	_	skill	_	NNS	86	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
12	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	86	_	_	_	_	_	_	_	O
14	frequency	_	frequency	_	NN	86	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	86	_	_	_	_	_	_	_	O
16	testing	_	test	_	VBG	86	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	86	_	_	_	_	_	_	_	O
18	that	_	that	_	IN	86	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
20	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
21	knows	_	know	_	VBZ	86	_	_	_	_	_	_	_	O
22	how	_	how	_	WRB	86	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
24	interpret	_	UNK	_	VB	86	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
26	blood	_	blood	_	NN	86	_	_	_	_	_	_	_	O
27	glucose	_	UNK	_	JJ	86	_	_	_	_	_	_	_	O
28	results	_	result	_	NNS	86	_	_	_	_	_	_	_	O
29	and	_	and	_	CC	86	_	_	_	_	_	_	_	O
30	what	_	what	_	WP	86	_	_	_	_	_	_	_	O
31	action	_	action	_	NN	86	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
33	take	_	take	_	VB	86	_	_	_	_	_	_	_	O
34	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
35	impact	_	impact	_	NN	86	_	_	_	_	_	_	_	O
36	on	_	on	_	IN	86	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
38	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
39	's	_	's	_	POS	86	_	_	_	_	_	_	_	O
40	quality	_	quality	_	NN	86	_	_	_	_	_	_	_	O
41	of	_	of	_	IN	86	_	_	_	_	_	_	_	O
42	life	_	life	_	NN	86	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
44	continued	_	continued	_	JJ	86	_	_	_	_	_	_	_	O
45	benefit	_	benefit	_	NN	86	_	_	_	_	_	_	_	O
46	to	_	to	_	TO	86	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
48	person	_	person	_	NN	86	_	_	_	_	_	_	_	O
49	the	_	the	_	DT	86	_	_	_	_	_	_	_	O
50	equipment	_	equipment	_	NN	86	_	_	_	_	_	_	_	S-Instrument
51	used	_	use	_	VBN	86	_	_	_	_	_	use.v	Using	O
52	.	_	.	_	.	86	_	_	_	_	_	_	_	O

1	drug	_	UNK	_	NN	87	_	_	_	_	_	_	_	S-Patient
2	treatment	_	treatment	_	NN	87	_	_	_	_	_	treatment.n	Cure	O

1	recommendations	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
2	in	_	in	_	IN	88	_	_	_	_	_	_	_	O
3	this	_	this	_	DT	88	_	_	_	_	_	_	_	O
4	section	_	section	_	NN	88	_	_	_	_	_	section.n	Part_whole	S-Part
5	that	_	that	_	IN	88	_	_	_	_	_	_	_	B-Whole
6	cover	_	cover	_	NN	88	_	_	_	_	_	_	_	I-Whole
7	dipeptidyl	_	UNK	_	NN	88	_	_	_	_	_	_	_	I-Whole
8	unk	_	UNK	_	JJ	88	_	_	_	_	_	_	_	I-Whole
9	(	_	(	_	(	88	_	_	_	_	_	_	_	I-Whole
10	dpp-4	_	UNK	_	NNP	88	_	_	_	_	_	_	_	I-Whole
11	)	_	)	_	)	88	_	_	_	_	_	_	_	I-Whole
12	inhibitors	_	UNK	_	NNS	88	_	_	_	_	_	_	_	I-Whole
13	,	_	,	_	,	88	_	_	_	_	_	_	_	I-Whole
14	unk	_	UNK	_	JJ	88	_	_	_	_	_	_	_	I-Whole
15	unk	_	UNK	_	NN	88	_	_	_	_	_	_	_	I-Whole
16	(	_	(	_	(	88	_	_	_	_	_	_	_	I-Whole
17	glp-1	_	UNK	_	NNP	88	_	_	_	_	_	_	_	I-Whole
18	)	_	)	_	)	88	_	_	_	_	_	_	_	I-Whole
19	unk	_	UNK	_	NNS	88	_	_	_	_	_	_	_	I-Whole
20	and	_	and	_	CC	88	_	_	_	_	_	_	_	I-Whole
21	sulfonylureas	_	UNK	_	NNS	88	_	_	_	_	_	_	_	I-Whole
22	refer	_	refer	_	VBP	88	_	_	_	_	_	_	_	I-Whole
23	to	_	to	_	TO	88	_	_	_	_	_	_	_	I-Whole
24	each	_	each	_	DT	88	_	_	_	_	_	_	_	I-Whole
25	of	_	of	_	IN	88	_	_	_	_	_	_	_	O
26	these	_	these	_	DT	88	_	_	_	_	_	_	_	O
27	groups	_	group	_	NNS	88	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	88	_	_	_	_	_	_	_	O
29	drugs	_	drug	_	NNS	88	_	_	_	_	_	_	_	O
30	at	_	at	_	IN	88	_	_	_	_	_	_	_	O
31	a	_	a	_	DT	88	_	_	_	_	_	_	_	O
32	class	_	class	_	NN	88	_	_	_	_	_	_	_	O
33	level	_	level	_	NN	88	_	_	_	_	_	_	_	O
34	.	_	.	_	.	88	_	_	_	_	_	_	_	O

1	recommendations	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
2	in	_	in	_	IN	88	_	_	_	_	_	_	_	O
3	this	_	this	_	DT	88	_	_	_	_	_	_	_	O
4	section	_	section	_	NN	88	_	_	_	_	_	_	_	O
5	that	_	that	_	IN	88	_	_	_	_	_	_	_	O
6	cover	_	cover	_	NN	88	_	_	_	_	_	_	_	O
7	dipeptidyl	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
9	(	_	(	_	(	88	_	_	_	_	_	_	_	O
10	dpp-4	_	UNK	_	NNP	88	_	_	_	_	_	_	_	O
11	)	_	)	_	)	88	_	_	_	_	_	_	_	O
12	inhibitors	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
13	,	_	,	_	,	88	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	JJ	88	_	_	_	_	_	_	_	B-Entity
15	unk	_	UNK	_	NN	88	_	_	_	_	_	_	_	I-Entity
16	(	_	(	_	(	88	_	_	_	_	_	_	_	I-Entity
17	glp-1	_	UNK	_	NNP	88	_	_	_	_	_	_	_	I-Entity
18	)	_	)	_	)	88	_	_	_	_	_	_	_	I-Entity
19	unk	_	UNK	_	NNS	88	_	_	_	_	_	_	_	I-Entity
20	and	_	and	_	CC	88	_	_	_	_	_	_	_	I-Entity
21	sulfonylureas	_	UNK	_	NNS	88	_	_	_	_	_	_	_	I-Entity
22	refer	_	refer	_	VBP	88	_	_	_	_	_	refer.v	Referring_by_name	O
23	to	_	to	_	TO	88	_	_	_	_	_	_	_	B-Name
24	each	_	each	_	DT	88	_	_	_	_	_	_	_	I-Name
25	of	_	of	_	IN	88	_	_	_	_	_	_	_	I-Name
26	these	_	these	_	DT	88	_	_	_	_	_	_	_	I-Name
27	groups	_	group	_	NNS	88	_	_	_	_	_	_	_	I-Name
28	of	_	of	_	IN	88	_	_	_	_	_	_	_	I-Name
29	drugs	_	drug	_	NNS	88	_	_	_	_	_	_	_	I-Name
30	at	_	at	_	IN	88	_	_	_	_	_	_	_	I-Name
31	a	_	a	_	DT	88	_	_	_	_	_	_	_	I-Name
32	class	_	class	_	NN	88	_	_	_	_	_	_	_	I-Name
33	level	_	level	_	NN	88	_	_	_	_	_	_	_	I-Name
34	.	_	.	_	.	88	_	_	_	_	_	_	_	O

1	recommendations	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
2	in	_	in	_	IN	88	_	_	_	_	_	_	_	O
3	this	_	this	_	DT	88	_	_	_	_	_	_	_	O
4	section	_	section	_	NN	88	_	_	_	_	_	_	_	O
5	that	_	that	_	IN	88	_	_	_	_	_	_	_	O
6	cover	_	cover	_	NN	88	_	_	_	_	_	_	_	O
7	dipeptidyl	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
9	(	_	(	_	(	88	_	_	_	_	_	_	_	O
10	dpp-4	_	UNK	_	NNP	88	_	_	_	_	_	_	_	O
11	)	_	)	_	)	88	_	_	_	_	_	_	_	O
12	inhibitors	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
13	,	_	,	_	,	88	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
16	(	_	(	_	(	88	_	_	_	_	_	_	_	O
17	glp-1	_	UNK	_	NNP	88	_	_	_	_	_	_	_	O
18	)	_	)	_	)	88	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	88	_	_	_	_	_	_	_	O
21	sulfonylureas	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
22	refer	_	refer	_	VBP	88	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	88	_	_	_	_	_	_	_	O
24	each	_	each	_	DT	88	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	88	_	_	_	_	_	_	_	O
26	these	_	these	_	DT	88	_	_	_	_	_	_	_	O
27	groups	_	group	_	NNS	88	_	_	_	_	_	group.n	Aggregate	S-Aggregate
28	of	_	of	_	IN	88	_	_	_	_	_	_	_	B-Individuals
29	drugs	_	drug	_	NNS	88	_	_	_	_	_	_	_	I-Individuals
30	at	_	at	_	IN	88	_	_	_	_	_	_	_	O
31	a	_	a	_	DT	88	_	_	_	_	_	_	_	O
32	class	_	class	_	NN	88	_	_	_	_	_	_	_	O
33	level	_	level	_	NN	88	_	_	_	_	_	_	_	O
34	.	_	.	_	.	88	_	_	_	_	_	_	_	O

1	recommendations	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
2	in	_	in	_	IN	88	_	_	_	_	_	_	_	O
3	this	_	this	_	DT	88	_	_	_	_	_	_	_	O
4	section	_	section	_	NN	88	_	_	_	_	_	_	_	O
5	that	_	that	_	IN	88	_	_	_	_	_	_	_	O
6	cover	_	cover	_	NN	88	_	_	_	_	_	_	_	O
7	dipeptidyl	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
9	(	_	(	_	(	88	_	_	_	_	_	_	_	O
10	dpp-4	_	UNK	_	NNP	88	_	_	_	_	_	_	_	O
11	)	_	)	_	)	88	_	_	_	_	_	_	_	O
12	inhibitors	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
13	,	_	,	_	,	88	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
16	(	_	(	_	(	88	_	_	_	_	_	_	_	O
17	glp-1	_	UNK	_	NNP	88	_	_	_	_	_	_	_	O
18	)	_	)	_	)	88	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	88	_	_	_	_	_	_	_	O
21	sulfonylureas	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
22	refer	_	refer	_	VBP	88	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	88	_	_	_	_	_	_	_	O
24	each	_	each	_	DT	88	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	88	_	_	_	_	_	_	_	O
26	these	_	these	_	DT	88	_	_	_	_	_	_	_	O
27	groups	_	group	_	NNS	88	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	88	_	_	_	_	_	_	_	O
29	drugs	_	drug	_	NNS	88	_	_	_	_	_	drug.n	Intoxicants	S-Intoxicant
30	at	_	at	_	IN	88	_	_	_	_	_	_	_	O
31	a	_	a	_	DT	88	_	_	_	_	_	_	_	O
32	class	_	class	_	NN	88	_	_	_	_	_	_	_	O
33	level	_	level	_	NN	88	_	_	_	_	_	_	_	O
34	.	_	.	_	.	88	_	_	_	_	_	_	_	O

1	recommendations	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
2	in	_	in	_	IN	88	_	_	_	_	_	_	_	O
3	this	_	this	_	DT	88	_	_	_	_	_	_	_	O
4	section	_	section	_	NN	88	_	_	_	_	_	_	_	O
5	that	_	that	_	IN	88	_	_	_	_	_	_	_	O
6	cover	_	cover	_	NN	88	_	_	_	_	_	_	_	O
7	dipeptidyl	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
9	(	_	(	_	(	88	_	_	_	_	_	_	_	O
10	dpp-4	_	UNK	_	NNP	88	_	_	_	_	_	_	_	O
11	)	_	)	_	)	88	_	_	_	_	_	_	_	O
12	inhibitors	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
13	,	_	,	_	,	88	_	_	_	_	_	_	_	O
14	unk	_	UNK	_	JJ	88	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	88	_	_	_	_	_	_	_	O
16	(	_	(	_	(	88	_	_	_	_	_	_	_	O
17	glp-1	_	UNK	_	NNP	88	_	_	_	_	_	_	_	O
18	)	_	)	_	)	88	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	88	_	_	_	_	_	_	_	O
21	sulfonylureas	_	UNK	_	NNS	88	_	_	_	_	_	_	_	O
22	refer	_	refer	_	VBP	88	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	88	_	_	_	_	_	_	_	O
24	each	_	each	_	DT	88	_	_	_	_	_	_	_	O
25	of	_	of	_	IN	88	_	_	_	_	_	_	_	O
26	these	_	these	_	DT	88	_	_	_	_	_	_	_	O
27	groups	_	group	_	NNS	88	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	88	_	_	_	_	_	_	_	O
29	drugs	_	drug	_	NNS	88	_	_	_	_	_	_	_	O
30	at	_	at	_	IN	88	_	_	_	_	_	_	_	O
31	a	_	a	_	DT	88	_	_	_	_	_	_	_	O
32	class	_	class	_	NN	88	_	_	_	_	_	class.n	Type	S-Subtype
33	level	_	level	_	NN	88	_	_	_	_	_	_	_	O
34	.	_	.	_	.	88	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	89	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	89	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	89	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	89	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	89	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	89	_	_	_	_	_	_	_	O
7	,	_	,	_	,	89	_	_	_	_	_	_	_	O
8	discuss	_	discuss	_	VBP	89	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	89	_	_	_	_	_	_	_	O
10	benefits	_	benefit	_	NNS	89	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	89	_	_	_	_	_	_	_	O
12	risks	_	risk	_	NNS	89	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	89	_	_	_	_	_	_	_	O
14	drug	_	drug	_	NN	89	_	_	_	_	_	_	_	O
15	treatment	_	treatment	_	NN	89	_	_	_	_	_	_	_	O
16	,	_	,	_	,	89	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	89	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	89	_	_	_	_	_	_	_	O
19	options	_	option	_	NNS	89	_	_	_	_	_	_	_	O
20	available	_	available	_	JJ	89	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	89	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	89	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	89	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	89	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	89	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	89	_	_	_	_	_	_	_	I-Category
7	,	_	,	_	,	89	_	_	_	_	_	_	_	O
8	discuss	_	discuss	_	VBP	89	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	89	_	_	_	_	_	_	_	O
10	benefits	_	benefit	_	NNS	89	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	89	_	_	_	_	_	_	_	O
12	risks	_	risk	_	NNS	89	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	89	_	_	_	_	_	_	_	O
14	drug	_	drug	_	NN	89	_	_	_	_	_	_	_	O
15	treatment	_	treatment	_	NN	89	_	_	_	_	_	_	_	O
16	,	_	,	_	,	89	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	89	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	89	_	_	_	_	_	_	_	O
19	options	_	option	_	NNS	89	_	_	_	_	_	_	_	O
20	available	_	available	_	JJ	89	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	89	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	89	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	89	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	89	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	89	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	89	_	_	_	_	_	_	_	O
7	,	_	,	_	,	89	_	_	_	_	_	_	_	O
8	discuss	_	discuss	_	VBP	89	_	_	_	_	_	discuss.v	Discussion	O
9	the	_	the	_	DT	89	_	_	_	_	_	_	_	B-Topic
10	benefits	_	benefit	_	NNS	89	_	_	_	_	_	_	_	I-Topic
11	and	_	and	_	CC	89	_	_	_	_	_	_	_	I-Topic
12	risks	_	risk	_	NNS	89	_	_	_	_	_	_	_	I-Topic
13	of	_	of	_	IN	89	_	_	_	_	_	_	_	I-Topic
14	drug	_	drug	_	NN	89	_	_	_	_	_	_	_	I-Topic
15	treatment	_	treatment	_	NN	89	_	_	_	_	_	_	_	I-Topic
16	,	_	,	_	,	89	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	89	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	89	_	_	_	_	_	_	_	O
19	options	_	option	_	NNS	89	_	_	_	_	_	_	_	O
20	available	_	available	_	JJ	89	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	89	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	89	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	89	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	89	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	89	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	89	_	_	_	_	_	_	_	O
7	,	_	,	_	,	89	_	_	_	_	_	_	_	O
8	discuss	_	discuss	_	VBP	89	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	89	_	_	_	_	_	_	_	O
10	benefits	_	benefit	_	NNS	89	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	89	_	_	_	_	_	_	_	O
12	risks	_	risk	_	NNS	89	_	_	_	_	_	risk.n	Run_risk	O
13	of	_	of	_	IN	89	_	_	_	_	_	_	_	B-Asset
14	drug	_	drug	_	NN	89	_	_	_	_	_	_	_	I-Asset
15	treatment	_	treatment	_	NN	89	_	_	_	_	_	_	_	I-Asset
16	,	_	,	_	,	89	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	89	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	89	_	_	_	_	_	_	_	O
19	options	_	option	_	NNS	89	_	_	_	_	_	_	_	O
20	available	_	available	_	JJ	89	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	89	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	89	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	89	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	89	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	89	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	89	_	_	_	_	_	_	_	O
7	,	_	,	_	,	89	_	_	_	_	_	_	_	O
8	discuss	_	discuss	_	VBP	89	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	89	_	_	_	_	_	_	_	O
10	benefits	_	benefit	_	NNS	89	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	89	_	_	_	_	_	_	_	O
12	risks	_	risk	_	NNS	89	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	89	_	_	_	_	_	_	_	O
14	drug	_	drug	_	NN	89	_	_	_	_	_	_	_	S-Patient
15	treatment	_	treatment	_	NN	89	_	_	_	_	_	treatment.n	Cure	O
16	,	_	,	_	,	89	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	89	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	89	_	_	_	_	_	_	_	O
19	options	_	option	_	NNS	89	_	_	_	_	_	_	_	O
20	available	_	available	_	JJ	89	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	89	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	89	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	89	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	89	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	89	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	89	_	_	_	_	_	_	_	O
7	,	_	,	_	,	89	_	_	_	_	_	_	_	O
8	discuss	_	discuss	_	VBP	89	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	89	_	_	_	_	_	_	_	O
10	benefits	_	benefit	_	NNS	89	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	89	_	_	_	_	_	_	_	O
12	risks	_	risk	_	NNS	89	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	89	_	_	_	_	_	_	_	O
14	drug	_	drug	_	NN	89	_	_	_	_	_	_	_	O
15	treatment	_	treatment	_	NN	89	_	_	_	_	_	_	_	O
16	,	_	,	_	,	89	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	89	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	89	_	_	_	_	_	_	_	O
19	options	_	option	_	NNS	89	_	_	_	_	_	option.n	Alternatives	O
20	available	_	available	_	JJ	89	_	_	_	_	_	_	_	O

1	base	_	Base	_	NNP	90	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	90	_	_	_	_	_	_	_	O
3	choice	_	choice	_	NN	90	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	90	_	_	_	_	_	_	_	O
5	drug	_	drug	_	NN	90	_	_	_	_	_	_	_	O
6	treatment	_	treatment	_	NN	90	_	_	_	_	_	_	_	O
7	(	_	(	_	(	90	_	_	_	_	_	_	_	O
8	s	_	s	_	PRP	90	_	_	_	_	_	_	_	O
9	)	_	)	_	)	90	_	_	_	_	_	_	_	O
10	on	_	on	_	IN	90	_	_	_	_	_	_	_	O
11	:	_	:	_	:	90	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	90	_	_	_	_	_	_	_	O
13	effectiveness	_	UNK	_	NN	90	_	_	_	_	_	_	_	O
14	of	_	of	_	IN	90	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	90	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	90	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	90	_	_	_	_	_	_	_	O
18	(	_	(	_	(	90	_	_	_	_	_	_	_	O
19	s	_	s	_	NN	90	_	_	_	_	_	_	_	O
20	)	_	)	_	)	90	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	90	_	_	_	_	_	_	_	O
22	terms	_	term	_	NNS	90	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	90	_	_	_	_	_	_	_	O
24	metabolic	_	UNK	_	JJ	90	_	_	_	_	_	_	_	S-Trigger
25	response	_	response	_	NN	90	_	_	_	_	_	response.n	Response	O

1	type	_	Type	_	$	91	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	91	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	91	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	91	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	91	_	_	_	_	_	_	_	O
6	:	_	:	_	:	91	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	91	_	_	_	_	_	_	_	O
8	(	_	(	_	(	91	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	91	_	_	_	_	_	_	_	O
10	)	_	)	_	)	91	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	91	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	91	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	91	_	_	_	_	_	_	_	O
14	)	_	)	_	)	91	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	91	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	91	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	91	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	91	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	91	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	91	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	91	_	_	_	_	_	_	_	O
8	(	_	(	_	(	91	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	91	_	_	_	_	_	_	_	O
10	)	_	)	_	)	91	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	91	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	91	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	91	_	_	_	_	_	_	_	O
14	)	_	)	_	)	91	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	92	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	92	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	92	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	92	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	92	_	_	_	_	_	_	_	O
6	(	_	(	_	(	92	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	92	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	92	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	92	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	92	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	92	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	92	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	92	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	92	_	_	_	_	_	_	_	O
18	)	_	)	_	)	92	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	92	_	_	_	_	_	_	_	S-Patient
24	treatment	_	treatment	_	NN	92	_	_	_	_	_	treatment.n	Cure	O
25	(	_	(	_	(	92	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	92	_	_	_	_	_	_	_	O
27	)	_	)	_	)	92	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	92	_	_	_	_	_	_	_	O
34	,	_	,	_	,	92	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	92	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	92	_	_	_	_	_	_	_	O
37	,	_	,	_	,	92	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
39	,	_	,	_	,	92	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	92	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	92	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	92	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	92	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	92	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	92	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
57	(	_	(	_	(	92	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	92	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	92	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	92	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	92	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	92	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	92	_	_	_	_	_	_	_	O
67	,	_	,	_	,	92	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	92	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	92	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	92	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	92	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
76	)	_	)	_	)	92	_	_	_	_	_	_	_	O
77	.	_	.	_	.	92	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	92	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	92	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	92	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	92	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	92	_	_	_	_	_	_	_	O
6	(	_	(	_	(	92	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	92	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	92	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	92	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	92	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	92	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	92	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	92	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	92	_	_	_	_	_	_	_	O
18	)	_	)	_	)	92	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	92	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	92	_	_	_	_	_	_	_	O
25	(	_	(	_	(	92	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	92	_	_	_	_	_	_	_	O
27	)	_	)	_	)	92	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	92	_	_	_	_	_	person.n	People	S-Person
30	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	92	_	_	_	_	_	_	_	O
34	,	_	,	_	,	92	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	92	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	92	_	_	_	_	_	_	_	O
37	,	_	,	_	,	92	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
39	,	_	,	_	,	92	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	92	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	92	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	92	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	92	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	92	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	92	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
57	(	_	(	_	(	92	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	92	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	92	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	92	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	92	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	92	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	92	_	_	_	_	_	_	_	O
67	,	_	,	_	,	92	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	92	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	92	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	92	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	92	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
76	)	_	)	_	)	92	_	_	_	_	_	_	_	O
77	.	_	.	_	.	92	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	92	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	92	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	92	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	92	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	92	_	_	_	_	_	_	_	O
6	(	_	(	_	(	92	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	92	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	92	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	92	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	92	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	92	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	92	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	92	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	92	_	_	_	_	_	_	_	O
18	)	_	)	_	)	92	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	92	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	92	_	_	_	_	_	_	_	O
25	(	_	(	_	(	92	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	92	_	_	_	_	_	_	_	O
27	)	_	)	_	)	92	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	92	_	_	_	_	_	individual.n	People	B-Person
32	clinical	_	UNK	_	JJ	92	_	_	_	_	_	_	_	I-Person
33	circumstances	_	circumstance	_	NNS	92	_	_	_	_	_	_	_	I-Person
34	,	_	,	_	,	92	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	92	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	92	_	_	_	_	_	_	_	O
37	,	_	,	_	,	92	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
39	,	_	,	_	,	92	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	92	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	92	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	92	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	92	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	92	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	92	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
57	(	_	(	_	(	92	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	92	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	92	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	92	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	92	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	92	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	92	_	_	_	_	_	_	_	O
67	,	_	,	_	,	92	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	92	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	92	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	92	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	92	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
76	)	_	)	_	)	92	_	_	_	_	_	_	_	O
77	.	_	.	_	.	92	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	92	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	92	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	92	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	92	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	92	_	_	_	_	_	_	_	O
6	(	_	(	_	(	92	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	92	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	92	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	92	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	92	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	92	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	92	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	92	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	92	_	_	_	_	_	_	_	O
18	)	_	)	_	)	92	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	92	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	92	_	_	_	_	_	_	_	O
25	(	_	(	_	(	92	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	92	_	_	_	_	_	_	_	O
27	)	_	)	_	)	92	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	92	_	_	_	_	_	_	_	O
34	,	_	,	_	,	92	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	92	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	92	_	_	_	_	_	example.n	Instance	S-Instance
37	,	_	,	_	,	92	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
39	,	_	,	_	,	92	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	92	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	92	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	92	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	92	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	92	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	92	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
57	(	_	(	_	(	92	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	92	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	92	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	92	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	92	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	92	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	92	_	_	_	_	_	_	_	O
67	,	_	,	_	,	92	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	92	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	92	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	92	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	92	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
76	)	_	)	_	)	92	_	_	_	_	_	_	_	O
77	.	_	.	_	.	92	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	92	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	92	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	92	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	92	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	92	_	_	_	_	_	_	_	O
6	(	_	(	_	(	92	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	92	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	92	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	92	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	92	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	92	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	92	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	92	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	92	_	_	_	_	_	_	_	O
18	)	_	)	_	)	92	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	92	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	92	_	_	_	_	_	_	_	O
25	(	_	(	_	(	92	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	92	_	_	_	_	_	_	_	O
27	)	_	)	_	)	92	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	92	_	_	_	_	_	_	_	O
34	,	_	,	_	,	92	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	92	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	92	_	_	_	_	_	_	_	O
37	,	_	,	_	,	92	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
39	,	_	,	_	,	92	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	92	_	_	_	_	_	risk.n	Run_risk	O
41	from	_	from	_	IN	92	_	_	_	_	_	_	_	B-Action
42	polypharmacy	_	UNK	_	NN	92	_	_	_	_	_	_	_	I-Action
43	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	92	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	92	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	92	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	92	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
57	(	_	(	_	(	92	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	92	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	92	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	92	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	92	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	92	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	92	_	_	_	_	_	_	_	O
67	,	_	,	_	,	92	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	92	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	92	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	92	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	92	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
76	)	_	)	_	)	92	_	_	_	_	_	_	_	O
77	.	_	.	_	.	92	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	92	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	92	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	92	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	92	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	92	_	_	_	_	_	_	_	O
6	(	_	(	_	(	92	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	92	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	92	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	92	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	92	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	92	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	92	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	92	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	92	_	_	_	_	_	_	_	O
18	)	_	)	_	)	92	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	92	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	92	_	_	_	_	_	_	_	O
25	(	_	(	_	(	92	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	92	_	_	_	_	_	_	_	O
27	)	_	)	_	)	92	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	92	_	_	_	_	_	_	_	O
34	,	_	,	_	,	92	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	92	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	92	_	_	_	_	_	_	_	O
37	,	_	,	_	,	92	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
39	,	_	,	_	,	92	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	92	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	92	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	92	_	_	_	_	_	person.n	People	S-Person
45	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	92	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	92	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	92	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	92	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
57	(	_	(	_	(	92	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	92	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	92	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	92	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	92	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	92	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	92	_	_	_	_	_	_	_	O
67	,	_	,	_	,	92	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	92	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	92	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	92	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	92	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
76	)	_	)	_	)	92	_	_	_	_	_	_	_	O
77	.	_	.	_	.	92	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	92	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	92	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	92	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	92	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	92	_	_	_	_	_	_	_	O
6	(	_	(	_	(	92	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	92	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	92	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	92	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	92	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	92	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	92	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	92	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	92	_	_	_	_	_	_	_	O
18	)	_	)	_	)	92	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	92	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	92	_	_	_	_	_	_	_	O
25	(	_	(	_	(	92	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	92	_	_	_	_	_	_	_	O
27	)	_	)	_	)	92	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	92	_	_	_	_	_	_	_	O
34	,	_	,	_	,	92	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	92	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	92	_	_	_	_	_	_	_	O
37	,	_	,	_	,	92	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
39	,	_	,	_	,	92	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	92	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	92	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	92	_	_	_	_	_	individual.n	People	S-Person
47	preferences	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	92	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	92	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	92	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	92	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
57	(	_	(	_	(	92	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	92	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	92	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	92	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	92	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	92	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	92	_	_	_	_	_	_	_	O
67	,	_	,	_	,	92	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	92	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	92	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	92	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	92	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
76	)	_	)	_	)	92	_	_	_	_	_	_	_	O
77	.	_	.	_	.	92	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	92	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	92	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	92	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	92	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	92	_	_	_	_	_	_	_	O
6	(	_	(	_	(	92	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	92	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	92	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	92	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	92	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	92	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	92	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	92	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	92	_	_	_	_	_	_	_	O
18	)	_	)	_	)	92	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	92	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	92	_	_	_	_	_	_	_	O
25	(	_	(	_	(	92	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	92	_	_	_	_	_	_	_	O
27	)	_	)	_	)	92	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	92	_	_	_	_	_	_	_	O
34	,	_	,	_	,	92	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	92	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	92	_	_	_	_	_	_	_	O
37	,	_	,	_	,	92	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
39	,	_	,	_	,	92	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	92	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	92	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	92	_	_	_	_	_	need.v	Needing	O
50	the	_	the	_	DT	92	_	_	_	_	_	_	_	B-Requirement
51	licensed	_	UNK	_	JJ	92	_	_	_	_	_	_	_	I-Requirement
52	indications	_	indication	_	NNS	92	_	_	_	_	_	_	_	I-Requirement
53	or	_	or	_	CC	92	_	_	_	_	_	_	_	I-Requirement
54	combinations	_	combination	_	NNS	92	_	_	_	_	_	_	_	I-Requirement
55	available	_	available	_	JJ	92	_	_	_	_	_	_	_	I-Requirement
56	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	I-Requirement
57	(	_	(	_	(	92	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	92	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	92	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	92	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	92	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	92	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	92	_	_	_	_	_	_	_	O
67	,	_	,	_	,	92	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	92	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	92	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	92	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	92	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
76	)	_	)	_	)	92	_	_	_	_	_	_	_	O
77	.	_	.	_	.	92	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	92	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	92	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	92	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	92	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	92	_	_	_	_	_	_	_	O
6	(	_	(	_	(	92	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	92	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	92	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	92	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	92	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	92	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	92	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	92	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	92	_	_	_	_	_	_	_	O
18	)	_	)	_	)	92	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	92	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	92	_	_	_	_	_	_	_	O
25	(	_	(	_	(	92	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	92	_	_	_	_	_	_	_	O
27	)	_	)	_	)	92	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	92	_	_	_	_	_	_	_	O
34	,	_	,	_	,	92	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	92	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	92	_	_	_	_	_	_	_	O
37	,	_	,	_	,	92	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
39	,	_	,	_	,	92	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	92	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	92	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	92	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	92	_	_	_	_	_	_	_	S-Descriptor
52	indications	_	indication	_	NNS	92	_	_	_	_	_	indication.n	Sign	S-Indicator
53	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	92	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	92	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
57	(	_	(	_	(	92	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	92	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	92	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	92	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	92	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	92	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	92	_	_	_	_	_	_	_	O
67	,	_	,	_	,	92	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	92	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	92	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	92	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	92	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
76	)	_	)	_	)	92	_	_	_	_	_	_	_	O
77	.	_	.	_	.	92	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	92	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	92	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	92	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	92	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	92	_	_	_	_	_	_	_	O
6	(	_	(	_	(	92	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	92	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	92	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	92	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	92	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	92	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	92	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	92	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	92	_	_	_	_	_	_	_	O
18	)	_	)	_	)	92	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	92	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	92	_	_	_	_	_	_	_	O
25	(	_	(	_	(	92	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	92	_	_	_	_	_	_	_	O
27	)	_	)	_	)	92	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	92	_	_	_	_	_	_	_	O
34	,	_	,	_	,	92	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	92	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	92	_	_	_	_	_	_	_	O
37	,	_	,	_	,	92	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
39	,	_	,	_	,	92	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	92	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	92	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	92	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	92	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	92	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	92	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	92	_	_	_	_	_	cost.n	Expensiveness	O
57	(	_	(	_	(	92	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	92	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	92	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	92	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	92	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	92	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	92	_	_	_	_	_	_	_	O
67	,	_	,	_	,	92	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	92	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	92	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	92	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	92	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
76	)	_	)	_	)	92	_	_	_	_	_	_	_	O
77	.	_	.	_	.	92	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	92	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	92	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	92	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	92	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	92	_	_	_	_	_	_	_	O
6	(	_	(	_	(	92	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	92	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	92	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	92	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	92	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	92	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	92	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	92	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	92	_	_	_	_	_	_	_	O
18	)	_	)	_	)	92	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	92	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	92	_	_	_	_	_	_	_	O
25	(	_	(	_	(	92	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	92	_	_	_	_	_	_	_	O
27	)	_	)	_	)	92	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	92	_	_	_	_	_	_	_	O
34	,	_	,	_	,	92	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	92	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	92	_	_	_	_	_	_	_	O
37	,	_	,	_	,	92	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
39	,	_	,	_	,	92	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	92	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	92	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	92	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	92	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	92	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	92	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
57	(	_	(	_	(	92	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	92	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	92	_	_	_	_	_	drug.n	Intoxicants	S-Intoxicant
61	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	92	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	92	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	92	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	92	_	_	_	_	_	_	_	O
67	,	_	,	_	,	92	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	92	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	92	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	92	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	92	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
76	)	_	)	_	)	92	_	_	_	_	_	_	_	O
77	.	_	.	_	.	92	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	92	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	92	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	92	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	92	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	92	_	_	_	_	_	_	_	O
6	(	_	(	_	(	92	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	92	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	92	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	92	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	92	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	92	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	92	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	92	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	92	_	_	_	_	_	_	_	O
18	)	_	)	_	)	92	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	92	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	92	_	_	_	_	_	_	_	O
25	(	_	(	_	(	92	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	92	_	_	_	_	_	_	_	O
27	)	_	)	_	)	92	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	92	_	_	_	_	_	_	_	O
34	,	_	,	_	,	92	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	92	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	92	_	_	_	_	_	_	_	O
37	,	_	,	_	,	92	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
39	,	_	,	_	,	92	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	92	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	92	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	92	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	92	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	92	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	92	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
57	(	_	(	_	(	92	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	92	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	92	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	92	_	_	_	_	_	same.a	Identicality	O
64	class	_	class	_	NN	92	_	_	_	_	_	_	_	S-Type
65	are	_	be	_	VBP	92	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	92	_	_	_	_	_	_	_	O
67	,	_	,	_	,	92	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	92	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	92	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	92	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	92	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
76	)	_	)	_	)	92	_	_	_	_	_	_	_	O
77	.	_	.	_	.	92	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	92	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	92	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	92	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	92	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	92	_	_	_	_	_	_	_	O
6	(	_	(	_	(	92	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	92	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	92	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	92	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	92	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	92	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	92	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	92	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	92	_	_	_	_	_	_	_	O
18	)	_	)	_	)	92	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	92	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	92	_	_	_	_	_	_	_	O
25	(	_	(	_	(	92	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	92	_	_	_	_	_	_	_	O
27	)	_	)	_	)	92	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	92	_	_	_	_	_	_	_	O
34	,	_	,	_	,	92	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	92	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	92	_	_	_	_	_	_	_	O
37	,	_	,	_	,	92	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
39	,	_	,	_	,	92	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	92	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	92	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	92	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	92	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	92	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	92	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
57	(	_	(	_	(	92	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	92	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	92	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	92	_	_	_	_	_	_	_	S-Type_property
64	class	_	class	_	NN	92	_	_	_	_	_	class.n	Type	S-Subtype
65	are	_	be	_	VBP	92	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	92	_	_	_	_	_	_	_	O
67	,	_	,	_	,	92	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	92	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	92	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	92	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	92	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
76	)	_	)	_	)	92	_	_	_	_	_	_	_	O
77	.	_	.	_	.	92	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	92	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	92	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	92	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	92	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	92	_	_	_	_	_	_	_	O
6	(	_	(	_	(	92	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	92	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	92	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	92	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	92	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	92	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	92	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	92	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	92	_	_	_	_	_	_	_	O
18	)	_	)	_	)	92	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	92	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	92	_	_	_	_	_	_	_	O
25	(	_	(	_	(	92	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	92	_	_	_	_	_	_	_	O
27	)	_	)	_	)	92	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	92	_	_	_	_	_	_	_	O
34	,	_	,	_	,	92	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	92	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	92	_	_	_	_	_	_	_	O
37	,	_	,	_	,	92	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
39	,	_	,	_	,	92	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	92	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	92	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	92	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	92	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	92	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	92	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
57	(	_	(	_	(	92	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	92	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	92	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	92	_	_	_	_	_	_	_	B-Evaluee
63	same	_	same	_	JJ	92	_	_	_	_	_	_	_	I-Evaluee
64	class	_	class	_	NN	92	_	_	_	_	_	_	_	I-Evaluee
65	are	_	be	_	VBP	92	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	92	_	_	_	_	_	appropriate.a	Suitability	O
67	,	_	,	_	,	92	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	92	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	92	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	92	_	_	_	_	_	_	_	O
74	acquisition	_	acquisition	_	NN	92	_	_	_	_	_	_	_	O
75	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
76	)	_	)	_	)	92	_	_	_	_	_	_	_	O
77	.	_	.	_	.	92	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	92	_	_	_	_	_	_	_	B-Chosen
2	updated	_	update	_	VBD	92	_	_	_	_	_	_	_	I-Chosen
3	may	_	May	_	NNP	92	_	_	_	_	_	_	_	I-Chosen
4	2017	_	UNK	_	CD	92	_	_	_	_	_	_	_	I-Chosen
5	safety	_	safety	_	NN	92	_	_	_	_	_	_	_	I-Chosen
6	(	_	(	_	(	92	_	_	_	_	_	_	_	I-Chosen
7	see	_	see	_	VB	92	_	_	_	_	_	_	_	I-Chosen
8	medicines	_	UNK	_	NNPS	92	_	_	_	_	_	_	_	I-Chosen
9	and	_	and	_	CC	92	_	_	_	_	_	_	_	I-Chosen
10	healthcare	_	UNK	_	NNP	92	_	_	_	_	_	_	_	I-Chosen
11	products	_	product	_	NNS	92	_	_	_	_	_	_	_	I-Chosen
12	regulatory	_	Regulatory	_	NNP	92	_	_	_	_	_	_	_	I-Chosen
13	agency	_	Agency	_	NNP	92	_	_	_	_	_	_	_	I-Chosen
14	[	_	[	_	NNP	92	_	_	_	_	_	_	_	I-Chosen
15	mhra	_	UNK	_	NNP	92	_	_	_	_	_	_	_	I-Chosen
16	]	_	]	_	NNP	92	_	_	_	_	_	_	_	I-Chosen
17	guidance	_	guidance	_	NN	92	_	_	_	_	_	_	_	I-Chosen
18	)	_	)	_	)	92	_	_	_	_	_	_	_	I-Chosen
19	and	_	and	_	CC	92	_	_	_	_	_	_	_	I-Chosen
20	tolerability	_	UNK	_	NN	92	_	_	_	_	_	_	_	I-Chosen
21	of	_	of	_	IN	92	_	_	_	_	_	_	_	I-Chosen
22	the	_	the	_	DT	92	_	_	_	_	_	_	_	I-Chosen
23	drug	_	drug	_	NN	92	_	_	_	_	_	_	_	I-Chosen
24	treatment	_	treatment	_	NN	92	_	_	_	_	_	_	_	I-Chosen
25	(	_	(	_	(	92	_	_	_	_	_	_	_	I-Chosen
26	s	_	s	_	PRP	92	_	_	_	_	_	_	_	I-Chosen
27	)	_	)	_	)	92	_	_	_	_	_	_	_	I-Chosen
28	the	_	the	_	DT	92	_	_	_	_	_	_	_	I-Chosen
29	person	_	person	_	NN	92	_	_	_	_	_	_	_	I-Chosen
30	's	_	's	_	POS	92	_	_	_	_	_	_	_	I-Chosen
31	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	I-Chosen
32	clinical	_	UNK	_	JJ	92	_	_	_	_	_	_	_	I-Chosen
33	circumstances	_	circumstance	_	NNS	92	_	_	_	_	_	_	_	I-Chosen
34	,	_	,	_	,	92	_	_	_	_	_	_	_	I-Chosen
35	for	_	for	_	IN	92	_	_	_	_	_	_	_	I-Chosen
36	example	_	example	_	NN	92	_	_	_	_	_	_	_	I-Chosen
37	,	_	,	_	,	92	_	_	_	_	_	_	_	I-Chosen
38	comorbidities	_	UNK	_	NNS	92	_	_	_	_	_	_	_	I-Chosen
39	,	_	,	_	,	92	_	_	_	_	_	_	_	I-Chosen
40	risks	_	risk	_	NNS	92	_	_	_	_	_	_	_	I-Chosen
41	from	_	from	_	IN	92	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	92	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	92	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	92	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	92	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
57	(	_	(	_	(	92	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	92	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	92	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	92	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	92	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	92	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	92	_	_	_	_	_	_	_	O
67	,	_	,	_	,	92	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	92	_	_	_	_	_	choose.v	Choosing	O
69	the	_	the	_	DT	92	_	_	_	_	_	_	_	B-Chosen
70	option	_	option	_	NN	92	_	_	_	_	_	_	_	I-Chosen
71	with	_	with	_	IN	92	_	_	_	_	_	_	_	I-Chosen
72	the	_	the	_	DT	92	_	_	_	_	_	_	_	I-Chosen
73	lowest	_	lowest	_	JJS	92	_	_	_	_	_	_	_	I-Chosen
74	acquisition	_	acquisition	_	NN	92	_	_	_	_	_	_	_	I-Chosen
75	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	I-Chosen
76	)	_	)	_	)	92	_	_	_	_	_	_	_	O
77	.	_	.	_	.	92	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	92	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	92	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	92	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	92	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	92	_	_	_	_	_	_	_	O
6	(	_	(	_	(	92	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	92	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	92	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	92	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	92	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	92	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	92	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	92	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	92	_	_	_	_	_	_	_	O
18	)	_	)	_	)	92	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	92	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	92	_	_	_	_	_	_	_	O
25	(	_	(	_	(	92	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	92	_	_	_	_	_	_	_	O
27	)	_	)	_	)	92	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	92	_	_	_	_	_	_	_	O
34	,	_	,	_	,	92	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	92	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	92	_	_	_	_	_	_	_	O
37	,	_	,	_	,	92	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
39	,	_	,	_	,	92	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	92	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	92	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	92	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	92	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	92	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	92	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
57	(	_	(	_	(	92	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	92	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	92	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	92	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	92	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	92	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	92	_	_	_	_	_	_	_	O
67	,	_	,	_	,	92	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	92	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	92	_	_	_	_	_	option.n	Alternatives	O
71	with	_	with	_	IN	92	_	_	_	_	_	_	_	B-Situation
72	the	_	the	_	DT	92	_	_	_	_	_	_	_	I-Situation
73	lowest	_	lowest	_	JJS	92	_	_	_	_	_	_	_	I-Situation
74	acquisition	_	acquisition	_	NN	92	_	_	_	_	_	_	_	I-Situation
75	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	I-Situation
76	)	_	)	_	)	92	_	_	_	_	_	_	_	O
77	.	_	.	_	.	92	_	_	_	_	_	_	_	O

1	last	_	Last	_	JJ	92	_	_	_	_	_	_	_	O
2	updated	_	update	_	VBD	92	_	_	_	_	_	_	_	O
3	may	_	May	_	NNP	92	_	_	_	_	_	_	_	O
4	2017	_	UNK	_	CD	92	_	_	_	_	_	_	_	O
5	safety	_	safety	_	NN	92	_	_	_	_	_	_	_	O
6	(	_	(	_	(	92	_	_	_	_	_	_	_	O
7	see	_	see	_	VB	92	_	_	_	_	_	_	_	O
8	medicines	_	UNK	_	NNPS	92	_	_	_	_	_	_	_	O
9	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
10	healthcare	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
11	products	_	product	_	NNS	92	_	_	_	_	_	_	_	O
12	regulatory	_	Regulatory	_	NNP	92	_	_	_	_	_	_	_	O
13	agency	_	Agency	_	NNP	92	_	_	_	_	_	_	_	O
14	[	_	[	_	NNP	92	_	_	_	_	_	_	_	O
15	mhra	_	UNK	_	NNP	92	_	_	_	_	_	_	_	O
16	]	_	]	_	NNP	92	_	_	_	_	_	_	_	O
17	guidance	_	guidance	_	NN	92	_	_	_	_	_	_	_	O
18	)	_	)	_	)	92	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
20	tolerability	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	92	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
23	drug	_	drug	_	NN	92	_	_	_	_	_	_	_	O
24	treatment	_	treatment	_	NN	92	_	_	_	_	_	_	_	O
25	(	_	(	_	(	92	_	_	_	_	_	_	_	O
26	s	_	s	_	PRP	92	_	_	_	_	_	_	_	O
27	)	_	)	_	)	92	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
29	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
30	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
31	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
32	clinical	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
33	circumstances	_	circumstance	_	NNS	92	_	_	_	_	_	_	_	O
34	,	_	,	_	,	92	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	92	_	_	_	_	_	_	_	O
36	example	_	example	_	NN	92	_	_	_	_	_	_	_	O
37	,	_	,	_	,	92	_	_	_	_	_	_	_	O
38	comorbidities	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
39	,	_	,	_	,	92	_	_	_	_	_	_	_	O
40	risks	_	risk	_	NNS	92	_	_	_	_	_	_	_	O
41	from	_	from	_	IN	92	_	_	_	_	_	_	_	O
42	polypharmacy	_	UNK	_	NN	92	_	_	_	_	_	_	_	O
43	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
44	person	_	person	_	NN	92	_	_	_	_	_	_	_	O
45	's	_	's	_	POS	92	_	_	_	_	_	_	_	O
46	individual	_	individual	_	JJ	92	_	_	_	_	_	_	_	O
47	preferences	_	UNK	_	NNS	92	_	_	_	_	_	_	_	O
48	and	_	and	_	CC	92	_	_	_	_	_	_	_	O
49	needs	_	need	_	VBZ	92	_	_	_	_	_	_	_	O
50	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
51	licensed	_	UNK	_	JJ	92	_	_	_	_	_	_	_	O
52	indications	_	indication	_	NNS	92	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	92	_	_	_	_	_	_	_	O
54	combinations	_	combination	_	NNS	92	_	_	_	_	_	_	_	O
55	available	_	available	_	JJ	92	_	_	_	_	_	_	_	O
56	cost	_	cost	_	NN	92	_	_	_	_	_	_	_	O
57	(	_	(	_	(	92	_	_	_	_	_	_	_	O
58	if	_	if	_	IN	92	_	_	_	_	_	_	_	O
59	2	_	2	_	CD	92	_	_	_	_	_	_	_	O
60	drugs	_	drug	_	NNS	92	_	_	_	_	_	_	_	O
61	in	_	in	_	IN	92	_	_	_	_	_	_	_	O
62	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
63	same	_	same	_	JJ	92	_	_	_	_	_	_	_	O
64	class	_	class	_	NN	92	_	_	_	_	_	_	_	O
65	are	_	be	_	VBP	92	_	_	_	_	_	_	_	O
66	appropriate	_	appropriate	_	JJ	92	_	_	_	_	_	_	_	O
67	,	_	,	_	,	92	_	_	_	_	_	_	_	O
68	choose	_	choose	_	VB	92	_	_	_	_	_	_	_	O
69	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
70	option	_	option	_	NN	92	_	_	_	_	_	_	_	O
71	with	_	with	_	IN	92	_	_	_	_	_	_	_	O
72	the	_	the	_	DT	92	_	_	_	_	_	_	_	O
73	lowest	_	lowest	_	JJS	92	_	_	_	_	_	_	_	B-Asset
74	acquisition	_	acquisition	_	NN	92	_	_	_	_	_	_	_	I-Asset
75	cost	_	cost	_	NN	92	_	_	_	_	_	cost.n	Expensiveness	O
76	)	_	)	_	)	92	_	_	_	_	_	_	_	O
77	.	_	.	_	.	92	_	_	_	_	_	_	_	O

1	rescue	_	Rescue	_	NNP	93	_	_	_	_	_	_	_	O
2	therapy	_	therapy	_	NN	93	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
3	at	_	at	_	IN	93	_	_	_	_	_	_	_	O
4	any	_	any	_	DT	93	_	_	_	_	_	_	_	O
5	phase	_	phase	_	NN	93	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	93	_	_	_	_	_	_	_	O
7	treatment	_	treatment	_	NN	93	_	_	_	_	_	_	_	O

1	rescue	_	Rescue	_	NNP	93	_	_	_	_	_	_	_	O
2	therapy	_	therapy	_	NN	93	_	_	_	_	_	_	_	O
3	at	_	at	_	IN	93	_	_	_	_	_	_	_	O
4	any	_	any	_	DT	93	_	_	_	_	_	_	_	O
5	phase	_	phase	_	NN	93	_	_	_	_	_	phase.n	Thermodynamic_phase	O
6	of	_	of	_	IN	93	_	_	_	_	_	_	_	O
7	treatment	_	treatment	_	NN	93	_	_	_	_	_	_	_	O

1	rescue	_	Rescue	_	NNP	93	_	_	_	_	_	_	_	O
2	therapy	_	therapy	_	NN	93	_	_	_	_	_	_	_	O
3	at	_	at	_	IN	93	_	_	_	_	_	_	_	O
4	any	_	any	_	DT	93	_	_	_	_	_	_	_	O
5	phase	_	phase	_	NN	93	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	93	_	_	_	_	_	_	_	O
7	treatment	_	treatment	_	NN	93	_	_	_	_	_	treatment.n	Cure	O

1	if	_	If	_	IN	94	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	94	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	94	_	_	_	_	_	adult.n	People_by_age	S-Person
4	with	_	with	_	IN	94	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	94	_	_	_	_	_	_	_	O
6	2	_	2	_	CD	94	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	94	_	_	_	_	_	_	_	O
8	is	_	be	_	VBZ	94	_	_	_	_	_	_	_	O
9	symptomatically	_	UNK	_	RB	94	_	_	_	_	_	_	_	O
10	unk	_	UNK	_	JJ	94	_	_	_	_	_	_	_	O
11	,	_	,	_	,	94	_	_	_	_	_	_	_	O
12	consider	_	consider	_	VB	94	_	_	_	_	_	_	_	O
13	insulin	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
14	(	_	(	_	(	94	_	_	_	_	_	_	_	O
15	see	_	see	_	VB	94	_	_	_	_	_	_	_	O
16	recommendations	_	UNK	_	NNS	94	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	VB	94	_	_	_	_	_	_	_	O
18	)	_	)	_	)	94	_	_	_	_	_	_	_	O
19	or	_	or	_	CC	94	_	_	_	_	_	_	_	O
20	a	_	a	_	DT	94	_	_	_	_	_	_	_	O
21	sulfonylurea	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
22	,	_	,	_	,	94	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	94	_	_	_	_	_	_	_	O
24	review	_	review	_	VB	94	_	_	_	_	_	_	_	O
25	treatment	_	treatment	_	NN	94	_	_	_	_	_	_	_	O
26	when	_	when	_	WRB	94	_	_	_	_	_	_	_	O
27	blood	_	blood	_	NN	94	_	_	_	_	_	_	_	O
28	glucose	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
29	control	_	control	_	NN	94	_	_	_	_	_	_	_	O
30	has	_	have	_	VBZ	94	_	_	_	_	_	_	_	O
31	been	_	be	_	VBN	94	_	_	_	_	_	_	_	O
32	achieved	_	achieve	_	VBN	94	_	_	_	_	_	_	_	O
33	.	_	.	_	.	94	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	94	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	94	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	94	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	94	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	94	_	_	_	_	_	type.n	Type	S-Subtype
6	2	_	2	_	CD	94	_	_	_	_	_	_	_	B-Category
7	diabetes	_	UNK	_	NNS	94	_	_	_	_	_	_	_	I-Category
8	is	_	be	_	VBZ	94	_	_	_	_	_	_	_	O
9	symptomatically	_	UNK	_	RB	94	_	_	_	_	_	_	_	O
10	unk	_	UNK	_	JJ	94	_	_	_	_	_	_	_	O
11	,	_	,	_	,	94	_	_	_	_	_	_	_	O
12	consider	_	consider	_	VB	94	_	_	_	_	_	_	_	O
13	insulin	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
14	(	_	(	_	(	94	_	_	_	_	_	_	_	O
15	see	_	see	_	VB	94	_	_	_	_	_	_	_	O
16	recommendations	_	UNK	_	NNS	94	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	VB	94	_	_	_	_	_	_	_	O
18	)	_	)	_	)	94	_	_	_	_	_	_	_	O
19	or	_	or	_	CC	94	_	_	_	_	_	_	_	O
20	a	_	a	_	DT	94	_	_	_	_	_	_	_	O
21	sulfonylurea	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
22	,	_	,	_	,	94	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	94	_	_	_	_	_	_	_	O
24	review	_	review	_	VB	94	_	_	_	_	_	_	_	O
25	treatment	_	treatment	_	NN	94	_	_	_	_	_	_	_	O
26	when	_	when	_	WRB	94	_	_	_	_	_	_	_	O
27	blood	_	blood	_	NN	94	_	_	_	_	_	_	_	O
28	glucose	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
29	control	_	control	_	NN	94	_	_	_	_	_	_	_	O
30	has	_	have	_	VBZ	94	_	_	_	_	_	_	_	O
31	been	_	be	_	VBN	94	_	_	_	_	_	_	_	O
32	achieved	_	achieve	_	VBN	94	_	_	_	_	_	_	_	O
33	.	_	.	_	.	94	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	94	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	94	_	_	_	_	_	_	_	B-Cognizer
3	adult	_	adult	_	NN	94	_	_	_	_	_	_	_	I-Cognizer
4	with	_	with	_	IN	94	_	_	_	_	_	_	_	I-Cognizer
5	type	_	type	_	JJ	94	_	_	_	_	_	_	_	I-Cognizer
6	2	_	2	_	CD	94	_	_	_	_	_	_	_	I-Cognizer
7	diabetes	_	UNK	_	NNS	94	_	_	_	_	_	_	_	I-Cognizer
8	is	_	be	_	VBZ	94	_	_	_	_	_	_	_	O
9	symptomatically	_	UNK	_	RB	94	_	_	_	_	_	_	_	O
10	unk	_	UNK	_	JJ	94	_	_	_	_	_	_	_	O
11	,	_	,	_	,	94	_	_	_	_	_	_	_	O
12	consider	_	consider	_	VB	94	_	_	_	_	_	consider.v	Categorization	O
13	insulin	_	UNK	_	NN	94	_	_	_	_	_	_	_	S-Item
14	(	_	(	_	(	94	_	_	_	_	_	_	_	O
15	see	_	see	_	VB	94	_	_	_	_	_	_	_	O
16	recommendations	_	UNK	_	NNS	94	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	VB	94	_	_	_	_	_	_	_	O
18	)	_	)	_	)	94	_	_	_	_	_	_	_	O
19	or	_	or	_	CC	94	_	_	_	_	_	_	_	O
20	a	_	a	_	DT	94	_	_	_	_	_	_	_	O
21	sulfonylurea	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
22	,	_	,	_	,	94	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	94	_	_	_	_	_	_	_	O
24	review	_	review	_	VB	94	_	_	_	_	_	_	_	O
25	treatment	_	treatment	_	NN	94	_	_	_	_	_	_	_	O
26	when	_	when	_	WRB	94	_	_	_	_	_	_	_	O
27	blood	_	blood	_	NN	94	_	_	_	_	_	_	_	O
28	glucose	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
29	control	_	control	_	NN	94	_	_	_	_	_	_	_	O
30	has	_	have	_	VBZ	94	_	_	_	_	_	_	_	O
31	been	_	be	_	VBN	94	_	_	_	_	_	_	_	O
32	achieved	_	achieve	_	VBN	94	_	_	_	_	_	_	_	O
33	.	_	.	_	.	94	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	94	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	94	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	94	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	94	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	94	_	_	_	_	_	_	_	O
6	2	_	2	_	CD	94	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	94	_	_	_	_	_	_	_	O
8	is	_	be	_	VBZ	94	_	_	_	_	_	_	_	O
9	symptomatically	_	UNK	_	RB	94	_	_	_	_	_	_	_	O
10	unk	_	UNK	_	JJ	94	_	_	_	_	_	_	_	O
11	,	_	,	_	,	94	_	_	_	_	_	_	_	O
12	consider	_	consider	_	VB	94	_	_	_	_	_	_	_	O
13	insulin	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
14	(	_	(	_	(	94	_	_	_	_	_	_	_	O
15	see	_	see	_	VB	94	_	_	_	_	_	_	_	O
16	recommendations	_	UNK	_	NNS	94	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	VB	94	_	_	_	_	_	_	_	O
18	)	_	)	_	)	94	_	_	_	_	_	_	_	O
19	or	_	or	_	CC	94	_	_	_	_	_	_	_	O
20	a	_	a	_	DT	94	_	_	_	_	_	_	_	O
21	sulfonylurea	_	UNK	_	NN	94	_	_	_	_	_	_	_	O
22	,	_	,	_	,	94	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	94	_	_	_	_	_	_	_	O
24	review	_	review	_	VB	94	_	_	_	_	_	_	_	O
25	treatment	_	treatment	_	NN	94	_	_	_	_	_	_	_	O
26	when	_	when	_	WRB	94	_	_	_	_	_	_	_	O
27	blood	_	blood	_	NN	94	_	_	_	_	_	_	_	B-Goal
28	glucose	_	UNK	_	NN	94	_	_	_	_	_	_	_	I-Goal
29	control	_	control	_	NN	94	_	_	_	_	_	_	_	I-Goal
30	has	_	have	_	VBZ	94	_	_	_	_	_	_	_	O
31	been	_	be	_	VBN	94	_	_	_	_	_	_	_	O
32	achieved	_	achieve	_	VBN	94	_	_	_	_	_	achieve.v	Accomplishment	O
33	.	_	.	_	.	94	_	_	_	_	_	_	_	O

1	initial	_	Initial	_	JJ	95	_	_	_	_	_	initial.a	Version_sequence	O
2	drug	_	drug	_	NN	95	_	_	_	_	_	_	_	B-Item
3	treatment	_	treatment	_	NN	95	_	_	_	_	_	_	_	I-Item

1	initial	_	Initial	_	JJ	95	_	_	_	_	_	_	_	O
2	drug	_	drug	_	NN	95	_	_	_	_	_	_	_	S-Patient
3	treatment	_	treatment	_	NN	95	_	_	_	_	_	treatment.n	Cure	O

1	offer	_	UNK	_	NN	96	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	96	_	_	_	_	_	_	_	O
3	metformin	_	UNK	_	NN	96	_	_	_	_	_	_	_	O
4	as	_	a	_	IN	96	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	96	_	_	_	_	_	_	_	O
6	initial	_	initial	_	JJ	96	_	_	_	_	_	_	_	O
7	drug	_	drug	_	NN	96	_	_	_	_	_	_	_	S-Patient
8	treatment	_	treatment	_	NN	96	_	_	_	_	_	treatment.n	Cure	O
9	for	_	for	_	IN	96	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	96	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	96	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	96	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	96	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	96	_	_	_	_	_	_	_	O
15	.	_	.	_	.	96	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	96	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	96	_	_	_	_	_	_	_	O
3	metformin	_	UNK	_	NN	96	_	_	_	_	_	_	_	O
4	as	_	a	_	IN	96	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	96	_	_	_	_	_	_	_	O
6	initial	_	initial	_	JJ	96	_	_	_	_	_	_	_	O
7	drug	_	drug	_	NN	96	_	_	_	_	_	_	_	O
8	treatment	_	treatment	_	NN	96	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	96	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	96	_	_	_	_	_	adult.n	People_by_age	S-Person
11	with	_	with	_	IN	96	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	96	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	96	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	96	_	_	_	_	_	_	_	O
15	.	_	.	_	.	96	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	96	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	96	_	_	_	_	_	_	_	O
3	metformin	_	UNK	_	NN	96	_	_	_	_	_	_	_	O
4	as	_	a	_	IN	96	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	96	_	_	_	_	_	_	_	O
6	initial	_	initial	_	JJ	96	_	_	_	_	_	_	_	O
7	drug	_	drug	_	NN	96	_	_	_	_	_	_	_	O
8	treatment	_	treatment	_	NN	96	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	96	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	96	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	96	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	96	_	_	_	_	_	type.n	Type	S-Subtype
13	2	_	2	_	CD	96	_	_	_	_	_	_	_	B-Category
14	diabetes	_	UNK	_	NNS	96	_	_	_	_	_	_	_	I-Category
15	.	_	.	_	.	96	_	_	_	_	_	_	_	O

1	gradually	_	Gradually	_	RB	97	_	_	_	_	_	_	_	O
2	increase	_	increase	_	VB	97	_	_	_	_	_	increase.v	Cause_change_of_position_on_a_scale	O
3	the	_	the	_	DT	97	_	_	_	_	_	_	_	O
4	dose	_	dose	_	NN	97	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	97	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	97	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	97	_	_	_	_	_	_	_	O
8	over	_	over	_	IN	97	_	_	_	_	_	_	_	O
9	several	_	several	_	JJ	97	_	_	_	_	_	_	_	O
10	weeks	_	week	_	NNS	97	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	97	_	_	_	_	_	_	_	O
12	minimise	_	UNK	_	VB	97	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	97	_	_	_	_	_	_	_	O
14	risk	_	risk	_	NN	97	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	97	_	_	_	_	_	_	_	O
16	gastrointestinal	_	UNK	_	JJ	97	_	_	_	_	_	_	_	O
17	side	_	side	_	NN	97	_	_	_	_	_	_	_	O
18	effects	_	effect	_	NNS	97	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	97	_	_	_	_	_	_	_	O
20	adults	_	adult	_	NNS	97	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	97	_	_	_	_	_	_	_	O
22	type	_	type	_	JJ	97	_	_	_	_	_	_	_	O
23	2	_	2	_	CD	97	_	_	_	_	_	_	_	O
24	diabetes	_	UNK	_	NNS	97	_	_	_	_	_	_	_	O
25	.	_	.	_	.	97	_	_	_	_	_	_	_	O

1	gradually	_	Gradually	_	RB	97	_	_	_	_	_	_	_	O
2	increase	_	increase	_	VB	97	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	97	_	_	_	_	_	_	_	O
4	dose	_	dose	_	NN	97	_	_	_	_	_	dose.n	Quantified_mass	S-Quantity
5	of	_	of	_	IN	97	_	_	_	_	_	_	_	B-Individuals
6	unk	_	UNK	_	JJ	97	_	_	_	_	_	_	_	I-Individuals
7	metformin	_	UNK	_	NN	97	_	_	_	_	_	_	_	I-Individuals
8	over	_	over	_	IN	97	_	_	_	_	_	_	_	O
9	several	_	several	_	JJ	97	_	_	_	_	_	_	_	O
10	weeks	_	week	_	NNS	97	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	97	_	_	_	_	_	_	_	O
12	minimise	_	UNK	_	VB	97	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	97	_	_	_	_	_	_	_	O
14	risk	_	risk	_	NN	97	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	97	_	_	_	_	_	_	_	O
16	gastrointestinal	_	UNK	_	JJ	97	_	_	_	_	_	_	_	O
17	side	_	side	_	NN	97	_	_	_	_	_	_	_	O
18	effects	_	effect	_	NNS	97	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	97	_	_	_	_	_	_	_	O
20	adults	_	adult	_	NNS	97	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	97	_	_	_	_	_	_	_	O
22	type	_	type	_	JJ	97	_	_	_	_	_	_	_	O
23	2	_	2	_	CD	97	_	_	_	_	_	_	_	O
24	diabetes	_	UNK	_	NNS	97	_	_	_	_	_	_	_	O
25	.	_	.	_	.	97	_	_	_	_	_	_	_	O

1	gradually	_	Gradually	_	RB	97	_	_	_	_	_	_	_	O
2	increase	_	increase	_	VB	97	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	97	_	_	_	_	_	_	_	O
4	dose	_	dose	_	NN	97	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	97	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	97	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	97	_	_	_	_	_	_	_	O
8	over	_	over	_	IN	97	_	_	_	_	_	_	_	O
9	several	_	several	_	JJ	97	_	_	_	_	_	several.a	Quantified_mass	S-Quantity
10	weeks	_	week	_	NNS	97	_	_	_	_	_	_	_	S-Individuals
11	to	_	to	_	TO	97	_	_	_	_	_	_	_	O
12	minimise	_	UNK	_	VB	97	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	97	_	_	_	_	_	_	_	O
14	risk	_	risk	_	NN	97	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	97	_	_	_	_	_	_	_	O
16	gastrointestinal	_	UNK	_	JJ	97	_	_	_	_	_	_	_	O
17	side	_	side	_	NN	97	_	_	_	_	_	_	_	O
18	effects	_	effect	_	NNS	97	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	97	_	_	_	_	_	_	_	O
20	adults	_	adult	_	NNS	97	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	97	_	_	_	_	_	_	_	O
22	type	_	type	_	JJ	97	_	_	_	_	_	_	_	O
23	2	_	2	_	CD	97	_	_	_	_	_	_	_	O
24	diabetes	_	UNK	_	NNS	97	_	_	_	_	_	_	_	O
25	.	_	.	_	.	97	_	_	_	_	_	_	_	O

1	gradually	_	Gradually	_	RB	97	_	_	_	_	_	_	_	O
2	increase	_	increase	_	VB	97	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	97	_	_	_	_	_	_	_	O
4	dose	_	dose	_	NN	97	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	97	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	97	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	97	_	_	_	_	_	_	_	O
8	over	_	over	_	IN	97	_	_	_	_	_	_	_	O
9	several	_	several	_	JJ	97	_	_	_	_	_	_	_	S-Count
10	weeks	_	week	_	NNS	97	_	_	_	_	_	week.n	Calendric_unit	S-Unit
11	to	_	to	_	TO	97	_	_	_	_	_	_	_	O
12	minimise	_	UNK	_	VB	97	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	97	_	_	_	_	_	_	_	O
14	risk	_	risk	_	NN	97	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	97	_	_	_	_	_	_	_	O
16	gastrointestinal	_	UNK	_	JJ	97	_	_	_	_	_	_	_	O
17	side	_	side	_	NN	97	_	_	_	_	_	_	_	O
18	effects	_	effect	_	NNS	97	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	97	_	_	_	_	_	_	_	O
20	adults	_	adult	_	NNS	97	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	97	_	_	_	_	_	_	_	O
22	type	_	type	_	JJ	97	_	_	_	_	_	_	_	O
23	2	_	2	_	CD	97	_	_	_	_	_	_	_	O
24	diabetes	_	UNK	_	NNS	97	_	_	_	_	_	_	_	O
25	.	_	.	_	.	97	_	_	_	_	_	_	_	O

1	gradually	_	Gradually	_	RB	97	_	_	_	_	_	_	_	O
2	increase	_	increase	_	VB	97	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	97	_	_	_	_	_	_	_	O
4	dose	_	dose	_	NN	97	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	97	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	97	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	97	_	_	_	_	_	_	_	O
8	over	_	over	_	IN	97	_	_	_	_	_	_	_	O
9	several	_	several	_	JJ	97	_	_	_	_	_	_	_	O
10	weeks	_	week	_	NNS	97	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	97	_	_	_	_	_	_	_	O
12	minimise	_	UNK	_	VB	97	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	97	_	_	_	_	_	_	_	O
14	risk	_	risk	_	NN	97	_	_	_	_	_	risk.n	Run_risk	O
15	of	_	of	_	IN	97	_	_	_	_	_	_	_	B-Asset
16	gastrointestinal	_	UNK	_	JJ	97	_	_	_	_	_	_	_	I-Asset
17	side	_	side	_	NN	97	_	_	_	_	_	_	_	I-Asset
18	effects	_	effect	_	NNS	97	_	_	_	_	_	_	_	I-Asset
19	in	_	in	_	IN	97	_	_	_	_	_	_	_	I-Asset
20	adults	_	adult	_	NNS	97	_	_	_	_	_	_	_	I-Asset
21	with	_	with	_	IN	97	_	_	_	_	_	_	_	I-Asset
22	type	_	type	_	JJ	97	_	_	_	_	_	_	_	I-Asset
23	2	_	2	_	CD	97	_	_	_	_	_	_	_	I-Asset
24	diabetes	_	UNK	_	NNS	97	_	_	_	_	_	_	_	I-Asset
25	.	_	.	_	.	97	_	_	_	_	_	_	_	O

1	gradually	_	Gradually	_	RB	97	_	_	_	_	_	_	_	O
2	increase	_	increase	_	VB	97	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	97	_	_	_	_	_	_	_	O
4	dose	_	dose	_	NN	97	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	97	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	97	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	97	_	_	_	_	_	_	_	O
8	over	_	over	_	IN	97	_	_	_	_	_	_	_	O
9	several	_	several	_	JJ	97	_	_	_	_	_	_	_	O
10	weeks	_	week	_	NNS	97	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	97	_	_	_	_	_	_	_	O
12	minimise	_	UNK	_	VB	97	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	97	_	_	_	_	_	_	_	O
14	risk	_	risk	_	NN	97	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	97	_	_	_	_	_	_	_	O
16	gastrointestinal	_	UNK	_	JJ	97	_	_	_	_	_	_	_	B-Dependent_entity
17	side	_	side	_	NN	97	_	_	_	_	_	_	_	I-Dependent_entity
18	effects	_	effect	_	NNS	97	_	_	_	_	_	effect.n	Objective_influence	O
19	in	_	in	_	IN	97	_	_	_	_	_	_	_	O
20	adults	_	adult	_	NNS	97	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	97	_	_	_	_	_	_	_	O
22	type	_	type	_	JJ	97	_	_	_	_	_	_	_	O
23	2	_	2	_	CD	97	_	_	_	_	_	_	_	O
24	diabetes	_	UNK	_	NNS	97	_	_	_	_	_	_	_	O
25	.	_	.	_	.	97	_	_	_	_	_	_	_	O

1	gradually	_	Gradually	_	RB	97	_	_	_	_	_	_	_	O
2	increase	_	increase	_	VB	97	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	97	_	_	_	_	_	_	_	O
4	dose	_	dose	_	NN	97	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	97	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	97	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	97	_	_	_	_	_	_	_	O
8	over	_	over	_	IN	97	_	_	_	_	_	_	_	O
9	several	_	several	_	JJ	97	_	_	_	_	_	_	_	O
10	weeks	_	week	_	NNS	97	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	97	_	_	_	_	_	_	_	O
12	minimise	_	UNK	_	VB	97	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	97	_	_	_	_	_	_	_	O
14	risk	_	risk	_	NN	97	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	97	_	_	_	_	_	_	_	O
16	gastrointestinal	_	UNK	_	JJ	97	_	_	_	_	_	_	_	O
17	side	_	side	_	NN	97	_	_	_	_	_	_	_	O
18	effects	_	effect	_	NNS	97	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	97	_	_	_	_	_	_	_	O
20	adults	_	adult	_	NNS	97	_	_	_	_	_	adult.n	People_by_age	S-Person
21	with	_	with	_	IN	97	_	_	_	_	_	_	_	O
22	type	_	type	_	JJ	97	_	_	_	_	_	_	_	O
23	2	_	2	_	CD	97	_	_	_	_	_	_	_	O
24	diabetes	_	UNK	_	NNS	97	_	_	_	_	_	_	_	O
25	.	_	.	_	.	97	_	_	_	_	_	_	_	O

1	gradually	_	Gradually	_	RB	97	_	_	_	_	_	_	_	O
2	increase	_	increase	_	VB	97	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	97	_	_	_	_	_	_	_	O
4	dose	_	dose	_	NN	97	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	97	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	97	_	_	_	_	_	_	_	O
7	metformin	_	UNK	_	NN	97	_	_	_	_	_	_	_	O
8	over	_	over	_	IN	97	_	_	_	_	_	_	_	O
9	several	_	several	_	JJ	97	_	_	_	_	_	_	_	O
10	weeks	_	week	_	NNS	97	_	_	_	_	_	_	_	O
11	to	_	to	_	TO	97	_	_	_	_	_	_	_	O
12	minimise	_	UNK	_	VB	97	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	97	_	_	_	_	_	_	_	O
14	risk	_	risk	_	NN	97	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	97	_	_	_	_	_	_	_	O
16	gastrointestinal	_	UNK	_	JJ	97	_	_	_	_	_	_	_	O
17	side	_	side	_	NN	97	_	_	_	_	_	_	_	O
18	effects	_	effect	_	NNS	97	_	_	_	_	_	_	_	O
19	in	_	in	_	IN	97	_	_	_	_	_	_	_	O
20	adults	_	adult	_	NNS	97	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	97	_	_	_	_	_	_	_	O
22	type	_	type	_	JJ	97	_	_	_	_	_	type.n	Type	S-Subtype
23	2	_	2	_	CD	97	_	_	_	_	_	_	_	B-Category
24	diabetes	_	UNK	_	NNS	97	_	_	_	_	_	_	_	I-Category
25	.	_	.	_	.	97	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	98	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	98	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	98	_	_	_	_	_	adult.n	People_by_age	S-Person
4	with	_	with	_	IN	98	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	98	_	_	_	_	_	_	_	O
6	2	_	2	_	CD	98	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	98	_	_	_	_	_	_	_	O
8	experiences	_	experience	_	NNS	98	_	_	_	_	_	_	_	O
9	gastrointestinal	_	UNK	_	JJ	98	_	_	_	_	_	_	_	O
10	side	_	side	_	NN	98	_	_	_	_	_	_	_	O
11	effects	_	effect	_	NNS	98	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	98	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	98	_	_	_	_	_	_	_	O
14	metformin	_	UNK	_	NN	98	_	_	_	_	_	_	_	O
15	,	_	,	_	,	98	_	_	_	_	_	_	_	O
16	consider	_	consider	_	VB	98	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	98	_	_	_	_	_	_	_	O
18	trial	_	trial	_	NN	98	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	98	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	98	_	_	_	_	_	_	_	O
21	metformin	_	UNK	_	NN	98	_	_	_	_	_	_	_	O
22	.	_	.	_	.	98	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	98	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	98	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	98	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	98	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	98	_	_	_	_	_	type.n	Type	S-Subtype
6	2	_	2	_	CD	98	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	98	_	_	_	_	_	_	_	O
8	experiences	_	experience	_	NNS	98	_	_	_	_	_	_	_	O
9	gastrointestinal	_	UNK	_	JJ	98	_	_	_	_	_	_	_	O
10	side	_	side	_	NN	98	_	_	_	_	_	_	_	O
11	effects	_	effect	_	NNS	98	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	98	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	98	_	_	_	_	_	_	_	O
14	metformin	_	UNK	_	NN	98	_	_	_	_	_	_	_	O
15	,	_	,	_	,	98	_	_	_	_	_	_	_	O
16	consider	_	consider	_	VB	98	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	98	_	_	_	_	_	_	_	O
18	trial	_	trial	_	NN	98	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	98	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	98	_	_	_	_	_	_	_	O
21	metformin	_	UNK	_	NN	98	_	_	_	_	_	_	_	O
22	.	_	.	_	.	98	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	98	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	98	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	98	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	98	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	98	_	_	_	_	_	_	_	O
6	2	_	2	_	CD	98	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	98	_	_	_	_	_	_	_	S-Protagonist
8	experiences	_	experience	_	NNS	98	_	_	_	_	_	experience.n	Expertise	O
9	gastrointestinal	_	UNK	_	JJ	98	_	_	_	_	_	_	_	O
10	side	_	side	_	NN	98	_	_	_	_	_	_	_	O
11	effects	_	effect	_	NNS	98	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	98	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	98	_	_	_	_	_	_	_	O
14	metformin	_	UNK	_	NN	98	_	_	_	_	_	_	_	O
15	,	_	,	_	,	98	_	_	_	_	_	_	_	O
16	consider	_	consider	_	VB	98	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	98	_	_	_	_	_	_	_	O
18	trial	_	trial	_	NN	98	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	98	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	98	_	_	_	_	_	_	_	O
21	metformin	_	UNK	_	NN	98	_	_	_	_	_	_	_	O
22	.	_	.	_	.	98	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	98	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	98	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	98	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	98	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	98	_	_	_	_	_	_	_	O
6	2	_	2	_	CD	98	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	98	_	_	_	_	_	_	_	O
8	experiences	_	experience	_	NNS	98	_	_	_	_	_	_	_	O
9	gastrointestinal	_	UNK	_	JJ	98	_	_	_	_	_	_	_	O
10	side	_	side	_	NN	98	_	_	_	_	_	side.n	Taking_sides	O
11	effects	_	effect	_	NNS	98	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	98	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	98	_	_	_	_	_	_	_	O
14	metformin	_	UNK	_	NN	98	_	_	_	_	_	_	_	O
15	,	_	,	_	,	98	_	_	_	_	_	_	_	O
16	consider	_	consider	_	VB	98	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	98	_	_	_	_	_	_	_	O
18	trial	_	trial	_	NN	98	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	98	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	98	_	_	_	_	_	_	_	O
21	metformin	_	UNK	_	NN	98	_	_	_	_	_	_	_	O
22	.	_	.	_	.	98	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	98	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	98	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	98	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	98	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	98	_	_	_	_	_	_	_	O
6	2	_	2	_	CD	98	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	98	_	_	_	_	_	_	_	O
8	experiences	_	experience	_	NNS	98	_	_	_	_	_	_	_	O
9	gastrointestinal	_	UNK	_	JJ	98	_	_	_	_	_	_	_	B-Dependent_entity
10	side	_	side	_	NN	98	_	_	_	_	_	_	_	I-Dependent_entity
11	effects	_	effect	_	NNS	98	_	_	_	_	_	effect.n	Objective_influence	O
12	with	_	with	_	IN	98	_	_	_	_	_	_	_	B-Dependent_entity
13	unk	_	UNK	_	JJ	98	_	_	_	_	_	_	_	I-Dependent_entity
14	metformin	_	UNK	_	NN	98	_	_	_	_	_	_	_	I-Dependent_entity
15	,	_	,	_	,	98	_	_	_	_	_	_	_	O
16	consider	_	consider	_	VB	98	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	98	_	_	_	_	_	_	_	O
18	trial	_	trial	_	NN	98	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	98	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	98	_	_	_	_	_	_	_	O
21	metformin	_	UNK	_	NN	98	_	_	_	_	_	_	_	O
22	.	_	.	_	.	98	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	98	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	98	_	_	_	_	_	_	_	B-Item
3	adult	_	adult	_	NN	98	_	_	_	_	_	_	_	I-Item
4	with	_	with	_	IN	98	_	_	_	_	_	_	_	I-Item
5	type	_	type	_	JJ	98	_	_	_	_	_	_	_	I-Item
6	2	_	2	_	CD	98	_	_	_	_	_	_	_	I-Item
7	diabetes	_	UNK	_	NNS	98	_	_	_	_	_	_	_	I-Item
8	experiences	_	experience	_	NNS	98	_	_	_	_	_	_	_	I-Item
9	gastrointestinal	_	UNK	_	JJ	98	_	_	_	_	_	_	_	I-Item
10	side	_	side	_	NN	98	_	_	_	_	_	_	_	I-Item
11	effects	_	effect	_	NNS	98	_	_	_	_	_	_	_	I-Item
12	with	_	with	_	IN	98	_	_	_	_	_	_	_	I-Item
13	unk	_	UNK	_	JJ	98	_	_	_	_	_	_	_	I-Item
14	metformin	_	UNK	_	NN	98	_	_	_	_	_	_	_	I-Item
15	,	_	,	_	,	98	_	_	_	_	_	_	_	O
16	consider	_	consider	_	VB	98	_	_	_	_	_	consider.v	Categorization	O
17	a	_	a	_	DT	98	_	_	_	_	_	_	_	B-Category
18	trial	_	trial	_	NN	98	_	_	_	_	_	_	_	I-Category
19	of	_	of	_	IN	98	_	_	_	_	_	_	_	I-Category
20	unk	_	UNK	_	JJ	98	_	_	_	_	_	_	_	I-Category
21	metformin	_	UNK	_	NN	98	_	_	_	_	_	_	_	I-Category
22	.	_	.	_	.	98	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	98	_	_	_	_	_	_	_	O
2	an	_	an	_	DT	98	_	_	_	_	_	_	_	O
3	adult	_	adult	_	NN	98	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	98	_	_	_	_	_	_	_	O
5	type	_	type	_	JJ	98	_	_	_	_	_	_	_	O
6	2	_	2	_	CD	98	_	_	_	_	_	_	_	O
7	diabetes	_	UNK	_	NNS	98	_	_	_	_	_	_	_	O
8	experiences	_	experience	_	NNS	98	_	_	_	_	_	_	_	O
9	gastrointestinal	_	UNK	_	JJ	98	_	_	_	_	_	_	_	O
10	side	_	side	_	NN	98	_	_	_	_	_	_	_	O
11	effects	_	effect	_	NNS	98	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	98	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	98	_	_	_	_	_	_	_	O
14	metformin	_	UNK	_	NN	98	_	_	_	_	_	_	_	O
15	,	_	,	_	,	98	_	_	_	_	_	_	_	O
16	consider	_	consider	_	VB	98	_	_	_	_	_	_	_	O
17	a	_	a	_	DT	98	_	_	_	_	_	_	_	O
18	trial	_	trial	_	NN	98	_	_	_	_	_	trial.n	Trial	S-Case
19	of	_	of	_	IN	98	_	_	_	_	_	_	_	B-Defendant
20	unk	_	UNK	_	JJ	98	_	_	_	_	_	_	_	I-Defendant
21	metformin	_	UNK	_	NN	98	_	_	_	_	_	_	_	I-Defendant
22	.	_	.	_	.	98	_	_	_	_	_	_	_	O

1	algorithm	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
2	for	_	for	_	IN	99	_	_	_	_	_	_	_	O
3	blood	_	blood	_	NN	99	_	_	_	_	_	_	_	B-Item
4	glucose	_	UNK	_	NN	99	_	_	_	_	_	_	_	I-Item
5	lowering	_	lower	_	VBG	99	_	_	_	_	_	lower.v	Cause_change_of_position_on_a_scale	O
6	therapy	_	therapy	_	NN	99	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	99	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	99	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	99	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O

1	algorithm	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
2	for	_	for	_	IN	99	_	_	_	_	_	_	_	O
3	blood	_	blood	_	NN	99	_	_	_	_	_	_	_	O
4	glucose	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
5	lowering	_	lower	_	VBG	99	_	_	_	_	_	_	_	O
6	therapy	_	therapy	_	NN	99	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	99	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	99	_	_	_	_	_	adult.n	People_by_age	S-Person
9	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	99	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O

1	algorithm	_	UNK	_	NNP	99	_	_	_	_	_	_	_	O
2	for	_	for	_	IN	99	_	_	_	_	_	_	_	O
3	blood	_	blood	_	NN	99	_	_	_	_	_	_	_	O
4	glucose	_	UNK	_	NN	99	_	_	_	_	_	_	_	O
5	lowering	_	lower	_	VBG	99	_	_	_	_	_	_	_	O
6	therapy	_	therapy	_	NN	99	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	99	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	99	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	99	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	99	_	_	_	_	_	type.n	Type	S-Subtype
11	2	_	2	_	CD	99	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	99	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	100	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	100	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	100	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	100	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	100	_	_	_	_	_	_	_	O
6	:	_	:	_	:	100	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	100	_	_	_	_	_	_	_	O
8	(	_	(	_	(	100	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	100	_	_	_	_	_	_	_	O
10	)	_	)	_	)	100	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	100	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	100	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	100	_	_	_	_	_	_	_	O
14	)	_	)	_	)	100	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	100	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	100	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	100	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	100	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	100	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	100	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	100	_	_	_	_	_	_	_	O
8	(	_	(	_	(	100	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	100	_	_	_	_	_	_	_	O
10	)	_	)	_	)	100	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	100	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	100	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	100	_	_	_	_	_	_	_	O
14	)	_	)	_	)	100	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	101	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	101	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	101	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	101	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	101	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	101	_	_	_	_	_	_	_	O
7	,	_	,	_	,	101	_	_	_	_	_	_	_	O
8	review	_	review	_	VBP	101	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	101	_	_	_	_	_	_	_	O
10	dose	_	dose	_	NN	101	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	101	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	101	_	_	_	_	_	_	_	O
13	if	_	if	_	IN	101	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	101	_	_	_	_	_	_	_	O
15	estimated	_	estimate	_	VBN	101	_	_	_	_	_	_	_	O
16	glomerular	_	UNK	_	JJ	101	_	_	_	_	_	_	_	O
17	filtration	_	filtration	_	NN	101	_	_	_	_	_	_	_	O
18	rate	_	rate	_	NN	101	_	_	_	_	_	_	_	O
19	(	_	(	_	(	101	_	_	_	_	_	_	_	O
20	egfr	_	UNK	_	NN	101	_	_	_	_	_	_	_	O
21	)	_	)	_	)	101	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	101	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	101	_	_	_	_	_	_	_	O
24	45	_	45	_	CD	101	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	NNS	101	_	_	_	_	_	_	_	O
26	m2	_	UNK	_	NN	101	_	_	_	_	_	_	_	O
27	:	_	:	_	:	101	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	101	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	101	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	101	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	101	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	101	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	101	_	_	_	_	_	_	_	I-Category
7	,	_	,	_	,	101	_	_	_	_	_	_	_	O
8	review	_	review	_	VBP	101	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	101	_	_	_	_	_	_	_	O
10	dose	_	dose	_	NN	101	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	101	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	101	_	_	_	_	_	_	_	O
13	if	_	if	_	IN	101	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	101	_	_	_	_	_	_	_	O
15	estimated	_	estimate	_	VBN	101	_	_	_	_	_	_	_	O
16	glomerular	_	UNK	_	JJ	101	_	_	_	_	_	_	_	O
17	filtration	_	filtration	_	NN	101	_	_	_	_	_	_	_	O
18	rate	_	rate	_	NN	101	_	_	_	_	_	_	_	O
19	(	_	(	_	(	101	_	_	_	_	_	_	_	O
20	egfr	_	UNK	_	NN	101	_	_	_	_	_	_	_	O
21	)	_	)	_	)	101	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	101	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	101	_	_	_	_	_	_	_	O
24	45	_	45	_	CD	101	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	NNS	101	_	_	_	_	_	_	_	O
26	m2	_	UNK	_	NN	101	_	_	_	_	_	_	_	O
27	:	_	:	_	:	101	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	101	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	101	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	101	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	101	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	101	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	101	_	_	_	_	_	_	_	O
7	,	_	,	_	,	101	_	_	_	_	_	_	_	O
8	review	_	review	_	VBP	101	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	101	_	_	_	_	_	_	_	O
10	dose	_	dose	_	NN	101	_	_	_	_	_	dose.n	Quantified_mass	S-Quantity
11	of	_	of	_	IN	101	_	_	_	_	_	_	_	B-Individuals
12	metformin	_	UNK	_	NN	101	_	_	_	_	_	_	_	I-Individuals
13	if	_	if	_	IN	101	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	101	_	_	_	_	_	_	_	O
15	estimated	_	estimate	_	VBN	101	_	_	_	_	_	_	_	O
16	glomerular	_	UNK	_	JJ	101	_	_	_	_	_	_	_	O
17	filtration	_	filtration	_	NN	101	_	_	_	_	_	_	_	O
18	rate	_	rate	_	NN	101	_	_	_	_	_	_	_	O
19	(	_	(	_	(	101	_	_	_	_	_	_	_	O
20	egfr	_	UNK	_	NN	101	_	_	_	_	_	_	_	O
21	)	_	)	_	)	101	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	101	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	101	_	_	_	_	_	_	_	O
24	45	_	45	_	CD	101	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	NNS	101	_	_	_	_	_	_	_	O
26	m2	_	UNK	_	NN	101	_	_	_	_	_	_	_	O
27	:	_	:	_	:	101	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	101	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	101	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	101	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	101	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	101	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	101	_	_	_	_	_	_	_	O
7	,	_	,	_	,	101	_	_	_	_	_	_	_	O
8	review	_	review	_	VBP	101	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	101	_	_	_	_	_	_	_	O
10	dose	_	dose	_	NN	101	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	101	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	101	_	_	_	_	_	_	_	O
13	if	_	if	_	IN	101	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	101	_	_	_	_	_	_	_	O
15	estimated	_	estimate	_	VBN	101	_	_	_	_	_	estimate.v	Estimating	O
16	glomerular	_	UNK	_	JJ	101	_	_	_	_	_	_	_	B-Estimation
17	filtration	_	filtration	_	NN	101	_	_	_	_	_	_	_	I-Estimation
18	rate	_	rate	_	NN	101	_	_	_	_	_	_	_	I-Estimation
19	(	_	(	_	(	101	_	_	_	_	_	_	_	O
20	egfr	_	UNK	_	NN	101	_	_	_	_	_	_	_	O
21	)	_	)	_	)	101	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	101	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	101	_	_	_	_	_	_	_	O
24	45	_	45	_	CD	101	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	NNS	101	_	_	_	_	_	_	_	O
26	m2	_	UNK	_	NN	101	_	_	_	_	_	_	_	O
27	:	_	:	_	:	101	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	101	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	101	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	101	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	101	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	101	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	101	_	_	_	_	_	_	_	O
7	,	_	,	_	,	101	_	_	_	_	_	_	_	O
8	review	_	review	_	VBP	101	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	101	_	_	_	_	_	_	_	O
10	dose	_	dose	_	NN	101	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	101	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	101	_	_	_	_	_	_	_	O
13	if	_	if	_	IN	101	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	101	_	_	_	_	_	_	_	O
15	estimated	_	estimate	_	VBN	101	_	_	_	_	_	_	_	O
16	glomerular	_	UNK	_	JJ	101	_	_	_	_	_	_	_	B-Entity
17	filtration	_	filtration	_	NN	101	_	_	_	_	_	_	_	I-Entity
18	rate	_	rate	_	NN	101	_	_	_	_	_	rate.n	Speed_description	S-Attribute
19	(	_	(	_	(	101	_	_	_	_	_	_	_	O
20	egfr	_	UNK	_	NN	101	_	_	_	_	_	_	_	O
21	)	_	)	_	)	101	_	_	_	_	_	_	_	O
22	is	_	be	_	VBZ	101	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	101	_	_	_	_	_	_	_	O
24	45	_	45	_	CD	101	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	NNS	101	_	_	_	_	_	_	_	O
26	m2	_	UNK	_	NN	101	_	_	_	_	_	_	_	O
27	:	_	:	_	:	101	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	101	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	101	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	101	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	101	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	101	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	101	_	_	_	_	_	_	_	O
7	,	_	,	_	,	101	_	_	_	_	_	_	_	O
8	review	_	review	_	VBP	101	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	101	_	_	_	_	_	_	_	O
10	dose	_	dose	_	NN	101	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	101	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	101	_	_	_	_	_	_	_	O
13	if	_	if	_	IN	101	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	101	_	_	_	_	_	_	_	B-Figure
15	estimated	_	estimate	_	VBN	101	_	_	_	_	_	_	_	I-Figure
16	glomerular	_	UNK	_	JJ	101	_	_	_	_	_	_	_	I-Figure
17	filtration	_	filtration	_	NN	101	_	_	_	_	_	_	_	I-Figure
18	rate	_	rate	_	NN	101	_	_	_	_	_	_	_	I-Figure
19	(	_	(	_	(	101	_	_	_	_	_	_	_	I-Figure
20	egfr	_	UNK	_	NN	101	_	_	_	_	_	_	_	I-Figure
21	)	_	)	_	)	101	_	_	_	_	_	_	_	I-Figure
22	is	_	be	_	VBZ	101	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	101	_	_	_	_	_	below.prep	Directional_locative_relation	O
24	45	_	45	_	CD	101	_	_	_	_	_	_	_	B-Ground
25	unk	_	UNK	_	NNS	101	_	_	_	_	_	_	_	I-Ground
26	m2	_	UNK	_	NN	101	_	_	_	_	_	_	_	I-Ground
27	:	_	:	_	:	101	_	_	_	_	_	_	_	O

1	prescribe	_	UNK	_	NNP	102	_	_	_	_	_	_	_	O
2	metformin	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
4	caution	_	caution	_	NN	102	_	_	_	_	_	caution.n	Statement	O
5	for	_	for	_	IN	102	_	_	_	_	_	_	_	O
6	those	_	those	_	DT	102	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	102	_	_	_	_	_	_	_	O
8	risk	_	risk	_	NN	102	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	102	_	_	_	_	_	_	_	O
11	sudden	_	sudden	_	JJ	102	_	_	_	_	_	_	_	O
12	deterioration	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	102	_	_	_	_	_	_	_	O
14	kidney	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
15	function	_	function	_	NN	102	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
17	those	_	those	_	DT	102	_	_	_	_	_	_	_	O
18	at	_	at	_	IN	102	_	_	_	_	_	_	_	O
19	risk	_	risk	_	NN	102	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
21	egfr	_	UNK	_	JJ	102	_	_	_	_	_	_	_	O
22	falling	_	fall	_	VBG	102	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	102	_	_	_	_	_	_	_	O
24	45	_	45	_	CD	102	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
26	m2	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
27	.	_	.	_	.	102	_	_	_	_	_	_	_	O

1	prescribe	_	UNK	_	NNP	102	_	_	_	_	_	_	_	O
2	metformin	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
4	caution	_	caution	_	NN	102	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	102	_	_	_	_	_	_	_	O
6	those	_	those	_	DT	102	_	_	_	_	_	_	_	S-Protagonist
7	at	_	at	_	IN	102	_	_	_	_	_	_	_	O
8	risk	_	risk	_	NN	102	_	_	_	_	_	risk.n	Run_risk	O
9	of	_	of	_	IN	102	_	_	_	_	_	_	_	B-Asset
10	a	_	a	_	DT	102	_	_	_	_	_	_	_	I-Asset
11	sudden	_	sudden	_	JJ	102	_	_	_	_	_	_	_	I-Asset
12	deterioration	_	UNK	_	NN	102	_	_	_	_	_	_	_	I-Asset
13	in	_	in	_	IN	102	_	_	_	_	_	_	_	I-Asset
14	kidney	_	UNK	_	NN	102	_	_	_	_	_	_	_	I-Asset
15	function	_	function	_	NN	102	_	_	_	_	_	_	_	I-Asset
16	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
17	those	_	those	_	DT	102	_	_	_	_	_	_	_	O
18	at	_	at	_	IN	102	_	_	_	_	_	_	_	O
19	risk	_	risk	_	NN	102	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
21	egfr	_	UNK	_	JJ	102	_	_	_	_	_	_	_	O
22	falling	_	fall	_	VBG	102	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	102	_	_	_	_	_	_	_	O
24	45	_	45	_	CD	102	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
26	m2	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
27	.	_	.	_	.	102	_	_	_	_	_	_	_	O

1	prescribe	_	UNK	_	NNP	102	_	_	_	_	_	_	_	O
2	metformin	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
4	caution	_	caution	_	NN	102	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	102	_	_	_	_	_	_	_	O
6	those	_	those	_	DT	102	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	102	_	_	_	_	_	_	_	O
8	risk	_	risk	_	NN	102	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	102	_	_	_	_	_	_	_	O
11	sudden	_	sudden	_	JJ	102	_	_	_	_	_	_	_	O
12	deterioration	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	102	_	_	_	_	_	_	_	O
14	kidney	_	UNK	_	NN	102	_	_	_	_	_	_	_	S-Determinant
15	function	_	function	_	NN	102	_	_	_	_	_	function.n	Contingency	O
16	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
17	those	_	those	_	DT	102	_	_	_	_	_	_	_	O
18	at	_	at	_	IN	102	_	_	_	_	_	_	_	O
19	risk	_	risk	_	NN	102	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
21	egfr	_	UNK	_	JJ	102	_	_	_	_	_	_	_	O
22	falling	_	fall	_	VBG	102	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	102	_	_	_	_	_	_	_	O
24	45	_	45	_	CD	102	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
26	m2	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
27	.	_	.	_	.	102	_	_	_	_	_	_	_	O

1	prescribe	_	UNK	_	NNP	102	_	_	_	_	_	_	_	O
2	metformin	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
4	caution	_	caution	_	NN	102	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	102	_	_	_	_	_	_	_	O
6	those	_	those	_	DT	102	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	102	_	_	_	_	_	_	_	O
8	risk	_	risk	_	NN	102	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	102	_	_	_	_	_	_	_	O
11	sudden	_	sudden	_	JJ	102	_	_	_	_	_	_	_	O
12	deterioration	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	102	_	_	_	_	_	_	_	O
14	kidney	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
15	function	_	function	_	NN	102	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
17	those	_	those	_	DT	102	_	_	_	_	_	_	_	S-Protagonist
18	at	_	at	_	IN	102	_	_	_	_	_	_	_	O
19	risk	_	risk	_	NN	102	_	_	_	_	_	risk.n	Run_risk	O
20	of	_	of	_	IN	102	_	_	_	_	_	_	_	B-Asset
21	egfr	_	UNK	_	JJ	102	_	_	_	_	_	_	_	I-Asset
22	falling	_	fall	_	VBG	102	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	102	_	_	_	_	_	_	_	O
24	45	_	45	_	CD	102	_	_	_	_	_	_	_	O
25	unk	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
26	m2	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
27	.	_	.	_	.	102	_	_	_	_	_	_	_	O

1	prescribe	_	UNK	_	NNP	102	_	_	_	_	_	_	_	O
2	metformin	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	102	_	_	_	_	_	_	_	O
4	caution	_	caution	_	NN	102	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	102	_	_	_	_	_	_	_	O
6	those	_	those	_	DT	102	_	_	_	_	_	_	_	O
7	at	_	at	_	IN	102	_	_	_	_	_	_	_	O
8	risk	_	risk	_	NN	102	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	102	_	_	_	_	_	_	_	O
11	sudden	_	sudden	_	JJ	102	_	_	_	_	_	_	_	O
12	deterioration	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	102	_	_	_	_	_	_	_	O
14	kidney	_	UNK	_	NN	102	_	_	_	_	_	_	_	O
15	function	_	function	_	NN	102	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	102	_	_	_	_	_	_	_	O
17	those	_	those	_	DT	102	_	_	_	_	_	_	_	O
18	at	_	at	_	IN	102	_	_	_	_	_	_	_	O
19	risk	_	risk	_	NN	102	_	_	_	_	_	_	_	O
20	of	_	of	_	IN	102	_	_	_	_	_	_	_	O
21	egfr	_	UNK	_	JJ	102	_	_	_	_	_	_	_	S-Figure
22	falling	_	fall	_	VBG	102	_	_	_	_	_	_	_	O
23	below	_	below	_	IN	102	_	_	_	_	_	below.prep	Directional_locative_relation	O
24	45	_	45	_	CD	102	_	_	_	_	_	_	_	B-Ground
25	unk	_	UNK	_	NN	102	_	_	_	_	_	_	_	I-Ground
26	m2	_	UNK	_	NN	102	_	_	_	_	_	_	_	I-Ground
27	.	_	.	_	.	102	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	103	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	103	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	103	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	103	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	103	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
7	,	_	,	_	,	103	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	103	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	103	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	103	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	103	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	103	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	103	_	_	_	_	_	_	_	O
15	,	_	,	_	,	103	_	_	_	_	_	_	_	O
16	consider	_	consider	_	VB	103	_	_	_	_	_	_	_	O
17	initial	_	initial	_	JJ	103	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	103	_	_	_	_	_	_	_	O
19	treatment	_	treatment	_	NN	103	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	103	_	_	_	_	_	_	_	O
21	:	_	:	_	:	103	_	_	_	_	_	_	_	O
22	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
23	dipeptidyl	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
24	unk	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
25	(	_	(	_	(	103	_	_	_	_	_	_	_	O
26	dpp-4	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
27	)	_	)	_	)	103	_	_	_	_	_	_	_	O
28	inhibitor	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
29	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
30	pioglitazone	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
31	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
32	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
33	sulfonylurea	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
34	.	_	.	_	.	103	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	103	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	103	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	103	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	103	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	103	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	103	_	_	_	_	_	_	_	I-Category
7	,	_	,	_	,	103	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	103	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	103	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	103	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	103	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	103	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	103	_	_	_	_	_	_	_	O
15	,	_	,	_	,	103	_	_	_	_	_	_	_	O
16	consider	_	consider	_	VB	103	_	_	_	_	_	_	_	O
17	initial	_	initial	_	JJ	103	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	103	_	_	_	_	_	_	_	O
19	treatment	_	treatment	_	NN	103	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	103	_	_	_	_	_	_	_	O
21	:	_	:	_	:	103	_	_	_	_	_	_	_	O
22	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
23	dipeptidyl	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
24	unk	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
25	(	_	(	_	(	103	_	_	_	_	_	_	_	O
26	dpp-4	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
27	)	_	)	_	)	103	_	_	_	_	_	_	_	O
28	inhibitor	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
29	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
30	pioglitazone	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
31	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
32	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
33	sulfonylurea	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
34	.	_	.	_	.	103	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	103	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	103	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	103	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	103	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	103	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
7	,	_	,	_	,	103	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	103	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	103	_	_	_	_	_	_	_	S-Item
10	is	_	be	_	VBZ	103	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	103	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	103	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	103	_	_	_	_	_	_	_	O
15	,	_	,	_	,	103	_	_	_	_	_	_	_	O
16	consider	_	consider	_	VB	103	_	_	_	_	_	consider.v	Categorization	O
17	initial	_	initial	_	JJ	103	_	_	_	_	_	_	_	B-Category
18	drug	_	drug	_	NN	103	_	_	_	_	_	_	_	I-Category
19	treatment	_	treatment	_	NN	103	_	_	_	_	_	_	_	I-Category
20	with	_	with	_	IN	103	_	_	_	_	_	_	_	I-Category
21	:	_	:	_	:	103	_	_	_	_	_	_	_	I-Category
22	a	_	a	_	DT	103	_	_	_	_	_	_	_	I-Category
23	dipeptidyl	_	UNK	_	JJ	103	_	_	_	_	_	_	_	I-Category
24	unk	_	UNK	_	NN	103	_	_	_	_	_	_	_	I-Category
25	(	_	(	_	(	103	_	_	_	_	_	_	_	I-Category
26	dpp-4	_	UNK	_	NNP	103	_	_	_	_	_	_	_	I-Category
27	)	_	)	_	)	103	_	_	_	_	_	_	_	I-Category
28	inhibitor	_	UNK	_	NN	103	_	_	_	_	_	_	_	I-Category
29	or	_	or	_	CC	103	_	_	_	_	_	_	_	I-Category
30	pioglitazone	_	UNK	_	NN	103	_	_	_	_	_	_	_	I-Category
31	or	_	or	_	CC	103	_	_	_	_	_	_	_	I-Category
32	a	_	a	_	DT	103	_	_	_	_	_	_	_	I-Category
33	sulfonylurea	_	UNK	_	NN	103	_	_	_	_	_	_	_	I-Category
34	.	_	.	_	.	103	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	103	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	103	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	103	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	103	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	103	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	103	_	_	_	_	_	_	_	O
7	,	_	,	_	,	103	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	103	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	103	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	103	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	103	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	103	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	103	_	_	_	_	_	_	_	O
15	,	_	,	_	,	103	_	_	_	_	_	_	_	O
16	consider	_	consider	_	VB	103	_	_	_	_	_	_	_	O
17	initial	_	initial	_	JJ	103	_	_	_	_	_	_	_	O
18	drug	_	drug	_	NN	103	_	_	_	_	_	_	_	S-Patient
19	treatment	_	treatment	_	NN	103	_	_	_	_	_	treatment.n	Cure	O
20	with	_	with	_	IN	103	_	_	_	_	_	_	_	O
21	:	_	:	_	:	103	_	_	_	_	_	_	_	O
22	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
23	dipeptidyl	_	UNK	_	JJ	103	_	_	_	_	_	_	_	O
24	unk	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
25	(	_	(	_	(	103	_	_	_	_	_	_	_	O
26	dpp-4	_	UNK	_	NNP	103	_	_	_	_	_	_	_	O
27	)	_	)	_	)	103	_	_	_	_	_	_	_	O
28	inhibitor	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
29	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
30	pioglitazone	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
31	or	_	or	_	CC	103	_	_	_	_	_	_	_	O
32	a	_	a	_	DT	103	_	_	_	_	_	_	_	O
33	sulfonylurea	_	UNK	_	NN	103	_	_	_	_	_	_	_	O
34	.	_	.	_	.	103	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	104	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	104	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	104	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	104	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	104	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	104	_	_	_	_	_	_	_	O
7	,	_	,	_	,	104	_	_	_	_	_	_	_	O
8	do	_	do	_	VBP	104	_	_	_	_	_	_	_	O
9	not	_	not	_	RB	104	_	_	_	_	_	_	_	O
10	offer	_	offer	_	VB	104	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	104	_	_	_	_	_	_	_	O
12	continue	_	continue	_	VB	104	_	_	_	_	_	_	_	O
13	pioglitazone	_	UNK	_	NN	104	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	104	_	_	_	_	_	_	_	O
15	they	_	they	_	PRP	104	_	_	_	_	_	_	_	O
16	have	_	have	_	VBP	104	_	_	_	_	_	_	_	O
17	any	_	any	_	DT	104	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	104	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	104	_	_	_	_	_	_	_	O
20	following	_	following	_	NN	104	_	_	_	_	_	_	_	O
21	:	_	:	_	:	104	_	_	_	_	_	_	_	O
22	heart	_	heart	_	NN	104	_	_	_	_	_	_	_	O
23	failure	_	failure	_	NN	104	_	_	_	_	_	_	_	O
24	or	_	or	_	CC	104	_	_	_	_	_	_	_	O
25	history	_	history	_	NN	104	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	104	_	_	_	_	_	_	_	O
27	heart	_	heart	_	NN	104	_	_	_	_	_	_	_	O
28	failure	_	failure	_	NN	104	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	104	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	104	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	104	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	104	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	104	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	104	_	_	_	_	_	_	_	I-Category
7	,	_	,	_	,	104	_	_	_	_	_	_	_	O
8	do	_	do	_	VBP	104	_	_	_	_	_	_	_	O
9	not	_	not	_	RB	104	_	_	_	_	_	_	_	O
10	offer	_	offer	_	VB	104	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	104	_	_	_	_	_	_	_	O
12	continue	_	continue	_	VB	104	_	_	_	_	_	_	_	O
13	pioglitazone	_	UNK	_	NN	104	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	104	_	_	_	_	_	_	_	O
15	they	_	they	_	PRP	104	_	_	_	_	_	_	_	O
16	have	_	have	_	VBP	104	_	_	_	_	_	_	_	O
17	any	_	any	_	DT	104	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	104	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	104	_	_	_	_	_	_	_	O
20	following	_	following	_	NN	104	_	_	_	_	_	_	_	O
21	:	_	:	_	:	104	_	_	_	_	_	_	_	O
22	heart	_	heart	_	NN	104	_	_	_	_	_	_	_	O
23	failure	_	failure	_	NN	104	_	_	_	_	_	_	_	O
24	or	_	or	_	CC	104	_	_	_	_	_	_	_	O
25	history	_	history	_	NN	104	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	104	_	_	_	_	_	_	_	O
27	heart	_	heart	_	NN	104	_	_	_	_	_	_	_	O
28	failure	_	failure	_	NN	104	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	104	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	104	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	104	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	104	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	104	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	104	_	_	_	_	_	_	_	O
7	,	_	,	_	,	104	_	_	_	_	_	_	_	O
8	do	_	do	_	VBP	104	_	_	_	_	_	_	_	O
9	not	_	not	_	RB	104	_	_	_	_	_	_	_	O
10	offer	_	offer	_	VB	104	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	104	_	_	_	_	_	_	_	O
12	continue	_	continue	_	VB	104	_	_	_	_	_	continue.v	Process_continue	O
13	pioglitazone	_	UNK	_	NN	104	_	_	_	_	_	_	_	S-Event
14	if	_	if	_	IN	104	_	_	_	_	_	_	_	O
15	they	_	they	_	PRP	104	_	_	_	_	_	_	_	O
16	have	_	have	_	VBP	104	_	_	_	_	_	_	_	O
17	any	_	any	_	DT	104	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	104	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	104	_	_	_	_	_	_	_	O
20	following	_	following	_	NN	104	_	_	_	_	_	_	_	O
21	:	_	:	_	:	104	_	_	_	_	_	_	_	O
22	heart	_	heart	_	NN	104	_	_	_	_	_	_	_	O
23	failure	_	failure	_	NN	104	_	_	_	_	_	_	_	O
24	or	_	or	_	CC	104	_	_	_	_	_	_	_	O
25	history	_	history	_	NN	104	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	104	_	_	_	_	_	_	_	O
27	heart	_	heart	_	NN	104	_	_	_	_	_	_	_	O
28	failure	_	failure	_	NN	104	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	104	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	104	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	104	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	104	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	104	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	104	_	_	_	_	_	_	_	O
7	,	_	,	_	,	104	_	_	_	_	_	_	_	O
8	do	_	do	_	VBP	104	_	_	_	_	_	_	_	O
9	not	_	not	_	RB	104	_	_	_	_	_	_	_	O
10	offer	_	offer	_	VB	104	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	104	_	_	_	_	_	_	_	O
12	continue	_	continue	_	VB	104	_	_	_	_	_	_	_	O
13	pioglitazone	_	UNK	_	NN	104	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	104	_	_	_	_	_	_	_	O
15	they	_	they	_	PRP	104	_	_	_	_	_	_	_	O
16	have	_	have	_	VBP	104	_	_	_	_	_	_	_	O
17	any	_	any	_	DT	104	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	104	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	104	_	_	_	_	_	_	_	O
20	following	_	following	_	NN	104	_	_	_	_	_	_	_	O
21	:	_	:	_	:	104	_	_	_	_	_	_	_	O
22	heart	_	heart	_	NN	104	_	_	_	_	_	_	_	S-Agent
23	failure	_	failure	_	NN	104	_	_	_	_	_	failure.n	Success_or_failure	O
24	or	_	or	_	CC	104	_	_	_	_	_	_	_	O
25	history	_	history	_	NN	104	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	104	_	_	_	_	_	_	_	O
27	heart	_	heart	_	NN	104	_	_	_	_	_	_	_	O
28	failure	_	failure	_	NN	104	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	104	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	104	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	104	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	104	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	104	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	104	_	_	_	_	_	_	_	O
7	,	_	,	_	,	104	_	_	_	_	_	_	_	O
8	do	_	do	_	VBP	104	_	_	_	_	_	_	_	O
9	not	_	not	_	RB	104	_	_	_	_	_	_	_	O
10	offer	_	offer	_	VB	104	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	104	_	_	_	_	_	_	_	O
12	continue	_	continue	_	VB	104	_	_	_	_	_	_	_	O
13	pioglitazone	_	UNK	_	NN	104	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	104	_	_	_	_	_	_	_	O
15	they	_	they	_	PRP	104	_	_	_	_	_	_	_	O
16	have	_	have	_	VBP	104	_	_	_	_	_	_	_	O
17	any	_	any	_	DT	104	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	104	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	104	_	_	_	_	_	_	_	O
20	following	_	following	_	NN	104	_	_	_	_	_	_	_	O
21	:	_	:	_	:	104	_	_	_	_	_	_	_	O
22	heart	_	heart	_	NN	104	_	_	_	_	_	_	_	O
23	failure	_	failure	_	NN	104	_	_	_	_	_	_	_	O
24	or	_	or	_	CC	104	_	_	_	_	_	_	_	O
25	history	_	history	_	NN	104	_	_	_	_	_	history.n	History	O
26	of	_	of	_	IN	104	_	_	_	_	_	_	_	B-Topic
27	heart	_	heart	_	NN	104	_	_	_	_	_	_	_	I-Topic
28	failure	_	failure	_	NN	104	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	104	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	104	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	104	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	104	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	104	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	104	_	_	_	_	_	_	_	O
7	,	_	,	_	,	104	_	_	_	_	_	_	_	O
8	do	_	do	_	VBP	104	_	_	_	_	_	_	_	O
9	not	_	not	_	RB	104	_	_	_	_	_	_	_	O
10	offer	_	offer	_	VB	104	_	_	_	_	_	_	_	O
11	or	_	or	_	CC	104	_	_	_	_	_	_	_	O
12	continue	_	continue	_	VB	104	_	_	_	_	_	_	_	O
13	pioglitazone	_	UNK	_	NN	104	_	_	_	_	_	_	_	O
14	if	_	if	_	IN	104	_	_	_	_	_	_	_	O
15	they	_	they	_	PRP	104	_	_	_	_	_	_	_	O
16	have	_	have	_	VBP	104	_	_	_	_	_	_	_	O
17	any	_	any	_	DT	104	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	104	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	104	_	_	_	_	_	_	_	O
20	following	_	following	_	NN	104	_	_	_	_	_	_	_	O
21	:	_	:	_	:	104	_	_	_	_	_	_	_	O
22	heart	_	heart	_	NN	104	_	_	_	_	_	_	_	O
23	failure	_	failure	_	NN	104	_	_	_	_	_	_	_	O
24	or	_	or	_	CC	104	_	_	_	_	_	_	_	O
25	history	_	history	_	NN	104	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	104	_	_	_	_	_	_	_	O
27	heart	_	heart	_	NN	104	_	_	_	_	_	_	_	S-Agent
28	failure	_	failure	_	NN	104	_	_	_	_	_	failure.n	Success_or_failure	O

1	type	_	Type	_	$	105	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	105	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	105	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	105	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	105	_	_	_	_	_	_	_	O
6	:	_	:	_	:	105	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	105	_	_	_	_	_	_	_	O
8	(	_	(	_	(	105	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	105	_	_	_	_	_	_	_	O
10	)	_	)	_	)	105	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	105	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	105	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	105	_	_	_	_	_	_	_	O
14	)	_	)	_	)	105	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	105	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	105	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	105	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	105	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	105	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	105	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	105	_	_	_	_	_	_	_	O
8	(	_	(	_	(	105	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	105	_	_	_	_	_	_	_	O
10	)	_	)	_	)	105	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	105	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	105	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	105	_	_	_	_	_	_	_	O
14	)	_	)	_	)	105	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	106	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	JJ	106	_	_	_	_	_	_	_	O
4	cotransporter	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	106	_	_	_	_	_	_	_	O
6	(	_	(	_	(	106	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	NNP	106	_	_	_	_	_	_	_	O
8	)	_	)	_	)	106	_	_	_	_	_	_	_	O
9	inhibitors	_	UNK	_	NNS	106	_	_	_	_	_	_	_	O
10	,	_	,	_	,	106	_	_	_	_	_	_	_	O
11	may	_	may	_	MD	106	_	_	_	_	_	_	_	O
12	be	_	be	_	VB	106	_	_	_	_	_	_	_	O
13	appropriate	_	appropriate	_	JJ	106	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	106	_	_	_	_	_	_	_	O
15	some	_	some	_	DT	106	_	_	_	_	_	_	_	O
16	adults	_	adult	_	NNS	106	_	_	_	_	_	adult.n	People_by_age	S-Person
17	with	_	with	_	IN	106	_	_	_	_	_	_	_	O
18	type	_	type	_	JJ	106	_	_	_	_	_	_	_	O
19	2	_	2	_	CD	106	_	_	_	_	_	_	_	O
20	diabetes	_	UNK	_	NNS	106	_	_	_	_	_	_	_	O
21	if	_	if	_	IN	106	_	_	_	_	_	_	_	O
22	metformin	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	106	_	_	_	_	_	_	_	O
24	contraindicated	_	UNK	_	VBN	106	_	_	_	_	_	_	_	O
25	or	_	or	_	CC	106	_	_	_	_	_	_	_	O
26	not	_	not	_	RB	106	_	_	_	_	_	_	_	O
27	tolerated	_	UNK	_	VBN	106	_	_	_	_	_	_	_	O
28	(	_	(	_	(	106	_	_	_	_	_	_	_	O
29	see	_	see	_	VB	106	_	_	_	_	_	_	_	O
30	nice	_	UNK	_	NNP	106	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	106	_	_	_	_	_	_	_	O
32	guidance	_	guidance	_	NN	106	_	_	_	_	_	_	_	O
33	on	_	on	_	IN	106	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
35	,	_	,	_	,	106	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	106	_	_	_	_	_	_	_	O
38	unk	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
39	as	_	a	_	IN	106	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	106	_	_	_	_	_	_	_	O
41	for	_	for	_	IN	106	_	_	_	_	_	_	_	O
42	treating	_	treat	_	VBG	106	_	_	_	_	_	_	_	O
43	type	_	type	_	NN	106	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	106	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	106	_	_	_	_	_	_	_	O
46	)	_	)	_	)	106	_	_	_	_	_	_	_	O
47	.	_	.	_	.	106	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	106	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	JJ	106	_	_	_	_	_	_	_	O
4	cotransporter	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	106	_	_	_	_	_	_	_	O
6	(	_	(	_	(	106	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	NNP	106	_	_	_	_	_	_	_	O
8	)	_	)	_	)	106	_	_	_	_	_	_	_	O
9	inhibitors	_	UNK	_	NNS	106	_	_	_	_	_	_	_	O
10	,	_	,	_	,	106	_	_	_	_	_	_	_	O
11	may	_	may	_	MD	106	_	_	_	_	_	_	_	O
12	be	_	be	_	VB	106	_	_	_	_	_	_	_	O
13	appropriate	_	appropriate	_	JJ	106	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	106	_	_	_	_	_	_	_	O
15	some	_	some	_	DT	106	_	_	_	_	_	_	_	O
16	adults	_	adult	_	NNS	106	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	106	_	_	_	_	_	_	_	O
18	type	_	type	_	JJ	106	_	_	_	_	_	type.n	Type	S-Subtype
19	2	_	2	_	CD	106	_	_	_	_	_	_	_	B-Category
20	diabetes	_	UNK	_	NNS	106	_	_	_	_	_	_	_	I-Category
21	if	_	if	_	IN	106	_	_	_	_	_	_	_	O
22	metformin	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	106	_	_	_	_	_	_	_	O
24	contraindicated	_	UNK	_	VBN	106	_	_	_	_	_	_	_	O
25	or	_	or	_	CC	106	_	_	_	_	_	_	_	O
26	not	_	not	_	RB	106	_	_	_	_	_	_	_	O
27	tolerated	_	UNK	_	VBN	106	_	_	_	_	_	_	_	O
28	(	_	(	_	(	106	_	_	_	_	_	_	_	O
29	see	_	see	_	VB	106	_	_	_	_	_	_	_	O
30	nice	_	UNK	_	NNP	106	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	106	_	_	_	_	_	_	_	O
32	guidance	_	guidance	_	NN	106	_	_	_	_	_	_	_	O
33	on	_	on	_	IN	106	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
35	,	_	,	_	,	106	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	106	_	_	_	_	_	_	_	O
38	unk	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
39	as	_	a	_	IN	106	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	106	_	_	_	_	_	_	_	O
41	for	_	for	_	IN	106	_	_	_	_	_	_	_	O
42	treating	_	treat	_	VBG	106	_	_	_	_	_	_	_	O
43	type	_	type	_	NN	106	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	106	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	106	_	_	_	_	_	_	_	O
46	)	_	)	_	)	106	_	_	_	_	_	_	_	O
47	.	_	.	_	.	106	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	106	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	JJ	106	_	_	_	_	_	_	_	O
4	cotransporter	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	106	_	_	_	_	_	_	_	O
6	(	_	(	_	(	106	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	NNP	106	_	_	_	_	_	_	_	O
8	)	_	)	_	)	106	_	_	_	_	_	_	_	O
9	inhibitors	_	UNK	_	NNS	106	_	_	_	_	_	_	_	O
10	,	_	,	_	,	106	_	_	_	_	_	_	_	O
11	may	_	may	_	MD	106	_	_	_	_	_	_	_	O
12	be	_	be	_	VB	106	_	_	_	_	_	_	_	O
13	appropriate	_	appropriate	_	JJ	106	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	106	_	_	_	_	_	_	_	O
15	some	_	some	_	DT	106	_	_	_	_	_	_	_	O
16	adults	_	adult	_	NNS	106	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	106	_	_	_	_	_	_	_	O
18	type	_	type	_	JJ	106	_	_	_	_	_	_	_	O
19	2	_	2	_	CD	106	_	_	_	_	_	_	_	O
20	diabetes	_	UNK	_	NNS	106	_	_	_	_	_	_	_	O
21	if	_	if	_	IN	106	_	_	_	_	_	_	_	O
22	metformin	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	106	_	_	_	_	_	_	_	O
24	contraindicated	_	UNK	_	VBN	106	_	_	_	_	_	_	_	O
25	or	_	or	_	CC	106	_	_	_	_	_	_	_	O
26	not	_	not	_	RB	106	_	_	_	_	_	_	_	O
27	tolerated	_	UNK	_	VBN	106	_	_	_	_	_	_	_	O
28	(	_	(	_	(	106	_	_	_	_	_	_	_	O
29	see	_	see	_	VB	106	_	_	_	_	_	_	_	O
30	nice	_	UNK	_	NNP	106	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	106	_	_	_	_	_	_	_	O
32	guidance	_	guidance	_	NN	106	_	_	_	_	_	_	_	O
33	on	_	on	_	IN	106	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
35	,	_	,	_	,	106	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	106	_	_	_	_	_	_	_	O
38	unk	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
39	as	_	a	_	IN	106	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	106	_	_	_	_	_	_	_	O
41	for	_	for	_	IN	106	_	_	_	_	_	_	_	O
42	treating	_	treat	_	VBG	106	_	_	_	_	_	treat.v	Medical_intervention	O
43	type	_	type	_	NN	106	_	_	_	_	_	_	_	B-Patient
44	2	_	2	_	CD	106	_	_	_	_	_	_	_	I-Patient
45	diabetes	_	UNK	_	NNS	106	_	_	_	_	_	_	_	I-Patient
46	)	_	)	_	)	106	_	_	_	_	_	_	_	O
47	.	_	.	_	.	106	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	106	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	JJ	106	_	_	_	_	_	_	_	O
4	cotransporter	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	106	_	_	_	_	_	_	_	O
6	(	_	(	_	(	106	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	NNP	106	_	_	_	_	_	_	_	O
8	)	_	)	_	)	106	_	_	_	_	_	_	_	O
9	inhibitors	_	UNK	_	NNS	106	_	_	_	_	_	_	_	O
10	,	_	,	_	,	106	_	_	_	_	_	_	_	O
11	may	_	may	_	MD	106	_	_	_	_	_	_	_	O
12	be	_	be	_	VB	106	_	_	_	_	_	_	_	O
13	appropriate	_	appropriate	_	JJ	106	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	106	_	_	_	_	_	_	_	O
15	some	_	some	_	DT	106	_	_	_	_	_	_	_	O
16	adults	_	adult	_	NNS	106	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	106	_	_	_	_	_	_	_	O
18	type	_	type	_	JJ	106	_	_	_	_	_	_	_	O
19	2	_	2	_	CD	106	_	_	_	_	_	_	_	O
20	diabetes	_	UNK	_	NNS	106	_	_	_	_	_	_	_	O
21	if	_	if	_	IN	106	_	_	_	_	_	_	_	O
22	metformin	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	106	_	_	_	_	_	_	_	O
24	contraindicated	_	UNK	_	VBN	106	_	_	_	_	_	_	_	O
25	or	_	or	_	CC	106	_	_	_	_	_	_	_	O
26	not	_	not	_	RB	106	_	_	_	_	_	_	_	O
27	tolerated	_	UNK	_	VBN	106	_	_	_	_	_	_	_	O
28	(	_	(	_	(	106	_	_	_	_	_	_	_	O
29	see	_	see	_	VB	106	_	_	_	_	_	_	_	O
30	nice	_	UNK	_	NNP	106	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	106	_	_	_	_	_	_	_	O
32	guidance	_	guidance	_	NN	106	_	_	_	_	_	_	_	O
33	on	_	on	_	IN	106	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
35	,	_	,	_	,	106	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	106	_	_	_	_	_	_	_	O
38	unk	_	UNK	_	NN	106	_	_	_	_	_	_	_	O
39	as	_	a	_	IN	106	_	_	_	_	_	_	_	O
40	unk	_	UNK	_	NNS	106	_	_	_	_	_	_	_	O
41	for	_	for	_	IN	106	_	_	_	_	_	_	_	O
42	treating	_	treat	_	VBG	106	_	_	_	_	_	_	_	O
43	type	_	type	_	NN	106	_	_	_	_	_	type.n	Type	S-Subtype
44	2	_	2	_	CD	106	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	106	_	_	_	_	_	_	_	O
46	)	_	)	_	)	106	_	_	_	_	_	_	_	O
47	.	_	.	_	.	106	_	_	_	_	_	_	_	O

1	first	_	First	_	NNP	107	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	107	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	107	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	107	_	_	_	_	_	_	_	S-Patient
5	treatment	_	treatment	_	NN	107	_	_	_	_	_	treatment.n	Cure	O

1	in	_	In	_	IN	108	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	108	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	108	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	108	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	108	_	_	_	_	_	_	_	O
7	,	_	,	_	,	108	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	108	_	_	_	_	_	_	_	O
9	initial	_	initial	_	JJ	108	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	108	_	_	_	_	_	_	_	O
11	treatment	_	treatment	_	NN	108	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
13	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
14	has	_	have	_	VBZ	108	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	108	_	_	_	_	_	_	_	O
16	continued	_	continue	_	VBN	108	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
18	control	_	control	_	VB	108	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	108	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
21	below	_	below	_	VB	108	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	108	_	_	_	_	_	_	_	O
23	person	_	person	_	NN	108	_	_	_	_	_	_	_	O
24	's	_	's	_	POS	108	_	_	_	_	_	_	_	O
25	individually	_	UNK	_	RB	108	_	_	_	_	_	_	_	O
26	agreed	_	agree	_	VBN	108	_	_	_	_	_	_	_	O
27	threshold	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
28	for	_	for	_	IN	108	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
30	,	_	,	_	,	108	_	_	_	_	_	_	_	O
31	consider	_	consider	_	VB	108	_	_	_	_	_	_	_	O
32	dual	_	dual	_	JJ	108	_	_	_	_	_	_	_	O
33	therapy	_	therapy	_	NN	108	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
35	:	_	:	_	:	108	_	_	_	_	_	_	_	O
36	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	108	_	_	_	_	_	_	_	O
39	dpp-4	_	UNK	_	JJ	108	_	_	_	_	_	_	_	O
40	inhibitor	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	108	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
44	pioglitazone	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	108	_	_	_	_	_	_	_	O
46	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
47	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
48	a	_	a	_	DT	108	_	_	_	_	_	_	_	O
49	sulfonylurea	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
50	.	_	.	_	.	108	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	108	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	108	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	108	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	108	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	108	_	_	_	_	_	_	_	I-Category
7	,	_	,	_	,	108	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	108	_	_	_	_	_	_	_	O
9	initial	_	initial	_	JJ	108	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	108	_	_	_	_	_	_	_	O
11	treatment	_	treatment	_	NN	108	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
13	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
14	has	_	have	_	VBZ	108	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	108	_	_	_	_	_	_	_	O
16	continued	_	continue	_	VBN	108	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
18	control	_	control	_	VB	108	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	108	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
21	below	_	below	_	VB	108	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	108	_	_	_	_	_	_	_	O
23	person	_	person	_	NN	108	_	_	_	_	_	_	_	O
24	's	_	's	_	POS	108	_	_	_	_	_	_	_	O
25	individually	_	UNK	_	RB	108	_	_	_	_	_	_	_	O
26	agreed	_	agree	_	VBN	108	_	_	_	_	_	_	_	O
27	threshold	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
28	for	_	for	_	IN	108	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
30	,	_	,	_	,	108	_	_	_	_	_	_	_	O
31	consider	_	consider	_	VB	108	_	_	_	_	_	_	_	O
32	dual	_	dual	_	JJ	108	_	_	_	_	_	_	_	O
33	therapy	_	therapy	_	NN	108	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
35	:	_	:	_	:	108	_	_	_	_	_	_	_	O
36	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	108	_	_	_	_	_	_	_	O
39	dpp-4	_	UNK	_	JJ	108	_	_	_	_	_	_	_	O
40	inhibitor	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	108	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
44	pioglitazone	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	108	_	_	_	_	_	_	_	O
46	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
47	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
48	a	_	a	_	DT	108	_	_	_	_	_	_	_	O
49	sulfonylurea	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
50	.	_	.	_	.	108	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	108	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	108	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	108	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	108	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	108	_	_	_	_	_	_	_	O
7	,	_	,	_	,	108	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	108	_	_	_	_	_	_	_	O
9	initial	_	initial	_	JJ	108	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	108	_	_	_	_	_	_	_	S-Patient
11	treatment	_	treatment	_	NN	108	_	_	_	_	_	treatment.n	Cure	O
12	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
13	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
14	has	_	have	_	VBZ	108	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	108	_	_	_	_	_	_	_	O
16	continued	_	continue	_	VBN	108	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
18	control	_	control	_	VB	108	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	108	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
21	below	_	below	_	VB	108	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	108	_	_	_	_	_	_	_	O
23	person	_	person	_	NN	108	_	_	_	_	_	_	_	O
24	's	_	's	_	POS	108	_	_	_	_	_	_	_	O
25	individually	_	UNK	_	RB	108	_	_	_	_	_	_	_	O
26	agreed	_	agree	_	VBN	108	_	_	_	_	_	_	_	O
27	threshold	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
28	for	_	for	_	IN	108	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
30	,	_	,	_	,	108	_	_	_	_	_	_	_	O
31	consider	_	consider	_	VB	108	_	_	_	_	_	_	_	O
32	dual	_	dual	_	JJ	108	_	_	_	_	_	_	_	O
33	therapy	_	therapy	_	NN	108	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
35	:	_	:	_	:	108	_	_	_	_	_	_	_	O
36	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	108	_	_	_	_	_	_	_	O
39	dpp-4	_	UNK	_	JJ	108	_	_	_	_	_	_	_	O
40	inhibitor	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	108	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
44	pioglitazone	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	108	_	_	_	_	_	_	_	O
46	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
47	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
48	a	_	a	_	DT	108	_	_	_	_	_	_	_	O
49	sulfonylurea	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
50	.	_	.	_	.	108	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	108	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	108	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	108	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	108	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	108	_	_	_	_	_	_	_	O
7	,	_	,	_	,	108	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	108	_	_	_	_	_	_	_	O
9	initial	_	initial	_	JJ	108	_	_	_	_	_	_	_	B-Event
10	drug	_	drug	_	NN	108	_	_	_	_	_	_	_	I-Event
11	treatment	_	treatment	_	NN	108	_	_	_	_	_	_	_	I-Event
12	with	_	with	_	IN	108	_	_	_	_	_	_	_	I-Event
13	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	I-Event
14	has	_	have	_	VBZ	108	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	108	_	_	_	_	_	_	_	O
16	continued	_	continue	_	VBN	108	_	_	_	_	_	continue.v	Process_continue	O
17	to	_	to	_	TO	108	_	_	_	_	_	_	_	B-Event
18	control	_	control	_	VB	108	_	_	_	_	_	_	_	I-Event
19	hba1c	_	UNK	_	NNP	108	_	_	_	_	_	_	_	I-Event
20	to	_	to	_	TO	108	_	_	_	_	_	_	_	I-Event
21	below	_	below	_	VB	108	_	_	_	_	_	_	_	I-Event
22	the	_	the	_	DT	108	_	_	_	_	_	_	_	I-Event
23	person	_	person	_	NN	108	_	_	_	_	_	_	_	I-Event
24	's	_	's	_	POS	108	_	_	_	_	_	_	_	I-Event
25	individually	_	UNK	_	RB	108	_	_	_	_	_	_	_	I-Event
26	agreed	_	agree	_	VBN	108	_	_	_	_	_	_	_	I-Event
27	threshold	_	UNK	_	NN	108	_	_	_	_	_	_	_	I-Event
28	for	_	for	_	IN	108	_	_	_	_	_	_	_	I-Event
29	intensification	_	UNK	_	NN	108	_	_	_	_	_	_	_	I-Event
30	,	_	,	_	,	108	_	_	_	_	_	_	_	O
31	consider	_	consider	_	VB	108	_	_	_	_	_	_	_	O
32	dual	_	dual	_	JJ	108	_	_	_	_	_	_	_	O
33	therapy	_	therapy	_	NN	108	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
35	:	_	:	_	:	108	_	_	_	_	_	_	_	O
36	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	108	_	_	_	_	_	_	_	O
39	dpp-4	_	UNK	_	JJ	108	_	_	_	_	_	_	_	O
40	inhibitor	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	108	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
44	pioglitazone	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	108	_	_	_	_	_	_	_	O
46	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
47	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
48	a	_	a	_	DT	108	_	_	_	_	_	_	_	O
49	sulfonylurea	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
50	.	_	.	_	.	108	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	108	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	108	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	108	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	108	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	108	_	_	_	_	_	_	_	O
7	,	_	,	_	,	108	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	108	_	_	_	_	_	_	_	O
9	initial	_	initial	_	JJ	108	_	_	_	_	_	_	_	B-Controlling_entity
10	drug	_	drug	_	NN	108	_	_	_	_	_	_	_	I-Controlling_entity
11	treatment	_	treatment	_	NN	108	_	_	_	_	_	_	_	I-Controlling_entity
12	with	_	with	_	IN	108	_	_	_	_	_	_	_	I-Controlling_entity
13	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	I-Controlling_entity
14	has	_	have	_	VBZ	108	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	108	_	_	_	_	_	_	_	O
16	continued	_	continue	_	VBN	108	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
18	control	_	control	_	VB	108	_	_	_	_	_	control.v	Being_in_control	O
19	hba1c	_	UNK	_	NNP	108	_	_	_	_	_	_	_	S-Dependent_entity
20	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
21	below	_	below	_	VB	108	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	108	_	_	_	_	_	_	_	O
23	person	_	person	_	NN	108	_	_	_	_	_	_	_	O
24	's	_	's	_	POS	108	_	_	_	_	_	_	_	O
25	individually	_	UNK	_	RB	108	_	_	_	_	_	_	_	O
26	agreed	_	agree	_	VBN	108	_	_	_	_	_	_	_	O
27	threshold	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
28	for	_	for	_	IN	108	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
30	,	_	,	_	,	108	_	_	_	_	_	_	_	O
31	consider	_	consider	_	VB	108	_	_	_	_	_	_	_	O
32	dual	_	dual	_	JJ	108	_	_	_	_	_	_	_	O
33	therapy	_	therapy	_	NN	108	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
35	:	_	:	_	:	108	_	_	_	_	_	_	_	O
36	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	108	_	_	_	_	_	_	_	O
39	dpp-4	_	UNK	_	JJ	108	_	_	_	_	_	_	_	O
40	inhibitor	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	108	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
44	pioglitazone	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	108	_	_	_	_	_	_	_	O
46	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
47	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
48	a	_	a	_	DT	108	_	_	_	_	_	_	_	O
49	sulfonylurea	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
50	.	_	.	_	.	108	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	108	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	108	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	108	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	108	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	108	_	_	_	_	_	_	_	O
7	,	_	,	_	,	108	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	108	_	_	_	_	_	_	_	O
9	initial	_	initial	_	JJ	108	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	108	_	_	_	_	_	_	_	O
11	treatment	_	treatment	_	NN	108	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
13	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
14	has	_	have	_	VBZ	108	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	108	_	_	_	_	_	_	_	O
16	continued	_	continue	_	VBN	108	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
18	control	_	control	_	VB	108	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	108	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
21	below	_	below	_	VB	108	_	_	_	_	_	below.prep	Directional_locative_relation	O
22	the	_	the	_	DT	108	_	_	_	_	_	_	_	O
23	person	_	person	_	NN	108	_	_	_	_	_	_	_	O
24	's	_	's	_	POS	108	_	_	_	_	_	_	_	O
25	individually	_	UNK	_	RB	108	_	_	_	_	_	_	_	O
26	agreed	_	agree	_	VBN	108	_	_	_	_	_	_	_	O
27	threshold	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
28	for	_	for	_	IN	108	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
30	,	_	,	_	,	108	_	_	_	_	_	_	_	O
31	consider	_	consider	_	VB	108	_	_	_	_	_	_	_	O
32	dual	_	dual	_	JJ	108	_	_	_	_	_	_	_	O
33	therapy	_	therapy	_	NN	108	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
35	:	_	:	_	:	108	_	_	_	_	_	_	_	O
36	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	108	_	_	_	_	_	_	_	O
39	dpp-4	_	UNK	_	JJ	108	_	_	_	_	_	_	_	O
40	inhibitor	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	108	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
44	pioglitazone	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	108	_	_	_	_	_	_	_	O
46	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
47	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
48	a	_	a	_	DT	108	_	_	_	_	_	_	_	O
49	sulfonylurea	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
50	.	_	.	_	.	108	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	108	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	108	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	108	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	108	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	108	_	_	_	_	_	_	_	O
7	,	_	,	_	,	108	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	108	_	_	_	_	_	_	_	O
9	initial	_	initial	_	JJ	108	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	108	_	_	_	_	_	_	_	O
11	treatment	_	treatment	_	NN	108	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
13	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
14	has	_	have	_	VBZ	108	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	108	_	_	_	_	_	_	_	O
16	continued	_	continue	_	VBN	108	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
18	control	_	control	_	VB	108	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	108	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
21	below	_	below	_	VB	108	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	108	_	_	_	_	_	_	_	O
23	person	_	person	_	NN	108	_	_	_	_	_	person.n	People	S-Person
24	's	_	's	_	POS	108	_	_	_	_	_	_	_	O
25	individually	_	UNK	_	RB	108	_	_	_	_	_	_	_	O
26	agreed	_	agree	_	VBN	108	_	_	_	_	_	_	_	O
27	threshold	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
28	for	_	for	_	IN	108	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
30	,	_	,	_	,	108	_	_	_	_	_	_	_	O
31	consider	_	consider	_	VB	108	_	_	_	_	_	_	_	O
32	dual	_	dual	_	JJ	108	_	_	_	_	_	_	_	O
33	therapy	_	therapy	_	NN	108	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
35	:	_	:	_	:	108	_	_	_	_	_	_	_	O
36	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	108	_	_	_	_	_	_	_	O
39	dpp-4	_	UNK	_	JJ	108	_	_	_	_	_	_	_	O
40	inhibitor	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	108	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
44	pioglitazone	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	108	_	_	_	_	_	_	_	O
46	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
47	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
48	a	_	a	_	DT	108	_	_	_	_	_	_	_	O
49	sulfonylurea	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
50	.	_	.	_	.	108	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	108	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	108	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	108	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	108	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	108	_	_	_	_	_	_	_	O
7	,	_	,	_	,	108	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	108	_	_	_	_	_	_	_	O
9	initial	_	initial	_	JJ	108	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	108	_	_	_	_	_	_	_	O
11	treatment	_	treatment	_	NN	108	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
13	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
14	has	_	have	_	VBZ	108	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	108	_	_	_	_	_	_	_	O
16	continued	_	continue	_	VBN	108	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
18	control	_	control	_	VB	108	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	108	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
21	below	_	below	_	VB	108	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	108	_	_	_	_	_	_	_	B-Party_1
23	person	_	person	_	NN	108	_	_	_	_	_	_	_	I-Party_1
24	's	_	's	_	POS	108	_	_	_	_	_	_	_	I-Party_1
25	individually	_	UNK	_	RB	108	_	_	_	_	_	_	_	S-Parties
26	agreed	_	agree	_	VBN	108	_	_	_	_	_	agree.v	Make_agreement_on_action	O
27	threshold	_	UNK	_	NN	108	_	_	_	_	_	_	_	B-Obligation
28	for	_	for	_	IN	108	_	_	_	_	_	_	_	I-Obligation
29	intensification	_	UNK	_	NN	108	_	_	_	_	_	_	_	I-Obligation
30	,	_	,	_	,	108	_	_	_	_	_	_	_	O
31	consider	_	consider	_	VB	108	_	_	_	_	_	_	_	O
32	dual	_	dual	_	JJ	108	_	_	_	_	_	_	_	O
33	therapy	_	therapy	_	NN	108	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
35	:	_	:	_	:	108	_	_	_	_	_	_	_	O
36	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	108	_	_	_	_	_	_	_	O
39	dpp-4	_	UNK	_	JJ	108	_	_	_	_	_	_	_	O
40	inhibitor	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	108	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
44	pioglitazone	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	108	_	_	_	_	_	_	_	O
46	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
47	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
48	a	_	a	_	DT	108	_	_	_	_	_	_	_	O
49	sulfonylurea	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
50	.	_	.	_	.	108	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	108	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	108	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	108	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	108	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	108	_	_	_	_	_	_	_	O
7	,	_	,	_	,	108	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	108	_	_	_	_	_	_	_	O
9	initial	_	initial	_	JJ	108	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	108	_	_	_	_	_	_	_	O
11	treatment	_	treatment	_	NN	108	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
13	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
14	has	_	have	_	VBZ	108	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	108	_	_	_	_	_	_	_	O
16	continued	_	continue	_	VBN	108	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
18	control	_	control	_	VB	108	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	108	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
21	below	_	below	_	VB	108	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	108	_	_	_	_	_	_	_	O
23	person	_	person	_	NN	108	_	_	_	_	_	_	_	O
24	's	_	's	_	POS	108	_	_	_	_	_	_	_	O
25	individually	_	UNK	_	RB	108	_	_	_	_	_	_	_	O
26	agreed	_	agree	_	VBN	108	_	_	_	_	_	_	_	O
27	threshold	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
28	for	_	for	_	IN	108	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
30	,	_	,	_	,	108	_	_	_	_	_	_	_	O
31	consider	_	consider	_	VB	108	_	_	_	_	_	consider.v	Categorization	O
32	dual	_	dual	_	JJ	108	_	_	_	_	_	_	_	B-Item
33	therapy	_	therapy	_	NN	108	_	_	_	_	_	_	_	I-Item
34	with	_	with	_	IN	108	_	_	_	_	_	_	_	S-Category
35	:	_	:	_	:	108	_	_	_	_	_	_	_	O
36	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	B-Category
37	and	_	and	_	CC	108	_	_	_	_	_	_	_	I-Category
38	a	_	a	_	DT	108	_	_	_	_	_	_	_	I-Category
39	dpp-4	_	UNK	_	JJ	108	_	_	_	_	_	_	_	I-Category
40	inhibitor	_	UNK	_	NN	108	_	_	_	_	_	_	_	I-Category
41	or	_	or	_	CC	108	_	_	_	_	_	_	_	I-Category
42	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	I-Category
43	and	_	and	_	CC	108	_	_	_	_	_	_	_	I-Category
44	pioglitazone	_	UNK	_	NN	108	_	_	_	_	_	_	_	I-Category
45	or	_	or	_	CC	108	_	_	_	_	_	_	_	I-Category
46	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	I-Category
47	and	_	and	_	CC	108	_	_	_	_	_	_	_	I-Category
48	a	_	a	_	DT	108	_	_	_	_	_	_	_	I-Category
49	sulfonylurea	_	UNK	_	NN	108	_	_	_	_	_	_	_	I-Category
50	.	_	.	_	.	108	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	108	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	108	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	108	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	108	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	108	_	_	_	_	_	_	_	O
7	,	_	,	_	,	108	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	108	_	_	_	_	_	_	_	O
9	initial	_	initial	_	JJ	108	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	108	_	_	_	_	_	_	_	O
11	treatment	_	treatment	_	NN	108	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
13	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
14	has	_	have	_	VBZ	108	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	108	_	_	_	_	_	_	_	O
16	continued	_	continue	_	VBN	108	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
18	control	_	control	_	VB	108	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	108	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
21	below	_	below	_	VB	108	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	108	_	_	_	_	_	_	_	O
23	person	_	person	_	NN	108	_	_	_	_	_	_	_	O
24	's	_	's	_	POS	108	_	_	_	_	_	_	_	O
25	individually	_	UNK	_	RB	108	_	_	_	_	_	_	_	O
26	agreed	_	agree	_	VBN	108	_	_	_	_	_	_	_	O
27	threshold	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
28	for	_	for	_	IN	108	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
30	,	_	,	_	,	108	_	_	_	_	_	_	_	O
31	consider	_	consider	_	VB	108	_	_	_	_	_	_	_	O
32	dual	_	dual	_	JJ	108	_	_	_	_	_	dual.a	Cardinal_numbers	S-Number
33	therapy	_	therapy	_	NN	108	_	_	_	_	_	_	_	S-Entity
34	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
35	:	_	:	_	:	108	_	_	_	_	_	_	_	O
36	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	108	_	_	_	_	_	_	_	O
39	dpp-4	_	UNK	_	JJ	108	_	_	_	_	_	_	_	O
40	inhibitor	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	108	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
44	pioglitazone	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	108	_	_	_	_	_	_	_	O
46	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
47	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
48	a	_	a	_	DT	108	_	_	_	_	_	_	_	O
49	sulfonylurea	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
50	.	_	.	_	.	108	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	108	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	108	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	108	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	108	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	108	_	_	_	_	_	_	_	O
7	,	_	,	_	,	108	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	108	_	_	_	_	_	_	_	O
9	initial	_	initial	_	JJ	108	_	_	_	_	_	_	_	O
10	drug	_	drug	_	NN	108	_	_	_	_	_	_	_	O
11	treatment	_	treatment	_	NN	108	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
13	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
14	has	_	have	_	VBZ	108	_	_	_	_	_	_	_	O
15	not	_	not	_	RB	108	_	_	_	_	_	_	_	O
16	continued	_	continue	_	VBN	108	_	_	_	_	_	_	_	O
17	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
18	control	_	control	_	VB	108	_	_	_	_	_	_	_	O
19	hba1c	_	UNK	_	NNP	108	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	108	_	_	_	_	_	_	_	O
21	below	_	below	_	VB	108	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	108	_	_	_	_	_	_	_	O
23	person	_	person	_	NN	108	_	_	_	_	_	_	_	O
24	's	_	's	_	POS	108	_	_	_	_	_	_	_	O
25	individually	_	UNK	_	RB	108	_	_	_	_	_	_	_	O
26	agreed	_	agree	_	VBN	108	_	_	_	_	_	_	_	O
27	threshold	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
28	for	_	for	_	IN	108	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
30	,	_	,	_	,	108	_	_	_	_	_	_	_	O
31	consider	_	consider	_	VB	108	_	_	_	_	_	_	_	O
32	dual	_	dual	_	JJ	108	_	_	_	_	_	_	_	O
33	therapy	_	therapy	_	NN	108	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
34	with	_	with	_	IN	108	_	_	_	_	_	_	_	O
35	:	_	:	_	:	108	_	_	_	_	_	_	_	O
36	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
37	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	108	_	_	_	_	_	_	_	O
39	dpp-4	_	UNK	_	JJ	108	_	_	_	_	_	_	_	O
40	inhibitor	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	108	_	_	_	_	_	_	_	O
42	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
43	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
44	pioglitazone	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	108	_	_	_	_	_	_	_	O
46	metformin	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
47	and	_	and	_	CC	108	_	_	_	_	_	_	_	O
48	a	_	a	_	DT	108	_	_	_	_	_	_	_	O
49	sulfonylurea	_	UNK	_	NN	108	_	_	_	_	_	_	_	O
50	.	_	.	_	.	108	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	109	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	109	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	109	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	109	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	109	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	109	_	_	_	_	_	_	_	O
7	,	_	,	_	,	109	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	109	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	109	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	109	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	109	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	109	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	109	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	109	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
16	initial	_	initial	_	JJ	109	_	_	_	_	_	_	_	O
17	drug	_	drug	_	NN	109	_	_	_	_	_	_	_	O
18	treatment	_	treatment	_	NN	109	_	_	_	_	_	_	_	O
19	has	_	have	_	VBZ	109	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	109	_	_	_	_	_	_	_	O
21	continued	_	continue	_	VBN	109	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	109	_	_	_	_	_	_	_	O
23	control	_	control	_	VB	109	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	109	_	_	_	_	_	_	_	O
25	to	_	to	_	TO	109	_	_	_	_	_	_	_	O
26	below	_	below	_	VB	109	_	_	_	_	_	_	_	O
27	the	_	the	_	DT	109	_	_	_	_	_	_	_	O
28	person	_	person	_	NN	109	_	_	_	_	_	_	_	O
29	's	_	's	_	POS	109	_	_	_	_	_	_	_	O
30	individually	_	UNK	_	RB	109	_	_	_	_	_	_	_	O
31	agreed	_	agree	_	VBN	109	_	_	_	_	_	_	_	O
32	threshold	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
33	for	_	for	_	IN	109	_	_	_	_	_	_	_	O
34	intensification	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
35	,	_	,	_	,	109	_	_	_	_	_	_	_	O
36	consider	_	consider	_	VB	109	_	_	_	_	_	_	_	O
37	dual	_	dual	_	JJ	109	_	_	_	_	_	_	_	O
38	therapy	_	therapy	_	NN	109	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	109	_	_	_	_	_	_	_	O
40	:	_	:	_	:	109	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
42	dpp-4	_	UNK	_	NNP	109	_	_	_	_	_	_	_	O
43	inhibitor	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
44	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
45	pioglitazone	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	109	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	JJ	109	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	109	_	_	_	_	_	_	_	O
54	pioglitazone	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
55	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
57	sulfonylurea	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
58	.	_	.	_	.	109	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	109	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	109	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	109	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	109	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	109	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	109	_	_	_	_	_	_	_	I-Category
7	,	_	,	_	,	109	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	109	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	109	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	109	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	109	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	109	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	109	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	109	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
16	initial	_	initial	_	JJ	109	_	_	_	_	_	_	_	O
17	drug	_	drug	_	NN	109	_	_	_	_	_	_	_	O
18	treatment	_	treatment	_	NN	109	_	_	_	_	_	_	_	O
19	has	_	have	_	VBZ	109	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	109	_	_	_	_	_	_	_	O
21	continued	_	continue	_	VBN	109	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	109	_	_	_	_	_	_	_	O
23	control	_	control	_	VB	109	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	109	_	_	_	_	_	_	_	O
25	to	_	to	_	TO	109	_	_	_	_	_	_	_	O
26	below	_	below	_	VB	109	_	_	_	_	_	_	_	O
27	the	_	the	_	DT	109	_	_	_	_	_	_	_	O
28	person	_	person	_	NN	109	_	_	_	_	_	_	_	O
29	's	_	's	_	POS	109	_	_	_	_	_	_	_	O
30	individually	_	UNK	_	RB	109	_	_	_	_	_	_	_	O
31	agreed	_	agree	_	VBN	109	_	_	_	_	_	_	_	O
32	threshold	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
33	for	_	for	_	IN	109	_	_	_	_	_	_	_	O
34	intensification	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
35	,	_	,	_	,	109	_	_	_	_	_	_	_	O
36	consider	_	consider	_	VB	109	_	_	_	_	_	_	_	O
37	dual	_	dual	_	JJ	109	_	_	_	_	_	_	_	O
38	therapy	_	therapy	_	NN	109	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	109	_	_	_	_	_	_	_	O
40	:	_	:	_	:	109	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
42	dpp-4	_	UNK	_	NNP	109	_	_	_	_	_	_	_	O
43	inhibitor	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
44	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
45	pioglitazone	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	109	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	JJ	109	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	109	_	_	_	_	_	_	_	O
54	pioglitazone	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
55	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
57	sulfonylurea	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
58	.	_	.	_	.	109	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	109	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	109	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	109	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	109	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	109	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	109	_	_	_	_	_	_	_	O
7	,	_	,	_	,	109	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	109	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	109	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	109	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	109	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	109	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	109	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	109	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
16	initial	_	initial	_	JJ	109	_	_	_	_	_	_	_	B-Activity
17	drug	_	drug	_	NN	109	_	_	_	_	_	_	_	I-Activity
18	treatment	_	treatment	_	NN	109	_	_	_	_	_	_	_	I-Activity
19	has	_	have	_	VBZ	109	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	109	_	_	_	_	_	_	_	O
21	continued	_	continue	_	VBN	109	_	_	_	_	_	continue.v	Activity_ongoing	O
22	to	_	to	_	TO	109	_	_	_	_	_	_	_	B-Activity
23	control	_	control	_	VB	109	_	_	_	_	_	_	_	I-Activity
24	hba1c	_	UNK	_	NNP	109	_	_	_	_	_	_	_	I-Activity
25	to	_	to	_	TO	109	_	_	_	_	_	_	_	I-Activity
26	below	_	below	_	VB	109	_	_	_	_	_	_	_	I-Activity
27	the	_	the	_	DT	109	_	_	_	_	_	_	_	I-Activity
28	person	_	person	_	NN	109	_	_	_	_	_	_	_	I-Activity
29	's	_	's	_	POS	109	_	_	_	_	_	_	_	I-Activity
30	individually	_	UNK	_	RB	109	_	_	_	_	_	_	_	I-Activity
31	agreed	_	agree	_	VBN	109	_	_	_	_	_	_	_	I-Activity
32	threshold	_	UNK	_	NN	109	_	_	_	_	_	_	_	I-Activity
33	for	_	for	_	IN	109	_	_	_	_	_	_	_	I-Activity
34	intensification	_	UNK	_	NN	109	_	_	_	_	_	_	_	I-Activity
35	,	_	,	_	,	109	_	_	_	_	_	_	_	O
36	consider	_	consider	_	VB	109	_	_	_	_	_	_	_	O
37	dual	_	dual	_	JJ	109	_	_	_	_	_	_	_	O
38	therapy	_	therapy	_	NN	109	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	109	_	_	_	_	_	_	_	O
40	:	_	:	_	:	109	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
42	dpp-4	_	UNK	_	NNP	109	_	_	_	_	_	_	_	O
43	inhibitor	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
44	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
45	pioglitazone	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	109	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	JJ	109	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	109	_	_	_	_	_	_	_	O
54	pioglitazone	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
55	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
57	sulfonylurea	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
58	.	_	.	_	.	109	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	109	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	109	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	109	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	109	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	109	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	109	_	_	_	_	_	_	_	O
7	,	_	,	_	,	109	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	109	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	109	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	109	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	109	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	109	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	109	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	109	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
16	initial	_	initial	_	JJ	109	_	_	_	_	_	_	_	O
17	drug	_	drug	_	NN	109	_	_	_	_	_	_	_	O
18	treatment	_	treatment	_	NN	109	_	_	_	_	_	_	_	O
19	has	_	have	_	VBZ	109	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	109	_	_	_	_	_	_	_	O
21	continued	_	continue	_	VBN	109	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	109	_	_	_	_	_	_	_	O
23	control	_	control	_	VB	109	_	_	_	_	_	control.v	Being_in_control	O
24	hba1c	_	UNK	_	NNP	109	_	_	_	_	_	_	_	B-Dependent_entity
25	to	_	to	_	TO	109	_	_	_	_	_	_	_	I-Dependent_entity
26	below	_	below	_	VB	109	_	_	_	_	_	_	_	I-Dependent_entity
27	the	_	the	_	DT	109	_	_	_	_	_	_	_	I-Dependent_entity
28	person	_	person	_	NN	109	_	_	_	_	_	_	_	I-Dependent_entity
29	's	_	's	_	POS	109	_	_	_	_	_	_	_	I-Dependent_entity
30	individually	_	UNK	_	RB	109	_	_	_	_	_	_	_	I-Dependent_entity
31	agreed	_	agree	_	VBN	109	_	_	_	_	_	_	_	I-Dependent_entity
32	threshold	_	UNK	_	NN	109	_	_	_	_	_	_	_	I-Dependent_entity
33	for	_	for	_	IN	109	_	_	_	_	_	_	_	I-Dependent_entity
34	intensification	_	UNK	_	NN	109	_	_	_	_	_	_	_	I-Dependent_entity
35	,	_	,	_	,	109	_	_	_	_	_	_	_	O
36	consider	_	consider	_	VB	109	_	_	_	_	_	_	_	O
37	dual	_	dual	_	JJ	109	_	_	_	_	_	_	_	O
38	therapy	_	therapy	_	NN	109	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	109	_	_	_	_	_	_	_	O
40	:	_	:	_	:	109	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
42	dpp-4	_	UNK	_	NNP	109	_	_	_	_	_	_	_	O
43	inhibitor	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
44	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
45	pioglitazone	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	109	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	JJ	109	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	109	_	_	_	_	_	_	_	O
54	pioglitazone	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
55	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
57	sulfonylurea	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
58	.	_	.	_	.	109	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	109	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	109	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	109	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	109	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	109	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	109	_	_	_	_	_	_	_	O
7	,	_	,	_	,	109	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	109	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	109	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	109	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	109	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	109	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	109	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	109	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
16	initial	_	initial	_	JJ	109	_	_	_	_	_	_	_	O
17	drug	_	drug	_	NN	109	_	_	_	_	_	_	_	O
18	treatment	_	treatment	_	NN	109	_	_	_	_	_	_	_	O
19	has	_	have	_	VBZ	109	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	109	_	_	_	_	_	_	_	O
21	continued	_	continue	_	VBN	109	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	109	_	_	_	_	_	_	_	O
23	control	_	control	_	VB	109	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	109	_	_	_	_	_	_	_	O
25	to	_	to	_	TO	109	_	_	_	_	_	_	_	O
26	below	_	below	_	VB	109	_	_	_	_	_	_	_	O
27	the	_	the	_	DT	109	_	_	_	_	_	_	_	O
28	person	_	person	_	NN	109	_	_	_	_	_	person.n	People	S-Person
29	's	_	's	_	POS	109	_	_	_	_	_	_	_	O
30	individually	_	UNK	_	RB	109	_	_	_	_	_	_	_	O
31	agreed	_	agree	_	VBN	109	_	_	_	_	_	_	_	O
32	threshold	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
33	for	_	for	_	IN	109	_	_	_	_	_	_	_	O
34	intensification	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
35	,	_	,	_	,	109	_	_	_	_	_	_	_	O
36	consider	_	consider	_	VB	109	_	_	_	_	_	_	_	O
37	dual	_	dual	_	JJ	109	_	_	_	_	_	_	_	O
38	therapy	_	therapy	_	NN	109	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	109	_	_	_	_	_	_	_	O
40	:	_	:	_	:	109	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
42	dpp-4	_	UNK	_	NNP	109	_	_	_	_	_	_	_	O
43	inhibitor	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
44	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
45	pioglitazone	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	109	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	JJ	109	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	109	_	_	_	_	_	_	_	O
54	pioglitazone	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
55	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
57	sulfonylurea	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
58	.	_	.	_	.	109	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	109	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	109	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	109	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	109	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	109	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	109	_	_	_	_	_	_	_	O
7	,	_	,	_	,	109	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	109	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	109	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	109	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	109	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	109	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	109	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	109	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
16	initial	_	initial	_	JJ	109	_	_	_	_	_	_	_	O
17	drug	_	drug	_	NN	109	_	_	_	_	_	_	_	O
18	treatment	_	treatment	_	NN	109	_	_	_	_	_	_	_	O
19	has	_	have	_	VBZ	109	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	109	_	_	_	_	_	_	_	O
21	continued	_	continue	_	VBN	109	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	109	_	_	_	_	_	_	_	O
23	control	_	control	_	VB	109	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	109	_	_	_	_	_	_	_	O
25	to	_	to	_	TO	109	_	_	_	_	_	_	_	O
26	below	_	below	_	VB	109	_	_	_	_	_	_	_	O
27	the	_	the	_	DT	109	_	_	_	_	_	_	_	B-Party_1
28	person	_	person	_	NN	109	_	_	_	_	_	_	_	I-Party_1
29	's	_	's	_	POS	109	_	_	_	_	_	_	_	I-Party_1
30	individually	_	UNK	_	RB	109	_	_	_	_	_	_	_	S-Parties
31	agreed	_	agree	_	VBN	109	_	_	_	_	_	agree.v	Make_agreement_on_action	O
32	threshold	_	UNK	_	NN	109	_	_	_	_	_	_	_	B-Obligation
33	for	_	for	_	IN	109	_	_	_	_	_	_	_	I-Obligation
34	intensification	_	UNK	_	NN	109	_	_	_	_	_	_	_	I-Obligation
35	,	_	,	_	,	109	_	_	_	_	_	_	_	O
36	consider	_	consider	_	VB	109	_	_	_	_	_	_	_	O
37	dual	_	dual	_	JJ	109	_	_	_	_	_	_	_	O
38	therapy	_	therapy	_	NN	109	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	109	_	_	_	_	_	_	_	O
40	:	_	:	_	:	109	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
42	dpp-4	_	UNK	_	NNP	109	_	_	_	_	_	_	_	O
43	inhibitor	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
44	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
45	pioglitazone	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	109	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	JJ	109	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	109	_	_	_	_	_	_	_	O
54	pioglitazone	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
55	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
57	sulfonylurea	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
58	.	_	.	_	.	109	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	109	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	109	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	109	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	109	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	109	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	109	_	_	_	_	_	_	_	O
7	,	_	,	_	,	109	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	109	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	109	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	109	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	109	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	109	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	109	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	109	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
16	initial	_	initial	_	JJ	109	_	_	_	_	_	_	_	O
17	drug	_	drug	_	NN	109	_	_	_	_	_	_	_	O
18	treatment	_	treatment	_	NN	109	_	_	_	_	_	_	_	O
19	has	_	have	_	VBZ	109	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	109	_	_	_	_	_	_	_	O
21	continued	_	continue	_	VBN	109	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	109	_	_	_	_	_	_	_	O
23	control	_	control	_	VB	109	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	109	_	_	_	_	_	_	_	O
25	to	_	to	_	TO	109	_	_	_	_	_	_	_	O
26	below	_	below	_	VB	109	_	_	_	_	_	_	_	O
27	the	_	the	_	DT	109	_	_	_	_	_	_	_	O
28	person	_	person	_	NN	109	_	_	_	_	_	_	_	O
29	's	_	's	_	POS	109	_	_	_	_	_	_	_	O
30	individually	_	UNK	_	RB	109	_	_	_	_	_	_	_	O
31	agreed	_	agree	_	VBN	109	_	_	_	_	_	_	_	O
32	threshold	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
33	for	_	for	_	IN	109	_	_	_	_	_	_	_	O
34	intensification	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
35	,	_	,	_	,	109	_	_	_	_	_	_	_	O
36	consider	_	consider	_	VB	109	_	_	_	_	_	consider.v	Categorization	O
37	dual	_	dual	_	JJ	109	_	_	_	_	_	_	_	B-Item
38	therapy	_	therapy	_	NN	109	_	_	_	_	_	_	_	I-Item
39	with	_	with	_	IN	109	_	_	_	_	_	_	_	S-Category
40	:	_	:	_	:	109	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	109	_	_	_	_	_	_	_	B-Category
42	dpp-4	_	UNK	_	NNP	109	_	_	_	_	_	_	_	I-Category
43	inhibitor	_	UNK	_	NN	109	_	_	_	_	_	_	_	I-Category
44	and	_	and	_	CC	109	_	_	_	_	_	_	_	I-Category
45	pioglitazone	_	UNK	_	NN	109	_	_	_	_	_	_	_	I-Category
46	or	_	or	_	CC	109	_	_	_	_	_	_	_	I-Category
47	a	_	a	_	DT	109	_	_	_	_	_	_	_	I-Category
48	dpp-4	_	UNK	_	JJ	109	_	_	_	_	_	_	_	I-Category
49	inhibitor	_	UNK	_	NN	109	_	_	_	_	_	_	_	I-Category
50	and	_	and	_	CC	109	_	_	_	_	_	_	_	I-Category
51	a	_	a	_	DT	109	_	_	_	_	_	_	_	I-Category
52	sulfonylurea	_	UNK	_	NN	109	_	_	_	_	_	_	_	I-Category
53	or	_	or	_	CC	109	_	_	_	_	_	_	_	I-Category
54	pioglitazone	_	UNK	_	NN	109	_	_	_	_	_	_	_	I-Category
55	and	_	and	_	CC	109	_	_	_	_	_	_	_	I-Category
56	a	_	a	_	DT	109	_	_	_	_	_	_	_	I-Category
57	sulfonylurea	_	UNK	_	NN	109	_	_	_	_	_	_	_	I-Category
58	.	_	.	_	.	109	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	109	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	109	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	109	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	109	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	109	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	109	_	_	_	_	_	_	_	O
7	,	_	,	_	,	109	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	109	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	109	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	109	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	109	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	109	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	109	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	109	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
16	initial	_	initial	_	JJ	109	_	_	_	_	_	_	_	O
17	drug	_	drug	_	NN	109	_	_	_	_	_	_	_	O
18	treatment	_	treatment	_	NN	109	_	_	_	_	_	_	_	O
19	has	_	have	_	VBZ	109	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	109	_	_	_	_	_	_	_	O
21	continued	_	continue	_	VBN	109	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	109	_	_	_	_	_	_	_	O
23	control	_	control	_	VB	109	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	109	_	_	_	_	_	_	_	O
25	to	_	to	_	TO	109	_	_	_	_	_	_	_	O
26	below	_	below	_	VB	109	_	_	_	_	_	_	_	O
27	the	_	the	_	DT	109	_	_	_	_	_	_	_	O
28	person	_	person	_	NN	109	_	_	_	_	_	_	_	O
29	's	_	's	_	POS	109	_	_	_	_	_	_	_	O
30	individually	_	UNK	_	RB	109	_	_	_	_	_	_	_	O
31	agreed	_	agree	_	VBN	109	_	_	_	_	_	_	_	O
32	threshold	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
33	for	_	for	_	IN	109	_	_	_	_	_	_	_	O
34	intensification	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
35	,	_	,	_	,	109	_	_	_	_	_	_	_	O
36	consider	_	consider	_	VB	109	_	_	_	_	_	_	_	O
37	dual	_	dual	_	JJ	109	_	_	_	_	_	dual.a	Cardinal_numbers	S-Number
38	therapy	_	therapy	_	NN	109	_	_	_	_	_	_	_	S-Entity
39	with	_	with	_	IN	109	_	_	_	_	_	_	_	O
40	:	_	:	_	:	109	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
42	dpp-4	_	UNK	_	NNP	109	_	_	_	_	_	_	_	O
43	inhibitor	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
44	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
45	pioglitazone	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	109	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	JJ	109	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	109	_	_	_	_	_	_	_	O
54	pioglitazone	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
55	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
57	sulfonylurea	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
58	.	_	.	_	.	109	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	109	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	109	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	109	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	109	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	109	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	109	_	_	_	_	_	_	_	O
7	,	_	,	_	,	109	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	109	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	109	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	109	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	109	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	109	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	109	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	109	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
16	initial	_	initial	_	JJ	109	_	_	_	_	_	_	_	O
17	drug	_	drug	_	NN	109	_	_	_	_	_	_	_	O
18	treatment	_	treatment	_	NN	109	_	_	_	_	_	_	_	O
19	has	_	have	_	VBZ	109	_	_	_	_	_	_	_	O
20	not	_	not	_	RB	109	_	_	_	_	_	_	_	O
21	continued	_	continue	_	VBN	109	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	109	_	_	_	_	_	_	_	O
23	control	_	control	_	VB	109	_	_	_	_	_	_	_	O
24	hba1c	_	UNK	_	NNP	109	_	_	_	_	_	_	_	O
25	to	_	to	_	TO	109	_	_	_	_	_	_	_	O
26	below	_	below	_	VB	109	_	_	_	_	_	_	_	O
27	the	_	the	_	DT	109	_	_	_	_	_	_	_	O
28	person	_	person	_	NN	109	_	_	_	_	_	_	_	O
29	's	_	's	_	POS	109	_	_	_	_	_	_	_	O
30	individually	_	UNK	_	RB	109	_	_	_	_	_	_	_	O
31	agreed	_	agree	_	VBN	109	_	_	_	_	_	_	_	O
32	threshold	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
33	for	_	for	_	IN	109	_	_	_	_	_	_	_	O
34	intensification	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
35	,	_	,	_	,	109	_	_	_	_	_	_	_	O
36	consider	_	consider	_	VB	109	_	_	_	_	_	_	_	O
37	dual	_	dual	_	JJ	109	_	_	_	_	_	_	_	O
38	therapy	_	therapy	_	NN	109	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
39	with	_	with	_	IN	109	_	_	_	_	_	_	_	O
40	:	_	:	_	:	109	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
42	dpp-4	_	UNK	_	NNP	109	_	_	_	_	_	_	_	O
43	inhibitor	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
44	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
45	pioglitazone	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	109	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	JJ	109	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	109	_	_	_	_	_	_	_	O
54	pioglitazone	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
55	and	_	and	_	CC	109	_	_	_	_	_	_	_	O
56	a	_	a	_	DT	109	_	_	_	_	_	_	_	O
57	sulfonylurea	_	UNK	_	NN	109	_	_	_	_	_	_	_	O
58	.	_	.	_	.	109	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	110	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	110	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	110	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	110	_	_	_	_	_	_	_	S-Total
6	including	_	include	_	VBG	110	_	_	_	_	_	include.v	Inclusion	O
7	unk	_	UNK	_	JJ	110	_	_	_	_	_	_	_	O
8	cotransporter	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
10	(	_	(	_	(	110	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	NNP	110	_	_	_	_	_	_	_	O
12	)	_	)	_	)	110	_	_	_	_	_	_	_	O
13	inhibitors	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
14	,	_	,	_	,	110	_	_	_	_	_	_	_	O
15	may	_	may	_	MD	110	_	_	_	_	_	_	_	O
16	be	_	be	_	VB	110	_	_	_	_	_	_	_	O
17	appropriate	_	appropriate	_	JJ	110	_	_	_	_	_	_	_	O
18	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
19	some	_	some	_	DT	110	_	_	_	_	_	_	_	O
20	people	_	people	_	NNS	110	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	110	_	_	_	_	_	_	_	O
22	type	_	type	_	JJ	110	_	_	_	_	_	_	_	O
23	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
24	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
25	;	_	;	_	:	110	_	_	_	_	_	_	_	O
26	see	_	see	_	VB	110	_	_	_	_	_	_	_	O
27	the	_	the	_	DT	110	_	_	_	_	_	_	_	O
28	nice	_	UNK	_	NNP	110	_	_	_	_	_	_	_	O
29	guidance	_	guidance	_	NN	110	_	_	_	_	_	_	_	O
30	on	_	on	_	IN	110	_	_	_	_	_	_	_	O
31	unk	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
32	in	_	in	_	IN	110	_	_	_	_	_	_	_	O
33	combination	_	combination	_	NN	110	_	_	_	_	_	_	_	O
34	therapy	_	therapy	_	NN	110	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
36	treating	_	treat	_	VBG	110	_	_	_	_	_	_	_	O
37	type	_	type	_	NN	110	_	_	_	_	_	_	_	O
38	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
39	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
40	,	_	,	_	,	110	_	_	_	_	_	_	_	O
41	unk	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
42	in	_	in	_	IN	110	_	_	_	_	_	_	_	O
43	combination	_	combination	_	NN	110	_	_	_	_	_	_	_	O
44	therapy	_	therapy	_	NN	110	_	_	_	_	_	_	_	O
45	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
46	treating	_	treat	_	VBG	110	_	_	_	_	_	_	_	O
47	type	_	type	_	NN	110	_	_	_	_	_	_	_	O
48	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
49	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	110	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
52	in	_	in	_	IN	110	_	_	_	_	_	_	_	O
53	combination	_	combination	_	NN	110	_	_	_	_	_	_	_	O
54	therapy	_	therapy	_	NN	110	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
56	treating	_	treat	_	VBG	110	_	_	_	_	_	_	_	O
57	type	_	type	_	NN	110	_	_	_	_	_	_	_	O
58	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
59	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
60	.	_	.	_	.	110	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	110	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	110	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	110	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	110	_	_	_	_	_	_	_	O
6	including	_	include	_	VBG	110	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	JJ	110	_	_	_	_	_	_	_	O
8	cotransporter	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
10	(	_	(	_	(	110	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	NNP	110	_	_	_	_	_	_	_	O
12	)	_	)	_	)	110	_	_	_	_	_	_	_	O
13	inhibitors	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
14	,	_	,	_	,	110	_	_	_	_	_	_	_	O
15	may	_	may	_	MD	110	_	_	_	_	_	_	_	O
16	be	_	be	_	VB	110	_	_	_	_	_	_	_	O
17	appropriate	_	appropriate	_	JJ	110	_	_	_	_	_	_	_	O
18	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
19	some	_	some	_	DT	110	_	_	_	_	_	_	_	O
20	people	_	people	_	NNS	110	_	_	_	_	_	people.n	People	S-Person
21	with	_	with	_	IN	110	_	_	_	_	_	_	_	O
22	type	_	type	_	JJ	110	_	_	_	_	_	_	_	O
23	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
24	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
25	;	_	;	_	:	110	_	_	_	_	_	_	_	O
26	see	_	see	_	VB	110	_	_	_	_	_	_	_	O
27	the	_	the	_	DT	110	_	_	_	_	_	_	_	O
28	nice	_	UNK	_	NNP	110	_	_	_	_	_	_	_	O
29	guidance	_	guidance	_	NN	110	_	_	_	_	_	_	_	O
30	on	_	on	_	IN	110	_	_	_	_	_	_	_	O
31	unk	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
32	in	_	in	_	IN	110	_	_	_	_	_	_	_	O
33	combination	_	combination	_	NN	110	_	_	_	_	_	_	_	O
34	therapy	_	therapy	_	NN	110	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
36	treating	_	treat	_	VBG	110	_	_	_	_	_	_	_	O
37	type	_	type	_	NN	110	_	_	_	_	_	_	_	O
38	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
39	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
40	,	_	,	_	,	110	_	_	_	_	_	_	_	O
41	unk	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
42	in	_	in	_	IN	110	_	_	_	_	_	_	_	O
43	combination	_	combination	_	NN	110	_	_	_	_	_	_	_	O
44	therapy	_	therapy	_	NN	110	_	_	_	_	_	_	_	O
45	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
46	treating	_	treat	_	VBG	110	_	_	_	_	_	_	_	O
47	type	_	type	_	NN	110	_	_	_	_	_	_	_	O
48	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
49	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	110	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
52	in	_	in	_	IN	110	_	_	_	_	_	_	_	O
53	combination	_	combination	_	NN	110	_	_	_	_	_	_	_	O
54	therapy	_	therapy	_	NN	110	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
56	treating	_	treat	_	VBG	110	_	_	_	_	_	_	_	O
57	type	_	type	_	NN	110	_	_	_	_	_	_	_	O
58	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
59	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
60	.	_	.	_	.	110	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	110	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	110	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	110	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	110	_	_	_	_	_	_	_	O
6	including	_	include	_	VBG	110	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	JJ	110	_	_	_	_	_	_	_	O
8	cotransporter	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
10	(	_	(	_	(	110	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	NNP	110	_	_	_	_	_	_	_	O
12	)	_	)	_	)	110	_	_	_	_	_	_	_	O
13	inhibitors	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
14	,	_	,	_	,	110	_	_	_	_	_	_	_	O
15	may	_	may	_	MD	110	_	_	_	_	_	_	_	O
16	be	_	be	_	VB	110	_	_	_	_	_	_	_	O
17	appropriate	_	appropriate	_	JJ	110	_	_	_	_	_	_	_	O
18	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
19	some	_	some	_	DT	110	_	_	_	_	_	_	_	O
20	people	_	people	_	NNS	110	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	110	_	_	_	_	_	_	_	O
22	type	_	type	_	JJ	110	_	_	_	_	_	type.n	Type	S-Subtype
23	2	_	2	_	CD	110	_	_	_	_	_	_	_	B-Category
24	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	I-Category
25	;	_	;	_	:	110	_	_	_	_	_	_	_	O
26	see	_	see	_	VB	110	_	_	_	_	_	_	_	O
27	the	_	the	_	DT	110	_	_	_	_	_	_	_	O
28	nice	_	UNK	_	NNP	110	_	_	_	_	_	_	_	O
29	guidance	_	guidance	_	NN	110	_	_	_	_	_	_	_	O
30	on	_	on	_	IN	110	_	_	_	_	_	_	_	O
31	unk	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
32	in	_	in	_	IN	110	_	_	_	_	_	_	_	O
33	combination	_	combination	_	NN	110	_	_	_	_	_	_	_	O
34	therapy	_	therapy	_	NN	110	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
36	treating	_	treat	_	VBG	110	_	_	_	_	_	_	_	O
37	type	_	type	_	NN	110	_	_	_	_	_	_	_	O
38	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
39	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
40	,	_	,	_	,	110	_	_	_	_	_	_	_	O
41	unk	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
42	in	_	in	_	IN	110	_	_	_	_	_	_	_	O
43	combination	_	combination	_	NN	110	_	_	_	_	_	_	_	O
44	therapy	_	therapy	_	NN	110	_	_	_	_	_	_	_	O
45	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
46	treating	_	treat	_	VBG	110	_	_	_	_	_	_	_	O
47	type	_	type	_	NN	110	_	_	_	_	_	_	_	O
48	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
49	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	110	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
52	in	_	in	_	IN	110	_	_	_	_	_	_	_	O
53	combination	_	combination	_	NN	110	_	_	_	_	_	_	_	O
54	therapy	_	therapy	_	NN	110	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
56	treating	_	treat	_	VBG	110	_	_	_	_	_	_	_	O
57	type	_	type	_	NN	110	_	_	_	_	_	_	_	O
58	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
59	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
60	.	_	.	_	.	110	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	110	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	110	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	110	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	110	_	_	_	_	_	_	_	O
6	including	_	include	_	VBG	110	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	JJ	110	_	_	_	_	_	_	_	O
8	cotransporter	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
10	(	_	(	_	(	110	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	NNP	110	_	_	_	_	_	_	_	O
12	)	_	)	_	)	110	_	_	_	_	_	_	_	O
13	inhibitors	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
14	,	_	,	_	,	110	_	_	_	_	_	_	_	O
15	may	_	may	_	MD	110	_	_	_	_	_	_	_	O
16	be	_	be	_	VB	110	_	_	_	_	_	_	_	O
17	appropriate	_	appropriate	_	JJ	110	_	_	_	_	_	_	_	O
18	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
19	some	_	some	_	DT	110	_	_	_	_	_	_	_	O
20	people	_	people	_	NNS	110	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	110	_	_	_	_	_	_	_	O
22	type	_	type	_	JJ	110	_	_	_	_	_	_	_	O
23	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
24	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
25	;	_	;	_	:	110	_	_	_	_	_	_	_	O
26	see	_	see	_	VB	110	_	_	_	_	_	_	_	O
27	the	_	the	_	DT	110	_	_	_	_	_	_	_	O
28	nice	_	UNK	_	NNP	110	_	_	_	_	_	_	_	O
29	guidance	_	guidance	_	NN	110	_	_	_	_	_	_	_	O
30	on	_	on	_	IN	110	_	_	_	_	_	_	_	O
31	unk	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
32	in	_	in	_	IN	110	_	_	_	_	_	_	_	O
33	combination	_	combination	_	NN	110	_	_	_	_	_	_	_	O
34	therapy	_	therapy	_	NN	110	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
36	treating	_	treat	_	VBG	110	_	_	_	_	_	treat.v	Medical_intervention	O
37	type	_	type	_	NN	110	_	_	_	_	_	_	_	B-Patient
38	2	_	2	_	CD	110	_	_	_	_	_	_	_	I-Patient
39	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	I-Patient
40	,	_	,	_	,	110	_	_	_	_	_	_	_	O
41	unk	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
42	in	_	in	_	IN	110	_	_	_	_	_	_	_	O
43	combination	_	combination	_	NN	110	_	_	_	_	_	_	_	O
44	therapy	_	therapy	_	NN	110	_	_	_	_	_	_	_	O
45	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
46	treating	_	treat	_	VBG	110	_	_	_	_	_	_	_	O
47	type	_	type	_	NN	110	_	_	_	_	_	_	_	O
48	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
49	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	110	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
52	in	_	in	_	IN	110	_	_	_	_	_	_	_	O
53	combination	_	combination	_	NN	110	_	_	_	_	_	_	_	O
54	therapy	_	therapy	_	NN	110	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
56	treating	_	treat	_	VBG	110	_	_	_	_	_	_	_	O
57	type	_	type	_	NN	110	_	_	_	_	_	_	_	O
58	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
59	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
60	.	_	.	_	.	110	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	110	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	110	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	110	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	110	_	_	_	_	_	_	_	O
6	including	_	include	_	VBG	110	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	JJ	110	_	_	_	_	_	_	_	O
8	cotransporter	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
10	(	_	(	_	(	110	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	NNP	110	_	_	_	_	_	_	_	O
12	)	_	)	_	)	110	_	_	_	_	_	_	_	O
13	inhibitors	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
14	,	_	,	_	,	110	_	_	_	_	_	_	_	O
15	may	_	may	_	MD	110	_	_	_	_	_	_	_	O
16	be	_	be	_	VB	110	_	_	_	_	_	_	_	O
17	appropriate	_	appropriate	_	JJ	110	_	_	_	_	_	_	_	O
18	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
19	some	_	some	_	DT	110	_	_	_	_	_	_	_	O
20	people	_	people	_	NNS	110	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	110	_	_	_	_	_	_	_	O
22	type	_	type	_	JJ	110	_	_	_	_	_	_	_	O
23	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
24	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
25	;	_	;	_	:	110	_	_	_	_	_	_	_	O
26	see	_	see	_	VB	110	_	_	_	_	_	_	_	O
27	the	_	the	_	DT	110	_	_	_	_	_	_	_	O
28	nice	_	UNK	_	NNP	110	_	_	_	_	_	_	_	O
29	guidance	_	guidance	_	NN	110	_	_	_	_	_	_	_	O
30	on	_	on	_	IN	110	_	_	_	_	_	_	_	O
31	unk	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
32	in	_	in	_	IN	110	_	_	_	_	_	_	_	O
33	combination	_	combination	_	NN	110	_	_	_	_	_	_	_	O
34	therapy	_	therapy	_	NN	110	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
36	treating	_	treat	_	VBG	110	_	_	_	_	_	_	_	O
37	type	_	type	_	NN	110	_	_	_	_	_	type.n	Type	S-Subtype
38	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
39	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
40	,	_	,	_	,	110	_	_	_	_	_	_	_	O
41	unk	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
42	in	_	in	_	IN	110	_	_	_	_	_	_	_	O
43	combination	_	combination	_	NN	110	_	_	_	_	_	_	_	O
44	therapy	_	therapy	_	NN	110	_	_	_	_	_	_	_	O
45	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
46	treating	_	treat	_	VBG	110	_	_	_	_	_	_	_	O
47	type	_	type	_	NN	110	_	_	_	_	_	_	_	O
48	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
49	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	110	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
52	in	_	in	_	IN	110	_	_	_	_	_	_	_	O
53	combination	_	combination	_	NN	110	_	_	_	_	_	_	_	O
54	therapy	_	therapy	_	NN	110	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
56	treating	_	treat	_	VBG	110	_	_	_	_	_	_	_	O
57	type	_	type	_	NN	110	_	_	_	_	_	_	_	O
58	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
59	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
60	.	_	.	_	.	110	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	110	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	110	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	110	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	110	_	_	_	_	_	_	_	O
6	including	_	include	_	VBG	110	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	JJ	110	_	_	_	_	_	_	_	O
8	cotransporter	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
10	(	_	(	_	(	110	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	NNP	110	_	_	_	_	_	_	_	O
12	)	_	)	_	)	110	_	_	_	_	_	_	_	O
13	inhibitors	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
14	,	_	,	_	,	110	_	_	_	_	_	_	_	O
15	may	_	may	_	MD	110	_	_	_	_	_	_	_	O
16	be	_	be	_	VB	110	_	_	_	_	_	_	_	O
17	appropriate	_	appropriate	_	JJ	110	_	_	_	_	_	_	_	O
18	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
19	some	_	some	_	DT	110	_	_	_	_	_	_	_	O
20	people	_	people	_	NNS	110	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	110	_	_	_	_	_	_	_	O
22	type	_	type	_	JJ	110	_	_	_	_	_	_	_	O
23	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
24	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
25	;	_	;	_	:	110	_	_	_	_	_	_	_	O
26	see	_	see	_	VB	110	_	_	_	_	_	_	_	O
27	the	_	the	_	DT	110	_	_	_	_	_	_	_	O
28	nice	_	UNK	_	NNP	110	_	_	_	_	_	_	_	O
29	guidance	_	guidance	_	NN	110	_	_	_	_	_	_	_	O
30	on	_	on	_	IN	110	_	_	_	_	_	_	_	O
31	unk	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
32	in	_	in	_	IN	110	_	_	_	_	_	_	_	O
33	combination	_	combination	_	NN	110	_	_	_	_	_	_	_	O
34	therapy	_	therapy	_	NN	110	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
36	treating	_	treat	_	VBG	110	_	_	_	_	_	_	_	O
37	type	_	type	_	NN	110	_	_	_	_	_	_	_	O
38	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
39	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
40	,	_	,	_	,	110	_	_	_	_	_	_	_	O
41	unk	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
42	in	_	in	_	IN	110	_	_	_	_	_	_	_	O
43	combination	_	combination	_	NN	110	_	_	_	_	_	_	_	O
44	therapy	_	therapy	_	NN	110	_	_	_	_	_	_	_	O
45	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
46	treating	_	treat	_	VBG	110	_	_	_	_	_	treat.v	Medical_intervention	O
47	type	_	type	_	NN	110	_	_	_	_	_	_	_	B-Patient
48	2	_	2	_	CD	110	_	_	_	_	_	_	_	I-Patient
49	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	I-Patient
50	and	_	and	_	CC	110	_	_	_	_	_	_	_	I-Patient
51	unk	_	UNK	_	NN	110	_	_	_	_	_	_	_	I-Patient
52	in	_	in	_	IN	110	_	_	_	_	_	_	_	B-Medical_condition
53	combination	_	combination	_	NN	110	_	_	_	_	_	_	_	I-Medical_condition
54	therapy	_	therapy	_	NN	110	_	_	_	_	_	_	_	I-Medical_condition
55	for	_	for	_	IN	110	_	_	_	_	_	_	_	I-Medical_condition
56	treating	_	treat	_	VBG	110	_	_	_	_	_	_	_	I-Medical_condition
57	type	_	type	_	NN	110	_	_	_	_	_	_	_	I-Medical_condition
58	2	_	2	_	CD	110	_	_	_	_	_	_	_	I-Medical_condition
59	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	I-Medical_condition
60	.	_	.	_	.	110	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	110	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	110	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	110	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	110	_	_	_	_	_	_	_	O
6	including	_	include	_	VBG	110	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	JJ	110	_	_	_	_	_	_	_	O
8	cotransporter	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
10	(	_	(	_	(	110	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	NNP	110	_	_	_	_	_	_	_	O
12	)	_	)	_	)	110	_	_	_	_	_	_	_	O
13	inhibitors	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
14	,	_	,	_	,	110	_	_	_	_	_	_	_	O
15	may	_	may	_	MD	110	_	_	_	_	_	_	_	O
16	be	_	be	_	VB	110	_	_	_	_	_	_	_	O
17	appropriate	_	appropriate	_	JJ	110	_	_	_	_	_	_	_	O
18	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
19	some	_	some	_	DT	110	_	_	_	_	_	_	_	O
20	people	_	people	_	NNS	110	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	110	_	_	_	_	_	_	_	O
22	type	_	type	_	JJ	110	_	_	_	_	_	_	_	O
23	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
24	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
25	;	_	;	_	:	110	_	_	_	_	_	_	_	O
26	see	_	see	_	VB	110	_	_	_	_	_	_	_	O
27	the	_	the	_	DT	110	_	_	_	_	_	_	_	O
28	nice	_	UNK	_	NNP	110	_	_	_	_	_	_	_	O
29	guidance	_	guidance	_	NN	110	_	_	_	_	_	_	_	O
30	on	_	on	_	IN	110	_	_	_	_	_	_	_	O
31	unk	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
32	in	_	in	_	IN	110	_	_	_	_	_	_	_	O
33	combination	_	combination	_	NN	110	_	_	_	_	_	_	_	O
34	therapy	_	therapy	_	NN	110	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
36	treating	_	treat	_	VBG	110	_	_	_	_	_	_	_	O
37	type	_	type	_	NN	110	_	_	_	_	_	_	_	O
38	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
39	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
40	,	_	,	_	,	110	_	_	_	_	_	_	_	O
41	unk	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
42	in	_	in	_	IN	110	_	_	_	_	_	_	_	O
43	combination	_	combination	_	NN	110	_	_	_	_	_	_	_	O
44	therapy	_	therapy	_	NN	110	_	_	_	_	_	_	_	O
45	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
46	treating	_	treat	_	VBG	110	_	_	_	_	_	_	_	O
47	type	_	type	_	NN	110	_	_	_	_	_	type.n	Type	S-Subtype
48	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
49	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	110	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
52	in	_	in	_	IN	110	_	_	_	_	_	_	_	O
53	combination	_	combination	_	NN	110	_	_	_	_	_	_	_	O
54	therapy	_	therapy	_	NN	110	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
56	treating	_	treat	_	VBG	110	_	_	_	_	_	_	_	O
57	type	_	type	_	NN	110	_	_	_	_	_	_	_	O
58	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
59	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
60	.	_	.	_	.	110	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	110	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	110	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	110	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	110	_	_	_	_	_	_	_	O
6	including	_	include	_	VBG	110	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	JJ	110	_	_	_	_	_	_	_	O
8	cotransporter	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
10	(	_	(	_	(	110	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	NNP	110	_	_	_	_	_	_	_	O
12	)	_	)	_	)	110	_	_	_	_	_	_	_	O
13	inhibitors	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
14	,	_	,	_	,	110	_	_	_	_	_	_	_	O
15	may	_	may	_	MD	110	_	_	_	_	_	_	_	O
16	be	_	be	_	VB	110	_	_	_	_	_	_	_	O
17	appropriate	_	appropriate	_	JJ	110	_	_	_	_	_	_	_	O
18	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
19	some	_	some	_	DT	110	_	_	_	_	_	_	_	O
20	people	_	people	_	NNS	110	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	110	_	_	_	_	_	_	_	O
22	type	_	type	_	JJ	110	_	_	_	_	_	_	_	O
23	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
24	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
25	;	_	;	_	:	110	_	_	_	_	_	_	_	O
26	see	_	see	_	VB	110	_	_	_	_	_	_	_	O
27	the	_	the	_	DT	110	_	_	_	_	_	_	_	O
28	nice	_	UNK	_	NNP	110	_	_	_	_	_	_	_	O
29	guidance	_	guidance	_	NN	110	_	_	_	_	_	_	_	O
30	on	_	on	_	IN	110	_	_	_	_	_	_	_	O
31	unk	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
32	in	_	in	_	IN	110	_	_	_	_	_	_	_	O
33	combination	_	combination	_	NN	110	_	_	_	_	_	_	_	O
34	therapy	_	therapy	_	NN	110	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
36	treating	_	treat	_	VBG	110	_	_	_	_	_	_	_	O
37	type	_	type	_	NN	110	_	_	_	_	_	_	_	O
38	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
39	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
40	,	_	,	_	,	110	_	_	_	_	_	_	_	O
41	unk	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
42	in	_	in	_	IN	110	_	_	_	_	_	_	_	O
43	combination	_	combination	_	NN	110	_	_	_	_	_	_	_	O
44	therapy	_	therapy	_	NN	110	_	_	_	_	_	_	_	O
45	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
46	treating	_	treat	_	VBG	110	_	_	_	_	_	_	_	O
47	type	_	type	_	NN	110	_	_	_	_	_	_	_	O
48	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
49	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	110	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
52	in	_	in	_	IN	110	_	_	_	_	_	_	_	O
53	combination	_	combination	_	NN	110	_	_	_	_	_	_	_	O
54	therapy	_	therapy	_	NN	110	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
56	treating	_	treat	_	VBG	110	_	_	_	_	_	treat.v	Medical_intervention	O
57	type	_	type	_	NN	110	_	_	_	_	_	_	_	B-Patient
58	2	_	2	_	CD	110	_	_	_	_	_	_	_	I-Patient
59	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	I-Patient
60	.	_	.	_	.	110	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	110	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	110	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	110	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	110	_	_	_	_	_	_	_	O
6	including	_	include	_	VBG	110	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	JJ	110	_	_	_	_	_	_	_	O
8	cotransporter	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
10	(	_	(	_	(	110	_	_	_	_	_	_	_	O
11	unk	_	UNK	_	NNP	110	_	_	_	_	_	_	_	O
12	)	_	)	_	)	110	_	_	_	_	_	_	_	O
13	inhibitors	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
14	,	_	,	_	,	110	_	_	_	_	_	_	_	O
15	may	_	may	_	MD	110	_	_	_	_	_	_	_	O
16	be	_	be	_	VB	110	_	_	_	_	_	_	_	O
17	appropriate	_	appropriate	_	JJ	110	_	_	_	_	_	_	_	O
18	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
19	some	_	some	_	DT	110	_	_	_	_	_	_	_	O
20	people	_	people	_	NNS	110	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	110	_	_	_	_	_	_	_	O
22	type	_	type	_	JJ	110	_	_	_	_	_	_	_	O
23	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
24	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
25	;	_	;	_	:	110	_	_	_	_	_	_	_	O
26	see	_	see	_	VB	110	_	_	_	_	_	_	_	O
27	the	_	the	_	DT	110	_	_	_	_	_	_	_	O
28	nice	_	UNK	_	NNP	110	_	_	_	_	_	_	_	O
29	guidance	_	guidance	_	NN	110	_	_	_	_	_	_	_	O
30	on	_	on	_	IN	110	_	_	_	_	_	_	_	O
31	unk	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
32	in	_	in	_	IN	110	_	_	_	_	_	_	_	O
33	combination	_	combination	_	NN	110	_	_	_	_	_	_	_	O
34	therapy	_	therapy	_	NN	110	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
36	treating	_	treat	_	VBG	110	_	_	_	_	_	_	_	O
37	type	_	type	_	NN	110	_	_	_	_	_	_	_	O
38	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
39	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
40	,	_	,	_	,	110	_	_	_	_	_	_	_	O
41	unk	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
42	in	_	in	_	IN	110	_	_	_	_	_	_	_	O
43	combination	_	combination	_	NN	110	_	_	_	_	_	_	_	O
44	therapy	_	therapy	_	NN	110	_	_	_	_	_	_	_	O
45	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
46	treating	_	treat	_	VBG	110	_	_	_	_	_	_	_	O
47	type	_	type	_	NN	110	_	_	_	_	_	_	_	O
48	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
49	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	110	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NN	110	_	_	_	_	_	_	_	O
52	in	_	in	_	IN	110	_	_	_	_	_	_	_	O
53	combination	_	combination	_	NN	110	_	_	_	_	_	_	_	O
54	therapy	_	therapy	_	NN	110	_	_	_	_	_	_	_	O
55	for	_	for	_	IN	110	_	_	_	_	_	_	_	O
56	treating	_	treat	_	VBG	110	_	_	_	_	_	_	_	O
57	type	_	type	_	NN	110	_	_	_	_	_	type.n	Type	S-Subtype
58	2	_	2	_	CD	110	_	_	_	_	_	_	_	O
59	diabetes	_	UNK	_	NNS	110	_	_	_	_	_	_	_	O
60	.	_	.	_	.	110	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	111	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	111	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	111	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	111	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	111	_	_	_	_	_	_	_	O
6	:	_	:	_	:	111	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	111	_	_	_	_	_	_	_	O
8	(	_	(	_	(	111	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	111	_	_	_	_	_	_	_	O
10	)	_	)	_	)	111	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	111	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	111	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	111	_	_	_	_	_	_	_	O
14	)	_	)	_	)	111	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	111	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	111	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	111	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	111	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	111	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	111	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	111	_	_	_	_	_	_	_	O
8	(	_	(	_	(	111	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	111	_	_	_	_	_	_	_	O
10	)	_	)	_	)	111	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	111	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	111	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	111	_	_	_	_	_	_	_	O
14	)	_	)	_	)	111	_	_	_	_	_	_	_	O

1	second	_	Second	_	JJ	112	_	_	_	_	_	_	_	O
2	intensification	_	UNK	_	NN	112	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	112	_	_	_	_	_	_	_	O
4	drug	_	drug	_	NN	112	_	_	_	_	_	_	_	S-Patient
5	treatment	_	treatment	_	NN	112	_	_	_	_	_	treatment.n	Cure	O

1	in	_	In	_	IN	113	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	113	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	113	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	113	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	113	_	_	_	_	_	_	_	O
7	,	_	,	_	,	113	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	113	_	_	_	_	_	_	_	O
9	dual	_	dual	_	JJ	113	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	113	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
14	another	_	another	_	DT	113	_	_	_	_	_	_	_	O
15	oral	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	113	_	_	_	_	_	_	_	O
17	(	_	(	_	(	113	_	_	_	_	_	_	_	O
18	see	_	see	_	VB	113	_	_	_	_	_	_	_	O
19	recommendation	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
20	)	_	)	_	)	113	_	_	_	_	_	_	_	O
21	has	_	have	_	VBZ	113	_	_	_	_	_	_	_	O
22	not	_	not	_	RB	113	_	_	_	_	_	_	_	O
23	continued	_	continue	_	VBN	113	_	_	_	_	_	_	_	O
24	to	_	to	_	TO	113	_	_	_	_	_	_	_	O
25	control	_	control	_	VB	113	_	_	_	_	_	_	_	O
26	hba1c	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	113	_	_	_	_	_	_	_	O
28	below	_	below	_	VB	113	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	113	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	113	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	113	_	_	_	_	_	_	_	O
32	individually	_	UNK	_	RB	113	_	_	_	_	_	_	_	O
33	agreed	_	agree	_	VBN	113	_	_	_	_	_	_	_	O
34	threshold	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	113	_	_	_	_	_	_	_	O
36	intensification	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
37	,	_	,	_	,	113	_	_	_	_	_	_	_	O
38	consider	_	consider	_	VB	113	_	_	_	_	_	_	_	O
39	either	_	either	_	DT	113	_	_	_	_	_	_	_	O
40	:	_	:	_	:	113	_	_	_	_	_	_	_	O
41	triple	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
42	therapy	_	therapy	_	NN	113	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
44	:	_	:	_	:	113	_	_	_	_	_	_	_	O
45	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
46	,	_	,	_	,	113	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	113	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
55	,	_	,	_	,	113	_	_	_	_	_	_	_	O
56	pioglitazone	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	113	_	_	_	_	_	_	_	O
61	starting	_	start	_	VBG	113	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
63	treatment	_	treatment	_	NN	113	_	_	_	_	_	_	_	O
64	(	_	(	_	(	113	_	_	_	_	_	_	_	O
65	see	_	see	_	VB	113	_	_	_	_	_	_	_	O
66	recommendations	_	UNK	_	NNS	113	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
68	)	_	)	_	)	113	_	_	_	_	_	_	_	O
69	.	_	.	_	.	113	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	113	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	113	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	113	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	113	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	113	_	_	_	_	_	_	_	I-Category
7	,	_	,	_	,	113	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	113	_	_	_	_	_	_	_	O
9	dual	_	dual	_	JJ	113	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	113	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
14	another	_	another	_	DT	113	_	_	_	_	_	_	_	O
15	oral	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	113	_	_	_	_	_	_	_	O
17	(	_	(	_	(	113	_	_	_	_	_	_	_	O
18	see	_	see	_	VB	113	_	_	_	_	_	_	_	O
19	recommendation	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
20	)	_	)	_	)	113	_	_	_	_	_	_	_	O
21	has	_	have	_	VBZ	113	_	_	_	_	_	_	_	O
22	not	_	not	_	RB	113	_	_	_	_	_	_	_	O
23	continued	_	continue	_	VBN	113	_	_	_	_	_	_	_	O
24	to	_	to	_	TO	113	_	_	_	_	_	_	_	O
25	control	_	control	_	VB	113	_	_	_	_	_	_	_	O
26	hba1c	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	113	_	_	_	_	_	_	_	O
28	below	_	below	_	VB	113	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	113	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	113	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	113	_	_	_	_	_	_	_	O
32	individually	_	UNK	_	RB	113	_	_	_	_	_	_	_	O
33	agreed	_	agree	_	VBN	113	_	_	_	_	_	_	_	O
34	threshold	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	113	_	_	_	_	_	_	_	O
36	intensification	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
37	,	_	,	_	,	113	_	_	_	_	_	_	_	O
38	consider	_	consider	_	VB	113	_	_	_	_	_	_	_	O
39	either	_	either	_	DT	113	_	_	_	_	_	_	_	O
40	:	_	:	_	:	113	_	_	_	_	_	_	_	O
41	triple	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
42	therapy	_	therapy	_	NN	113	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
44	:	_	:	_	:	113	_	_	_	_	_	_	_	O
45	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
46	,	_	,	_	,	113	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	113	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
55	,	_	,	_	,	113	_	_	_	_	_	_	_	O
56	pioglitazone	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	113	_	_	_	_	_	_	_	O
61	starting	_	start	_	VBG	113	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
63	treatment	_	treatment	_	NN	113	_	_	_	_	_	_	_	O
64	(	_	(	_	(	113	_	_	_	_	_	_	_	O
65	see	_	see	_	VB	113	_	_	_	_	_	_	_	O
66	recommendations	_	UNK	_	NNS	113	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
68	)	_	)	_	)	113	_	_	_	_	_	_	_	O
69	.	_	.	_	.	113	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	113	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	113	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	113	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	113	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	113	_	_	_	_	_	_	_	O
7	,	_	,	_	,	113	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	113	_	_	_	_	_	_	_	O
9	dual	_	dual	_	JJ	113	_	_	_	_	_	dual.a	Cardinal_numbers	S-Number
10	therapy	_	therapy	_	NN	113	_	_	_	_	_	_	_	S-Entity
11	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
14	another	_	another	_	DT	113	_	_	_	_	_	_	_	O
15	oral	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	113	_	_	_	_	_	_	_	O
17	(	_	(	_	(	113	_	_	_	_	_	_	_	O
18	see	_	see	_	VB	113	_	_	_	_	_	_	_	O
19	recommendation	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
20	)	_	)	_	)	113	_	_	_	_	_	_	_	O
21	has	_	have	_	VBZ	113	_	_	_	_	_	_	_	O
22	not	_	not	_	RB	113	_	_	_	_	_	_	_	O
23	continued	_	continue	_	VBN	113	_	_	_	_	_	_	_	O
24	to	_	to	_	TO	113	_	_	_	_	_	_	_	O
25	control	_	control	_	VB	113	_	_	_	_	_	_	_	O
26	hba1c	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	113	_	_	_	_	_	_	_	O
28	below	_	below	_	VB	113	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	113	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	113	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	113	_	_	_	_	_	_	_	O
32	individually	_	UNK	_	RB	113	_	_	_	_	_	_	_	O
33	agreed	_	agree	_	VBN	113	_	_	_	_	_	_	_	O
34	threshold	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	113	_	_	_	_	_	_	_	O
36	intensification	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
37	,	_	,	_	,	113	_	_	_	_	_	_	_	O
38	consider	_	consider	_	VB	113	_	_	_	_	_	_	_	O
39	either	_	either	_	DT	113	_	_	_	_	_	_	_	O
40	:	_	:	_	:	113	_	_	_	_	_	_	_	O
41	triple	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
42	therapy	_	therapy	_	NN	113	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
44	:	_	:	_	:	113	_	_	_	_	_	_	_	O
45	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
46	,	_	,	_	,	113	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	113	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
55	,	_	,	_	,	113	_	_	_	_	_	_	_	O
56	pioglitazone	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	113	_	_	_	_	_	_	_	O
61	starting	_	start	_	VBG	113	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
63	treatment	_	treatment	_	NN	113	_	_	_	_	_	_	_	O
64	(	_	(	_	(	113	_	_	_	_	_	_	_	O
65	see	_	see	_	VB	113	_	_	_	_	_	_	_	O
66	recommendations	_	UNK	_	NNS	113	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
68	)	_	)	_	)	113	_	_	_	_	_	_	_	O
69	.	_	.	_	.	113	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	113	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	113	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	113	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	113	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	113	_	_	_	_	_	_	_	O
7	,	_	,	_	,	113	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	113	_	_	_	_	_	_	_	O
9	dual	_	dual	_	JJ	113	_	_	_	_	_	_	_	S-Type
10	therapy	_	therapy	_	NN	113	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
11	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
14	another	_	another	_	DT	113	_	_	_	_	_	_	_	O
15	oral	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	113	_	_	_	_	_	_	_	O
17	(	_	(	_	(	113	_	_	_	_	_	_	_	O
18	see	_	see	_	VB	113	_	_	_	_	_	_	_	O
19	recommendation	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
20	)	_	)	_	)	113	_	_	_	_	_	_	_	O
21	has	_	have	_	VBZ	113	_	_	_	_	_	_	_	O
22	not	_	not	_	RB	113	_	_	_	_	_	_	_	O
23	continued	_	continue	_	VBN	113	_	_	_	_	_	_	_	O
24	to	_	to	_	TO	113	_	_	_	_	_	_	_	O
25	control	_	control	_	VB	113	_	_	_	_	_	_	_	O
26	hba1c	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	113	_	_	_	_	_	_	_	O
28	below	_	below	_	VB	113	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	113	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	113	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	113	_	_	_	_	_	_	_	O
32	individually	_	UNK	_	RB	113	_	_	_	_	_	_	_	O
33	agreed	_	agree	_	VBN	113	_	_	_	_	_	_	_	O
34	threshold	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	113	_	_	_	_	_	_	_	O
36	intensification	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
37	,	_	,	_	,	113	_	_	_	_	_	_	_	O
38	consider	_	consider	_	VB	113	_	_	_	_	_	_	_	O
39	either	_	either	_	DT	113	_	_	_	_	_	_	_	O
40	:	_	:	_	:	113	_	_	_	_	_	_	_	O
41	triple	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
42	therapy	_	therapy	_	NN	113	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
44	:	_	:	_	:	113	_	_	_	_	_	_	_	O
45	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
46	,	_	,	_	,	113	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	113	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
55	,	_	,	_	,	113	_	_	_	_	_	_	_	O
56	pioglitazone	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	113	_	_	_	_	_	_	_	O
61	starting	_	start	_	VBG	113	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
63	treatment	_	treatment	_	NN	113	_	_	_	_	_	_	_	O
64	(	_	(	_	(	113	_	_	_	_	_	_	_	O
65	see	_	see	_	VB	113	_	_	_	_	_	_	_	O
66	recommendations	_	UNK	_	NNS	113	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
68	)	_	)	_	)	113	_	_	_	_	_	_	_	O
69	.	_	.	_	.	113	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	113	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	113	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	113	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	113	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	113	_	_	_	_	_	_	_	O
7	,	_	,	_	,	113	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	113	_	_	_	_	_	_	_	O
9	dual	_	dual	_	JJ	113	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	113	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
14	another	_	another	_	DT	113	_	_	_	_	_	another.n	Increment	O
15	oral	_	UNK	_	JJ	113	_	_	_	_	_	_	_	B-Class
16	drug	_	drug	_	NN	113	_	_	_	_	_	_	_	I-Class
17	(	_	(	_	(	113	_	_	_	_	_	_	_	O
18	see	_	see	_	VB	113	_	_	_	_	_	_	_	O
19	recommendation	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
20	)	_	)	_	)	113	_	_	_	_	_	_	_	O
21	has	_	have	_	VBZ	113	_	_	_	_	_	_	_	O
22	not	_	not	_	RB	113	_	_	_	_	_	_	_	O
23	continued	_	continue	_	VBN	113	_	_	_	_	_	_	_	O
24	to	_	to	_	TO	113	_	_	_	_	_	_	_	O
25	control	_	control	_	VB	113	_	_	_	_	_	_	_	O
26	hba1c	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	113	_	_	_	_	_	_	_	O
28	below	_	below	_	VB	113	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	113	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	113	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	113	_	_	_	_	_	_	_	O
32	individually	_	UNK	_	RB	113	_	_	_	_	_	_	_	O
33	agreed	_	agree	_	VBN	113	_	_	_	_	_	_	_	O
34	threshold	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	113	_	_	_	_	_	_	_	O
36	intensification	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
37	,	_	,	_	,	113	_	_	_	_	_	_	_	O
38	consider	_	consider	_	VB	113	_	_	_	_	_	_	_	O
39	either	_	either	_	DT	113	_	_	_	_	_	_	_	O
40	:	_	:	_	:	113	_	_	_	_	_	_	_	O
41	triple	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
42	therapy	_	therapy	_	NN	113	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
44	:	_	:	_	:	113	_	_	_	_	_	_	_	O
45	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
46	,	_	,	_	,	113	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	113	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
55	,	_	,	_	,	113	_	_	_	_	_	_	_	O
56	pioglitazone	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	113	_	_	_	_	_	_	_	O
61	starting	_	start	_	VBG	113	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
63	treatment	_	treatment	_	NN	113	_	_	_	_	_	_	_	O
64	(	_	(	_	(	113	_	_	_	_	_	_	_	O
65	see	_	see	_	VB	113	_	_	_	_	_	_	_	O
66	recommendations	_	UNK	_	NNS	113	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
68	)	_	)	_	)	113	_	_	_	_	_	_	_	O
69	.	_	.	_	.	113	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	113	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	113	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	113	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	113	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	113	_	_	_	_	_	_	_	O
7	,	_	,	_	,	113	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	113	_	_	_	_	_	_	_	O
9	dual	_	dual	_	JJ	113	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	113	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
14	another	_	another	_	DT	113	_	_	_	_	_	_	_	O
15	oral	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	113	_	_	_	_	_	_	_	O
17	(	_	(	_	(	113	_	_	_	_	_	_	_	O
18	see	_	see	_	VB	113	_	_	_	_	_	_	_	O
19	recommendation	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
20	)	_	)	_	)	113	_	_	_	_	_	_	_	O
21	has	_	have	_	VBZ	113	_	_	_	_	_	_	_	O
22	not	_	not	_	RB	113	_	_	_	_	_	_	_	O
23	continued	_	continue	_	VBN	113	_	_	_	_	_	continue.v	Activity_ongoing	O
24	to	_	to	_	TO	113	_	_	_	_	_	_	_	B-Activity
25	control	_	control	_	VB	113	_	_	_	_	_	_	_	I-Activity
26	hba1c	_	UNK	_	NNP	113	_	_	_	_	_	_	_	I-Activity
27	to	_	to	_	TO	113	_	_	_	_	_	_	_	I-Activity
28	below	_	below	_	VB	113	_	_	_	_	_	_	_	I-Activity
29	the	_	the	_	DT	113	_	_	_	_	_	_	_	I-Activity
30	person	_	person	_	NN	113	_	_	_	_	_	_	_	I-Activity
31	's	_	's	_	POS	113	_	_	_	_	_	_	_	I-Activity
32	individually	_	UNK	_	RB	113	_	_	_	_	_	_	_	I-Activity
33	agreed	_	agree	_	VBN	113	_	_	_	_	_	_	_	I-Activity
34	threshold	_	UNK	_	NN	113	_	_	_	_	_	_	_	I-Activity
35	for	_	for	_	IN	113	_	_	_	_	_	_	_	I-Activity
36	intensification	_	UNK	_	NN	113	_	_	_	_	_	_	_	I-Activity
37	,	_	,	_	,	113	_	_	_	_	_	_	_	O
38	consider	_	consider	_	VB	113	_	_	_	_	_	_	_	O
39	either	_	either	_	DT	113	_	_	_	_	_	_	_	O
40	:	_	:	_	:	113	_	_	_	_	_	_	_	O
41	triple	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
42	therapy	_	therapy	_	NN	113	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
44	:	_	:	_	:	113	_	_	_	_	_	_	_	O
45	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
46	,	_	,	_	,	113	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	113	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
55	,	_	,	_	,	113	_	_	_	_	_	_	_	O
56	pioglitazone	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	113	_	_	_	_	_	_	_	O
61	starting	_	start	_	VBG	113	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
63	treatment	_	treatment	_	NN	113	_	_	_	_	_	_	_	O
64	(	_	(	_	(	113	_	_	_	_	_	_	_	O
65	see	_	see	_	VB	113	_	_	_	_	_	_	_	O
66	recommendations	_	UNK	_	NNS	113	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
68	)	_	)	_	)	113	_	_	_	_	_	_	_	O
69	.	_	.	_	.	113	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	113	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	113	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	113	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	113	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	113	_	_	_	_	_	_	_	O
7	,	_	,	_	,	113	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	113	_	_	_	_	_	_	_	O
9	dual	_	dual	_	JJ	113	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	113	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
14	another	_	another	_	DT	113	_	_	_	_	_	_	_	O
15	oral	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	113	_	_	_	_	_	_	_	O
17	(	_	(	_	(	113	_	_	_	_	_	_	_	O
18	see	_	see	_	VB	113	_	_	_	_	_	_	_	O
19	recommendation	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
20	)	_	)	_	)	113	_	_	_	_	_	_	_	O
21	has	_	have	_	VBZ	113	_	_	_	_	_	_	_	O
22	not	_	not	_	RB	113	_	_	_	_	_	_	_	O
23	continued	_	continue	_	VBN	113	_	_	_	_	_	_	_	O
24	to	_	to	_	TO	113	_	_	_	_	_	_	_	O
25	control	_	control	_	VB	113	_	_	_	_	_	control.v	Being_in_control	O
26	hba1c	_	UNK	_	NNP	113	_	_	_	_	_	_	_	S-Dependent_entity
27	to	_	to	_	TO	113	_	_	_	_	_	_	_	O
28	below	_	below	_	VB	113	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	113	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	113	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	113	_	_	_	_	_	_	_	O
32	individually	_	UNK	_	RB	113	_	_	_	_	_	_	_	O
33	agreed	_	agree	_	VBN	113	_	_	_	_	_	_	_	O
34	threshold	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	113	_	_	_	_	_	_	_	O
36	intensification	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
37	,	_	,	_	,	113	_	_	_	_	_	_	_	O
38	consider	_	consider	_	VB	113	_	_	_	_	_	_	_	O
39	either	_	either	_	DT	113	_	_	_	_	_	_	_	O
40	:	_	:	_	:	113	_	_	_	_	_	_	_	O
41	triple	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
42	therapy	_	therapy	_	NN	113	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
44	:	_	:	_	:	113	_	_	_	_	_	_	_	O
45	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
46	,	_	,	_	,	113	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	113	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
55	,	_	,	_	,	113	_	_	_	_	_	_	_	O
56	pioglitazone	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	113	_	_	_	_	_	_	_	O
61	starting	_	start	_	VBG	113	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
63	treatment	_	treatment	_	NN	113	_	_	_	_	_	_	_	O
64	(	_	(	_	(	113	_	_	_	_	_	_	_	O
65	see	_	see	_	VB	113	_	_	_	_	_	_	_	O
66	recommendations	_	UNK	_	NNS	113	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
68	)	_	)	_	)	113	_	_	_	_	_	_	_	O
69	.	_	.	_	.	113	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	113	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	113	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	113	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	113	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	113	_	_	_	_	_	_	_	O
7	,	_	,	_	,	113	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	113	_	_	_	_	_	_	_	O
9	dual	_	dual	_	JJ	113	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	113	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
14	another	_	another	_	DT	113	_	_	_	_	_	_	_	O
15	oral	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	113	_	_	_	_	_	_	_	O
17	(	_	(	_	(	113	_	_	_	_	_	_	_	O
18	see	_	see	_	VB	113	_	_	_	_	_	_	_	O
19	recommendation	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
20	)	_	)	_	)	113	_	_	_	_	_	_	_	O
21	has	_	have	_	VBZ	113	_	_	_	_	_	_	_	O
22	not	_	not	_	RB	113	_	_	_	_	_	_	_	O
23	continued	_	continue	_	VBN	113	_	_	_	_	_	_	_	O
24	to	_	to	_	TO	113	_	_	_	_	_	_	_	O
25	control	_	control	_	VB	113	_	_	_	_	_	_	_	O
26	hba1c	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	113	_	_	_	_	_	_	_	O
28	below	_	below	_	VB	113	_	_	_	_	_	below.prep	Directional_locative_relation	O
29	the	_	the	_	DT	113	_	_	_	_	_	_	_	B-Ground
30	person	_	person	_	NN	113	_	_	_	_	_	_	_	I-Ground
31	's	_	's	_	POS	113	_	_	_	_	_	_	_	I-Ground
32	individually	_	UNK	_	RB	113	_	_	_	_	_	_	_	I-Ground
33	agreed	_	agree	_	VBN	113	_	_	_	_	_	_	_	I-Ground
34	threshold	_	UNK	_	NN	113	_	_	_	_	_	_	_	I-Ground
35	for	_	for	_	IN	113	_	_	_	_	_	_	_	I-Ground
36	intensification	_	UNK	_	NN	113	_	_	_	_	_	_	_	I-Ground
37	,	_	,	_	,	113	_	_	_	_	_	_	_	O
38	consider	_	consider	_	VB	113	_	_	_	_	_	_	_	O
39	either	_	either	_	DT	113	_	_	_	_	_	_	_	O
40	:	_	:	_	:	113	_	_	_	_	_	_	_	O
41	triple	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
42	therapy	_	therapy	_	NN	113	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
44	:	_	:	_	:	113	_	_	_	_	_	_	_	O
45	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
46	,	_	,	_	,	113	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	113	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
55	,	_	,	_	,	113	_	_	_	_	_	_	_	O
56	pioglitazone	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	113	_	_	_	_	_	_	_	O
61	starting	_	start	_	VBG	113	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
63	treatment	_	treatment	_	NN	113	_	_	_	_	_	_	_	O
64	(	_	(	_	(	113	_	_	_	_	_	_	_	O
65	see	_	see	_	VB	113	_	_	_	_	_	_	_	O
66	recommendations	_	UNK	_	NNS	113	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
68	)	_	)	_	)	113	_	_	_	_	_	_	_	O
69	.	_	.	_	.	113	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	113	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	113	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	113	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	113	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	113	_	_	_	_	_	_	_	O
7	,	_	,	_	,	113	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	113	_	_	_	_	_	_	_	O
9	dual	_	dual	_	JJ	113	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	113	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
14	another	_	another	_	DT	113	_	_	_	_	_	_	_	O
15	oral	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	113	_	_	_	_	_	_	_	O
17	(	_	(	_	(	113	_	_	_	_	_	_	_	O
18	see	_	see	_	VB	113	_	_	_	_	_	_	_	O
19	recommendation	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
20	)	_	)	_	)	113	_	_	_	_	_	_	_	O
21	has	_	have	_	VBZ	113	_	_	_	_	_	_	_	O
22	not	_	not	_	RB	113	_	_	_	_	_	_	_	O
23	continued	_	continue	_	VBN	113	_	_	_	_	_	_	_	O
24	to	_	to	_	TO	113	_	_	_	_	_	_	_	O
25	control	_	control	_	VB	113	_	_	_	_	_	_	_	O
26	hba1c	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	113	_	_	_	_	_	_	_	O
28	below	_	below	_	VB	113	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	113	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	113	_	_	_	_	_	person.n	People	S-Person
31	's	_	's	_	POS	113	_	_	_	_	_	_	_	O
32	individually	_	UNK	_	RB	113	_	_	_	_	_	_	_	O
33	agreed	_	agree	_	VBN	113	_	_	_	_	_	_	_	O
34	threshold	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	113	_	_	_	_	_	_	_	O
36	intensification	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
37	,	_	,	_	,	113	_	_	_	_	_	_	_	O
38	consider	_	consider	_	VB	113	_	_	_	_	_	_	_	O
39	either	_	either	_	DT	113	_	_	_	_	_	_	_	O
40	:	_	:	_	:	113	_	_	_	_	_	_	_	O
41	triple	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
42	therapy	_	therapy	_	NN	113	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
44	:	_	:	_	:	113	_	_	_	_	_	_	_	O
45	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
46	,	_	,	_	,	113	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	113	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
55	,	_	,	_	,	113	_	_	_	_	_	_	_	O
56	pioglitazone	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	113	_	_	_	_	_	_	_	O
61	starting	_	start	_	VBG	113	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
63	treatment	_	treatment	_	NN	113	_	_	_	_	_	_	_	O
64	(	_	(	_	(	113	_	_	_	_	_	_	_	O
65	see	_	see	_	VB	113	_	_	_	_	_	_	_	O
66	recommendations	_	UNK	_	NNS	113	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
68	)	_	)	_	)	113	_	_	_	_	_	_	_	O
69	.	_	.	_	.	113	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	113	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	113	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	113	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	113	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	113	_	_	_	_	_	_	_	O
7	,	_	,	_	,	113	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	113	_	_	_	_	_	_	_	O
9	dual	_	dual	_	JJ	113	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	113	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
14	another	_	another	_	DT	113	_	_	_	_	_	_	_	O
15	oral	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	113	_	_	_	_	_	_	_	O
17	(	_	(	_	(	113	_	_	_	_	_	_	_	O
18	see	_	see	_	VB	113	_	_	_	_	_	_	_	O
19	recommendation	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
20	)	_	)	_	)	113	_	_	_	_	_	_	_	O
21	has	_	have	_	VBZ	113	_	_	_	_	_	_	_	O
22	not	_	not	_	RB	113	_	_	_	_	_	_	_	O
23	continued	_	continue	_	VBN	113	_	_	_	_	_	_	_	O
24	to	_	to	_	TO	113	_	_	_	_	_	_	_	O
25	control	_	control	_	VB	113	_	_	_	_	_	_	_	O
26	hba1c	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	113	_	_	_	_	_	_	_	O
28	below	_	below	_	VB	113	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	113	_	_	_	_	_	_	_	B-Party_1
30	person	_	person	_	NN	113	_	_	_	_	_	_	_	I-Party_1
31	's	_	's	_	POS	113	_	_	_	_	_	_	_	I-Party_1
32	individually	_	UNK	_	RB	113	_	_	_	_	_	_	_	S-Parties
33	agreed	_	agree	_	VBN	113	_	_	_	_	_	agree.v	Make_agreement_on_action	O
34	threshold	_	UNK	_	NN	113	_	_	_	_	_	_	_	B-Obligation
35	for	_	for	_	IN	113	_	_	_	_	_	_	_	I-Obligation
36	intensification	_	UNK	_	NN	113	_	_	_	_	_	_	_	I-Obligation
37	,	_	,	_	,	113	_	_	_	_	_	_	_	O
38	consider	_	consider	_	VB	113	_	_	_	_	_	_	_	O
39	either	_	either	_	DT	113	_	_	_	_	_	_	_	O
40	:	_	:	_	:	113	_	_	_	_	_	_	_	O
41	triple	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
42	therapy	_	therapy	_	NN	113	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
44	:	_	:	_	:	113	_	_	_	_	_	_	_	O
45	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
46	,	_	,	_	,	113	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	113	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
55	,	_	,	_	,	113	_	_	_	_	_	_	_	O
56	pioglitazone	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	113	_	_	_	_	_	_	_	O
61	starting	_	start	_	VBG	113	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
63	treatment	_	treatment	_	NN	113	_	_	_	_	_	_	_	O
64	(	_	(	_	(	113	_	_	_	_	_	_	_	O
65	see	_	see	_	VB	113	_	_	_	_	_	_	_	O
66	recommendations	_	UNK	_	NNS	113	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
68	)	_	)	_	)	113	_	_	_	_	_	_	_	O
69	.	_	.	_	.	113	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	113	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	113	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	113	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	113	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	113	_	_	_	_	_	_	_	O
7	,	_	,	_	,	113	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	113	_	_	_	_	_	_	_	O
9	dual	_	dual	_	JJ	113	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	113	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
14	another	_	another	_	DT	113	_	_	_	_	_	_	_	O
15	oral	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	113	_	_	_	_	_	_	_	O
17	(	_	(	_	(	113	_	_	_	_	_	_	_	O
18	see	_	see	_	VB	113	_	_	_	_	_	_	_	O
19	recommendation	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
20	)	_	)	_	)	113	_	_	_	_	_	_	_	O
21	has	_	have	_	VBZ	113	_	_	_	_	_	_	_	O
22	not	_	not	_	RB	113	_	_	_	_	_	_	_	O
23	continued	_	continue	_	VBN	113	_	_	_	_	_	_	_	O
24	to	_	to	_	TO	113	_	_	_	_	_	_	_	O
25	control	_	control	_	VB	113	_	_	_	_	_	_	_	O
26	hba1c	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	113	_	_	_	_	_	_	_	O
28	below	_	below	_	VB	113	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	113	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	113	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	113	_	_	_	_	_	_	_	O
32	individually	_	UNK	_	RB	113	_	_	_	_	_	_	_	O
33	agreed	_	agree	_	VBN	113	_	_	_	_	_	_	_	O
34	threshold	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	113	_	_	_	_	_	_	_	O
36	intensification	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
37	,	_	,	_	,	113	_	_	_	_	_	_	_	O
38	consider	_	consider	_	VB	113	_	_	_	_	_	consider.v	Categorization	O
39	either	_	either	_	DT	113	_	_	_	_	_	_	_	S-Category
40	:	_	:	_	:	113	_	_	_	_	_	_	_	O
41	triple	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
42	therapy	_	therapy	_	NN	113	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
44	:	_	:	_	:	113	_	_	_	_	_	_	_	O
45	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
46	,	_	,	_	,	113	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	113	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
55	,	_	,	_	,	113	_	_	_	_	_	_	_	O
56	pioglitazone	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	113	_	_	_	_	_	_	_	O
61	starting	_	start	_	VBG	113	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
63	treatment	_	treatment	_	NN	113	_	_	_	_	_	_	_	O
64	(	_	(	_	(	113	_	_	_	_	_	_	_	O
65	see	_	see	_	VB	113	_	_	_	_	_	_	_	O
66	recommendations	_	UNK	_	NNS	113	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
68	)	_	)	_	)	113	_	_	_	_	_	_	_	O
69	.	_	.	_	.	113	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	113	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	113	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	113	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	113	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	113	_	_	_	_	_	_	_	O
7	,	_	,	_	,	113	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	113	_	_	_	_	_	_	_	O
9	dual	_	dual	_	JJ	113	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	113	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
14	another	_	another	_	DT	113	_	_	_	_	_	_	_	O
15	oral	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	113	_	_	_	_	_	_	_	O
17	(	_	(	_	(	113	_	_	_	_	_	_	_	O
18	see	_	see	_	VB	113	_	_	_	_	_	_	_	O
19	recommendation	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
20	)	_	)	_	)	113	_	_	_	_	_	_	_	O
21	has	_	have	_	VBZ	113	_	_	_	_	_	_	_	O
22	not	_	not	_	RB	113	_	_	_	_	_	_	_	O
23	continued	_	continue	_	VBN	113	_	_	_	_	_	_	_	O
24	to	_	to	_	TO	113	_	_	_	_	_	_	_	O
25	control	_	control	_	VB	113	_	_	_	_	_	_	_	O
26	hba1c	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	113	_	_	_	_	_	_	_	O
28	below	_	below	_	VB	113	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	113	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	113	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	113	_	_	_	_	_	_	_	O
32	individually	_	UNK	_	RB	113	_	_	_	_	_	_	_	O
33	agreed	_	agree	_	VBN	113	_	_	_	_	_	_	_	O
34	threshold	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	113	_	_	_	_	_	_	_	O
36	intensification	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
37	,	_	,	_	,	113	_	_	_	_	_	_	_	O
38	consider	_	consider	_	VB	113	_	_	_	_	_	_	_	O
39	either	_	either	_	DT	113	_	_	_	_	_	_	_	O
40	:	_	:	_	:	113	_	_	_	_	_	_	_	O
41	triple	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
42	therapy	_	therapy	_	NN	113	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
43	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
44	:	_	:	_	:	113	_	_	_	_	_	_	_	O
45	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
46	,	_	,	_	,	113	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
48	dpp-4	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
49	inhibitor	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
50	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
51	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
52	sulfonylurea	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
53	or	_	or	_	CC	113	_	_	_	_	_	_	_	O
54	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
55	,	_	,	_	,	113	_	_	_	_	_	_	_	O
56	pioglitazone	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	113	_	_	_	_	_	_	_	O
61	starting	_	start	_	VBG	113	_	_	_	_	_	_	_	O
62	unk	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
63	treatment	_	treatment	_	NN	113	_	_	_	_	_	_	_	O
64	(	_	(	_	(	113	_	_	_	_	_	_	_	O
65	see	_	see	_	VB	113	_	_	_	_	_	_	_	O
66	recommendations	_	UNK	_	NNS	113	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
68	)	_	)	_	)	113	_	_	_	_	_	_	_	O
69	.	_	.	_	.	113	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	113	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	113	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	113	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	113	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	113	_	_	_	_	_	_	_	O
7	,	_	,	_	,	113	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	113	_	_	_	_	_	_	_	O
9	dual	_	dual	_	JJ	113	_	_	_	_	_	_	_	O
10	therapy	_	therapy	_	NN	113	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
12	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
13	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
14	another	_	another	_	DT	113	_	_	_	_	_	_	_	O
15	oral	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
16	drug	_	drug	_	NN	113	_	_	_	_	_	_	_	O
17	(	_	(	_	(	113	_	_	_	_	_	_	_	O
18	see	_	see	_	VB	113	_	_	_	_	_	_	_	O
19	recommendation	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
20	)	_	)	_	)	113	_	_	_	_	_	_	_	O
21	has	_	have	_	VBZ	113	_	_	_	_	_	_	_	O
22	not	_	not	_	RB	113	_	_	_	_	_	_	_	O
23	continued	_	continue	_	VBN	113	_	_	_	_	_	_	_	O
24	to	_	to	_	TO	113	_	_	_	_	_	_	_	O
25	control	_	control	_	VB	113	_	_	_	_	_	_	_	O
26	hba1c	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
27	to	_	to	_	TO	113	_	_	_	_	_	_	_	O
28	below	_	below	_	VB	113	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	113	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	113	_	_	_	_	_	_	_	O
31	's	_	's	_	POS	113	_	_	_	_	_	_	_	O
32	individually	_	UNK	_	RB	113	_	_	_	_	_	_	_	O
33	agreed	_	agree	_	VBN	113	_	_	_	_	_	_	_	O
34	threshold	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
35	for	_	for	_	IN	113	_	_	_	_	_	_	_	O
36	intensification	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
37	,	_	,	_	,	113	_	_	_	_	_	_	_	O
38	consider	_	consider	_	VB	113	_	_	_	_	_	_	_	O
39	either	_	either	_	DT	113	_	_	_	_	_	_	_	O
40	:	_	:	_	:	113	_	_	_	_	_	_	_	O
41	triple	_	UNK	_	JJ	113	_	_	_	_	_	_	_	O
42	therapy	_	therapy	_	NN	113	_	_	_	_	_	_	_	O
43	with	_	with	_	IN	113	_	_	_	_	_	_	_	O
44	:	_	:	_	:	113	_	_	_	_	_	_	_	O
45	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
46	,	_	,	_	,	113	_	_	_	_	_	_	_	O
47	a	_	a	_	DT	113	_	_	_	_	_	_	_	B-Agent
48	dpp-4	_	UNK	_	NNP	113	_	_	_	_	_	_	_	I-Agent
49	inhibitor	_	UNK	_	NN	113	_	_	_	_	_	_	_	I-Agent
50	and	_	and	_	CC	113	_	_	_	_	_	_	_	I-Agent
51	a	_	a	_	DT	113	_	_	_	_	_	_	_	I-Agent
52	sulfonylurea	_	UNK	_	NN	113	_	_	_	_	_	_	_	I-Agent
53	or	_	or	_	CC	113	_	_	_	_	_	_	_	I-Agent
54	metformin	_	UNK	_	NN	113	_	_	_	_	_	_	_	I-Agent
55	,	_	,	_	,	113	_	_	_	_	_	_	_	O
56	pioglitazone	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
57	and	_	and	_	CC	113	_	_	_	_	_	_	_	O
58	a	_	a	_	DT	113	_	_	_	_	_	_	_	O
59	sulfonylurea	_	UNK	_	NN	113	_	_	_	_	_	_	_	O
60	or	_	or	_	CC	113	_	_	_	_	_	_	_	O
61	starting	_	start	_	VBG	113	_	_	_	_	_	start.v	Activity_start	O
62	unk	_	UNK	_	JJ	113	_	_	_	_	_	_	_	B-Activity
63	treatment	_	treatment	_	NN	113	_	_	_	_	_	_	_	I-Activity
64	(	_	(	_	(	113	_	_	_	_	_	_	_	O
65	see	_	see	_	VB	113	_	_	_	_	_	_	_	O
66	recommendations	_	UNK	_	NNS	113	_	_	_	_	_	_	_	O
67	unk	_	UNK	_	NNP	113	_	_	_	_	_	_	_	O
68	)	_	)	_	)	113	_	_	_	_	_	_	_	O
69	.	_	.	_	.	113	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	114	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	114	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
4	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	114	_	_	_	_	_	_	_	O
11	(	_	(	_	(	114	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	114	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
14	)	_	)	_	)	114	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	114	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	114	_	_	_	_	_	_	_	O
18	,	_	,	_	,	114	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
23	,	_	,	_	,	114	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	114	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	114	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
29	,	_	,	_	,	114	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
36	(	_	(	_	(	114	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
38	)	_	)	_	)	114	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	114	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	114	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	114	_	_	_	_	_	_	_	O
47	:	_	:	_	:	114	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	114	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	114	_	_	_	_	_	_	_	O
56	(	_	(	_	(	114	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	114	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	114	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	114	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	114	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	114	_	_	_	_	_	_	_	O
63	,	_	,	_	,	114	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	114	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	114	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	114	_	_	_	_	_	_	_	O
70	)	_	)	_	)	114	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	114	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	114	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	114	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	114	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	114	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	114	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	114	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	114	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
89	:	_	:	_	:	114	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	114	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	114	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	114	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	114	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	114	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
108	.	_	.	_	.	114	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	114	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	114	_	_	_	_	_	other.a	Increment	O
9	oral	_	UNK	_	JJ	114	_	_	_	_	_	_	_	B-Class
10	drugs	_	drug	_	NNS	114	_	_	_	_	_	_	_	I-Class
11	(	_	(	_	(	114	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	114	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
14	)	_	)	_	)	114	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	114	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	114	_	_	_	_	_	_	_	O
18	,	_	,	_	,	114	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
23	,	_	,	_	,	114	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	114	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	114	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
29	,	_	,	_	,	114	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
36	(	_	(	_	(	114	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
38	)	_	)	_	)	114	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	114	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	114	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	114	_	_	_	_	_	_	_	O
47	:	_	:	_	:	114	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	114	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	114	_	_	_	_	_	_	_	O
56	(	_	(	_	(	114	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	114	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	114	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	114	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	114	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	114	_	_	_	_	_	_	_	O
63	,	_	,	_	,	114	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	114	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	114	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	114	_	_	_	_	_	_	_	O
70	)	_	)	_	)	114	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	114	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	114	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	114	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	114	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	114	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	114	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	114	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	114	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
89	:	_	:	_	:	114	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	114	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	114	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	114	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	114	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	114	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
108	.	_	.	_	.	114	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	114	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	114	_	_	_	_	_	_	_	S-Descriptor
10	drugs	_	drug	_	NNS	114	_	_	_	_	_	drug.n	Intoxicants	S-Intoxicant
11	(	_	(	_	(	114	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	114	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
14	)	_	)	_	)	114	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	114	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	114	_	_	_	_	_	_	_	O
18	,	_	,	_	,	114	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
23	,	_	,	_	,	114	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	114	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	114	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
29	,	_	,	_	,	114	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
36	(	_	(	_	(	114	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
38	)	_	)	_	)	114	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	114	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	114	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	114	_	_	_	_	_	_	_	O
47	:	_	:	_	:	114	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	114	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	114	_	_	_	_	_	_	_	O
56	(	_	(	_	(	114	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	114	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	114	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	114	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	114	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	114	_	_	_	_	_	_	_	O
63	,	_	,	_	,	114	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	114	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	114	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	114	_	_	_	_	_	_	_	O
70	)	_	)	_	)	114	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	114	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	114	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	114	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	114	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	114	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	114	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	114	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	114	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
89	:	_	:	_	:	114	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	114	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	114	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	114	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	114	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	114	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
108	.	_	.	_	.	114	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	114	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	114	_	_	_	_	_	_	_	O
11	(	_	(	_	(	114	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	114	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	114	_	_	_	_	_	_	_	B-Entity
14	)	_	)	_	)	114	_	_	_	_	_	_	_	I-Entity
15	is	_	be	_	VBZ	114	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	114	_	_	_	_	_	effective.a	Usefulness	O
18	,	_	,	_	,	114	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
23	,	_	,	_	,	114	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	114	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	114	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
29	,	_	,	_	,	114	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
36	(	_	(	_	(	114	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
38	)	_	)	_	)	114	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	114	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	114	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	114	_	_	_	_	_	_	_	O
47	:	_	:	_	:	114	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	114	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	114	_	_	_	_	_	_	_	O
56	(	_	(	_	(	114	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	114	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	114	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	114	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	114	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	114	_	_	_	_	_	_	_	O
63	,	_	,	_	,	114	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	114	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	114	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	114	_	_	_	_	_	_	_	O
70	)	_	)	_	)	114	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	114	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	114	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	114	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	114	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	114	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	114	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	114	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	114	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
89	:	_	:	_	:	114	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	114	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	114	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	114	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	114	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	114	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
108	.	_	.	_	.	114	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	114	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	114	_	_	_	_	_	_	_	O
11	(	_	(	_	(	114	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	114	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
14	)	_	)	_	)	114	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	114	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	114	_	_	_	_	_	_	_	O
18	,	_	,	_	,	114	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
23	,	_	,	_	,	114	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	114	_	_	_	_	_	consider.v	Categorization	O
25	combination	_	combination	_	NN	114	_	_	_	_	_	_	_	B-Category
26	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	I-Category
27	with	_	with	_	IN	114	_	_	_	_	_	_	_	I-Category
28	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	I-Category
29	,	_	,	_	,	114	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
36	(	_	(	_	(	114	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
38	)	_	)	_	)	114	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	114	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	114	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	114	_	_	_	_	_	_	_	O
47	:	_	:	_	:	114	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	114	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	114	_	_	_	_	_	_	_	O
56	(	_	(	_	(	114	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	114	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	114	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	114	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	114	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	114	_	_	_	_	_	_	_	O
63	,	_	,	_	,	114	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	114	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	114	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	114	_	_	_	_	_	_	_	O
70	)	_	)	_	)	114	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	114	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	114	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	114	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	114	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	114	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	114	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	114	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	114	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
89	:	_	:	_	:	114	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	114	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	114	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	114	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	114	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	114	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
108	.	_	.	_	.	114	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	114	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	114	_	_	_	_	_	_	_	O
11	(	_	(	_	(	114	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	114	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
14	)	_	)	_	)	114	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	114	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	114	_	_	_	_	_	_	_	O
18	,	_	,	_	,	114	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
23	,	_	,	_	,	114	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	114	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	114	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	114	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
27	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
29	,	_	,	_	,	114	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
36	(	_	(	_	(	114	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
38	)	_	)	_	)	114	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	114	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	114	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	114	_	_	_	_	_	_	_	O
47	:	_	:	_	:	114	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	114	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	114	_	_	_	_	_	_	_	O
56	(	_	(	_	(	114	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	114	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	114	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	114	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	114	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	114	_	_	_	_	_	_	_	O
63	,	_	,	_	,	114	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	114	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	114	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	114	_	_	_	_	_	_	_	O
70	)	_	)	_	)	114	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	114	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	114	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	114	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	114	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	114	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	114	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	114	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	114	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
89	:	_	:	_	:	114	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	114	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	114	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	114	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	114	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	114	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
108	.	_	.	_	.	114	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	114	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	114	_	_	_	_	_	_	_	O
11	(	_	(	_	(	114	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	114	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
14	)	_	)	_	)	114	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	114	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	114	_	_	_	_	_	_	_	O
18	,	_	,	_	,	114	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
23	,	_	,	_	,	114	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	114	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	114	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
29	,	_	,	_	,	114	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
36	(	_	(	_	(	114	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
38	)	_	)	_	)	114	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	114	_	_	_	_	_	adult.n	People_by_age	S-Person
42	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	114	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	114	_	_	_	_	_	_	_	O
47	:	_	:	_	:	114	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	114	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	114	_	_	_	_	_	_	_	O
56	(	_	(	_	(	114	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	114	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	114	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	114	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	114	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	114	_	_	_	_	_	_	_	O
63	,	_	,	_	,	114	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	114	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	114	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	114	_	_	_	_	_	_	_	O
70	)	_	)	_	)	114	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	114	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	114	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	114	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	114	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	114	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	114	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	114	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	114	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
89	:	_	:	_	:	114	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	114	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	114	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	114	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	114	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	114	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
108	.	_	.	_	.	114	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	114	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	114	_	_	_	_	_	_	_	O
11	(	_	(	_	(	114	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	114	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
14	)	_	)	_	)	114	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	114	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	114	_	_	_	_	_	_	_	O
18	,	_	,	_	,	114	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
23	,	_	,	_	,	114	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	114	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	114	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
29	,	_	,	_	,	114	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
36	(	_	(	_	(	114	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
38	)	_	)	_	)	114	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	114	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	114	_	_	_	_	_	type.n	Type	S-Subtype
44	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	114	_	_	_	_	_	_	_	O
47	:	_	:	_	:	114	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	114	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	114	_	_	_	_	_	_	_	O
56	(	_	(	_	(	114	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	114	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	114	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	114	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	114	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	114	_	_	_	_	_	_	_	O
63	,	_	,	_	,	114	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	114	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	114	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	114	_	_	_	_	_	_	_	O
70	)	_	)	_	)	114	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	114	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	114	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	114	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	114	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	114	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	114	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	114	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	114	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
89	:	_	:	_	:	114	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	114	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	114	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	114	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	114	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	114	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
108	.	_	.	_	.	114	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	114	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	114	_	_	_	_	_	_	_	O
11	(	_	(	_	(	114	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	114	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
14	)	_	)	_	)	114	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	114	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	114	_	_	_	_	_	_	_	O
18	,	_	,	_	,	114	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
23	,	_	,	_	,	114	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	114	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	114	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
29	,	_	,	_	,	114	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
36	(	_	(	_	(	114	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
38	)	_	)	_	)	114	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	114	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	114	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	114	_	_	_	_	_	_	_	O
47	:	_	:	_	:	114	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	114	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	114	_	_	_	_	_	_	_	O
56	(	_	(	_	(	114	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	114	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	114	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	114	_	_	_	_	_	people.n	People	S-Person
61	from	_	from	_	IN	114	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	114	_	_	_	_	_	_	_	O
63	,	_	,	_	,	114	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	114	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	114	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	114	_	_	_	_	_	_	_	O
70	)	_	)	_	)	114	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	114	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	114	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	114	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	114	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	114	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	114	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	114	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	114	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
89	:	_	:	_	:	114	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	114	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	114	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	114	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	114	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	114	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
108	.	_	.	_	.	114	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	114	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	114	_	_	_	_	_	_	_	O
11	(	_	(	_	(	114	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	114	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
14	)	_	)	_	)	114	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	114	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	114	_	_	_	_	_	_	_	O
18	,	_	,	_	,	114	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
23	,	_	,	_	,	114	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	114	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	114	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
29	,	_	,	_	,	114	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
36	(	_	(	_	(	114	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
38	)	_	)	_	)	114	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	114	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	114	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	114	_	_	_	_	_	_	_	O
47	:	_	:	_	:	114	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	114	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	114	_	_	_	_	_	_	_	O
56	(	_	(	_	(	114	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	114	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	114	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	114	_	_	_	_	_	_	_	S-Entity
61	from	_	from	_	IN	114	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	114	_	_	_	_	_	black.a	Color	S-Color
63	,	_	,	_	,	114	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	114	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	114	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	114	_	_	_	_	_	_	_	O
70	)	_	)	_	)	114	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	114	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	114	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	114	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	114	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	114	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	114	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	114	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	114	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
89	:	_	:	_	:	114	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	114	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	114	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	114	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	114	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	114	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
108	.	_	.	_	.	114	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	114	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	114	_	_	_	_	_	_	_	O
11	(	_	(	_	(	114	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	114	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
14	)	_	)	_	)	114	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	114	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	114	_	_	_	_	_	_	_	O
18	,	_	,	_	,	114	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
23	,	_	,	_	,	114	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	114	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	114	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
29	,	_	,	_	,	114	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
36	(	_	(	_	(	114	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
38	)	_	)	_	)	114	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	114	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	114	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	114	_	_	_	_	_	_	_	O
47	:	_	:	_	:	114	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	114	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	114	_	_	_	_	_	_	_	O
56	(	_	(	_	(	114	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	114	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	114	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	114	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	114	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	114	_	_	_	_	_	_	_	O
63	,	_	,	_	,	114	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	114	_	_	_	_	_	other.a	Increment	O
67	minority	_	minority	_	NN	114	_	_	_	_	_	_	_	B-Class
68	ethnic	_	ethnic	_	JJ	114	_	_	_	_	_	_	_	I-Class
69	groups	_	group	_	NNS	114	_	_	_	_	_	_	_	I-Class
70	)	_	)	_	)	114	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	114	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	114	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	114	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	114	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	114	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	114	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	114	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	114	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
89	:	_	:	_	:	114	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	114	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	114	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	114	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	114	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	114	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
108	.	_	.	_	.	114	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	114	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	114	_	_	_	_	_	_	_	O
11	(	_	(	_	(	114	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	114	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
14	)	_	)	_	)	114	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	114	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	114	_	_	_	_	_	_	_	O
18	,	_	,	_	,	114	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
23	,	_	,	_	,	114	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	114	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	114	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
29	,	_	,	_	,	114	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
36	(	_	(	_	(	114	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
38	)	_	)	_	)	114	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	114	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	114	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	114	_	_	_	_	_	_	_	O
47	:	_	:	_	:	114	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	114	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	114	_	_	_	_	_	_	_	O
56	(	_	(	_	(	114	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	114	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	114	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	114	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	114	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	114	_	_	_	_	_	_	_	O
63	,	_	,	_	,	114	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	114	_	_	_	_	_	_	_	B-Aggregate_property
68	ethnic	_	ethnic	_	JJ	114	_	_	_	_	_	_	_	I-Aggregate_property
69	groups	_	group	_	NNS	114	_	_	_	_	_	group.n	Aggregate	S-Aggregate
70	)	_	)	_	)	114	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	114	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	114	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	114	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	114	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	114	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	114	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	114	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	114	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
89	:	_	:	_	:	114	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	114	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	114	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	114	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	114	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	114	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
108	.	_	.	_	.	114	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	114	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	114	_	_	_	_	_	_	_	O
11	(	_	(	_	(	114	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	114	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
14	)	_	)	_	)	114	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	114	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	114	_	_	_	_	_	_	_	O
18	,	_	,	_	,	114	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
23	,	_	,	_	,	114	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	114	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	114	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
29	,	_	,	_	,	114	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
36	(	_	(	_	(	114	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
38	)	_	)	_	)	114	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	114	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	114	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	114	_	_	_	_	_	_	_	O
47	:	_	:	_	:	114	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	114	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	114	_	_	_	_	_	_	_	O
56	(	_	(	_	(	114	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	114	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	114	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	114	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	114	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	114	_	_	_	_	_	_	_	O
63	,	_	,	_	,	114	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	114	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	114	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	114	_	_	_	_	_	_	_	O
70	)	_	)	_	)	114	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	114	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	114	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	114	_	_	_	_	_	other.a	Increment	O
76	medical	_	medical	_	JJ	114	_	_	_	_	_	_	_	B-Class
77	problems	_	problem	_	NNS	114	_	_	_	_	_	_	_	I-Class
78	associated	_	associate	_	VBN	114	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	114	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	114	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	114	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
89	:	_	:	_	:	114	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	114	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	114	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	114	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	114	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	114	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
108	.	_	.	_	.	114	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	114	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	114	_	_	_	_	_	_	_	O
11	(	_	(	_	(	114	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	114	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
14	)	_	)	_	)	114	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	114	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	114	_	_	_	_	_	_	_	O
18	,	_	,	_	,	114	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
23	,	_	,	_	,	114	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	114	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	114	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
29	,	_	,	_	,	114	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
36	(	_	(	_	(	114	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
38	)	_	)	_	)	114	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	114	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	114	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	114	_	_	_	_	_	_	_	O
47	:	_	:	_	:	114	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	114	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	114	_	_	_	_	_	_	_	O
56	(	_	(	_	(	114	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	114	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	114	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	114	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	114	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	114	_	_	_	_	_	_	_	O
63	,	_	,	_	,	114	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	114	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	114	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	114	_	_	_	_	_	_	_	O
70	)	_	)	_	)	114	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	114	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	114	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	114	_	_	_	_	_	_	_	S-Experiencer
77	problems	_	problem	_	NNS	114	_	_	_	_	_	problem.n	Predicament	S-Situation
78	associated	_	associate	_	VBN	114	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	114	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	114	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	114	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
89	:	_	:	_	:	114	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	114	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	114	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	114	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	114	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	114	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
108	.	_	.	_	.	114	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	114	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	114	_	_	_	_	_	_	_	O
11	(	_	(	_	(	114	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	114	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
14	)	_	)	_	)	114	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	114	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	114	_	_	_	_	_	_	_	O
18	,	_	,	_	,	114	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
23	,	_	,	_	,	114	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	114	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	114	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
29	,	_	,	_	,	114	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
36	(	_	(	_	(	114	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
38	)	_	)	_	)	114	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	114	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	114	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	114	_	_	_	_	_	_	_	O
47	:	_	:	_	:	114	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	114	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	114	_	_	_	_	_	_	_	O
56	(	_	(	_	(	114	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	114	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	114	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	114	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	114	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	114	_	_	_	_	_	_	_	O
63	,	_	,	_	,	114	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	114	_	_	_	_	_	_	_	B-Partner_1
65	and	_	and	_	CC	114	_	_	_	_	_	_	_	I-Partner_1
66	other	_	other	_	JJ	114	_	_	_	_	_	_	_	I-Partner_1
67	minority	_	minority	_	NN	114	_	_	_	_	_	_	_	I-Partner_1
68	ethnic	_	ethnic	_	JJ	114	_	_	_	_	_	_	_	I-Partner_1
69	groups	_	group	_	NNS	114	_	_	_	_	_	_	_	I-Partner_1
70	)	_	)	_	)	114	_	_	_	_	_	_	_	I-Partner_1
71	and	_	and	_	CC	114	_	_	_	_	_	_	_	I-Partner_1
72	specific	_	specific	_	JJ	114	_	_	_	_	_	_	_	I-Partner_1
73	psychological	_	psychological	_	JJ	114	_	_	_	_	_	_	_	I-Partner_1
74	or	_	or	_	CC	114	_	_	_	_	_	_	_	I-Partner_1
75	other	_	other	_	JJ	114	_	_	_	_	_	_	_	I-Partner_1
76	medical	_	medical	_	JJ	114	_	_	_	_	_	_	_	I-Partner_1
77	problems	_	problem	_	NNS	114	_	_	_	_	_	_	_	I-Partner_1
78	associated	_	associate	_	VBN	114	_	_	_	_	_	associate.v	Collaboration	O
79	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	114	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	114	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	114	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
89	:	_	:	_	:	114	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	114	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	114	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	114	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	114	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	114	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
108	.	_	.	_	.	114	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	114	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	114	_	_	_	_	_	_	_	O
11	(	_	(	_	(	114	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	114	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
14	)	_	)	_	)	114	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	114	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	114	_	_	_	_	_	_	_	O
18	,	_	,	_	,	114	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
23	,	_	,	_	,	114	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	114	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	114	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
29	,	_	,	_	,	114	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
36	(	_	(	_	(	114	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
38	)	_	)	_	)	114	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	114	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	114	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	114	_	_	_	_	_	_	_	O
47	:	_	:	_	:	114	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	114	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	114	_	_	_	_	_	_	_	O
56	(	_	(	_	(	114	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	114	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	114	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	114	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	114	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	114	_	_	_	_	_	_	_	O
63	,	_	,	_	,	114	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	114	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	114	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	114	_	_	_	_	_	_	_	O
70	)	_	)	_	)	114	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	114	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	114	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	114	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	114	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	114	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	114	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	114	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	114	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
89	:	_	:	_	:	114	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	114	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	114	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
94	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	114	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	114	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	114	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	114	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
108	.	_	.	_	.	114	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	114	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	114	_	_	_	_	_	_	_	O
11	(	_	(	_	(	114	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	114	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
14	)	_	)	_	)	114	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	114	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	114	_	_	_	_	_	_	_	O
18	,	_	,	_	,	114	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
23	,	_	,	_	,	114	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	114	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	114	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
29	,	_	,	_	,	114	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
36	(	_	(	_	(	114	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
38	)	_	)	_	)	114	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	114	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	114	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	114	_	_	_	_	_	_	_	O
47	:	_	:	_	:	114	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	114	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	114	_	_	_	_	_	_	_	O
56	(	_	(	_	(	114	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	114	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	114	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	114	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	114	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	114	_	_	_	_	_	_	_	O
63	,	_	,	_	,	114	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	114	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	114	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	114	_	_	_	_	_	_	_	O
70	)	_	)	_	)	114	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	114	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	114	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	114	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	114	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	114	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	114	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	114	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	114	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
89	:	_	:	_	:	114	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	114	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	114	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	114	_	_	_	_	_	significant.a	Importance	O
97	occupational	_	UNK	_	JJ	114	_	_	_	_	_	_	_	B-Factor
98	implications	_	UNK	_	NNS	114	_	_	_	_	_	_	_	I-Factor
99	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	114	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	114	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	114	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
108	.	_	.	_	.	114	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	114	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	114	_	_	_	_	_	_	_	O
11	(	_	(	_	(	114	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	114	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
14	)	_	)	_	)	114	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	114	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	114	_	_	_	_	_	_	_	O
18	,	_	,	_	,	114	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
23	,	_	,	_	,	114	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	114	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	114	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
29	,	_	,	_	,	114	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
36	(	_	(	_	(	114	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
38	)	_	)	_	)	114	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	114	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	114	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	114	_	_	_	_	_	_	_	O
47	:	_	:	_	:	114	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	114	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	114	_	_	_	_	_	_	_	O
56	(	_	(	_	(	114	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	114	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	114	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	114	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	114	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	114	_	_	_	_	_	_	_	O
63	,	_	,	_	,	114	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	114	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	114	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	114	_	_	_	_	_	_	_	O
70	)	_	)	_	)	114	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	114	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	114	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	114	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	114	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	114	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	114	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	114	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	114	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
89	:	_	:	_	:	114	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	114	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	114	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	114	_	_	_	_	_	weight.n	Dimension	S-Dimension
101	loss	_	loss	_	NN	114	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	114	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
106	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
107	comorbidities	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
108	.	_	.	_	.	114	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	114	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	114	_	_	_	_	_	_	_	O
11	(	_	(	_	(	114	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	114	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
14	)	_	)	_	)	114	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	114	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	114	_	_	_	_	_	_	_	O
18	,	_	,	_	,	114	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
23	,	_	,	_	,	114	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	114	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	114	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
29	,	_	,	_	,	114	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
36	(	_	(	_	(	114	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
38	)	_	)	_	)	114	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	114	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	114	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	114	_	_	_	_	_	_	_	O
47	:	_	:	_	:	114	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	114	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	114	_	_	_	_	_	_	_	O
56	(	_	(	_	(	114	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	114	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	114	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	114	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	114	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	114	_	_	_	_	_	_	_	O
63	,	_	,	_	,	114	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	114	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	114	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	114	_	_	_	_	_	_	_	O
70	)	_	)	_	)	114	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	114	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	114	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	114	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	114	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	114	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	114	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	114	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	114	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
89	:	_	:	_	:	114	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	114	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	114	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	114	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	114	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	114	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	114	_	_	_	_	_	other.a	Increment	O
105	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	B-Class
106	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	I-Class
107	comorbidities	_	UNK	_	NNS	114	_	_	_	_	_	_	_	I-Class
108	.	_	.	_	.	114	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	114	_	_	_	_	_	_	_	O
2	triple	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
5	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
7	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
8	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
9	oral	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
10	drugs	_	drug	_	NNS	114	_	_	_	_	_	_	_	O
11	(	_	(	_	(	114	_	_	_	_	_	_	_	O
12	see	_	see	_	VB	114	_	_	_	_	_	_	_	O
13	recommendation	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
14	)	_	)	_	)	114	_	_	_	_	_	_	_	O
15	is	_	be	_	VBZ	114	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	114	_	_	_	_	_	_	_	O
18	,	_	,	_	,	114	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	114	_	_	_	_	_	_	_	O
20	tolerated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
22	contraindicated	_	UNK	_	VBN	114	_	_	_	_	_	_	_	O
23	,	_	,	_	,	114	_	_	_	_	_	_	_	O
24	consider	_	consider	_	VB	114	_	_	_	_	_	_	_	O
25	combination	_	combination	_	NN	114	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
27	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
28	metformin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
29	,	_	,	_	,	114	_	_	_	_	_	_	_	O
30	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
31	sulfonylurea	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
36	(	_	(	_	(	114	_	_	_	_	_	_	_	O
37	glp-1	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
38	)	_	)	_	)	114	_	_	_	_	_	_	_	O
39	mimetic	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
41	adults	_	adult	_	NNS	114	_	_	_	_	_	_	_	O
42	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
43	type	_	type	_	JJ	114	_	_	_	_	_	_	_	O
44	2	_	2	_	CD	114	_	_	_	_	_	_	_	O
45	diabetes	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
46	who	_	who	_	WP	114	_	_	_	_	_	_	_	O
47	:	_	:	_	:	114	_	_	_	_	_	_	_	O
48	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
49	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
50	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
51	of	_	of	_	IN	114	_	_	_	_	_	_	_	O
52	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
53	kg/m2	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
54	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
55	higher	_	higher	_	JJR	114	_	_	_	_	_	_	_	O
56	(	_	(	_	(	114	_	_	_	_	_	_	_	O
57	adjust	_	UNK	_	VBP	114	_	_	_	_	_	_	_	O
58	accordingly	_	accordingly	_	RB	114	_	_	_	_	_	_	_	O
59	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
60	people	_	people	_	NNS	114	_	_	_	_	_	_	_	O
61	from	_	from	_	IN	114	_	_	_	_	_	_	_	O
62	black	_	black	_	JJ	114	_	_	_	_	_	_	_	O
63	,	_	,	_	,	114	_	_	_	_	_	_	_	O
64	asian	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
65	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
66	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
67	minority	_	minority	_	NN	114	_	_	_	_	_	_	_	O
68	ethnic	_	ethnic	_	JJ	114	_	_	_	_	_	_	_	O
69	groups	_	group	_	NNS	114	_	_	_	_	_	_	_	O
70	)	_	)	_	)	114	_	_	_	_	_	_	_	O
71	and	_	and	_	CC	114	_	_	_	_	_	_	_	O
72	specific	_	specific	_	JJ	114	_	_	_	_	_	_	_	O
73	psychological	_	psychological	_	JJ	114	_	_	_	_	_	_	_	O
74	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
75	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
76	medical	_	medical	_	JJ	114	_	_	_	_	_	_	_	O
77	problems	_	problem	_	NNS	114	_	_	_	_	_	_	_	O
78	associated	_	associate	_	VBN	114	_	_	_	_	_	_	_	O
79	with	_	with	_	IN	114	_	_	_	_	_	_	_	O
80	obesity	_	obesity	_	NN	114	_	_	_	_	_	_	_	O
81	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
82	have	_	have	_	VBP	114	_	_	_	_	_	_	_	O
83	a	_	a	_	DT	114	_	_	_	_	_	_	_	O
84	bmi	_	UNK	_	NNP	114	_	_	_	_	_	_	_	O
85	lower	_	lower	_	JJR	114	_	_	_	_	_	_	_	O
86	than	_	than	_	IN	114	_	_	_	_	_	_	_	O
87	35	_	UNK	_	CD	114	_	_	_	_	_	_	_	O
88	unk	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
89	:	_	:	_	:	114	_	_	_	_	_	_	_	O
90	for	_	for	_	IN	114	_	_	_	_	_	_	_	O
91	whom	_	whom	_	WP	114	_	_	_	_	_	_	_	O
92	insulin	_	UNK	_	NN	114	_	_	_	_	_	_	_	O
93	therapy	_	therapy	_	NN	114	_	_	_	_	_	_	_	O
94	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
95	have	_	have	_	VB	114	_	_	_	_	_	_	_	O
96	significant	_	significant	_	JJ	114	_	_	_	_	_	_	_	O
97	occupational	_	UNK	_	JJ	114	_	_	_	_	_	_	_	O
98	implications	_	UNK	_	NNS	114	_	_	_	_	_	_	_	O
99	or	_	or	_	CC	114	_	_	_	_	_	_	_	O
100	weight	_	weight	_	JJ	114	_	_	_	_	_	_	_	O
101	loss	_	loss	_	NN	114	_	_	_	_	_	_	_	O
102	would	_	would	_	MD	114	_	_	_	_	_	_	_	O
103	benefit	_	benefit	_	VB	114	_	_	_	_	_	_	_	O
104	other	_	other	_	JJ	114	_	_	_	_	_	_	_	O
105	significant	_	significant	_	JJ	114	_	_	_	_	_	significant.a	Importance	O
106	unk	_	UNK	_	JJ	114	_	_	_	_	_	_	_	B-Factor
107	comorbidities	_	UNK	_	NNS	114	_	_	_	_	_	_	_	I-Factor
108	.	_	.	_	.	114	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	115	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	115	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	115	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	115	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	115	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	115	_	_	_	_	_	_	_	O
7	,	_	,	_	,	115	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	115	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	115	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	115	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	115	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
15	,	_	,	_	,	115	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	115	_	_	_	_	_	_	_	O
17	if	_	if	_	IN	115	_	_	_	_	_	_	_	O
18	dual	_	dual	_	JJ	115	_	_	_	_	_	_	_	O
19	therapy	_	therapy	_	NN	115	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	115	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	115	_	_	_	_	_	_	_	O
22	oral	_	UNK	_	JJ	115	_	_	_	_	_	_	_	O
23	drugs	_	drug	_	NNS	115	_	_	_	_	_	_	_	O
24	(	_	(	_	(	115	_	_	_	_	_	_	_	O
25	see	_	see	_	VB	115	_	_	_	_	_	_	_	O
26	recommendation	_	UNK	_	NN	115	_	_	_	_	_	_	_	O
27	)	_	)	_	)	115	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	115	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	115	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	115	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	115	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	115	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	115	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	115	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	115	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	115	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	115	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	115	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	115	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	115	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	115	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	115	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	115	_	_	_	_	_	_	_	O
44	,	_	,	_	,	115	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	115	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	JJ	115	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	115	_	_	_	_	_	_	_	O
48	(	_	(	_	(	115	_	_	_	_	_	_	_	O
49	see	_	see	_	VB	115	_	_	_	_	_	_	_	O
50	recommendations	_	UNK	_	NNS	115	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NNP	115	_	_	_	_	_	_	_	O
52	)	_	)	_	)	115	_	_	_	_	_	_	_	O
53	.	_	.	_	.	115	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	115	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	115	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	115	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	115	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	115	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	115	_	_	_	_	_	_	_	I-Category
7	,	_	,	_	,	115	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	115	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	115	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	115	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	115	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
15	,	_	,	_	,	115	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	115	_	_	_	_	_	_	_	O
17	if	_	if	_	IN	115	_	_	_	_	_	_	_	O
18	dual	_	dual	_	JJ	115	_	_	_	_	_	_	_	O
19	therapy	_	therapy	_	NN	115	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	115	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	115	_	_	_	_	_	_	_	O
22	oral	_	UNK	_	JJ	115	_	_	_	_	_	_	_	O
23	drugs	_	drug	_	NNS	115	_	_	_	_	_	_	_	O
24	(	_	(	_	(	115	_	_	_	_	_	_	_	O
25	see	_	see	_	VB	115	_	_	_	_	_	_	_	O
26	recommendation	_	UNK	_	NN	115	_	_	_	_	_	_	_	O
27	)	_	)	_	)	115	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	115	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	115	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	115	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	115	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	115	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	115	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	115	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	115	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	115	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	115	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	115	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	115	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	115	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	115	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	115	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	115	_	_	_	_	_	_	_	O
44	,	_	,	_	,	115	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	115	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	JJ	115	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	115	_	_	_	_	_	_	_	O
48	(	_	(	_	(	115	_	_	_	_	_	_	_	O
49	see	_	see	_	VB	115	_	_	_	_	_	_	_	O
50	recommendations	_	UNK	_	NNS	115	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NNP	115	_	_	_	_	_	_	_	O
52	)	_	)	_	)	115	_	_	_	_	_	_	_	O
53	.	_	.	_	.	115	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	115	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	115	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	115	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	115	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	115	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	115	_	_	_	_	_	_	_	O
7	,	_	,	_	,	115	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	115	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	115	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	115	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	115	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
15	,	_	,	_	,	115	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	115	_	_	_	_	_	_	_	O
17	if	_	if	_	IN	115	_	_	_	_	_	_	_	O
18	dual	_	dual	_	JJ	115	_	_	_	_	_	dual.a	Cardinal_numbers	S-Number
19	therapy	_	therapy	_	NN	115	_	_	_	_	_	_	_	S-Entity
20	with	_	with	_	IN	115	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	115	_	_	_	_	_	_	_	O
22	oral	_	UNK	_	JJ	115	_	_	_	_	_	_	_	O
23	drugs	_	drug	_	NNS	115	_	_	_	_	_	_	_	O
24	(	_	(	_	(	115	_	_	_	_	_	_	_	O
25	see	_	see	_	VB	115	_	_	_	_	_	_	_	O
26	recommendation	_	UNK	_	NN	115	_	_	_	_	_	_	_	O
27	)	_	)	_	)	115	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	115	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	115	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	115	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	115	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	115	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	115	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	115	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	115	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	115	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	115	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	115	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	115	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	115	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	115	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	115	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	115	_	_	_	_	_	_	_	O
44	,	_	,	_	,	115	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	115	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	JJ	115	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	115	_	_	_	_	_	_	_	O
48	(	_	(	_	(	115	_	_	_	_	_	_	_	O
49	see	_	see	_	VB	115	_	_	_	_	_	_	_	O
50	recommendations	_	UNK	_	NNS	115	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NNP	115	_	_	_	_	_	_	_	O
52	)	_	)	_	)	115	_	_	_	_	_	_	_	O
53	.	_	.	_	.	115	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	115	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	115	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	115	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	115	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	115	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	115	_	_	_	_	_	_	_	O
7	,	_	,	_	,	115	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	115	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	115	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	115	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	115	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
15	,	_	,	_	,	115	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	115	_	_	_	_	_	_	_	O
17	if	_	if	_	IN	115	_	_	_	_	_	_	_	O
18	dual	_	dual	_	JJ	115	_	_	_	_	_	_	_	O
19	therapy	_	therapy	_	NN	115	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
20	with	_	with	_	IN	115	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	115	_	_	_	_	_	_	_	O
22	oral	_	UNK	_	JJ	115	_	_	_	_	_	_	_	O
23	drugs	_	drug	_	NNS	115	_	_	_	_	_	_	_	O
24	(	_	(	_	(	115	_	_	_	_	_	_	_	O
25	see	_	see	_	VB	115	_	_	_	_	_	_	_	O
26	recommendation	_	UNK	_	NN	115	_	_	_	_	_	_	_	O
27	)	_	)	_	)	115	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	115	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	115	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	115	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	115	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	115	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	115	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	115	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	115	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	115	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	115	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	115	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	115	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	115	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	115	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	115	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	115	_	_	_	_	_	_	_	O
44	,	_	,	_	,	115	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	115	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	JJ	115	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	115	_	_	_	_	_	_	_	O
48	(	_	(	_	(	115	_	_	_	_	_	_	_	O
49	see	_	see	_	VB	115	_	_	_	_	_	_	_	O
50	recommendations	_	UNK	_	NNS	115	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NNP	115	_	_	_	_	_	_	_	O
52	)	_	)	_	)	115	_	_	_	_	_	_	_	O
53	.	_	.	_	.	115	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	115	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	115	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	115	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	115	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	115	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	115	_	_	_	_	_	_	_	O
7	,	_	,	_	,	115	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	115	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	115	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	115	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	115	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
15	,	_	,	_	,	115	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	115	_	_	_	_	_	_	_	O
17	if	_	if	_	IN	115	_	_	_	_	_	_	_	O
18	dual	_	dual	_	JJ	115	_	_	_	_	_	_	_	O
19	therapy	_	therapy	_	NN	115	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	115	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	115	_	_	_	_	_	_	_	B-Descriptor
22	oral	_	UNK	_	JJ	115	_	_	_	_	_	_	_	I-Descriptor
23	drugs	_	drug	_	NNS	115	_	_	_	_	_	drug.n	Intoxicants	S-Intoxicant
24	(	_	(	_	(	115	_	_	_	_	_	_	_	O
25	see	_	see	_	VB	115	_	_	_	_	_	_	_	O
26	recommendation	_	UNK	_	NN	115	_	_	_	_	_	_	_	O
27	)	_	)	_	)	115	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	115	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	115	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	115	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	115	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	115	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	115	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	115	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	115	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	115	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	115	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	115	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	115	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	115	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	115	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	115	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	115	_	_	_	_	_	_	_	O
44	,	_	,	_	,	115	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	115	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	JJ	115	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	115	_	_	_	_	_	_	_	O
48	(	_	(	_	(	115	_	_	_	_	_	_	_	O
49	see	_	see	_	VB	115	_	_	_	_	_	_	_	O
50	recommendations	_	UNK	_	NNS	115	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NNP	115	_	_	_	_	_	_	_	O
52	)	_	)	_	)	115	_	_	_	_	_	_	_	O
53	.	_	.	_	.	115	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	115	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	115	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	115	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	115	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	115	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	115	_	_	_	_	_	_	_	O
7	,	_	,	_	,	115	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	115	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	115	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	115	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	115	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
15	,	_	,	_	,	115	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	115	_	_	_	_	_	_	_	O
17	if	_	if	_	IN	115	_	_	_	_	_	_	_	O
18	dual	_	dual	_	JJ	115	_	_	_	_	_	_	_	O
19	therapy	_	therapy	_	NN	115	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	115	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	115	_	_	_	_	_	_	_	B-Agent
22	oral	_	UNK	_	JJ	115	_	_	_	_	_	_	_	I-Agent
23	drugs	_	drug	_	NNS	115	_	_	_	_	_	_	_	I-Agent
24	(	_	(	_	(	115	_	_	_	_	_	_	_	I-Agent
25	see	_	see	_	VB	115	_	_	_	_	_	_	_	I-Agent
26	recommendation	_	UNK	_	NN	115	_	_	_	_	_	_	_	I-Agent
27	)	_	)	_	)	115	_	_	_	_	_	_	_	I-Agent
28	has	_	have	_	VBZ	115	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	115	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	115	_	_	_	_	_	continue.v	Activity_ongoing	O
31	to	_	to	_	TO	115	_	_	_	_	_	_	_	B-Activity
32	control	_	control	_	VB	115	_	_	_	_	_	_	_	I-Activity
33	hba1c	_	UNK	_	NNP	115	_	_	_	_	_	_	_	I-Activity
34	to	_	to	_	TO	115	_	_	_	_	_	_	_	I-Activity
35	below	_	below	_	VB	115	_	_	_	_	_	_	_	I-Activity
36	the	_	the	_	DT	115	_	_	_	_	_	_	_	I-Activity
37	person	_	person	_	NN	115	_	_	_	_	_	_	_	I-Activity
38	's	_	's	_	POS	115	_	_	_	_	_	_	_	I-Activity
39	individually	_	UNK	_	RB	115	_	_	_	_	_	_	_	I-Activity
40	agreed	_	agree	_	VBN	115	_	_	_	_	_	_	_	I-Activity
41	threshold	_	UNK	_	NN	115	_	_	_	_	_	_	_	I-Activity
42	for	_	for	_	IN	115	_	_	_	_	_	_	_	I-Activity
43	intensification	_	UNK	_	NN	115	_	_	_	_	_	_	_	I-Activity
44	,	_	,	_	,	115	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	115	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	JJ	115	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	115	_	_	_	_	_	_	_	O
48	(	_	(	_	(	115	_	_	_	_	_	_	_	O
49	see	_	see	_	VB	115	_	_	_	_	_	_	_	O
50	recommendations	_	UNK	_	NNS	115	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NNP	115	_	_	_	_	_	_	_	O
52	)	_	)	_	)	115	_	_	_	_	_	_	_	O
53	.	_	.	_	.	115	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	115	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	115	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	115	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	115	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	115	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	115	_	_	_	_	_	_	_	O
7	,	_	,	_	,	115	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	115	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	115	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	115	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	115	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
15	,	_	,	_	,	115	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	115	_	_	_	_	_	_	_	O
17	if	_	if	_	IN	115	_	_	_	_	_	_	_	O
18	dual	_	dual	_	JJ	115	_	_	_	_	_	_	_	O
19	therapy	_	therapy	_	NN	115	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	115	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	115	_	_	_	_	_	_	_	O
22	oral	_	UNK	_	JJ	115	_	_	_	_	_	_	_	O
23	drugs	_	drug	_	NNS	115	_	_	_	_	_	_	_	O
24	(	_	(	_	(	115	_	_	_	_	_	_	_	O
25	see	_	see	_	VB	115	_	_	_	_	_	_	_	O
26	recommendation	_	UNK	_	NN	115	_	_	_	_	_	_	_	O
27	)	_	)	_	)	115	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	115	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	115	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	115	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	115	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	115	_	_	_	_	_	control.v	Being_in_control	O
33	hba1c	_	UNK	_	NNP	115	_	_	_	_	_	_	_	B-Dependent_entity
34	to	_	to	_	TO	115	_	_	_	_	_	_	_	I-Dependent_entity
35	below	_	below	_	VB	115	_	_	_	_	_	_	_	I-Dependent_entity
36	the	_	the	_	DT	115	_	_	_	_	_	_	_	I-Dependent_entity
37	person	_	person	_	NN	115	_	_	_	_	_	_	_	I-Dependent_entity
38	's	_	's	_	POS	115	_	_	_	_	_	_	_	I-Dependent_entity
39	individually	_	UNK	_	RB	115	_	_	_	_	_	_	_	I-Dependent_entity
40	agreed	_	agree	_	VBN	115	_	_	_	_	_	_	_	I-Dependent_entity
41	threshold	_	UNK	_	NN	115	_	_	_	_	_	_	_	I-Dependent_entity
42	for	_	for	_	IN	115	_	_	_	_	_	_	_	I-Dependent_entity
43	intensification	_	UNK	_	NN	115	_	_	_	_	_	_	_	I-Dependent_entity
44	,	_	,	_	,	115	_	_	_	_	_	_	_	I-Dependent_entity
45	consider	_	consider	_	VB	115	_	_	_	_	_	_	_	I-Dependent_entity
46	unk	_	UNK	_	JJ	115	_	_	_	_	_	_	_	I-Dependent_entity
47	treatment	_	treatment	_	NN	115	_	_	_	_	_	_	_	I-Dependent_entity
48	(	_	(	_	(	115	_	_	_	_	_	_	_	I-Dependent_entity
49	see	_	see	_	VB	115	_	_	_	_	_	_	_	I-Dependent_entity
50	recommendations	_	UNK	_	NNS	115	_	_	_	_	_	_	_	I-Dependent_entity
51	unk	_	UNK	_	NNP	115	_	_	_	_	_	_	_	I-Dependent_entity
52	)	_	)	_	)	115	_	_	_	_	_	_	_	I-Dependent_entity
53	.	_	.	_	.	115	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	115	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	115	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	115	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	115	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	115	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	115	_	_	_	_	_	_	_	O
7	,	_	,	_	,	115	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	115	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	115	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	115	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	115	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
15	,	_	,	_	,	115	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	115	_	_	_	_	_	_	_	O
17	if	_	if	_	IN	115	_	_	_	_	_	_	_	O
18	dual	_	dual	_	JJ	115	_	_	_	_	_	_	_	O
19	therapy	_	therapy	_	NN	115	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	115	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	115	_	_	_	_	_	_	_	B-Figure
22	oral	_	UNK	_	JJ	115	_	_	_	_	_	_	_	I-Figure
23	drugs	_	drug	_	NNS	115	_	_	_	_	_	_	_	I-Figure
24	(	_	(	_	(	115	_	_	_	_	_	_	_	I-Figure
25	see	_	see	_	VB	115	_	_	_	_	_	_	_	I-Figure
26	recommendation	_	UNK	_	NN	115	_	_	_	_	_	_	_	I-Figure
27	)	_	)	_	)	115	_	_	_	_	_	_	_	I-Figure
28	has	_	have	_	VBZ	115	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	115	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	115	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	115	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	115	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	115	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	115	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	115	_	_	_	_	_	below.prep	Directional_locative_relation	O
36	the	_	the	_	DT	115	_	_	_	_	_	_	_	B-Ground
37	person	_	person	_	NN	115	_	_	_	_	_	_	_	I-Ground
38	's	_	's	_	POS	115	_	_	_	_	_	_	_	I-Ground
39	individually	_	UNK	_	RB	115	_	_	_	_	_	_	_	I-Ground
40	agreed	_	agree	_	VBN	115	_	_	_	_	_	_	_	I-Ground
41	threshold	_	UNK	_	NN	115	_	_	_	_	_	_	_	I-Ground
42	for	_	for	_	IN	115	_	_	_	_	_	_	_	I-Ground
43	intensification	_	UNK	_	NN	115	_	_	_	_	_	_	_	I-Ground
44	,	_	,	_	,	115	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	115	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	JJ	115	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	115	_	_	_	_	_	_	_	O
48	(	_	(	_	(	115	_	_	_	_	_	_	_	O
49	see	_	see	_	VB	115	_	_	_	_	_	_	_	O
50	recommendations	_	UNK	_	NNS	115	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NNP	115	_	_	_	_	_	_	_	O
52	)	_	)	_	)	115	_	_	_	_	_	_	_	O
53	.	_	.	_	.	115	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	115	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	115	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	115	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	115	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	115	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	115	_	_	_	_	_	_	_	O
7	,	_	,	_	,	115	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	115	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	115	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	115	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	115	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
15	,	_	,	_	,	115	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	115	_	_	_	_	_	_	_	O
17	if	_	if	_	IN	115	_	_	_	_	_	_	_	O
18	dual	_	dual	_	JJ	115	_	_	_	_	_	_	_	O
19	therapy	_	therapy	_	NN	115	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	115	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	115	_	_	_	_	_	_	_	O
22	oral	_	UNK	_	JJ	115	_	_	_	_	_	_	_	O
23	drugs	_	drug	_	NNS	115	_	_	_	_	_	_	_	O
24	(	_	(	_	(	115	_	_	_	_	_	_	_	O
25	see	_	see	_	VB	115	_	_	_	_	_	_	_	O
26	recommendation	_	UNK	_	NN	115	_	_	_	_	_	_	_	O
27	)	_	)	_	)	115	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	115	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	115	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	115	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	115	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	115	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	115	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	115	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	115	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	115	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	115	_	_	_	_	_	person.n	People	S-Person
38	's	_	's	_	POS	115	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	115	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	115	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	115	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	115	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	115	_	_	_	_	_	_	_	O
44	,	_	,	_	,	115	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	115	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	JJ	115	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	115	_	_	_	_	_	_	_	O
48	(	_	(	_	(	115	_	_	_	_	_	_	_	O
49	see	_	see	_	VB	115	_	_	_	_	_	_	_	O
50	recommendations	_	UNK	_	NNS	115	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NNP	115	_	_	_	_	_	_	_	O
52	)	_	)	_	)	115	_	_	_	_	_	_	_	O
53	.	_	.	_	.	115	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	115	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	115	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	115	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	115	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	115	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	115	_	_	_	_	_	_	_	O
7	,	_	,	_	,	115	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	115	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	115	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	115	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	115	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
15	,	_	,	_	,	115	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	115	_	_	_	_	_	_	_	O
17	if	_	if	_	IN	115	_	_	_	_	_	_	_	O
18	dual	_	dual	_	JJ	115	_	_	_	_	_	_	_	O
19	therapy	_	therapy	_	NN	115	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	115	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	115	_	_	_	_	_	_	_	O
22	oral	_	UNK	_	JJ	115	_	_	_	_	_	_	_	O
23	drugs	_	drug	_	NNS	115	_	_	_	_	_	_	_	O
24	(	_	(	_	(	115	_	_	_	_	_	_	_	O
25	see	_	see	_	VB	115	_	_	_	_	_	_	_	O
26	recommendation	_	UNK	_	NN	115	_	_	_	_	_	_	_	O
27	)	_	)	_	)	115	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	115	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	115	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	115	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	115	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	115	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	115	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	115	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	115	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	115	_	_	_	_	_	_	_	B-Party_1
37	person	_	person	_	NN	115	_	_	_	_	_	_	_	I-Party_1
38	's	_	's	_	POS	115	_	_	_	_	_	_	_	I-Party_1
39	individually	_	UNK	_	RB	115	_	_	_	_	_	_	_	S-Parties
40	agreed	_	agree	_	VBN	115	_	_	_	_	_	agree.v	Make_agreement_on_action	O
41	threshold	_	UNK	_	NN	115	_	_	_	_	_	_	_	B-Obligation
42	for	_	for	_	IN	115	_	_	_	_	_	_	_	I-Obligation
43	intensification	_	UNK	_	NN	115	_	_	_	_	_	_	_	I-Obligation
44	,	_	,	_	,	115	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	115	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	JJ	115	_	_	_	_	_	_	_	O
47	treatment	_	treatment	_	NN	115	_	_	_	_	_	_	_	O
48	(	_	(	_	(	115	_	_	_	_	_	_	_	O
49	see	_	see	_	VB	115	_	_	_	_	_	_	_	O
50	recommendations	_	UNK	_	NNS	115	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NNP	115	_	_	_	_	_	_	_	O
52	)	_	)	_	)	115	_	_	_	_	_	_	_	O
53	.	_	.	_	.	115	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	115	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	115	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	115	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	115	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	115	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	115	_	_	_	_	_	_	_	O
7	,	_	,	_	,	115	_	_	_	_	_	_	_	O
8	if	_	if	_	IN	115	_	_	_	_	_	_	_	O
9	metformin	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	115	_	_	_	_	_	_	_	O
11	contraindicated	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
12	or	_	or	_	CC	115	_	_	_	_	_	_	_	O
13	not	_	not	_	RB	115	_	_	_	_	_	_	_	O
14	tolerated	_	UNK	_	VBN	115	_	_	_	_	_	_	_	O
15	,	_	,	_	,	115	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	115	_	_	_	_	_	_	_	O
17	if	_	if	_	IN	115	_	_	_	_	_	_	_	O
18	dual	_	dual	_	JJ	115	_	_	_	_	_	_	_	O
19	therapy	_	therapy	_	NN	115	_	_	_	_	_	_	_	O
20	with	_	with	_	IN	115	_	_	_	_	_	_	_	O
21	2	_	2	_	CD	115	_	_	_	_	_	_	_	O
22	oral	_	UNK	_	JJ	115	_	_	_	_	_	_	_	O
23	drugs	_	drug	_	NNS	115	_	_	_	_	_	_	_	O
24	(	_	(	_	(	115	_	_	_	_	_	_	_	O
25	see	_	see	_	VB	115	_	_	_	_	_	_	_	O
26	recommendation	_	UNK	_	NN	115	_	_	_	_	_	_	_	O
27	)	_	)	_	)	115	_	_	_	_	_	_	_	O
28	has	_	have	_	VBZ	115	_	_	_	_	_	_	_	O
29	not	_	not	_	RB	115	_	_	_	_	_	_	_	O
30	continued	_	continue	_	VBN	115	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	115	_	_	_	_	_	_	_	O
32	control	_	control	_	VB	115	_	_	_	_	_	_	_	O
33	hba1c	_	UNK	_	NNP	115	_	_	_	_	_	_	_	O
34	to	_	to	_	TO	115	_	_	_	_	_	_	_	O
35	below	_	below	_	VB	115	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	115	_	_	_	_	_	_	_	O
37	person	_	person	_	NN	115	_	_	_	_	_	_	_	O
38	's	_	's	_	POS	115	_	_	_	_	_	_	_	O
39	individually	_	UNK	_	RB	115	_	_	_	_	_	_	_	O
40	agreed	_	agree	_	VBN	115	_	_	_	_	_	_	_	O
41	threshold	_	UNK	_	NN	115	_	_	_	_	_	_	_	O
42	for	_	for	_	IN	115	_	_	_	_	_	_	_	O
43	intensification	_	UNK	_	NN	115	_	_	_	_	_	_	_	O
44	,	_	,	_	,	115	_	_	_	_	_	_	_	O
45	consider	_	consider	_	VB	115	_	_	_	_	_	consider.v	Categorization	O
46	unk	_	UNK	_	JJ	115	_	_	_	_	_	_	_	B-Item
47	treatment	_	treatment	_	NN	115	_	_	_	_	_	_	_	I-Item
48	(	_	(	_	(	115	_	_	_	_	_	_	_	O
49	see	_	see	_	VB	115	_	_	_	_	_	_	_	O
50	recommendations	_	UNK	_	NNS	115	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	NNP	115	_	_	_	_	_	_	_	O
52	)	_	)	_	)	115	_	_	_	_	_	_	_	O
53	.	_	.	_	.	115	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	116	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	116	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	116	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	116	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	116	_	_	_	_	_	_	_	O
6	:	_	:	_	:	116	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	116	_	_	_	_	_	_	_	O
8	(	_	(	_	(	116	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	116	_	_	_	_	_	_	_	O
10	)	_	)	_	)	116	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	116	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	116	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	116	_	_	_	_	_	_	_	O
14	)	_	)	_	)	116	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	116	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	116	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	116	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	116	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	116	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	116	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	116	_	_	_	_	_	_	_	O
8	(	_	(	_	(	116	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	116	_	_	_	_	_	_	_	O
10	)	_	)	_	)	116	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	116	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	116	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	116	_	_	_	_	_	_	_	O
14	)	_	)	_	)	116	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	117	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	117	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	117	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	117	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	117	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	117	_	_	_	_	_	_	_	O
7	,	_	,	_	,	117	_	_	_	_	_	_	_	O
8	only	_	only	_	RB	117	_	_	_	_	_	_	_	O
9	offer	_	offer	_	VBP	117	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	117	_	_	_	_	_	_	_	O
11	glp-1	_	UNK	_	NNP	117	_	_	_	_	_	_	_	O
12	mimetic	_	UNK	_	NN	117	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	117	_	_	_	_	_	_	_	O
14	combination	_	combination	_	NN	117	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	117	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	117	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	117	_	_	_	_	_	_	_	O
18	specialist	_	specialist	_	NN	117	_	_	_	_	_	_	_	O
19	care	_	care	_	NN	117	_	_	_	_	_	_	_	O
20	advice	_	advice	_	NN	117	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	117	_	_	_	_	_	_	_	O
22	ongoing	_	ongoing	_	VBG	117	_	_	_	_	_	_	_	O
23	support	_	support	_	NN	117	_	_	_	_	_	_	_	O
24	from	_	from	_	IN	117	_	_	_	_	_	_	_	O
25	a	_	a	_	DT	117	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	JJ	117	_	_	_	_	_	_	_	O
27	multidisciplinary	_	UNK	_	JJ	117	_	_	_	_	_	_	_	O
28	team	_	team	_	NN	117	_	_	_	_	_	_	_	O
29	.	_	.	_	.	117	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	117	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	117	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	117	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	117	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	117	_	_	_	_	_	_	_	B-Category
6	diabetes	_	UNK	_	NNS	117	_	_	_	_	_	_	_	I-Category
7	,	_	,	_	,	117	_	_	_	_	_	_	_	O
8	only	_	only	_	RB	117	_	_	_	_	_	_	_	O
9	offer	_	offer	_	VBP	117	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	117	_	_	_	_	_	_	_	O
11	glp-1	_	UNK	_	NNP	117	_	_	_	_	_	_	_	O
12	mimetic	_	UNK	_	NN	117	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	117	_	_	_	_	_	_	_	O
14	combination	_	combination	_	NN	117	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	117	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	117	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	117	_	_	_	_	_	_	_	O
18	specialist	_	specialist	_	NN	117	_	_	_	_	_	_	_	O
19	care	_	care	_	NN	117	_	_	_	_	_	_	_	O
20	advice	_	advice	_	NN	117	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	117	_	_	_	_	_	_	_	O
22	ongoing	_	ongoing	_	VBG	117	_	_	_	_	_	_	_	O
23	support	_	support	_	NN	117	_	_	_	_	_	_	_	O
24	from	_	from	_	IN	117	_	_	_	_	_	_	_	O
25	a	_	a	_	DT	117	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	JJ	117	_	_	_	_	_	_	_	O
27	multidisciplinary	_	UNK	_	JJ	117	_	_	_	_	_	_	_	O
28	team	_	team	_	NN	117	_	_	_	_	_	_	_	O
29	.	_	.	_	.	117	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	117	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	117	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	117	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	117	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	117	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	117	_	_	_	_	_	_	_	O
7	,	_	,	_	,	117	_	_	_	_	_	_	_	O
8	only	_	only	_	RB	117	_	_	_	_	_	_	_	O
9	offer	_	offer	_	VBP	117	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	117	_	_	_	_	_	_	_	O
11	glp-1	_	UNK	_	NNP	117	_	_	_	_	_	_	_	O
12	mimetic	_	UNK	_	NN	117	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	117	_	_	_	_	_	_	_	O
14	combination	_	combination	_	NN	117	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	117	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	117	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	117	_	_	_	_	_	_	_	O
18	specialist	_	specialist	_	NN	117	_	_	_	_	_	_	_	O
19	care	_	care	_	NN	117	_	_	_	_	_	_	_	O
20	advice	_	advice	_	NN	117	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	117	_	_	_	_	_	_	_	O
22	ongoing	_	ongoing	_	VBG	117	_	_	_	_	_	ongoing.a	Process_continue	O
23	support	_	support	_	NN	117	_	_	_	_	_	_	_	S-Event
24	from	_	from	_	IN	117	_	_	_	_	_	_	_	O
25	a	_	a	_	DT	117	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	JJ	117	_	_	_	_	_	_	_	O
27	multidisciplinary	_	UNK	_	JJ	117	_	_	_	_	_	_	_	O
28	team	_	team	_	NN	117	_	_	_	_	_	_	_	O
29	.	_	.	_	.	117	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	117	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	117	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	117	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	117	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	117	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	117	_	_	_	_	_	_	_	O
7	,	_	,	_	,	117	_	_	_	_	_	_	_	O
8	only	_	only	_	RB	117	_	_	_	_	_	_	_	O
9	offer	_	offer	_	VBP	117	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	117	_	_	_	_	_	_	_	O
11	glp-1	_	UNK	_	NNP	117	_	_	_	_	_	_	_	O
12	mimetic	_	UNK	_	NN	117	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	117	_	_	_	_	_	_	_	O
14	combination	_	combination	_	NN	117	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	117	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	117	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	117	_	_	_	_	_	_	_	O
18	specialist	_	specialist	_	NN	117	_	_	_	_	_	_	_	O
19	care	_	care	_	NN	117	_	_	_	_	_	_	_	O
20	advice	_	advice	_	NN	117	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	117	_	_	_	_	_	_	_	O
22	ongoing	_	ongoing	_	VBG	117	_	_	_	_	_	_	_	O
23	support	_	support	_	NN	117	_	_	_	_	_	_	_	O
24	from	_	from	_	IN	117	_	_	_	_	_	_	_	O
25	a	_	a	_	DT	117	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	JJ	117	_	_	_	_	_	_	_	B-Aggregate_property
27	multidisciplinary	_	UNK	_	JJ	117	_	_	_	_	_	_	_	I-Aggregate_property
28	team	_	team	_	NN	117	_	_	_	_	_	team.n	Aggregate	S-Aggregate
29	.	_	.	_	.	117	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	118	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	118	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	118	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	118	_	_	_	_	_	_	_	S-Total
6	including	_	include	_	VBG	118	_	_	_	_	_	include.v	Inclusion	O
7	unk	_	UNK	_	JJ	118	_	_	_	_	_	_	_	B-Part
8	inhibitors	_	UNK	_	NNS	118	_	_	_	_	_	_	_	I-Part
9	,	_	,	_	,	118	_	_	_	_	_	_	_	O
10	may	_	may	_	MD	118	_	_	_	_	_	_	_	O
11	be	_	be	_	VB	118	_	_	_	_	_	_	_	O
12	appropriate	_	appropriate	_	JJ	118	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
14	some	_	some	_	DT	118	_	_	_	_	_	_	_	O
15	people	_	people	_	NNS	118	_	_	_	_	_	_	_	O
16	with	_	with	_	IN	118	_	_	_	_	_	_	_	O
17	type	_	type	_	JJ	118	_	_	_	_	_	_	_	O
18	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
19	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
20	;	_	;	_	:	118	_	_	_	_	_	_	_	O
21	see	_	see	_	VB	118	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	118	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	118	_	_	_	_	_	_	_	O
24	guidance	_	guidance	_	NN	118	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	118	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
28	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
30	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
31	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
32	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
35	,	_	,	_	,	118	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
38	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
41	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
42	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
45	,	_	,	_	,	118	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
47	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	118	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
50	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
51	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
52	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
53	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
54	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
55	and	_	and	_	CC	118	_	_	_	_	_	_	_	O
56	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
57	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
58	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
59	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
60	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
61	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
62	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
63	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
64	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
65	.	_	.	_	.	118	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	118	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	118	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	118	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	118	_	_	_	_	_	_	_	O
6	including	_	include	_	VBG	118	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	JJ	118	_	_	_	_	_	_	_	O
8	inhibitors	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
9	,	_	,	_	,	118	_	_	_	_	_	_	_	O
10	may	_	may	_	MD	118	_	_	_	_	_	_	_	O
11	be	_	be	_	VB	118	_	_	_	_	_	_	_	O
12	appropriate	_	appropriate	_	JJ	118	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
14	some	_	some	_	DT	118	_	_	_	_	_	_	_	O
15	people	_	people	_	NNS	118	_	_	_	_	_	people.n	People	S-Person
16	with	_	with	_	IN	118	_	_	_	_	_	_	_	O
17	type	_	type	_	JJ	118	_	_	_	_	_	_	_	O
18	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
19	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
20	;	_	;	_	:	118	_	_	_	_	_	_	_	O
21	see	_	see	_	VB	118	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	118	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	118	_	_	_	_	_	_	_	O
24	guidance	_	guidance	_	NN	118	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	118	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
28	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
30	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
31	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
32	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
35	,	_	,	_	,	118	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
38	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
41	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
42	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
45	,	_	,	_	,	118	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
47	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	118	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
50	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
51	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
52	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
53	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
54	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
55	and	_	and	_	CC	118	_	_	_	_	_	_	_	O
56	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
57	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
58	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
59	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
60	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
61	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
62	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
63	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
64	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
65	.	_	.	_	.	118	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	118	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	118	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	118	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	118	_	_	_	_	_	_	_	O
6	including	_	include	_	VBG	118	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	JJ	118	_	_	_	_	_	_	_	O
8	inhibitors	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
9	,	_	,	_	,	118	_	_	_	_	_	_	_	O
10	may	_	may	_	MD	118	_	_	_	_	_	_	_	O
11	be	_	be	_	VB	118	_	_	_	_	_	_	_	O
12	appropriate	_	appropriate	_	JJ	118	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
14	some	_	some	_	DT	118	_	_	_	_	_	_	_	O
15	people	_	people	_	NNS	118	_	_	_	_	_	_	_	O
16	with	_	with	_	IN	118	_	_	_	_	_	_	_	O
17	type	_	type	_	JJ	118	_	_	_	_	_	type.n	Type	S-Subtype
18	2	_	2	_	CD	118	_	_	_	_	_	_	_	B-Category
19	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	I-Category
20	;	_	;	_	:	118	_	_	_	_	_	_	_	O
21	see	_	see	_	VB	118	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	118	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	118	_	_	_	_	_	_	_	O
24	guidance	_	guidance	_	NN	118	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	118	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
28	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
30	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
31	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
32	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
35	,	_	,	_	,	118	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
38	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
41	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
42	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
45	,	_	,	_	,	118	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
47	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	118	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
50	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
51	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
52	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
53	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
54	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
55	and	_	and	_	CC	118	_	_	_	_	_	_	_	O
56	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
57	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
58	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
59	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
60	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
61	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
62	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
63	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
64	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
65	.	_	.	_	.	118	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	118	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	118	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	118	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	118	_	_	_	_	_	_	_	O
6	including	_	include	_	VBG	118	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	JJ	118	_	_	_	_	_	_	_	O
8	inhibitors	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
9	,	_	,	_	,	118	_	_	_	_	_	_	_	O
10	may	_	may	_	MD	118	_	_	_	_	_	_	_	O
11	be	_	be	_	VB	118	_	_	_	_	_	_	_	O
12	appropriate	_	appropriate	_	JJ	118	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
14	some	_	some	_	DT	118	_	_	_	_	_	_	_	O
15	people	_	people	_	NNS	118	_	_	_	_	_	_	_	O
16	with	_	with	_	IN	118	_	_	_	_	_	_	_	O
17	type	_	type	_	JJ	118	_	_	_	_	_	_	_	O
18	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
19	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
20	;	_	;	_	:	118	_	_	_	_	_	_	_	O
21	see	_	see	_	VB	118	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	118	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	118	_	_	_	_	_	_	_	O
24	guidance	_	guidance	_	NN	118	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	118	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
28	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
30	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
31	treating	_	treat	_	VBG	118	_	_	_	_	_	treat.v	Medical_intervention	O
32	type	_	type	_	NN	118	_	_	_	_	_	_	_	B-Patient
33	2	_	2	_	CD	118	_	_	_	_	_	_	_	I-Patient
34	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	I-Patient
35	,	_	,	_	,	118	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
38	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
41	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
42	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
45	,	_	,	_	,	118	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
47	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	118	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
50	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
51	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
52	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
53	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
54	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
55	and	_	and	_	CC	118	_	_	_	_	_	_	_	O
56	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
57	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
58	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
59	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
60	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
61	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
62	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
63	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
64	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
65	.	_	.	_	.	118	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	118	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	118	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	118	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	118	_	_	_	_	_	_	_	O
6	including	_	include	_	VBG	118	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	JJ	118	_	_	_	_	_	_	_	O
8	inhibitors	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
9	,	_	,	_	,	118	_	_	_	_	_	_	_	O
10	may	_	may	_	MD	118	_	_	_	_	_	_	_	O
11	be	_	be	_	VB	118	_	_	_	_	_	_	_	O
12	appropriate	_	appropriate	_	JJ	118	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
14	some	_	some	_	DT	118	_	_	_	_	_	_	_	O
15	people	_	people	_	NNS	118	_	_	_	_	_	_	_	O
16	with	_	with	_	IN	118	_	_	_	_	_	_	_	O
17	type	_	type	_	JJ	118	_	_	_	_	_	_	_	O
18	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
19	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
20	;	_	;	_	:	118	_	_	_	_	_	_	_	O
21	see	_	see	_	VB	118	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	118	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	118	_	_	_	_	_	_	_	O
24	guidance	_	guidance	_	NN	118	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	118	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
28	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
30	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
31	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
32	type	_	type	_	NN	118	_	_	_	_	_	type.n	Type	S-Subtype
33	2	_	2	_	CD	118	_	_	_	_	_	_	_	B-Category
34	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	I-Category
35	,	_	,	_	,	118	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
38	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
41	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
42	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
45	,	_	,	_	,	118	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
47	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	118	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
50	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
51	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
52	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
53	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
54	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
55	and	_	and	_	CC	118	_	_	_	_	_	_	_	O
56	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
57	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
58	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
59	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
60	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
61	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
62	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
63	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
64	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
65	.	_	.	_	.	118	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	118	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	118	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	118	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	118	_	_	_	_	_	_	_	O
6	including	_	include	_	VBG	118	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	JJ	118	_	_	_	_	_	_	_	O
8	inhibitors	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
9	,	_	,	_	,	118	_	_	_	_	_	_	_	O
10	may	_	may	_	MD	118	_	_	_	_	_	_	_	O
11	be	_	be	_	VB	118	_	_	_	_	_	_	_	O
12	appropriate	_	appropriate	_	JJ	118	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
14	some	_	some	_	DT	118	_	_	_	_	_	_	_	O
15	people	_	people	_	NNS	118	_	_	_	_	_	_	_	O
16	with	_	with	_	IN	118	_	_	_	_	_	_	_	O
17	type	_	type	_	JJ	118	_	_	_	_	_	_	_	O
18	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
19	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
20	;	_	;	_	:	118	_	_	_	_	_	_	_	O
21	see	_	see	_	VB	118	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	118	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	118	_	_	_	_	_	_	_	O
24	guidance	_	guidance	_	NN	118	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	118	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
28	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
30	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
31	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
32	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
35	,	_	,	_	,	118	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
38	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
41	treating	_	treat	_	VBG	118	_	_	_	_	_	treat.v	Medical_intervention	O
42	type	_	type	_	NN	118	_	_	_	_	_	_	_	B-Patient
43	2	_	2	_	CD	118	_	_	_	_	_	_	_	I-Patient
44	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	I-Patient
45	,	_	,	_	,	118	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
47	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	118	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
50	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
51	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
52	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
53	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
54	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
55	and	_	and	_	CC	118	_	_	_	_	_	_	_	O
56	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
57	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
58	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
59	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
60	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
61	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
62	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
63	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
64	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
65	.	_	.	_	.	118	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	118	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	118	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	118	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	118	_	_	_	_	_	_	_	O
6	including	_	include	_	VBG	118	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	JJ	118	_	_	_	_	_	_	_	O
8	inhibitors	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
9	,	_	,	_	,	118	_	_	_	_	_	_	_	O
10	may	_	may	_	MD	118	_	_	_	_	_	_	_	O
11	be	_	be	_	VB	118	_	_	_	_	_	_	_	O
12	appropriate	_	appropriate	_	JJ	118	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
14	some	_	some	_	DT	118	_	_	_	_	_	_	_	O
15	people	_	people	_	NNS	118	_	_	_	_	_	_	_	O
16	with	_	with	_	IN	118	_	_	_	_	_	_	_	O
17	type	_	type	_	JJ	118	_	_	_	_	_	_	_	O
18	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
19	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
20	;	_	;	_	:	118	_	_	_	_	_	_	_	O
21	see	_	see	_	VB	118	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	118	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	118	_	_	_	_	_	_	_	O
24	guidance	_	guidance	_	NN	118	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	118	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
28	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
30	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
31	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
32	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
35	,	_	,	_	,	118	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
38	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
41	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
42	type	_	type	_	NN	118	_	_	_	_	_	type.n	Type	S-Subtype
43	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
45	,	_	,	_	,	118	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
47	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	118	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
50	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
51	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
52	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
53	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
54	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
55	and	_	and	_	CC	118	_	_	_	_	_	_	_	O
56	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
57	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
58	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
59	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
60	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
61	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
62	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
63	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
64	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
65	.	_	.	_	.	118	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	118	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	118	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	118	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	118	_	_	_	_	_	_	_	O
6	including	_	include	_	VBG	118	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	JJ	118	_	_	_	_	_	_	_	O
8	inhibitors	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
9	,	_	,	_	,	118	_	_	_	_	_	_	_	O
10	may	_	may	_	MD	118	_	_	_	_	_	_	_	O
11	be	_	be	_	VB	118	_	_	_	_	_	_	_	O
12	appropriate	_	appropriate	_	JJ	118	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
14	some	_	some	_	DT	118	_	_	_	_	_	_	_	O
15	people	_	people	_	NNS	118	_	_	_	_	_	_	_	O
16	with	_	with	_	IN	118	_	_	_	_	_	_	_	O
17	type	_	type	_	JJ	118	_	_	_	_	_	_	_	O
18	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
19	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
20	;	_	;	_	:	118	_	_	_	_	_	_	_	O
21	see	_	see	_	VB	118	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	118	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	118	_	_	_	_	_	_	_	O
24	guidance	_	guidance	_	NN	118	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	118	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
28	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
30	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
31	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
32	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
35	,	_	,	_	,	118	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
38	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
41	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
42	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
45	,	_	,	_	,	118	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
47	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	118	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
50	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
51	treating	_	treat	_	VBG	118	_	_	_	_	_	treat.v	Medical_intervention	O
52	type	_	type	_	NN	118	_	_	_	_	_	_	_	B-Patient
53	2	_	2	_	CD	118	_	_	_	_	_	_	_	I-Patient
54	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	I-Patient
55	and	_	and	_	CC	118	_	_	_	_	_	_	_	I-Patient
56	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	I-Patient
57	in	_	in	_	IN	118	_	_	_	_	_	_	_	B-Medical_condition
58	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	I-Medical_condition
59	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	I-Medical_condition
60	for	_	for	_	IN	118	_	_	_	_	_	_	_	I-Medical_condition
61	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	I-Medical_condition
62	type	_	type	_	NN	118	_	_	_	_	_	_	_	I-Medical_condition
63	2	_	2	_	CD	118	_	_	_	_	_	_	_	I-Medical_condition
64	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	I-Medical_condition
65	.	_	.	_	.	118	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	118	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	118	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	118	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	118	_	_	_	_	_	_	_	O
6	including	_	include	_	VBG	118	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	JJ	118	_	_	_	_	_	_	_	O
8	inhibitors	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
9	,	_	,	_	,	118	_	_	_	_	_	_	_	O
10	may	_	may	_	MD	118	_	_	_	_	_	_	_	O
11	be	_	be	_	VB	118	_	_	_	_	_	_	_	O
12	appropriate	_	appropriate	_	JJ	118	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
14	some	_	some	_	DT	118	_	_	_	_	_	_	_	O
15	people	_	people	_	NNS	118	_	_	_	_	_	_	_	O
16	with	_	with	_	IN	118	_	_	_	_	_	_	_	O
17	type	_	type	_	JJ	118	_	_	_	_	_	_	_	O
18	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
19	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
20	;	_	;	_	:	118	_	_	_	_	_	_	_	O
21	see	_	see	_	VB	118	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	118	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	118	_	_	_	_	_	_	_	O
24	guidance	_	guidance	_	NN	118	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	118	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
28	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
30	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
31	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
32	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
35	,	_	,	_	,	118	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
38	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
41	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
42	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
45	,	_	,	_	,	118	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
47	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	118	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
50	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
51	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
52	type	_	type	_	NN	118	_	_	_	_	_	type.n	Type	S-Subtype
53	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
54	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
55	and	_	and	_	CC	118	_	_	_	_	_	_	_	O
56	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
57	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
58	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
59	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
60	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
61	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
62	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
63	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
64	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
65	.	_	.	_	.	118	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	118	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	118	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	118	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	118	_	_	_	_	_	_	_	O
6	including	_	include	_	VBG	118	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	JJ	118	_	_	_	_	_	_	_	O
8	inhibitors	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
9	,	_	,	_	,	118	_	_	_	_	_	_	_	O
10	may	_	may	_	MD	118	_	_	_	_	_	_	_	O
11	be	_	be	_	VB	118	_	_	_	_	_	_	_	O
12	appropriate	_	appropriate	_	JJ	118	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
14	some	_	some	_	DT	118	_	_	_	_	_	_	_	O
15	people	_	people	_	NNS	118	_	_	_	_	_	_	_	O
16	with	_	with	_	IN	118	_	_	_	_	_	_	_	O
17	type	_	type	_	JJ	118	_	_	_	_	_	_	_	O
18	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
19	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
20	;	_	;	_	:	118	_	_	_	_	_	_	_	O
21	see	_	see	_	VB	118	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	118	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	118	_	_	_	_	_	_	_	O
24	guidance	_	guidance	_	NN	118	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	118	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
28	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
30	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
31	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
32	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
35	,	_	,	_	,	118	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
38	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
41	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
42	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
45	,	_	,	_	,	118	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
47	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	118	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
50	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
51	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
52	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
53	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
54	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
55	and	_	and	_	CC	118	_	_	_	_	_	_	_	O
56	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
57	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
58	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
59	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
60	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
61	treating	_	treat	_	VBG	118	_	_	_	_	_	treat.v	Medical_intervention	O
62	type	_	type	_	NN	118	_	_	_	_	_	_	_	B-Patient
63	2	_	2	_	CD	118	_	_	_	_	_	_	_	I-Patient
64	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	I-Patient
65	.	_	.	_	.	118	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	118	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	118	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	118	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	118	_	_	_	_	_	_	_	O
6	including	_	include	_	VBG	118	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	JJ	118	_	_	_	_	_	_	_	O
8	inhibitors	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
9	,	_	,	_	,	118	_	_	_	_	_	_	_	O
10	may	_	may	_	MD	118	_	_	_	_	_	_	_	O
11	be	_	be	_	VB	118	_	_	_	_	_	_	_	O
12	appropriate	_	appropriate	_	JJ	118	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
14	some	_	some	_	DT	118	_	_	_	_	_	_	_	O
15	people	_	people	_	NNS	118	_	_	_	_	_	_	_	O
16	with	_	with	_	IN	118	_	_	_	_	_	_	_	O
17	type	_	type	_	JJ	118	_	_	_	_	_	_	_	O
18	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
19	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
20	;	_	;	_	:	118	_	_	_	_	_	_	_	O
21	see	_	see	_	VB	118	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	118	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	118	_	_	_	_	_	_	_	O
24	guidance	_	guidance	_	NN	118	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	118	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
28	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
30	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
31	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
32	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
35	,	_	,	_	,	118	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
38	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
41	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
42	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
45	,	_	,	_	,	118	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
47	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
48	triple	_	UNK	_	JJ	118	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
50	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
51	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
52	type	_	type	_	NN	118	_	_	_	_	_	_	_	O
53	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
54	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
55	and	_	and	_	CC	118	_	_	_	_	_	_	_	O
56	unk	_	UNK	_	NN	118	_	_	_	_	_	_	_	O
57	in	_	in	_	IN	118	_	_	_	_	_	_	_	O
58	combination	_	combination	_	NN	118	_	_	_	_	_	_	_	O
59	therapy	_	therapy	_	NN	118	_	_	_	_	_	_	_	O
60	for	_	for	_	IN	118	_	_	_	_	_	_	_	O
61	treating	_	treat	_	VBG	118	_	_	_	_	_	_	_	O
62	type	_	type	_	NN	118	_	_	_	_	_	type.n	Type	S-Subtype
63	2	_	2	_	CD	118	_	_	_	_	_	_	_	O
64	diabetes	_	UNK	_	NNS	118	_	_	_	_	_	_	_	O
65	.	_	.	_	.	118	_	_	_	_	_	_	_	O

1	unk	_	UNK	_	JJ	119	_	_	_	_	_	_	_	S-Place
2	treatments	_	treatment	_	NNS	119	_	_	_	_	_	treatment.n	Cure	O

1	when	_	When	_	WRB	120	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	120	_	_	_	_	_	start.v	Activity_start	O
3	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	B-Activity
4	therapy	_	therapy	_	NN	120	_	_	_	_	_	_	_	I-Activity
5	in	_	in	_	IN	120	_	_	_	_	_	_	_	I-Activity
6	adults	_	adult	_	NNS	120	_	_	_	_	_	_	_	I-Activity
7	with	_	with	_	IN	120	_	_	_	_	_	_	_	I-Activity
8	type	_	type	_	JJ	120	_	_	_	_	_	_	_	I-Activity
9	2	_	2	_	CD	120	_	_	_	_	_	_	_	I-Activity
10	diabetes	_	UNK	_	NNS	120	_	_	_	_	_	_	_	I-Activity
11	,	_	,	_	,	120	_	_	_	_	_	_	_	I-Activity
12	use	_	use	_	VBP	120	_	_	_	_	_	_	_	I-Activity
13	a	_	a	_	DT	120	_	_	_	_	_	_	_	I-Activity
14	structured	_	UNK	_	JJ	120	_	_	_	_	_	_	_	I-Activity
15	programme	_	UNK	_	NN	120	_	_	_	_	_	_	_	I-Activity
16	employing	_	employ	_	VBG	120	_	_	_	_	_	_	_	I-Activity
17	active	_	active	_	JJ	120	_	_	_	_	_	_	_	I-Activity
18	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	I-Activity
19	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	I-Activity
20	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	I-Activity
21	that	_	that	_	WDT	120	_	_	_	_	_	_	_	I-Activity
22	encompasses	_	encompass	_	VBZ	120	_	_	_	_	_	_	_	I-Activity
23	:	_	:	_	:	120	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	O
25	technique	_	technique	_	NN	120	_	_	_	_	_	_	_	O
26	,	_	,	_	,	120	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	120	_	_	_	_	_	_	_	O
28	rotating	_	UNK	_	VBG	120	_	_	_	_	_	_	_	O
29	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	O
30	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	120	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	120	_	_	_	_	_	_	_	O
33	repeated	_	repeat	_	VBN	120	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	120	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	120	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	120	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	120	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	120	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	120	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	O
41	continuing	_	continue	_	VBG	120	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	120	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	120	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	120	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	120	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	120	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	120	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	120	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	120	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	120	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	120	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	120	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	120	_	_	_	_	_	adult.n	People_by_age	S-Person
7	with	_	with	_	IN	120	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	120	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	120	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	120	_	_	_	_	_	_	_	O
11	,	_	,	_	,	120	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	120	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	120	_	_	_	_	_	_	_	O
14	structured	_	UNK	_	JJ	120	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
16	employing	_	employ	_	VBG	120	_	_	_	_	_	_	_	O
17	active	_	active	_	JJ	120	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
19	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	O
20	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	120	_	_	_	_	_	_	_	O
22	encompasses	_	encompass	_	VBZ	120	_	_	_	_	_	_	_	O
23	:	_	:	_	:	120	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	O
25	technique	_	technique	_	NN	120	_	_	_	_	_	_	_	O
26	,	_	,	_	,	120	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	120	_	_	_	_	_	_	_	O
28	rotating	_	UNK	_	VBG	120	_	_	_	_	_	_	_	O
29	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	O
30	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	120	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	120	_	_	_	_	_	_	_	O
33	repeated	_	repeat	_	VBN	120	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	120	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	120	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	120	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	120	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	120	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	120	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	O
41	continuing	_	continue	_	VBG	120	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	120	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	120	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	120	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	120	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	120	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	120	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	120	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	120	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	120	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	120	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	120	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	120	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	120	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	120	_	_	_	_	_	type.n	Type	S-Subtype
9	2	_	2	_	CD	120	_	_	_	_	_	_	_	B-Category
10	diabetes	_	UNK	_	NNS	120	_	_	_	_	_	_	_	I-Category
11	,	_	,	_	,	120	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	120	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	120	_	_	_	_	_	_	_	O
14	structured	_	UNK	_	JJ	120	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
16	employing	_	employ	_	VBG	120	_	_	_	_	_	_	_	O
17	active	_	active	_	JJ	120	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
19	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	O
20	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	120	_	_	_	_	_	_	_	O
22	encompasses	_	encompass	_	VBZ	120	_	_	_	_	_	_	_	O
23	:	_	:	_	:	120	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	O
25	technique	_	technique	_	NN	120	_	_	_	_	_	_	_	O
26	,	_	,	_	,	120	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	120	_	_	_	_	_	_	_	O
28	rotating	_	UNK	_	VBG	120	_	_	_	_	_	_	_	O
29	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	O
30	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	120	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	120	_	_	_	_	_	_	_	O
33	repeated	_	repeat	_	VBN	120	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	120	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	120	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	120	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	120	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	120	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	120	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	O
41	continuing	_	continue	_	VBG	120	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	120	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	120	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	120	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	120	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	120	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	120	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	120	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	120	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	120	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	120	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	120	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	120	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	120	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	120	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	120	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	120	_	_	_	_	_	_	_	O
11	,	_	,	_	,	120	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	120	_	_	_	_	_	use.v	Using	O
13	a	_	a	_	DT	120	_	_	_	_	_	_	_	B-Instrument
14	structured	_	UNK	_	JJ	120	_	_	_	_	_	_	_	I-Instrument
15	programme	_	UNK	_	NN	120	_	_	_	_	_	_	_	I-Instrument
16	employing	_	employ	_	VBG	120	_	_	_	_	_	_	_	I-Instrument
17	active	_	active	_	JJ	120	_	_	_	_	_	_	_	I-Instrument
18	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	I-Instrument
19	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	I-Instrument
20	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	I-Instrument
21	that	_	that	_	WDT	120	_	_	_	_	_	_	_	I-Instrument
22	encompasses	_	encompass	_	VBZ	120	_	_	_	_	_	_	_	I-Instrument
23	:	_	:	_	:	120	_	_	_	_	_	_	_	I-Instrument
24	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	I-Instrument
25	technique	_	technique	_	NN	120	_	_	_	_	_	_	_	I-Instrument
26	,	_	,	_	,	120	_	_	_	_	_	_	_	I-Instrument
27	including	_	include	_	VBG	120	_	_	_	_	_	_	_	I-Instrument
28	rotating	_	UNK	_	VBG	120	_	_	_	_	_	_	_	I-Instrument
29	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	I-Instrument
30	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	I-Instrument
31	and	_	and	_	CC	120	_	_	_	_	_	_	_	I-Instrument
32	avoiding	_	avoid	_	VBG	120	_	_	_	_	_	_	_	I-Instrument
33	repeated	_	repeat	_	VBN	120	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	120	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	120	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	120	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	120	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	120	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	120	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	O
41	continuing	_	continue	_	VBG	120	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	120	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	120	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	120	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	120	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	120	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	120	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	120	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	120	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	120	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	120	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	120	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	120	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	120	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	120	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	120	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	120	_	_	_	_	_	_	_	O
11	,	_	,	_	,	120	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	120	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	120	_	_	_	_	_	_	_	B-Agent
14	structured	_	UNK	_	JJ	120	_	_	_	_	_	_	_	I-Agent
15	programme	_	UNK	_	NN	120	_	_	_	_	_	_	_	I-Agent
16	employing	_	employ	_	VBG	120	_	_	_	_	_	employ.v	Using	O
17	active	_	active	_	JJ	120	_	_	_	_	_	_	_	B-Instrument
18	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	I-Instrument
19	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	I-Instrument
20	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	I-Instrument
21	that	_	that	_	WDT	120	_	_	_	_	_	_	_	I-Instrument
22	encompasses	_	encompass	_	VBZ	120	_	_	_	_	_	_	_	I-Instrument
23	:	_	:	_	:	120	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	O
25	technique	_	technique	_	NN	120	_	_	_	_	_	_	_	O
26	,	_	,	_	,	120	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	120	_	_	_	_	_	_	_	O
28	rotating	_	UNK	_	VBG	120	_	_	_	_	_	_	_	O
29	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	O
30	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	120	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	120	_	_	_	_	_	_	_	O
33	repeated	_	repeat	_	VBN	120	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	120	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	120	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	120	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	120	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	120	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	120	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	O
41	continuing	_	continue	_	VBG	120	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	120	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	120	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	120	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	120	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	120	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	120	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	120	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	120	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	120	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	120	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	120	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	120	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	120	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	120	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	120	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	120	_	_	_	_	_	_	_	O
11	,	_	,	_	,	120	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	120	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	120	_	_	_	_	_	_	_	O
14	structured	_	UNK	_	JJ	120	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
16	employing	_	employ	_	VBG	120	_	_	_	_	_	_	_	O
17	active	_	active	_	JJ	120	_	_	_	_	_	active.a	Being_active	O
18	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
19	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	O
20	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	120	_	_	_	_	_	_	_	O
22	encompasses	_	encompass	_	VBZ	120	_	_	_	_	_	_	_	O
23	:	_	:	_	:	120	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	O
25	technique	_	technique	_	NN	120	_	_	_	_	_	_	_	O
26	,	_	,	_	,	120	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	120	_	_	_	_	_	_	_	O
28	rotating	_	UNK	_	VBG	120	_	_	_	_	_	_	_	O
29	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	O
30	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	120	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	120	_	_	_	_	_	_	_	O
33	repeated	_	repeat	_	VBN	120	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	120	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	120	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	120	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	120	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	120	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	120	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	O
41	continuing	_	continue	_	VBG	120	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	120	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	120	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	120	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	120	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	120	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	120	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	120	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	120	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	120	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	120	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	120	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	120	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	120	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	120	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	120	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	120	_	_	_	_	_	_	_	O
11	,	_	,	_	,	120	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	120	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	120	_	_	_	_	_	_	_	O
14	structured	_	UNK	_	JJ	120	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
16	employing	_	employ	_	VBG	120	_	_	_	_	_	_	_	O
17	active	_	active	_	JJ	120	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	S-Mass
19	dose	_	dose	_	JJ	120	_	_	_	_	_	dose.n	Quantified_mass	S-Quantity
20	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	120	_	_	_	_	_	_	_	O
22	encompasses	_	encompass	_	VBZ	120	_	_	_	_	_	_	_	O
23	:	_	:	_	:	120	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	O
25	technique	_	technique	_	NN	120	_	_	_	_	_	_	_	O
26	,	_	,	_	,	120	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	120	_	_	_	_	_	_	_	O
28	rotating	_	UNK	_	VBG	120	_	_	_	_	_	_	_	O
29	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	O
30	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	120	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	120	_	_	_	_	_	_	_	O
33	repeated	_	repeat	_	VBN	120	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	120	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	120	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	120	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	120	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	120	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	120	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	O
41	continuing	_	continue	_	VBG	120	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	120	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	120	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	120	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	120	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	120	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	120	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	120	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	120	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	120	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	120	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	120	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	120	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	120	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	120	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	120	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	120	_	_	_	_	_	_	_	O
11	,	_	,	_	,	120	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	120	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	120	_	_	_	_	_	_	_	O
14	structured	_	UNK	_	JJ	120	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
16	employing	_	employ	_	VBG	120	_	_	_	_	_	_	_	O
17	active	_	active	_	JJ	120	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
19	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	O
20	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	120	_	_	_	_	_	_	_	O
22	encompasses	_	encompass	_	VBZ	120	_	_	_	_	_	_	_	O
23	:	_	:	_	:	120	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	S-Purpose
25	technique	_	technique	_	NN	120	_	_	_	_	_	technique.n	Means	O
26	,	_	,	_	,	120	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	120	_	_	_	_	_	_	_	O
28	rotating	_	UNK	_	VBG	120	_	_	_	_	_	_	_	O
29	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	O
30	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	120	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	120	_	_	_	_	_	_	_	O
33	repeated	_	repeat	_	VBN	120	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	120	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	120	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	120	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	120	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	120	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	120	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	O
41	continuing	_	continue	_	VBG	120	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	120	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	120	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	120	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	120	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	120	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	120	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	120	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	120	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	120	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	120	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	120	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	120	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	120	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	120	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	120	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	120	_	_	_	_	_	_	_	O
11	,	_	,	_	,	120	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	120	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	120	_	_	_	_	_	_	_	O
14	structured	_	UNK	_	JJ	120	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
16	employing	_	employ	_	VBG	120	_	_	_	_	_	_	_	O
17	active	_	active	_	JJ	120	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
19	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	O
20	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	120	_	_	_	_	_	_	_	O
22	encompasses	_	encompass	_	VBZ	120	_	_	_	_	_	_	_	O
23	:	_	:	_	:	120	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	B-Total
25	technique	_	technique	_	NN	120	_	_	_	_	_	_	_	I-Total
26	,	_	,	_	,	120	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	120	_	_	_	_	_	include.v	Inclusion	O
28	rotating	_	UNK	_	VBG	120	_	_	_	_	_	_	_	B-Part
29	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	I-Part
30	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	I-Part
31	and	_	and	_	CC	120	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	120	_	_	_	_	_	_	_	O
33	repeated	_	repeat	_	VBN	120	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	120	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	120	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	120	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	120	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	120	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	120	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	O
41	continuing	_	continue	_	VBG	120	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	120	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	120	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	120	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	120	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	120	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	120	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	120	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	120	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	120	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	120	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	120	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	120	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	120	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	120	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	120	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	120	_	_	_	_	_	_	_	O
11	,	_	,	_	,	120	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	120	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	120	_	_	_	_	_	_	_	O
14	structured	_	UNK	_	JJ	120	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
16	employing	_	employ	_	VBG	120	_	_	_	_	_	_	_	O
17	active	_	active	_	JJ	120	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
19	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	O
20	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	120	_	_	_	_	_	_	_	O
22	encompasses	_	encompass	_	VBZ	120	_	_	_	_	_	_	_	O
23	:	_	:	_	:	120	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	O
25	technique	_	technique	_	NN	120	_	_	_	_	_	_	_	O
26	,	_	,	_	,	120	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	120	_	_	_	_	_	_	_	O
28	rotating	_	UNK	_	VBG	120	_	_	_	_	_	_	_	O
29	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	S-Use
30	sites	_	site	_	NNS	120	_	_	_	_	_	site.n	Locale_by_use	S-Locale
31	and	_	and	_	CC	120	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	120	_	_	_	_	_	_	_	O
33	repeated	_	repeat	_	VBN	120	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	120	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	120	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	120	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	120	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	120	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	120	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	O
41	continuing	_	continue	_	VBG	120	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	120	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	120	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	120	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	120	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	120	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	120	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	120	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	120	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	120	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	120	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	120	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	120	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	120	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	120	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	120	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	120	_	_	_	_	_	_	_	O
11	,	_	,	_	,	120	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	120	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	120	_	_	_	_	_	_	_	O
14	structured	_	UNK	_	JJ	120	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
16	employing	_	employ	_	VBG	120	_	_	_	_	_	_	_	O
17	active	_	active	_	JJ	120	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
19	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	O
20	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	120	_	_	_	_	_	_	_	O
22	encompasses	_	encompass	_	VBZ	120	_	_	_	_	_	_	_	O
23	:	_	:	_	:	120	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	O
25	technique	_	technique	_	NN	120	_	_	_	_	_	_	_	O
26	,	_	,	_	,	120	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	120	_	_	_	_	_	_	_	O
28	rotating	_	UNK	_	VBG	120	_	_	_	_	_	_	_	O
29	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	O
30	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	120	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	120	_	_	_	_	_	avoid.v	Avoiding	O
33	repeated	_	repeat	_	VBN	120	_	_	_	_	_	_	_	B-Undesirable_situation
34	injections	_	injection	_	NNS	120	_	_	_	_	_	_	_	I-Undesirable_situation
35	at	_	at	_	IN	120	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	120	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	120	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	120	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	120	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	O
41	continuing	_	continue	_	VBG	120	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	120	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	120	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	120	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	120	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	120	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	120	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	120	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	120	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	120	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	120	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	120	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	120	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	120	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	120	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	120	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	120	_	_	_	_	_	_	_	O
11	,	_	,	_	,	120	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	120	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	120	_	_	_	_	_	_	_	O
14	structured	_	UNK	_	JJ	120	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
16	employing	_	employ	_	VBG	120	_	_	_	_	_	_	_	O
17	active	_	active	_	JJ	120	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
19	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	O
20	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	120	_	_	_	_	_	_	_	O
22	encompasses	_	encompass	_	VBZ	120	_	_	_	_	_	_	_	O
23	:	_	:	_	:	120	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	O
25	technique	_	technique	_	NN	120	_	_	_	_	_	_	_	O
26	,	_	,	_	,	120	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	120	_	_	_	_	_	_	_	O
28	rotating	_	UNK	_	VBG	120	_	_	_	_	_	_	_	O
29	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	O
30	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	120	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	120	_	_	_	_	_	_	_	O
33	repeated	_	repeat	_	VBN	120	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	120	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	120	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	120	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	120	_	_	_	_	_	same.a	Identicality	O
38	point	_	point	_	NN	120	_	_	_	_	_	_	_	B-Type
39	within	_	within	_	IN	120	_	_	_	_	_	_	_	I-Type
40	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	I-Type
41	continuing	_	continue	_	VBG	120	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	120	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	120	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	120	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	120	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	120	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	120	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	120	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	120	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	120	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	120	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	120	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	120	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	120	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	120	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	120	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	120	_	_	_	_	_	_	_	O
11	,	_	,	_	,	120	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	120	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	120	_	_	_	_	_	_	_	O
14	structured	_	UNK	_	JJ	120	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
16	employing	_	employ	_	VBG	120	_	_	_	_	_	_	_	O
17	active	_	active	_	JJ	120	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
19	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	O
20	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	120	_	_	_	_	_	_	_	O
22	encompasses	_	encompass	_	VBZ	120	_	_	_	_	_	_	_	O
23	:	_	:	_	:	120	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	O
25	technique	_	technique	_	NN	120	_	_	_	_	_	_	_	O
26	,	_	,	_	,	120	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	120	_	_	_	_	_	_	_	O
28	rotating	_	UNK	_	VBG	120	_	_	_	_	_	_	_	O
29	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	O
30	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	120	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	120	_	_	_	_	_	_	_	O
33	repeated	_	repeat	_	VBN	120	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	120	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	120	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	120	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	120	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	120	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	120	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	120	_	_	_	_	_	site.n	Locale_by_use	S-Locale
41	continuing	_	continue	_	VBG	120	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	120	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	120	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	120	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	120	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	120	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	120	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	120	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	120	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	120	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	120	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	120	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	120	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	120	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	120	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	120	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	120	_	_	_	_	_	_	_	O
11	,	_	,	_	,	120	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	120	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	120	_	_	_	_	_	_	_	O
14	structured	_	UNK	_	JJ	120	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
16	employing	_	employ	_	VBG	120	_	_	_	_	_	_	_	O
17	active	_	active	_	JJ	120	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
19	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	O
20	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	120	_	_	_	_	_	_	_	O
22	encompasses	_	encompass	_	VBZ	120	_	_	_	_	_	_	_	O
23	:	_	:	_	:	120	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	O
25	technique	_	technique	_	NN	120	_	_	_	_	_	_	_	O
26	,	_	,	_	,	120	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	120	_	_	_	_	_	_	_	O
28	rotating	_	UNK	_	VBG	120	_	_	_	_	_	_	_	O
29	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	O
30	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	120	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	120	_	_	_	_	_	_	_	O
33	repeated	_	repeat	_	VBN	120	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	120	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	120	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	120	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	120	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	120	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	120	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	S-Activity
41	continuing	_	continue	_	VBG	120	_	_	_	_	_	continue.v	Activity_ongoing	O
42	telephone	_	telephone	_	NN	120	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	120	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	120	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	120	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	120	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	120	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	120	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	120	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	120	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	120	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	120	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	120	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	120	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	120	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	120	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	120	_	_	_	_	_	_	_	O
11	,	_	,	_	,	120	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	120	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	120	_	_	_	_	_	_	_	O
14	structured	_	UNK	_	JJ	120	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
16	employing	_	employ	_	VBG	120	_	_	_	_	_	_	_	O
17	active	_	active	_	JJ	120	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
19	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	O
20	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	120	_	_	_	_	_	_	_	O
22	encompasses	_	encompass	_	VBZ	120	_	_	_	_	_	_	_	O
23	:	_	:	_	:	120	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	O
25	technique	_	technique	_	NN	120	_	_	_	_	_	_	_	O
26	,	_	,	_	,	120	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	120	_	_	_	_	_	_	_	O
28	rotating	_	UNK	_	VBG	120	_	_	_	_	_	_	_	O
29	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	O
30	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	120	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	120	_	_	_	_	_	_	_	O
33	repeated	_	repeat	_	VBN	120	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	120	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	120	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	120	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	120	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	120	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	120	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	O
41	continuing	_	continue	_	VBG	120	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	120	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	120	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	120	_	_	_	_	_	_	_	S-Mass
45	dose	_	dose	_	JJ	120	_	_	_	_	_	dose.n	Quantified_mass	S-Quantity
46	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	120	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	120	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	120	_	_	_	_	_	_	_	O
50	dietary	_	UNK	_	JJ	120	_	_	_	_	_	_	_	O
51	understanding	_	understanding	_	NN	120	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	120	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	120	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	120	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	120	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	120	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	120	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	120	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	120	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	120	_	_	_	_	_	_	_	O
11	,	_	,	_	,	120	_	_	_	_	_	_	_	O
12	use	_	use	_	VBP	120	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	120	_	_	_	_	_	_	_	O
14	structured	_	UNK	_	JJ	120	_	_	_	_	_	_	_	O
15	programme	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
16	employing	_	employ	_	VBG	120	_	_	_	_	_	_	_	O
17	active	_	active	_	JJ	120	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
19	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	O
20	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	120	_	_	_	_	_	_	_	O
22	encompasses	_	encompass	_	VBZ	120	_	_	_	_	_	_	_	O
23	:	_	:	_	:	120	_	_	_	_	_	_	_	O
24	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	O
25	technique	_	technique	_	NN	120	_	_	_	_	_	_	_	O
26	,	_	,	_	,	120	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	120	_	_	_	_	_	_	_	O
28	rotating	_	UNK	_	VBG	120	_	_	_	_	_	_	_	O
29	injection	_	injection	_	NN	120	_	_	_	_	_	_	_	O
30	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	O
31	and	_	and	_	CC	120	_	_	_	_	_	_	_	O
32	avoiding	_	avoid	_	VBG	120	_	_	_	_	_	_	_	O
33	repeated	_	repeat	_	VBN	120	_	_	_	_	_	_	_	O
34	injections	_	injection	_	NNS	120	_	_	_	_	_	_	_	O
35	at	_	at	_	IN	120	_	_	_	_	_	_	_	O
36	the	_	the	_	DT	120	_	_	_	_	_	_	_	O
37	same	_	same	_	JJ	120	_	_	_	_	_	_	_	O
38	point	_	point	_	NN	120	_	_	_	_	_	_	_	O
39	within	_	within	_	IN	120	_	_	_	_	_	_	_	O
40	sites	_	site	_	NNS	120	_	_	_	_	_	_	_	O
41	continuing	_	continue	_	VBG	120	_	_	_	_	_	_	_	O
42	telephone	_	telephone	_	NN	120	_	_	_	_	_	_	_	O
43	support	_	support	_	NN	120	_	_	_	_	_	_	_	O
44	self-monitoring	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
45	dose	_	dose	_	JJ	120	_	_	_	_	_	_	_	O
46	titration	_	UNK	_	NN	120	_	_	_	_	_	_	_	O
47	to	_	to	_	TO	120	_	_	_	_	_	_	_	O
48	target	_	target	_	NN	120	_	_	_	_	_	_	_	O
49	levels	_	level	_	NNS	120	_	_	_	_	_	_	_	B-Content
50	dietary	_	UNK	_	JJ	120	_	_	_	_	_	_	_	I-Content
51	understanding	_	understanding	_	NN	120	_	_	_	_	_	understanding.n	Awareness	O

1	when	_	When	_	WRB	121	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	121	_	_	_	_	_	start.v	Activity_start	O
3	insulin	_	UNK	_	NN	121	_	_	_	_	_	_	_	B-Activity
4	therapy	_	therapy	_	NN	121	_	_	_	_	_	_	_	I-Activity
5	in	_	in	_	IN	121	_	_	_	_	_	_	_	I-Activity
6	adults	_	adult	_	NNS	121	_	_	_	_	_	_	_	I-Activity
7	with	_	with	_	IN	121	_	_	_	_	_	_	_	I-Activity
8	type	_	type	_	JJ	121	_	_	_	_	_	_	_	I-Activity
9	2	_	2	_	CD	121	_	_	_	_	_	_	_	I-Activity
10	diabetes	_	UNK	_	NNS	121	_	_	_	_	_	_	_	I-Activity
11	,	_	,	_	,	121	_	_	_	_	_	_	_	O
12	continue	_	continue	_	VBP	121	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	121	_	_	_	_	_	_	_	O
14	offer	_	offer	_	VB	121	_	_	_	_	_	_	_	O
15	metformin	_	UNK	_	NN	121	_	_	_	_	_	_	_	O
16	for	_	for	_	IN	121	_	_	_	_	_	_	_	O
17	people	_	people	_	NNS	121	_	_	_	_	_	_	_	O
18	without	_	without	_	IN	121	_	_	_	_	_	_	_	O
19	contraindications	_	UNK	_	NNS	121	_	_	_	_	_	_	_	O
20	or	_	or	_	CC	121	_	_	_	_	_	_	_	O
21	intolerance	_	UNK	_	NN	121	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	121	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	121	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	121	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	121	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	121	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	121	_	_	_	_	_	adult.n	People_by_age	S-Person
7	with	_	with	_	IN	121	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	121	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	121	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	121	_	_	_	_	_	_	_	O
11	,	_	,	_	,	121	_	_	_	_	_	_	_	O
12	continue	_	continue	_	VBP	121	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	121	_	_	_	_	_	_	_	O
14	offer	_	offer	_	VB	121	_	_	_	_	_	_	_	O
15	metformin	_	UNK	_	NN	121	_	_	_	_	_	_	_	O
16	for	_	for	_	IN	121	_	_	_	_	_	_	_	O
17	people	_	people	_	NNS	121	_	_	_	_	_	_	_	O
18	without	_	without	_	IN	121	_	_	_	_	_	_	_	O
19	contraindications	_	UNK	_	NNS	121	_	_	_	_	_	_	_	O
20	or	_	or	_	CC	121	_	_	_	_	_	_	_	O
21	intolerance	_	UNK	_	NN	121	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	121	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	121	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	121	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	121	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	121	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	121	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	121	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	121	_	_	_	_	_	type.n	Type	S-Subtype
9	2	_	2	_	CD	121	_	_	_	_	_	_	_	B-Category
10	diabetes	_	UNK	_	NNS	121	_	_	_	_	_	_	_	I-Category
11	,	_	,	_	,	121	_	_	_	_	_	_	_	O
12	continue	_	continue	_	VBP	121	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	121	_	_	_	_	_	_	_	O
14	offer	_	offer	_	VB	121	_	_	_	_	_	_	_	O
15	metformin	_	UNK	_	NN	121	_	_	_	_	_	_	_	O
16	for	_	for	_	IN	121	_	_	_	_	_	_	_	O
17	people	_	people	_	NNS	121	_	_	_	_	_	_	_	O
18	without	_	without	_	IN	121	_	_	_	_	_	_	_	O
19	contraindications	_	UNK	_	NNS	121	_	_	_	_	_	_	_	O
20	or	_	or	_	CC	121	_	_	_	_	_	_	_	O
21	intolerance	_	UNK	_	NN	121	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	121	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	121	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	121	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	121	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	121	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	121	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	121	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	121	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	121	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	121	_	_	_	_	_	_	_	O
11	,	_	,	_	,	121	_	_	_	_	_	_	_	O
12	continue	_	continue	_	VBP	121	_	_	_	_	_	continue.v	Activity_ongoing	O
13	to	_	to	_	TO	121	_	_	_	_	_	_	_	B-Activity
14	offer	_	offer	_	VB	121	_	_	_	_	_	_	_	I-Activity
15	metformin	_	UNK	_	NN	121	_	_	_	_	_	_	_	I-Activity
16	for	_	for	_	IN	121	_	_	_	_	_	_	_	I-Activity
17	people	_	people	_	NNS	121	_	_	_	_	_	_	_	I-Activity
18	without	_	without	_	IN	121	_	_	_	_	_	_	_	I-Activity
19	contraindications	_	UNK	_	NNS	121	_	_	_	_	_	_	_	I-Activity
20	or	_	or	_	CC	121	_	_	_	_	_	_	_	I-Activity
21	intolerance	_	UNK	_	NN	121	_	_	_	_	_	_	_	I-Activity

1	when	_	When	_	WRB	121	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	121	_	_	_	_	_	_	_	O
3	insulin	_	UNK	_	NN	121	_	_	_	_	_	_	_	O
4	therapy	_	therapy	_	NN	121	_	_	_	_	_	_	_	O
5	in	_	in	_	IN	121	_	_	_	_	_	_	_	O
6	adults	_	adult	_	NNS	121	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	121	_	_	_	_	_	_	_	O
8	type	_	type	_	JJ	121	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	121	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	121	_	_	_	_	_	_	_	O
11	,	_	,	_	,	121	_	_	_	_	_	_	_	O
12	continue	_	continue	_	VBP	121	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	121	_	_	_	_	_	_	_	O
14	offer	_	offer	_	VB	121	_	_	_	_	_	_	_	O
15	metformin	_	UNK	_	NN	121	_	_	_	_	_	_	_	O
16	for	_	for	_	IN	121	_	_	_	_	_	_	_	O
17	people	_	people	_	NNS	121	_	_	_	_	_	people.n	People	S-Person
18	without	_	without	_	IN	121	_	_	_	_	_	_	_	O
19	contraindications	_	UNK	_	NNS	121	_	_	_	_	_	_	_	O
20	or	_	or	_	CC	121	_	_	_	_	_	_	_	O
21	intolerance	_	UNK	_	NN	121	_	_	_	_	_	_	_	O

1	review	_	Review	_	VB	122	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	122	_	_	_	_	_	_	_	O
3	continued	_	continued	_	JJ	122	_	_	_	_	_	_	_	S-Degree
4	need	_	need	_	NN	122	_	_	_	_	_	need.n	Needing	O
5	for	_	for	_	IN	122	_	_	_	_	_	_	_	B-Dependent
6	other	_	other	_	JJ	122	_	_	_	_	_	_	_	I-Dependent
7	blood	_	blood	_	NN	122	_	_	_	_	_	_	_	I-Dependent
8	glucose	_	UNK	_	JJ	122	_	_	_	_	_	_	_	I-Dependent
9	lowering	_	lower	_	VBG	122	_	_	_	_	_	_	_	I-Dependent
10	therapies	_	therapy	_	NNS	122	_	_	_	_	_	_	_	I-Dependent
11	.	_	.	_	.	122	_	_	_	_	_	_	_	O

1	review	_	Review	_	VB	122	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	122	_	_	_	_	_	_	_	O
3	continued	_	continued	_	JJ	122	_	_	_	_	_	_	_	O
4	need	_	need	_	NN	122	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	122	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	122	_	_	_	_	_	other.a	Increment	O
7	blood	_	blood	_	NN	122	_	_	_	_	_	_	_	B-Class
8	glucose	_	UNK	_	JJ	122	_	_	_	_	_	_	_	I-Class
9	lowering	_	lower	_	VBG	122	_	_	_	_	_	_	_	I-Class
10	therapies	_	therapy	_	NNS	122	_	_	_	_	_	_	_	I-Class
11	.	_	.	_	.	122	_	_	_	_	_	_	_	O

1	review	_	Review	_	VB	122	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	122	_	_	_	_	_	_	_	O
3	continued	_	continued	_	JJ	122	_	_	_	_	_	_	_	O
4	need	_	need	_	NN	122	_	_	_	_	_	_	_	O
5	for	_	for	_	IN	122	_	_	_	_	_	_	_	O
6	other	_	other	_	JJ	122	_	_	_	_	_	_	_	O
7	blood	_	blood	_	NN	122	_	_	_	_	_	_	_	B-Item
8	glucose	_	UNK	_	JJ	122	_	_	_	_	_	_	_	I-Item
9	lowering	_	lower	_	VBG	122	_	_	_	_	_	lower.v	Cause_change_of_position_on_a_scale	O
10	therapies	_	therapy	_	NNS	122	_	_	_	_	_	_	_	O
11	.	_	.	_	.	122	_	_	_	_	_	_	_	O

1	start	_	UNK	_	NNP	123	_	_	_	_	_	_	_	O
2	insulin	_	UNK	_	NN	123	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	123	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	123	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	123	_	_	_	_	_	adult.n	People_by_age	S-Person
6	with	_	with	_	IN	123	_	_	_	_	_	_	_	O
7	type	_	type	_	JJ	123	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	123	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	123	_	_	_	_	_	_	_	O
10	from	_	from	_	IN	123	_	_	_	_	_	_	_	O
11	a	_	a	_	DT	123	_	_	_	_	_	_	_	O
12	choice	_	choice	_	NN	123	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	123	_	_	_	_	_	_	_	O
14	a	_	a	_	DT	123	_	_	_	_	_	_	_	O
15	number	_	number	_	NN	123	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	123	_	_	_	_	_	_	_	O
17	insulin	_	UNK	_	NN	123	_	_	_	_	_	_	_	O
18	types	_	type	_	NNS	123	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	123	_	_	_	_	_	_	_	O
20	regimens	_	UNK	_	NNS	123	_	_	_	_	_	_	_	O
21	:	_	:	_	:	123	_	_	_	_	_	_	_	O

1	start	_	UNK	_	NNP	123	_	_	_	_	_	_	_	O
2	insulin	_	UNK	_	NN	123	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	123	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	123	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	123	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	123	_	_	_	_	_	_	_	O
7	type	_	type	_	JJ	123	_	_	_	_	_	type.n	Type	S-Subtype
8	2	_	2	_	CD	123	_	_	_	_	_	_	_	B-Category
9	diabetes	_	UNK	_	NNS	123	_	_	_	_	_	_	_	I-Category
10	from	_	from	_	IN	123	_	_	_	_	_	_	_	O
11	a	_	a	_	DT	123	_	_	_	_	_	_	_	O
12	choice	_	choice	_	NN	123	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	123	_	_	_	_	_	_	_	O
14	a	_	a	_	DT	123	_	_	_	_	_	_	_	O
15	number	_	number	_	NN	123	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	123	_	_	_	_	_	_	_	O
17	insulin	_	UNK	_	NN	123	_	_	_	_	_	_	_	O
18	types	_	type	_	NNS	123	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	123	_	_	_	_	_	_	_	O
20	regimens	_	UNK	_	NNS	123	_	_	_	_	_	_	_	O
21	:	_	:	_	:	123	_	_	_	_	_	_	_	O

1	start	_	UNK	_	NNP	123	_	_	_	_	_	_	_	O
2	insulin	_	UNK	_	NN	123	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	123	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	123	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	123	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	123	_	_	_	_	_	_	_	O
7	type	_	type	_	JJ	123	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	123	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	123	_	_	_	_	_	_	_	O
10	from	_	from	_	IN	123	_	_	_	_	_	_	_	O
11	a	_	a	_	DT	123	_	_	_	_	_	_	_	O
12	choice	_	choice	_	NN	123	_	_	_	_	_	choice.n	Choosing	O
13	of	_	of	_	IN	123	_	_	_	_	_	_	_	B-Topic
14	a	_	a	_	DT	123	_	_	_	_	_	_	_	I-Topic
15	number	_	number	_	NN	123	_	_	_	_	_	_	_	I-Topic
16	of	_	of	_	IN	123	_	_	_	_	_	_	_	I-Topic
17	insulin	_	UNK	_	NN	123	_	_	_	_	_	_	_	I-Topic
18	types	_	type	_	NNS	123	_	_	_	_	_	_	_	I-Topic
19	and	_	and	_	CC	123	_	_	_	_	_	_	_	I-Topic
20	regimens	_	UNK	_	NNS	123	_	_	_	_	_	_	_	I-Topic
21	:	_	:	_	:	123	_	_	_	_	_	_	_	O

1	start	_	UNK	_	NNP	123	_	_	_	_	_	_	_	O
2	insulin	_	UNK	_	NN	123	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	123	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	123	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	123	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	123	_	_	_	_	_	_	_	O
7	type	_	type	_	JJ	123	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	123	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	123	_	_	_	_	_	_	_	O
10	from	_	from	_	IN	123	_	_	_	_	_	_	_	O
11	a	_	a	_	DT	123	_	_	_	_	_	_	_	O
12	choice	_	choice	_	NN	123	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	123	_	_	_	_	_	_	_	O
14	a	_	a	_	DT	123	_	_	_	_	_	_	_	O
15	number	_	number	_	NN	123	_	_	_	_	_	number.n	Cardinal_numbers	S-Number
16	of	_	of	_	IN	123	_	_	_	_	_	_	_	B-Entity
17	insulin	_	UNK	_	NN	123	_	_	_	_	_	_	_	I-Entity
18	types	_	type	_	NNS	123	_	_	_	_	_	_	_	I-Entity
19	and	_	and	_	CC	123	_	_	_	_	_	_	_	I-Entity
20	regimens	_	UNK	_	NNS	123	_	_	_	_	_	_	_	I-Entity
21	:	_	:	_	:	123	_	_	_	_	_	_	_	O

1	start	_	UNK	_	NNP	123	_	_	_	_	_	_	_	O
2	insulin	_	UNK	_	NN	123	_	_	_	_	_	_	_	O
3	therapy	_	therapy	_	NN	123	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	123	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	123	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	123	_	_	_	_	_	_	_	O
7	type	_	type	_	JJ	123	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	123	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	123	_	_	_	_	_	_	_	O
10	from	_	from	_	IN	123	_	_	_	_	_	_	_	O
11	a	_	a	_	DT	123	_	_	_	_	_	_	_	O
12	choice	_	choice	_	NN	123	_	_	_	_	_	_	_	O
13	of	_	of	_	IN	123	_	_	_	_	_	_	_	O
14	a	_	a	_	DT	123	_	_	_	_	_	_	_	O
15	number	_	number	_	NN	123	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	123	_	_	_	_	_	_	_	O
17	insulin	_	UNK	_	NN	123	_	_	_	_	_	_	_	S-Category
18	types	_	type	_	NNS	123	_	_	_	_	_	type.n	Type	S-Subtype
19	and	_	and	_	CC	123	_	_	_	_	_	_	_	O
20	regimens	_	UNK	_	NNS	123	_	_	_	_	_	_	_	O
21	:	_	:	_	:	123	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	124	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	124	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	124	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	124	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	124	_	_	_	_	_	_	_	O
6	:	_	:	_	:	124	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	124	_	_	_	_	_	_	_	O
8	(	_	(	_	(	124	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	124	_	_	_	_	_	_	_	O
10	)	_	)	_	)	124	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	124	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	124	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	124	_	_	_	_	_	_	_	O
14	)	_	)	_	)	124	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	124	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	124	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	124	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	124	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	124	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	124	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	124	_	_	_	_	_	_	_	O
8	(	_	(	_	(	124	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	124	_	_	_	_	_	_	_	O
10	)	_	)	_	)	124	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	124	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	124	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	124	_	_	_	_	_	_	_	O
14	)	_	)	_	)	124	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	125	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	125	_	_	_	_	_	start.v	Process_start	O
3	both	_	both	_	DT	125	_	_	_	_	_	_	_	B-Event
4	nph	_	UNK	_	NNP	125	_	_	_	_	_	_	_	I-Event
5	and	_	and	_	CC	125	_	_	_	_	_	_	_	I-Event
6	short-acting	_	UNK	_	JJ	125	_	_	_	_	_	_	_	I-Event
7	insulin	_	UNK	_	NN	125	_	_	_	_	_	_	_	I-Event
8	(	_	(	_	(	125	_	_	_	_	_	_	_	O
9	particularly	_	particularly	_	RB	125	_	_	_	_	_	_	_	O
10	if	_	if	_	IN	125	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	125	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	125	_	_	_	_	_	_	_	O
13	's	_	's	_	POS	125	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	125	_	_	_	_	_	_	_	O
2	starting	_	start	_	VBG	125	_	_	_	_	_	_	_	O
3	both	_	both	_	DT	125	_	_	_	_	_	_	_	O
4	nph	_	UNK	_	NNP	125	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	125	_	_	_	_	_	_	_	O
6	short-acting	_	UNK	_	JJ	125	_	_	_	_	_	_	_	O
7	insulin	_	UNK	_	NN	125	_	_	_	_	_	_	_	O
8	(	_	(	_	(	125	_	_	_	_	_	_	_	O
9	particularly	_	particularly	_	RB	125	_	_	_	_	_	_	_	O
10	if	_	if	_	IN	125	_	_	_	_	_	_	_	O
11	the	_	the	_	DT	125	_	_	_	_	_	_	_	O
12	person	_	person	_	NN	125	_	_	_	_	_	person.n	People	S-Person
13	's	_	's	_	POS	125	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
2	,	_	,	_	,	126	_	_	_	_	_	_	_	O
3	as	_	a	_	IN	126	_	_	_	_	_	_	_	O
4	an	_	an	_	DT	126	_	_	_	_	_	_	_	O
5	alternative	_	alternative	_	NN	126	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
7	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	O
8	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
9	,	_	,	_	,	126	_	_	_	_	_	_	_	O
10	using	_	use	_	VBG	126	_	_	_	_	_	use.v	Using	O
11	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	B-Instrument
12	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	I-Instrument
13	or	_	or	_	CC	126	_	_	_	_	_	_	_	I-Instrument
14	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	I-Instrument
15	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	I-Instrument
16	if	_	if	_	IN	126	_	_	_	_	_	_	_	O
17	:	_	:	_	:	126	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
20	needs	_	need	_	VBZ	126	_	_	_	_	_	_	_	O
21	assistance	_	assistance	_	NN	126	_	_	_	_	_	_	_	O
22	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
23	a	_	a	_	DT	126	_	_	_	_	_	_	_	O
24	carer	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
25	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
26	healthcare	_	healthcare	_	JJ	126	_	_	_	_	_	_	_	O
27	professional	_	professional	_	JJ	126	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
29	inject	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
30	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
31	,	_	,	_	,	126	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	126	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	126	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	126	_	_	_	_	_	_	_	O
35	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
37	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
38	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
40	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
41	reduce	_	reduce	_	VB	126	_	_	_	_	_	_	_	O
42	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
43	frequency	_	frequency	_	NN	126	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	126	_	_	_	_	_	_	_	O
45	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	O
46	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
47	twice	_	twice	_	RB	126	_	_	_	_	_	_	_	O
48	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
49	once	_	once	_	VB	126	_	_	_	_	_	_	_	O
50	daily	_	daily	_	JJ	126	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
52	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
53	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
54	's	_	's	_	POS	126	_	_	_	_	_	_	_	O
55	lifestyle	_	lifestyle	_	NN	126	_	_	_	_	_	_	_	O
56	is	_	be	_	VBZ	126	_	_	_	_	_	_	_	O
57	restricted	_	restrict	_	VBN	126	_	_	_	_	_	_	_	O
58	by	_	by	_	IN	126	_	_	_	_	_	_	_	O
59	recurrent	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
60	symptomatic	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
61	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
62	episodes	_	episode	_	NNS	126	_	_	_	_	_	_	_	O
63	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
64	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
65	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
66	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
67	otherwise	_	otherwise	_	VB	126	_	_	_	_	_	_	_	O
68	need	_	need	_	VB	126	_	_	_	_	_	_	_	O
69	twice-daily	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
70	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	O
71	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
72	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	O
73	in	_	in	_	IN	126	_	_	_	_	_	_	_	O
74	combination	_	combination	_	NN	126	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	126	_	_	_	_	_	_	_	O
76	oral	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
77	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
78	drugs	_	drug	_	NNS	126	_	_	_	_	_	_	_	O
79	.	_	.	_	.	126	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
2	,	_	,	_	,	126	_	_	_	_	_	_	_	O
3	as	_	a	_	IN	126	_	_	_	_	_	_	_	O
4	an	_	an	_	DT	126	_	_	_	_	_	_	_	O
5	alternative	_	alternative	_	NN	126	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
7	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	O
8	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
9	,	_	,	_	,	126	_	_	_	_	_	_	_	O
10	using	_	use	_	VBG	126	_	_	_	_	_	_	_	O
11	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
12	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
16	if	_	if	_	IN	126	_	_	_	_	_	_	_	O
17	:	_	:	_	:	126	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	126	_	_	_	_	_	person.n	People	S-Person
20	needs	_	need	_	VBZ	126	_	_	_	_	_	_	_	O
21	assistance	_	assistance	_	NN	126	_	_	_	_	_	_	_	O
22	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
23	a	_	a	_	DT	126	_	_	_	_	_	_	_	O
24	carer	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
25	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
26	healthcare	_	healthcare	_	JJ	126	_	_	_	_	_	_	_	O
27	professional	_	professional	_	JJ	126	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
29	inject	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
30	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
31	,	_	,	_	,	126	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	126	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	126	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	126	_	_	_	_	_	_	_	O
35	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
37	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
38	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
40	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
41	reduce	_	reduce	_	VB	126	_	_	_	_	_	_	_	O
42	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
43	frequency	_	frequency	_	NN	126	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	126	_	_	_	_	_	_	_	O
45	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	O
46	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
47	twice	_	twice	_	RB	126	_	_	_	_	_	_	_	O
48	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
49	once	_	once	_	VB	126	_	_	_	_	_	_	_	O
50	daily	_	daily	_	JJ	126	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
52	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
53	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
54	's	_	's	_	POS	126	_	_	_	_	_	_	_	O
55	lifestyle	_	lifestyle	_	NN	126	_	_	_	_	_	_	_	O
56	is	_	be	_	VBZ	126	_	_	_	_	_	_	_	O
57	restricted	_	restrict	_	VBN	126	_	_	_	_	_	_	_	O
58	by	_	by	_	IN	126	_	_	_	_	_	_	_	O
59	recurrent	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
60	symptomatic	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
61	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
62	episodes	_	episode	_	NNS	126	_	_	_	_	_	_	_	O
63	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
64	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
65	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
66	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
67	otherwise	_	otherwise	_	VB	126	_	_	_	_	_	_	_	O
68	need	_	need	_	VB	126	_	_	_	_	_	_	_	O
69	twice-daily	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
70	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	O
71	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
72	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	O
73	in	_	in	_	IN	126	_	_	_	_	_	_	_	O
74	combination	_	combination	_	NN	126	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	126	_	_	_	_	_	_	_	O
76	oral	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
77	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
78	drugs	_	drug	_	NNS	126	_	_	_	_	_	_	_	O
79	.	_	.	_	.	126	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
2	,	_	,	_	,	126	_	_	_	_	_	_	_	O
3	as	_	a	_	IN	126	_	_	_	_	_	_	_	O
4	an	_	an	_	DT	126	_	_	_	_	_	_	_	O
5	alternative	_	alternative	_	NN	126	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
7	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	O
8	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
9	,	_	,	_	,	126	_	_	_	_	_	_	_	O
10	using	_	use	_	VBG	126	_	_	_	_	_	_	_	O
11	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
12	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
16	if	_	if	_	IN	126	_	_	_	_	_	_	_	O
17	:	_	:	_	:	126	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	126	_	_	_	_	_	_	_	B-Cognizer
19	person	_	person	_	NN	126	_	_	_	_	_	_	_	I-Cognizer
20	needs	_	need	_	VBZ	126	_	_	_	_	_	need.v	Needing	O
21	assistance	_	assistance	_	NN	126	_	_	_	_	_	_	_	S-Requirement
22	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
23	a	_	a	_	DT	126	_	_	_	_	_	_	_	O
24	carer	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
25	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
26	healthcare	_	healthcare	_	JJ	126	_	_	_	_	_	_	_	O
27	professional	_	professional	_	JJ	126	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
29	inject	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
30	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
31	,	_	,	_	,	126	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	126	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	126	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	126	_	_	_	_	_	_	_	O
35	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
37	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
38	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
40	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
41	reduce	_	reduce	_	VB	126	_	_	_	_	_	_	_	O
42	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
43	frequency	_	frequency	_	NN	126	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	126	_	_	_	_	_	_	_	O
45	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	O
46	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
47	twice	_	twice	_	RB	126	_	_	_	_	_	_	_	O
48	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
49	once	_	once	_	VB	126	_	_	_	_	_	_	_	O
50	daily	_	daily	_	JJ	126	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
52	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
53	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
54	's	_	's	_	POS	126	_	_	_	_	_	_	_	O
55	lifestyle	_	lifestyle	_	NN	126	_	_	_	_	_	_	_	O
56	is	_	be	_	VBZ	126	_	_	_	_	_	_	_	O
57	restricted	_	restrict	_	VBN	126	_	_	_	_	_	_	_	O
58	by	_	by	_	IN	126	_	_	_	_	_	_	_	O
59	recurrent	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
60	symptomatic	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
61	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
62	episodes	_	episode	_	NNS	126	_	_	_	_	_	_	_	O
63	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
64	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
65	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
66	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
67	otherwise	_	otherwise	_	VB	126	_	_	_	_	_	_	_	O
68	need	_	need	_	VB	126	_	_	_	_	_	_	_	O
69	twice-daily	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
70	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	O
71	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
72	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	O
73	in	_	in	_	IN	126	_	_	_	_	_	_	_	O
74	combination	_	combination	_	NN	126	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	126	_	_	_	_	_	_	_	O
76	oral	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
77	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
78	drugs	_	drug	_	NNS	126	_	_	_	_	_	_	_	O
79	.	_	.	_	.	126	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
2	,	_	,	_	,	126	_	_	_	_	_	_	_	O
3	as	_	a	_	IN	126	_	_	_	_	_	_	_	O
4	an	_	an	_	DT	126	_	_	_	_	_	_	_	O
5	alternative	_	alternative	_	NN	126	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
7	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	O
8	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
9	,	_	,	_	,	126	_	_	_	_	_	_	_	O
10	using	_	use	_	VBG	126	_	_	_	_	_	_	_	O
11	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
12	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
16	if	_	if	_	IN	126	_	_	_	_	_	_	_	O
17	:	_	:	_	:	126	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	126	_	_	_	_	_	_	_	S-Helper
20	needs	_	need	_	VBZ	126	_	_	_	_	_	_	_	O
21	assistance	_	assistance	_	NN	126	_	_	_	_	_	assistance.n	Assistance	O
22	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
23	a	_	a	_	DT	126	_	_	_	_	_	_	_	O
24	carer	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
25	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
26	healthcare	_	healthcare	_	JJ	126	_	_	_	_	_	_	_	O
27	professional	_	professional	_	JJ	126	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
29	inject	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
30	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
31	,	_	,	_	,	126	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	126	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	126	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	126	_	_	_	_	_	_	_	O
35	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
37	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
38	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
40	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
41	reduce	_	reduce	_	VB	126	_	_	_	_	_	_	_	O
42	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
43	frequency	_	frequency	_	NN	126	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	126	_	_	_	_	_	_	_	O
45	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	O
46	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
47	twice	_	twice	_	RB	126	_	_	_	_	_	_	_	O
48	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
49	once	_	once	_	VB	126	_	_	_	_	_	_	_	O
50	daily	_	daily	_	JJ	126	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
52	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
53	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
54	's	_	's	_	POS	126	_	_	_	_	_	_	_	O
55	lifestyle	_	lifestyle	_	NN	126	_	_	_	_	_	_	_	O
56	is	_	be	_	VBZ	126	_	_	_	_	_	_	_	O
57	restricted	_	restrict	_	VBN	126	_	_	_	_	_	_	_	O
58	by	_	by	_	IN	126	_	_	_	_	_	_	_	O
59	recurrent	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
60	symptomatic	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
61	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
62	episodes	_	episode	_	NNS	126	_	_	_	_	_	_	_	O
63	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
64	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
65	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
66	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
67	otherwise	_	otherwise	_	VB	126	_	_	_	_	_	_	_	O
68	need	_	need	_	VB	126	_	_	_	_	_	_	_	O
69	twice-daily	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
70	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	O
71	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
72	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	O
73	in	_	in	_	IN	126	_	_	_	_	_	_	_	O
74	combination	_	combination	_	NN	126	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	126	_	_	_	_	_	_	_	O
76	oral	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
77	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
78	drugs	_	drug	_	NNS	126	_	_	_	_	_	_	_	O
79	.	_	.	_	.	126	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
2	,	_	,	_	,	126	_	_	_	_	_	_	_	O
3	as	_	a	_	IN	126	_	_	_	_	_	_	_	O
4	an	_	an	_	DT	126	_	_	_	_	_	_	_	O
5	alternative	_	alternative	_	NN	126	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
7	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	O
8	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
9	,	_	,	_	,	126	_	_	_	_	_	_	_	O
10	using	_	use	_	VBG	126	_	_	_	_	_	_	_	O
11	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
12	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
16	if	_	if	_	IN	126	_	_	_	_	_	_	_	O
17	:	_	:	_	:	126	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
20	needs	_	need	_	VBZ	126	_	_	_	_	_	_	_	O
21	assistance	_	assistance	_	NN	126	_	_	_	_	_	_	_	O
22	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
23	a	_	a	_	DT	126	_	_	_	_	_	_	_	O
24	carer	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
25	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
26	healthcare	_	healthcare	_	JJ	126	_	_	_	_	_	_	_	O
27	professional	_	professional	_	JJ	126	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
29	inject	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
30	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
31	,	_	,	_	,	126	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	126	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	126	_	_	_	_	_	use.n	Using	O
34	of	_	of	_	IN	126	_	_	_	_	_	_	_	B-Instrument
35	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	I-Instrument
36	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	I-Instrument
37	or	_	or	_	CC	126	_	_	_	_	_	_	_	I-Instrument
38	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	I-Instrument
39	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	I-Instrument
40	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
41	reduce	_	reduce	_	VB	126	_	_	_	_	_	_	_	O
42	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
43	frequency	_	frequency	_	NN	126	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	126	_	_	_	_	_	_	_	O
45	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	O
46	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
47	twice	_	twice	_	RB	126	_	_	_	_	_	_	_	O
48	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
49	once	_	once	_	VB	126	_	_	_	_	_	_	_	O
50	daily	_	daily	_	JJ	126	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
52	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
53	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
54	's	_	's	_	POS	126	_	_	_	_	_	_	_	O
55	lifestyle	_	lifestyle	_	NN	126	_	_	_	_	_	_	_	O
56	is	_	be	_	VBZ	126	_	_	_	_	_	_	_	O
57	restricted	_	restrict	_	VBN	126	_	_	_	_	_	_	_	O
58	by	_	by	_	IN	126	_	_	_	_	_	_	_	O
59	recurrent	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
60	symptomatic	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
61	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
62	episodes	_	episode	_	NNS	126	_	_	_	_	_	_	_	O
63	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
64	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
65	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
66	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
67	otherwise	_	otherwise	_	VB	126	_	_	_	_	_	_	_	O
68	need	_	need	_	VB	126	_	_	_	_	_	_	_	O
69	twice-daily	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
70	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	O
71	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
72	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	O
73	in	_	in	_	IN	126	_	_	_	_	_	_	_	O
74	combination	_	combination	_	NN	126	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	126	_	_	_	_	_	_	_	O
76	oral	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
77	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
78	drugs	_	drug	_	NNS	126	_	_	_	_	_	_	_	O
79	.	_	.	_	.	126	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
2	,	_	,	_	,	126	_	_	_	_	_	_	_	O
3	as	_	a	_	IN	126	_	_	_	_	_	_	_	O
4	an	_	an	_	DT	126	_	_	_	_	_	_	_	O
5	alternative	_	alternative	_	NN	126	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
7	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	O
8	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
9	,	_	,	_	,	126	_	_	_	_	_	_	_	O
10	using	_	use	_	VBG	126	_	_	_	_	_	_	_	O
11	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
12	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
16	if	_	if	_	IN	126	_	_	_	_	_	_	_	O
17	:	_	:	_	:	126	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
20	needs	_	need	_	VBZ	126	_	_	_	_	_	_	_	O
21	assistance	_	assistance	_	NN	126	_	_	_	_	_	_	_	B-Agent
22	from	_	from	_	IN	126	_	_	_	_	_	_	_	I-Agent
23	a	_	a	_	DT	126	_	_	_	_	_	_	_	I-Agent
24	carer	_	UNK	_	NN	126	_	_	_	_	_	_	_	I-Agent
25	or	_	or	_	CC	126	_	_	_	_	_	_	_	I-Agent
26	healthcare	_	healthcare	_	JJ	126	_	_	_	_	_	_	_	I-Agent
27	professional	_	professional	_	JJ	126	_	_	_	_	_	_	_	I-Agent
28	to	_	to	_	TO	126	_	_	_	_	_	_	_	I-Agent
29	inject	_	UNK	_	VB	126	_	_	_	_	_	_	_	I-Agent
30	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	I-Agent
31	,	_	,	_	,	126	_	_	_	_	_	_	_	I-Agent
32	and	_	and	_	CC	126	_	_	_	_	_	_	_	I-Agent
33	use	_	use	_	NN	126	_	_	_	_	_	_	_	I-Agent
34	of	_	of	_	IN	126	_	_	_	_	_	_	_	I-Agent
35	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	I-Agent
36	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	I-Agent
37	or	_	or	_	CC	126	_	_	_	_	_	_	_	I-Agent
38	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	I-Agent
39	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	I-Agent
40	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
41	reduce	_	reduce	_	VB	126	_	_	_	_	_	reduce.v	Cause_change_of_position_on_a_scale	O
42	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
43	frequency	_	frequency	_	NN	126	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	126	_	_	_	_	_	_	_	O
45	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	O
46	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
47	twice	_	twice	_	RB	126	_	_	_	_	_	_	_	O
48	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
49	once	_	once	_	VB	126	_	_	_	_	_	_	_	O
50	daily	_	daily	_	JJ	126	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
52	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
53	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
54	's	_	's	_	POS	126	_	_	_	_	_	_	_	O
55	lifestyle	_	lifestyle	_	NN	126	_	_	_	_	_	_	_	O
56	is	_	be	_	VBZ	126	_	_	_	_	_	_	_	O
57	restricted	_	restrict	_	VBN	126	_	_	_	_	_	_	_	O
58	by	_	by	_	IN	126	_	_	_	_	_	_	_	O
59	recurrent	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
60	symptomatic	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
61	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
62	episodes	_	episode	_	NNS	126	_	_	_	_	_	_	_	O
63	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
64	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
65	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
66	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
67	otherwise	_	otherwise	_	VB	126	_	_	_	_	_	_	_	O
68	need	_	need	_	VB	126	_	_	_	_	_	_	_	O
69	twice-daily	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
70	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	O
71	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
72	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	O
73	in	_	in	_	IN	126	_	_	_	_	_	_	_	O
74	combination	_	combination	_	NN	126	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	126	_	_	_	_	_	_	_	O
76	oral	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
77	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
78	drugs	_	drug	_	NNS	126	_	_	_	_	_	_	_	O
79	.	_	.	_	.	126	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
2	,	_	,	_	,	126	_	_	_	_	_	_	_	O
3	as	_	a	_	IN	126	_	_	_	_	_	_	_	O
4	an	_	an	_	DT	126	_	_	_	_	_	_	_	O
5	alternative	_	alternative	_	NN	126	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
7	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	O
8	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
9	,	_	,	_	,	126	_	_	_	_	_	_	_	O
10	using	_	use	_	VBG	126	_	_	_	_	_	_	_	O
11	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
12	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
16	if	_	if	_	IN	126	_	_	_	_	_	_	_	O
17	:	_	:	_	:	126	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
20	needs	_	need	_	VBZ	126	_	_	_	_	_	_	_	O
21	assistance	_	assistance	_	NN	126	_	_	_	_	_	_	_	O
22	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
23	a	_	a	_	DT	126	_	_	_	_	_	_	_	O
24	carer	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
25	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
26	healthcare	_	healthcare	_	JJ	126	_	_	_	_	_	_	_	O
27	professional	_	professional	_	JJ	126	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
29	inject	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
30	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
31	,	_	,	_	,	126	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	126	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	126	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	126	_	_	_	_	_	_	_	O
35	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
37	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
38	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
40	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
41	reduce	_	reduce	_	VB	126	_	_	_	_	_	_	_	O
42	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
43	frequency	_	frequency	_	NN	126	_	_	_	_	_	frequency.n	Frequency	O
44	of	_	of	_	IN	126	_	_	_	_	_	_	_	B-Event
45	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	I-Event
46	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
47	twice	_	twice	_	RB	126	_	_	_	_	_	_	_	O
48	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
49	once	_	once	_	VB	126	_	_	_	_	_	_	_	O
50	daily	_	daily	_	JJ	126	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
52	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
53	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
54	's	_	's	_	POS	126	_	_	_	_	_	_	_	O
55	lifestyle	_	lifestyle	_	NN	126	_	_	_	_	_	_	_	O
56	is	_	be	_	VBZ	126	_	_	_	_	_	_	_	O
57	restricted	_	restrict	_	VBN	126	_	_	_	_	_	_	_	O
58	by	_	by	_	IN	126	_	_	_	_	_	_	_	O
59	recurrent	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
60	symptomatic	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
61	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
62	episodes	_	episode	_	NNS	126	_	_	_	_	_	_	_	O
63	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
64	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
65	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
66	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
67	otherwise	_	otherwise	_	VB	126	_	_	_	_	_	_	_	O
68	need	_	need	_	VB	126	_	_	_	_	_	_	_	O
69	twice-daily	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
70	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	O
71	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
72	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	O
73	in	_	in	_	IN	126	_	_	_	_	_	_	_	O
74	combination	_	combination	_	NN	126	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	126	_	_	_	_	_	_	_	O
76	oral	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
77	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
78	drugs	_	drug	_	NNS	126	_	_	_	_	_	_	_	O
79	.	_	.	_	.	126	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
2	,	_	,	_	,	126	_	_	_	_	_	_	_	O
3	as	_	a	_	IN	126	_	_	_	_	_	_	_	O
4	an	_	an	_	DT	126	_	_	_	_	_	_	_	O
5	alternative	_	alternative	_	NN	126	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
7	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	O
8	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
9	,	_	,	_	,	126	_	_	_	_	_	_	_	O
10	using	_	use	_	VBG	126	_	_	_	_	_	_	_	O
11	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
12	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
16	if	_	if	_	IN	126	_	_	_	_	_	_	_	O
17	:	_	:	_	:	126	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
20	needs	_	need	_	VBZ	126	_	_	_	_	_	_	_	O
21	assistance	_	assistance	_	NN	126	_	_	_	_	_	_	_	O
22	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
23	a	_	a	_	DT	126	_	_	_	_	_	_	_	O
24	carer	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
25	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
26	healthcare	_	healthcare	_	JJ	126	_	_	_	_	_	_	_	O
27	professional	_	professional	_	JJ	126	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
29	inject	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
30	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
31	,	_	,	_	,	126	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	126	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	126	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	126	_	_	_	_	_	_	_	O
35	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
37	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
38	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
40	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
41	reduce	_	reduce	_	VB	126	_	_	_	_	_	_	_	O
42	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
43	frequency	_	frequency	_	NN	126	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	126	_	_	_	_	_	_	_	O
45	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	O
46	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
47	twice	_	twice	_	RB	126	_	_	_	_	_	_	_	O
48	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
49	once	_	once	_	VB	126	_	_	_	_	_	_	_	O
50	daily	_	daily	_	JJ	126	_	_	_	_	_	daily.a	Frequency	S-Interval
51	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
52	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
53	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
54	's	_	's	_	POS	126	_	_	_	_	_	_	_	O
55	lifestyle	_	lifestyle	_	NN	126	_	_	_	_	_	_	_	O
56	is	_	be	_	VBZ	126	_	_	_	_	_	_	_	O
57	restricted	_	restrict	_	VBN	126	_	_	_	_	_	_	_	O
58	by	_	by	_	IN	126	_	_	_	_	_	_	_	O
59	recurrent	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
60	symptomatic	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
61	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
62	episodes	_	episode	_	NNS	126	_	_	_	_	_	_	_	O
63	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
64	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
65	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
66	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
67	otherwise	_	otherwise	_	VB	126	_	_	_	_	_	_	_	O
68	need	_	need	_	VB	126	_	_	_	_	_	_	_	O
69	twice-daily	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
70	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	O
71	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
72	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	O
73	in	_	in	_	IN	126	_	_	_	_	_	_	_	O
74	combination	_	combination	_	NN	126	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	126	_	_	_	_	_	_	_	O
76	oral	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
77	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
78	drugs	_	drug	_	NNS	126	_	_	_	_	_	_	_	O
79	.	_	.	_	.	126	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
2	,	_	,	_	,	126	_	_	_	_	_	_	_	O
3	as	_	a	_	IN	126	_	_	_	_	_	_	_	O
4	an	_	an	_	DT	126	_	_	_	_	_	_	_	O
5	alternative	_	alternative	_	NN	126	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
7	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	O
8	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
9	,	_	,	_	,	126	_	_	_	_	_	_	_	O
10	using	_	use	_	VBG	126	_	_	_	_	_	_	_	O
11	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
12	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
16	if	_	if	_	IN	126	_	_	_	_	_	_	_	O
17	:	_	:	_	:	126	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
20	needs	_	need	_	VBZ	126	_	_	_	_	_	_	_	O
21	assistance	_	assistance	_	NN	126	_	_	_	_	_	_	_	O
22	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
23	a	_	a	_	DT	126	_	_	_	_	_	_	_	O
24	carer	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
25	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
26	healthcare	_	healthcare	_	JJ	126	_	_	_	_	_	_	_	O
27	professional	_	professional	_	JJ	126	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
29	inject	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
30	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
31	,	_	,	_	,	126	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	126	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	126	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	126	_	_	_	_	_	_	_	O
35	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
37	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
38	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
40	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
41	reduce	_	reduce	_	VB	126	_	_	_	_	_	_	_	O
42	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
43	frequency	_	frequency	_	NN	126	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	126	_	_	_	_	_	_	_	O
45	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	O
46	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
47	twice	_	twice	_	RB	126	_	_	_	_	_	_	_	O
48	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
49	once	_	once	_	VB	126	_	_	_	_	_	_	_	O
50	daily	_	daily	_	JJ	126	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
52	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
53	person	_	person	_	NN	126	_	_	_	_	_	person.n	People	S-Person
54	's	_	's	_	POS	126	_	_	_	_	_	_	_	O
55	lifestyle	_	lifestyle	_	NN	126	_	_	_	_	_	_	_	O
56	is	_	be	_	VBZ	126	_	_	_	_	_	_	_	O
57	restricted	_	restrict	_	VBN	126	_	_	_	_	_	_	_	O
58	by	_	by	_	IN	126	_	_	_	_	_	_	_	O
59	recurrent	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
60	symptomatic	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
61	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
62	episodes	_	episode	_	NNS	126	_	_	_	_	_	_	_	O
63	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
64	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
65	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
66	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
67	otherwise	_	otherwise	_	VB	126	_	_	_	_	_	_	_	O
68	need	_	need	_	VB	126	_	_	_	_	_	_	_	O
69	twice-daily	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
70	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	O
71	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
72	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	O
73	in	_	in	_	IN	126	_	_	_	_	_	_	_	O
74	combination	_	combination	_	NN	126	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	126	_	_	_	_	_	_	_	O
76	oral	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
77	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
78	drugs	_	drug	_	NNS	126	_	_	_	_	_	_	_	O
79	.	_	.	_	.	126	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
2	,	_	,	_	,	126	_	_	_	_	_	_	_	O
3	as	_	a	_	IN	126	_	_	_	_	_	_	_	O
4	an	_	an	_	DT	126	_	_	_	_	_	_	_	O
5	alternative	_	alternative	_	NN	126	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
7	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	O
8	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
9	,	_	,	_	,	126	_	_	_	_	_	_	_	O
10	using	_	use	_	VBG	126	_	_	_	_	_	_	_	O
11	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
12	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
16	if	_	if	_	IN	126	_	_	_	_	_	_	_	O
17	:	_	:	_	:	126	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
20	needs	_	need	_	VBZ	126	_	_	_	_	_	_	_	O
21	assistance	_	assistance	_	NN	126	_	_	_	_	_	_	_	O
22	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
23	a	_	a	_	DT	126	_	_	_	_	_	_	_	O
24	carer	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
25	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
26	healthcare	_	healthcare	_	JJ	126	_	_	_	_	_	_	_	O
27	professional	_	professional	_	JJ	126	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
29	inject	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
30	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
31	,	_	,	_	,	126	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	126	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	126	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	126	_	_	_	_	_	_	_	O
35	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
37	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
38	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
40	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
41	reduce	_	reduce	_	VB	126	_	_	_	_	_	_	_	O
42	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
43	frequency	_	frequency	_	NN	126	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	126	_	_	_	_	_	_	_	O
45	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	O
46	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
47	twice	_	twice	_	RB	126	_	_	_	_	_	_	_	O
48	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
49	once	_	once	_	VB	126	_	_	_	_	_	_	_	O
50	daily	_	daily	_	JJ	126	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
52	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
53	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
54	's	_	's	_	POS	126	_	_	_	_	_	_	_	O
55	lifestyle	_	lifestyle	_	NN	126	_	_	_	_	_	_	_	O
56	is	_	be	_	VBZ	126	_	_	_	_	_	_	_	O
57	restricted	_	restrict	_	VBN	126	_	_	_	_	_	_	_	O
58	by	_	by	_	IN	126	_	_	_	_	_	_	_	O
59	recurrent	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
60	symptomatic	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
61	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	S-Place
62	episodes	_	episode	_	NNS	126	_	_	_	_	_	episode.n	Event	S-Event
63	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
64	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
65	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
66	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
67	otherwise	_	otherwise	_	VB	126	_	_	_	_	_	_	_	O
68	need	_	need	_	VB	126	_	_	_	_	_	_	_	O
69	twice-daily	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
70	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	O
71	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
72	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	O
73	in	_	in	_	IN	126	_	_	_	_	_	_	_	O
74	combination	_	combination	_	NN	126	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	126	_	_	_	_	_	_	_	O
76	oral	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
77	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
78	drugs	_	drug	_	NNS	126	_	_	_	_	_	_	_	O
79	.	_	.	_	.	126	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
2	,	_	,	_	,	126	_	_	_	_	_	_	_	O
3	as	_	a	_	IN	126	_	_	_	_	_	_	_	O
4	an	_	an	_	DT	126	_	_	_	_	_	_	_	O
5	alternative	_	alternative	_	NN	126	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
7	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	O
8	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
9	,	_	,	_	,	126	_	_	_	_	_	_	_	O
10	using	_	use	_	VBG	126	_	_	_	_	_	_	_	O
11	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
12	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
16	if	_	if	_	IN	126	_	_	_	_	_	_	_	O
17	:	_	:	_	:	126	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
20	needs	_	need	_	VBZ	126	_	_	_	_	_	_	_	O
21	assistance	_	assistance	_	NN	126	_	_	_	_	_	_	_	O
22	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
23	a	_	a	_	DT	126	_	_	_	_	_	_	_	O
24	carer	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
25	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
26	healthcare	_	healthcare	_	JJ	126	_	_	_	_	_	_	_	O
27	professional	_	professional	_	JJ	126	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
29	inject	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
30	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
31	,	_	,	_	,	126	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	126	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	126	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	126	_	_	_	_	_	_	_	O
35	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
37	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
38	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
40	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
41	reduce	_	reduce	_	VB	126	_	_	_	_	_	_	_	O
42	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
43	frequency	_	frequency	_	NN	126	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	126	_	_	_	_	_	_	_	O
45	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	O
46	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
47	twice	_	twice	_	RB	126	_	_	_	_	_	_	_	O
48	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
49	once	_	once	_	VB	126	_	_	_	_	_	_	_	O
50	daily	_	daily	_	JJ	126	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
52	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
53	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
54	's	_	's	_	POS	126	_	_	_	_	_	_	_	O
55	lifestyle	_	lifestyle	_	NN	126	_	_	_	_	_	_	_	O
56	is	_	be	_	VBZ	126	_	_	_	_	_	_	_	O
57	restricted	_	restrict	_	VBN	126	_	_	_	_	_	_	_	O
58	by	_	by	_	IN	126	_	_	_	_	_	_	_	O
59	recurrent	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
60	symptomatic	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
61	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
62	episodes	_	episode	_	NNS	126	_	_	_	_	_	_	_	O
63	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
64	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
65	person	_	person	_	NN	126	_	_	_	_	_	person.n	People	S-Person
66	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
67	otherwise	_	otherwise	_	VB	126	_	_	_	_	_	_	_	O
68	need	_	need	_	VB	126	_	_	_	_	_	_	_	O
69	twice-daily	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
70	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	O
71	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
72	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	O
73	in	_	in	_	IN	126	_	_	_	_	_	_	_	O
74	combination	_	combination	_	NN	126	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	126	_	_	_	_	_	_	_	O
76	oral	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
77	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
78	drugs	_	drug	_	NNS	126	_	_	_	_	_	_	_	O
79	.	_	.	_	.	126	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
2	,	_	,	_	,	126	_	_	_	_	_	_	_	O
3	as	_	a	_	IN	126	_	_	_	_	_	_	_	O
4	an	_	an	_	DT	126	_	_	_	_	_	_	_	O
5	alternative	_	alternative	_	NN	126	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
7	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	O
8	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
9	,	_	,	_	,	126	_	_	_	_	_	_	_	O
10	using	_	use	_	VBG	126	_	_	_	_	_	_	_	O
11	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
12	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
16	if	_	if	_	IN	126	_	_	_	_	_	_	_	O
17	:	_	:	_	:	126	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
20	needs	_	need	_	VBZ	126	_	_	_	_	_	_	_	O
21	assistance	_	assistance	_	NN	126	_	_	_	_	_	_	_	O
22	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
23	a	_	a	_	DT	126	_	_	_	_	_	_	_	O
24	carer	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
25	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
26	healthcare	_	healthcare	_	JJ	126	_	_	_	_	_	_	_	O
27	professional	_	professional	_	JJ	126	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
29	inject	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
30	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
31	,	_	,	_	,	126	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	126	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	126	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	126	_	_	_	_	_	_	_	O
35	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
37	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
38	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
40	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
41	reduce	_	reduce	_	VB	126	_	_	_	_	_	_	_	O
42	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
43	frequency	_	frequency	_	NN	126	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	126	_	_	_	_	_	_	_	O
45	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	O
46	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
47	twice	_	twice	_	RB	126	_	_	_	_	_	_	_	O
48	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
49	once	_	once	_	VB	126	_	_	_	_	_	_	_	O
50	daily	_	daily	_	JJ	126	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
52	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
53	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
54	's	_	's	_	POS	126	_	_	_	_	_	_	_	O
55	lifestyle	_	lifestyle	_	NN	126	_	_	_	_	_	_	_	O
56	is	_	be	_	VBZ	126	_	_	_	_	_	_	_	O
57	restricted	_	restrict	_	VBN	126	_	_	_	_	_	_	_	O
58	by	_	by	_	IN	126	_	_	_	_	_	_	_	O
59	recurrent	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
60	symptomatic	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
61	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
62	episodes	_	episode	_	NNS	126	_	_	_	_	_	_	_	O
63	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
64	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
65	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
66	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
67	otherwise	_	otherwise	_	VB	126	_	_	_	_	_	otherwise.adv	Negative_conditional	O
68	need	_	need	_	VB	126	_	_	_	_	_	_	_	B-Profiled_possibility
69	twice-daily	_	UNK	_	JJ	126	_	_	_	_	_	_	_	I-Profiled_possibility
70	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	I-Profiled_possibility
71	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	I-Profiled_possibility
72	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	I-Profiled_possibility
73	in	_	in	_	IN	126	_	_	_	_	_	_	_	I-Profiled_possibility
74	combination	_	combination	_	NN	126	_	_	_	_	_	_	_	I-Profiled_possibility
75	with	_	with	_	IN	126	_	_	_	_	_	_	_	I-Profiled_possibility
76	oral	_	UNK	_	JJ	126	_	_	_	_	_	_	_	I-Profiled_possibility
77	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	I-Profiled_possibility
78	drugs	_	drug	_	NNS	126	_	_	_	_	_	_	_	I-Profiled_possibility
79	.	_	.	_	.	126	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
2	,	_	,	_	,	126	_	_	_	_	_	_	_	O
3	as	_	a	_	IN	126	_	_	_	_	_	_	_	O
4	an	_	an	_	DT	126	_	_	_	_	_	_	_	O
5	alternative	_	alternative	_	NN	126	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
7	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	O
8	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
9	,	_	,	_	,	126	_	_	_	_	_	_	_	O
10	using	_	use	_	VBG	126	_	_	_	_	_	_	_	O
11	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
12	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
16	if	_	if	_	IN	126	_	_	_	_	_	_	_	O
17	:	_	:	_	:	126	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
20	needs	_	need	_	VBZ	126	_	_	_	_	_	_	_	O
21	assistance	_	assistance	_	NN	126	_	_	_	_	_	_	_	O
22	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
23	a	_	a	_	DT	126	_	_	_	_	_	_	_	O
24	carer	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
25	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
26	healthcare	_	healthcare	_	JJ	126	_	_	_	_	_	_	_	O
27	professional	_	professional	_	JJ	126	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
29	inject	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
30	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
31	,	_	,	_	,	126	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	126	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	126	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	126	_	_	_	_	_	_	_	O
35	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
37	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
38	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
40	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
41	reduce	_	reduce	_	VB	126	_	_	_	_	_	_	_	O
42	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
43	frequency	_	frequency	_	NN	126	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	126	_	_	_	_	_	_	_	O
45	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	O
46	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
47	twice	_	twice	_	RB	126	_	_	_	_	_	_	_	O
48	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
49	once	_	once	_	VB	126	_	_	_	_	_	_	_	O
50	daily	_	daily	_	JJ	126	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
52	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
53	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
54	's	_	's	_	POS	126	_	_	_	_	_	_	_	O
55	lifestyle	_	lifestyle	_	NN	126	_	_	_	_	_	_	_	O
56	is	_	be	_	VBZ	126	_	_	_	_	_	_	_	O
57	restricted	_	restrict	_	VBN	126	_	_	_	_	_	_	_	O
58	by	_	by	_	IN	126	_	_	_	_	_	_	_	O
59	recurrent	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
60	symptomatic	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
61	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
62	episodes	_	episode	_	NNS	126	_	_	_	_	_	_	_	O
63	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
64	the	_	the	_	DT	126	_	_	_	_	_	_	_	B-Cognizer
65	person	_	person	_	NN	126	_	_	_	_	_	_	_	I-Cognizer
66	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
67	otherwise	_	otherwise	_	VB	126	_	_	_	_	_	_	_	O
68	need	_	need	_	VB	126	_	_	_	_	_	need.v	Needing	O
69	twice-daily	_	UNK	_	JJ	126	_	_	_	_	_	_	_	B-Requirement
70	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	I-Requirement
71	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	I-Requirement
72	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	I-Requirement
73	in	_	in	_	IN	126	_	_	_	_	_	_	_	I-Requirement
74	combination	_	combination	_	NN	126	_	_	_	_	_	_	_	I-Requirement
75	with	_	with	_	IN	126	_	_	_	_	_	_	_	I-Requirement
76	oral	_	UNK	_	JJ	126	_	_	_	_	_	_	_	I-Requirement
77	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	I-Requirement
78	drugs	_	drug	_	NNS	126	_	_	_	_	_	_	_	I-Requirement
79	.	_	.	_	.	126	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
2	,	_	,	_	,	126	_	_	_	_	_	_	_	O
3	as	_	a	_	IN	126	_	_	_	_	_	_	_	O
4	an	_	an	_	DT	126	_	_	_	_	_	_	_	O
5	alternative	_	alternative	_	NN	126	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
7	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	O
8	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
9	,	_	,	_	,	126	_	_	_	_	_	_	_	O
10	using	_	use	_	VBG	126	_	_	_	_	_	_	_	O
11	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
12	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
16	if	_	if	_	IN	126	_	_	_	_	_	_	_	O
17	:	_	:	_	:	126	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
20	needs	_	need	_	VBZ	126	_	_	_	_	_	_	_	O
21	assistance	_	assistance	_	NN	126	_	_	_	_	_	_	_	O
22	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
23	a	_	a	_	DT	126	_	_	_	_	_	_	_	O
24	carer	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
25	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
26	healthcare	_	healthcare	_	JJ	126	_	_	_	_	_	_	_	O
27	professional	_	professional	_	JJ	126	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
29	inject	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
30	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
31	,	_	,	_	,	126	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	126	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	126	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	126	_	_	_	_	_	_	_	O
35	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
37	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
38	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
40	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
41	reduce	_	reduce	_	VB	126	_	_	_	_	_	_	_	O
42	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
43	frequency	_	frequency	_	NN	126	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	126	_	_	_	_	_	_	_	O
45	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	O
46	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
47	twice	_	twice	_	RB	126	_	_	_	_	_	_	_	O
48	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
49	once	_	once	_	VB	126	_	_	_	_	_	_	_	O
50	daily	_	daily	_	JJ	126	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
52	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
53	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
54	's	_	's	_	POS	126	_	_	_	_	_	_	_	O
55	lifestyle	_	lifestyle	_	NN	126	_	_	_	_	_	_	_	O
56	is	_	be	_	VBZ	126	_	_	_	_	_	_	_	O
57	restricted	_	restrict	_	VBN	126	_	_	_	_	_	_	_	O
58	by	_	by	_	IN	126	_	_	_	_	_	_	_	O
59	recurrent	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
60	symptomatic	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
61	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
62	episodes	_	episode	_	NNS	126	_	_	_	_	_	_	_	O
63	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
64	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
65	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
66	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
67	otherwise	_	otherwise	_	VB	126	_	_	_	_	_	_	_	O
68	need	_	need	_	VB	126	_	_	_	_	_	_	_	O
69	twice-daily	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
70	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	O
71	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
72	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	O
73	in	_	in	_	IN	126	_	_	_	_	_	_	_	O
74	combination	_	combination	_	NN	126	_	_	_	_	_	combination.n	Aggregate	S-Aggregate
75	with	_	with	_	IN	126	_	_	_	_	_	_	_	B-Individuals
76	oral	_	UNK	_	JJ	126	_	_	_	_	_	_	_	I-Individuals
77	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	I-Individuals
78	drugs	_	drug	_	NNS	126	_	_	_	_	_	_	_	I-Individuals
79	.	_	.	_	.	126	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
2	,	_	,	_	,	126	_	_	_	_	_	_	_	O
3	as	_	a	_	IN	126	_	_	_	_	_	_	_	O
4	an	_	an	_	DT	126	_	_	_	_	_	_	_	O
5	alternative	_	alternative	_	NN	126	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
7	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	O
8	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
9	,	_	,	_	,	126	_	_	_	_	_	_	_	O
10	using	_	use	_	VBG	126	_	_	_	_	_	_	_	O
11	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
12	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
13	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
16	if	_	if	_	IN	126	_	_	_	_	_	_	_	O
17	:	_	:	_	:	126	_	_	_	_	_	_	_	O
18	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
19	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
20	needs	_	need	_	VBZ	126	_	_	_	_	_	_	_	O
21	assistance	_	assistance	_	NN	126	_	_	_	_	_	_	_	O
22	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
23	a	_	a	_	DT	126	_	_	_	_	_	_	_	O
24	carer	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
25	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
26	healthcare	_	healthcare	_	JJ	126	_	_	_	_	_	_	_	O
27	professional	_	professional	_	JJ	126	_	_	_	_	_	_	_	O
28	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
29	inject	_	UNK	_	VB	126	_	_	_	_	_	_	_	O
30	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
31	,	_	,	_	,	126	_	_	_	_	_	_	_	O
32	and	_	and	_	CC	126	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	126	_	_	_	_	_	_	_	O
34	of	_	of	_	IN	126	_	_	_	_	_	_	_	O
35	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
37	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
38	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
40	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
41	reduce	_	reduce	_	VB	126	_	_	_	_	_	_	_	O
42	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
43	frequency	_	frequency	_	NN	126	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	126	_	_	_	_	_	_	_	O
45	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	O
46	from	_	from	_	IN	126	_	_	_	_	_	_	_	O
47	twice	_	twice	_	RB	126	_	_	_	_	_	_	_	O
48	to	_	to	_	TO	126	_	_	_	_	_	_	_	O
49	once	_	once	_	VB	126	_	_	_	_	_	_	_	O
50	daily	_	daily	_	JJ	126	_	_	_	_	_	_	_	O
51	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
52	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
53	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
54	's	_	's	_	POS	126	_	_	_	_	_	_	_	O
55	lifestyle	_	lifestyle	_	NN	126	_	_	_	_	_	_	_	O
56	is	_	be	_	VBZ	126	_	_	_	_	_	_	_	O
57	restricted	_	restrict	_	VBN	126	_	_	_	_	_	_	_	O
58	by	_	by	_	IN	126	_	_	_	_	_	_	_	O
59	recurrent	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
60	symptomatic	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
61	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
62	episodes	_	episode	_	NNS	126	_	_	_	_	_	_	_	O
63	or	_	or	_	CC	126	_	_	_	_	_	_	_	O
64	the	_	the	_	DT	126	_	_	_	_	_	_	_	O
65	person	_	person	_	NN	126	_	_	_	_	_	_	_	O
66	would	_	would	_	MD	126	_	_	_	_	_	_	_	O
67	otherwise	_	otherwise	_	VB	126	_	_	_	_	_	_	_	O
68	need	_	need	_	VB	126	_	_	_	_	_	_	_	O
69	twice-daily	_	UNK	_	JJ	126	_	_	_	_	_	_	_	O
70	nph	_	UNK	_	NNP	126	_	_	_	_	_	_	_	O
71	insulin	_	UNK	_	NN	126	_	_	_	_	_	_	_	O
72	injections	_	injection	_	NNS	126	_	_	_	_	_	_	_	O
73	in	_	in	_	IN	126	_	_	_	_	_	_	_	O
74	combination	_	combination	_	NN	126	_	_	_	_	_	_	_	O
75	with	_	with	_	IN	126	_	_	_	_	_	_	_	O
76	oral	_	UNK	_	JJ	126	_	_	_	_	_	_	_	B-Descriptor
77	unk	_	UNK	_	JJ	126	_	_	_	_	_	_	_	I-Descriptor
78	drugs	_	drug	_	NNS	126	_	_	_	_	_	drug.n	Intoxicants	S-Intoxicant
79	.	_	.	_	.	126	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	127	_	_	_	_	_	_	_	O
2	pre-mixed	_	UNK	_	JJ	127	_	_	_	_	_	_	_	B-Agent
3	(	_	(	_	(	127	_	_	_	_	_	_	_	I-Agent
4	biphasic	_	UNK	_	JJ	127	_	_	_	_	_	_	_	I-Agent
5	)	_	)	_	)	127	_	_	_	_	_	_	_	I-Agent
6	preparations	_	preparation	_	NNS	127	_	_	_	_	_	preparation.n	Activity_prepare	O
7	that	_	that	_	WDT	127	_	_	_	_	_	_	_	B-Activity
8	include	_	include	_	VBP	127	_	_	_	_	_	_	_	I-Activity
9	short-acting	_	UNK	_	JJ	127	_	_	_	_	_	_	_	I-Activity
10	insulin	_	UNK	_	NN	127	_	_	_	_	_	_	_	I-Activity
11	analogues	_	UNK	_	NNS	127	_	_	_	_	_	_	_	I-Activity
12	,	_	,	_	,	127	_	_	_	_	_	_	_	I-Activity
13	rather	_	rather	_	RB	127	_	_	_	_	_	_	_	I-Activity
14	than	_	than	_	IN	127	_	_	_	_	_	_	_	I-Activity
15	pre-mixed	_	UNK	_	JJ	127	_	_	_	_	_	_	_	I-Activity
16	(	_	(	_	(	127	_	_	_	_	_	_	_	I-Activity
17	biphasic	_	UNK	_	JJ	127	_	_	_	_	_	_	_	I-Activity
18	)	_	)	_	)	127	_	_	_	_	_	_	_	I-Activity
19	preparations	_	preparation	_	NNS	127	_	_	_	_	_	_	_	I-Activity
20	that	_	that	_	WDT	127	_	_	_	_	_	_	_	I-Activity
21	include	_	include	_	VBP	127	_	_	_	_	_	_	_	I-Activity
22	short-acting	_	UNK	_	JJ	127	_	_	_	_	_	_	_	I-Activity
23	human	_	human	_	JJ	127	_	_	_	_	_	_	_	I-Activity
24	insulin	_	UNK	_	NN	127	_	_	_	_	_	_	_	I-Activity
25	preparations	_	preparation	_	NNS	127	_	_	_	_	_	_	_	I-Activity
26	,	_	,	_	,	127	_	_	_	_	_	_	_	I-Activity
27	if	_	if	_	IN	127	_	_	_	_	_	_	_	O
28	:	_	:	_	:	127	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	127	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	127	_	_	_	_	_	_	_	O
31	prefers	_	UNK	_	NNS	127	_	_	_	_	_	_	_	O
32	injecting	_	UNK	_	VBG	127	_	_	_	_	_	_	_	O
33	insulin	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
34	immediately	_	immediately	_	RB	127	_	_	_	_	_	_	_	O
35	before	_	before	_	IN	127	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	127	_	_	_	_	_	_	_	O
37	meal	_	meal	_	NN	127	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	127	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
40	is	_	be	_	VBZ	127	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	127	_	_	_	_	_	_	_	O
42	problem	_	problem	_	NN	127	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	127	_	_	_	_	_	_	_	O
44	blood	_	blood	_	NN	127	_	_	_	_	_	_	_	O
45	glucose	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
46	levels	_	level	_	NNS	127	_	_	_	_	_	_	_	O
47	rise	_	rise	_	VBP	127	_	_	_	_	_	_	_	O
48	markedly	_	UNK	_	RB	127	_	_	_	_	_	_	_	O
49	after	_	after	_	IN	127	_	_	_	_	_	_	_	O
50	meals	_	meal	_	NNS	127	_	_	_	_	_	_	_	O
51	.	_	.	_	.	127	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	127	_	_	_	_	_	_	_	O
2	pre-mixed	_	UNK	_	JJ	127	_	_	_	_	_	_	_	B-Total
3	(	_	(	_	(	127	_	_	_	_	_	_	_	I-Total
4	biphasic	_	UNK	_	JJ	127	_	_	_	_	_	_	_	I-Total
5	)	_	)	_	)	127	_	_	_	_	_	_	_	I-Total
6	preparations	_	preparation	_	NNS	127	_	_	_	_	_	_	_	I-Total
7	that	_	that	_	WDT	127	_	_	_	_	_	_	_	I-Total
8	include	_	include	_	VBP	127	_	_	_	_	_	include.v	Inclusion	O
9	short-acting	_	UNK	_	JJ	127	_	_	_	_	_	_	_	B-Part
10	insulin	_	UNK	_	NN	127	_	_	_	_	_	_	_	I-Part
11	analogues	_	UNK	_	NNS	127	_	_	_	_	_	_	_	I-Part
12	,	_	,	_	,	127	_	_	_	_	_	_	_	I-Part
13	rather	_	rather	_	RB	127	_	_	_	_	_	_	_	I-Part
14	than	_	than	_	IN	127	_	_	_	_	_	_	_	I-Part
15	pre-mixed	_	UNK	_	JJ	127	_	_	_	_	_	_	_	I-Part
16	(	_	(	_	(	127	_	_	_	_	_	_	_	I-Part
17	biphasic	_	UNK	_	JJ	127	_	_	_	_	_	_	_	I-Part
18	)	_	)	_	)	127	_	_	_	_	_	_	_	I-Part
19	preparations	_	preparation	_	NNS	127	_	_	_	_	_	_	_	I-Part
20	that	_	that	_	WDT	127	_	_	_	_	_	_	_	I-Part
21	include	_	include	_	VBP	127	_	_	_	_	_	_	_	I-Part
22	short-acting	_	UNK	_	JJ	127	_	_	_	_	_	_	_	I-Part
23	human	_	human	_	JJ	127	_	_	_	_	_	_	_	I-Part
24	insulin	_	UNK	_	NN	127	_	_	_	_	_	_	_	I-Part
25	preparations	_	preparation	_	NNS	127	_	_	_	_	_	_	_	I-Part
26	,	_	,	_	,	127	_	_	_	_	_	_	_	I-Part
27	if	_	if	_	IN	127	_	_	_	_	_	_	_	I-Part
28	:	_	:	_	:	127	_	_	_	_	_	_	_	I-Part
29	a	_	a	_	DT	127	_	_	_	_	_	_	_	I-Part
30	person	_	person	_	NN	127	_	_	_	_	_	_	_	I-Part
31	prefers	_	UNK	_	NNS	127	_	_	_	_	_	_	_	I-Part
32	injecting	_	UNK	_	VBG	127	_	_	_	_	_	_	_	I-Part
33	insulin	_	UNK	_	NN	127	_	_	_	_	_	_	_	I-Part
34	immediately	_	immediately	_	RB	127	_	_	_	_	_	_	_	I-Part
35	before	_	before	_	IN	127	_	_	_	_	_	_	_	I-Part
36	a	_	a	_	DT	127	_	_	_	_	_	_	_	I-Part
37	meal	_	meal	_	NN	127	_	_	_	_	_	_	_	I-Part
38	or	_	or	_	CC	127	_	_	_	_	_	_	_	I-Part
39	unk	_	UNK	_	NN	127	_	_	_	_	_	_	_	I-Part
40	is	_	be	_	VBZ	127	_	_	_	_	_	_	_	I-Part
41	a	_	a	_	DT	127	_	_	_	_	_	_	_	I-Part
42	problem	_	problem	_	NN	127	_	_	_	_	_	_	_	I-Part
43	or	_	or	_	CC	127	_	_	_	_	_	_	_	I-Part
44	blood	_	blood	_	NN	127	_	_	_	_	_	_	_	I-Part
45	glucose	_	UNK	_	NN	127	_	_	_	_	_	_	_	I-Part
46	levels	_	level	_	NNS	127	_	_	_	_	_	_	_	I-Part
47	rise	_	rise	_	VBP	127	_	_	_	_	_	_	_	I-Part
48	markedly	_	UNK	_	RB	127	_	_	_	_	_	_	_	I-Part
49	after	_	after	_	IN	127	_	_	_	_	_	_	_	O
50	meals	_	meal	_	NNS	127	_	_	_	_	_	_	_	O
51	.	_	.	_	.	127	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	127	_	_	_	_	_	_	_	O
2	pre-mixed	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
3	(	_	(	_	(	127	_	_	_	_	_	_	_	O
4	biphasic	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
5	)	_	)	_	)	127	_	_	_	_	_	_	_	O
6	preparations	_	preparation	_	NNS	127	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	127	_	_	_	_	_	_	_	O
8	include	_	include	_	VBP	127	_	_	_	_	_	_	_	O
9	short-acting	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
10	insulin	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
11	analogues	_	UNK	_	NNS	127	_	_	_	_	_	_	_	O
12	,	_	,	_	,	127	_	_	_	_	_	_	_	O
13	rather	_	rather	_	RB	127	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	127	_	_	_	_	_	_	_	O
15	pre-mixed	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
16	(	_	(	_	(	127	_	_	_	_	_	_	_	O
17	biphasic	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
18	)	_	)	_	)	127	_	_	_	_	_	_	_	O
19	preparations	_	preparation	_	NNS	127	_	_	_	_	_	preparation.n	Activity_prepare	O
20	that	_	that	_	WDT	127	_	_	_	_	_	_	_	B-Activity
21	include	_	include	_	VBP	127	_	_	_	_	_	_	_	I-Activity
22	short-acting	_	UNK	_	JJ	127	_	_	_	_	_	_	_	I-Activity
23	human	_	human	_	JJ	127	_	_	_	_	_	_	_	I-Activity
24	insulin	_	UNK	_	NN	127	_	_	_	_	_	_	_	I-Activity
25	preparations	_	preparation	_	NNS	127	_	_	_	_	_	_	_	I-Activity
26	,	_	,	_	,	127	_	_	_	_	_	_	_	O
27	if	_	if	_	IN	127	_	_	_	_	_	_	_	O
28	:	_	:	_	:	127	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	127	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	127	_	_	_	_	_	_	_	O
31	prefers	_	UNK	_	NNS	127	_	_	_	_	_	_	_	O
32	injecting	_	UNK	_	VBG	127	_	_	_	_	_	_	_	O
33	insulin	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
34	immediately	_	immediately	_	RB	127	_	_	_	_	_	_	_	O
35	before	_	before	_	IN	127	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	127	_	_	_	_	_	_	_	O
37	meal	_	meal	_	NN	127	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	127	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
40	is	_	be	_	VBZ	127	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	127	_	_	_	_	_	_	_	O
42	problem	_	problem	_	NN	127	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	127	_	_	_	_	_	_	_	O
44	blood	_	blood	_	NN	127	_	_	_	_	_	_	_	O
45	glucose	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
46	levels	_	level	_	NNS	127	_	_	_	_	_	_	_	O
47	rise	_	rise	_	VBP	127	_	_	_	_	_	_	_	O
48	markedly	_	UNK	_	RB	127	_	_	_	_	_	_	_	O
49	after	_	after	_	IN	127	_	_	_	_	_	_	_	O
50	meals	_	meal	_	NNS	127	_	_	_	_	_	_	_	O
51	.	_	.	_	.	127	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	127	_	_	_	_	_	_	_	O
2	pre-mixed	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
3	(	_	(	_	(	127	_	_	_	_	_	_	_	O
4	biphasic	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
5	)	_	)	_	)	127	_	_	_	_	_	_	_	O
6	preparations	_	preparation	_	NNS	127	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	127	_	_	_	_	_	_	_	O
8	include	_	include	_	VBP	127	_	_	_	_	_	_	_	O
9	short-acting	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
10	insulin	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
11	analogues	_	UNK	_	NNS	127	_	_	_	_	_	_	_	O
12	,	_	,	_	,	127	_	_	_	_	_	_	_	O
13	rather	_	rather	_	RB	127	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	127	_	_	_	_	_	_	_	O
15	pre-mixed	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
16	(	_	(	_	(	127	_	_	_	_	_	_	_	O
17	biphasic	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
18	)	_	)	_	)	127	_	_	_	_	_	_	_	O
19	preparations	_	preparation	_	NNS	127	_	_	_	_	_	_	_	O
20	that	_	that	_	WDT	127	_	_	_	_	_	_	_	S-Total
21	include	_	include	_	VBP	127	_	_	_	_	_	include.v	Inclusion	O
22	short-acting	_	UNK	_	JJ	127	_	_	_	_	_	_	_	B-Part
23	human	_	human	_	JJ	127	_	_	_	_	_	_	_	I-Part
24	insulin	_	UNK	_	NN	127	_	_	_	_	_	_	_	I-Part
25	preparations	_	preparation	_	NNS	127	_	_	_	_	_	_	_	I-Part
26	,	_	,	_	,	127	_	_	_	_	_	_	_	O
27	if	_	if	_	IN	127	_	_	_	_	_	_	_	O
28	:	_	:	_	:	127	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	127	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	127	_	_	_	_	_	_	_	O
31	prefers	_	UNK	_	NNS	127	_	_	_	_	_	_	_	O
32	injecting	_	UNK	_	VBG	127	_	_	_	_	_	_	_	O
33	insulin	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
34	immediately	_	immediately	_	RB	127	_	_	_	_	_	_	_	O
35	before	_	before	_	IN	127	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	127	_	_	_	_	_	_	_	O
37	meal	_	meal	_	NN	127	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	127	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
40	is	_	be	_	VBZ	127	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	127	_	_	_	_	_	_	_	O
42	problem	_	problem	_	NN	127	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	127	_	_	_	_	_	_	_	O
44	blood	_	blood	_	NN	127	_	_	_	_	_	_	_	O
45	glucose	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
46	levels	_	level	_	NNS	127	_	_	_	_	_	_	_	O
47	rise	_	rise	_	VBP	127	_	_	_	_	_	_	_	O
48	markedly	_	UNK	_	RB	127	_	_	_	_	_	_	_	O
49	after	_	after	_	IN	127	_	_	_	_	_	_	_	O
50	meals	_	meal	_	NNS	127	_	_	_	_	_	_	_	O
51	.	_	.	_	.	127	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	127	_	_	_	_	_	_	_	O
2	pre-mixed	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
3	(	_	(	_	(	127	_	_	_	_	_	_	_	O
4	biphasic	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
5	)	_	)	_	)	127	_	_	_	_	_	_	_	O
6	preparations	_	preparation	_	NNS	127	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	127	_	_	_	_	_	_	_	O
8	include	_	include	_	VBP	127	_	_	_	_	_	_	_	O
9	short-acting	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
10	insulin	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
11	analogues	_	UNK	_	NNS	127	_	_	_	_	_	_	_	O
12	,	_	,	_	,	127	_	_	_	_	_	_	_	O
13	rather	_	rather	_	RB	127	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	127	_	_	_	_	_	_	_	O
15	pre-mixed	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
16	(	_	(	_	(	127	_	_	_	_	_	_	_	O
17	biphasic	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
18	)	_	)	_	)	127	_	_	_	_	_	_	_	O
19	preparations	_	preparation	_	NNS	127	_	_	_	_	_	_	_	O
20	that	_	that	_	WDT	127	_	_	_	_	_	_	_	O
21	include	_	include	_	VBP	127	_	_	_	_	_	_	_	O
22	short-acting	_	UNK	_	JJ	127	_	_	_	_	_	_	_	B-Activity
23	human	_	human	_	JJ	127	_	_	_	_	_	_	_	I-Activity
24	insulin	_	UNK	_	NN	127	_	_	_	_	_	_	_	I-Activity
25	preparations	_	preparation	_	NNS	127	_	_	_	_	_	preparation.n	Activity_prepare	O
26	,	_	,	_	,	127	_	_	_	_	_	_	_	O
27	if	_	if	_	IN	127	_	_	_	_	_	_	_	O
28	:	_	:	_	:	127	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	127	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	127	_	_	_	_	_	_	_	O
31	prefers	_	UNK	_	NNS	127	_	_	_	_	_	_	_	O
32	injecting	_	UNK	_	VBG	127	_	_	_	_	_	_	_	O
33	insulin	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
34	immediately	_	immediately	_	RB	127	_	_	_	_	_	_	_	O
35	before	_	before	_	IN	127	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	127	_	_	_	_	_	_	_	O
37	meal	_	meal	_	NN	127	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	127	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
40	is	_	be	_	VBZ	127	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	127	_	_	_	_	_	_	_	O
42	problem	_	problem	_	NN	127	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	127	_	_	_	_	_	_	_	O
44	blood	_	blood	_	NN	127	_	_	_	_	_	_	_	O
45	glucose	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
46	levels	_	level	_	NNS	127	_	_	_	_	_	_	_	O
47	rise	_	rise	_	VBP	127	_	_	_	_	_	_	_	O
48	markedly	_	UNK	_	RB	127	_	_	_	_	_	_	_	O
49	after	_	after	_	IN	127	_	_	_	_	_	_	_	O
50	meals	_	meal	_	NNS	127	_	_	_	_	_	_	_	O
51	.	_	.	_	.	127	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	127	_	_	_	_	_	_	_	O
2	pre-mixed	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
3	(	_	(	_	(	127	_	_	_	_	_	_	_	O
4	biphasic	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
5	)	_	)	_	)	127	_	_	_	_	_	_	_	O
6	preparations	_	preparation	_	NNS	127	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	127	_	_	_	_	_	_	_	O
8	include	_	include	_	VBP	127	_	_	_	_	_	_	_	O
9	short-acting	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
10	insulin	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
11	analogues	_	UNK	_	NNS	127	_	_	_	_	_	_	_	O
12	,	_	,	_	,	127	_	_	_	_	_	_	_	O
13	rather	_	rather	_	RB	127	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	127	_	_	_	_	_	_	_	O
15	pre-mixed	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
16	(	_	(	_	(	127	_	_	_	_	_	_	_	O
17	biphasic	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
18	)	_	)	_	)	127	_	_	_	_	_	_	_	O
19	preparations	_	preparation	_	NNS	127	_	_	_	_	_	_	_	O
20	that	_	that	_	WDT	127	_	_	_	_	_	_	_	O
21	include	_	include	_	VBP	127	_	_	_	_	_	_	_	O
22	short-acting	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
23	human	_	human	_	JJ	127	_	_	_	_	_	_	_	O
24	insulin	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
25	preparations	_	preparation	_	NNS	127	_	_	_	_	_	_	_	O
26	,	_	,	_	,	127	_	_	_	_	_	_	_	O
27	if	_	if	_	IN	127	_	_	_	_	_	_	_	O
28	:	_	:	_	:	127	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	127	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	127	_	_	_	_	_	person.n	People	S-Person
31	prefers	_	UNK	_	NNS	127	_	_	_	_	_	_	_	O
32	injecting	_	UNK	_	VBG	127	_	_	_	_	_	_	_	O
33	insulin	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
34	immediately	_	immediately	_	RB	127	_	_	_	_	_	_	_	O
35	before	_	before	_	IN	127	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	127	_	_	_	_	_	_	_	O
37	meal	_	meal	_	NN	127	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	127	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
40	is	_	be	_	VBZ	127	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	127	_	_	_	_	_	_	_	O
42	problem	_	problem	_	NN	127	_	_	_	_	_	_	_	O
43	or	_	or	_	CC	127	_	_	_	_	_	_	_	O
44	blood	_	blood	_	NN	127	_	_	_	_	_	_	_	O
45	glucose	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
46	levels	_	level	_	NNS	127	_	_	_	_	_	_	_	O
47	rise	_	rise	_	VBP	127	_	_	_	_	_	_	_	O
48	markedly	_	UNK	_	RB	127	_	_	_	_	_	_	_	O
49	after	_	after	_	IN	127	_	_	_	_	_	_	_	O
50	meals	_	meal	_	NNS	127	_	_	_	_	_	_	_	O
51	.	_	.	_	.	127	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	127	_	_	_	_	_	_	_	O
2	pre-mixed	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
3	(	_	(	_	(	127	_	_	_	_	_	_	_	O
4	biphasic	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
5	)	_	)	_	)	127	_	_	_	_	_	_	_	O
6	preparations	_	preparation	_	NNS	127	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	127	_	_	_	_	_	_	_	O
8	include	_	include	_	VBP	127	_	_	_	_	_	_	_	O
9	short-acting	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
10	insulin	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
11	analogues	_	UNK	_	NNS	127	_	_	_	_	_	_	_	O
12	,	_	,	_	,	127	_	_	_	_	_	_	_	O
13	rather	_	rather	_	RB	127	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	127	_	_	_	_	_	_	_	O
15	pre-mixed	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
16	(	_	(	_	(	127	_	_	_	_	_	_	_	O
17	biphasic	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
18	)	_	)	_	)	127	_	_	_	_	_	_	_	O
19	preparations	_	preparation	_	NNS	127	_	_	_	_	_	_	_	O
20	that	_	that	_	WDT	127	_	_	_	_	_	_	_	O
21	include	_	include	_	VBP	127	_	_	_	_	_	_	_	O
22	short-acting	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
23	human	_	human	_	JJ	127	_	_	_	_	_	_	_	O
24	insulin	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
25	preparations	_	preparation	_	NNS	127	_	_	_	_	_	_	_	O
26	,	_	,	_	,	127	_	_	_	_	_	_	_	O
27	if	_	if	_	IN	127	_	_	_	_	_	_	_	O
28	:	_	:	_	:	127	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	127	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	127	_	_	_	_	_	_	_	O
31	prefers	_	UNK	_	NNS	127	_	_	_	_	_	_	_	O
32	injecting	_	UNK	_	VBG	127	_	_	_	_	_	_	_	O
33	insulin	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
34	immediately	_	immediately	_	RB	127	_	_	_	_	_	_	_	O
35	before	_	before	_	IN	127	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	127	_	_	_	_	_	_	_	O
37	meal	_	meal	_	NN	127	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	127	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
40	is	_	be	_	VBZ	127	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	127	_	_	_	_	_	_	_	O
42	problem	_	problem	_	NN	127	_	_	_	_	_	problem.n	Predicament	O
43	or	_	or	_	CC	127	_	_	_	_	_	_	_	O
44	blood	_	blood	_	NN	127	_	_	_	_	_	_	_	O
45	glucose	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
46	levels	_	level	_	NNS	127	_	_	_	_	_	_	_	O
47	rise	_	rise	_	VBP	127	_	_	_	_	_	_	_	O
48	markedly	_	UNK	_	RB	127	_	_	_	_	_	_	_	O
49	after	_	after	_	IN	127	_	_	_	_	_	_	_	O
50	meals	_	meal	_	NNS	127	_	_	_	_	_	_	_	O
51	.	_	.	_	.	127	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	127	_	_	_	_	_	_	_	O
2	pre-mixed	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
3	(	_	(	_	(	127	_	_	_	_	_	_	_	O
4	biphasic	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
5	)	_	)	_	)	127	_	_	_	_	_	_	_	O
6	preparations	_	preparation	_	NNS	127	_	_	_	_	_	_	_	O
7	that	_	that	_	WDT	127	_	_	_	_	_	_	_	O
8	include	_	include	_	VBP	127	_	_	_	_	_	_	_	O
9	short-acting	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
10	insulin	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
11	analogues	_	UNK	_	NNS	127	_	_	_	_	_	_	_	O
12	,	_	,	_	,	127	_	_	_	_	_	_	_	O
13	rather	_	rather	_	RB	127	_	_	_	_	_	_	_	O
14	than	_	than	_	IN	127	_	_	_	_	_	_	_	O
15	pre-mixed	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
16	(	_	(	_	(	127	_	_	_	_	_	_	_	O
17	biphasic	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
18	)	_	)	_	)	127	_	_	_	_	_	_	_	O
19	preparations	_	preparation	_	NNS	127	_	_	_	_	_	_	_	O
20	that	_	that	_	WDT	127	_	_	_	_	_	_	_	O
21	include	_	include	_	VBP	127	_	_	_	_	_	_	_	O
22	short-acting	_	UNK	_	JJ	127	_	_	_	_	_	_	_	O
23	human	_	human	_	JJ	127	_	_	_	_	_	_	_	O
24	insulin	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
25	preparations	_	preparation	_	NNS	127	_	_	_	_	_	_	_	O
26	,	_	,	_	,	127	_	_	_	_	_	_	_	O
27	if	_	if	_	IN	127	_	_	_	_	_	_	_	O
28	:	_	:	_	:	127	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	127	_	_	_	_	_	_	_	O
30	person	_	person	_	NN	127	_	_	_	_	_	_	_	O
31	prefers	_	UNK	_	NNS	127	_	_	_	_	_	_	_	O
32	injecting	_	UNK	_	VBG	127	_	_	_	_	_	_	_	O
33	insulin	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
34	immediately	_	immediately	_	RB	127	_	_	_	_	_	_	_	O
35	before	_	before	_	IN	127	_	_	_	_	_	_	_	O
36	a	_	a	_	DT	127	_	_	_	_	_	_	_	O
37	meal	_	meal	_	NN	127	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	127	_	_	_	_	_	_	_	O
39	unk	_	UNK	_	NN	127	_	_	_	_	_	_	_	O
40	is	_	be	_	VBZ	127	_	_	_	_	_	_	_	O
41	a	_	a	_	DT	127	_	_	_	_	_	_	_	B-Item
42	problem	_	problem	_	NN	127	_	_	_	_	_	_	_	I-Item
43	or	_	or	_	CC	127	_	_	_	_	_	_	_	I-Item
44	blood	_	blood	_	NN	127	_	_	_	_	_	_	_	I-Item
45	glucose	_	UNK	_	NN	127	_	_	_	_	_	_	_	I-Item
46	levels	_	level	_	NNS	127	_	_	_	_	_	_	_	I-Item
47	rise	_	rise	_	VBP	127	_	_	_	_	_	rise.v	Change_position_on_a_scale	O
48	markedly	_	UNK	_	RB	127	_	_	_	_	_	_	_	S-Time
49	after	_	after	_	IN	127	_	_	_	_	_	_	_	B-Place
50	meals	_	meal	_	NNS	127	_	_	_	_	_	_	_	I-Place
51	.	_	.	_	.	127	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	128	_	_	_	_	_	_	_	O
2	switching	_	switch	_	VBG	128	_	_	_	_	_	switch.v	Exchange	O
3	to	_	to	_	TO	128	_	_	_	_	_	_	_	B-Themes
4	insulin	_	UNK	_	VB	128	_	_	_	_	_	_	_	I-Themes
5	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	I-Themes
6	or	_	or	_	CC	128	_	_	_	_	_	_	_	I-Themes
7	insulin	_	UNK	_	NN	128	_	_	_	_	_	_	_	I-Themes
8	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	I-Themes
9	from	_	from	_	IN	128	_	_	_	_	_	_	_	I-Themes
10	nph	_	UNK	_	NNP	128	_	_	_	_	_	_	_	I-Themes
11	insulin	_	UNK	_	NN	128	_	_	_	_	_	_	_	I-Themes
12	in	_	in	_	IN	128	_	_	_	_	_	_	_	I-Themes
13	adults	_	adult	_	NNS	128	_	_	_	_	_	_	_	I-Themes
14	with	_	with	_	IN	128	_	_	_	_	_	_	_	I-Themes
15	type	_	type	_	JJ	128	_	_	_	_	_	_	_	I-Themes
16	2	_	2	_	CD	128	_	_	_	_	_	_	_	I-Themes
17	diabetes	_	UNK	_	NNS	128	_	_	_	_	_	_	_	I-Themes
18	:	_	:	_	:	128	_	_	_	_	_	_	_	O
19	who	_	who	_	WP	128	_	_	_	_	_	_	_	O
20	do	_	do	_	VBP	128	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	128	_	_	_	_	_	_	_	O
22	reach	_	reach	_	VB	128	_	_	_	_	_	_	_	O
23	their	_	their	_	PRP$	128	_	_	_	_	_	_	_	O
24	target	_	target	_	NN	128	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	128	_	_	_	_	_	_	_	O
26	because	_	because	_	IN	128	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	128	_	_	_	_	_	_	_	O
28	significant	_	significant	_	JJ	128	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	128	_	_	_	_	_	_	_	O
31	who	_	who	_	WP	128	_	_	_	_	_	_	_	O
32	experience	_	experience	_	VBP	128	_	_	_	_	_	_	_	O
33	significant	_	significant	_	JJ	128	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
35	on	_	on	_	IN	128	_	_	_	_	_	_	_	O
36	nph	_	UNK	_	NNP	128	_	_	_	_	_	_	_	O
37	insulin	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
38	irrespective	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
39	of	_	of	_	IN	128	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	128	_	_	_	_	_	_	_	O
41	level	_	level	_	NN	128	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	128	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	128	_	_	_	_	_	_	_	O
2	switching	_	switch	_	VBG	128	_	_	_	_	_	_	_	O
3	to	_	to	_	TO	128	_	_	_	_	_	_	_	O
4	insulin	_	UNK	_	VB	128	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
6	or	_	or	_	CC	128	_	_	_	_	_	_	_	O
7	insulin	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
9	from	_	from	_	IN	128	_	_	_	_	_	_	_	O
10	nph	_	UNK	_	NNP	128	_	_	_	_	_	_	_	O
11	insulin	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	128	_	_	_	_	_	_	_	O
13	adults	_	adult	_	NNS	128	_	_	_	_	_	adult.n	People_by_age	S-Person
14	with	_	with	_	IN	128	_	_	_	_	_	_	_	O
15	type	_	type	_	JJ	128	_	_	_	_	_	_	_	O
16	2	_	2	_	CD	128	_	_	_	_	_	_	_	O
17	diabetes	_	UNK	_	NNS	128	_	_	_	_	_	_	_	O
18	:	_	:	_	:	128	_	_	_	_	_	_	_	O
19	who	_	who	_	WP	128	_	_	_	_	_	_	_	O
20	do	_	do	_	VBP	128	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	128	_	_	_	_	_	_	_	O
22	reach	_	reach	_	VB	128	_	_	_	_	_	_	_	O
23	their	_	their	_	PRP$	128	_	_	_	_	_	_	_	O
24	target	_	target	_	NN	128	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	128	_	_	_	_	_	_	_	O
26	because	_	because	_	IN	128	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	128	_	_	_	_	_	_	_	O
28	significant	_	significant	_	JJ	128	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	128	_	_	_	_	_	_	_	O
31	who	_	who	_	WP	128	_	_	_	_	_	_	_	O
32	experience	_	experience	_	VBP	128	_	_	_	_	_	_	_	O
33	significant	_	significant	_	JJ	128	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
35	on	_	on	_	IN	128	_	_	_	_	_	_	_	O
36	nph	_	UNK	_	NNP	128	_	_	_	_	_	_	_	O
37	insulin	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
38	irrespective	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
39	of	_	of	_	IN	128	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	128	_	_	_	_	_	_	_	O
41	level	_	level	_	NN	128	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	128	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	128	_	_	_	_	_	_	_	O
2	switching	_	switch	_	VBG	128	_	_	_	_	_	_	_	O
3	to	_	to	_	TO	128	_	_	_	_	_	_	_	O
4	insulin	_	UNK	_	VB	128	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
6	or	_	or	_	CC	128	_	_	_	_	_	_	_	O
7	insulin	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
9	from	_	from	_	IN	128	_	_	_	_	_	_	_	O
10	nph	_	UNK	_	NNP	128	_	_	_	_	_	_	_	O
11	insulin	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	128	_	_	_	_	_	_	_	O
13	adults	_	adult	_	NNS	128	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	128	_	_	_	_	_	_	_	O
15	type	_	type	_	JJ	128	_	_	_	_	_	type.n	Type	S-Subtype
16	2	_	2	_	CD	128	_	_	_	_	_	_	_	B-Category
17	diabetes	_	UNK	_	NNS	128	_	_	_	_	_	_	_	I-Category
18	:	_	:	_	:	128	_	_	_	_	_	_	_	O
19	who	_	who	_	WP	128	_	_	_	_	_	_	_	O
20	do	_	do	_	VBP	128	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	128	_	_	_	_	_	_	_	O
22	reach	_	reach	_	VB	128	_	_	_	_	_	_	_	O
23	their	_	their	_	PRP$	128	_	_	_	_	_	_	_	O
24	target	_	target	_	NN	128	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	128	_	_	_	_	_	_	_	O
26	because	_	because	_	IN	128	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	128	_	_	_	_	_	_	_	O
28	significant	_	significant	_	JJ	128	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	128	_	_	_	_	_	_	_	O
31	who	_	who	_	WP	128	_	_	_	_	_	_	_	O
32	experience	_	experience	_	VBP	128	_	_	_	_	_	_	_	O
33	significant	_	significant	_	JJ	128	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
35	on	_	on	_	IN	128	_	_	_	_	_	_	_	O
36	nph	_	UNK	_	NNP	128	_	_	_	_	_	_	_	O
37	insulin	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
38	irrespective	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
39	of	_	of	_	IN	128	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	128	_	_	_	_	_	_	_	O
41	level	_	level	_	NN	128	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	128	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	128	_	_	_	_	_	_	_	O
2	switching	_	switch	_	VBG	128	_	_	_	_	_	_	_	O
3	to	_	to	_	TO	128	_	_	_	_	_	_	_	O
4	insulin	_	UNK	_	VB	128	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
6	or	_	or	_	CC	128	_	_	_	_	_	_	_	O
7	insulin	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
9	from	_	from	_	IN	128	_	_	_	_	_	_	_	O
10	nph	_	UNK	_	NNP	128	_	_	_	_	_	_	_	O
11	insulin	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	128	_	_	_	_	_	_	_	O
13	adults	_	adult	_	NNS	128	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	128	_	_	_	_	_	_	_	O
15	type	_	type	_	JJ	128	_	_	_	_	_	_	_	O
16	2	_	2	_	CD	128	_	_	_	_	_	_	_	O
17	diabetes	_	UNK	_	NNS	128	_	_	_	_	_	_	_	O
18	:	_	:	_	:	128	_	_	_	_	_	_	_	O
19	who	_	who	_	WP	128	_	_	_	_	_	_	_	S-Theme
20	do	_	do	_	VBP	128	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	128	_	_	_	_	_	_	_	O
22	reach	_	reach	_	VB	128	_	_	_	_	_	reach.v	Arriving	O
23	their	_	their	_	PRP$	128	_	_	_	_	_	_	_	B-Goal
24	target	_	target	_	NN	128	_	_	_	_	_	_	_	I-Goal
25	hba1c	_	UNK	_	NNP	128	_	_	_	_	_	_	_	I-Goal
26	because	_	because	_	IN	128	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	128	_	_	_	_	_	_	_	O
28	significant	_	significant	_	JJ	128	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	128	_	_	_	_	_	_	_	O
31	who	_	who	_	WP	128	_	_	_	_	_	_	_	O
32	experience	_	experience	_	VBP	128	_	_	_	_	_	_	_	O
33	significant	_	significant	_	JJ	128	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
35	on	_	on	_	IN	128	_	_	_	_	_	_	_	O
36	nph	_	UNK	_	NNP	128	_	_	_	_	_	_	_	O
37	insulin	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
38	irrespective	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
39	of	_	of	_	IN	128	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	128	_	_	_	_	_	_	_	O
41	level	_	level	_	NN	128	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	128	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	128	_	_	_	_	_	_	_	O
2	switching	_	switch	_	VBG	128	_	_	_	_	_	_	_	O
3	to	_	to	_	TO	128	_	_	_	_	_	_	_	O
4	insulin	_	UNK	_	VB	128	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
6	or	_	or	_	CC	128	_	_	_	_	_	_	_	O
7	insulin	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
9	from	_	from	_	IN	128	_	_	_	_	_	_	_	O
10	nph	_	UNK	_	NNP	128	_	_	_	_	_	_	_	O
11	insulin	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	128	_	_	_	_	_	_	_	O
13	adults	_	adult	_	NNS	128	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	128	_	_	_	_	_	_	_	O
15	type	_	type	_	JJ	128	_	_	_	_	_	_	_	O
16	2	_	2	_	CD	128	_	_	_	_	_	_	_	O
17	diabetes	_	UNK	_	NNS	128	_	_	_	_	_	_	_	O
18	:	_	:	_	:	128	_	_	_	_	_	_	_	O
19	who	_	who	_	WP	128	_	_	_	_	_	_	_	B-Cause
20	do	_	do	_	VBP	128	_	_	_	_	_	_	_	I-Cause
21	not	_	not	_	RB	128	_	_	_	_	_	_	_	I-Cause
22	reach	_	reach	_	VB	128	_	_	_	_	_	_	_	I-Cause
23	their	_	their	_	PRP$	128	_	_	_	_	_	_	_	I-Cause
24	target	_	target	_	NN	128	_	_	_	_	_	_	_	I-Cause
25	hba1c	_	UNK	_	NNP	128	_	_	_	_	_	_	_	I-Cause
26	because	_	because	_	IN	128	_	_	_	_	_	because.c	Causation	O
27	of	_	of	_	IN	128	_	_	_	_	_	_	_	B-Effect
28	significant	_	significant	_	JJ	128	_	_	_	_	_	_	_	I-Effect
29	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	I-Effect
30	or	_	or	_	CC	128	_	_	_	_	_	_	_	O
31	who	_	who	_	WP	128	_	_	_	_	_	_	_	O
32	experience	_	experience	_	VBP	128	_	_	_	_	_	_	_	O
33	significant	_	significant	_	JJ	128	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
35	on	_	on	_	IN	128	_	_	_	_	_	_	_	O
36	nph	_	UNK	_	NNP	128	_	_	_	_	_	_	_	O
37	insulin	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
38	irrespective	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
39	of	_	of	_	IN	128	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	128	_	_	_	_	_	_	_	O
41	level	_	level	_	NN	128	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	128	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	128	_	_	_	_	_	_	_	O
2	switching	_	switch	_	VBG	128	_	_	_	_	_	_	_	O
3	to	_	to	_	TO	128	_	_	_	_	_	_	_	O
4	insulin	_	UNK	_	VB	128	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
6	or	_	or	_	CC	128	_	_	_	_	_	_	_	O
7	insulin	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
9	from	_	from	_	IN	128	_	_	_	_	_	_	_	O
10	nph	_	UNK	_	NNP	128	_	_	_	_	_	_	_	O
11	insulin	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	128	_	_	_	_	_	_	_	O
13	adults	_	adult	_	NNS	128	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	128	_	_	_	_	_	_	_	O
15	type	_	type	_	JJ	128	_	_	_	_	_	_	_	O
16	2	_	2	_	CD	128	_	_	_	_	_	_	_	O
17	diabetes	_	UNK	_	NNS	128	_	_	_	_	_	_	_	O
18	:	_	:	_	:	128	_	_	_	_	_	_	_	O
19	who	_	who	_	WP	128	_	_	_	_	_	_	_	O
20	do	_	do	_	VBP	128	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	128	_	_	_	_	_	_	_	O
22	reach	_	reach	_	VB	128	_	_	_	_	_	_	_	O
23	their	_	their	_	PRP$	128	_	_	_	_	_	_	_	O
24	target	_	target	_	NN	128	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	128	_	_	_	_	_	_	_	O
26	because	_	because	_	IN	128	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	128	_	_	_	_	_	_	_	O
28	significant	_	significant	_	JJ	128	_	_	_	_	_	significant.a	Importance	O
29	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	S-Factor
30	or	_	or	_	CC	128	_	_	_	_	_	_	_	O
31	who	_	who	_	WP	128	_	_	_	_	_	_	_	O
32	experience	_	experience	_	VBP	128	_	_	_	_	_	_	_	O
33	significant	_	significant	_	JJ	128	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
35	on	_	on	_	IN	128	_	_	_	_	_	_	_	O
36	nph	_	UNK	_	NNP	128	_	_	_	_	_	_	_	O
37	insulin	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
38	irrespective	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
39	of	_	of	_	IN	128	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	128	_	_	_	_	_	_	_	O
41	level	_	level	_	NN	128	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	128	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	128	_	_	_	_	_	_	_	O
2	switching	_	switch	_	VBG	128	_	_	_	_	_	_	_	O
3	to	_	to	_	TO	128	_	_	_	_	_	_	_	O
4	insulin	_	UNK	_	VB	128	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
6	or	_	or	_	CC	128	_	_	_	_	_	_	_	O
7	insulin	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
9	from	_	from	_	IN	128	_	_	_	_	_	_	_	O
10	nph	_	UNK	_	NNP	128	_	_	_	_	_	_	_	O
11	insulin	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	128	_	_	_	_	_	_	_	O
13	adults	_	adult	_	NNS	128	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	128	_	_	_	_	_	_	_	O
15	type	_	type	_	JJ	128	_	_	_	_	_	_	_	O
16	2	_	2	_	CD	128	_	_	_	_	_	_	_	O
17	diabetes	_	UNK	_	NNS	128	_	_	_	_	_	_	_	O
18	:	_	:	_	:	128	_	_	_	_	_	_	_	O
19	who	_	who	_	WP	128	_	_	_	_	_	_	_	O
20	do	_	do	_	VBP	128	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	128	_	_	_	_	_	_	_	O
22	reach	_	reach	_	VB	128	_	_	_	_	_	_	_	O
23	their	_	their	_	PRP$	128	_	_	_	_	_	_	_	O
24	target	_	target	_	NN	128	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	128	_	_	_	_	_	_	_	O
26	because	_	because	_	IN	128	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	128	_	_	_	_	_	_	_	O
28	significant	_	significant	_	JJ	128	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	128	_	_	_	_	_	_	_	O
31	who	_	who	_	WP	128	_	_	_	_	_	_	_	S-Experiencer
32	experience	_	experience	_	VBP	128	_	_	_	_	_	experience.v	Feeling	O
33	significant	_	significant	_	JJ	128	_	_	_	_	_	_	_	B-Emotional_state
34	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	I-Emotional_state
35	on	_	on	_	IN	128	_	_	_	_	_	_	_	O
36	nph	_	UNK	_	NNP	128	_	_	_	_	_	_	_	O
37	insulin	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
38	irrespective	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
39	of	_	of	_	IN	128	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	128	_	_	_	_	_	_	_	O
41	level	_	level	_	NN	128	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	128	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	128	_	_	_	_	_	_	_	O
2	switching	_	switch	_	VBG	128	_	_	_	_	_	_	_	O
3	to	_	to	_	TO	128	_	_	_	_	_	_	_	O
4	insulin	_	UNK	_	VB	128	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
6	or	_	or	_	CC	128	_	_	_	_	_	_	_	O
7	insulin	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
8	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
9	from	_	from	_	IN	128	_	_	_	_	_	_	_	O
10	nph	_	UNK	_	NNP	128	_	_	_	_	_	_	_	O
11	insulin	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	128	_	_	_	_	_	_	_	O
13	adults	_	adult	_	NNS	128	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	128	_	_	_	_	_	_	_	O
15	type	_	type	_	JJ	128	_	_	_	_	_	_	_	O
16	2	_	2	_	CD	128	_	_	_	_	_	_	_	O
17	diabetes	_	UNK	_	NNS	128	_	_	_	_	_	_	_	O
18	:	_	:	_	:	128	_	_	_	_	_	_	_	O
19	who	_	who	_	WP	128	_	_	_	_	_	_	_	O
20	do	_	do	_	VBP	128	_	_	_	_	_	_	_	O
21	not	_	not	_	RB	128	_	_	_	_	_	_	_	O
22	reach	_	reach	_	VB	128	_	_	_	_	_	_	_	O
23	their	_	their	_	PRP$	128	_	_	_	_	_	_	_	O
24	target	_	target	_	NN	128	_	_	_	_	_	_	_	O
25	hba1c	_	UNK	_	NNP	128	_	_	_	_	_	_	_	O
26	because	_	because	_	IN	128	_	_	_	_	_	_	_	O
27	of	_	of	_	IN	128	_	_	_	_	_	_	_	O
28	significant	_	significant	_	JJ	128	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	128	_	_	_	_	_	_	_	O
31	who	_	who	_	WP	128	_	_	_	_	_	_	_	O
32	experience	_	experience	_	VBP	128	_	_	_	_	_	_	_	O
33	significant	_	significant	_	JJ	128	_	_	_	_	_	significant.a	Importance	O
34	unk	_	UNK	_	NN	128	_	_	_	_	_	_	_	S-Factor
35	on	_	on	_	IN	128	_	_	_	_	_	_	_	O
36	nph	_	UNK	_	NNP	128	_	_	_	_	_	_	_	O
37	insulin	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
38	irrespective	_	UNK	_	NN	128	_	_	_	_	_	_	_	O
39	of	_	of	_	IN	128	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	128	_	_	_	_	_	_	_	O
41	level	_	level	_	NN	128	_	_	_	_	_	_	_	O
42	of	_	of	_	IN	128	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	129	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	129	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	129	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	129	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	129	_	_	_	_	_	_	_	O
6	:	_	:	_	:	129	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	129	_	_	_	_	_	_	_	O
8	(	_	(	_	(	129	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	129	_	_	_	_	_	_	_	O
10	)	_	)	_	)	129	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	129	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	129	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	129	_	_	_	_	_	_	_	O
14	)	_	)	_	)	129	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	129	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	129	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	129	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	129	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	129	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	129	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	129	_	_	_	_	_	_	_	O
8	(	_	(	_	(	129	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	129	_	_	_	_	_	_	_	O
10	)	_	)	_	)	129	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	129	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	129	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	129	_	_	_	_	_	_	_	O
14	)	_	)	_	)	129	_	_	_	_	_	_	_	O

1	monitor	_	Monitor	_	NNP	130	_	_	_	_	_	_	_	S-Origin
2	adults	_	adult	_	NNS	130	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	130	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	130	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	130	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	130	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	130	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	130	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	130	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	130	_	_	_	_	_	_	_	O
11	basal	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
12	insulin	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
13	regimen	_	UNK	_	NNS	130	_	_	_	_	_	_	_	O
14	(	_	(	_	(	130	_	_	_	_	_	_	_	O
15	nph	_	UNK	_	NNP	130	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
17	,	_	,	_	,	130	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
20	or	_	or	_	CC	130	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
23	)	_	)	_	)	130	_	_	_	_	_	_	_	O
24	for	_	for	_	IN	130	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	130	_	_	_	_	_	_	_	O
26	need	_	need	_	NN	130	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	130	_	_	_	_	_	_	_	O
28	short-acting	_	UNK	_	JJ	130	_	_	_	_	_	_	_	O
29	insulin	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
30	before	_	before	_	IN	130	_	_	_	_	_	_	_	O
31	meals	_	meal	_	NNS	130	_	_	_	_	_	_	_	O
32	(	_	(	_	(	130	_	_	_	_	_	_	_	O
33	or	_	or	_	CC	130	_	_	_	_	_	_	_	O
34	a	_	a	_	DT	130	_	_	_	_	_	_	_	O
35	pre-mixed	_	UNK	_	JJ	130	_	_	_	_	_	_	_	O
36	[	_	[	_	NN	130	_	_	_	_	_	_	_	O
37	biphasic	_	UNK	_	JJ	130	_	_	_	_	_	_	_	O
38	]	_	]	_	NNP	130	_	_	_	_	_	_	_	O
39	insulin	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
40	preparation	_	preparation	_	NN	130	_	_	_	_	_	_	_	O
41	)	_	)	_	)	130	_	_	_	_	_	_	_	O
42	.	_	.	_	.	130	_	_	_	_	_	_	_	O

1	monitor	_	Monitor	_	NNP	130	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	130	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	130	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	130	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	130	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	130	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	130	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	130	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	130	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	130	_	_	_	_	_	_	_	O
11	basal	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
12	insulin	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
13	regimen	_	UNK	_	NNS	130	_	_	_	_	_	_	_	O
14	(	_	(	_	(	130	_	_	_	_	_	_	_	O
15	nph	_	UNK	_	NNP	130	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
17	,	_	,	_	,	130	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
20	or	_	or	_	CC	130	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
23	)	_	)	_	)	130	_	_	_	_	_	_	_	O
24	for	_	for	_	IN	130	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	130	_	_	_	_	_	_	_	O
26	need	_	need	_	NN	130	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	130	_	_	_	_	_	_	_	O
28	short-acting	_	UNK	_	JJ	130	_	_	_	_	_	_	_	O
29	insulin	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
30	before	_	before	_	IN	130	_	_	_	_	_	_	_	O
31	meals	_	meal	_	NNS	130	_	_	_	_	_	_	_	O
32	(	_	(	_	(	130	_	_	_	_	_	_	_	O
33	or	_	or	_	CC	130	_	_	_	_	_	_	_	O
34	a	_	a	_	DT	130	_	_	_	_	_	_	_	O
35	pre-mixed	_	UNK	_	JJ	130	_	_	_	_	_	_	_	O
36	[	_	[	_	NN	130	_	_	_	_	_	_	_	O
37	biphasic	_	UNK	_	JJ	130	_	_	_	_	_	_	_	O
38	]	_	]	_	NNP	130	_	_	_	_	_	_	_	O
39	insulin	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
40	preparation	_	preparation	_	NN	130	_	_	_	_	_	_	_	O
41	)	_	)	_	)	130	_	_	_	_	_	_	_	O
42	.	_	.	_	.	130	_	_	_	_	_	_	_	O

1	monitor	_	Monitor	_	NNP	130	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	130	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	130	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	130	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	130	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	130	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	130	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	130	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	130	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	130	_	_	_	_	_	_	_	O
11	basal	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
12	insulin	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
13	regimen	_	UNK	_	NNS	130	_	_	_	_	_	_	_	O
14	(	_	(	_	(	130	_	_	_	_	_	_	_	O
15	nph	_	UNK	_	NNP	130	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
17	,	_	,	_	,	130	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
20	or	_	or	_	CC	130	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
23	)	_	)	_	)	130	_	_	_	_	_	_	_	O
24	for	_	for	_	IN	130	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	130	_	_	_	_	_	_	_	O
26	need	_	need	_	NN	130	_	_	_	_	_	need.n	Needing	O
27	for	_	for	_	IN	130	_	_	_	_	_	_	_	B-Dependent
28	short-acting	_	UNK	_	JJ	130	_	_	_	_	_	_	_	I-Dependent
29	insulin	_	UNK	_	NN	130	_	_	_	_	_	_	_	I-Dependent
30	before	_	before	_	IN	130	_	_	_	_	_	_	_	O
31	meals	_	meal	_	NNS	130	_	_	_	_	_	_	_	O
32	(	_	(	_	(	130	_	_	_	_	_	_	_	O
33	or	_	or	_	CC	130	_	_	_	_	_	_	_	O
34	a	_	a	_	DT	130	_	_	_	_	_	_	_	O
35	pre-mixed	_	UNK	_	JJ	130	_	_	_	_	_	_	_	O
36	[	_	[	_	NN	130	_	_	_	_	_	_	_	O
37	biphasic	_	UNK	_	JJ	130	_	_	_	_	_	_	_	O
38	]	_	]	_	NNP	130	_	_	_	_	_	_	_	O
39	insulin	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
40	preparation	_	preparation	_	NN	130	_	_	_	_	_	_	_	O
41	)	_	)	_	)	130	_	_	_	_	_	_	_	O
42	.	_	.	_	.	130	_	_	_	_	_	_	_	O

1	monitor	_	Monitor	_	NNP	130	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	130	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	130	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	130	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	130	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	130	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	130	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	130	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	130	_	_	_	_	_	_	_	O
10	a	_	a	_	DT	130	_	_	_	_	_	_	_	O
11	basal	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
12	insulin	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
13	regimen	_	UNK	_	NNS	130	_	_	_	_	_	_	_	O
14	(	_	(	_	(	130	_	_	_	_	_	_	_	O
15	nph	_	UNK	_	NNP	130	_	_	_	_	_	_	_	O
16	insulin	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
17	,	_	,	_	,	130	_	_	_	_	_	_	_	O
18	insulin	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
20	or	_	or	_	CC	130	_	_	_	_	_	_	_	O
21	insulin	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
23	)	_	)	_	)	130	_	_	_	_	_	_	_	O
24	for	_	for	_	IN	130	_	_	_	_	_	_	_	O
25	the	_	the	_	DT	130	_	_	_	_	_	_	_	O
26	need	_	need	_	NN	130	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	130	_	_	_	_	_	_	_	O
28	short-acting	_	UNK	_	JJ	130	_	_	_	_	_	_	_	O
29	insulin	_	UNK	_	NN	130	_	_	_	_	_	_	_	O
30	before	_	before	_	IN	130	_	_	_	_	_	_	_	O
31	meals	_	meal	_	NNS	130	_	_	_	_	_	_	_	O
32	(	_	(	_	(	130	_	_	_	_	_	_	_	O
33	or	_	or	_	CC	130	_	_	_	_	_	_	_	O
34	a	_	a	_	DT	130	_	_	_	_	_	_	_	O
35	pre-mixed	_	UNK	_	JJ	130	_	_	_	_	_	_	_	O
36	[	_	[	_	NN	130	_	_	_	_	_	_	_	O
37	biphasic	_	UNK	_	JJ	130	_	_	_	_	_	_	_	O
38	]	_	]	_	NNP	130	_	_	_	_	_	_	_	O
39	insulin	_	UNK	_	NN	130	_	_	_	_	_	_	_	S-Activity
40	preparation	_	preparation	_	NN	130	_	_	_	_	_	preparation.n	Activity_prepare	O
41	)	_	)	_	)	130	_	_	_	_	_	_	_	O
42	.	_	.	_	.	130	_	_	_	_	_	_	_	O

1	monitor	_	Monitor	_	NNP	131	_	_	_	_	_	_	_	S-Origin
2	adults	_	adult	_	NNS	131	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	131	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	131	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	131	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	131	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	131	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	131	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	131	_	_	_	_	_	_	_	O
10	pre-mixed	_	UNK	_	JJ	131	_	_	_	_	_	_	_	O
11	(	_	(	_	(	131	_	_	_	_	_	_	_	O
12	biphasic	_	UNK	_	JJ	131	_	_	_	_	_	_	_	O
13	)	_	)	_	)	131	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	131	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	131	_	_	_	_	_	_	_	O
17	need	_	need	_	NN	131	_	_	_	_	_	_	_	O
18	for	_	for	_	IN	131	_	_	_	_	_	_	_	O
19	a	_	a	_	DT	131	_	_	_	_	_	_	_	O
20	further	_	further	_	JJ	131	_	_	_	_	_	_	_	O
21	injection	_	injection	_	NN	131	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	131	_	_	_	_	_	_	_	O
23	short-acting	_	UNK	_	JJ	131	_	_	_	_	_	_	_	O
24	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
25	before	_	before	_	IN	131	_	_	_	_	_	_	_	O
26	meals	_	meal	_	NNS	131	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	131	_	_	_	_	_	_	_	O
28	for	_	for	_	IN	131	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	131	_	_	_	_	_	_	_	O
30	change	_	change	_	NN	131	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	131	_	_	_	_	_	_	_	O
32	a	_	a	_	DT	131	_	_	_	_	_	_	_	O
33	basal	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
34	bolus	_	UNK	_	JJ	131	_	_	_	_	_	_	_	O
35	regimen	_	UNK	_	NNS	131	_	_	_	_	_	_	_	O
36	with	_	with	_	IN	131	_	_	_	_	_	_	_	O
37	nph	_	UNK	_	NNP	131	_	_	_	_	_	_	_	O
38	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
39	or	_	or	_	CC	131	_	_	_	_	_	_	_	O
40	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
41	unk	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
42	or	_	or	_	CC	131	_	_	_	_	_	_	_	O
43	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
44	unk	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
45	,	_	,	_	,	131	_	_	_	_	_	_	_	O
46	if	_	if	_	IN	131	_	_	_	_	_	_	_	O
47	blood	_	blood	_	VBN	131	_	_	_	_	_	_	_	O
48	glucose	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
49	control	_	control	_	NN	131	_	_	_	_	_	_	_	O
50	remains	_	remain	_	VBZ	131	_	_	_	_	_	_	_	O
51	inadequate	_	UNK	_	JJ	131	_	_	_	_	_	_	_	O
52	.	_	.	_	.	131	_	_	_	_	_	_	_	O

1	monitor	_	Monitor	_	NNP	131	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	131	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	131	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	131	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	131	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	131	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	131	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	131	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	131	_	_	_	_	_	_	_	O
10	pre-mixed	_	UNK	_	JJ	131	_	_	_	_	_	_	_	O
11	(	_	(	_	(	131	_	_	_	_	_	_	_	O
12	biphasic	_	UNK	_	JJ	131	_	_	_	_	_	_	_	O
13	)	_	)	_	)	131	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	131	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	131	_	_	_	_	_	_	_	O
17	need	_	need	_	NN	131	_	_	_	_	_	_	_	O
18	for	_	for	_	IN	131	_	_	_	_	_	_	_	O
19	a	_	a	_	DT	131	_	_	_	_	_	_	_	O
20	further	_	further	_	JJ	131	_	_	_	_	_	_	_	O
21	injection	_	injection	_	NN	131	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	131	_	_	_	_	_	_	_	O
23	short-acting	_	UNK	_	JJ	131	_	_	_	_	_	_	_	O
24	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
25	before	_	before	_	IN	131	_	_	_	_	_	_	_	O
26	meals	_	meal	_	NNS	131	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	131	_	_	_	_	_	_	_	O
28	for	_	for	_	IN	131	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	131	_	_	_	_	_	_	_	O
30	change	_	change	_	NN	131	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	131	_	_	_	_	_	_	_	O
32	a	_	a	_	DT	131	_	_	_	_	_	_	_	O
33	basal	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
34	bolus	_	UNK	_	JJ	131	_	_	_	_	_	_	_	O
35	regimen	_	UNK	_	NNS	131	_	_	_	_	_	_	_	O
36	with	_	with	_	IN	131	_	_	_	_	_	_	_	O
37	nph	_	UNK	_	NNP	131	_	_	_	_	_	_	_	O
38	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
39	or	_	or	_	CC	131	_	_	_	_	_	_	_	O
40	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
41	unk	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
42	or	_	or	_	CC	131	_	_	_	_	_	_	_	O
43	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
44	unk	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
45	,	_	,	_	,	131	_	_	_	_	_	_	_	O
46	if	_	if	_	IN	131	_	_	_	_	_	_	_	O
47	blood	_	blood	_	VBN	131	_	_	_	_	_	_	_	O
48	glucose	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
49	control	_	control	_	NN	131	_	_	_	_	_	_	_	O
50	remains	_	remain	_	VBZ	131	_	_	_	_	_	_	_	O
51	inadequate	_	UNK	_	JJ	131	_	_	_	_	_	_	_	O
52	.	_	.	_	.	131	_	_	_	_	_	_	_	O

1	monitor	_	Monitor	_	NNP	131	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	131	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	131	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	131	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	131	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	131	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	131	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	131	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	131	_	_	_	_	_	_	_	O
10	pre-mixed	_	UNK	_	JJ	131	_	_	_	_	_	_	_	O
11	(	_	(	_	(	131	_	_	_	_	_	_	_	O
12	biphasic	_	UNK	_	JJ	131	_	_	_	_	_	_	_	O
13	)	_	)	_	)	131	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	131	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	131	_	_	_	_	_	_	_	O
17	need	_	need	_	NN	131	_	_	_	_	_	need.n	Needing	S-Requirement
18	for	_	for	_	IN	131	_	_	_	_	_	_	_	B-Dependent
19	a	_	a	_	DT	131	_	_	_	_	_	_	_	I-Dependent
20	further	_	further	_	JJ	131	_	_	_	_	_	_	_	I-Dependent
21	injection	_	injection	_	NN	131	_	_	_	_	_	_	_	I-Dependent
22	of	_	of	_	IN	131	_	_	_	_	_	_	_	I-Dependent
23	short-acting	_	UNK	_	JJ	131	_	_	_	_	_	_	_	I-Dependent
24	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	I-Dependent
25	before	_	before	_	IN	131	_	_	_	_	_	_	_	O
26	meals	_	meal	_	NNS	131	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	131	_	_	_	_	_	_	_	O
28	for	_	for	_	IN	131	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	131	_	_	_	_	_	_	_	O
30	change	_	change	_	NN	131	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	131	_	_	_	_	_	_	_	O
32	a	_	a	_	DT	131	_	_	_	_	_	_	_	O
33	basal	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
34	bolus	_	UNK	_	JJ	131	_	_	_	_	_	_	_	O
35	regimen	_	UNK	_	NNS	131	_	_	_	_	_	_	_	O
36	with	_	with	_	IN	131	_	_	_	_	_	_	_	O
37	nph	_	UNK	_	NNP	131	_	_	_	_	_	_	_	O
38	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
39	or	_	or	_	CC	131	_	_	_	_	_	_	_	O
40	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
41	unk	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
42	or	_	or	_	CC	131	_	_	_	_	_	_	_	O
43	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
44	unk	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
45	,	_	,	_	,	131	_	_	_	_	_	_	_	O
46	if	_	if	_	IN	131	_	_	_	_	_	_	_	O
47	blood	_	blood	_	VBN	131	_	_	_	_	_	_	_	O
48	glucose	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
49	control	_	control	_	NN	131	_	_	_	_	_	_	_	O
50	remains	_	remain	_	VBZ	131	_	_	_	_	_	_	_	O
51	inadequate	_	UNK	_	JJ	131	_	_	_	_	_	_	_	O
52	.	_	.	_	.	131	_	_	_	_	_	_	_	O

1	monitor	_	Monitor	_	NNP	131	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	131	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	131	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	131	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	131	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	131	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	131	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	131	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	131	_	_	_	_	_	_	_	O
10	pre-mixed	_	UNK	_	JJ	131	_	_	_	_	_	_	_	O
11	(	_	(	_	(	131	_	_	_	_	_	_	_	O
12	biphasic	_	UNK	_	JJ	131	_	_	_	_	_	_	_	O
13	)	_	)	_	)	131	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	131	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	131	_	_	_	_	_	_	_	O
17	need	_	need	_	NN	131	_	_	_	_	_	_	_	O
18	for	_	for	_	IN	131	_	_	_	_	_	_	_	O
19	a	_	a	_	DT	131	_	_	_	_	_	_	_	O
20	further	_	further	_	JJ	131	_	_	_	_	_	further.a	Increment	O
21	injection	_	injection	_	NN	131	_	_	_	_	_	_	_	B-Class
22	of	_	of	_	IN	131	_	_	_	_	_	_	_	I-Class
23	short-acting	_	UNK	_	JJ	131	_	_	_	_	_	_	_	I-Class
24	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	I-Class
25	before	_	before	_	IN	131	_	_	_	_	_	_	_	O
26	meals	_	meal	_	NNS	131	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	131	_	_	_	_	_	_	_	O
28	for	_	for	_	IN	131	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	131	_	_	_	_	_	_	_	O
30	change	_	change	_	NN	131	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	131	_	_	_	_	_	_	_	O
32	a	_	a	_	DT	131	_	_	_	_	_	_	_	O
33	basal	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
34	bolus	_	UNK	_	JJ	131	_	_	_	_	_	_	_	O
35	regimen	_	UNK	_	NNS	131	_	_	_	_	_	_	_	O
36	with	_	with	_	IN	131	_	_	_	_	_	_	_	O
37	nph	_	UNK	_	NNP	131	_	_	_	_	_	_	_	O
38	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
39	or	_	or	_	CC	131	_	_	_	_	_	_	_	O
40	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
41	unk	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
42	or	_	or	_	CC	131	_	_	_	_	_	_	_	O
43	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
44	unk	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
45	,	_	,	_	,	131	_	_	_	_	_	_	_	O
46	if	_	if	_	IN	131	_	_	_	_	_	_	_	O
47	blood	_	blood	_	VBN	131	_	_	_	_	_	_	_	O
48	glucose	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
49	control	_	control	_	NN	131	_	_	_	_	_	_	_	O
50	remains	_	remain	_	VBZ	131	_	_	_	_	_	_	_	O
51	inadequate	_	UNK	_	JJ	131	_	_	_	_	_	_	_	O
52	.	_	.	_	.	131	_	_	_	_	_	_	_	O

1	monitor	_	Monitor	_	NNP	131	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	131	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	131	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	131	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	131	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	131	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	131	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	131	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	131	_	_	_	_	_	_	_	O
10	pre-mixed	_	UNK	_	JJ	131	_	_	_	_	_	_	_	O
11	(	_	(	_	(	131	_	_	_	_	_	_	_	O
12	biphasic	_	UNK	_	JJ	131	_	_	_	_	_	_	_	O
13	)	_	)	_	)	131	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	131	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	131	_	_	_	_	_	_	_	O
17	need	_	need	_	NN	131	_	_	_	_	_	_	_	O
18	for	_	for	_	IN	131	_	_	_	_	_	_	_	O
19	a	_	a	_	DT	131	_	_	_	_	_	_	_	O
20	further	_	further	_	JJ	131	_	_	_	_	_	_	_	O
21	injection	_	injection	_	NN	131	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	131	_	_	_	_	_	_	_	O
23	short-acting	_	UNK	_	JJ	131	_	_	_	_	_	_	_	O
24	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
25	before	_	before	_	IN	131	_	_	_	_	_	_	_	O
26	meals	_	meal	_	NNS	131	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	131	_	_	_	_	_	_	_	O
28	for	_	for	_	IN	131	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	131	_	_	_	_	_	_	_	O
30	change	_	change	_	NN	131	_	_	_	_	_	change.n	Undergo_change	O
31	to	_	to	_	TO	131	_	_	_	_	_	_	_	B-Final_situation
32	a	_	a	_	DT	131	_	_	_	_	_	_	_	I-Final_situation
33	basal	_	UNK	_	NN	131	_	_	_	_	_	_	_	I-Final_situation
34	bolus	_	UNK	_	JJ	131	_	_	_	_	_	_	_	I-Final_situation
35	regimen	_	UNK	_	NNS	131	_	_	_	_	_	_	_	I-Final_situation
36	with	_	with	_	IN	131	_	_	_	_	_	_	_	I-Final_situation
37	nph	_	UNK	_	NNP	131	_	_	_	_	_	_	_	I-Final_situation
38	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	I-Final_situation
39	or	_	or	_	CC	131	_	_	_	_	_	_	_	I-Final_situation
40	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	I-Final_situation
41	unk	_	UNK	_	NN	131	_	_	_	_	_	_	_	I-Final_situation
42	or	_	or	_	CC	131	_	_	_	_	_	_	_	I-Final_situation
43	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	I-Final_situation
44	unk	_	UNK	_	NN	131	_	_	_	_	_	_	_	I-Final_situation
45	,	_	,	_	,	131	_	_	_	_	_	_	_	O
46	if	_	if	_	IN	131	_	_	_	_	_	_	_	O
47	blood	_	blood	_	VBN	131	_	_	_	_	_	_	_	O
48	glucose	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
49	control	_	control	_	NN	131	_	_	_	_	_	_	_	O
50	remains	_	remain	_	VBZ	131	_	_	_	_	_	_	_	O
51	inadequate	_	UNK	_	JJ	131	_	_	_	_	_	_	_	O
52	.	_	.	_	.	131	_	_	_	_	_	_	_	O

1	monitor	_	Monitor	_	NNP	131	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	131	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	131	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	131	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	131	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	131	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	131	_	_	_	_	_	_	_	O
8	are	_	be	_	VBP	131	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	131	_	_	_	_	_	_	_	O
10	pre-mixed	_	UNK	_	JJ	131	_	_	_	_	_	_	_	O
11	(	_	(	_	(	131	_	_	_	_	_	_	_	O
12	biphasic	_	UNK	_	JJ	131	_	_	_	_	_	_	_	O
13	)	_	)	_	)	131	_	_	_	_	_	_	_	O
14	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	131	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	131	_	_	_	_	_	_	_	O
17	need	_	need	_	NN	131	_	_	_	_	_	_	_	O
18	for	_	for	_	IN	131	_	_	_	_	_	_	_	O
19	a	_	a	_	DT	131	_	_	_	_	_	_	_	O
20	further	_	further	_	JJ	131	_	_	_	_	_	_	_	O
21	injection	_	injection	_	NN	131	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	131	_	_	_	_	_	_	_	O
23	short-acting	_	UNK	_	JJ	131	_	_	_	_	_	_	_	O
24	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
25	before	_	before	_	IN	131	_	_	_	_	_	_	_	O
26	meals	_	meal	_	NNS	131	_	_	_	_	_	_	_	O
27	or	_	or	_	CC	131	_	_	_	_	_	_	_	O
28	for	_	for	_	IN	131	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	131	_	_	_	_	_	_	_	O
30	change	_	change	_	NN	131	_	_	_	_	_	_	_	O
31	to	_	to	_	TO	131	_	_	_	_	_	_	_	O
32	a	_	a	_	DT	131	_	_	_	_	_	_	_	O
33	basal	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
34	bolus	_	UNK	_	JJ	131	_	_	_	_	_	_	_	O
35	regimen	_	UNK	_	NNS	131	_	_	_	_	_	_	_	O
36	with	_	with	_	IN	131	_	_	_	_	_	_	_	O
37	nph	_	UNK	_	NNP	131	_	_	_	_	_	_	_	O
38	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
39	or	_	or	_	CC	131	_	_	_	_	_	_	_	O
40	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
41	unk	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
42	or	_	or	_	CC	131	_	_	_	_	_	_	_	O
43	insulin	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
44	unk	_	UNK	_	NN	131	_	_	_	_	_	_	_	O
45	,	_	,	_	,	131	_	_	_	_	_	_	_	O
46	if	_	if	_	IN	131	_	_	_	_	_	_	_	O
47	blood	_	blood	_	VBN	131	_	_	_	_	_	_	_	B-Entity
48	glucose	_	UNK	_	NN	131	_	_	_	_	_	_	_	I-Entity
49	control	_	control	_	NN	131	_	_	_	_	_	_	_	I-Entity
50	remains	_	remain	_	VBZ	131	_	_	_	_	_	remain.v	State_continue	O
51	inadequate	_	UNK	_	JJ	131	_	_	_	_	_	_	_	S-State
52	.	_	.	_	.	131	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	132	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	132	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	132	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	132	_	_	_	_	_	_	_	S-Total
6	including	_	include	_	VBG	132	_	_	_	_	_	include.v	Inclusion	O
7	unk	_	UNK	_	JJ	132	_	_	_	_	_	_	_	B-Part
8	inhibitors	_	UNK	_	NNS	132	_	_	_	_	_	_	_	I-Part
9	,	_	,	_	,	132	_	_	_	_	_	_	_	O
10	may	_	may	_	MD	132	_	_	_	_	_	_	_	O
11	be	_	be	_	VB	132	_	_	_	_	_	_	_	O
12	appropriate	_	appropriate	_	JJ	132	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
14	some	_	some	_	DT	132	_	_	_	_	_	_	_	O
15	people	_	people	_	NNS	132	_	_	_	_	_	_	_	O
16	with	_	with	_	IN	132	_	_	_	_	_	_	_	O
17	type	_	type	_	JJ	132	_	_	_	_	_	_	_	O
18	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
19	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
20	;	_	;	_	:	132	_	_	_	_	_	_	_	O
21	see	_	see	_	VB	132	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	132	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	132	_	_	_	_	_	_	_	O
24	guidance	_	guidance	_	NN	132	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	132	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	132	_	_	_	_	_	_	_	O
28	combination	_	combination	_	NN	132	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	132	_	_	_	_	_	_	_	O
30	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
31	treating	_	treat	_	VBG	132	_	_	_	_	_	_	_	O
32	type	_	type	_	NN	132	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
35	,	_	,	_	,	132	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	132	_	_	_	_	_	_	_	O
38	combination	_	combination	_	NN	132	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	132	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
41	treating	_	treat	_	VBG	132	_	_	_	_	_	_	_	O
42	type	_	type	_	NN	132	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
45	and	_	and	_	CC	132	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
47	in	_	in	_	IN	132	_	_	_	_	_	_	_	O
48	combination	_	combination	_	NN	132	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	132	_	_	_	_	_	_	_	O
50	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
51	treating	_	treat	_	VBG	132	_	_	_	_	_	_	_	O
52	type	_	type	_	NN	132	_	_	_	_	_	_	_	O
53	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
54	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
55	.	_	.	_	.	132	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	132	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	132	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	132	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	132	_	_	_	_	_	_	_	O
6	including	_	include	_	VBG	132	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	JJ	132	_	_	_	_	_	_	_	O
8	inhibitors	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
9	,	_	,	_	,	132	_	_	_	_	_	_	_	O
10	may	_	may	_	MD	132	_	_	_	_	_	_	_	O
11	be	_	be	_	VB	132	_	_	_	_	_	_	_	O
12	appropriate	_	appropriate	_	JJ	132	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
14	some	_	some	_	DT	132	_	_	_	_	_	_	_	O
15	people	_	people	_	NNS	132	_	_	_	_	_	people.n	People	S-Person
16	with	_	with	_	IN	132	_	_	_	_	_	_	_	O
17	type	_	type	_	JJ	132	_	_	_	_	_	_	_	O
18	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
19	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
20	;	_	;	_	:	132	_	_	_	_	_	_	_	O
21	see	_	see	_	VB	132	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	132	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	132	_	_	_	_	_	_	_	O
24	guidance	_	guidance	_	NN	132	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	132	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	132	_	_	_	_	_	_	_	O
28	combination	_	combination	_	NN	132	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	132	_	_	_	_	_	_	_	O
30	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
31	treating	_	treat	_	VBG	132	_	_	_	_	_	_	_	O
32	type	_	type	_	NN	132	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
35	,	_	,	_	,	132	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	132	_	_	_	_	_	_	_	O
38	combination	_	combination	_	NN	132	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	132	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
41	treating	_	treat	_	VBG	132	_	_	_	_	_	_	_	O
42	type	_	type	_	NN	132	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
45	and	_	and	_	CC	132	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
47	in	_	in	_	IN	132	_	_	_	_	_	_	_	O
48	combination	_	combination	_	NN	132	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	132	_	_	_	_	_	_	_	O
50	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
51	treating	_	treat	_	VBG	132	_	_	_	_	_	_	_	O
52	type	_	type	_	NN	132	_	_	_	_	_	_	_	O
53	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
54	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
55	.	_	.	_	.	132	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	132	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	132	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	132	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	132	_	_	_	_	_	_	_	O
6	including	_	include	_	VBG	132	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	JJ	132	_	_	_	_	_	_	_	O
8	inhibitors	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
9	,	_	,	_	,	132	_	_	_	_	_	_	_	O
10	may	_	may	_	MD	132	_	_	_	_	_	_	_	O
11	be	_	be	_	VB	132	_	_	_	_	_	_	_	O
12	appropriate	_	appropriate	_	JJ	132	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
14	some	_	some	_	DT	132	_	_	_	_	_	_	_	O
15	people	_	people	_	NNS	132	_	_	_	_	_	_	_	O
16	with	_	with	_	IN	132	_	_	_	_	_	_	_	O
17	type	_	type	_	JJ	132	_	_	_	_	_	type.n	Type	S-Subtype
18	2	_	2	_	CD	132	_	_	_	_	_	_	_	B-Category
19	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	I-Category
20	;	_	;	_	:	132	_	_	_	_	_	_	_	O
21	see	_	see	_	VB	132	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	132	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	132	_	_	_	_	_	_	_	O
24	guidance	_	guidance	_	NN	132	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	132	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	132	_	_	_	_	_	_	_	O
28	combination	_	combination	_	NN	132	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	132	_	_	_	_	_	_	_	O
30	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
31	treating	_	treat	_	VBG	132	_	_	_	_	_	_	_	O
32	type	_	type	_	NN	132	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
35	,	_	,	_	,	132	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	132	_	_	_	_	_	_	_	O
38	combination	_	combination	_	NN	132	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	132	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
41	treating	_	treat	_	VBG	132	_	_	_	_	_	_	_	O
42	type	_	type	_	NN	132	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
45	and	_	and	_	CC	132	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
47	in	_	in	_	IN	132	_	_	_	_	_	_	_	O
48	combination	_	combination	_	NN	132	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	132	_	_	_	_	_	_	_	O
50	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
51	treating	_	treat	_	VBG	132	_	_	_	_	_	_	_	O
52	type	_	type	_	NN	132	_	_	_	_	_	_	_	O
53	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
54	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
55	.	_	.	_	.	132	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	132	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	132	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	132	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	132	_	_	_	_	_	_	_	O
6	including	_	include	_	VBG	132	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	JJ	132	_	_	_	_	_	_	_	O
8	inhibitors	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
9	,	_	,	_	,	132	_	_	_	_	_	_	_	O
10	may	_	may	_	MD	132	_	_	_	_	_	_	_	O
11	be	_	be	_	VB	132	_	_	_	_	_	_	_	O
12	appropriate	_	appropriate	_	JJ	132	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
14	some	_	some	_	DT	132	_	_	_	_	_	_	_	O
15	people	_	people	_	NNS	132	_	_	_	_	_	_	_	O
16	with	_	with	_	IN	132	_	_	_	_	_	_	_	O
17	type	_	type	_	JJ	132	_	_	_	_	_	_	_	O
18	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
19	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
20	;	_	;	_	:	132	_	_	_	_	_	_	_	O
21	see	_	see	_	VB	132	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	132	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	132	_	_	_	_	_	_	_	O
24	guidance	_	guidance	_	NN	132	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	132	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	132	_	_	_	_	_	_	_	O
28	combination	_	combination	_	NN	132	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	132	_	_	_	_	_	_	_	O
30	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
31	treating	_	treat	_	VBG	132	_	_	_	_	_	treat.v	Medical_intervention	O
32	type	_	type	_	NN	132	_	_	_	_	_	_	_	B-Patient
33	2	_	2	_	CD	132	_	_	_	_	_	_	_	I-Patient
34	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	I-Patient
35	,	_	,	_	,	132	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	132	_	_	_	_	_	_	_	O
38	combination	_	combination	_	NN	132	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	132	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
41	treating	_	treat	_	VBG	132	_	_	_	_	_	_	_	O
42	type	_	type	_	NN	132	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
45	and	_	and	_	CC	132	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
47	in	_	in	_	IN	132	_	_	_	_	_	_	_	O
48	combination	_	combination	_	NN	132	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	132	_	_	_	_	_	_	_	O
50	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
51	treating	_	treat	_	VBG	132	_	_	_	_	_	_	_	O
52	type	_	type	_	NN	132	_	_	_	_	_	_	_	O
53	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
54	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
55	.	_	.	_	.	132	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	132	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	132	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	132	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	132	_	_	_	_	_	_	_	O
6	including	_	include	_	VBG	132	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	JJ	132	_	_	_	_	_	_	_	O
8	inhibitors	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
9	,	_	,	_	,	132	_	_	_	_	_	_	_	O
10	may	_	may	_	MD	132	_	_	_	_	_	_	_	O
11	be	_	be	_	VB	132	_	_	_	_	_	_	_	O
12	appropriate	_	appropriate	_	JJ	132	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
14	some	_	some	_	DT	132	_	_	_	_	_	_	_	O
15	people	_	people	_	NNS	132	_	_	_	_	_	_	_	O
16	with	_	with	_	IN	132	_	_	_	_	_	_	_	O
17	type	_	type	_	JJ	132	_	_	_	_	_	_	_	O
18	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
19	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
20	;	_	;	_	:	132	_	_	_	_	_	_	_	O
21	see	_	see	_	VB	132	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	132	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	132	_	_	_	_	_	_	_	O
24	guidance	_	guidance	_	NN	132	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	132	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	132	_	_	_	_	_	_	_	O
28	combination	_	combination	_	NN	132	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	132	_	_	_	_	_	_	_	O
30	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
31	treating	_	treat	_	VBG	132	_	_	_	_	_	_	_	O
32	type	_	type	_	NN	132	_	_	_	_	_	type.n	Type	S-Subtype
33	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
35	,	_	,	_	,	132	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	132	_	_	_	_	_	_	_	O
38	combination	_	combination	_	NN	132	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	132	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
41	treating	_	treat	_	VBG	132	_	_	_	_	_	_	_	O
42	type	_	type	_	NN	132	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
45	and	_	and	_	CC	132	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
47	in	_	in	_	IN	132	_	_	_	_	_	_	_	O
48	combination	_	combination	_	NN	132	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	132	_	_	_	_	_	_	_	O
50	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
51	treating	_	treat	_	VBG	132	_	_	_	_	_	_	_	O
52	type	_	type	_	NN	132	_	_	_	_	_	_	_	O
53	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
54	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
55	.	_	.	_	.	132	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	132	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	132	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	132	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	132	_	_	_	_	_	_	_	O
6	including	_	include	_	VBG	132	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	JJ	132	_	_	_	_	_	_	_	O
8	inhibitors	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
9	,	_	,	_	,	132	_	_	_	_	_	_	_	O
10	may	_	may	_	MD	132	_	_	_	_	_	_	_	O
11	be	_	be	_	VB	132	_	_	_	_	_	_	_	O
12	appropriate	_	appropriate	_	JJ	132	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
14	some	_	some	_	DT	132	_	_	_	_	_	_	_	O
15	people	_	people	_	NNS	132	_	_	_	_	_	_	_	O
16	with	_	with	_	IN	132	_	_	_	_	_	_	_	O
17	type	_	type	_	JJ	132	_	_	_	_	_	_	_	O
18	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
19	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
20	;	_	;	_	:	132	_	_	_	_	_	_	_	O
21	see	_	see	_	VB	132	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	132	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	132	_	_	_	_	_	_	_	O
24	guidance	_	guidance	_	NN	132	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	132	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	132	_	_	_	_	_	_	_	O
28	combination	_	combination	_	NN	132	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	132	_	_	_	_	_	_	_	O
30	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
31	treating	_	treat	_	VBG	132	_	_	_	_	_	_	_	O
32	type	_	type	_	NN	132	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
35	,	_	,	_	,	132	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	132	_	_	_	_	_	_	_	O
38	combination	_	combination	_	NN	132	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	132	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
41	treating	_	treat	_	VBG	132	_	_	_	_	_	treat.v	Medical_intervention	O
42	type	_	type	_	NN	132	_	_	_	_	_	_	_	B-Patient
43	2	_	2	_	CD	132	_	_	_	_	_	_	_	I-Patient
44	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	I-Patient
45	and	_	and	_	CC	132	_	_	_	_	_	_	_	I-Patient
46	unk	_	UNK	_	NN	132	_	_	_	_	_	_	_	I-Patient
47	in	_	in	_	IN	132	_	_	_	_	_	_	_	B-Medical_condition
48	combination	_	combination	_	NN	132	_	_	_	_	_	_	_	I-Medical_condition
49	therapy	_	therapy	_	NN	132	_	_	_	_	_	_	_	I-Medical_condition
50	for	_	for	_	IN	132	_	_	_	_	_	_	_	I-Medical_condition
51	treating	_	treat	_	VBG	132	_	_	_	_	_	_	_	I-Medical_condition
52	type	_	type	_	NN	132	_	_	_	_	_	_	_	I-Medical_condition
53	2	_	2	_	CD	132	_	_	_	_	_	_	_	I-Medical_condition
54	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	I-Medical_condition
55	.	_	.	_	.	132	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	132	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	132	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	132	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	132	_	_	_	_	_	_	_	O
6	including	_	include	_	VBG	132	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	JJ	132	_	_	_	_	_	_	_	O
8	inhibitors	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
9	,	_	,	_	,	132	_	_	_	_	_	_	_	O
10	may	_	may	_	MD	132	_	_	_	_	_	_	_	O
11	be	_	be	_	VB	132	_	_	_	_	_	_	_	O
12	appropriate	_	appropriate	_	JJ	132	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
14	some	_	some	_	DT	132	_	_	_	_	_	_	_	O
15	people	_	people	_	NNS	132	_	_	_	_	_	_	_	O
16	with	_	with	_	IN	132	_	_	_	_	_	_	_	O
17	type	_	type	_	JJ	132	_	_	_	_	_	_	_	O
18	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
19	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
20	;	_	;	_	:	132	_	_	_	_	_	_	_	O
21	see	_	see	_	VB	132	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	132	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	132	_	_	_	_	_	_	_	O
24	guidance	_	guidance	_	NN	132	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	132	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	132	_	_	_	_	_	_	_	O
28	combination	_	combination	_	NN	132	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	132	_	_	_	_	_	_	_	O
30	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
31	treating	_	treat	_	VBG	132	_	_	_	_	_	_	_	O
32	type	_	type	_	NN	132	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
35	,	_	,	_	,	132	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	132	_	_	_	_	_	_	_	O
38	combination	_	combination	_	NN	132	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	132	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
41	treating	_	treat	_	VBG	132	_	_	_	_	_	_	_	O
42	type	_	type	_	NN	132	_	_	_	_	_	type.n	Type	S-Subtype
43	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
45	and	_	and	_	CC	132	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
47	in	_	in	_	IN	132	_	_	_	_	_	_	_	O
48	combination	_	combination	_	NN	132	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	132	_	_	_	_	_	_	_	O
50	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
51	treating	_	treat	_	VBG	132	_	_	_	_	_	_	_	O
52	type	_	type	_	NN	132	_	_	_	_	_	_	_	O
53	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
54	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
55	.	_	.	_	.	132	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	132	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	132	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	132	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	132	_	_	_	_	_	_	_	O
6	including	_	include	_	VBG	132	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	JJ	132	_	_	_	_	_	_	_	O
8	inhibitors	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
9	,	_	,	_	,	132	_	_	_	_	_	_	_	O
10	may	_	may	_	MD	132	_	_	_	_	_	_	_	O
11	be	_	be	_	VB	132	_	_	_	_	_	_	_	O
12	appropriate	_	appropriate	_	JJ	132	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
14	some	_	some	_	DT	132	_	_	_	_	_	_	_	O
15	people	_	people	_	NNS	132	_	_	_	_	_	_	_	O
16	with	_	with	_	IN	132	_	_	_	_	_	_	_	O
17	type	_	type	_	JJ	132	_	_	_	_	_	_	_	O
18	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
19	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
20	;	_	;	_	:	132	_	_	_	_	_	_	_	O
21	see	_	see	_	VB	132	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	132	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	132	_	_	_	_	_	_	_	O
24	guidance	_	guidance	_	NN	132	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	132	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	132	_	_	_	_	_	_	_	O
28	combination	_	combination	_	NN	132	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	132	_	_	_	_	_	_	_	O
30	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
31	treating	_	treat	_	VBG	132	_	_	_	_	_	_	_	O
32	type	_	type	_	NN	132	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
35	,	_	,	_	,	132	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	132	_	_	_	_	_	_	_	O
38	combination	_	combination	_	NN	132	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	132	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
41	treating	_	treat	_	VBG	132	_	_	_	_	_	_	_	O
42	type	_	type	_	NN	132	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
45	and	_	and	_	CC	132	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
47	in	_	in	_	IN	132	_	_	_	_	_	_	_	O
48	combination	_	combination	_	NN	132	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	132	_	_	_	_	_	_	_	O
50	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
51	treating	_	treat	_	VBG	132	_	_	_	_	_	treat.v	Medical_intervention	O
52	type	_	type	_	NN	132	_	_	_	_	_	_	_	B-Patient
53	2	_	2	_	CD	132	_	_	_	_	_	_	_	I-Patient
54	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	I-Patient
55	.	_	.	_	.	132	_	_	_	_	_	_	_	O

1	treatment	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
2	with	_	with	_	IN	132	_	_	_	_	_	_	_	O
3	combinations	_	combination	_	NNS	132	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	132	_	_	_	_	_	_	_	O
5	medicines	_	medicine	_	NNS	132	_	_	_	_	_	_	_	O
6	including	_	include	_	VBG	132	_	_	_	_	_	_	_	O
7	unk	_	UNK	_	JJ	132	_	_	_	_	_	_	_	O
8	inhibitors	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
9	,	_	,	_	,	132	_	_	_	_	_	_	_	O
10	may	_	may	_	MD	132	_	_	_	_	_	_	_	O
11	be	_	be	_	VB	132	_	_	_	_	_	_	_	O
12	appropriate	_	appropriate	_	JJ	132	_	_	_	_	_	_	_	O
13	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
14	some	_	some	_	DT	132	_	_	_	_	_	_	_	O
15	people	_	people	_	NNS	132	_	_	_	_	_	_	_	O
16	with	_	with	_	IN	132	_	_	_	_	_	_	_	O
17	type	_	type	_	JJ	132	_	_	_	_	_	_	_	O
18	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
19	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
20	;	_	;	_	:	132	_	_	_	_	_	_	_	O
21	see	_	see	_	VB	132	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	132	_	_	_	_	_	_	_	O
23	nice	_	UNK	_	NNP	132	_	_	_	_	_	_	_	O
24	guidance	_	guidance	_	NN	132	_	_	_	_	_	_	_	O
25	on	_	on	_	IN	132	_	_	_	_	_	_	_	O
26	unk	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	132	_	_	_	_	_	_	_	O
28	combination	_	combination	_	NN	132	_	_	_	_	_	_	_	O
29	therapy	_	therapy	_	NN	132	_	_	_	_	_	_	_	O
30	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
31	treating	_	treat	_	VBG	132	_	_	_	_	_	_	_	O
32	type	_	type	_	NN	132	_	_	_	_	_	_	_	O
33	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
34	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
35	,	_	,	_	,	132	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	132	_	_	_	_	_	_	_	O
38	combination	_	combination	_	NN	132	_	_	_	_	_	_	_	O
39	therapy	_	therapy	_	NN	132	_	_	_	_	_	_	_	O
40	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
41	treating	_	treat	_	VBG	132	_	_	_	_	_	_	_	O
42	type	_	type	_	NN	132	_	_	_	_	_	_	_	O
43	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
44	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
45	and	_	and	_	CC	132	_	_	_	_	_	_	_	O
46	unk	_	UNK	_	NN	132	_	_	_	_	_	_	_	O
47	in	_	in	_	IN	132	_	_	_	_	_	_	_	O
48	combination	_	combination	_	NN	132	_	_	_	_	_	_	_	O
49	therapy	_	therapy	_	NN	132	_	_	_	_	_	_	_	O
50	for	_	for	_	IN	132	_	_	_	_	_	_	_	O
51	treating	_	treat	_	VBG	132	_	_	_	_	_	_	_	O
52	type	_	type	_	NN	132	_	_	_	_	_	type.n	Type	S-Subtype
53	2	_	2	_	CD	132	_	_	_	_	_	_	_	O
54	diabetes	_	UNK	_	NNS	132	_	_	_	_	_	_	_	O
55	.	_	.	_	.	132	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	133	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	133	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	133	_	_	_	_	_	_	_	O
4	insulin	_	UNK	_	NN	133	_	_	_	_	_	_	_	O
5	delivery	_	delivery	_	NN	133	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	133	_	_	_	_	_	_	_	O
7	adults	_	adult	_	NNS	133	_	_	_	_	_	adult.n	People_by_age	S-Person
8	with	_	with	_	IN	133	_	_	_	_	_	_	_	O
9	type	_	type	_	JJ	133	_	_	_	_	_	_	_	O
10	2	_	2	_	CD	133	_	_	_	_	_	_	_	O
11	diabetes	_	UNK	_	NNS	133	_	_	_	_	_	_	_	O
12	,	_	,	_	,	133	_	_	_	_	_	_	_	O
13	see	_	see	_	VBP	133	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	133	_	_	_	_	_	_	_	O
15	insulin	_	UNK	_	NN	133	_	_	_	_	_	_	_	O
16	delivery	_	delivery	_	NN	133	_	_	_	_	_	_	_	O
17	section	_	section	_	NN	133	_	_	_	_	_	_	_	O
18	in	_	in	_	IN	133	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	133	_	_	_	_	_	_	_	O
20	nice	_	UNK	_	NNP	133	_	_	_	_	_	_	_	O
21	guideline	_	guideline	_	NN	133	_	_	_	_	_	_	_	O
22	on	_	on	_	IN	133	_	_	_	_	_	_	_	O
23	type	_	type	_	NN	133	_	_	_	_	_	_	_	O
24	1	_	1	_	CD	133	_	_	_	_	_	_	_	O
25	diabetes	_	UNK	_	NNS	133	_	_	_	_	_	_	_	O
26	.	_	.	_	.	133	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	133	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	133	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	133	_	_	_	_	_	_	_	O
4	insulin	_	UNK	_	NN	133	_	_	_	_	_	_	_	O
5	delivery	_	delivery	_	NN	133	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	133	_	_	_	_	_	_	_	O
7	adults	_	adult	_	NNS	133	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	133	_	_	_	_	_	_	_	O
9	type	_	type	_	JJ	133	_	_	_	_	_	type.n	Type	S-Subtype
10	2	_	2	_	CD	133	_	_	_	_	_	_	_	B-Category
11	diabetes	_	UNK	_	NNS	133	_	_	_	_	_	_	_	I-Category
12	,	_	,	_	,	133	_	_	_	_	_	_	_	O
13	see	_	see	_	VBP	133	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	133	_	_	_	_	_	_	_	O
15	insulin	_	UNK	_	NN	133	_	_	_	_	_	_	_	O
16	delivery	_	delivery	_	NN	133	_	_	_	_	_	_	_	O
17	section	_	section	_	NN	133	_	_	_	_	_	_	_	O
18	in	_	in	_	IN	133	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	133	_	_	_	_	_	_	_	O
20	nice	_	UNK	_	NNP	133	_	_	_	_	_	_	_	O
21	guideline	_	guideline	_	NN	133	_	_	_	_	_	_	_	O
22	on	_	on	_	IN	133	_	_	_	_	_	_	_	O
23	type	_	type	_	NN	133	_	_	_	_	_	_	_	O
24	1	_	1	_	CD	133	_	_	_	_	_	_	_	O
25	diabetes	_	UNK	_	NNS	133	_	_	_	_	_	_	_	O
26	.	_	.	_	.	133	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	133	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	133	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	133	_	_	_	_	_	_	_	O
4	insulin	_	UNK	_	NN	133	_	_	_	_	_	_	_	O
5	delivery	_	delivery	_	NN	133	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	133	_	_	_	_	_	_	_	O
7	adults	_	adult	_	NNS	133	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	133	_	_	_	_	_	_	_	O
9	type	_	type	_	JJ	133	_	_	_	_	_	_	_	O
10	2	_	2	_	CD	133	_	_	_	_	_	_	_	O
11	diabetes	_	UNK	_	NNS	133	_	_	_	_	_	_	_	O
12	,	_	,	_	,	133	_	_	_	_	_	_	_	O
13	see	_	see	_	VBP	133	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	133	_	_	_	_	_	_	_	O
15	insulin	_	UNK	_	NN	133	_	_	_	_	_	_	_	S-Theme
16	delivery	_	delivery	_	NN	133	_	_	_	_	_	delivery.n	Delivery	O
17	section	_	section	_	NN	133	_	_	_	_	_	_	_	O
18	in	_	in	_	IN	133	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	133	_	_	_	_	_	_	_	O
20	nice	_	UNK	_	NNP	133	_	_	_	_	_	_	_	O
21	guideline	_	guideline	_	NN	133	_	_	_	_	_	_	_	O
22	on	_	on	_	IN	133	_	_	_	_	_	_	_	O
23	type	_	type	_	NN	133	_	_	_	_	_	_	_	O
24	1	_	1	_	CD	133	_	_	_	_	_	_	_	O
25	diabetes	_	UNK	_	NNS	133	_	_	_	_	_	_	_	O
26	.	_	.	_	.	133	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	133	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	133	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	133	_	_	_	_	_	_	_	O
4	insulin	_	UNK	_	NN	133	_	_	_	_	_	_	_	O
5	delivery	_	delivery	_	NN	133	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	133	_	_	_	_	_	_	_	O
7	adults	_	adult	_	NNS	133	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	133	_	_	_	_	_	_	_	O
9	type	_	type	_	JJ	133	_	_	_	_	_	_	_	O
10	2	_	2	_	CD	133	_	_	_	_	_	_	_	O
11	diabetes	_	UNK	_	NNS	133	_	_	_	_	_	_	_	O
12	,	_	,	_	,	133	_	_	_	_	_	_	_	O
13	see	_	see	_	VBP	133	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	133	_	_	_	_	_	_	_	O
15	insulin	_	UNK	_	NN	133	_	_	_	_	_	_	_	B-Whole
16	delivery	_	delivery	_	NN	133	_	_	_	_	_	_	_	I-Whole
17	section	_	section	_	NN	133	_	_	_	_	_	section.n	Part_whole	S-Part
18	in	_	in	_	IN	133	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	133	_	_	_	_	_	_	_	O
20	nice	_	UNK	_	NNP	133	_	_	_	_	_	_	_	O
21	guideline	_	guideline	_	NN	133	_	_	_	_	_	_	_	O
22	on	_	on	_	IN	133	_	_	_	_	_	_	_	O
23	type	_	type	_	NN	133	_	_	_	_	_	_	_	O
24	1	_	1	_	CD	133	_	_	_	_	_	_	_	O
25	diabetes	_	UNK	_	NNS	133	_	_	_	_	_	_	_	O
26	.	_	.	_	.	133	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	133	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	133	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	133	_	_	_	_	_	_	_	O
4	insulin	_	UNK	_	NN	133	_	_	_	_	_	_	_	O
5	delivery	_	delivery	_	NN	133	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	133	_	_	_	_	_	_	_	O
7	adults	_	adult	_	NNS	133	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	133	_	_	_	_	_	_	_	O
9	type	_	type	_	JJ	133	_	_	_	_	_	_	_	O
10	2	_	2	_	CD	133	_	_	_	_	_	_	_	O
11	diabetes	_	UNK	_	NNS	133	_	_	_	_	_	_	_	O
12	,	_	,	_	,	133	_	_	_	_	_	_	_	O
13	see	_	see	_	VBP	133	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	133	_	_	_	_	_	_	_	O
15	insulin	_	UNK	_	NN	133	_	_	_	_	_	_	_	O
16	delivery	_	delivery	_	NN	133	_	_	_	_	_	_	_	O
17	section	_	section	_	NN	133	_	_	_	_	_	_	_	O
18	in	_	in	_	IN	133	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	133	_	_	_	_	_	_	_	O
20	nice	_	UNK	_	NNP	133	_	_	_	_	_	_	_	O
21	guideline	_	guideline	_	NN	133	_	_	_	_	_	_	_	O
22	on	_	on	_	IN	133	_	_	_	_	_	_	_	O
23	type	_	type	_	NN	133	_	_	_	_	_	type.n	Type	S-Subtype
24	1	_	1	_	CD	133	_	_	_	_	_	_	_	B-Category
25	diabetes	_	UNK	_	NNS	133	_	_	_	_	_	_	_	I-Category
26	.	_	.	_	.	133	_	_	_	_	_	_	_	O

1	think	_	Think	_	VBP	134	_	_	_	_	_	think.v	Opinion	O
2	about	_	about	_	IN	134	_	_	_	_	_	_	_	B-Opinion
3	a	_	a	_	DT	134	_	_	_	_	_	_	_	I-Opinion
4	diagnosis	_	UNK	_	NN	134	_	_	_	_	_	_	_	I-Opinion
5	of	_	of	_	IN	134	_	_	_	_	_	_	_	I-Opinion
6	gastroparesis	_	UNK	_	NN	134	_	_	_	_	_	_	_	I-Opinion
7	in	_	in	_	IN	134	_	_	_	_	_	_	_	I-Opinion
8	adults	_	adult	_	NNS	134	_	_	_	_	_	_	_	I-Opinion
9	with	_	with	_	IN	134	_	_	_	_	_	_	_	I-Opinion
10	type	_	type	_	JJ	134	_	_	_	_	_	_	_	I-Opinion
11	2	_	2	_	CD	134	_	_	_	_	_	_	_	I-Opinion
12	diabetes	_	UNK	_	NNS	134	_	_	_	_	_	_	_	I-Opinion
13	with	_	with	_	IN	134	_	_	_	_	_	_	_	I-Opinion
14	erratic	_	UNK	_	JJ	134	_	_	_	_	_	_	_	I-Opinion
15	blood	_	blood	_	NN	134	_	_	_	_	_	_	_	I-Opinion
16	glucose	_	UNK	_	VB	134	_	_	_	_	_	_	_	I-Opinion
17	control	_	control	_	NN	134	_	_	_	_	_	_	_	I-Opinion
18	or	_	or	_	CC	134	_	_	_	_	_	_	_	I-Opinion
19	unexplained	_	UNK	_	JJ	134	_	_	_	_	_	_	_	I-Opinion
20	gastric	_	UNK	_	JJ	134	_	_	_	_	_	_	_	I-Opinion
21	bloating	_	UNK	_	NN	134	_	_	_	_	_	_	_	I-Opinion
22	or	_	or	_	CC	134	_	_	_	_	_	_	_	O
23	vomiting	_	UNK	_	NN	134	_	_	_	_	_	_	_	O
24	,	_	,	_	,	134	_	_	_	_	_	_	_	O
25	taking	_	take	_	VBG	134	_	_	_	_	_	_	_	O
26	into	_	into	_	IN	134	_	_	_	_	_	_	_	O
27	account	_	account	_	NN	134	_	_	_	_	_	_	_	O
28	possible	_	possible	_	JJ	134	_	_	_	_	_	_	_	O
29	alternative	_	alternative	_	JJ	134	_	_	_	_	_	_	_	O
30	diagnoses	_	UNK	_	NNS	134	_	_	_	_	_	_	_	O
31	[	_	[	_	JJ	134	_	_	_	_	_	_	_	O
32	2009	_	UNK	_	CD	134	_	_	_	_	_	_	_	O
33	,	_	,	_	,	134	_	_	_	_	_	_	_	O
34	amended	_	UNK	_	VBD	134	_	_	_	_	_	_	_	O
35	2015	_	2015	_	CD	134	_	_	_	_	_	_	_	O
36	]	_	]	_	NN	134	_	_	_	_	_	_	_	O

1	think	_	Think	_	VBP	134	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	134	_	_	_	_	_	_	_	O
3	a	_	a	_	DT	134	_	_	_	_	_	_	_	O
4	diagnosis	_	UNK	_	NN	134	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	134	_	_	_	_	_	_	_	O
6	gastroparesis	_	UNK	_	NN	134	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	134	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	134	_	_	_	_	_	adult.n	People_by_age	S-Person
9	with	_	with	_	IN	134	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	134	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	134	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	134	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	134	_	_	_	_	_	_	_	O
14	erratic	_	UNK	_	JJ	134	_	_	_	_	_	_	_	O
15	blood	_	blood	_	NN	134	_	_	_	_	_	_	_	O
16	glucose	_	UNK	_	VB	134	_	_	_	_	_	_	_	O
17	control	_	control	_	NN	134	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	134	_	_	_	_	_	_	_	O
19	unexplained	_	UNK	_	JJ	134	_	_	_	_	_	_	_	O
20	gastric	_	UNK	_	JJ	134	_	_	_	_	_	_	_	O
21	bloating	_	UNK	_	NN	134	_	_	_	_	_	_	_	O
22	or	_	or	_	CC	134	_	_	_	_	_	_	_	O
23	vomiting	_	UNK	_	NN	134	_	_	_	_	_	_	_	O
24	,	_	,	_	,	134	_	_	_	_	_	_	_	O
25	taking	_	take	_	VBG	134	_	_	_	_	_	_	_	O
26	into	_	into	_	IN	134	_	_	_	_	_	_	_	O
27	account	_	account	_	NN	134	_	_	_	_	_	_	_	O
28	possible	_	possible	_	JJ	134	_	_	_	_	_	_	_	O
29	alternative	_	alternative	_	JJ	134	_	_	_	_	_	_	_	O
30	diagnoses	_	UNK	_	NNS	134	_	_	_	_	_	_	_	O
31	[	_	[	_	JJ	134	_	_	_	_	_	_	_	O
32	2009	_	UNK	_	CD	134	_	_	_	_	_	_	_	O
33	,	_	,	_	,	134	_	_	_	_	_	_	_	O
34	amended	_	UNK	_	VBD	134	_	_	_	_	_	_	_	O
35	2015	_	2015	_	CD	134	_	_	_	_	_	_	_	O
36	]	_	]	_	NN	134	_	_	_	_	_	_	_	O

1	think	_	Think	_	VBP	134	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	134	_	_	_	_	_	_	_	O
3	a	_	a	_	DT	134	_	_	_	_	_	_	_	O
4	diagnosis	_	UNK	_	NN	134	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	134	_	_	_	_	_	_	_	O
6	gastroparesis	_	UNK	_	NN	134	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	134	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	134	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	134	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	134	_	_	_	_	_	type.n	Type	S-Subtype
11	2	_	2	_	CD	134	_	_	_	_	_	_	_	B-Category
12	diabetes	_	UNK	_	NNS	134	_	_	_	_	_	_	_	I-Category
13	with	_	with	_	IN	134	_	_	_	_	_	_	_	O
14	erratic	_	UNK	_	JJ	134	_	_	_	_	_	_	_	O
15	blood	_	blood	_	NN	134	_	_	_	_	_	_	_	O
16	glucose	_	UNK	_	VB	134	_	_	_	_	_	_	_	O
17	control	_	control	_	NN	134	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	134	_	_	_	_	_	_	_	O
19	unexplained	_	UNK	_	JJ	134	_	_	_	_	_	_	_	O
20	gastric	_	UNK	_	JJ	134	_	_	_	_	_	_	_	O
21	bloating	_	UNK	_	NN	134	_	_	_	_	_	_	_	O
22	or	_	or	_	CC	134	_	_	_	_	_	_	_	O
23	vomiting	_	UNK	_	NN	134	_	_	_	_	_	_	_	O
24	,	_	,	_	,	134	_	_	_	_	_	_	_	O
25	taking	_	take	_	VBG	134	_	_	_	_	_	_	_	O
26	into	_	into	_	IN	134	_	_	_	_	_	_	_	O
27	account	_	account	_	NN	134	_	_	_	_	_	_	_	O
28	possible	_	possible	_	JJ	134	_	_	_	_	_	_	_	O
29	alternative	_	alternative	_	JJ	134	_	_	_	_	_	_	_	O
30	diagnoses	_	UNK	_	NNS	134	_	_	_	_	_	_	_	O
31	[	_	[	_	JJ	134	_	_	_	_	_	_	_	O
32	2009	_	UNK	_	CD	134	_	_	_	_	_	_	_	O
33	,	_	,	_	,	134	_	_	_	_	_	_	_	O
34	amended	_	UNK	_	VBD	134	_	_	_	_	_	_	_	O
35	2015	_	2015	_	CD	134	_	_	_	_	_	_	_	O
36	]	_	]	_	NN	134	_	_	_	_	_	_	_	O

1	think	_	Think	_	VBP	134	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	134	_	_	_	_	_	_	_	O
3	a	_	a	_	DT	134	_	_	_	_	_	_	_	O
4	diagnosis	_	UNK	_	NN	134	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	134	_	_	_	_	_	_	_	O
6	gastroparesis	_	UNK	_	NN	134	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	134	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	134	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	134	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	134	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	134	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	134	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	134	_	_	_	_	_	_	_	O
14	erratic	_	UNK	_	JJ	134	_	_	_	_	_	_	_	O
15	blood	_	blood	_	NN	134	_	_	_	_	_	_	_	O
16	glucose	_	UNK	_	VB	134	_	_	_	_	_	_	_	O
17	control	_	control	_	NN	134	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	134	_	_	_	_	_	_	_	O
19	unexplained	_	UNK	_	JJ	134	_	_	_	_	_	_	_	O
20	gastric	_	UNK	_	JJ	134	_	_	_	_	_	_	_	O
21	bloating	_	UNK	_	NN	134	_	_	_	_	_	_	_	O
22	or	_	or	_	CC	134	_	_	_	_	_	_	_	O
23	vomiting	_	UNK	_	NN	134	_	_	_	_	_	_	_	O
24	,	_	,	_	,	134	_	_	_	_	_	_	_	O
25	taking	_	take	_	VBG	134	_	_	_	_	_	_	_	O
26	into	_	into	_	IN	134	_	_	_	_	_	_	_	O
27	account	_	account	_	NN	134	_	_	_	_	_	account.n	Text	O
28	possible	_	possible	_	JJ	134	_	_	_	_	_	_	_	O
29	alternative	_	alternative	_	JJ	134	_	_	_	_	_	_	_	O
30	diagnoses	_	UNK	_	NNS	134	_	_	_	_	_	_	_	O
31	[	_	[	_	JJ	134	_	_	_	_	_	_	_	O
32	2009	_	UNK	_	CD	134	_	_	_	_	_	_	_	O
33	,	_	,	_	,	134	_	_	_	_	_	_	_	O
34	amended	_	UNK	_	VBD	134	_	_	_	_	_	_	_	O
35	2015	_	2015	_	CD	134	_	_	_	_	_	_	_	O
36	]	_	]	_	NN	134	_	_	_	_	_	_	_	O

1	think	_	Think	_	VBP	134	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	134	_	_	_	_	_	_	_	O
3	a	_	a	_	DT	134	_	_	_	_	_	_	_	O
4	diagnosis	_	UNK	_	NN	134	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	134	_	_	_	_	_	_	_	O
6	gastroparesis	_	UNK	_	NN	134	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	134	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	134	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	134	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	134	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	134	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	134	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	134	_	_	_	_	_	_	_	O
14	erratic	_	UNK	_	JJ	134	_	_	_	_	_	_	_	O
15	blood	_	blood	_	NN	134	_	_	_	_	_	_	_	O
16	glucose	_	UNK	_	VB	134	_	_	_	_	_	_	_	O
17	control	_	control	_	NN	134	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	134	_	_	_	_	_	_	_	O
19	unexplained	_	UNK	_	JJ	134	_	_	_	_	_	_	_	O
20	gastric	_	UNK	_	JJ	134	_	_	_	_	_	_	_	O
21	bloating	_	UNK	_	NN	134	_	_	_	_	_	_	_	O
22	or	_	or	_	CC	134	_	_	_	_	_	_	_	O
23	vomiting	_	UNK	_	NN	134	_	_	_	_	_	_	_	O
24	,	_	,	_	,	134	_	_	_	_	_	_	_	O
25	taking	_	take	_	VBG	134	_	_	_	_	_	_	_	O
26	into	_	into	_	IN	134	_	_	_	_	_	_	_	O
27	account	_	account	_	NN	134	_	_	_	_	_	_	_	S-Hypothetical_event
28	possible	_	possible	_	JJ	134	_	_	_	_	_	possible.a	Likelihood	O
29	alternative	_	alternative	_	JJ	134	_	_	_	_	_	_	_	O
30	diagnoses	_	UNK	_	NNS	134	_	_	_	_	_	_	_	O
31	[	_	[	_	JJ	134	_	_	_	_	_	_	_	O
32	2009	_	UNK	_	CD	134	_	_	_	_	_	_	_	O
33	,	_	,	_	,	134	_	_	_	_	_	_	_	O
34	amended	_	UNK	_	VBD	134	_	_	_	_	_	_	_	O
35	2015	_	2015	_	CD	134	_	_	_	_	_	_	_	O
36	]	_	]	_	NN	134	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	135	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	135	_	_	_	_	_	adult.n	People_by_age	S-Person
3	with	_	with	_	IN	135	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	135	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	135	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	135	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	135	_	_	_	_	_	_	_	O
8	have	_	have	_	VBP	135	_	_	_	_	_	_	_	O
9	vomiting	_	UNK	_	VBG	135	_	_	_	_	_	_	_	O
10	caused	_	cause	_	VBN	135	_	_	_	_	_	_	_	O
11	by	_	by	_	IN	135	_	_	_	_	_	_	_	O
12	gastroparesis	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
13	,	_	,	_	,	135	_	_	_	_	_	_	_	O
14	explain	_	explain	_	VBP	135	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	135	_	_	_	_	_	_	_	O
16	:	_	:	_	:	135	_	_	_	_	_	_	_	O
17	there	_	there	_	EX	135	_	_	_	_	_	_	_	O
18	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	135	_	_	_	_	_	_	_	O
20	strong	_	strong	_	JJ	135	_	_	_	_	_	_	_	O
21	evidence	_	evidence	_	NN	135	_	_	_	_	_	_	_	O
22	that	_	that	_	IN	135	_	_	_	_	_	_	_	O
23	any	_	any	_	DT	135	_	_	_	_	_	_	_	O
24	available	_	available	_	JJ	135	_	_	_	_	_	_	_	O
25	antiemetic	_	UNK	_	JJ	135	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	135	_	_	_	_	_	_	_	O
27	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
28	effective	_	effective	_	JJ	135	_	_	_	_	_	_	_	O
29	some	_	some	_	DT	135	_	_	_	_	_	_	_	O
30	people	_	people	_	NNS	135	_	_	_	_	_	_	_	O
31	have	_	have	_	VBP	135	_	_	_	_	_	_	_	O
32	had	_	have	_	VBN	135	_	_	_	_	_	_	_	O
33	benefit	_	benefit	_	VBN	135	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	135	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
36	,	_	,	_	,	135	_	_	_	_	_	_	_	O
37	erythromycin	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	135	_	_	_	_	_	_	_	O
39	metoclopramide	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
40	.	_	.	_	.	135	_	_	_	_	_	_	_	O
41	the	_	the	_	DT	135	_	_	_	_	_	_	_	O
42	strongest	_	strongest	_	JJS	135	_	_	_	_	_	_	_	O
43	evidence	_	evidence	_	NN	135	_	_	_	_	_	_	_	O
44	for	_	for	_	IN	135	_	_	_	_	_	_	_	O
45	effectiveness	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
46	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	135	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
49	,	_	,	_	,	135	_	_	_	_	_	_	_	O
50	but	_	but	_	CC	135	_	_	_	_	_	_	_	O
51	prescribers	_	UNK	_	NNS	135	_	_	_	_	_	_	_	O
52	must	_	must	_	MD	135	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	135	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	135	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	135	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	135	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	135	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	135	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	135	_	_	_	_	_	_	_	O
8	have	_	have	_	VBP	135	_	_	_	_	_	_	_	O
9	vomiting	_	UNK	_	VBG	135	_	_	_	_	_	_	_	O
10	caused	_	cause	_	VBN	135	_	_	_	_	_	_	_	O
11	by	_	by	_	IN	135	_	_	_	_	_	_	_	O
12	gastroparesis	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
13	,	_	,	_	,	135	_	_	_	_	_	_	_	O
14	explain	_	explain	_	VBP	135	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	135	_	_	_	_	_	_	_	O
16	:	_	:	_	:	135	_	_	_	_	_	_	_	O
17	there	_	there	_	EX	135	_	_	_	_	_	_	_	O
18	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	135	_	_	_	_	_	_	_	O
20	strong	_	strong	_	JJ	135	_	_	_	_	_	_	_	O
21	evidence	_	evidence	_	NN	135	_	_	_	_	_	_	_	O
22	that	_	that	_	IN	135	_	_	_	_	_	_	_	O
23	any	_	any	_	DT	135	_	_	_	_	_	_	_	O
24	available	_	available	_	JJ	135	_	_	_	_	_	_	_	O
25	antiemetic	_	UNK	_	JJ	135	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	135	_	_	_	_	_	_	_	O
27	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
28	effective	_	effective	_	JJ	135	_	_	_	_	_	_	_	O
29	some	_	some	_	DT	135	_	_	_	_	_	_	_	O
30	people	_	people	_	NNS	135	_	_	_	_	_	_	_	O
31	have	_	have	_	VBP	135	_	_	_	_	_	_	_	O
32	had	_	have	_	VBN	135	_	_	_	_	_	_	_	O
33	benefit	_	benefit	_	VBN	135	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	135	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
36	,	_	,	_	,	135	_	_	_	_	_	_	_	O
37	erythromycin	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	135	_	_	_	_	_	_	_	O
39	metoclopramide	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
40	.	_	.	_	.	135	_	_	_	_	_	_	_	O
41	the	_	the	_	DT	135	_	_	_	_	_	_	_	O
42	strongest	_	strongest	_	JJS	135	_	_	_	_	_	_	_	O
43	evidence	_	evidence	_	NN	135	_	_	_	_	_	_	_	O
44	for	_	for	_	IN	135	_	_	_	_	_	_	_	O
45	effectiveness	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
46	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	135	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
49	,	_	,	_	,	135	_	_	_	_	_	_	_	O
50	but	_	but	_	CC	135	_	_	_	_	_	_	_	O
51	prescribers	_	UNK	_	NNS	135	_	_	_	_	_	_	_	O
52	must	_	must	_	MD	135	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	135	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	135	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	135	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	135	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	135	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	135	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	135	_	_	_	_	_	_	_	S-Cause
8	have	_	have	_	VBP	135	_	_	_	_	_	_	_	O
9	vomiting	_	UNK	_	VBG	135	_	_	_	_	_	_	_	O
10	caused	_	cause	_	VBN	135	_	_	_	_	_	cause.v	Causation	O
11	by	_	by	_	IN	135	_	_	_	_	_	_	_	B-Effect
12	gastroparesis	_	UNK	_	NN	135	_	_	_	_	_	_	_	I-Effect
13	,	_	,	_	,	135	_	_	_	_	_	_	_	O
14	explain	_	explain	_	VBP	135	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	135	_	_	_	_	_	_	_	O
16	:	_	:	_	:	135	_	_	_	_	_	_	_	O
17	there	_	there	_	EX	135	_	_	_	_	_	_	_	O
18	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	135	_	_	_	_	_	_	_	O
20	strong	_	strong	_	JJ	135	_	_	_	_	_	_	_	O
21	evidence	_	evidence	_	NN	135	_	_	_	_	_	_	_	O
22	that	_	that	_	IN	135	_	_	_	_	_	_	_	O
23	any	_	any	_	DT	135	_	_	_	_	_	_	_	O
24	available	_	available	_	JJ	135	_	_	_	_	_	_	_	O
25	antiemetic	_	UNK	_	JJ	135	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	135	_	_	_	_	_	_	_	O
27	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
28	effective	_	effective	_	JJ	135	_	_	_	_	_	_	_	O
29	some	_	some	_	DT	135	_	_	_	_	_	_	_	O
30	people	_	people	_	NNS	135	_	_	_	_	_	_	_	O
31	have	_	have	_	VBP	135	_	_	_	_	_	_	_	O
32	had	_	have	_	VBN	135	_	_	_	_	_	_	_	O
33	benefit	_	benefit	_	VBN	135	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	135	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
36	,	_	,	_	,	135	_	_	_	_	_	_	_	O
37	erythromycin	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	135	_	_	_	_	_	_	_	O
39	metoclopramide	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
40	.	_	.	_	.	135	_	_	_	_	_	_	_	O
41	the	_	the	_	DT	135	_	_	_	_	_	_	_	O
42	strongest	_	strongest	_	JJS	135	_	_	_	_	_	_	_	O
43	evidence	_	evidence	_	NN	135	_	_	_	_	_	_	_	O
44	for	_	for	_	IN	135	_	_	_	_	_	_	_	O
45	effectiveness	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
46	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	135	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
49	,	_	,	_	,	135	_	_	_	_	_	_	_	O
50	but	_	but	_	CC	135	_	_	_	_	_	_	_	O
51	prescribers	_	UNK	_	NNS	135	_	_	_	_	_	_	_	O
52	must	_	must	_	MD	135	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	135	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	135	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	135	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	135	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	135	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	135	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	135	_	_	_	_	_	_	_	S-Fact
8	have	_	have	_	VBP	135	_	_	_	_	_	_	_	O
9	vomiting	_	UNK	_	VBG	135	_	_	_	_	_	_	_	O
10	caused	_	cause	_	VBN	135	_	_	_	_	_	_	_	O
11	by	_	by	_	IN	135	_	_	_	_	_	_	_	O
12	gastroparesis	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
13	,	_	,	_	,	135	_	_	_	_	_	_	_	O
14	explain	_	explain	_	VBP	135	_	_	_	_	_	explain.v	Explaining_the_facts	O
15	that	_	that	_	IN	135	_	_	_	_	_	_	_	B-State_of_affairs
16	:	_	:	_	:	135	_	_	_	_	_	_	_	I-State_of_affairs
17	there	_	there	_	EX	135	_	_	_	_	_	_	_	I-State_of_affairs
18	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	I-State_of_affairs
19	not	_	not	_	RB	135	_	_	_	_	_	_	_	I-State_of_affairs
20	strong	_	strong	_	JJ	135	_	_	_	_	_	_	_	I-State_of_affairs
21	evidence	_	evidence	_	NN	135	_	_	_	_	_	_	_	I-State_of_affairs
22	that	_	that	_	IN	135	_	_	_	_	_	_	_	I-State_of_affairs
23	any	_	any	_	DT	135	_	_	_	_	_	_	_	I-State_of_affairs
24	available	_	available	_	JJ	135	_	_	_	_	_	_	_	I-State_of_affairs
25	antiemetic	_	UNK	_	JJ	135	_	_	_	_	_	_	_	I-State_of_affairs
26	therapy	_	therapy	_	NN	135	_	_	_	_	_	_	_	I-State_of_affairs
27	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	I-State_of_affairs
28	effective	_	effective	_	JJ	135	_	_	_	_	_	_	_	I-State_of_affairs
29	some	_	some	_	DT	135	_	_	_	_	_	_	_	I-State_of_affairs
30	people	_	people	_	NNS	135	_	_	_	_	_	_	_	I-State_of_affairs
31	have	_	have	_	VBP	135	_	_	_	_	_	_	_	I-State_of_affairs
32	had	_	have	_	VBN	135	_	_	_	_	_	_	_	I-State_of_affairs
33	benefit	_	benefit	_	VBN	135	_	_	_	_	_	_	_	I-State_of_affairs
34	with	_	with	_	IN	135	_	_	_	_	_	_	_	I-State_of_affairs
35	unk	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
36	,	_	,	_	,	135	_	_	_	_	_	_	_	O
37	erythromycin	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	135	_	_	_	_	_	_	_	O
39	metoclopramide	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
40	.	_	.	_	.	135	_	_	_	_	_	_	_	O
41	the	_	the	_	DT	135	_	_	_	_	_	_	_	O
42	strongest	_	strongest	_	JJS	135	_	_	_	_	_	_	_	O
43	evidence	_	evidence	_	NN	135	_	_	_	_	_	_	_	O
44	for	_	for	_	IN	135	_	_	_	_	_	_	_	O
45	effectiveness	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
46	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	135	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
49	,	_	,	_	,	135	_	_	_	_	_	_	_	O
50	but	_	but	_	CC	135	_	_	_	_	_	_	_	O
51	prescribers	_	UNK	_	NNS	135	_	_	_	_	_	_	_	O
52	must	_	must	_	MD	135	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	135	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	135	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	135	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	135	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	135	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	135	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	135	_	_	_	_	_	_	_	O
8	have	_	have	_	VBP	135	_	_	_	_	_	_	_	O
9	vomiting	_	UNK	_	VBG	135	_	_	_	_	_	_	_	O
10	caused	_	cause	_	VBN	135	_	_	_	_	_	_	_	O
11	by	_	by	_	IN	135	_	_	_	_	_	_	_	O
12	gastroparesis	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
13	,	_	,	_	,	135	_	_	_	_	_	_	_	O
14	explain	_	explain	_	VBP	135	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	135	_	_	_	_	_	_	_	O
16	:	_	:	_	:	135	_	_	_	_	_	_	_	O
17	there	_	there	_	EX	135	_	_	_	_	_	there.adv	Locative_relation	S-Ground
18	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	135	_	_	_	_	_	_	_	O
20	strong	_	strong	_	JJ	135	_	_	_	_	_	_	_	O
21	evidence	_	evidence	_	NN	135	_	_	_	_	_	_	_	O
22	that	_	that	_	IN	135	_	_	_	_	_	_	_	O
23	any	_	any	_	DT	135	_	_	_	_	_	_	_	O
24	available	_	available	_	JJ	135	_	_	_	_	_	_	_	O
25	antiemetic	_	UNK	_	JJ	135	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	135	_	_	_	_	_	_	_	O
27	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
28	effective	_	effective	_	JJ	135	_	_	_	_	_	_	_	O
29	some	_	some	_	DT	135	_	_	_	_	_	_	_	O
30	people	_	people	_	NNS	135	_	_	_	_	_	_	_	O
31	have	_	have	_	VBP	135	_	_	_	_	_	_	_	O
32	had	_	have	_	VBN	135	_	_	_	_	_	_	_	O
33	benefit	_	benefit	_	VBN	135	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	135	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
36	,	_	,	_	,	135	_	_	_	_	_	_	_	O
37	erythromycin	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	135	_	_	_	_	_	_	_	O
39	metoclopramide	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
40	.	_	.	_	.	135	_	_	_	_	_	_	_	O
41	the	_	the	_	DT	135	_	_	_	_	_	_	_	O
42	strongest	_	strongest	_	JJS	135	_	_	_	_	_	_	_	O
43	evidence	_	evidence	_	NN	135	_	_	_	_	_	_	_	O
44	for	_	for	_	IN	135	_	_	_	_	_	_	_	O
45	effectiveness	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
46	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	135	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
49	,	_	,	_	,	135	_	_	_	_	_	_	_	O
50	but	_	but	_	CC	135	_	_	_	_	_	_	_	O
51	prescribers	_	UNK	_	NNS	135	_	_	_	_	_	_	_	O
52	must	_	must	_	MD	135	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	135	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	135	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	135	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	135	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	135	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	135	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	135	_	_	_	_	_	_	_	O
8	have	_	have	_	VBP	135	_	_	_	_	_	_	_	O
9	vomiting	_	UNK	_	VBG	135	_	_	_	_	_	_	_	O
10	caused	_	cause	_	VBN	135	_	_	_	_	_	_	_	O
11	by	_	by	_	IN	135	_	_	_	_	_	_	_	O
12	gastroparesis	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
13	,	_	,	_	,	135	_	_	_	_	_	_	_	O
14	explain	_	explain	_	VBP	135	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	135	_	_	_	_	_	_	_	O
16	:	_	:	_	:	135	_	_	_	_	_	_	_	O
17	there	_	there	_	EX	135	_	_	_	_	_	_	_	O
18	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	135	_	_	_	_	_	_	_	O
20	strong	_	strong	_	JJ	135	_	_	_	_	_	strong.a	Level_of_force_exertion	O
21	evidence	_	evidence	_	NN	135	_	_	_	_	_	_	_	S-Exerter
22	that	_	that	_	IN	135	_	_	_	_	_	_	_	O
23	any	_	any	_	DT	135	_	_	_	_	_	_	_	O
24	available	_	available	_	JJ	135	_	_	_	_	_	_	_	O
25	antiemetic	_	UNK	_	JJ	135	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	135	_	_	_	_	_	_	_	O
27	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
28	effective	_	effective	_	JJ	135	_	_	_	_	_	_	_	O
29	some	_	some	_	DT	135	_	_	_	_	_	_	_	O
30	people	_	people	_	NNS	135	_	_	_	_	_	_	_	O
31	have	_	have	_	VBP	135	_	_	_	_	_	_	_	O
32	had	_	have	_	VBN	135	_	_	_	_	_	_	_	O
33	benefit	_	benefit	_	VBN	135	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	135	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
36	,	_	,	_	,	135	_	_	_	_	_	_	_	O
37	erythromycin	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	135	_	_	_	_	_	_	_	O
39	metoclopramide	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
40	.	_	.	_	.	135	_	_	_	_	_	_	_	O
41	the	_	the	_	DT	135	_	_	_	_	_	_	_	O
42	strongest	_	strongest	_	JJS	135	_	_	_	_	_	_	_	O
43	evidence	_	evidence	_	NN	135	_	_	_	_	_	_	_	O
44	for	_	for	_	IN	135	_	_	_	_	_	_	_	O
45	effectiveness	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
46	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	135	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
49	,	_	,	_	,	135	_	_	_	_	_	_	_	O
50	but	_	but	_	CC	135	_	_	_	_	_	_	_	O
51	prescribers	_	UNK	_	NNS	135	_	_	_	_	_	_	_	O
52	must	_	must	_	MD	135	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	135	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	135	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	135	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	135	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	135	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	135	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	135	_	_	_	_	_	_	_	O
8	have	_	have	_	VBP	135	_	_	_	_	_	_	_	O
9	vomiting	_	UNK	_	VBG	135	_	_	_	_	_	_	_	O
10	caused	_	cause	_	VBN	135	_	_	_	_	_	_	_	O
11	by	_	by	_	IN	135	_	_	_	_	_	_	_	O
12	gastroparesis	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
13	,	_	,	_	,	135	_	_	_	_	_	_	_	O
14	explain	_	explain	_	VBP	135	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	135	_	_	_	_	_	_	_	O
16	:	_	:	_	:	135	_	_	_	_	_	_	_	O
17	there	_	there	_	EX	135	_	_	_	_	_	_	_	O
18	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	135	_	_	_	_	_	_	_	O
20	strong	_	strong	_	JJ	135	_	_	_	_	_	_	_	O
21	evidence	_	evidence	_	NN	135	_	_	_	_	_	evidence.n	Evidence	S-Support
22	that	_	that	_	IN	135	_	_	_	_	_	_	_	B-Proposition
23	any	_	any	_	DT	135	_	_	_	_	_	_	_	I-Proposition
24	available	_	available	_	JJ	135	_	_	_	_	_	_	_	I-Proposition
25	antiemetic	_	UNK	_	JJ	135	_	_	_	_	_	_	_	I-Proposition
26	therapy	_	therapy	_	NN	135	_	_	_	_	_	_	_	I-Proposition
27	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	I-Proposition
28	effective	_	effective	_	JJ	135	_	_	_	_	_	_	_	I-Proposition
29	some	_	some	_	DT	135	_	_	_	_	_	_	_	I-Proposition
30	people	_	people	_	NNS	135	_	_	_	_	_	_	_	I-Proposition
31	have	_	have	_	VBP	135	_	_	_	_	_	_	_	I-Proposition
32	had	_	have	_	VBN	135	_	_	_	_	_	_	_	I-Proposition
33	benefit	_	benefit	_	VBN	135	_	_	_	_	_	_	_	I-Proposition
34	with	_	with	_	IN	135	_	_	_	_	_	_	_	I-Proposition
35	unk	_	UNK	_	NN	135	_	_	_	_	_	_	_	I-Proposition
36	,	_	,	_	,	135	_	_	_	_	_	_	_	I-Proposition
37	erythromycin	_	UNK	_	NN	135	_	_	_	_	_	_	_	I-Proposition
38	or	_	or	_	CC	135	_	_	_	_	_	_	_	I-Proposition
39	metoclopramide	_	UNK	_	NN	135	_	_	_	_	_	_	_	I-Proposition
40	.	_	.	_	.	135	_	_	_	_	_	_	_	I-Proposition
41	the	_	the	_	DT	135	_	_	_	_	_	_	_	I-Proposition
42	strongest	_	strongest	_	JJS	135	_	_	_	_	_	_	_	O
43	evidence	_	evidence	_	NN	135	_	_	_	_	_	_	_	O
44	for	_	for	_	IN	135	_	_	_	_	_	_	_	O
45	effectiveness	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
46	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	135	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
49	,	_	,	_	,	135	_	_	_	_	_	_	_	O
50	but	_	but	_	CC	135	_	_	_	_	_	_	_	O
51	prescribers	_	UNK	_	NNS	135	_	_	_	_	_	_	_	O
52	must	_	must	_	MD	135	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	135	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	135	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	135	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	135	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	135	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	135	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	135	_	_	_	_	_	_	_	O
8	have	_	have	_	VBP	135	_	_	_	_	_	_	_	O
9	vomiting	_	UNK	_	VBG	135	_	_	_	_	_	_	_	O
10	caused	_	cause	_	VBN	135	_	_	_	_	_	_	_	O
11	by	_	by	_	IN	135	_	_	_	_	_	_	_	O
12	gastroparesis	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
13	,	_	,	_	,	135	_	_	_	_	_	_	_	O
14	explain	_	explain	_	VBP	135	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	135	_	_	_	_	_	_	_	O
16	:	_	:	_	:	135	_	_	_	_	_	_	_	O
17	there	_	there	_	EX	135	_	_	_	_	_	_	_	O
18	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	135	_	_	_	_	_	_	_	O
20	strong	_	strong	_	JJ	135	_	_	_	_	_	_	_	O
21	evidence	_	evidence	_	NN	135	_	_	_	_	_	_	_	O
22	that	_	that	_	IN	135	_	_	_	_	_	_	_	O
23	any	_	any	_	DT	135	_	_	_	_	_	_	_	O
24	available	_	available	_	JJ	135	_	_	_	_	_	_	_	O
25	antiemetic	_	UNK	_	JJ	135	_	_	_	_	_	_	_	S-Type
26	therapy	_	therapy	_	NN	135	_	_	_	_	_	therapy.n	Medical_specialties	S-Specialty
27	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
28	effective	_	effective	_	JJ	135	_	_	_	_	_	_	_	O
29	some	_	some	_	DT	135	_	_	_	_	_	_	_	O
30	people	_	people	_	NNS	135	_	_	_	_	_	_	_	O
31	have	_	have	_	VBP	135	_	_	_	_	_	_	_	O
32	had	_	have	_	VBN	135	_	_	_	_	_	_	_	O
33	benefit	_	benefit	_	VBN	135	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	135	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
36	,	_	,	_	,	135	_	_	_	_	_	_	_	O
37	erythromycin	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	135	_	_	_	_	_	_	_	O
39	metoclopramide	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
40	.	_	.	_	.	135	_	_	_	_	_	_	_	O
41	the	_	the	_	DT	135	_	_	_	_	_	_	_	O
42	strongest	_	strongest	_	JJS	135	_	_	_	_	_	_	_	O
43	evidence	_	evidence	_	NN	135	_	_	_	_	_	_	_	O
44	for	_	for	_	IN	135	_	_	_	_	_	_	_	O
45	effectiveness	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
46	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	135	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
49	,	_	,	_	,	135	_	_	_	_	_	_	_	O
50	but	_	but	_	CC	135	_	_	_	_	_	_	_	O
51	prescribers	_	UNK	_	NNS	135	_	_	_	_	_	_	_	O
52	must	_	must	_	MD	135	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	135	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	135	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	135	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	135	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	135	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	135	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	135	_	_	_	_	_	_	_	O
8	have	_	have	_	VBP	135	_	_	_	_	_	_	_	O
9	vomiting	_	UNK	_	VBG	135	_	_	_	_	_	_	_	O
10	caused	_	cause	_	VBN	135	_	_	_	_	_	_	_	O
11	by	_	by	_	IN	135	_	_	_	_	_	_	_	O
12	gastroparesis	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
13	,	_	,	_	,	135	_	_	_	_	_	_	_	O
14	explain	_	explain	_	VBP	135	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	135	_	_	_	_	_	_	_	O
16	:	_	:	_	:	135	_	_	_	_	_	_	_	O
17	there	_	there	_	EX	135	_	_	_	_	_	_	_	O
18	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	135	_	_	_	_	_	_	_	O
20	strong	_	strong	_	JJ	135	_	_	_	_	_	_	_	O
21	evidence	_	evidence	_	NN	135	_	_	_	_	_	_	_	O
22	that	_	that	_	IN	135	_	_	_	_	_	_	_	O
23	any	_	any	_	DT	135	_	_	_	_	_	_	_	B-Entity
24	available	_	available	_	JJ	135	_	_	_	_	_	_	_	I-Entity
25	antiemetic	_	UNK	_	JJ	135	_	_	_	_	_	_	_	I-Entity
26	therapy	_	therapy	_	NN	135	_	_	_	_	_	_	_	I-Entity
27	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
28	effective	_	effective	_	JJ	135	_	_	_	_	_	effective.a	Usefulness	O
29	some	_	some	_	DT	135	_	_	_	_	_	_	_	B-Entity
30	people	_	people	_	NNS	135	_	_	_	_	_	_	_	I-Entity
31	have	_	have	_	VBP	135	_	_	_	_	_	_	_	O
32	had	_	have	_	VBN	135	_	_	_	_	_	_	_	O
33	benefit	_	benefit	_	VBN	135	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	135	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
36	,	_	,	_	,	135	_	_	_	_	_	_	_	O
37	erythromycin	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	135	_	_	_	_	_	_	_	O
39	metoclopramide	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
40	.	_	.	_	.	135	_	_	_	_	_	_	_	O
41	the	_	the	_	DT	135	_	_	_	_	_	_	_	O
42	strongest	_	strongest	_	JJS	135	_	_	_	_	_	_	_	O
43	evidence	_	evidence	_	NN	135	_	_	_	_	_	_	_	O
44	for	_	for	_	IN	135	_	_	_	_	_	_	_	O
45	effectiveness	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
46	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	135	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
49	,	_	,	_	,	135	_	_	_	_	_	_	_	O
50	but	_	but	_	CC	135	_	_	_	_	_	_	_	O
51	prescribers	_	UNK	_	NNS	135	_	_	_	_	_	_	_	O
52	must	_	must	_	MD	135	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	135	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	135	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	135	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	135	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	135	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	135	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	135	_	_	_	_	_	_	_	O
8	have	_	have	_	VBP	135	_	_	_	_	_	_	_	O
9	vomiting	_	UNK	_	VBG	135	_	_	_	_	_	_	_	O
10	caused	_	cause	_	VBN	135	_	_	_	_	_	_	_	O
11	by	_	by	_	IN	135	_	_	_	_	_	_	_	O
12	gastroparesis	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
13	,	_	,	_	,	135	_	_	_	_	_	_	_	O
14	explain	_	explain	_	VBP	135	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	135	_	_	_	_	_	_	_	O
16	:	_	:	_	:	135	_	_	_	_	_	_	_	O
17	there	_	there	_	EX	135	_	_	_	_	_	_	_	O
18	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	135	_	_	_	_	_	_	_	O
20	strong	_	strong	_	JJ	135	_	_	_	_	_	_	_	O
21	evidence	_	evidence	_	NN	135	_	_	_	_	_	_	_	O
22	that	_	that	_	IN	135	_	_	_	_	_	_	_	O
23	any	_	any	_	DT	135	_	_	_	_	_	_	_	O
24	available	_	available	_	JJ	135	_	_	_	_	_	_	_	O
25	antiemetic	_	UNK	_	JJ	135	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	135	_	_	_	_	_	_	_	O
27	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
28	effective	_	effective	_	JJ	135	_	_	_	_	_	_	_	O
29	some	_	some	_	DT	135	_	_	_	_	_	_	_	O
30	people	_	people	_	NNS	135	_	_	_	_	_	people.n	People	S-Person
31	have	_	have	_	VBP	135	_	_	_	_	_	_	_	O
32	had	_	have	_	VBN	135	_	_	_	_	_	_	_	O
33	benefit	_	benefit	_	VBN	135	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	135	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
36	,	_	,	_	,	135	_	_	_	_	_	_	_	O
37	erythromycin	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	135	_	_	_	_	_	_	_	O
39	metoclopramide	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
40	.	_	.	_	.	135	_	_	_	_	_	_	_	O
41	the	_	the	_	DT	135	_	_	_	_	_	_	_	O
42	strongest	_	strongest	_	JJS	135	_	_	_	_	_	_	_	O
43	evidence	_	evidence	_	NN	135	_	_	_	_	_	_	_	O
44	for	_	for	_	IN	135	_	_	_	_	_	_	_	O
45	effectiveness	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
46	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	135	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
49	,	_	,	_	,	135	_	_	_	_	_	_	_	O
50	but	_	but	_	CC	135	_	_	_	_	_	_	_	O
51	prescribers	_	UNK	_	NNS	135	_	_	_	_	_	_	_	O
52	must	_	must	_	MD	135	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	135	_	_	_	_	_	_	_	O
2	adults	_	adult	_	NNS	135	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	135	_	_	_	_	_	_	_	O
4	type	_	type	_	JJ	135	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	135	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	NNS	135	_	_	_	_	_	_	_	O
7	who	_	who	_	WP	135	_	_	_	_	_	_	_	O
8	have	_	have	_	VBP	135	_	_	_	_	_	_	_	O
9	vomiting	_	UNK	_	VBG	135	_	_	_	_	_	_	_	O
10	caused	_	cause	_	VBN	135	_	_	_	_	_	_	_	O
11	by	_	by	_	IN	135	_	_	_	_	_	_	_	O
12	gastroparesis	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
13	,	_	,	_	,	135	_	_	_	_	_	_	_	O
14	explain	_	explain	_	VBP	135	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	135	_	_	_	_	_	_	_	O
16	:	_	:	_	:	135	_	_	_	_	_	_	_	O
17	there	_	there	_	EX	135	_	_	_	_	_	_	_	O
18	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
19	not	_	not	_	RB	135	_	_	_	_	_	_	_	O
20	strong	_	strong	_	JJ	135	_	_	_	_	_	_	_	O
21	evidence	_	evidence	_	NN	135	_	_	_	_	_	_	_	O
22	that	_	that	_	IN	135	_	_	_	_	_	_	_	O
23	any	_	any	_	DT	135	_	_	_	_	_	_	_	O
24	available	_	available	_	JJ	135	_	_	_	_	_	_	_	O
25	antiemetic	_	UNK	_	JJ	135	_	_	_	_	_	_	_	O
26	therapy	_	therapy	_	NN	135	_	_	_	_	_	_	_	O
27	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
28	effective	_	effective	_	JJ	135	_	_	_	_	_	_	_	O
29	some	_	some	_	DT	135	_	_	_	_	_	_	_	O
30	people	_	people	_	NNS	135	_	_	_	_	_	_	_	O
31	have	_	have	_	VBP	135	_	_	_	_	_	_	_	O
32	had	_	have	_	VBN	135	_	_	_	_	_	_	_	O
33	benefit	_	benefit	_	VBN	135	_	_	_	_	_	_	_	O
34	with	_	with	_	IN	135	_	_	_	_	_	_	_	O
35	unk	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
36	,	_	,	_	,	135	_	_	_	_	_	_	_	O
37	erythromycin	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
38	or	_	or	_	CC	135	_	_	_	_	_	_	_	O
39	metoclopramide	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
40	.	_	.	_	.	135	_	_	_	_	_	_	_	O
41	the	_	the	_	DT	135	_	_	_	_	_	_	_	O
42	strongest	_	strongest	_	JJS	135	_	_	_	_	_	_	_	O
43	evidence	_	evidence	_	NN	135	_	_	_	_	_	evidence.n	Evidence	S-Support
44	for	_	for	_	IN	135	_	_	_	_	_	_	_	O
45	effectiveness	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
46	is	_	be	_	VBZ	135	_	_	_	_	_	_	_	O
47	for	_	for	_	IN	135	_	_	_	_	_	_	_	O
48	unk	_	UNK	_	NN	135	_	_	_	_	_	_	_	O
49	,	_	,	_	,	135	_	_	_	_	_	_	_	O
50	but	_	but	_	CC	135	_	_	_	_	_	_	_	O
51	prescribers	_	UNK	_	NNS	135	_	_	_	_	_	_	_	O
52	must	_	must	_	MD	135	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	136	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	136	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	136	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	136	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	136	_	_	_	_	_	_	_	O
6	:	_	:	_	:	136	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	136	_	_	_	_	_	_	_	O
8	(	_	(	_	(	136	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	136	_	_	_	_	_	_	_	O
10	)	_	)	_	)	136	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	136	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	136	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	136	_	_	_	_	_	_	_	O
14	)	_	)	_	)	136	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	136	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	136	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	136	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	136	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	136	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	136	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	136	_	_	_	_	_	_	_	O
8	(	_	(	_	(	136	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	136	_	_	_	_	_	_	_	O
10	)	_	)	_	)	136	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	136	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	136	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	136	_	_	_	_	_	_	_	O
14	)	_	)	_	)	136	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	137	_	_	_	_	_	_	_	O
2	treating	_	treat	_	VBG	137	_	_	_	_	_	treat.v	Medical_intervention	O
3	vomiting	_	UNK	_	VBG	137	_	_	_	_	_	_	_	O
4	caused	_	cause	_	VBN	137	_	_	_	_	_	_	_	O
5	by	_	by	_	IN	137	_	_	_	_	_	_	_	B-Medical_condition
6	gastroparesis	_	UNK	_	NN	137	_	_	_	_	_	_	_	I-Medical_condition
7	in	_	in	_	IN	137	_	_	_	_	_	_	_	I-Medical_condition
8	adults	_	adult	_	NNS	137	_	_	_	_	_	_	_	I-Medical_condition
9	with	_	with	_	IN	137	_	_	_	_	_	_	_	I-Medical_condition
10	type	_	type	_	JJ	137	_	_	_	_	_	_	_	I-Medical_condition
11	2	_	2	_	CD	137	_	_	_	_	_	_	_	I-Medical_condition
12	diabetes	_	UNK	_	NNS	137	_	_	_	_	_	_	_	I-Medical_condition
13	:	_	:	_	:	137	_	_	_	_	_	_	_	O
14	consider	_	consider	_	VB	137	_	_	_	_	_	_	_	O
15	alternating	_	UNK	_	VBG	137	_	_	_	_	_	_	_	O
16	use	_	use	_	NN	137	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	137	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	137	_	_	_	_	_	_	_	O
20	metoclopramide	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
21	consider	_	consider	_	VB	137	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
23	only	_	only	_	RB	137	_	_	_	_	_	_	_	O
24	in	_	in	_	IN	137	_	_	_	_	_	_	_	O
25	exceptional	_	UNK	_	JJ	137	_	_	_	_	_	_	_	O
26	circumstances	_	circumstance	_	NNS	137	_	_	_	_	_	_	_	O
27	(	_	(	_	(	137	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	137	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	137	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	137	_	_	_	_	_	_	_	O
32	only	_	only	_	JJ	137	_	_	_	_	_	_	_	O
33	effective	_	effective	_	JJ	137	_	_	_	_	_	_	_	O
34	treatment	_	treatment	_	NN	137	_	_	_	_	_	_	_	O
35	)	_	)	_	)	137	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	137	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	137	_	_	_	_	_	_	_	O
38	accordance	_	accordance	_	NN	137	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	137	_	_	_	_	_	_	_	O
40	mhra	_	UNK	_	NNP	137	_	_	_	_	_	_	_	O
41	guidance	_	guidance	_	NN	137	_	_	_	_	_	_	_	O
42	.	_	.	_	.	137	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	137	_	_	_	_	_	_	_	O
2	treating	_	treat	_	VBG	137	_	_	_	_	_	_	_	O
3	vomiting	_	UNK	_	VBG	137	_	_	_	_	_	_	_	O
4	caused	_	cause	_	VBN	137	_	_	_	_	_	cause.v	Causation	O
5	by	_	by	_	IN	137	_	_	_	_	_	_	_	B-Effect
6	gastroparesis	_	UNK	_	NN	137	_	_	_	_	_	_	_	I-Effect
7	in	_	in	_	IN	137	_	_	_	_	_	_	_	I-Effect
8	adults	_	adult	_	NNS	137	_	_	_	_	_	_	_	I-Effect
9	with	_	with	_	IN	137	_	_	_	_	_	_	_	I-Effect
10	type	_	type	_	JJ	137	_	_	_	_	_	_	_	I-Effect
11	2	_	2	_	CD	137	_	_	_	_	_	_	_	I-Effect
12	diabetes	_	UNK	_	NNS	137	_	_	_	_	_	_	_	I-Effect
13	:	_	:	_	:	137	_	_	_	_	_	_	_	O
14	consider	_	consider	_	VB	137	_	_	_	_	_	_	_	O
15	alternating	_	UNK	_	VBG	137	_	_	_	_	_	_	_	O
16	use	_	use	_	NN	137	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	137	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	137	_	_	_	_	_	_	_	O
20	metoclopramide	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
21	consider	_	consider	_	VB	137	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
23	only	_	only	_	RB	137	_	_	_	_	_	_	_	O
24	in	_	in	_	IN	137	_	_	_	_	_	_	_	O
25	exceptional	_	UNK	_	JJ	137	_	_	_	_	_	_	_	O
26	circumstances	_	circumstance	_	NNS	137	_	_	_	_	_	_	_	O
27	(	_	(	_	(	137	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	137	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	137	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	137	_	_	_	_	_	_	_	O
32	only	_	only	_	JJ	137	_	_	_	_	_	_	_	O
33	effective	_	effective	_	JJ	137	_	_	_	_	_	_	_	O
34	treatment	_	treatment	_	NN	137	_	_	_	_	_	_	_	O
35	)	_	)	_	)	137	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	137	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	137	_	_	_	_	_	_	_	O
38	accordance	_	accordance	_	NN	137	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	137	_	_	_	_	_	_	_	O
40	mhra	_	UNK	_	NNP	137	_	_	_	_	_	_	_	O
41	guidance	_	guidance	_	NN	137	_	_	_	_	_	_	_	O
42	.	_	.	_	.	137	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	137	_	_	_	_	_	_	_	O
2	treating	_	treat	_	VBG	137	_	_	_	_	_	_	_	O
3	vomiting	_	UNK	_	VBG	137	_	_	_	_	_	_	_	O
4	caused	_	cause	_	VBN	137	_	_	_	_	_	_	_	O
5	by	_	by	_	IN	137	_	_	_	_	_	_	_	O
6	gastroparesis	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	137	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	137	_	_	_	_	_	adult.n	People_by_age	S-Person
9	with	_	with	_	IN	137	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	137	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	137	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	137	_	_	_	_	_	_	_	O
13	:	_	:	_	:	137	_	_	_	_	_	_	_	O
14	consider	_	consider	_	VB	137	_	_	_	_	_	_	_	O
15	alternating	_	UNK	_	VBG	137	_	_	_	_	_	_	_	O
16	use	_	use	_	NN	137	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	137	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	137	_	_	_	_	_	_	_	O
20	metoclopramide	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
21	consider	_	consider	_	VB	137	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
23	only	_	only	_	RB	137	_	_	_	_	_	_	_	O
24	in	_	in	_	IN	137	_	_	_	_	_	_	_	O
25	exceptional	_	UNK	_	JJ	137	_	_	_	_	_	_	_	O
26	circumstances	_	circumstance	_	NNS	137	_	_	_	_	_	_	_	O
27	(	_	(	_	(	137	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	137	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	137	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	137	_	_	_	_	_	_	_	O
32	only	_	only	_	JJ	137	_	_	_	_	_	_	_	O
33	effective	_	effective	_	JJ	137	_	_	_	_	_	_	_	O
34	treatment	_	treatment	_	NN	137	_	_	_	_	_	_	_	O
35	)	_	)	_	)	137	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	137	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	137	_	_	_	_	_	_	_	O
38	accordance	_	accordance	_	NN	137	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	137	_	_	_	_	_	_	_	O
40	mhra	_	UNK	_	NNP	137	_	_	_	_	_	_	_	O
41	guidance	_	guidance	_	NN	137	_	_	_	_	_	_	_	O
42	.	_	.	_	.	137	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	137	_	_	_	_	_	_	_	O
2	treating	_	treat	_	VBG	137	_	_	_	_	_	_	_	O
3	vomiting	_	UNK	_	VBG	137	_	_	_	_	_	_	_	O
4	caused	_	cause	_	VBN	137	_	_	_	_	_	_	_	O
5	by	_	by	_	IN	137	_	_	_	_	_	_	_	O
6	gastroparesis	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	137	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	137	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	137	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	137	_	_	_	_	_	type.n	Type	S-Subtype
11	2	_	2	_	CD	137	_	_	_	_	_	_	_	B-Category
12	diabetes	_	UNK	_	NNS	137	_	_	_	_	_	_	_	I-Category
13	:	_	:	_	:	137	_	_	_	_	_	_	_	O
14	consider	_	consider	_	VB	137	_	_	_	_	_	_	_	O
15	alternating	_	UNK	_	VBG	137	_	_	_	_	_	_	_	O
16	use	_	use	_	NN	137	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	137	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	137	_	_	_	_	_	_	_	O
20	metoclopramide	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
21	consider	_	consider	_	VB	137	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
23	only	_	only	_	RB	137	_	_	_	_	_	_	_	O
24	in	_	in	_	IN	137	_	_	_	_	_	_	_	O
25	exceptional	_	UNK	_	JJ	137	_	_	_	_	_	_	_	O
26	circumstances	_	circumstance	_	NNS	137	_	_	_	_	_	_	_	O
27	(	_	(	_	(	137	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	137	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	137	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	137	_	_	_	_	_	_	_	O
32	only	_	only	_	JJ	137	_	_	_	_	_	_	_	O
33	effective	_	effective	_	JJ	137	_	_	_	_	_	_	_	O
34	treatment	_	treatment	_	NN	137	_	_	_	_	_	_	_	O
35	)	_	)	_	)	137	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	137	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	137	_	_	_	_	_	_	_	O
38	accordance	_	accordance	_	NN	137	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	137	_	_	_	_	_	_	_	O
40	mhra	_	UNK	_	NNP	137	_	_	_	_	_	_	_	O
41	guidance	_	guidance	_	NN	137	_	_	_	_	_	_	_	O
42	.	_	.	_	.	137	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	137	_	_	_	_	_	_	_	O
2	treating	_	treat	_	VBG	137	_	_	_	_	_	_	_	O
3	vomiting	_	UNK	_	VBG	137	_	_	_	_	_	_	_	O
4	caused	_	cause	_	VBN	137	_	_	_	_	_	_	_	O
5	by	_	by	_	IN	137	_	_	_	_	_	_	_	O
6	gastroparesis	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	137	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	137	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	137	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	137	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	137	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	137	_	_	_	_	_	_	_	O
13	:	_	:	_	:	137	_	_	_	_	_	_	_	O
14	consider	_	consider	_	VB	137	_	_	_	_	_	consider.v	Categorization	O
15	alternating	_	UNK	_	VBG	137	_	_	_	_	_	_	_	B-Category
16	use	_	use	_	NN	137	_	_	_	_	_	_	_	I-Category
17	of	_	of	_	IN	137	_	_	_	_	_	_	_	I-Category
18	unk	_	UNK	_	NN	137	_	_	_	_	_	_	_	I-Category
19	and	_	and	_	CC	137	_	_	_	_	_	_	_	I-Category
20	metoclopramide	_	UNK	_	NN	137	_	_	_	_	_	_	_	I-Category
21	consider	_	consider	_	VB	137	_	_	_	_	_	_	_	I-Category
22	unk	_	UNK	_	NN	137	_	_	_	_	_	_	_	I-Category
23	only	_	only	_	RB	137	_	_	_	_	_	_	_	I-Category
24	in	_	in	_	IN	137	_	_	_	_	_	_	_	I-Category
25	exceptional	_	UNK	_	JJ	137	_	_	_	_	_	_	_	I-Category
26	circumstances	_	circumstance	_	NNS	137	_	_	_	_	_	_	_	I-Category
27	(	_	(	_	(	137	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	137	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	137	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	137	_	_	_	_	_	_	_	O
32	only	_	only	_	JJ	137	_	_	_	_	_	_	_	O
33	effective	_	effective	_	JJ	137	_	_	_	_	_	_	_	O
34	treatment	_	treatment	_	NN	137	_	_	_	_	_	_	_	O
35	)	_	)	_	)	137	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	137	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	137	_	_	_	_	_	_	_	O
38	accordance	_	accordance	_	NN	137	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	137	_	_	_	_	_	_	_	O
40	mhra	_	UNK	_	NNP	137	_	_	_	_	_	_	_	O
41	guidance	_	guidance	_	NN	137	_	_	_	_	_	_	_	O
42	.	_	.	_	.	137	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	137	_	_	_	_	_	_	_	O
2	treating	_	treat	_	VBG	137	_	_	_	_	_	_	_	O
3	vomiting	_	UNK	_	VBG	137	_	_	_	_	_	_	_	O
4	caused	_	cause	_	VBN	137	_	_	_	_	_	_	_	O
5	by	_	by	_	IN	137	_	_	_	_	_	_	_	O
6	gastroparesis	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	137	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	137	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	137	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	137	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	137	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	137	_	_	_	_	_	_	_	O
13	:	_	:	_	:	137	_	_	_	_	_	_	_	O
14	consider	_	consider	_	VB	137	_	_	_	_	_	_	_	O
15	alternating	_	UNK	_	VBG	137	_	_	_	_	_	_	_	O
16	use	_	use	_	NN	137	_	_	_	_	_	use.n	Using	O
17	of	_	of	_	IN	137	_	_	_	_	_	_	_	B-Instrument
18	unk	_	UNK	_	NN	137	_	_	_	_	_	_	_	I-Instrument
19	and	_	and	_	CC	137	_	_	_	_	_	_	_	O
20	metoclopramide	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
21	consider	_	consider	_	VB	137	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
23	only	_	only	_	RB	137	_	_	_	_	_	_	_	O
24	in	_	in	_	IN	137	_	_	_	_	_	_	_	O
25	exceptional	_	UNK	_	JJ	137	_	_	_	_	_	_	_	O
26	circumstances	_	circumstance	_	NNS	137	_	_	_	_	_	_	_	O
27	(	_	(	_	(	137	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	137	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	137	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	137	_	_	_	_	_	_	_	O
32	only	_	only	_	JJ	137	_	_	_	_	_	_	_	O
33	effective	_	effective	_	JJ	137	_	_	_	_	_	_	_	O
34	treatment	_	treatment	_	NN	137	_	_	_	_	_	_	_	O
35	)	_	)	_	)	137	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	137	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	137	_	_	_	_	_	_	_	O
38	accordance	_	accordance	_	NN	137	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	137	_	_	_	_	_	_	_	O
40	mhra	_	UNK	_	NNP	137	_	_	_	_	_	_	_	O
41	guidance	_	guidance	_	NN	137	_	_	_	_	_	_	_	O
42	.	_	.	_	.	137	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	137	_	_	_	_	_	_	_	O
2	treating	_	treat	_	VBG	137	_	_	_	_	_	_	_	O
3	vomiting	_	UNK	_	VBG	137	_	_	_	_	_	_	_	O
4	caused	_	cause	_	VBN	137	_	_	_	_	_	_	_	O
5	by	_	by	_	IN	137	_	_	_	_	_	_	_	O
6	gastroparesis	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	137	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	137	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	137	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	137	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	137	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	137	_	_	_	_	_	_	_	O
13	:	_	:	_	:	137	_	_	_	_	_	_	_	O
14	consider	_	consider	_	VB	137	_	_	_	_	_	_	_	O
15	alternating	_	UNK	_	VBG	137	_	_	_	_	_	_	_	O
16	use	_	use	_	NN	137	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	137	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	137	_	_	_	_	_	_	_	O
20	metoclopramide	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
21	consider	_	consider	_	VB	137	_	_	_	_	_	consider.v	Categorization	O
22	unk	_	UNK	_	NN	137	_	_	_	_	_	_	_	B-Category
23	only	_	only	_	RB	137	_	_	_	_	_	_	_	I-Category
24	in	_	in	_	IN	137	_	_	_	_	_	_	_	I-Category
25	exceptional	_	UNK	_	JJ	137	_	_	_	_	_	_	_	I-Category
26	circumstances	_	circumstance	_	NNS	137	_	_	_	_	_	_	_	I-Category
27	(	_	(	_	(	137	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	137	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	137	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	137	_	_	_	_	_	_	_	O
32	only	_	only	_	JJ	137	_	_	_	_	_	_	_	O
33	effective	_	effective	_	JJ	137	_	_	_	_	_	_	_	O
34	treatment	_	treatment	_	NN	137	_	_	_	_	_	_	_	O
35	)	_	)	_	)	137	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	137	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	137	_	_	_	_	_	_	_	O
38	accordance	_	accordance	_	NN	137	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	137	_	_	_	_	_	_	_	O
40	mhra	_	UNK	_	NNP	137	_	_	_	_	_	_	_	O
41	guidance	_	guidance	_	NN	137	_	_	_	_	_	_	_	O
42	.	_	.	_	.	137	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	137	_	_	_	_	_	_	_	O
2	treating	_	treat	_	VBG	137	_	_	_	_	_	_	_	O
3	vomiting	_	UNK	_	VBG	137	_	_	_	_	_	_	_	O
4	caused	_	cause	_	VBN	137	_	_	_	_	_	_	_	O
5	by	_	by	_	IN	137	_	_	_	_	_	_	_	O
6	gastroparesis	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	137	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	137	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	137	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	137	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	137	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	137	_	_	_	_	_	_	_	O
13	:	_	:	_	:	137	_	_	_	_	_	_	_	O
14	consider	_	consider	_	VB	137	_	_	_	_	_	_	_	O
15	alternating	_	UNK	_	VBG	137	_	_	_	_	_	_	_	O
16	use	_	use	_	NN	137	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	137	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	137	_	_	_	_	_	_	_	O
20	metoclopramide	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
21	consider	_	consider	_	VB	137	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
23	only	_	only	_	RB	137	_	_	_	_	_	_	_	O
24	in	_	in	_	IN	137	_	_	_	_	_	_	_	O
25	exceptional	_	UNK	_	JJ	137	_	_	_	_	_	_	_	O
26	circumstances	_	circumstance	_	NNS	137	_	_	_	_	_	_	_	O
27	(	_	(	_	(	137	_	_	_	_	_	_	_	O
28	if	_	if	_	IN	137	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	NN	137	_	_	_	_	_	_	_	O
30	is	_	be	_	VBZ	137	_	_	_	_	_	_	_	O
31	the	_	the	_	DT	137	_	_	_	_	_	_	_	O
32	only	_	only	_	JJ	137	_	_	_	_	_	_	_	O
33	effective	_	effective	_	JJ	137	_	_	_	_	_	effective.a	Usefulness	O
34	treatment	_	treatment	_	NN	137	_	_	_	_	_	_	_	S-Entity
35	)	_	)	_	)	137	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	137	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	137	_	_	_	_	_	_	_	O
38	accordance	_	accordance	_	NN	137	_	_	_	_	_	_	_	O
39	with	_	with	_	IN	137	_	_	_	_	_	_	_	O
40	mhra	_	UNK	_	NNP	137	_	_	_	_	_	_	_	O
41	guidance	_	guidance	_	NN	137	_	_	_	_	_	_	_	O
42	.	_	.	_	.	137	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	138	_	_	_	_	_	_	_	O
2	gastroparesis	_	UNK	_	NN	138	_	_	_	_	_	_	_	S-Suspect
3	is	_	be	_	VBZ	138	_	_	_	_	_	_	_	O
4	suspected	_	suspect	_	VBN	138	_	_	_	_	_	suspect.v	Suspicion	O
5	,	_	,	_	,	138	_	_	_	_	_	_	_	O
6	consider	_	consider	_	VB	138	_	_	_	_	_	_	_	O
7	referral	_	UNK	_	JJ	138	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	138	_	_	_	_	_	_	_	O
9	specialist	_	specialist	_	VB	138	_	_	_	_	_	_	_	O
10	services	_	service	_	NNS	138	_	_	_	_	_	_	_	O
11	if	_	if	_	IN	138	_	_	_	_	_	_	_	O
12	:	_	:	_	:	138	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	138	_	_	_	_	_	_	_	O
14	differential	_	differential	_	JJ	138	_	_	_	_	_	_	_	O
15	diagnosis	_	UNK	_	NN	138	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	138	_	_	_	_	_	_	_	O
17	in	_	in	_	IN	138	_	_	_	_	_	_	_	O
18	doubt	_	doubt	_	NN	138	_	_	_	_	_	_	_	O
19	or	_	or	_	CC	138	_	_	_	_	_	_	_	O
20	persistent	_	persistent	_	NN	138	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	138	_	_	_	_	_	_	_	O
22	severe	_	severe	_	JJ	138	_	_	_	_	_	_	_	O
23	vomiting	_	UNK	_	NN	138	_	_	_	_	_	_	_	O
24	occurs	_	UNK	_	NNS	138	_	_	_	_	_	_	_	O
25	.	_	.	_	.	138	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	138	_	_	_	_	_	_	_	O
2	gastroparesis	_	UNK	_	NN	138	_	_	_	_	_	_	_	S-Cognizer
3	is	_	be	_	VBZ	138	_	_	_	_	_	_	_	O
4	suspected	_	suspect	_	VBN	138	_	_	_	_	_	_	_	O
5	,	_	,	_	,	138	_	_	_	_	_	_	_	O
6	consider	_	consider	_	VB	138	_	_	_	_	_	consider.v	Categorization	O
7	referral	_	UNK	_	JJ	138	_	_	_	_	_	_	_	B-Category
8	to	_	to	_	TO	138	_	_	_	_	_	_	_	I-Category
9	specialist	_	specialist	_	VB	138	_	_	_	_	_	_	_	I-Category
10	services	_	service	_	NNS	138	_	_	_	_	_	_	_	I-Category
11	if	_	if	_	IN	138	_	_	_	_	_	_	_	I-Category
12	:	_	:	_	:	138	_	_	_	_	_	_	_	I-Category
13	the	_	the	_	DT	138	_	_	_	_	_	_	_	I-Category
14	differential	_	differential	_	JJ	138	_	_	_	_	_	_	_	I-Category
15	diagnosis	_	UNK	_	NN	138	_	_	_	_	_	_	_	I-Category
16	is	_	be	_	VBZ	138	_	_	_	_	_	_	_	I-Category
17	in	_	in	_	IN	138	_	_	_	_	_	_	_	I-Category
18	doubt	_	doubt	_	NN	138	_	_	_	_	_	_	_	I-Category
19	or	_	or	_	CC	138	_	_	_	_	_	_	_	I-Category
20	persistent	_	persistent	_	NN	138	_	_	_	_	_	_	_	I-Category
21	or	_	or	_	CC	138	_	_	_	_	_	_	_	I-Category
22	severe	_	severe	_	JJ	138	_	_	_	_	_	_	_	I-Category
23	vomiting	_	UNK	_	NN	138	_	_	_	_	_	_	_	I-Category
24	occurs	_	UNK	_	NNS	138	_	_	_	_	_	_	_	I-Category
25	.	_	.	_	.	138	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	138	_	_	_	_	_	_	_	O
2	gastroparesis	_	UNK	_	NN	138	_	_	_	_	_	_	_	O
3	is	_	be	_	VBZ	138	_	_	_	_	_	_	_	O
4	suspected	_	suspect	_	VBN	138	_	_	_	_	_	_	_	O
5	,	_	,	_	,	138	_	_	_	_	_	_	_	O
6	consider	_	consider	_	VB	138	_	_	_	_	_	_	_	O
7	referral	_	UNK	_	JJ	138	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	138	_	_	_	_	_	_	_	O
9	specialist	_	specialist	_	VB	138	_	_	_	_	_	specialist.n	Expertise	S-Protagonist
10	services	_	service	_	NNS	138	_	_	_	_	_	_	_	O
11	if	_	if	_	IN	138	_	_	_	_	_	_	_	O
12	:	_	:	_	:	138	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	138	_	_	_	_	_	_	_	O
14	differential	_	differential	_	JJ	138	_	_	_	_	_	_	_	O
15	diagnosis	_	UNK	_	NN	138	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	138	_	_	_	_	_	_	_	O
17	in	_	in	_	IN	138	_	_	_	_	_	_	_	O
18	doubt	_	doubt	_	NN	138	_	_	_	_	_	_	_	O
19	or	_	or	_	CC	138	_	_	_	_	_	_	_	O
20	persistent	_	persistent	_	NN	138	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	138	_	_	_	_	_	_	_	O
22	severe	_	severe	_	JJ	138	_	_	_	_	_	_	_	O
23	vomiting	_	UNK	_	NN	138	_	_	_	_	_	_	_	O
24	occurs	_	UNK	_	NNS	138	_	_	_	_	_	_	_	O
25	.	_	.	_	.	138	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	138	_	_	_	_	_	_	_	O
2	gastroparesis	_	UNK	_	NN	138	_	_	_	_	_	_	_	O
3	is	_	be	_	VBZ	138	_	_	_	_	_	_	_	O
4	suspected	_	suspect	_	VBN	138	_	_	_	_	_	_	_	O
5	,	_	,	_	,	138	_	_	_	_	_	_	_	O
6	consider	_	consider	_	VB	138	_	_	_	_	_	_	_	O
7	referral	_	UNK	_	JJ	138	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	138	_	_	_	_	_	_	_	O
9	specialist	_	specialist	_	VB	138	_	_	_	_	_	_	_	S-Domain
10	services	_	service	_	NNS	138	_	_	_	_	_	service.n	Public_services	S-Institution
11	if	_	if	_	IN	138	_	_	_	_	_	_	_	O
12	:	_	:	_	:	138	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	138	_	_	_	_	_	_	_	O
14	differential	_	differential	_	JJ	138	_	_	_	_	_	_	_	O
15	diagnosis	_	UNK	_	NN	138	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	138	_	_	_	_	_	_	_	O
17	in	_	in	_	IN	138	_	_	_	_	_	_	_	O
18	doubt	_	doubt	_	NN	138	_	_	_	_	_	_	_	O
19	or	_	or	_	CC	138	_	_	_	_	_	_	_	O
20	persistent	_	persistent	_	NN	138	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	138	_	_	_	_	_	_	_	O
22	severe	_	severe	_	JJ	138	_	_	_	_	_	_	_	O
23	vomiting	_	UNK	_	NN	138	_	_	_	_	_	_	_	O
24	occurs	_	UNK	_	NNS	138	_	_	_	_	_	_	_	O
25	.	_	.	_	.	138	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	138	_	_	_	_	_	_	_	O
2	gastroparesis	_	UNK	_	NN	138	_	_	_	_	_	_	_	O
3	is	_	be	_	VBZ	138	_	_	_	_	_	_	_	O
4	suspected	_	suspect	_	VBN	138	_	_	_	_	_	_	_	O
5	,	_	,	_	,	138	_	_	_	_	_	_	_	O
6	consider	_	consider	_	VB	138	_	_	_	_	_	_	_	O
7	referral	_	UNK	_	JJ	138	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	138	_	_	_	_	_	_	_	O
9	specialist	_	specialist	_	VB	138	_	_	_	_	_	_	_	O
10	services	_	service	_	NNS	138	_	_	_	_	_	_	_	O
11	if	_	if	_	IN	138	_	_	_	_	_	_	_	O
12	:	_	:	_	:	138	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	138	_	_	_	_	_	_	_	B-Cognizer
14	differential	_	differential	_	JJ	138	_	_	_	_	_	_	_	I-Cognizer
15	diagnosis	_	UNK	_	NN	138	_	_	_	_	_	_	_	I-Cognizer
16	is	_	be	_	VBZ	138	_	_	_	_	_	_	_	O
17	in	_	in	_	IN	138	_	_	_	_	_	_	_	O
18	doubt	_	doubt	_	NN	138	_	_	_	_	_	doubt.n	Certainty	O
19	or	_	or	_	CC	138	_	_	_	_	_	_	_	O
20	persistent	_	persistent	_	NN	138	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	138	_	_	_	_	_	_	_	O
22	severe	_	severe	_	JJ	138	_	_	_	_	_	_	_	O
23	vomiting	_	UNK	_	NN	138	_	_	_	_	_	_	_	O
24	occurs	_	UNK	_	NNS	138	_	_	_	_	_	_	_	O
25	.	_	.	_	.	138	_	_	_	_	_	_	_	O

1	if	_	If	_	IN	138	_	_	_	_	_	_	_	O
2	gastroparesis	_	UNK	_	NN	138	_	_	_	_	_	_	_	O
3	is	_	be	_	VBZ	138	_	_	_	_	_	_	_	O
4	suspected	_	suspect	_	VBN	138	_	_	_	_	_	_	_	O
5	,	_	,	_	,	138	_	_	_	_	_	_	_	O
6	consider	_	consider	_	VB	138	_	_	_	_	_	_	_	O
7	referral	_	UNK	_	JJ	138	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	138	_	_	_	_	_	_	_	O
9	specialist	_	specialist	_	VB	138	_	_	_	_	_	_	_	O
10	services	_	service	_	NNS	138	_	_	_	_	_	_	_	O
11	if	_	if	_	IN	138	_	_	_	_	_	_	_	O
12	:	_	:	_	:	138	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	138	_	_	_	_	_	_	_	O
14	differential	_	differential	_	JJ	138	_	_	_	_	_	_	_	O
15	diagnosis	_	UNK	_	NN	138	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	138	_	_	_	_	_	_	_	O
17	in	_	in	_	IN	138	_	_	_	_	_	_	_	O
18	doubt	_	doubt	_	NN	138	_	_	_	_	_	_	_	O
19	or	_	or	_	CC	138	_	_	_	_	_	_	_	O
20	persistent	_	persistent	_	NN	138	_	_	_	_	_	persistent.a	Duration_description	O
21	or	_	or	_	CC	138	_	_	_	_	_	_	_	O
22	severe	_	severe	_	JJ	138	_	_	_	_	_	_	_	O
23	vomiting	_	UNK	_	NN	138	_	_	_	_	_	_	_	B-Eventuality
24	occurs	_	UNK	_	NNS	138	_	_	_	_	_	_	_	I-Eventuality
25	.	_	.	_	.	138	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	139	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	139	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	139	_	_	_	_	_	_	_	O
4	managing	_	manage	_	VBG	139	_	_	_	_	_	_	_	O
5	painful	_	UNK	_	JJ	139	_	_	_	_	_	_	_	O
6	diabetic	_	UNK	_	JJ	139	_	_	_	_	_	_	_	O
7	peripheral	_	peripheral	_	JJ	139	_	_	_	_	_	_	_	O
8	neuropathy	_	UNK	_	NN	139	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	139	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	139	_	_	_	_	_	adult.n	People_by_age	S-Person
11	with	_	with	_	IN	139	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	139	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	139	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	139	_	_	_	_	_	_	_	O
15	,	_	,	_	,	139	_	_	_	_	_	_	_	O
16	see	_	see	_	VBP	139	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	139	_	_	_	_	_	_	_	O
18	nice	_	UNK	_	NNP	139	_	_	_	_	_	_	_	O
19	guideline	_	guideline	_	NN	139	_	_	_	_	_	_	_	O
20	on	_	on	_	IN	139	_	_	_	_	_	_	_	O
21	neuropathic	_	UNK	_	JJ	139	_	_	_	_	_	_	_	O
22	pain	_	UNK	_	NN	139	_	_	_	_	_	_	_	O
23	in	_	in	_	IN	139	_	_	_	_	_	_	_	O
24	adults	_	adult	_	NNS	139	_	_	_	_	_	_	_	O
25	.	_	.	_	.	139	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	139	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	139	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	139	_	_	_	_	_	_	_	O
4	managing	_	manage	_	VBG	139	_	_	_	_	_	_	_	O
5	painful	_	UNK	_	JJ	139	_	_	_	_	_	_	_	O
6	diabetic	_	UNK	_	JJ	139	_	_	_	_	_	_	_	O
7	peripheral	_	peripheral	_	JJ	139	_	_	_	_	_	_	_	O
8	neuropathy	_	UNK	_	NN	139	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	139	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	139	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	139	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	139	_	_	_	_	_	type.n	Type	S-Subtype
13	2	_	2	_	CD	139	_	_	_	_	_	_	_	B-Category
14	diabetes	_	UNK	_	NNS	139	_	_	_	_	_	_	_	I-Category
15	,	_	,	_	,	139	_	_	_	_	_	_	_	O
16	see	_	see	_	VBP	139	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	139	_	_	_	_	_	_	_	O
18	nice	_	UNK	_	NNP	139	_	_	_	_	_	_	_	O
19	guideline	_	guideline	_	NN	139	_	_	_	_	_	_	_	O
20	on	_	on	_	IN	139	_	_	_	_	_	_	_	O
21	neuropathic	_	UNK	_	JJ	139	_	_	_	_	_	_	_	O
22	pain	_	UNK	_	NN	139	_	_	_	_	_	_	_	O
23	in	_	in	_	IN	139	_	_	_	_	_	_	_	O
24	adults	_	adult	_	NNS	139	_	_	_	_	_	_	_	O
25	.	_	.	_	.	139	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	139	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	139	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	139	_	_	_	_	_	_	_	O
4	managing	_	manage	_	VBG	139	_	_	_	_	_	_	_	O
5	painful	_	UNK	_	JJ	139	_	_	_	_	_	_	_	O
6	diabetic	_	UNK	_	JJ	139	_	_	_	_	_	_	_	O
7	peripheral	_	peripheral	_	JJ	139	_	_	_	_	_	_	_	O
8	neuropathy	_	UNK	_	NN	139	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	139	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	139	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	139	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	139	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	139	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	139	_	_	_	_	_	_	_	O
15	,	_	,	_	,	139	_	_	_	_	_	_	_	O
16	see	_	see	_	VBP	139	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	139	_	_	_	_	_	_	_	O
18	nice	_	UNK	_	NNP	139	_	_	_	_	_	_	_	O
19	guideline	_	guideline	_	NN	139	_	_	_	_	_	_	_	O
20	on	_	on	_	IN	139	_	_	_	_	_	_	_	O
21	neuropathic	_	UNK	_	JJ	139	_	_	_	_	_	_	_	O
22	pain	_	UNK	_	NN	139	_	_	_	_	_	_	_	O
23	in	_	in	_	IN	139	_	_	_	_	_	_	_	O
24	adults	_	adult	_	NNS	139	_	_	_	_	_	adult.n	People_by_age	S-Person
25	.	_	.	_	.	139	_	_	_	_	_	_	_	O

1	think	_	Think	_	VB	141	_	_	_	_	_	think.v	Opinion	O
2	about	_	about	_	IN	141	_	_	_	_	_	_	_	B-Opinion
3	the	_	the	_	DT	141	_	_	_	_	_	_	_	I-Opinion
4	possibility	_	possibility	_	NN	141	_	_	_	_	_	_	_	I-Opinion
5	of	_	of	_	IN	141	_	_	_	_	_	_	_	I-Opinion
6	contributory	_	UNK	_	JJ	141	_	_	_	_	_	_	_	I-Opinion
7	sympathetic	_	UNK	_	JJ	141	_	_	_	_	_	_	_	I-Opinion
8	nervous	_	nervous	_	JJ	141	_	_	_	_	_	_	_	I-Opinion
9	system	_	system	_	NN	141	_	_	_	_	_	_	_	I-Opinion
10	damage	_	damage	_	NN	141	_	_	_	_	_	_	_	I-Opinion
11	for	_	for	_	IN	141	_	_	_	_	_	_	_	I-Opinion
12	adults	_	adult	_	NNS	141	_	_	_	_	_	_	_	I-Opinion
13	with	_	with	_	IN	141	_	_	_	_	_	_	_	I-Opinion
14	type	_	type	_	JJ	141	_	_	_	_	_	_	_	I-Opinion
15	2	_	2	_	CD	141	_	_	_	_	_	_	_	I-Opinion
16	diabetes	_	UNK	_	NNS	141	_	_	_	_	_	_	_	I-Opinion
17	who	_	who	_	WP	141	_	_	_	_	_	_	_	I-Opinion
18	lose	_	lose	_	VBP	141	_	_	_	_	_	_	_	I-Opinion
19	the	_	the	_	DT	141	_	_	_	_	_	_	_	I-Opinion
20	warning	_	warning	_	NN	141	_	_	_	_	_	_	_	I-Opinion
21	signs	_	sign	_	NNS	141	_	_	_	_	_	_	_	I-Opinion
22	of	_	of	_	IN	141	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NN	141	_	_	_	_	_	_	_	O
24	.	_	.	_	.	141	_	_	_	_	_	_	_	O
25	[	_	[	_	JJ	141	_	_	_	_	_	_	_	O
26	2009	_	UNK	_	CD	141	_	_	_	_	_	_	_	O
27	,	_	,	_	,	141	_	_	_	_	_	_	_	O
28	amended	_	UNK	_	VBD	141	_	_	_	_	_	_	_	O
29	2015	_	2015	_	CD	141	_	_	_	_	_	_	_	O
30	]	_	]	_	NN	141	_	_	_	_	_	_	_	O

1	think	_	Think	_	VB	141	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	141	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	141	_	_	_	_	_	_	_	O
4	possibility	_	possibility	_	NN	141	_	_	_	_	_	possibility.n	Likelihood	O
5	of	_	of	_	IN	141	_	_	_	_	_	_	_	B-Hypothetical_event
6	contributory	_	UNK	_	JJ	141	_	_	_	_	_	_	_	I-Hypothetical_event
7	sympathetic	_	UNK	_	JJ	141	_	_	_	_	_	_	_	I-Hypothetical_event
8	nervous	_	nervous	_	JJ	141	_	_	_	_	_	_	_	I-Hypothetical_event
9	system	_	system	_	NN	141	_	_	_	_	_	_	_	I-Hypothetical_event
10	damage	_	damage	_	NN	141	_	_	_	_	_	_	_	I-Hypothetical_event
11	for	_	for	_	IN	141	_	_	_	_	_	_	_	I-Hypothetical_event
12	adults	_	adult	_	NNS	141	_	_	_	_	_	_	_	I-Hypothetical_event
13	with	_	with	_	IN	141	_	_	_	_	_	_	_	I-Hypothetical_event
14	type	_	type	_	JJ	141	_	_	_	_	_	_	_	I-Hypothetical_event
15	2	_	2	_	CD	141	_	_	_	_	_	_	_	I-Hypothetical_event
16	diabetes	_	UNK	_	NNS	141	_	_	_	_	_	_	_	I-Hypothetical_event
17	who	_	who	_	WP	141	_	_	_	_	_	_	_	I-Hypothetical_event
18	lose	_	lose	_	VBP	141	_	_	_	_	_	_	_	I-Hypothetical_event
19	the	_	the	_	DT	141	_	_	_	_	_	_	_	I-Hypothetical_event
20	warning	_	warning	_	NN	141	_	_	_	_	_	_	_	I-Hypothetical_event
21	signs	_	sign	_	NNS	141	_	_	_	_	_	_	_	I-Hypothetical_event
22	of	_	of	_	IN	141	_	_	_	_	_	_	_	I-Hypothetical_event
23	unk	_	UNK	_	NN	141	_	_	_	_	_	_	_	I-Hypothetical_event
24	.	_	.	_	.	141	_	_	_	_	_	_	_	O
25	[	_	[	_	JJ	141	_	_	_	_	_	_	_	O
26	2009	_	UNK	_	CD	141	_	_	_	_	_	_	_	O
27	,	_	,	_	,	141	_	_	_	_	_	_	_	O
28	amended	_	UNK	_	VBD	141	_	_	_	_	_	_	_	O
29	2015	_	2015	_	CD	141	_	_	_	_	_	_	_	O
30	]	_	]	_	NN	141	_	_	_	_	_	_	_	O

1	think	_	Think	_	VB	141	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	141	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	141	_	_	_	_	_	_	_	O
4	possibility	_	possibility	_	NN	141	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	141	_	_	_	_	_	_	_	O
6	contributory	_	UNK	_	JJ	141	_	_	_	_	_	_	_	O
7	sympathetic	_	UNK	_	JJ	141	_	_	_	_	_	_	_	O
8	nervous	_	nervous	_	JJ	141	_	_	_	_	_	_	_	O
9	system	_	system	_	NN	141	_	_	_	_	_	system.n	System	S-Complex
10	damage	_	damage	_	NN	141	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	141	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	141	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	141	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	141	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	141	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	141	_	_	_	_	_	_	_	O
17	who	_	who	_	WP	141	_	_	_	_	_	_	_	O
18	lose	_	lose	_	VBP	141	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	141	_	_	_	_	_	_	_	O
20	warning	_	warning	_	NN	141	_	_	_	_	_	_	_	O
21	signs	_	sign	_	NNS	141	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	141	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NN	141	_	_	_	_	_	_	_	O
24	.	_	.	_	.	141	_	_	_	_	_	_	_	O
25	[	_	[	_	JJ	141	_	_	_	_	_	_	_	O
26	2009	_	UNK	_	CD	141	_	_	_	_	_	_	_	O
27	,	_	,	_	,	141	_	_	_	_	_	_	_	O
28	amended	_	UNK	_	VBD	141	_	_	_	_	_	_	_	O
29	2015	_	2015	_	CD	141	_	_	_	_	_	_	_	O
30	]	_	]	_	NN	141	_	_	_	_	_	_	_	O

1	think	_	Think	_	VB	141	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	141	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	141	_	_	_	_	_	_	_	O
4	possibility	_	possibility	_	NN	141	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	141	_	_	_	_	_	_	_	O
6	contributory	_	UNK	_	JJ	141	_	_	_	_	_	_	_	O
7	sympathetic	_	UNK	_	JJ	141	_	_	_	_	_	_	_	O
8	nervous	_	nervous	_	JJ	141	_	_	_	_	_	_	_	O
9	system	_	system	_	NN	141	_	_	_	_	_	_	_	S-Patient
10	damage	_	damage	_	NN	141	_	_	_	_	_	damage.n	Damaging	O
11	for	_	for	_	IN	141	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	141	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	141	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	141	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	141	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	141	_	_	_	_	_	_	_	O
17	who	_	who	_	WP	141	_	_	_	_	_	_	_	O
18	lose	_	lose	_	VBP	141	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	141	_	_	_	_	_	_	_	O
20	warning	_	warning	_	NN	141	_	_	_	_	_	_	_	O
21	signs	_	sign	_	NNS	141	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	141	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NN	141	_	_	_	_	_	_	_	O
24	.	_	.	_	.	141	_	_	_	_	_	_	_	O
25	[	_	[	_	JJ	141	_	_	_	_	_	_	_	O
26	2009	_	UNK	_	CD	141	_	_	_	_	_	_	_	O
27	,	_	,	_	,	141	_	_	_	_	_	_	_	O
28	amended	_	UNK	_	VBD	141	_	_	_	_	_	_	_	O
29	2015	_	2015	_	CD	141	_	_	_	_	_	_	_	O
30	]	_	]	_	NN	141	_	_	_	_	_	_	_	O

1	think	_	Think	_	VB	141	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	141	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	141	_	_	_	_	_	_	_	O
4	possibility	_	possibility	_	NN	141	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	141	_	_	_	_	_	_	_	O
6	contributory	_	UNK	_	JJ	141	_	_	_	_	_	_	_	O
7	sympathetic	_	UNK	_	JJ	141	_	_	_	_	_	_	_	O
8	nervous	_	nervous	_	JJ	141	_	_	_	_	_	_	_	O
9	system	_	system	_	NN	141	_	_	_	_	_	_	_	O
10	damage	_	damage	_	NN	141	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	141	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	141	_	_	_	_	_	adult.n	People_by_age	S-Person
13	with	_	with	_	IN	141	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	141	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	141	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	141	_	_	_	_	_	_	_	O
17	who	_	who	_	WP	141	_	_	_	_	_	_	_	O
18	lose	_	lose	_	VBP	141	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	141	_	_	_	_	_	_	_	O
20	warning	_	warning	_	NN	141	_	_	_	_	_	_	_	O
21	signs	_	sign	_	NNS	141	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	141	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NN	141	_	_	_	_	_	_	_	O
24	.	_	.	_	.	141	_	_	_	_	_	_	_	O
25	[	_	[	_	JJ	141	_	_	_	_	_	_	_	O
26	2009	_	UNK	_	CD	141	_	_	_	_	_	_	_	O
27	,	_	,	_	,	141	_	_	_	_	_	_	_	O
28	amended	_	UNK	_	VBD	141	_	_	_	_	_	_	_	O
29	2015	_	2015	_	CD	141	_	_	_	_	_	_	_	O
30	]	_	]	_	NN	141	_	_	_	_	_	_	_	O

1	think	_	Think	_	VB	141	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	141	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	141	_	_	_	_	_	_	_	O
4	possibility	_	possibility	_	NN	141	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	141	_	_	_	_	_	_	_	O
6	contributory	_	UNK	_	JJ	141	_	_	_	_	_	_	_	O
7	sympathetic	_	UNK	_	JJ	141	_	_	_	_	_	_	_	O
8	nervous	_	nervous	_	JJ	141	_	_	_	_	_	_	_	O
9	system	_	system	_	NN	141	_	_	_	_	_	_	_	O
10	damage	_	damage	_	NN	141	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	141	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	141	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	141	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	141	_	_	_	_	_	type.n	Type	S-Subtype
15	2	_	2	_	CD	141	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	141	_	_	_	_	_	_	_	O
17	who	_	who	_	WP	141	_	_	_	_	_	_	_	O
18	lose	_	lose	_	VBP	141	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	141	_	_	_	_	_	_	_	O
20	warning	_	warning	_	NN	141	_	_	_	_	_	_	_	O
21	signs	_	sign	_	NNS	141	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	141	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	NN	141	_	_	_	_	_	_	_	O
24	.	_	.	_	.	141	_	_	_	_	_	_	_	O
25	[	_	[	_	JJ	141	_	_	_	_	_	_	_	O
26	2009	_	UNK	_	CD	141	_	_	_	_	_	_	_	O
27	,	_	,	_	,	141	_	_	_	_	_	_	_	O
28	amended	_	UNK	_	VBD	141	_	_	_	_	_	_	_	O
29	2015	_	2015	_	CD	141	_	_	_	_	_	_	_	O
30	]	_	]	_	NN	141	_	_	_	_	_	_	_	O

1	think	_	Think	_	VB	141	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	141	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	141	_	_	_	_	_	_	_	O
4	possibility	_	possibility	_	NN	141	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	141	_	_	_	_	_	_	_	O
6	contributory	_	UNK	_	JJ	141	_	_	_	_	_	_	_	O
7	sympathetic	_	UNK	_	JJ	141	_	_	_	_	_	_	_	O
8	nervous	_	nervous	_	JJ	141	_	_	_	_	_	_	_	O
9	system	_	system	_	NN	141	_	_	_	_	_	_	_	O
10	damage	_	damage	_	NN	141	_	_	_	_	_	_	_	O
11	for	_	for	_	IN	141	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	141	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	141	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	141	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	141	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	141	_	_	_	_	_	_	_	O
17	who	_	who	_	WP	141	_	_	_	_	_	_	_	O
18	lose	_	lose	_	VBP	141	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	141	_	_	_	_	_	_	_	O
20	warning	_	warning	_	NN	141	_	_	_	_	_	_	_	S-Reliability
21	signs	_	sign	_	NNS	141	_	_	_	_	_	sign.n	Sign	S-Indicator
22	of	_	of	_	IN	141	_	_	_	_	_	_	_	B-Indicated
23	unk	_	UNK	_	NN	141	_	_	_	_	_	_	_	I-Indicated
24	.	_	.	_	.	141	_	_	_	_	_	_	_	O
25	[	_	[	_	JJ	141	_	_	_	_	_	_	_	O
26	2009	_	UNK	_	CD	141	_	_	_	_	_	_	_	O
27	,	_	,	_	,	141	_	_	_	_	_	_	_	O
28	amended	_	UNK	_	VBD	141	_	_	_	_	_	_	_	O
29	2015	_	2015	_	CD	141	_	_	_	_	_	_	_	O
30	]	_	]	_	NN	141	_	_	_	_	_	_	_	O

1	think	_	Think	_	VB	142	_	_	_	_	_	think.v	Opinion	O
2	about	_	about	_	IN	142	_	_	_	_	_	_	_	B-Opinion
3	the	_	the	_	DT	142	_	_	_	_	_	_	_	I-Opinion
4	possibility	_	possibility	_	NN	142	_	_	_	_	_	_	_	I-Opinion
5	of	_	of	_	IN	142	_	_	_	_	_	_	_	I-Opinion
6	autonomic	_	UNK	_	JJ	142	_	_	_	_	_	_	_	I-Opinion
7	neuropathy	_	UNK	_	JJ	142	_	_	_	_	_	_	_	I-Opinion
8	affecting	_	affect	_	VBG	142	_	_	_	_	_	_	_	I-Opinion
9	the	_	the	_	DT	142	_	_	_	_	_	_	_	I-Opinion
10	gut	_	UNK	_	NN	142	_	_	_	_	_	_	_	I-Opinion
11	in	_	in	_	IN	142	_	_	_	_	_	_	_	I-Opinion
12	adults	_	adult	_	NNS	142	_	_	_	_	_	_	_	I-Opinion
13	with	_	with	_	IN	142	_	_	_	_	_	_	_	I-Opinion
14	type	_	type	_	JJ	142	_	_	_	_	_	_	_	I-Opinion
15	2	_	2	_	CD	142	_	_	_	_	_	_	_	I-Opinion
16	diabetes	_	UNK	_	NNS	142	_	_	_	_	_	_	_	I-Opinion
17	who	_	who	_	WP	142	_	_	_	_	_	_	_	I-Opinion
18	have	_	have	_	VBP	142	_	_	_	_	_	_	_	I-Opinion
19	unexplained	_	UNK	_	VBN	142	_	_	_	_	_	_	_	I-Opinion
20	diarrhoea	_	UNK	_	RP	142	_	_	_	_	_	_	_	I-Opinion
21	that	_	that	_	IN	142	_	_	_	_	_	_	_	I-Opinion
22	happens	_	happen	_	VBZ	142	_	_	_	_	_	_	_	O
23	particularly	_	particularly	_	RB	142	_	_	_	_	_	_	_	O
24	at	_	at	_	IN	142	_	_	_	_	_	_	_	O
25	night	_	night	_	NN	142	_	_	_	_	_	_	_	O
26	[	_	[	_	NN	142	_	_	_	_	_	_	_	O
27	2009	_	UNK	_	CD	142	_	_	_	_	_	_	_	O
28	,	_	,	_	,	142	_	_	_	_	_	_	_	O
29	amended	_	UNK	_	VBD	142	_	_	_	_	_	_	_	O
30	2015	_	2015	_	CD	142	_	_	_	_	_	_	_	O
31	]	_	]	_	NN	142	_	_	_	_	_	_	_	O

1	think	_	Think	_	VB	142	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	142	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	142	_	_	_	_	_	_	_	O
4	possibility	_	possibility	_	NN	142	_	_	_	_	_	possibility.n	Likelihood	O
5	of	_	of	_	IN	142	_	_	_	_	_	_	_	B-Hypothetical_event
6	autonomic	_	UNK	_	JJ	142	_	_	_	_	_	_	_	I-Hypothetical_event
7	neuropathy	_	UNK	_	JJ	142	_	_	_	_	_	_	_	I-Hypothetical_event
8	affecting	_	affect	_	VBG	142	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	142	_	_	_	_	_	_	_	O
10	gut	_	UNK	_	NN	142	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	142	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	142	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	142	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	142	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	142	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	142	_	_	_	_	_	_	_	O
17	who	_	who	_	WP	142	_	_	_	_	_	_	_	O
18	have	_	have	_	VBP	142	_	_	_	_	_	_	_	O
19	unexplained	_	UNK	_	VBN	142	_	_	_	_	_	_	_	O
20	diarrhoea	_	UNK	_	RP	142	_	_	_	_	_	_	_	O
21	that	_	that	_	IN	142	_	_	_	_	_	_	_	O
22	happens	_	happen	_	VBZ	142	_	_	_	_	_	_	_	O
23	particularly	_	particularly	_	RB	142	_	_	_	_	_	_	_	O
24	at	_	at	_	IN	142	_	_	_	_	_	_	_	O
25	night	_	night	_	NN	142	_	_	_	_	_	_	_	O
26	[	_	[	_	NN	142	_	_	_	_	_	_	_	O
27	2009	_	UNK	_	CD	142	_	_	_	_	_	_	_	O
28	,	_	,	_	,	142	_	_	_	_	_	_	_	O
29	amended	_	UNK	_	VBD	142	_	_	_	_	_	_	_	O
30	2015	_	2015	_	CD	142	_	_	_	_	_	_	_	O
31	]	_	]	_	NN	142	_	_	_	_	_	_	_	O

1	think	_	Think	_	VB	142	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	142	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	142	_	_	_	_	_	_	_	O
4	possibility	_	possibility	_	NN	142	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	142	_	_	_	_	_	_	_	O
6	autonomic	_	UNK	_	JJ	142	_	_	_	_	_	_	_	B-Dependent_entity
7	neuropathy	_	UNK	_	JJ	142	_	_	_	_	_	_	_	I-Dependent_entity
8	affecting	_	affect	_	VBG	142	_	_	_	_	_	affect.v	Objective_influence	O
9	the	_	the	_	DT	142	_	_	_	_	_	_	_	O
10	gut	_	UNK	_	NN	142	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	142	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	142	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	142	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	142	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	142	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	142	_	_	_	_	_	_	_	O
17	who	_	who	_	WP	142	_	_	_	_	_	_	_	O
18	have	_	have	_	VBP	142	_	_	_	_	_	_	_	O
19	unexplained	_	UNK	_	VBN	142	_	_	_	_	_	_	_	O
20	diarrhoea	_	UNK	_	RP	142	_	_	_	_	_	_	_	O
21	that	_	that	_	IN	142	_	_	_	_	_	_	_	O
22	happens	_	happen	_	VBZ	142	_	_	_	_	_	_	_	O
23	particularly	_	particularly	_	RB	142	_	_	_	_	_	_	_	O
24	at	_	at	_	IN	142	_	_	_	_	_	_	_	O
25	night	_	night	_	NN	142	_	_	_	_	_	_	_	O
26	[	_	[	_	NN	142	_	_	_	_	_	_	_	O
27	2009	_	UNK	_	CD	142	_	_	_	_	_	_	_	O
28	,	_	,	_	,	142	_	_	_	_	_	_	_	O
29	amended	_	UNK	_	VBD	142	_	_	_	_	_	_	_	O
30	2015	_	2015	_	CD	142	_	_	_	_	_	_	_	O
31	]	_	]	_	NN	142	_	_	_	_	_	_	_	O

1	think	_	Think	_	VB	142	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	142	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	142	_	_	_	_	_	_	_	O
4	possibility	_	possibility	_	NN	142	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	142	_	_	_	_	_	_	_	O
6	autonomic	_	UNK	_	JJ	142	_	_	_	_	_	_	_	O
7	neuropathy	_	UNK	_	JJ	142	_	_	_	_	_	_	_	O
8	affecting	_	affect	_	VBG	142	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	142	_	_	_	_	_	_	_	O
10	gut	_	UNK	_	NN	142	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	142	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	142	_	_	_	_	_	adult.n	People_by_age	S-Person
13	with	_	with	_	IN	142	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	142	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	142	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	142	_	_	_	_	_	_	_	O
17	who	_	who	_	WP	142	_	_	_	_	_	_	_	O
18	have	_	have	_	VBP	142	_	_	_	_	_	_	_	O
19	unexplained	_	UNK	_	VBN	142	_	_	_	_	_	_	_	O
20	diarrhoea	_	UNK	_	RP	142	_	_	_	_	_	_	_	O
21	that	_	that	_	IN	142	_	_	_	_	_	_	_	O
22	happens	_	happen	_	VBZ	142	_	_	_	_	_	_	_	O
23	particularly	_	particularly	_	RB	142	_	_	_	_	_	_	_	O
24	at	_	at	_	IN	142	_	_	_	_	_	_	_	O
25	night	_	night	_	NN	142	_	_	_	_	_	_	_	O
26	[	_	[	_	NN	142	_	_	_	_	_	_	_	O
27	2009	_	UNK	_	CD	142	_	_	_	_	_	_	_	O
28	,	_	,	_	,	142	_	_	_	_	_	_	_	O
29	amended	_	UNK	_	VBD	142	_	_	_	_	_	_	_	O
30	2015	_	2015	_	CD	142	_	_	_	_	_	_	_	O
31	]	_	]	_	NN	142	_	_	_	_	_	_	_	O

1	think	_	Think	_	VB	142	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	142	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	142	_	_	_	_	_	_	_	O
4	possibility	_	possibility	_	NN	142	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	142	_	_	_	_	_	_	_	O
6	autonomic	_	UNK	_	JJ	142	_	_	_	_	_	_	_	O
7	neuropathy	_	UNK	_	JJ	142	_	_	_	_	_	_	_	O
8	affecting	_	affect	_	VBG	142	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	142	_	_	_	_	_	_	_	O
10	gut	_	UNK	_	NN	142	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	142	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	142	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	142	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	142	_	_	_	_	_	type.n	Type	S-Subtype
15	2	_	2	_	CD	142	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	142	_	_	_	_	_	_	_	O
17	who	_	who	_	WP	142	_	_	_	_	_	_	_	O
18	have	_	have	_	VBP	142	_	_	_	_	_	_	_	O
19	unexplained	_	UNK	_	VBN	142	_	_	_	_	_	_	_	O
20	diarrhoea	_	UNK	_	RP	142	_	_	_	_	_	_	_	O
21	that	_	that	_	IN	142	_	_	_	_	_	_	_	O
22	happens	_	happen	_	VBZ	142	_	_	_	_	_	_	_	O
23	particularly	_	particularly	_	RB	142	_	_	_	_	_	_	_	O
24	at	_	at	_	IN	142	_	_	_	_	_	_	_	O
25	night	_	night	_	NN	142	_	_	_	_	_	_	_	O
26	[	_	[	_	NN	142	_	_	_	_	_	_	_	O
27	2009	_	UNK	_	CD	142	_	_	_	_	_	_	_	O
28	,	_	,	_	,	142	_	_	_	_	_	_	_	O
29	amended	_	UNK	_	VBD	142	_	_	_	_	_	_	_	O
30	2015	_	2015	_	CD	142	_	_	_	_	_	_	_	O
31	]	_	]	_	NN	142	_	_	_	_	_	_	_	O

1	think	_	Think	_	VB	142	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	142	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	142	_	_	_	_	_	_	_	O
4	possibility	_	possibility	_	NN	142	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	142	_	_	_	_	_	_	_	O
6	autonomic	_	UNK	_	JJ	142	_	_	_	_	_	_	_	O
7	neuropathy	_	UNK	_	JJ	142	_	_	_	_	_	_	_	O
8	affecting	_	affect	_	VBG	142	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	142	_	_	_	_	_	_	_	O
10	gut	_	UNK	_	NN	142	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	142	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	142	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	142	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	142	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	142	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	142	_	_	_	_	_	_	_	O
17	who	_	who	_	WP	142	_	_	_	_	_	_	_	O
18	have	_	have	_	VBP	142	_	_	_	_	_	_	_	O
19	unexplained	_	UNK	_	VBN	142	_	_	_	_	_	_	_	O
20	diarrhoea	_	UNK	_	RP	142	_	_	_	_	_	_	_	O
21	that	_	that	_	IN	142	_	_	_	_	_	_	_	S-Event
22	happens	_	happen	_	VBZ	142	_	_	_	_	_	happen.v	Event	O
23	particularly	_	particularly	_	RB	142	_	_	_	_	_	_	_	O
24	at	_	at	_	IN	142	_	_	_	_	_	_	_	O
25	night	_	night	_	NN	142	_	_	_	_	_	_	_	O
26	[	_	[	_	NN	142	_	_	_	_	_	_	_	O
27	2009	_	UNK	_	CD	142	_	_	_	_	_	_	_	O
28	,	_	,	_	,	142	_	_	_	_	_	_	_	O
29	amended	_	UNK	_	VBD	142	_	_	_	_	_	_	_	O
30	2015	_	2015	_	CD	142	_	_	_	_	_	_	_	O
31	]	_	]	_	NN	142	_	_	_	_	_	_	_	O

1	think	_	Think	_	VB	142	_	_	_	_	_	_	_	O
2	about	_	about	_	IN	142	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	142	_	_	_	_	_	_	_	O
4	possibility	_	possibility	_	NN	142	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	142	_	_	_	_	_	_	_	O
6	autonomic	_	UNK	_	JJ	142	_	_	_	_	_	_	_	O
7	neuropathy	_	UNK	_	JJ	142	_	_	_	_	_	_	_	O
8	affecting	_	affect	_	VBG	142	_	_	_	_	_	_	_	O
9	the	_	the	_	DT	142	_	_	_	_	_	_	_	O
10	gut	_	UNK	_	NN	142	_	_	_	_	_	_	_	O
11	in	_	in	_	IN	142	_	_	_	_	_	_	_	O
12	adults	_	adult	_	NNS	142	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	142	_	_	_	_	_	_	_	O
14	type	_	type	_	JJ	142	_	_	_	_	_	_	_	O
15	2	_	2	_	CD	142	_	_	_	_	_	_	_	O
16	diabetes	_	UNK	_	NNS	142	_	_	_	_	_	_	_	O
17	who	_	who	_	WP	142	_	_	_	_	_	_	_	O
18	have	_	have	_	VBP	142	_	_	_	_	_	_	_	O
19	unexplained	_	UNK	_	VBN	142	_	_	_	_	_	_	_	O
20	diarrhoea	_	UNK	_	RP	142	_	_	_	_	_	_	_	O
21	that	_	that	_	IN	142	_	_	_	_	_	_	_	O
22	happens	_	happen	_	VBZ	142	_	_	_	_	_	_	_	O
23	particularly	_	particularly	_	RB	142	_	_	_	_	_	_	_	O
24	at	_	at	_	IN	142	_	_	_	_	_	_	_	O
25	night	_	night	_	NN	142	_	_	_	_	_	night.n	Calendric_unit	S-Unit
26	[	_	[	_	NN	142	_	_	_	_	_	_	_	O
27	2009	_	UNK	_	CD	142	_	_	_	_	_	_	_	O
28	,	_	,	_	,	142	_	_	_	_	_	_	_	O
29	amended	_	UNK	_	VBD	142	_	_	_	_	_	_	_	O
30	2015	_	2015	_	CD	142	_	_	_	_	_	_	_	O
31	]	_	]	_	NN	142	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	143	_	_	_	_	_	_	_	O
2	using	_	use	_	VBG	143	_	_	_	_	_	use.v	Using	O
3	tricyclic	_	UNK	_	JJ	143	_	_	_	_	_	_	_	B-Instrument
4	drugs	_	drug	_	NNS	143	_	_	_	_	_	_	_	I-Instrument
5	and	_	and	_	CC	143	_	_	_	_	_	_	_	I-Instrument
6	antihypertensive	_	UNK	_	JJ	143	_	_	_	_	_	_	_	I-Instrument
7	drug	_	drug	_	NN	143	_	_	_	_	_	_	_	I-Instrument
8	treatments	_	treatment	_	NNS	143	_	_	_	_	_	_	_	I-Instrument
9	in	_	in	_	IN	143	_	_	_	_	_	_	_	B-Purpose
10	adults	_	adult	_	NNS	143	_	_	_	_	_	_	_	I-Purpose
11	with	_	with	_	IN	143	_	_	_	_	_	_	_	I-Purpose
12	type	_	type	_	JJ	143	_	_	_	_	_	_	_	I-Purpose
13	2	_	2	_	CD	143	_	_	_	_	_	_	_	I-Purpose
14	diabetes	_	UNK	_	NNS	143	_	_	_	_	_	_	_	I-Purpose
15	who	_	who	_	WP	143	_	_	_	_	_	_	_	I-Purpose
16	have	_	have	_	VBP	143	_	_	_	_	_	_	_	I-Purpose
17	autonomic	_	UNK	_	VBN	143	_	_	_	_	_	_	_	I-Purpose
18	neuropathy	_	UNK	_	JJ	143	_	_	_	_	_	_	_	I-Purpose
19	,	_	,	_	,	143	_	_	_	_	_	_	_	O
20	be	_	be	_	VB	143	_	_	_	_	_	_	_	O
21	aware	_	aware	_	JJ	143	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	143	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	143	_	_	_	_	_	_	_	O
24	increased	_	increase	_	VBN	143	_	_	_	_	_	_	_	O
25	likelihood	_	likelihood	_	NN	143	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	143	_	_	_	_	_	_	_	O
27	side	_	side	_	JJ	143	_	_	_	_	_	_	_	O
28	effects	_	effect	_	NNS	143	_	_	_	_	_	_	_	O
29	such	_	such	_	JJ	143	_	_	_	_	_	_	_	O
30	as	_	a	_	IN	143	_	_	_	_	_	_	_	O
31	orthostatic	_	UNK	_	JJ	143	_	_	_	_	_	_	_	O
32	hypotension	_	UNK	_	NN	143	_	_	_	_	_	_	_	O
33	.	_	.	_	.	143	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	143	_	_	_	_	_	_	_	O
2	using	_	use	_	VBG	143	_	_	_	_	_	_	_	O
3	tricyclic	_	UNK	_	JJ	143	_	_	_	_	_	_	_	O
4	drugs	_	drug	_	NNS	143	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	143	_	_	_	_	_	_	_	O
6	antihypertensive	_	UNK	_	JJ	143	_	_	_	_	_	_	_	O
7	drug	_	drug	_	NN	143	_	_	_	_	_	_	_	O
8	treatments	_	treatment	_	NNS	143	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	143	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	143	_	_	_	_	_	adult.n	People_by_age	S-Person
11	with	_	with	_	IN	143	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	143	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	143	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	143	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	143	_	_	_	_	_	_	_	O
16	have	_	have	_	VBP	143	_	_	_	_	_	_	_	O
17	autonomic	_	UNK	_	VBN	143	_	_	_	_	_	_	_	O
18	neuropathy	_	UNK	_	JJ	143	_	_	_	_	_	_	_	O
19	,	_	,	_	,	143	_	_	_	_	_	_	_	O
20	be	_	be	_	VB	143	_	_	_	_	_	_	_	O
21	aware	_	aware	_	JJ	143	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	143	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	143	_	_	_	_	_	_	_	O
24	increased	_	increase	_	VBN	143	_	_	_	_	_	_	_	O
25	likelihood	_	likelihood	_	NN	143	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	143	_	_	_	_	_	_	_	O
27	side	_	side	_	JJ	143	_	_	_	_	_	_	_	O
28	effects	_	effect	_	NNS	143	_	_	_	_	_	_	_	O
29	such	_	such	_	JJ	143	_	_	_	_	_	_	_	O
30	as	_	a	_	IN	143	_	_	_	_	_	_	_	O
31	orthostatic	_	UNK	_	JJ	143	_	_	_	_	_	_	_	O
32	hypotension	_	UNK	_	NN	143	_	_	_	_	_	_	_	O
33	.	_	.	_	.	143	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	143	_	_	_	_	_	_	_	O
2	using	_	use	_	VBG	143	_	_	_	_	_	_	_	O
3	tricyclic	_	UNK	_	JJ	143	_	_	_	_	_	_	_	O
4	drugs	_	drug	_	NNS	143	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	143	_	_	_	_	_	_	_	O
6	antihypertensive	_	UNK	_	JJ	143	_	_	_	_	_	_	_	O
7	drug	_	drug	_	NN	143	_	_	_	_	_	_	_	O
8	treatments	_	treatment	_	NNS	143	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	143	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	143	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	143	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	143	_	_	_	_	_	type.n	Type	S-Subtype
13	2	_	2	_	CD	143	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	143	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	143	_	_	_	_	_	_	_	O
16	have	_	have	_	VBP	143	_	_	_	_	_	_	_	O
17	autonomic	_	UNK	_	VBN	143	_	_	_	_	_	_	_	O
18	neuropathy	_	UNK	_	JJ	143	_	_	_	_	_	_	_	O
19	,	_	,	_	,	143	_	_	_	_	_	_	_	O
20	be	_	be	_	VB	143	_	_	_	_	_	_	_	O
21	aware	_	aware	_	JJ	143	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	143	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	143	_	_	_	_	_	_	_	O
24	increased	_	increase	_	VBN	143	_	_	_	_	_	_	_	O
25	likelihood	_	likelihood	_	NN	143	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	143	_	_	_	_	_	_	_	O
27	side	_	side	_	JJ	143	_	_	_	_	_	_	_	O
28	effects	_	effect	_	NNS	143	_	_	_	_	_	_	_	O
29	such	_	such	_	JJ	143	_	_	_	_	_	_	_	O
30	as	_	a	_	IN	143	_	_	_	_	_	_	_	O
31	orthostatic	_	UNK	_	JJ	143	_	_	_	_	_	_	_	O
32	hypotension	_	UNK	_	NN	143	_	_	_	_	_	_	_	O
33	.	_	.	_	.	143	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	143	_	_	_	_	_	_	_	O
2	using	_	use	_	VBG	143	_	_	_	_	_	_	_	O
3	tricyclic	_	UNK	_	JJ	143	_	_	_	_	_	_	_	O
4	drugs	_	drug	_	NNS	143	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	143	_	_	_	_	_	_	_	O
6	antihypertensive	_	UNK	_	JJ	143	_	_	_	_	_	_	_	O
7	drug	_	drug	_	NN	143	_	_	_	_	_	_	_	O
8	treatments	_	treatment	_	NNS	143	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	143	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	143	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	143	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	143	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	143	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	143	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	143	_	_	_	_	_	_	_	S-Cognizer
16	have	_	have	_	VBP	143	_	_	_	_	_	_	_	O
17	autonomic	_	UNK	_	VBN	143	_	_	_	_	_	_	_	O
18	neuropathy	_	UNK	_	JJ	143	_	_	_	_	_	_	_	O
19	,	_	,	_	,	143	_	_	_	_	_	_	_	O
20	be	_	be	_	VB	143	_	_	_	_	_	_	_	O
21	aware	_	aware	_	JJ	143	_	_	_	_	_	aware.a	Awareness	O
22	of	_	of	_	IN	143	_	_	_	_	_	_	_	B-Content
23	the	_	the	_	DT	143	_	_	_	_	_	_	_	I-Content
24	increased	_	increase	_	VBN	143	_	_	_	_	_	_	_	I-Content
25	likelihood	_	likelihood	_	NN	143	_	_	_	_	_	_	_	I-Content
26	of	_	of	_	IN	143	_	_	_	_	_	_	_	I-Content
27	side	_	side	_	JJ	143	_	_	_	_	_	_	_	I-Content
28	effects	_	effect	_	NNS	143	_	_	_	_	_	_	_	I-Content
29	such	_	such	_	JJ	143	_	_	_	_	_	_	_	I-Content
30	as	_	a	_	IN	143	_	_	_	_	_	_	_	I-Content
31	orthostatic	_	UNK	_	JJ	143	_	_	_	_	_	_	_	I-Content
32	hypotension	_	UNK	_	NN	143	_	_	_	_	_	_	_	I-Content
33	.	_	.	_	.	143	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	143	_	_	_	_	_	_	_	O
2	using	_	use	_	VBG	143	_	_	_	_	_	_	_	O
3	tricyclic	_	UNK	_	JJ	143	_	_	_	_	_	_	_	O
4	drugs	_	drug	_	NNS	143	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	143	_	_	_	_	_	_	_	O
6	antihypertensive	_	UNK	_	JJ	143	_	_	_	_	_	_	_	O
7	drug	_	drug	_	NN	143	_	_	_	_	_	_	_	O
8	treatments	_	treatment	_	NNS	143	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	143	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	143	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	143	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	143	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	143	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	143	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	143	_	_	_	_	_	_	_	O
16	have	_	have	_	VBP	143	_	_	_	_	_	_	_	O
17	autonomic	_	UNK	_	VBN	143	_	_	_	_	_	_	_	O
18	neuropathy	_	UNK	_	JJ	143	_	_	_	_	_	_	_	O
19	,	_	,	_	,	143	_	_	_	_	_	_	_	O
20	be	_	be	_	VB	143	_	_	_	_	_	_	_	O
21	aware	_	aware	_	JJ	143	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	143	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	143	_	_	_	_	_	_	_	O
24	increased	_	increase	_	VBN	143	_	_	_	_	_	increase.v	Change_position_on_a_scale	O
25	likelihood	_	likelihood	_	NN	143	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	143	_	_	_	_	_	_	_	B-Attribute
27	side	_	side	_	JJ	143	_	_	_	_	_	_	_	I-Attribute
28	effects	_	effect	_	NNS	143	_	_	_	_	_	_	_	I-Attribute
29	such	_	such	_	JJ	143	_	_	_	_	_	_	_	I-Attribute
30	as	_	a	_	IN	143	_	_	_	_	_	_	_	I-Attribute
31	orthostatic	_	UNK	_	JJ	143	_	_	_	_	_	_	_	I-Attribute
32	hypotension	_	UNK	_	NN	143	_	_	_	_	_	_	_	I-Attribute
33	.	_	.	_	.	143	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	143	_	_	_	_	_	_	_	O
2	using	_	use	_	VBG	143	_	_	_	_	_	_	_	O
3	tricyclic	_	UNK	_	JJ	143	_	_	_	_	_	_	_	O
4	drugs	_	drug	_	NNS	143	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	143	_	_	_	_	_	_	_	O
6	antihypertensive	_	UNK	_	JJ	143	_	_	_	_	_	_	_	O
7	drug	_	drug	_	NN	143	_	_	_	_	_	_	_	O
8	treatments	_	treatment	_	NNS	143	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	143	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	143	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	143	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	143	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	143	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	143	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	143	_	_	_	_	_	_	_	O
16	have	_	have	_	VBP	143	_	_	_	_	_	_	_	O
17	autonomic	_	UNK	_	VBN	143	_	_	_	_	_	_	_	O
18	neuropathy	_	UNK	_	JJ	143	_	_	_	_	_	_	_	O
19	,	_	,	_	,	143	_	_	_	_	_	_	_	O
20	be	_	be	_	VB	143	_	_	_	_	_	_	_	O
21	aware	_	aware	_	JJ	143	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	143	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	143	_	_	_	_	_	_	_	O
24	increased	_	increase	_	VBN	143	_	_	_	_	_	_	_	O
25	likelihood	_	likelihood	_	NN	143	_	_	_	_	_	likelihood.n	Likelihood	O
26	of	_	of	_	IN	143	_	_	_	_	_	_	_	B-Hypothetical_event
27	side	_	side	_	JJ	143	_	_	_	_	_	_	_	I-Hypothetical_event
28	effects	_	effect	_	NNS	143	_	_	_	_	_	_	_	I-Hypothetical_event
29	such	_	such	_	JJ	143	_	_	_	_	_	_	_	I-Hypothetical_event
30	as	_	a	_	IN	143	_	_	_	_	_	_	_	I-Hypothetical_event
31	orthostatic	_	UNK	_	JJ	143	_	_	_	_	_	_	_	I-Hypothetical_event
32	hypotension	_	UNK	_	NN	143	_	_	_	_	_	_	_	I-Hypothetical_event
33	.	_	.	_	.	143	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	143	_	_	_	_	_	_	_	O
2	using	_	use	_	VBG	143	_	_	_	_	_	_	_	O
3	tricyclic	_	UNK	_	JJ	143	_	_	_	_	_	_	_	O
4	drugs	_	drug	_	NNS	143	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	143	_	_	_	_	_	_	_	O
6	antihypertensive	_	UNK	_	JJ	143	_	_	_	_	_	_	_	O
7	drug	_	drug	_	NN	143	_	_	_	_	_	_	_	O
8	treatments	_	treatment	_	NNS	143	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	143	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	143	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	143	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	143	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	143	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	143	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	143	_	_	_	_	_	_	_	O
16	have	_	have	_	VBP	143	_	_	_	_	_	_	_	O
17	autonomic	_	UNK	_	VBN	143	_	_	_	_	_	_	_	O
18	neuropathy	_	UNK	_	JJ	143	_	_	_	_	_	_	_	O
19	,	_	,	_	,	143	_	_	_	_	_	_	_	O
20	be	_	be	_	VB	143	_	_	_	_	_	_	_	O
21	aware	_	aware	_	JJ	143	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	143	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	143	_	_	_	_	_	_	_	O
24	increased	_	increase	_	VBN	143	_	_	_	_	_	_	_	O
25	likelihood	_	likelihood	_	NN	143	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	143	_	_	_	_	_	_	_	O
27	side	_	side	_	JJ	143	_	_	_	_	_	side.v	Taking_sides	O
28	effects	_	effect	_	NNS	143	_	_	_	_	_	_	_	O
29	such	_	such	_	JJ	143	_	_	_	_	_	_	_	O
30	as	_	a	_	IN	143	_	_	_	_	_	_	_	O
31	orthostatic	_	UNK	_	JJ	143	_	_	_	_	_	_	_	O
32	hypotension	_	UNK	_	NN	143	_	_	_	_	_	_	_	O
33	.	_	.	_	.	143	_	_	_	_	_	_	_	O

1	when	_	When	_	WRB	143	_	_	_	_	_	_	_	O
2	using	_	use	_	VBG	143	_	_	_	_	_	_	_	O
3	tricyclic	_	UNK	_	JJ	143	_	_	_	_	_	_	_	O
4	drugs	_	drug	_	NNS	143	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	143	_	_	_	_	_	_	_	O
6	antihypertensive	_	UNK	_	JJ	143	_	_	_	_	_	_	_	O
7	drug	_	drug	_	NN	143	_	_	_	_	_	_	_	O
8	treatments	_	treatment	_	NNS	143	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	143	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	143	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	143	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	143	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	143	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	143	_	_	_	_	_	_	_	O
15	who	_	who	_	WP	143	_	_	_	_	_	_	_	O
16	have	_	have	_	VBP	143	_	_	_	_	_	_	_	O
17	autonomic	_	UNK	_	VBN	143	_	_	_	_	_	_	_	O
18	neuropathy	_	UNK	_	JJ	143	_	_	_	_	_	_	_	O
19	,	_	,	_	,	143	_	_	_	_	_	_	_	O
20	be	_	be	_	VB	143	_	_	_	_	_	_	_	O
21	aware	_	aware	_	JJ	143	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	143	_	_	_	_	_	_	_	O
23	the	_	the	_	DT	143	_	_	_	_	_	_	_	O
24	increased	_	increase	_	VBN	143	_	_	_	_	_	_	_	O
25	likelihood	_	likelihood	_	NN	143	_	_	_	_	_	_	_	O
26	of	_	of	_	IN	143	_	_	_	_	_	_	_	O
27	side	_	side	_	JJ	143	_	_	_	_	_	_	_	S-Influencing_entity
28	effects	_	effect	_	NNS	143	_	_	_	_	_	effect.n	Objective_influence	O
29	such	_	such	_	JJ	143	_	_	_	_	_	_	_	O
30	as	_	a	_	IN	143	_	_	_	_	_	_	_	O
31	orthostatic	_	UNK	_	JJ	143	_	_	_	_	_	_	_	O
32	hypotension	_	UNK	_	NN	143	_	_	_	_	_	_	_	O
33	.	_	.	_	.	143	_	_	_	_	_	_	_	O

1	investigate	_	UNK	_	NNP	144	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	144	_	_	_	_	_	_	_	O
3	possibility	_	possibility	_	NN	144	_	_	_	_	_	possibility.n	Likelihood	O
4	of	_	of	_	IN	144	_	_	_	_	_	_	_	B-Hypothetical_event
5	autonomic	_	UNK	_	JJ	144	_	_	_	_	_	_	_	I-Hypothetical_event
6	neuropathy	_	UNK	_	JJ	144	_	_	_	_	_	_	_	I-Hypothetical_event
7	affecting	_	affect	_	VBG	144	_	_	_	_	_	_	_	I-Hypothetical_event
8	the	_	the	_	DT	144	_	_	_	_	_	_	_	I-Hypothetical_event
9	bladder	_	UNK	_	NN	144	_	_	_	_	_	_	_	I-Hypothetical_event
10	in	_	in	_	IN	144	_	_	_	_	_	_	_	I-Hypothetical_event
11	adults	_	adult	_	NNS	144	_	_	_	_	_	_	_	I-Hypothetical_event
12	with	_	with	_	IN	144	_	_	_	_	_	_	_	I-Hypothetical_event
13	type	_	type	_	JJ	144	_	_	_	_	_	_	_	I-Hypothetical_event
14	2	_	2	_	CD	144	_	_	_	_	_	_	_	I-Hypothetical_event
15	diabetes	_	UNK	_	NNS	144	_	_	_	_	_	_	_	I-Hypothetical_event
16	who	_	who	_	WP	144	_	_	_	_	_	_	_	I-Hypothetical_event
17	have	_	have	_	VBP	144	_	_	_	_	_	_	_	I-Hypothetical_event
18	unexplained	_	UNK	_	VBN	144	_	_	_	_	_	_	_	I-Hypothetical_event
19	unk	_	UNK	_	JJ	144	_	_	_	_	_	_	_	I-Hypothetical_event
20	problems	_	problem	_	NNS	144	_	_	_	_	_	_	_	I-Hypothetical_event
21	.	_	.	_	.	144	_	_	_	_	_	_	_	O

1	investigate	_	UNK	_	NNP	144	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	144	_	_	_	_	_	_	_	O
3	possibility	_	possibility	_	NN	144	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	144	_	_	_	_	_	_	_	O
5	autonomic	_	UNK	_	JJ	144	_	_	_	_	_	_	_	B-Dependent_entity
6	neuropathy	_	UNK	_	JJ	144	_	_	_	_	_	_	_	I-Dependent_entity
7	affecting	_	affect	_	VBG	144	_	_	_	_	_	affect.v	Objective_influence	O
8	the	_	the	_	DT	144	_	_	_	_	_	_	_	B-Dependent_entity
9	bladder	_	UNK	_	NN	144	_	_	_	_	_	_	_	I-Dependent_entity
10	in	_	in	_	IN	144	_	_	_	_	_	_	_	I-Dependent_entity
11	adults	_	adult	_	NNS	144	_	_	_	_	_	_	_	I-Dependent_entity
12	with	_	with	_	IN	144	_	_	_	_	_	_	_	I-Dependent_entity
13	type	_	type	_	JJ	144	_	_	_	_	_	_	_	I-Dependent_entity
14	2	_	2	_	CD	144	_	_	_	_	_	_	_	I-Dependent_entity
15	diabetes	_	UNK	_	NNS	144	_	_	_	_	_	_	_	I-Dependent_entity
16	who	_	who	_	WP	144	_	_	_	_	_	_	_	I-Dependent_entity
17	have	_	have	_	VBP	144	_	_	_	_	_	_	_	I-Dependent_entity
18	unexplained	_	UNK	_	VBN	144	_	_	_	_	_	_	_	I-Dependent_entity
19	unk	_	UNK	_	JJ	144	_	_	_	_	_	_	_	I-Dependent_entity
20	problems	_	problem	_	NNS	144	_	_	_	_	_	_	_	I-Dependent_entity
21	.	_	.	_	.	144	_	_	_	_	_	_	_	O

1	investigate	_	UNK	_	NNP	144	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	144	_	_	_	_	_	_	_	O
3	possibility	_	possibility	_	NN	144	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	144	_	_	_	_	_	_	_	O
5	autonomic	_	UNK	_	JJ	144	_	_	_	_	_	_	_	O
6	neuropathy	_	UNK	_	JJ	144	_	_	_	_	_	_	_	O
7	affecting	_	affect	_	VBG	144	_	_	_	_	_	_	_	O
8	the	_	the	_	DT	144	_	_	_	_	_	_	_	O
9	bladder	_	UNK	_	NN	144	_	_	_	_	_	_	_	O
10	in	_	in	_	IN	144	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	144	_	_	_	_	_	adult.n	People_by_age	S-Person
12	with	_	with	_	IN	144	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	144	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	144	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	144	_	_	_	_	_	_	_	O
16	who	_	who	_	WP	144	_	_	_	_	_	_	_	O
17	have	_	have	_	VBP	144	_	_	_	_	_	_	_	O
18	unexplained	_	UNK	_	VBN	144	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	144	_	_	_	_	_	_	_	O
20	problems	_	problem	_	NNS	144	_	_	_	_	_	_	_	O
21	.	_	.	_	.	144	_	_	_	_	_	_	_	O

1	investigate	_	UNK	_	NNP	144	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	144	_	_	_	_	_	_	_	O
3	possibility	_	possibility	_	NN	144	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	144	_	_	_	_	_	_	_	O
5	autonomic	_	UNK	_	JJ	144	_	_	_	_	_	_	_	O
6	neuropathy	_	UNK	_	JJ	144	_	_	_	_	_	_	_	O
7	affecting	_	affect	_	VBG	144	_	_	_	_	_	_	_	O
8	the	_	the	_	DT	144	_	_	_	_	_	_	_	O
9	bladder	_	UNK	_	NN	144	_	_	_	_	_	_	_	O
10	in	_	in	_	IN	144	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	144	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	144	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	144	_	_	_	_	_	type.n	Type	S-Subtype
14	2	_	2	_	CD	144	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	144	_	_	_	_	_	_	_	O
16	who	_	who	_	WP	144	_	_	_	_	_	_	_	O
17	have	_	have	_	VBP	144	_	_	_	_	_	_	_	O
18	unexplained	_	UNK	_	VBN	144	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	144	_	_	_	_	_	_	_	O
20	problems	_	problem	_	NNS	144	_	_	_	_	_	_	_	O
21	.	_	.	_	.	144	_	_	_	_	_	_	_	O

1	investigate	_	UNK	_	NNP	144	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	144	_	_	_	_	_	_	_	O
3	possibility	_	possibility	_	NN	144	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	144	_	_	_	_	_	_	_	O
5	autonomic	_	UNK	_	JJ	144	_	_	_	_	_	_	_	O
6	neuropathy	_	UNK	_	JJ	144	_	_	_	_	_	_	_	O
7	affecting	_	affect	_	VBG	144	_	_	_	_	_	_	_	O
8	the	_	the	_	DT	144	_	_	_	_	_	_	_	O
9	bladder	_	UNK	_	NN	144	_	_	_	_	_	_	_	O
10	in	_	in	_	IN	144	_	_	_	_	_	_	_	O
11	adults	_	adult	_	NNS	144	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	144	_	_	_	_	_	_	_	O
13	type	_	type	_	JJ	144	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	144	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	144	_	_	_	_	_	_	_	O
16	who	_	who	_	WP	144	_	_	_	_	_	_	_	O
17	have	_	have	_	VBP	144	_	_	_	_	_	_	_	O
18	unexplained	_	UNK	_	VBN	144	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	144	_	_	_	_	_	_	_	S-Place
20	problems	_	problem	_	NNS	144	_	_	_	_	_	problem.n	Predicament	S-Situation
21	.	_	.	_	.	144	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	145	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	145	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	145	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	145	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	145	_	_	_	_	_	_	_	O
6	:	_	:	_	:	145	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	145	_	_	_	_	_	_	_	O
8	(	_	(	_	(	145	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	145	_	_	_	_	_	_	_	O
10	)	_	)	_	)	145	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	145	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	145	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	145	_	_	_	_	_	_	_	O
14	)	_	)	_	)	145	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	145	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	145	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	145	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	145	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	145	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	145	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	145	_	_	_	_	_	_	_	O
8	(	_	(	_	(	145	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	145	_	_	_	_	_	_	_	O
10	)	_	)	_	)	145	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	145	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	145	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	145	_	_	_	_	_	_	_	O
14	)	_	)	_	)	145	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	146	_	_	_	_	_	_	_	O
2	managing	_	manage	_	VBG	146	_	_	_	_	_	_	_	O
3	autonomic	_	UNK	_	JJ	146	_	_	_	_	_	_	_	O
4	neuropathy	_	UNK	_	NN	146	_	_	_	_	_	_	_	S-Indicated
5	symptoms	_	symptom	_	NNS	146	_	_	_	_	_	symptom.n	Sign	O
6	,	_	,	_	,	146	_	_	_	_	_	_	_	O
7	include	_	include	_	VBP	146	_	_	_	_	_	_	_	O
8	specific	_	specific	_	JJ	146	_	_	_	_	_	_	_	O
9	interventions	_	UNK	_	NNS	146	_	_	_	_	_	_	_	O
10	indicated	_	indicate	_	VBN	146	_	_	_	_	_	_	_	O
11	by	_	by	_	IN	146	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	146	_	_	_	_	_	_	_	O
13	manifestations	_	UNK	_	NNS	146	_	_	_	_	_	_	_	O
14	(	_	(	_	(	146	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	146	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	146	_	_	_	_	_	_	_	O
17	,	_	,	_	,	146	_	_	_	_	_	_	_	O
18	for	_	for	_	IN	146	_	_	_	_	_	_	_	O
19	abnormal	_	UNK	_	JJ	146	_	_	_	_	_	_	_	O
20	sweating	_	UNK	_	NN	146	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	146	_	_	_	_	_	_	_	O
22	nocturnal	_	UNK	_	JJ	146	_	_	_	_	_	_	_	O
23	diarrhoea	_	UNK	_	NN	146	_	_	_	_	_	_	_	O
24	)	_	)	_	)	146	_	_	_	_	_	_	_	O
25	.	_	.	_	.	146	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	146	_	_	_	_	_	_	_	B-Total
2	managing	_	manage	_	VBG	146	_	_	_	_	_	_	_	I-Total
3	autonomic	_	UNK	_	JJ	146	_	_	_	_	_	_	_	I-Total
4	neuropathy	_	UNK	_	NN	146	_	_	_	_	_	_	_	I-Total
5	symptoms	_	symptom	_	NNS	146	_	_	_	_	_	_	_	I-Total
6	,	_	,	_	,	146	_	_	_	_	_	_	_	I-Total
7	include	_	include	_	VBP	146	_	_	_	_	_	include.v	Inclusion	O
8	specific	_	specific	_	JJ	146	_	_	_	_	_	_	_	B-Part
9	interventions	_	UNK	_	NNS	146	_	_	_	_	_	_	_	I-Part
10	indicated	_	indicate	_	VBN	146	_	_	_	_	_	_	_	I-Part
11	by	_	by	_	IN	146	_	_	_	_	_	_	_	I-Part
12	the	_	the	_	DT	146	_	_	_	_	_	_	_	I-Part
13	manifestations	_	UNK	_	NNS	146	_	_	_	_	_	_	_	I-Part
14	(	_	(	_	(	146	_	_	_	_	_	_	_	I-Part
15	for	_	for	_	IN	146	_	_	_	_	_	_	_	I-Part
16	example	_	example	_	NN	146	_	_	_	_	_	_	_	I-Part
17	,	_	,	_	,	146	_	_	_	_	_	_	_	I-Part
18	for	_	for	_	IN	146	_	_	_	_	_	_	_	I-Part
19	abnormal	_	UNK	_	JJ	146	_	_	_	_	_	_	_	I-Part
20	sweating	_	UNK	_	NN	146	_	_	_	_	_	_	_	I-Part
21	or	_	or	_	CC	146	_	_	_	_	_	_	_	I-Part
22	nocturnal	_	UNK	_	JJ	146	_	_	_	_	_	_	_	I-Part
23	diarrhoea	_	UNK	_	NN	146	_	_	_	_	_	_	_	I-Part
24	)	_	)	_	)	146	_	_	_	_	_	_	_	I-Part
25	.	_	.	_	.	146	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	146	_	_	_	_	_	_	_	O
2	managing	_	manage	_	VBG	146	_	_	_	_	_	_	_	O
3	autonomic	_	UNK	_	JJ	146	_	_	_	_	_	_	_	O
4	neuropathy	_	UNK	_	NN	146	_	_	_	_	_	_	_	O
5	symptoms	_	symptom	_	NNS	146	_	_	_	_	_	_	_	O
6	,	_	,	_	,	146	_	_	_	_	_	_	_	O
7	include	_	include	_	VBP	146	_	_	_	_	_	_	_	O
8	specific	_	specific	_	JJ	146	_	_	_	_	_	_	_	B-Message
9	interventions	_	UNK	_	NNS	146	_	_	_	_	_	_	_	I-Message
10	indicated	_	indicate	_	VBN	146	_	_	_	_	_	indicate.v	Communication	O
11	by	_	by	_	IN	146	_	_	_	_	_	_	_	B-Message
12	the	_	the	_	DT	146	_	_	_	_	_	_	_	I-Message
13	manifestations	_	UNK	_	NNS	146	_	_	_	_	_	_	_	I-Message
14	(	_	(	_	(	146	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	146	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	146	_	_	_	_	_	_	_	O
17	,	_	,	_	,	146	_	_	_	_	_	_	_	O
18	for	_	for	_	IN	146	_	_	_	_	_	_	_	O
19	abnormal	_	UNK	_	JJ	146	_	_	_	_	_	_	_	O
20	sweating	_	UNK	_	NN	146	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	146	_	_	_	_	_	_	_	O
22	nocturnal	_	UNK	_	JJ	146	_	_	_	_	_	_	_	O
23	diarrhoea	_	UNK	_	NN	146	_	_	_	_	_	_	_	O
24	)	_	)	_	)	146	_	_	_	_	_	_	_	O
25	.	_	.	_	.	146	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	146	_	_	_	_	_	_	_	O
2	managing	_	manage	_	VBG	146	_	_	_	_	_	_	_	O
3	autonomic	_	UNK	_	JJ	146	_	_	_	_	_	_	_	O
4	neuropathy	_	UNK	_	NN	146	_	_	_	_	_	_	_	O
5	symptoms	_	symptom	_	NNS	146	_	_	_	_	_	_	_	O
6	,	_	,	_	,	146	_	_	_	_	_	_	_	O
7	include	_	include	_	VBP	146	_	_	_	_	_	_	_	O
8	specific	_	specific	_	JJ	146	_	_	_	_	_	_	_	O
9	interventions	_	UNK	_	NNS	146	_	_	_	_	_	_	_	O
10	indicated	_	indicate	_	VBN	146	_	_	_	_	_	_	_	O
11	by	_	by	_	IN	146	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	146	_	_	_	_	_	_	_	O
13	manifestations	_	UNK	_	NNS	146	_	_	_	_	_	_	_	O
14	(	_	(	_	(	146	_	_	_	_	_	_	_	O
15	for	_	for	_	IN	146	_	_	_	_	_	_	_	O
16	example	_	example	_	NN	146	_	_	_	_	_	example.n	Instance	S-Instance
17	,	_	,	_	,	146	_	_	_	_	_	_	_	O
18	for	_	for	_	IN	146	_	_	_	_	_	_	_	O
19	abnormal	_	UNK	_	JJ	146	_	_	_	_	_	_	_	O
20	sweating	_	UNK	_	NN	146	_	_	_	_	_	_	_	O
21	or	_	or	_	CC	146	_	_	_	_	_	_	_	O
22	nocturnal	_	UNK	_	JJ	146	_	_	_	_	_	_	_	O
23	diarrhoea	_	UNK	_	NN	146	_	_	_	_	_	_	_	O
24	)	_	)	_	)	146	_	_	_	_	_	_	_	O
25	.	_	.	_	.	146	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	147	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	147	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	147	_	_	_	_	_	_	_	O
4	preventing	_	UNK	_	NN	147	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	147	_	_	_	_	_	_	_	O
6	managing	_	manage	_	VBG	147	_	_	_	_	_	_	_	O
7	foot	_	foot	_	NN	147	_	_	_	_	_	foot.n	Body_parts	S-Body_part
8	problems	_	problem	_	NNS	147	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	147	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	147	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	147	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	147	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	147	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	147	_	_	_	_	_	_	_	O
15	,	_	,	_	,	147	_	_	_	_	_	_	_	O
16	see	_	see	_	VBP	147	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	147	_	_	_	_	_	_	_	O
18	nice	_	UNK	_	NNP	147	_	_	_	_	_	_	_	O
19	guideline	_	guideline	_	NN	147	_	_	_	_	_	_	_	O
20	on	_	on	_	IN	147	_	_	_	_	_	_	_	O
21	diabetic	_	UNK	_	JJ	147	_	_	_	_	_	_	_	O
22	foot	_	foot	_	NN	147	_	_	_	_	_	_	_	O
23	problems	_	problem	_	NNS	147	_	_	_	_	_	_	_	O
24	.	_	.	_	.	147	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	147	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	147	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	147	_	_	_	_	_	_	_	O
4	preventing	_	UNK	_	NN	147	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	147	_	_	_	_	_	_	_	O
6	managing	_	manage	_	VBG	147	_	_	_	_	_	_	_	O
7	foot	_	foot	_	NN	147	_	_	_	_	_	_	_	S-Domain
8	problems	_	problem	_	NNS	147	_	_	_	_	_	problem.n	Predicament	S-Situation
9	in	_	in	_	IN	147	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	147	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	147	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	147	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	147	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	147	_	_	_	_	_	_	_	O
15	,	_	,	_	,	147	_	_	_	_	_	_	_	O
16	see	_	see	_	VBP	147	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	147	_	_	_	_	_	_	_	O
18	nice	_	UNK	_	NNP	147	_	_	_	_	_	_	_	O
19	guideline	_	guideline	_	NN	147	_	_	_	_	_	_	_	O
20	on	_	on	_	IN	147	_	_	_	_	_	_	_	O
21	diabetic	_	UNK	_	JJ	147	_	_	_	_	_	_	_	O
22	foot	_	foot	_	NN	147	_	_	_	_	_	_	_	O
23	problems	_	problem	_	NNS	147	_	_	_	_	_	_	_	O
24	.	_	.	_	.	147	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	147	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	147	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	147	_	_	_	_	_	_	_	O
4	preventing	_	UNK	_	NN	147	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	147	_	_	_	_	_	_	_	O
6	managing	_	manage	_	VBG	147	_	_	_	_	_	_	_	O
7	foot	_	foot	_	NN	147	_	_	_	_	_	_	_	O
8	problems	_	problem	_	NNS	147	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	147	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	147	_	_	_	_	_	adult.n	People_by_age	S-Person
11	with	_	with	_	IN	147	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	147	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	147	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	147	_	_	_	_	_	_	_	O
15	,	_	,	_	,	147	_	_	_	_	_	_	_	O
16	see	_	see	_	VBP	147	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	147	_	_	_	_	_	_	_	O
18	nice	_	UNK	_	NNP	147	_	_	_	_	_	_	_	O
19	guideline	_	guideline	_	NN	147	_	_	_	_	_	_	_	O
20	on	_	on	_	IN	147	_	_	_	_	_	_	_	O
21	diabetic	_	UNK	_	JJ	147	_	_	_	_	_	_	_	O
22	foot	_	foot	_	NN	147	_	_	_	_	_	_	_	O
23	problems	_	problem	_	NNS	147	_	_	_	_	_	_	_	O
24	.	_	.	_	.	147	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	147	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	147	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	147	_	_	_	_	_	_	_	O
4	preventing	_	UNK	_	NN	147	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	147	_	_	_	_	_	_	_	O
6	managing	_	manage	_	VBG	147	_	_	_	_	_	_	_	O
7	foot	_	foot	_	NN	147	_	_	_	_	_	_	_	O
8	problems	_	problem	_	NNS	147	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	147	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	147	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	147	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	147	_	_	_	_	_	type.n	Type	S-Subtype
13	2	_	2	_	CD	147	_	_	_	_	_	_	_	B-Category
14	diabetes	_	UNK	_	NNS	147	_	_	_	_	_	_	_	I-Category
15	,	_	,	_	,	147	_	_	_	_	_	_	_	O
16	see	_	see	_	VBP	147	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	147	_	_	_	_	_	_	_	O
18	nice	_	UNK	_	NNP	147	_	_	_	_	_	_	_	O
19	guideline	_	guideline	_	NN	147	_	_	_	_	_	_	_	O
20	on	_	on	_	IN	147	_	_	_	_	_	_	_	O
21	diabetic	_	UNK	_	JJ	147	_	_	_	_	_	_	_	O
22	foot	_	foot	_	NN	147	_	_	_	_	_	_	_	O
23	problems	_	problem	_	NNS	147	_	_	_	_	_	_	_	O
24	.	_	.	_	.	147	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	147	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	147	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	147	_	_	_	_	_	_	_	O
4	preventing	_	UNK	_	NN	147	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	147	_	_	_	_	_	_	_	O
6	managing	_	manage	_	VBG	147	_	_	_	_	_	_	_	O
7	foot	_	foot	_	NN	147	_	_	_	_	_	_	_	O
8	problems	_	problem	_	NNS	147	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	147	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	147	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	147	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	147	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	147	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	147	_	_	_	_	_	_	_	O
15	,	_	,	_	,	147	_	_	_	_	_	_	_	O
16	see	_	see	_	VBP	147	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	147	_	_	_	_	_	_	_	O
18	nice	_	UNK	_	NNP	147	_	_	_	_	_	_	_	O
19	guideline	_	guideline	_	NN	147	_	_	_	_	_	_	_	O
20	on	_	on	_	IN	147	_	_	_	_	_	_	_	O
21	diabetic	_	UNK	_	JJ	147	_	_	_	_	_	_	_	S-Possessor
22	foot	_	foot	_	NN	147	_	_	_	_	_	foot.n	Body_parts	S-Body_part
23	problems	_	problem	_	NNS	147	_	_	_	_	_	_	_	O
24	.	_	.	_	.	147	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	147	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	147	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	147	_	_	_	_	_	_	_	O
4	preventing	_	UNK	_	NN	147	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	147	_	_	_	_	_	_	_	O
6	managing	_	manage	_	VBG	147	_	_	_	_	_	_	_	O
7	foot	_	foot	_	NN	147	_	_	_	_	_	_	_	O
8	problems	_	problem	_	NNS	147	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	147	_	_	_	_	_	_	_	O
10	adults	_	adult	_	NNS	147	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	147	_	_	_	_	_	_	_	O
12	type	_	type	_	JJ	147	_	_	_	_	_	_	_	O
13	2	_	2	_	CD	147	_	_	_	_	_	_	_	O
14	diabetes	_	UNK	_	NNS	147	_	_	_	_	_	_	_	O
15	,	_	,	_	,	147	_	_	_	_	_	_	_	O
16	see	_	see	_	VBP	147	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	147	_	_	_	_	_	_	_	O
18	nice	_	UNK	_	NNP	147	_	_	_	_	_	_	_	O
19	guideline	_	guideline	_	NN	147	_	_	_	_	_	_	_	O
20	on	_	on	_	IN	147	_	_	_	_	_	_	_	O
21	diabetic	_	UNK	_	JJ	147	_	_	_	_	_	_	_	B-Domain
22	foot	_	foot	_	NN	147	_	_	_	_	_	_	_	I-Domain
23	problems	_	problem	_	NNS	147	_	_	_	_	_	problem.n	Predicament	S-Situation
24	.	_	.	_	.	147	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	148	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	148	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	148	_	_	_	_	_	_	_	O
4	managing	_	manage	_	VBG	148	_	_	_	_	_	_	_	O
5	kidney	_	UNK	_	NN	148	_	_	_	_	_	_	_	S-Patient
6	disease	_	disease	_	NN	148	_	_	_	_	_	disease.n	Medical_conditions	S-Ailment
7	in	_	in	_	IN	148	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	148	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	148	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	148	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	148	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	148	_	_	_	_	_	_	_	O
13	,	_	,	_	,	148	_	_	_	_	_	_	_	O
14	see	_	see	_	VBP	148	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	148	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	148	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	148	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	148	_	_	_	_	_	_	_	O
4	managing	_	manage	_	VBG	148	_	_	_	_	_	_	_	O
5	kidney	_	UNK	_	NN	148	_	_	_	_	_	_	_	O
6	disease	_	disease	_	NN	148	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	148	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	148	_	_	_	_	_	adult.n	People_by_age	S-Person
9	with	_	with	_	IN	148	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	148	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	148	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	148	_	_	_	_	_	_	_	O
13	,	_	,	_	,	148	_	_	_	_	_	_	_	O
14	see	_	see	_	VBP	148	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	148	_	_	_	_	_	_	_	O

1	for	_	For	_	IN	148	_	_	_	_	_	_	_	O
2	guidance	_	guidance	_	NN	148	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	148	_	_	_	_	_	_	_	O
4	managing	_	manage	_	VBG	148	_	_	_	_	_	_	_	O
5	kidney	_	UNK	_	NN	148	_	_	_	_	_	_	_	O
6	disease	_	disease	_	NN	148	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	148	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	148	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	148	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	148	_	_	_	_	_	type.n	Type	S-Subtype
11	2	_	2	_	CD	148	_	_	_	_	_	_	_	B-Category
12	diabetes	_	UNK	_	NNS	148	_	_	_	_	_	_	_	I-Category
13	,	_	,	_	,	148	_	_	_	_	_	_	_	O
14	see	_	see	_	VBP	148	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	148	_	_	_	_	_	_	_	O

1	nice	_	UNK	_	NNP	149	_	_	_	_	_	_	_	O
2	guideline	_	guideline	_	NN	149	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	149	_	_	_	_	_	_	_	O
4	chronic	_	UNK	_	JJ	149	_	_	_	_	_	_	_	O
5	kidney	_	UNK	_	NN	149	_	_	_	_	_	_	_	S-Patient
6	disease	_	disease	_	NN	149	_	_	_	_	_	disease.n	Medical_conditions	S-Ailment
7	in	_	in	_	IN	149	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	149	_	_	_	_	_	_	_	O
9	.	_	.	_	.	149	_	_	_	_	_	_	_	O

1	nice	_	UNK	_	NNP	149	_	_	_	_	_	_	_	O
2	guideline	_	guideline	_	NN	149	_	_	_	_	_	_	_	O
3	on	_	on	_	IN	149	_	_	_	_	_	_	_	O
4	chronic	_	UNK	_	JJ	149	_	_	_	_	_	_	_	O
5	kidney	_	UNK	_	NN	149	_	_	_	_	_	_	_	O
6	disease	_	disease	_	NN	149	_	_	_	_	_	_	_	O
7	in	_	in	_	IN	149	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	149	_	_	_	_	_	adult.n	People_by_age	S-Person
9	.	_	.	_	.	149	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	150	_	_	_	_	_	_	_	O
2	men	_	men	_	NNS	150	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	150	_	_	_	_	_	_	_	O
4	type	_	type	_	NN	150	_	_	_	_	_	type.n	Type	S-Subtype
5	2	_	2	_	CD	150	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	VBZ	150	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	150	_	_	_	_	_	_	_	O
8	opportunity	_	opportunity	_	NN	150	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	150	_	_	_	_	_	_	_	O
10	discuss	_	discuss	_	VB	150	_	_	_	_	_	_	_	O
11	erectile	_	UNK	_	JJ	150	_	_	_	_	_	_	_	O
12	dysfunction	_	UNK	_	NN	150	_	_	_	_	_	_	_	O
13	as	_	a	_	IN	150	_	_	_	_	_	_	_	O
14	part	_	part	_	NN	150	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	150	_	_	_	_	_	_	_	O
16	their	_	their	_	PRP$	150	_	_	_	_	_	_	_	O
17	annual	_	annual	_	JJ	150	_	_	_	_	_	_	_	O
18	review	_	review	_	NN	150	_	_	_	_	_	_	_	O
19	.	_	.	_	.	150	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	150	_	_	_	_	_	_	_	O
2	men	_	men	_	NNS	150	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	150	_	_	_	_	_	_	_	O
4	type	_	type	_	NN	150	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	150	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	VBZ	150	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	150	_	_	_	_	_	_	_	O
8	opportunity	_	opportunity	_	NN	150	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	150	_	_	_	_	_	_	_	O
10	discuss	_	discuss	_	VB	150	_	_	_	_	_	discuss.v	Discussion	O
11	erectile	_	UNK	_	JJ	150	_	_	_	_	_	_	_	B-Topic
12	dysfunction	_	UNK	_	NN	150	_	_	_	_	_	_	_	I-Topic
13	as	_	a	_	IN	150	_	_	_	_	_	_	_	O
14	part	_	part	_	NN	150	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	150	_	_	_	_	_	_	_	O
16	their	_	their	_	PRP$	150	_	_	_	_	_	_	_	O
17	annual	_	annual	_	JJ	150	_	_	_	_	_	_	_	O
18	review	_	review	_	NN	150	_	_	_	_	_	_	_	O
19	.	_	.	_	.	150	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	150	_	_	_	_	_	_	_	O
2	men	_	men	_	NNS	150	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	150	_	_	_	_	_	_	_	O
4	type	_	type	_	NN	150	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	150	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	VBZ	150	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	150	_	_	_	_	_	_	_	O
8	opportunity	_	opportunity	_	NN	150	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	150	_	_	_	_	_	_	_	O
10	discuss	_	discuss	_	VB	150	_	_	_	_	_	_	_	O
11	erectile	_	UNK	_	JJ	150	_	_	_	_	_	_	_	O
12	dysfunction	_	UNK	_	NN	150	_	_	_	_	_	_	_	O
13	as	_	a	_	IN	150	_	_	_	_	_	_	_	O
14	part	_	part	_	NN	150	_	_	_	_	_	part.n	Part_whole	S-Part
15	of	_	of	_	IN	150	_	_	_	_	_	_	_	B-Whole
16	their	_	their	_	PRP$	150	_	_	_	_	_	_	_	I-Whole
17	annual	_	annual	_	JJ	150	_	_	_	_	_	_	_	I-Whole
18	review	_	review	_	NN	150	_	_	_	_	_	_	_	I-Whole
19	.	_	.	_	.	150	_	_	_	_	_	_	_	O

1	offer	_	UNK	_	NN	150	_	_	_	_	_	_	_	O
2	men	_	men	_	NNS	150	_	_	_	_	_	_	_	O
3	with	_	with	_	IN	150	_	_	_	_	_	_	_	O
4	type	_	type	_	NN	150	_	_	_	_	_	_	_	O
5	2	_	2	_	CD	150	_	_	_	_	_	_	_	O
6	diabetes	_	UNK	_	VBZ	150	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	150	_	_	_	_	_	_	_	O
8	opportunity	_	opportunity	_	NN	150	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	150	_	_	_	_	_	_	_	O
10	discuss	_	discuss	_	VB	150	_	_	_	_	_	_	_	O
11	erectile	_	UNK	_	JJ	150	_	_	_	_	_	_	_	O
12	dysfunction	_	UNK	_	NN	150	_	_	_	_	_	_	_	O
13	as	_	a	_	IN	150	_	_	_	_	_	_	_	O
14	part	_	part	_	NN	150	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	150	_	_	_	_	_	_	_	O
16	their	_	their	_	PRP$	150	_	_	_	_	_	_	_	O
17	annual	_	annual	_	JJ	150	_	_	_	_	_	annual.a	Frequency	S-Interval
18	review	_	review	_	NN	150	_	_	_	_	_	_	_	O
19	.	_	.	_	.	150	_	_	_	_	_	_	_	O

1	assess	_	UNK	_	NNP	151	_	_	_	_	_	_	_	O
2	,	_	,	_	,	151	_	_	_	_	_	_	_	O
3	educate	_	educate	_	NN	151	_	_	_	_	_	educate.v	Education_teaching	O
4	and	_	and	_	CC	151	_	_	_	_	_	_	_	O
5	support	_	support	_	NN	151	_	_	_	_	_	_	_	O
6	men	_	men	_	NNS	151	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	151	_	_	_	_	_	_	_	O
8	type	_	type	_	NN	151	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	151	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	151	_	_	_	_	_	_	_	O
11	who	_	who	_	WP	151	_	_	_	_	_	_	_	O
12	have	_	have	_	VBP	151	_	_	_	_	_	_	_	O
13	problematic	_	UNK	_	JJ	151	_	_	_	_	_	_	_	O
14	erectile	_	UNK	_	NN	151	_	_	_	_	_	_	_	O
15	dysfunction	_	UNK	_	NN	151	_	_	_	_	_	_	_	O
16	,	_	,	_	,	151	_	_	_	_	_	_	_	O
17	addressing	_	address	_	VBG	151	_	_	_	_	_	_	_	O
18	contributory	_	UNK	_	JJ	151	_	_	_	_	_	_	_	O
19	factors	_	factor	_	NNS	151	_	_	_	_	_	_	_	O
20	such	_	such	_	JJ	151	_	_	_	_	_	_	_	O
21	as	_	a	_	IN	151	_	_	_	_	_	_	_	O
22	cardiovascular	_	UNK	_	JJ	151	_	_	_	_	_	_	_	O
23	disease	_	disease	_	NN	151	_	_	_	_	_	_	_	O
24	as	_	a	_	RB	151	_	_	_	_	_	_	_	O
25	well	_	well	_	RB	151	_	_	_	_	_	_	_	O
26	as	_	a	_	IN	151	_	_	_	_	_	_	_	O
27	possible	_	possible	_	JJ	151	_	_	_	_	_	_	_	O
28	treatment	_	treatment	_	NN	151	_	_	_	_	_	_	_	O
29	options	_	option	_	NNS	151	_	_	_	_	_	_	_	O
30	.	_	.	_	.	151	_	_	_	_	_	_	_	O

1	assess	_	UNK	_	NNP	151	_	_	_	_	_	_	_	O
2	,	_	,	_	,	151	_	_	_	_	_	_	_	O
3	educate	_	educate	_	NN	151	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	151	_	_	_	_	_	_	_	O
5	support	_	support	_	NN	151	_	_	_	_	_	_	_	O
6	men	_	men	_	NNS	151	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	151	_	_	_	_	_	_	_	O
8	type	_	type	_	NN	151	_	_	_	_	_	type.n	Type	S-Subtype
9	2	_	2	_	CD	151	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	151	_	_	_	_	_	_	_	O
11	who	_	who	_	WP	151	_	_	_	_	_	_	_	O
12	have	_	have	_	VBP	151	_	_	_	_	_	_	_	O
13	problematic	_	UNK	_	JJ	151	_	_	_	_	_	_	_	O
14	erectile	_	UNK	_	NN	151	_	_	_	_	_	_	_	O
15	dysfunction	_	UNK	_	NN	151	_	_	_	_	_	_	_	O
16	,	_	,	_	,	151	_	_	_	_	_	_	_	O
17	addressing	_	address	_	VBG	151	_	_	_	_	_	_	_	O
18	contributory	_	UNK	_	JJ	151	_	_	_	_	_	_	_	O
19	factors	_	factor	_	NNS	151	_	_	_	_	_	_	_	O
20	such	_	such	_	JJ	151	_	_	_	_	_	_	_	O
21	as	_	a	_	IN	151	_	_	_	_	_	_	_	O
22	cardiovascular	_	UNK	_	JJ	151	_	_	_	_	_	_	_	O
23	disease	_	disease	_	NN	151	_	_	_	_	_	_	_	O
24	as	_	a	_	RB	151	_	_	_	_	_	_	_	O
25	well	_	well	_	RB	151	_	_	_	_	_	_	_	O
26	as	_	a	_	IN	151	_	_	_	_	_	_	_	O
27	possible	_	possible	_	JJ	151	_	_	_	_	_	_	_	O
28	treatment	_	treatment	_	NN	151	_	_	_	_	_	_	_	O
29	options	_	option	_	NNS	151	_	_	_	_	_	_	_	O
30	.	_	.	_	.	151	_	_	_	_	_	_	_	O

1	assess	_	UNK	_	NNP	151	_	_	_	_	_	_	_	O
2	,	_	,	_	,	151	_	_	_	_	_	_	_	O
3	educate	_	educate	_	NN	151	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	151	_	_	_	_	_	_	_	O
5	support	_	support	_	NN	151	_	_	_	_	_	_	_	O
6	men	_	men	_	NNS	151	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	151	_	_	_	_	_	_	_	O
8	type	_	type	_	NN	151	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	151	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	151	_	_	_	_	_	_	_	O
11	who	_	who	_	WP	151	_	_	_	_	_	_	_	O
12	have	_	have	_	VBP	151	_	_	_	_	_	_	_	O
13	problematic	_	UNK	_	JJ	151	_	_	_	_	_	_	_	O
14	erectile	_	UNK	_	NN	151	_	_	_	_	_	_	_	O
15	dysfunction	_	UNK	_	NN	151	_	_	_	_	_	_	_	O
16	,	_	,	_	,	151	_	_	_	_	_	_	_	O
17	addressing	_	address	_	VBG	151	_	_	_	_	_	_	_	O
18	contributory	_	UNK	_	JJ	151	_	_	_	_	_	_	_	O
19	factors	_	factor	_	NNS	151	_	_	_	_	_	_	_	O
20	such	_	such	_	JJ	151	_	_	_	_	_	_	_	O
21	as	_	a	_	IN	151	_	_	_	_	_	_	_	O
22	cardiovascular	_	UNK	_	JJ	151	_	_	_	_	_	_	_	S-Patient
23	disease	_	disease	_	NN	151	_	_	_	_	_	disease.n	Medical_conditions	S-Ailment
24	as	_	a	_	RB	151	_	_	_	_	_	_	_	O
25	well	_	well	_	RB	151	_	_	_	_	_	_	_	O
26	as	_	a	_	IN	151	_	_	_	_	_	_	_	O
27	possible	_	possible	_	JJ	151	_	_	_	_	_	_	_	O
28	treatment	_	treatment	_	NN	151	_	_	_	_	_	_	_	O
29	options	_	option	_	NNS	151	_	_	_	_	_	_	_	O
30	.	_	.	_	.	151	_	_	_	_	_	_	_	O

1	assess	_	UNK	_	NNP	151	_	_	_	_	_	_	_	O
2	,	_	,	_	,	151	_	_	_	_	_	_	_	O
3	educate	_	educate	_	NN	151	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	151	_	_	_	_	_	_	_	O
5	support	_	support	_	NN	151	_	_	_	_	_	_	_	O
6	men	_	men	_	NNS	151	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	151	_	_	_	_	_	_	_	O
8	type	_	type	_	NN	151	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	151	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	151	_	_	_	_	_	_	_	O
11	who	_	who	_	WP	151	_	_	_	_	_	_	_	O
12	have	_	have	_	VBP	151	_	_	_	_	_	_	_	O
13	problematic	_	UNK	_	JJ	151	_	_	_	_	_	_	_	O
14	erectile	_	UNK	_	NN	151	_	_	_	_	_	_	_	O
15	dysfunction	_	UNK	_	NN	151	_	_	_	_	_	_	_	O
16	,	_	,	_	,	151	_	_	_	_	_	_	_	O
17	addressing	_	address	_	VBG	151	_	_	_	_	_	_	_	O
18	contributory	_	UNK	_	JJ	151	_	_	_	_	_	_	_	O
19	factors	_	factor	_	NNS	151	_	_	_	_	_	_	_	O
20	such	_	such	_	JJ	151	_	_	_	_	_	_	_	O
21	as	_	a	_	IN	151	_	_	_	_	_	_	_	O
22	cardiovascular	_	UNK	_	JJ	151	_	_	_	_	_	_	_	O
23	disease	_	disease	_	NN	151	_	_	_	_	_	_	_	O
24	as	_	a	_	RB	151	_	_	_	_	_	_	_	O
25	well	_	well	_	RB	151	_	_	_	_	_	_	_	O
26	as	_	a	_	IN	151	_	_	_	_	_	_	_	O
27	possible	_	possible	_	JJ	151	_	_	_	_	_	possible.a	Likelihood	O
28	treatment	_	treatment	_	NN	151	_	_	_	_	_	_	_	B-Hypothetical_event
29	options	_	option	_	NNS	151	_	_	_	_	_	_	_	I-Hypothetical_event
30	.	_	.	_	.	151	_	_	_	_	_	_	_	O

1	assess	_	UNK	_	NNP	151	_	_	_	_	_	_	_	O
2	,	_	,	_	,	151	_	_	_	_	_	_	_	O
3	educate	_	educate	_	NN	151	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	151	_	_	_	_	_	_	_	O
5	support	_	support	_	NN	151	_	_	_	_	_	_	_	O
6	men	_	men	_	NNS	151	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	151	_	_	_	_	_	_	_	O
8	type	_	type	_	NN	151	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	151	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	151	_	_	_	_	_	_	_	O
11	who	_	who	_	WP	151	_	_	_	_	_	_	_	O
12	have	_	have	_	VBP	151	_	_	_	_	_	_	_	O
13	problematic	_	UNK	_	JJ	151	_	_	_	_	_	_	_	O
14	erectile	_	UNK	_	NN	151	_	_	_	_	_	_	_	O
15	dysfunction	_	UNK	_	NN	151	_	_	_	_	_	_	_	O
16	,	_	,	_	,	151	_	_	_	_	_	_	_	O
17	addressing	_	address	_	VBG	151	_	_	_	_	_	_	_	O
18	contributory	_	UNK	_	JJ	151	_	_	_	_	_	_	_	O
19	factors	_	factor	_	NNS	151	_	_	_	_	_	_	_	O
20	such	_	such	_	JJ	151	_	_	_	_	_	_	_	O
21	as	_	a	_	IN	151	_	_	_	_	_	_	_	O
22	cardiovascular	_	UNK	_	JJ	151	_	_	_	_	_	_	_	O
23	disease	_	disease	_	NN	151	_	_	_	_	_	_	_	O
24	as	_	a	_	RB	151	_	_	_	_	_	_	_	O
25	well	_	well	_	RB	151	_	_	_	_	_	_	_	O
26	as	_	a	_	IN	151	_	_	_	_	_	_	_	O
27	possible	_	possible	_	JJ	151	_	_	_	_	_	_	_	O
28	treatment	_	treatment	_	NN	151	_	_	_	_	_	treatment.n	Cure	O
29	options	_	option	_	NNS	151	_	_	_	_	_	_	_	O
30	.	_	.	_	.	151	_	_	_	_	_	_	_	O

1	assess	_	UNK	_	NNP	151	_	_	_	_	_	_	_	O
2	,	_	,	_	,	151	_	_	_	_	_	_	_	O
3	educate	_	educate	_	NN	151	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	151	_	_	_	_	_	_	_	O
5	support	_	support	_	NN	151	_	_	_	_	_	_	_	O
6	men	_	men	_	NNS	151	_	_	_	_	_	_	_	O
7	with	_	with	_	IN	151	_	_	_	_	_	_	_	O
8	type	_	type	_	NN	151	_	_	_	_	_	_	_	O
9	2	_	2	_	CD	151	_	_	_	_	_	_	_	O
10	diabetes	_	UNK	_	NNS	151	_	_	_	_	_	_	_	O
11	who	_	who	_	WP	151	_	_	_	_	_	_	_	O
12	have	_	have	_	VBP	151	_	_	_	_	_	_	_	O
13	problematic	_	UNK	_	JJ	151	_	_	_	_	_	_	_	O
14	erectile	_	UNK	_	NN	151	_	_	_	_	_	_	_	O
15	dysfunction	_	UNK	_	NN	151	_	_	_	_	_	_	_	O
16	,	_	,	_	,	151	_	_	_	_	_	_	_	O
17	addressing	_	address	_	VBG	151	_	_	_	_	_	_	_	O
18	contributory	_	UNK	_	JJ	151	_	_	_	_	_	_	_	O
19	factors	_	factor	_	NNS	151	_	_	_	_	_	_	_	O
20	such	_	such	_	JJ	151	_	_	_	_	_	_	_	O
21	as	_	a	_	IN	151	_	_	_	_	_	_	_	O
22	cardiovascular	_	UNK	_	JJ	151	_	_	_	_	_	_	_	O
23	disease	_	disease	_	NN	151	_	_	_	_	_	_	_	O
24	as	_	a	_	RB	151	_	_	_	_	_	_	_	O
25	well	_	well	_	RB	151	_	_	_	_	_	_	_	O
26	as	_	a	_	IN	151	_	_	_	_	_	_	_	O
27	possible	_	possible	_	JJ	151	_	_	_	_	_	_	_	O
28	treatment	_	treatment	_	NN	151	_	_	_	_	_	_	_	S-Situation
29	options	_	option	_	NNS	151	_	_	_	_	_	option.n	Alternatives	O
30	.	_	.	_	.	151	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	152	_	_	_	_	_	_	_	O
2	a	_	a	_	DT	152	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	JJ	152	_	_	_	_	_	_	_	O
4	inhibitor	_	UNK	_	NN	152	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	152	_	_	_	_	_	_	_	O
6	treat	_	treat	_	VB	152	_	_	_	_	_	treat.v	Medical_intervention	O
7	problematic	_	UNK	_	JJ	152	_	_	_	_	_	_	_	B-Medical_condition
8	erectile	_	UNK	_	JJ	152	_	_	_	_	_	_	_	I-Medical_condition
9	dysfunction	_	UNK	_	NN	152	_	_	_	_	_	_	_	I-Medical_condition
10	in	_	in	_	IN	152	_	_	_	_	_	_	_	I-Medical_condition
11	men	_	men	_	NNS	152	_	_	_	_	_	_	_	I-Medical_condition
12	with	_	with	_	IN	152	_	_	_	_	_	_	_	I-Medical_condition
13	type	_	type	_	NN	152	_	_	_	_	_	_	_	I-Medical_condition
14	2	_	2	_	CD	152	_	_	_	_	_	_	_	I-Medical_condition
15	diabetes	_	UNK	_	NNS	152	_	_	_	_	_	_	_	I-Medical_condition
16	,	_	,	_	,	152	_	_	_	_	_	_	_	O
17	initially	_	initially	_	RB	152	_	_	_	_	_	_	_	O
18	choosing	_	choose	_	VBG	152	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	152	_	_	_	_	_	_	_	O
20	drug	_	drug	_	NN	152	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	152	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	152	_	_	_	_	_	_	_	O
23	lowest	_	lowest	_	JJS	152	_	_	_	_	_	_	_	O
24	acquisition	_	acquisition	_	NN	152	_	_	_	_	_	_	_	O
25	cost	_	cost	_	NN	152	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	152	_	_	_	_	_	_	_	O
27	taking	_	take	_	VBG	152	_	_	_	_	_	_	_	O
28	into	_	into	_	IN	152	_	_	_	_	_	_	_	O
29	account	_	account	_	NN	152	_	_	_	_	_	_	_	O
30	any	_	any	_	DT	152	_	_	_	_	_	_	_	O
31	contraindications	_	UNK	_	NNS	152	_	_	_	_	_	_	_	O
32	.	_	.	_	.	152	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	152	_	_	_	_	_	_	_	O
2	a	_	a	_	DT	152	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	JJ	152	_	_	_	_	_	_	_	O
4	inhibitor	_	UNK	_	NN	152	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	152	_	_	_	_	_	_	_	O
6	treat	_	treat	_	VB	152	_	_	_	_	_	_	_	O
7	problematic	_	UNK	_	JJ	152	_	_	_	_	_	_	_	O
8	erectile	_	UNK	_	JJ	152	_	_	_	_	_	_	_	O
9	dysfunction	_	UNK	_	NN	152	_	_	_	_	_	_	_	O
10	in	_	in	_	IN	152	_	_	_	_	_	_	_	O
11	men	_	men	_	NNS	152	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	152	_	_	_	_	_	_	_	O
13	type	_	type	_	NN	152	_	_	_	_	_	type.n	Type	S-Subtype
14	2	_	2	_	CD	152	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	152	_	_	_	_	_	_	_	O
16	,	_	,	_	,	152	_	_	_	_	_	_	_	O
17	initially	_	initially	_	RB	152	_	_	_	_	_	_	_	O
18	choosing	_	choose	_	VBG	152	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	152	_	_	_	_	_	_	_	O
20	drug	_	drug	_	NN	152	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	152	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	152	_	_	_	_	_	_	_	O
23	lowest	_	lowest	_	JJS	152	_	_	_	_	_	_	_	O
24	acquisition	_	acquisition	_	NN	152	_	_	_	_	_	_	_	O
25	cost	_	cost	_	NN	152	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	152	_	_	_	_	_	_	_	O
27	taking	_	take	_	VBG	152	_	_	_	_	_	_	_	O
28	into	_	into	_	IN	152	_	_	_	_	_	_	_	O
29	account	_	account	_	NN	152	_	_	_	_	_	_	_	O
30	any	_	any	_	DT	152	_	_	_	_	_	_	_	O
31	contraindications	_	UNK	_	NNS	152	_	_	_	_	_	_	_	O
32	.	_	.	_	.	152	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	152	_	_	_	_	_	_	_	B-Chosen
2	a	_	a	_	DT	152	_	_	_	_	_	_	_	I-Chosen
3	unk	_	UNK	_	JJ	152	_	_	_	_	_	_	_	I-Chosen
4	inhibitor	_	UNK	_	NN	152	_	_	_	_	_	_	_	I-Chosen
5	to	_	to	_	TO	152	_	_	_	_	_	_	_	I-Chosen
6	treat	_	treat	_	VB	152	_	_	_	_	_	_	_	I-Chosen
7	problematic	_	UNK	_	JJ	152	_	_	_	_	_	_	_	I-Chosen
8	erectile	_	UNK	_	JJ	152	_	_	_	_	_	_	_	I-Chosen
9	dysfunction	_	UNK	_	NN	152	_	_	_	_	_	_	_	I-Chosen
10	in	_	in	_	IN	152	_	_	_	_	_	_	_	I-Chosen
11	men	_	men	_	NNS	152	_	_	_	_	_	_	_	I-Chosen
12	with	_	with	_	IN	152	_	_	_	_	_	_	_	I-Chosen
13	type	_	type	_	NN	152	_	_	_	_	_	_	_	I-Chosen
14	2	_	2	_	CD	152	_	_	_	_	_	_	_	I-Chosen
15	diabetes	_	UNK	_	NNS	152	_	_	_	_	_	_	_	I-Chosen
16	,	_	,	_	,	152	_	_	_	_	_	_	_	I-Chosen
17	initially	_	initially	_	RB	152	_	_	_	_	_	_	_	S-Manner
18	choosing	_	choose	_	VBG	152	_	_	_	_	_	choose.v	Choosing	O
19	the	_	the	_	DT	152	_	_	_	_	_	_	_	B-Chosen
20	drug	_	drug	_	NN	152	_	_	_	_	_	_	_	I-Chosen
21	with	_	with	_	IN	152	_	_	_	_	_	_	_	I-Chosen
22	the	_	the	_	DT	152	_	_	_	_	_	_	_	I-Chosen
23	lowest	_	lowest	_	JJS	152	_	_	_	_	_	_	_	I-Chosen
24	acquisition	_	acquisition	_	NN	152	_	_	_	_	_	_	_	I-Chosen
25	cost	_	cost	_	NN	152	_	_	_	_	_	_	_	I-Chosen
26	and	_	and	_	CC	152	_	_	_	_	_	_	_	I-Chosen
27	taking	_	take	_	VBG	152	_	_	_	_	_	_	_	I-Chosen
28	into	_	into	_	IN	152	_	_	_	_	_	_	_	I-Chosen
29	account	_	account	_	NN	152	_	_	_	_	_	_	_	I-Chosen
30	any	_	any	_	DT	152	_	_	_	_	_	_	_	I-Chosen
31	contraindications	_	UNK	_	NNS	152	_	_	_	_	_	_	_	I-Chosen
32	.	_	.	_	.	152	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	152	_	_	_	_	_	_	_	O
2	a	_	a	_	DT	152	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	JJ	152	_	_	_	_	_	_	_	O
4	inhibitor	_	UNK	_	NN	152	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	152	_	_	_	_	_	_	_	O
6	treat	_	treat	_	VB	152	_	_	_	_	_	_	_	O
7	problematic	_	UNK	_	JJ	152	_	_	_	_	_	_	_	O
8	erectile	_	UNK	_	JJ	152	_	_	_	_	_	_	_	O
9	dysfunction	_	UNK	_	NN	152	_	_	_	_	_	_	_	O
10	in	_	in	_	IN	152	_	_	_	_	_	_	_	O
11	men	_	men	_	NNS	152	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	152	_	_	_	_	_	_	_	O
13	type	_	type	_	NN	152	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	152	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	152	_	_	_	_	_	_	_	O
16	,	_	,	_	,	152	_	_	_	_	_	_	_	O
17	initially	_	initially	_	RB	152	_	_	_	_	_	_	_	O
18	choosing	_	choose	_	VBG	152	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	152	_	_	_	_	_	_	_	O
20	drug	_	drug	_	NN	152	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	152	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	152	_	_	_	_	_	_	_	O
23	lowest	_	lowest	_	JJS	152	_	_	_	_	_	_	_	B-Goods
24	acquisition	_	acquisition	_	NN	152	_	_	_	_	_	_	_	I-Goods
25	cost	_	cost	_	NN	152	_	_	_	_	_	cost.n	Expensiveness	O
26	and	_	and	_	CC	152	_	_	_	_	_	_	_	O
27	taking	_	take	_	VBG	152	_	_	_	_	_	_	_	O
28	into	_	into	_	IN	152	_	_	_	_	_	_	_	O
29	account	_	account	_	NN	152	_	_	_	_	_	_	_	O
30	any	_	any	_	DT	152	_	_	_	_	_	_	_	O
31	contraindications	_	UNK	_	NNS	152	_	_	_	_	_	_	_	O
32	.	_	.	_	.	152	_	_	_	_	_	_	_	O

1	consider	_	UNK	_	VB	152	_	_	_	_	_	_	_	O
2	a	_	a	_	DT	152	_	_	_	_	_	_	_	O
3	unk	_	UNK	_	JJ	152	_	_	_	_	_	_	_	O
4	inhibitor	_	UNK	_	NN	152	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	152	_	_	_	_	_	_	_	O
6	treat	_	treat	_	VB	152	_	_	_	_	_	_	_	O
7	problematic	_	UNK	_	JJ	152	_	_	_	_	_	_	_	O
8	erectile	_	UNK	_	JJ	152	_	_	_	_	_	_	_	O
9	dysfunction	_	UNK	_	NN	152	_	_	_	_	_	_	_	O
10	in	_	in	_	IN	152	_	_	_	_	_	_	_	O
11	men	_	men	_	NNS	152	_	_	_	_	_	_	_	O
12	with	_	with	_	IN	152	_	_	_	_	_	_	_	O
13	type	_	type	_	NN	152	_	_	_	_	_	_	_	O
14	2	_	2	_	CD	152	_	_	_	_	_	_	_	O
15	diabetes	_	UNK	_	NNS	152	_	_	_	_	_	_	_	O
16	,	_	,	_	,	152	_	_	_	_	_	_	_	O
17	initially	_	initially	_	RB	152	_	_	_	_	_	_	_	O
18	choosing	_	choose	_	VBG	152	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	152	_	_	_	_	_	_	_	O
20	drug	_	drug	_	NN	152	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	152	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	152	_	_	_	_	_	_	_	O
23	lowest	_	lowest	_	JJS	152	_	_	_	_	_	_	_	O
24	acquisition	_	acquisition	_	NN	152	_	_	_	_	_	_	_	O
25	cost	_	cost	_	NN	152	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	152	_	_	_	_	_	_	_	O
27	taking	_	take	_	VBG	152	_	_	_	_	_	_	_	O
28	into	_	into	_	IN	152	_	_	_	_	_	_	_	O
29	account	_	account	_	NN	152	_	_	_	_	_	account.n	Text	O
30	any	_	any	_	DT	152	_	_	_	_	_	_	_	B-Text
31	contraindications	_	UNK	_	NNS	152	_	_	_	_	_	_	_	I-Text
32	.	_	.	_	.	152	_	_	_	_	_	_	_	O

1	following	_	Following	_	VBG	153	_	_	_	_	_	_	_	O
2	discussion	_	discussion	_	NN	153	_	_	_	_	_	discussion.n	Discussion	O
3	,	_	,	_	,	153	_	_	_	_	_	_	_	O
4	refer	_	refer	_	VBP	153	_	_	_	_	_	_	_	O
5	men	_	men	_	NNS	153	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	153	_	_	_	_	_	_	_	O
7	type	_	type	_	NN	153	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	153	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	153	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	153	_	_	_	_	_	_	_	O
11	a	_	a	_	DT	153	_	_	_	_	_	_	_	O
12	service	_	service	_	NN	153	_	_	_	_	_	_	_	O
13	offering	_	offer	_	VBG	153	_	_	_	_	_	_	_	O
14	other	_	other	_	JJ	153	_	_	_	_	_	_	_	O
15	medical	_	medical	_	JJ	153	_	_	_	_	_	_	_	O
16	,	_	,	_	,	153	_	_	_	_	_	_	_	O
17	surgical	_	UNK	_	JJ	153	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	153	_	_	_	_	_	_	_	O
19	psychological	_	psychological	_	JJ	153	_	_	_	_	_	_	_	O
20	management	_	management	_	NN	153	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	153	_	_	_	_	_	_	_	O
22	erectile	_	UNK	_	JJ	153	_	_	_	_	_	_	_	O
23	dysfunction	_	UNK	_	NN	153	_	_	_	_	_	_	_	O
24	if	_	if	_	IN	153	_	_	_	_	_	_	_	O
25	treatment	_	treatment	_	NN	153	_	_	_	_	_	_	_	O
26	(	_	(	_	(	153	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	153	_	_	_	_	_	_	_	O
28	a	_	a	_	DT	153	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	JJ	153	_	_	_	_	_	_	_	O
30	inhibitor	_	UNK	_	NN	153	_	_	_	_	_	_	_	O
31	,	_	,	_	,	153	_	_	_	_	_	_	_	O
32	as	_	a	_	IN	153	_	_	_	_	_	_	_	O
33	appropriate	_	appropriate	_	NN	153	_	_	_	_	_	_	_	O
34	)	_	)	_	)	153	_	_	_	_	_	_	_	O
35	has	_	have	_	VBZ	153	_	_	_	_	_	_	_	O
36	been	_	be	_	VBN	153	_	_	_	_	_	_	_	O
37	unsuccessful	_	unsuccessful	_	JJ	153	_	_	_	_	_	_	_	O
38	.	_	.	_	.	153	_	_	_	_	_	_	_	O

1	following	_	Following	_	VBG	153	_	_	_	_	_	_	_	O
2	discussion	_	discussion	_	NN	153	_	_	_	_	_	_	_	O
3	,	_	,	_	,	153	_	_	_	_	_	_	_	O
4	refer	_	refer	_	VBP	153	_	_	_	_	_	refer.v	Referring_by_name	O
5	men	_	men	_	NNS	153	_	_	_	_	_	_	_	S-Entity
6	with	_	with	_	IN	153	_	_	_	_	_	_	_	O
7	type	_	type	_	NN	153	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	153	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	153	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	153	_	_	_	_	_	_	_	O
11	a	_	a	_	DT	153	_	_	_	_	_	_	_	O
12	service	_	service	_	NN	153	_	_	_	_	_	_	_	O
13	offering	_	offer	_	VBG	153	_	_	_	_	_	_	_	O
14	other	_	other	_	JJ	153	_	_	_	_	_	_	_	O
15	medical	_	medical	_	JJ	153	_	_	_	_	_	_	_	O
16	,	_	,	_	,	153	_	_	_	_	_	_	_	O
17	surgical	_	UNK	_	JJ	153	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	153	_	_	_	_	_	_	_	O
19	psychological	_	psychological	_	JJ	153	_	_	_	_	_	_	_	O
20	management	_	management	_	NN	153	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	153	_	_	_	_	_	_	_	O
22	erectile	_	UNK	_	JJ	153	_	_	_	_	_	_	_	O
23	dysfunction	_	UNK	_	NN	153	_	_	_	_	_	_	_	O
24	if	_	if	_	IN	153	_	_	_	_	_	_	_	O
25	treatment	_	treatment	_	NN	153	_	_	_	_	_	_	_	O
26	(	_	(	_	(	153	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	153	_	_	_	_	_	_	_	O
28	a	_	a	_	DT	153	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	JJ	153	_	_	_	_	_	_	_	O
30	inhibitor	_	UNK	_	NN	153	_	_	_	_	_	_	_	O
31	,	_	,	_	,	153	_	_	_	_	_	_	_	O
32	as	_	a	_	IN	153	_	_	_	_	_	_	_	O
33	appropriate	_	appropriate	_	NN	153	_	_	_	_	_	_	_	O
34	)	_	)	_	)	153	_	_	_	_	_	_	_	O
35	has	_	have	_	VBZ	153	_	_	_	_	_	_	_	O
36	been	_	be	_	VBN	153	_	_	_	_	_	_	_	O
37	unsuccessful	_	unsuccessful	_	JJ	153	_	_	_	_	_	_	_	O
38	.	_	.	_	.	153	_	_	_	_	_	_	_	O

1	following	_	Following	_	VBG	153	_	_	_	_	_	_	_	O
2	discussion	_	discussion	_	NN	153	_	_	_	_	_	_	_	O
3	,	_	,	_	,	153	_	_	_	_	_	_	_	O
4	refer	_	refer	_	VBP	153	_	_	_	_	_	_	_	O
5	men	_	men	_	NNS	153	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	153	_	_	_	_	_	_	_	O
7	type	_	type	_	NN	153	_	_	_	_	_	type.n	Type	S-Subtype
8	2	_	2	_	CD	153	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	153	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	153	_	_	_	_	_	_	_	O
11	a	_	a	_	DT	153	_	_	_	_	_	_	_	O
12	service	_	service	_	NN	153	_	_	_	_	_	_	_	O
13	offering	_	offer	_	VBG	153	_	_	_	_	_	_	_	O
14	other	_	other	_	JJ	153	_	_	_	_	_	_	_	O
15	medical	_	medical	_	JJ	153	_	_	_	_	_	_	_	O
16	,	_	,	_	,	153	_	_	_	_	_	_	_	O
17	surgical	_	UNK	_	JJ	153	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	153	_	_	_	_	_	_	_	O
19	psychological	_	psychological	_	JJ	153	_	_	_	_	_	_	_	O
20	management	_	management	_	NN	153	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	153	_	_	_	_	_	_	_	O
22	erectile	_	UNK	_	JJ	153	_	_	_	_	_	_	_	O
23	dysfunction	_	UNK	_	NN	153	_	_	_	_	_	_	_	O
24	if	_	if	_	IN	153	_	_	_	_	_	_	_	O
25	treatment	_	treatment	_	NN	153	_	_	_	_	_	_	_	O
26	(	_	(	_	(	153	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	153	_	_	_	_	_	_	_	O
28	a	_	a	_	DT	153	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	JJ	153	_	_	_	_	_	_	_	O
30	inhibitor	_	UNK	_	NN	153	_	_	_	_	_	_	_	O
31	,	_	,	_	,	153	_	_	_	_	_	_	_	O
32	as	_	a	_	IN	153	_	_	_	_	_	_	_	O
33	appropriate	_	appropriate	_	NN	153	_	_	_	_	_	_	_	O
34	)	_	)	_	)	153	_	_	_	_	_	_	_	O
35	has	_	have	_	VBZ	153	_	_	_	_	_	_	_	O
36	been	_	be	_	VBN	153	_	_	_	_	_	_	_	O
37	unsuccessful	_	unsuccessful	_	JJ	153	_	_	_	_	_	_	_	O
38	.	_	.	_	.	153	_	_	_	_	_	_	_	O

1	following	_	Following	_	VBG	153	_	_	_	_	_	_	_	O
2	discussion	_	discussion	_	NN	153	_	_	_	_	_	_	_	O
3	,	_	,	_	,	153	_	_	_	_	_	_	_	O
4	refer	_	refer	_	VBP	153	_	_	_	_	_	_	_	O
5	men	_	men	_	NNS	153	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	153	_	_	_	_	_	_	_	O
7	type	_	type	_	NN	153	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	153	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	153	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	153	_	_	_	_	_	_	_	O
11	a	_	a	_	DT	153	_	_	_	_	_	_	_	O
12	service	_	service	_	NN	153	_	_	_	_	_	_	_	O
13	offering	_	offer	_	VBG	153	_	_	_	_	_	_	_	O
14	other	_	other	_	JJ	153	_	_	_	_	_	other.a	Increment	O
15	medical	_	medical	_	JJ	153	_	_	_	_	_	_	_	S-Class
16	,	_	,	_	,	153	_	_	_	_	_	_	_	O
17	surgical	_	UNK	_	JJ	153	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	153	_	_	_	_	_	_	_	O
19	psychological	_	psychological	_	JJ	153	_	_	_	_	_	_	_	O
20	management	_	management	_	NN	153	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	153	_	_	_	_	_	_	_	O
22	erectile	_	UNK	_	JJ	153	_	_	_	_	_	_	_	O
23	dysfunction	_	UNK	_	NN	153	_	_	_	_	_	_	_	O
24	if	_	if	_	IN	153	_	_	_	_	_	_	_	O
25	treatment	_	treatment	_	NN	153	_	_	_	_	_	_	_	O
26	(	_	(	_	(	153	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	153	_	_	_	_	_	_	_	O
28	a	_	a	_	DT	153	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	JJ	153	_	_	_	_	_	_	_	O
30	inhibitor	_	UNK	_	NN	153	_	_	_	_	_	_	_	O
31	,	_	,	_	,	153	_	_	_	_	_	_	_	O
32	as	_	a	_	IN	153	_	_	_	_	_	_	_	O
33	appropriate	_	appropriate	_	NN	153	_	_	_	_	_	_	_	O
34	)	_	)	_	)	153	_	_	_	_	_	_	_	O
35	has	_	have	_	VBZ	153	_	_	_	_	_	_	_	O
36	been	_	be	_	VBN	153	_	_	_	_	_	_	_	O
37	unsuccessful	_	unsuccessful	_	JJ	153	_	_	_	_	_	_	_	O
38	.	_	.	_	.	153	_	_	_	_	_	_	_	O

1	following	_	Following	_	VBG	153	_	_	_	_	_	_	_	O
2	discussion	_	discussion	_	NN	153	_	_	_	_	_	_	_	O
3	,	_	,	_	,	153	_	_	_	_	_	_	_	O
4	refer	_	refer	_	VBP	153	_	_	_	_	_	_	_	O
5	men	_	men	_	NNS	153	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	153	_	_	_	_	_	_	_	O
7	type	_	type	_	NN	153	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	153	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	153	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	153	_	_	_	_	_	_	_	O
11	a	_	a	_	DT	153	_	_	_	_	_	_	_	O
12	service	_	service	_	NN	153	_	_	_	_	_	_	_	O
13	offering	_	offer	_	VBG	153	_	_	_	_	_	_	_	O
14	other	_	other	_	JJ	153	_	_	_	_	_	_	_	O
15	medical	_	medical	_	JJ	153	_	_	_	_	_	_	_	O
16	,	_	,	_	,	153	_	_	_	_	_	_	_	O
17	surgical	_	UNK	_	JJ	153	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	153	_	_	_	_	_	_	_	O
19	psychological	_	psychological	_	JJ	153	_	_	_	_	_	_	_	O
20	management	_	management	_	NN	153	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	153	_	_	_	_	_	_	_	O
22	erectile	_	UNK	_	JJ	153	_	_	_	_	_	_	_	O
23	dysfunction	_	UNK	_	NN	153	_	_	_	_	_	_	_	O
24	if	_	if	_	IN	153	_	_	_	_	_	_	_	O
25	treatment	_	treatment	_	NN	153	_	_	_	_	_	treatment.n	Cure	O
26	(	_	(	_	(	153	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	153	_	_	_	_	_	_	_	O
28	a	_	a	_	DT	153	_	_	_	_	_	_	_	O
29	unk	_	UNK	_	JJ	153	_	_	_	_	_	_	_	O
30	inhibitor	_	UNK	_	NN	153	_	_	_	_	_	_	_	O
31	,	_	,	_	,	153	_	_	_	_	_	_	_	O
32	as	_	a	_	IN	153	_	_	_	_	_	_	_	O
33	appropriate	_	appropriate	_	NN	153	_	_	_	_	_	_	_	O
34	)	_	)	_	)	153	_	_	_	_	_	_	_	O
35	has	_	have	_	VBZ	153	_	_	_	_	_	_	_	O
36	been	_	be	_	VBN	153	_	_	_	_	_	_	_	O
37	unsuccessful	_	unsuccessful	_	JJ	153	_	_	_	_	_	_	_	O
38	.	_	.	_	.	153	_	_	_	_	_	_	_	O

1	following	_	Following	_	VBG	153	_	_	_	_	_	_	_	O
2	discussion	_	discussion	_	NN	153	_	_	_	_	_	_	_	O
3	,	_	,	_	,	153	_	_	_	_	_	_	_	O
4	refer	_	refer	_	VBP	153	_	_	_	_	_	_	_	O
5	men	_	men	_	NNS	153	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	153	_	_	_	_	_	_	_	O
7	type	_	type	_	NN	153	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	153	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	153	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	153	_	_	_	_	_	_	_	O
11	a	_	a	_	DT	153	_	_	_	_	_	_	_	O
12	service	_	service	_	NN	153	_	_	_	_	_	_	_	O
13	offering	_	offer	_	VBG	153	_	_	_	_	_	_	_	O
14	other	_	other	_	JJ	153	_	_	_	_	_	_	_	O
15	medical	_	medical	_	JJ	153	_	_	_	_	_	_	_	O
16	,	_	,	_	,	153	_	_	_	_	_	_	_	O
17	surgical	_	UNK	_	JJ	153	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	153	_	_	_	_	_	_	_	O
19	psychological	_	psychological	_	JJ	153	_	_	_	_	_	_	_	O
20	management	_	management	_	NN	153	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	153	_	_	_	_	_	_	_	O
22	erectile	_	UNK	_	JJ	153	_	_	_	_	_	_	_	O
23	dysfunction	_	UNK	_	NN	153	_	_	_	_	_	_	_	O
24	if	_	if	_	IN	153	_	_	_	_	_	_	_	O
25	treatment	_	treatment	_	NN	153	_	_	_	_	_	_	_	S-Part
26	(	_	(	_	(	153	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	153	_	_	_	_	_	include.v	Inclusion	O
28	a	_	a	_	DT	153	_	_	_	_	_	_	_	B-Part
29	unk	_	UNK	_	JJ	153	_	_	_	_	_	_	_	I-Part
30	inhibitor	_	UNK	_	NN	153	_	_	_	_	_	_	_	I-Part
31	,	_	,	_	,	153	_	_	_	_	_	_	_	O
32	as	_	a	_	IN	153	_	_	_	_	_	_	_	O
33	appropriate	_	appropriate	_	NN	153	_	_	_	_	_	_	_	O
34	)	_	)	_	)	153	_	_	_	_	_	_	_	O
35	has	_	have	_	VBZ	153	_	_	_	_	_	_	_	O
36	been	_	be	_	VBN	153	_	_	_	_	_	_	_	O
37	unsuccessful	_	unsuccessful	_	JJ	153	_	_	_	_	_	_	_	O
38	.	_	.	_	.	153	_	_	_	_	_	_	_	O

1	following	_	Following	_	VBG	153	_	_	_	_	_	_	_	O
2	discussion	_	discussion	_	NN	153	_	_	_	_	_	_	_	O
3	,	_	,	_	,	153	_	_	_	_	_	_	_	O
4	refer	_	refer	_	VBP	153	_	_	_	_	_	_	_	O
5	men	_	men	_	NNS	153	_	_	_	_	_	_	_	O
6	with	_	with	_	IN	153	_	_	_	_	_	_	_	O
7	type	_	type	_	NN	153	_	_	_	_	_	_	_	O
8	2	_	2	_	CD	153	_	_	_	_	_	_	_	O
9	diabetes	_	UNK	_	NNS	153	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	153	_	_	_	_	_	_	_	O
11	a	_	a	_	DT	153	_	_	_	_	_	_	_	O
12	service	_	service	_	NN	153	_	_	_	_	_	_	_	O
13	offering	_	offer	_	VBG	153	_	_	_	_	_	_	_	O
14	other	_	other	_	JJ	153	_	_	_	_	_	_	_	O
15	medical	_	medical	_	JJ	153	_	_	_	_	_	_	_	O
16	,	_	,	_	,	153	_	_	_	_	_	_	_	O
17	surgical	_	UNK	_	JJ	153	_	_	_	_	_	_	_	O
18	or	_	or	_	CC	153	_	_	_	_	_	_	_	O
19	psychological	_	psychological	_	JJ	153	_	_	_	_	_	_	_	O
20	management	_	management	_	NN	153	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	153	_	_	_	_	_	_	_	O
22	erectile	_	UNK	_	JJ	153	_	_	_	_	_	_	_	O
23	dysfunction	_	UNK	_	NN	153	_	_	_	_	_	_	_	O
24	if	_	if	_	IN	153	_	_	_	_	_	_	_	O
25	treatment	_	treatment	_	NN	153	_	_	_	_	_	_	_	O
26	(	_	(	_	(	153	_	_	_	_	_	_	_	O
27	including	_	include	_	VBG	153	_	_	_	_	_	_	_	O
28	a	_	a	_	DT	153	_	_	_	_	_	_	_	B-Agent
29	unk	_	UNK	_	JJ	153	_	_	_	_	_	_	_	I-Agent
30	inhibitor	_	UNK	_	NN	153	_	_	_	_	_	_	_	I-Agent
31	,	_	,	_	,	153	_	_	_	_	_	_	_	I-Agent
32	as	_	a	_	IN	153	_	_	_	_	_	_	_	I-Agent
33	appropriate	_	appropriate	_	NN	153	_	_	_	_	_	_	_	I-Agent
34	)	_	)	_	)	153	_	_	_	_	_	_	_	I-Agent
35	has	_	have	_	VBZ	153	_	_	_	_	_	_	_	O
36	been	_	be	_	VBN	153	_	_	_	_	_	_	_	O
37	unsuccessful	_	unsuccessful	_	JJ	153	_	_	_	_	_	unsuccessful.a	Success_or_failure	O
38	.	_	.	_	.	153	_	_	_	_	_	_	_	O

1	on	_	On	_	IN	154	_	_	_	_	_	_	_	O
2	diagnosis	_	UNK	_	NN	154	_	_	_	_	_	_	_	O
3	,	_	,	_	,	154	_	_	_	_	_	_	_	O
4	gps	_	UNK	_	NNP	154	_	_	_	_	_	_	_	S-Speaker
5	should	_	should	_	MD	154	_	_	_	_	_	_	_	O
6	immediately	_	immediately	_	RB	154	_	_	_	_	_	_	_	O
7	refer	_	refer	_	VB	154	_	_	_	_	_	refer.v	Referring_by_name	O
8	adults	_	adult	_	NNS	154	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	154	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	154	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	154	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	154	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	154	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	154	_	_	_	_	_	_	_	O
15	local	_	local	_	JJ	154	_	_	_	_	_	_	_	O
16	eye	_	eye	_	NN	154	_	_	_	_	_	_	_	O
17	screening	_	screening	_	NN	154	_	_	_	_	_	_	_	O
18	service	_	service	_	NN	154	_	_	_	_	_	_	_	O

1	on	_	On	_	IN	154	_	_	_	_	_	_	_	O
2	diagnosis	_	UNK	_	NN	154	_	_	_	_	_	_	_	O
3	,	_	,	_	,	154	_	_	_	_	_	_	_	O
4	gps	_	UNK	_	NNP	154	_	_	_	_	_	_	_	O
5	should	_	should	_	MD	154	_	_	_	_	_	_	_	O
6	immediately	_	immediately	_	RB	154	_	_	_	_	_	_	_	O
7	refer	_	refer	_	VB	154	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	154	_	_	_	_	_	adult.n	People_by_age	S-Person
9	with	_	with	_	IN	154	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	154	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	154	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	154	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	154	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	154	_	_	_	_	_	_	_	O
15	local	_	local	_	JJ	154	_	_	_	_	_	_	_	O
16	eye	_	eye	_	NN	154	_	_	_	_	_	_	_	O
17	screening	_	screening	_	NN	154	_	_	_	_	_	_	_	O
18	service	_	service	_	NN	154	_	_	_	_	_	_	_	O

1	on	_	On	_	IN	154	_	_	_	_	_	_	_	O
2	diagnosis	_	UNK	_	NN	154	_	_	_	_	_	_	_	O
3	,	_	,	_	,	154	_	_	_	_	_	_	_	O
4	gps	_	UNK	_	NNP	154	_	_	_	_	_	_	_	O
5	should	_	should	_	MD	154	_	_	_	_	_	_	_	O
6	immediately	_	immediately	_	RB	154	_	_	_	_	_	_	_	O
7	refer	_	refer	_	VB	154	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	154	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	154	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	154	_	_	_	_	_	type.n	Type	S-Subtype
11	2	_	2	_	CD	154	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	154	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	154	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	154	_	_	_	_	_	_	_	O
15	local	_	local	_	JJ	154	_	_	_	_	_	_	_	O
16	eye	_	eye	_	NN	154	_	_	_	_	_	_	_	O
17	screening	_	screening	_	NN	154	_	_	_	_	_	_	_	O
18	service	_	service	_	NN	154	_	_	_	_	_	_	_	O

1	on	_	On	_	IN	154	_	_	_	_	_	_	_	O
2	diagnosis	_	UNK	_	NN	154	_	_	_	_	_	_	_	O
3	,	_	,	_	,	154	_	_	_	_	_	_	_	O
4	gps	_	UNK	_	NNP	154	_	_	_	_	_	_	_	O
5	should	_	should	_	MD	154	_	_	_	_	_	_	_	O
6	immediately	_	immediately	_	RB	154	_	_	_	_	_	_	_	O
7	refer	_	refer	_	VB	154	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	154	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	154	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	154	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	154	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	154	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	154	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	154	_	_	_	_	_	_	_	O
15	local	_	local	_	JJ	154	_	_	_	_	_	local.a	Political_locales	B-Locale
16	eye	_	eye	_	NN	154	_	_	_	_	_	_	_	I-Locale
17	screening	_	screening	_	NN	154	_	_	_	_	_	_	_	I-Locale
18	service	_	service	_	NN	154	_	_	_	_	_	_	_	I-Locale

1	on	_	On	_	IN	154	_	_	_	_	_	_	_	O
2	diagnosis	_	UNK	_	NN	154	_	_	_	_	_	_	_	O
3	,	_	,	_	,	154	_	_	_	_	_	_	_	O
4	gps	_	UNK	_	NNP	154	_	_	_	_	_	_	_	O
5	should	_	should	_	MD	154	_	_	_	_	_	_	_	O
6	immediately	_	immediately	_	RB	154	_	_	_	_	_	_	_	O
7	refer	_	refer	_	VB	154	_	_	_	_	_	_	_	O
8	adults	_	adult	_	NNS	154	_	_	_	_	_	_	_	O
9	with	_	with	_	IN	154	_	_	_	_	_	_	_	O
10	type	_	type	_	JJ	154	_	_	_	_	_	_	_	O
11	2	_	2	_	CD	154	_	_	_	_	_	_	_	O
12	diabetes	_	UNK	_	NNS	154	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	154	_	_	_	_	_	_	_	O
14	the	_	the	_	DT	154	_	_	_	_	_	_	_	O
15	local	_	local	_	JJ	154	_	_	_	_	_	_	_	S-Possessor
16	eye	_	eye	_	NN	154	_	_	_	_	_	eye.n	Body_parts	S-Body_part
17	screening	_	screening	_	NN	154	_	_	_	_	_	_	_	O
18	service	_	service	_	NN	154	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	155	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	155	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	155	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	155	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	155	_	_	_	_	_	_	_	O
6	:	_	:	_	:	155	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	155	_	_	_	_	_	_	_	O
8	(	_	(	_	(	155	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	155	_	_	_	_	_	_	_	O
10	)	_	)	_	)	155	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	155	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	155	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	155	_	_	_	_	_	_	_	O
14	)	_	)	_	)	155	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	155	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	155	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	155	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	155	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	155	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	155	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	155	_	_	_	_	_	_	_	O
8	(	_	(	_	(	155	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	155	_	_	_	_	_	_	_	O
10	)	_	)	_	)	155	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	155	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	155	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	155	_	_	_	_	_	_	_	O
14	)	_	)	_	)	155	_	_	_	_	_	_	_	O

1	explain	_	UNK	_	VB	156	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	156	_	_	_	_	_	_	_	O
3	reasons	_	reason	_	NNS	156	_	_	_	_	_	reason.n	Reason	O
4	for	_	for	_	IN	156	_	_	_	_	_	_	_	O
5	,	_	,	_	,	156	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	156	_	_	_	_	_	_	_	O
7	success	_	success	_	NN	156	_	_	_	_	_	_	_	O
8	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
9	,	_	,	_	,	156	_	_	_	_	_	_	_	O
10	eye	_	eye	_	NN	156	_	_	_	_	_	_	_	O
11	screening	_	screen	_	VBG	156	_	_	_	_	_	_	_	O
12	systems	_	system	_	NNS	156	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	156	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	156	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	156	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	156	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	156	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	156	_	_	_	_	_	_	_	O
19	,	_	,	_	,	156	_	_	_	_	_	_	_	O
20	so	_	so	_	IN	156	_	_	_	_	_	_	_	O
21	that	_	that	_	DT	156	_	_	_	_	_	_	_	O
22	attendance	_	attendance	_	NN	156	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	156	_	_	_	_	_	_	_	O
24	not	_	not	_	RB	156	_	_	_	_	_	_	_	O
25	reduced	_	reduce	_	VBN	156	_	_	_	_	_	_	_	O
26	by	_	by	_	IN	156	_	_	_	_	_	_	_	O
27	lack	_	lack	_	NN	156	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
29	knowledge	_	knowledge	_	NN	156	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	156	_	_	_	_	_	_	_	O
31	fear	_	fear	_	NN	156	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
33	outcome	_	UNK	_	NN	156	_	_	_	_	_	_	_	O
34	.	_	.	_	.	156	_	_	_	_	_	_	_	O

1	explain	_	UNK	_	VB	156	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	156	_	_	_	_	_	_	_	O
3	reasons	_	reason	_	NNS	156	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	156	_	_	_	_	_	_	_	O
5	,	_	,	_	,	156	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	156	_	_	_	_	_	_	_	O
7	success	_	success	_	NN	156	_	_	_	_	_	success.n	Success_or_failure	O
8	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
9	,	_	,	_	,	156	_	_	_	_	_	_	_	O
10	eye	_	eye	_	NN	156	_	_	_	_	_	_	_	O
11	screening	_	screen	_	VBG	156	_	_	_	_	_	_	_	O
12	systems	_	system	_	NNS	156	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	156	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	156	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	156	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	156	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	156	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	156	_	_	_	_	_	_	_	O
19	,	_	,	_	,	156	_	_	_	_	_	_	_	O
20	so	_	so	_	IN	156	_	_	_	_	_	_	_	O
21	that	_	that	_	DT	156	_	_	_	_	_	_	_	O
22	attendance	_	attendance	_	NN	156	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	156	_	_	_	_	_	_	_	O
24	not	_	not	_	RB	156	_	_	_	_	_	_	_	O
25	reduced	_	reduce	_	VBN	156	_	_	_	_	_	_	_	O
26	by	_	by	_	IN	156	_	_	_	_	_	_	_	O
27	lack	_	lack	_	NN	156	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
29	knowledge	_	knowledge	_	NN	156	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	156	_	_	_	_	_	_	_	O
31	fear	_	fear	_	NN	156	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
33	outcome	_	UNK	_	NN	156	_	_	_	_	_	_	_	O
34	.	_	.	_	.	156	_	_	_	_	_	_	_	O

1	explain	_	UNK	_	VB	156	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	156	_	_	_	_	_	_	_	O
3	reasons	_	reason	_	NNS	156	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	156	_	_	_	_	_	_	_	O
5	,	_	,	_	,	156	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	156	_	_	_	_	_	_	_	O
7	success	_	success	_	NN	156	_	_	_	_	_	_	_	O
8	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
9	,	_	,	_	,	156	_	_	_	_	_	_	_	O
10	eye	_	eye	_	NN	156	_	_	_	_	_	eye.n	Body_parts	S-Body_part
11	screening	_	screen	_	VBG	156	_	_	_	_	_	_	_	O
12	systems	_	system	_	NNS	156	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	156	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	156	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	156	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	156	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	156	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	156	_	_	_	_	_	_	_	O
19	,	_	,	_	,	156	_	_	_	_	_	_	_	O
20	so	_	so	_	IN	156	_	_	_	_	_	_	_	O
21	that	_	that	_	DT	156	_	_	_	_	_	_	_	O
22	attendance	_	attendance	_	NN	156	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	156	_	_	_	_	_	_	_	O
24	not	_	not	_	RB	156	_	_	_	_	_	_	_	O
25	reduced	_	reduce	_	VBN	156	_	_	_	_	_	_	_	O
26	by	_	by	_	IN	156	_	_	_	_	_	_	_	O
27	lack	_	lack	_	NN	156	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
29	knowledge	_	knowledge	_	NN	156	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	156	_	_	_	_	_	_	_	O
31	fear	_	fear	_	NN	156	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
33	outcome	_	UNK	_	NN	156	_	_	_	_	_	_	_	O
34	.	_	.	_	.	156	_	_	_	_	_	_	_	O

1	explain	_	UNK	_	VB	156	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	156	_	_	_	_	_	_	_	O
3	reasons	_	reason	_	NNS	156	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	156	_	_	_	_	_	_	_	O
5	,	_	,	_	,	156	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	156	_	_	_	_	_	_	_	O
7	success	_	success	_	NN	156	_	_	_	_	_	_	_	O
8	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
9	,	_	,	_	,	156	_	_	_	_	_	_	_	O
10	eye	_	eye	_	NN	156	_	_	_	_	_	_	_	B-Function
11	screening	_	screen	_	VBG	156	_	_	_	_	_	_	_	I-Function
12	systems	_	system	_	NNS	156	_	_	_	_	_	system.n	System	S-Complex
13	to	_	to	_	TO	156	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	156	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	156	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	156	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	156	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	156	_	_	_	_	_	_	_	O
19	,	_	,	_	,	156	_	_	_	_	_	_	_	O
20	so	_	so	_	IN	156	_	_	_	_	_	_	_	O
21	that	_	that	_	DT	156	_	_	_	_	_	_	_	O
22	attendance	_	attendance	_	NN	156	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	156	_	_	_	_	_	_	_	O
24	not	_	not	_	RB	156	_	_	_	_	_	_	_	O
25	reduced	_	reduce	_	VBN	156	_	_	_	_	_	_	_	O
26	by	_	by	_	IN	156	_	_	_	_	_	_	_	O
27	lack	_	lack	_	NN	156	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
29	knowledge	_	knowledge	_	NN	156	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	156	_	_	_	_	_	_	_	O
31	fear	_	fear	_	NN	156	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
33	outcome	_	UNK	_	NN	156	_	_	_	_	_	_	_	O
34	.	_	.	_	.	156	_	_	_	_	_	_	_	O

1	explain	_	UNK	_	VB	156	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	156	_	_	_	_	_	_	_	O
3	reasons	_	reason	_	NNS	156	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	156	_	_	_	_	_	_	_	O
5	,	_	,	_	,	156	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	156	_	_	_	_	_	_	_	O
7	success	_	success	_	NN	156	_	_	_	_	_	_	_	O
8	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
9	,	_	,	_	,	156	_	_	_	_	_	_	_	O
10	eye	_	eye	_	NN	156	_	_	_	_	_	_	_	O
11	screening	_	screen	_	VBG	156	_	_	_	_	_	_	_	O
12	systems	_	system	_	NNS	156	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	156	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	156	_	_	_	_	_	adult.n	People_by_age	S-Person
15	with	_	with	_	IN	156	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	156	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	156	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	156	_	_	_	_	_	_	_	O
19	,	_	,	_	,	156	_	_	_	_	_	_	_	O
20	so	_	so	_	IN	156	_	_	_	_	_	_	_	O
21	that	_	that	_	DT	156	_	_	_	_	_	_	_	O
22	attendance	_	attendance	_	NN	156	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	156	_	_	_	_	_	_	_	O
24	not	_	not	_	RB	156	_	_	_	_	_	_	_	O
25	reduced	_	reduce	_	VBN	156	_	_	_	_	_	_	_	O
26	by	_	by	_	IN	156	_	_	_	_	_	_	_	O
27	lack	_	lack	_	NN	156	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
29	knowledge	_	knowledge	_	NN	156	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	156	_	_	_	_	_	_	_	O
31	fear	_	fear	_	NN	156	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
33	outcome	_	UNK	_	NN	156	_	_	_	_	_	_	_	O
34	.	_	.	_	.	156	_	_	_	_	_	_	_	O

1	explain	_	UNK	_	VB	156	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	156	_	_	_	_	_	_	_	O
3	reasons	_	reason	_	NNS	156	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	156	_	_	_	_	_	_	_	O
5	,	_	,	_	,	156	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	156	_	_	_	_	_	_	_	O
7	success	_	success	_	NN	156	_	_	_	_	_	_	_	O
8	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
9	,	_	,	_	,	156	_	_	_	_	_	_	_	O
10	eye	_	eye	_	NN	156	_	_	_	_	_	_	_	O
11	screening	_	screen	_	VBG	156	_	_	_	_	_	_	_	O
12	systems	_	system	_	NNS	156	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	156	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	156	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	156	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	156	_	_	_	_	_	type.n	Type	S-Subtype
17	2	_	2	_	CD	156	_	_	_	_	_	_	_	B-Category
18	diabetes	_	UNK	_	NNS	156	_	_	_	_	_	_	_	I-Category
19	,	_	,	_	,	156	_	_	_	_	_	_	_	O
20	so	_	so	_	IN	156	_	_	_	_	_	_	_	O
21	that	_	that	_	DT	156	_	_	_	_	_	_	_	O
22	attendance	_	attendance	_	NN	156	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	156	_	_	_	_	_	_	_	O
24	not	_	not	_	RB	156	_	_	_	_	_	_	_	O
25	reduced	_	reduce	_	VBN	156	_	_	_	_	_	_	_	O
26	by	_	by	_	IN	156	_	_	_	_	_	_	_	O
27	lack	_	lack	_	NN	156	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
29	knowledge	_	knowledge	_	NN	156	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	156	_	_	_	_	_	_	_	O
31	fear	_	fear	_	NN	156	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
33	outcome	_	UNK	_	NN	156	_	_	_	_	_	_	_	O
34	.	_	.	_	.	156	_	_	_	_	_	_	_	O

1	explain	_	UNK	_	VB	156	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	156	_	_	_	_	_	_	_	O
3	reasons	_	reason	_	NNS	156	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	156	_	_	_	_	_	_	_	O
5	,	_	,	_	,	156	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	156	_	_	_	_	_	_	_	O
7	success	_	success	_	NN	156	_	_	_	_	_	_	_	O
8	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
9	,	_	,	_	,	156	_	_	_	_	_	_	_	O
10	eye	_	eye	_	NN	156	_	_	_	_	_	_	_	O
11	screening	_	screen	_	VBG	156	_	_	_	_	_	_	_	O
12	systems	_	system	_	NNS	156	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	156	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	156	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	156	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	156	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	156	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	156	_	_	_	_	_	_	_	O
19	,	_	,	_	,	156	_	_	_	_	_	_	_	O
20	so	_	so	_	IN	156	_	_	_	_	_	_	_	O
21	that	_	that	_	DT	156	_	_	_	_	_	_	_	O
22	attendance	_	attendance	_	NN	156	_	_	_	_	_	attendance.n	Attending	O
23	is	_	be	_	VBZ	156	_	_	_	_	_	_	_	O
24	not	_	not	_	RB	156	_	_	_	_	_	_	_	O
25	reduced	_	reduce	_	VBN	156	_	_	_	_	_	_	_	O
26	by	_	by	_	IN	156	_	_	_	_	_	_	_	O
27	lack	_	lack	_	NN	156	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
29	knowledge	_	knowledge	_	NN	156	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	156	_	_	_	_	_	_	_	O
31	fear	_	fear	_	NN	156	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
33	outcome	_	UNK	_	NN	156	_	_	_	_	_	_	_	O
34	.	_	.	_	.	156	_	_	_	_	_	_	_	O

1	explain	_	UNK	_	VB	156	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	156	_	_	_	_	_	_	_	O
3	reasons	_	reason	_	NNS	156	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	156	_	_	_	_	_	_	_	O
5	,	_	,	_	,	156	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	156	_	_	_	_	_	_	_	O
7	success	_	success	_	NN	156	_	_	_	_	_	_	_	O
8	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
9	,	_	,	_	,	156	_	_	_	_	_	_	_	O
10	eye	_	eye	_	NN	156	_	_	_	_	_	_	_	O
11	screening	_	screen	_	VBG	156	_	_	_	_	_	_	_	O
12	systems	_	system	_	NNS	156	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	156	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	156	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	156	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	156	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	156	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	156	_	_	_	_	_	_	_	O
19	,	_	,	_	,	156	_	_	_	_	_	_	_	O
20	so	_	so	_	IN	156	_	_	_	_	_	_	_	O
21	that	_	that	_	DT	156	_	_	_	_	_	_	_	B-Item
22	attendance	_	attendance	_	NN	156	_	_	_	_	_	_	_	I-Item
23	is	_	be	_	VBZ	156	_	_	_	_	_	_	_	O
24	not	_	not	_	RB	156	_	_	_	_	_	_	_	O
25	reduced	_	reduce	_	VBN	156	_	_	_	_	_	reduce.v	Cause_change_of_position_on_a_scale	O
26	by	_	by	_	IN	156	_	_	_	_	_	_	_	B-Value_2
27	lack	_	lack	_	NN	156	_	_	_	_	_	_	_	I-Value_2
28	of	_	of	_	IN	156	_	_	_	_	_	_	_	I-Value_2
29	knowledge	_	knowledge	_	NN	156	_	_	_	_	_	_	_	I-Value_2
30	or	_	or	_	CC	156	_	_	_	_	_	_	_	O
31	fear	_	fear	_	NN	156	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
33	outcome	_	UNK	_	NN	156	_	_	_	_	_	_	_	O
34	.	_	.	_	.	156	_	_	_	_	_	_	_	O

1	explain	_	UNK	_	VB	156	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	156	_	_	_	_	_	_	_	O
3	reasons	_	reason	_	NNS	156	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	156	_	_	_	_	_	_	_	O
5	,	_	,	_	,	156	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	156	_	_	_	_	_	_	_	O
7	success	_	success	_	NN	156	_	_	_	_	_	_	_	O
8	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
9	,	_	,	_	,	156	_	_	_	_	_	_	_	O
10	eye	_	eye	_	NN	156	_	_	_	_	_	_	_	O
11	screening	_	screen	_	VBG	156	_	_	_	_	_	_	_	O
12	systems	_	system	_	NNS	156	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	156	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	156	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	156	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	156	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	156	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	156	_	_	_	_	_	_	_	O
19	,	_	,	_	,	156	_	_	_	_	_	_	_	O
20	so	_	so	_	IN	156	_	_	_	_	_	_	_	O
21	that	_	that	_	DT	156	_	_	_	_	_	_	_	O
22	attendance	_	attendance	_	NN	156	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	156	_	_	_	_	_	_	_	O
24	not	_	not	_	RB	156	_	_	_	_	_	_	_	O
25	reduced	_	reduce	_	VBN	156	_	_	_	_	_	_	_	O
26	by	_	by	_	IN	156	_	_	_	_	_	_	_	O
27	lack	_	lack	_	NN	156	_	_	_	_	_	lack.n	Possession	O
28	of	_	of	_	IN	156	_	_	_	_	_	_	_	B-Possession
29	knowledge	_	knowledge	_	NN	156	_	_	_	_	_	_	_	I-Possession
30	or	_	or	_	CC	156	_	_	_	_	_	_	_	O
31	fear	_	fear	_	NN	156	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
33	outcome	_	UNK	_	NN	156	_	_	_	_	_	_	_	O
34	.	_	.	_	.	156	_	_	_	_	_	_	_	O

1	explain	_	UNK	_	VB	156	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	156	_	_	_	_	_	_	_	O
3	reasons	_	reason	_	NNS	156	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	156	_	_	_	_	_	_	_	O
5	,	_	,	_	,	156	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	156	_	_	_	_	_	_	_	O
7	success	_	success	_	NN	156	_	_	_	_	_	_	_	O
8	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
9	,	_	,	_	,	156	_	_	_	_	_	_	_	O
10	eye	_	eye	_	NN	156	_	_	_	_	_	_	_	O
11	screening	_	screen	_	VBG	156	_	_	_	_	_	_	_	O
12	systems	_	system	_	NNS	156	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	156	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	156	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	156	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	156	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	156	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	156	_	_	_	_	_	_	_	O
19	,	_	,	_	,	156	_	_	_	_	_	_	_	O
20	so	_	so	_	IN	156	_	_	_	_	_	_	_	O
21	that	_	that	_	DT	156	_	_	_	_	_	_	_	O
22	attendance	_	attendance	_	NN	156	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	156	_	_	_	_	_	_	_	O
24	not	_	not	_	RB	156	_	_	_	_	_	_	_	O
25	reduced	_	reduce	_	VBN	156	_	_	_	_	_	_	_	O
26	by	_	by	_	IN	156	_	_	_	_	_	_	_	O
27	lack	_	lack	_	NN	156	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
29	knowledge	_	knowledge	_	NN	156	_	_	_	_	_	knowledge.n	Awareness	O
30	or	_	or	_	CC	156	_	_	_	_	_	_	_	O
31	fear	_	fear	_	NN	156	_	_	_	_	_	_	_	O
32	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
33	outcome	_	UNK	_	NN	156	_	_	_	_	_	_	_	O
34	.	_	.	_	.	156	_	_	_	_	_	_	_	O

1	explain	_	UNK	_	VB	156	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	156	_	_	_	_	_	_	_	O
3	reasons	_	reason	_	NNS	156	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	156	_	_	_	_	_	_	_	O
5	,	_	,	_	,	156	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	156	_	_	_	_	_	_	_	O
7	success	_	success	_	NN	156	_	_	_	_	_	_	_	O
8	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
9	,	_	,	_	,	156	_	_	_	_	_	_	_	O
10	eye	_	eye	_	NN	156	_	_	_	_	_	_	_	O
11	screening	_	screen	_	VBG	156	_	_	_	_	_	_	_	O
12	systems	_	system	_	NNS	156	_	_	_	_	_	_	_	O
13	to	_	to	_	TO	156	_	_	_	_	_	_	_	O
14	adults	_	adult	_	NNS	156	_	_	_	_	_	_	_	O
15	with	_	with	_	IN	156	_	_	_	_	_	_	_	O
16	type	_	type	_	JJ	156	_	_	_	_	_	_	_	O
17	2	_	2	_	CD	156	_	_	_	_	_	_	_	O
18	diabetes	_	UNK	_	NNS	156	_	_	_	_	_	_	_	O
19	,	_	,	_	,	156	_	_	_	_	_	_	_	O
20	so	_	so	_	IN	156	_	_	_	_	_	_	_	O
21	that	_	that	_	DT	156	_	_	_	_	_	_	_	O
22	attendance	_	attendance	_	NN	156	_	_	_	_	_	_	_	O
23	is	_	be	_	VBZ	156	_	_	_	_	_	_	_	O
24	not	_	not	_	RB	156	_	_	_	_	_	_	_	O
25	reduced	_	reduce	_	VBN	156	_	_	_	_	_	_	_	O
26	by	_	by	_	IN	156	_	_	_	_	_	_	_	O
27	lack	_	lack	_	NN	156	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	156	_	_	_	_	_	_	_	O
29	knowledge	_	knowledge	_	NN	156	_	_	_	_	_	_	_	O
30	or	_	or	_	CC	156	_	_	_	_	_	_	_	O
31	fear	_	fear	_	NN	156	_	_	_	_	_	fear.n	Fear	O
32	of	_	of	_	IN	156	_	_	_	_	_	_	_	B-Stimulus
33	outcome	_	UNK	_	NN	156	_	_	_	_	_	_	_	I-Stimulus
34	.	_	.	_	.	156	_	_	_	_	_	_	_	O

1	discussions	_	UNK	_	NNS	157	_	_	_	_	_	_	_	S-State_of_affairs
2	should	_	should	_	MD	157	_	_	_	_	_	should.v	Desirable_event	O
3	include	_	include	_	VB	157	_	_	_	_	_	_	_	O
4	precautions	_	precaution	_	NNS	157	_	_	_	_	_	_	_	B-State_of_affairs
5	for	_	for	_	IN	157	_	_	_	_	_	_	_	I-State_of_affairs
6	driving	_	UNK	_	NN	157	_	_	_	_	_	_	_	I-State_of_affairs
7	.	_	.	_	.	157	_	_	_	_	_	_	_	O

1	discussions	_	UNK	_	NNS	157	_	_	_	_	_	_	_	S-Total
2	should	_	should	_	MD	157	_	_	_	_	_	_	_	O
3	include	_	include	_	VB	157	_	_	_	_	_	include.v	Inclusion	O
4	precautions	_	precaution	_	NNS	157	_	_	_	_	_	_	_	B-Part
5	for	_	for	_	IN	157	_	_	_	_	_	_	_	I-Part
6	driving	_	UNK	_	NN	157	_	_	_	_	_	_	_	I-Part
7	.	_	.	_	.	157	_	_	_	_	_	_	_	O

1	depending	_	UNK	_	VBG	158	_	_	_	_	_	_	_	O
2	on	_	on	_	IN	158	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	158	_	_	_	_	_	_	_	O
4	findings	_	finding	_	NNS	158	_	_	_	_	_	finding.n	Documents	S-Document
5	,	_	,	_	,	158	_	_	_	_	_	_	_	O
6	follow	_	follow	_	VBP	158	_	_	_	_	_	_	_	O
7	structured	_	structure	_	VBN	158	_	_	_	_	_	_	_	O
8	eye	_	eye	_	NN	158	_	_	_	_	_	_	_	O
9	screening	_	screening	_	NN	158	_	_	_	_	_	_	_	O
10	by	_	by	_	IN	158	_	_	_	_	_	_	_	O
11	:	_	:	_	:	158	_	_	_	_	_	_	_	O
12	routine	_	routine	_	JJ	158	_	_	_	_	_	_	_	O
13	review	_	review	_	NN	158	_	_	_	_	_	_	_	O
14	in	_	in	_	IN	158	_	_	_	_	_	_	_	O
15	1	_	1	_	CD	158	_	_	_	_	_	_	_	O
16	year	_	year	_	NN	158	_	_	_	_	_	_	_	O
17	or	_	or	_	CC	158	_	_	_	_	_	_	_	O
18	earlier	_	earlier	_	JJR	158	_	_	_	_	_	_	_	O
19	review	_	review	_	NN	158	_	_	_	_	_	_	_	O
20	or	_	or	_	CC	158	_	_	_	_	_	_	_	O
21	referral	_	UNK	_	JJ	158	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	158	_	_	_	_	_	_	_	O
23	an	_	an	_	DT	158	_	_	_	_	_	_	_	O
24	ophthalmologist	_	UNK	_	NN	158	_	_	_	_	_	_	_	O
25	.	_	.	_	.	158	_	_	_	_	_	_	_	O

1	depending	_	UNK	_	VBG	158	_	_	_	_	_	_	_	O
2	on	_	on	_	IN	158	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	158	_	_	_	_	_	_	_	O
4	findings	_	finding	_	NNS	158	_	_	_	_	_	_	_	O
5	,	_	,	_	,	158	_	_	_	_	_	_	_	O
6	follow	_	follow	_	VBP	158	_	_	_	_	_	follow.v	Relative_time	O
7	structured	_	structure	_	VBN	158	_	_	_	_	_	_	_	B-Focal_occasion
8	eye	_	eye	_	NN	158	_	_	_	_	_	_	_	I-Focal_occasion
9	screening	_	screening	_	NN	158	_	_	_	_	_	_	_	I-Focal_occasion
10	by	_	by	_	IN	158	_	_	_	_	_	_	_	S-Explanation
11	:	_	:	_	:	158	_	_	_	_	_	_	_	O
12	routine	_	routine	_	JJ	158	_	_	_	_	_	_	_	O
13	review	_	review	_	NN	158	_	_	_	_	_	_	_	O
14	in	_	in	_	IN	158	_	_	_	_	_	_	_	O
15	1	_	1	_	CD	158	_	_	_	_	_	_	_	O
16	year	_	year	_	NN	158	_	_	_	_	_	_	_	O
17	or	_	or	_	CC	158	_	_	_	_	_	_	_	O
18	earlier	_	earlier	_	JJR	158	_	_	_	_	_	_	_	O
19	review	_	review	_	NN	158	_	_	_	_	_	_	_	O
20	or	_	or	_	CC	158	_	_	_	_	_	_	_	O
21	referral	_	UNK	_	JJ	158	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	158	_	_	_	_	_	_	_	O
23	an	_	an	_	DT	158	_	_	_	_	_	_	_	O
24	ophthalmologist	_	UNK	_	NN	158	_	_	_	_	_	_	_	O
25	.	_	.	_	.	158	_	_	_	_	_	_	_	O

1	depending	_	UNK	_	VBG	158	_	_	_	_	_	_	_	O
2	on	_	on	_	IN	158	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	158	_	_	_	_	_	_	_	O
4	findings	_	finding	_	NNS	158	_	_	_	_	_	_	_	O
5	,	_	,	_	,	158	_	_	_	_	_	_	_	O
6	follow	_	follow	_	VBP	158	_	_	_	_	_	_	_	O
7	structured	_	structure	_	VBN	158	_	_	_	_	_	_	_	O
8	eye	_	eye	_	NN	158	_	_	_	_	_	eye.n	Body_parts	S-Body_part
9	screening	_	screening	_	NN	158	_	_	_	_	_	_	_	O
10	by	_	by	_	IN	158	_	_	_	_	_	_	_	O
11	:	_	:	_	:	158	_	_	_	_	_	_	_	O
12	routine	_	routine	_	JJ	158	_	_	_	_	_	_	_	O
13	review	_	review	_	NN	158	_	_	_	_	_	_	_	O
14	in	_	in	_	IN	158	_	_	_	_	_	_	_	O
15	1	_	1	_	CD	158	_	_	_	_	_	_	_	O
16	year	_	year	_	NN	158	_	_	_	_	_	_	_	O
17	or	_	or	_	CC	158	_	_	_	_	_	_	_	O
18	earlier	_	earlier	_	JJR	158	_	_	_	_	_	_	_	O
19	review	_	review	_	NN	158	_	_	_	_	_	_	_	O
20	or	_	or	_	CC	158	_	_	_	_	_	_	_	O
21	referral	_	UNK	_	JJ	158	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	158	_	_	_	_	_	_	_	O
23	an	_	an	_	DT	158	_	_	_	_	_	_	_	O
24	ophthalmologist	_	UNK	_	NN	158	_	_	_	_	_	_	_	O
25	.	_	.	_	.	158	_	_	_	_	_	_	_	O

1	depending	_	UNK	_	VBG	158	_	_	_	_	_	_	_	O
2	on	_	on	_	IN	158	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	158	_	_	_	_	_	_	_	O
4	findings	_	finding	_	NNS	158	_	_	_	_	_	_	_	O
5	,	_	,	_	,	158	_	_	_	_	_	_	_	O
6	follow	_	follow	_	VBP	158	_	_	_	_	_	_	_	O
7	structured	_	structure	_	VBN	158	_	_	_	_	_	_	_	O
8	eye	_	eye	_	NN	158	_	_	_	_	_	_	_	O
9	screening	_	screening	_	NN	158	_	_	_	_	_	_	_	O
10	by	_	by	_	IN	158	_	_	_	_	_	_	_	O
11	:	_	:	_	:	158	_	_	_	_	_	_	_	O
12	routine	_	routine	_	JJ	158	_	_	_	_	_	_	_	O
13	review	_	review	_	NN	158	_	_	_	_	_	_	_	O
14	in	_	in	_	IN	158	_	_	_	_	_	_	_	O
15	1	_	1	_	CD	158	_	_	_	_	_	_	_	S-Relative_time
16	year	_	year	_	NN	158	_	_	_	_	_	year.n	Calendric_unit	S-Unit
17	or	_	or	_	CC	158	_	_	_	_	_	_	_	O
18	earlier	_	earlier	_	JJR	158	_	_	_	_	_	_	_	O
19	review	_	review	_	NN	158	_	_	_	_	_	_	_	O
20	or	_	or	_	CC	158	_	_	_	_	_	_	_	O
21	referral	_	UNK	_	JJ	158	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	158	_	_	_	_	_	_	_	O
23	an	_	an	_	DT	158	_	_	_	_	_	_	_	O
24	ophthalmologist	_	UNK	_	NN	158	_	_	_	_	_	_	_	O
25	.	_	.	_	.	158	_	_	_	_	_	_	_	O

1	depending	_	UNK	_	VBG	158	_	_	_	_	_	_	_	O
2	on	_	on	_	IN	158	_	_	_	_	_	_	_	O
3	the	_	the	_	DT	158	_	_	_	_	_	_	_	O
4	findings	_	finding	_	NNS	158	_	_	_	_	_	_	_	O
5	,	_	,	_	,	158	_	_	_	_	_	_	_	O
6	follow	_	follow	_	VBP	158	_	_	_	_	_	_	_	O
7	structured	_	structure	_	VBN	158	_	_	_	_	_	_	_	O
8	eye	_	eye	_	NN	158	_	_	_	_	_	_	_	O
9	screening	_	screening	_	NN	158	_	_	_	_	_	_	_	O
10	by	_	by	_	IN	158	_	_	_	_	_	_	_	O
11	:	_	:	_	:	158	_	_	_	_	_	_	_	O
12	routine	_	routine	_	JJ	158	_	_	_	_	_	_	_	O
13	review	_	review	_	NN	158	_	_	_	_	_	_	_	O
14	in	_	in	_	IN	158	_	_	_	_	_	_	_	O
15	1	_	1	_	CD	158	_	_	_	_	_	_	_	O
16	year	_	year	_	NN	158	_	_	_	_	_	_	_	O
17	or	_	or	_	CC	158	_	_	_	_	_	_	_	O
18	earlier	_	earlier	_	JJR	158	_	_	_	_	_	earlier.a	Temporal_subregion	S-Subpart
19	review	_	review	_	NN	158	_	_	_	_	_	_	_	S-Time_period
20	or	_	or	_	CC	158	_	_	_	_	_	_	_	O
21	referral	_	UNK	_	JJ	158	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	158	_	_	_	_	_	_	_	O
23	an	_	an	_	DT	158	_	_	_	_	_	_	_	O
24	ophthalmologist	_	UNK	_	NN	158	_	_	_	_	_	_	_	O
25	.	_	.	_	.	158	_	_	_	_	_	_	_	O

1	arrange	_	UNK	_	NNP	160	_	_	_	_	_	_	_	O
2	rapid	_	rapid	_	JJ	160	_	_	_	_	_	rapid.a	Taking_time	O
3	review	_	review	_	NN	160	_	_	_	_	_	_	_	S-Activity
4	by	_	by	_	IN	160	_	_	_	_	_	_	_	O
5	an	_	an	_	DT	160	_	_	_	_	_	_	_	O
6	ophthalmologist	_	UNK	_	NN	160	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	160	_	_	_	_	_	_	_	O
8	new	_	new	_	JJ	160	_	_	_	_	_	_	_	O
9	vessel	_	vessel	_	NN	160	_	_	_	_	_	_	_	O
10	formation	_	formation	_	NN	160	_	_	_	_	_	_	_	O
11	.	_	.	_	.	160	_	_	_	_	_	_	_	O

1	arrange	_	UNK	_	NNP	160	_	_	_	_	_	_	_	O
2	rapid	_	rapid	_	JJ	160	_	_	_	_	_	_	_	O
3	review	_	review	_	NN	160	_	_	_	_	_	_	_	O
4	by	_	by	_	IN	160	_	_	_	_	_	_	_	O
5	an	_	an	_	DT	160	_	_	_	_	_	_	_	O
6	ophthalmologist	_	UNK	_	NN	160	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	160	_	_	_	_	_	_	_	O
8	new	_	new	_	JJ	160	_	_	_	_	_	new.a	Age	S-Age
9	vessel	_	vessel	_	NN	160	_	_	_	_	_	_	_	B-Entity
10	formation	_	formation	_	NN	160	_	_	_	_	_	_	_	I-Entity
11	.	_	.	_	.	160	_	_	_	_	_	_	_	O

1	arrange	_	UNK	_	NNP	160	_	_	_	_	_	_	_	O
2	rapid	_	rapid	_	JJ	160	_	_	_	_	_	_	_	O
3	review	_	review	_	NN	160	_	_	_	_	_	_	_	O
4	by	_	by	_	IN	160	_	_	_	_	_	_	_	O
5	an	_	an	_	DT	160	_	_	_	_	_	_	_	O
6	ophthalmologist	_	UNK	_	NN	160	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	160	_	_	_	_	_	_	_	O
8	new	_	new	_	JJ	160	_	_	_	_	_	_	_	O
9	vessel	_	vessel	_	NN	160	_	_	_	_	_	vessel.n	Vehicle	S-Vehicle
10	formation	_	formation	_	NN	160	_	_	_	_	_	_	_	O
11	.	_	.	_	.	160	_	_	_	_	_	_	_	O

1	arrange	_	UNK	_	NNP	160	_	_	_	_	_	_	_	O
2	rapid	_	rapid	_	JJ	160	_	_	_	_	_	_	_	O
3	review	_	review	_	NN	160	_	_	_	_	_	_	_	O
4	by	_	by	_	IN	160	_	_	_	_	_	_	_	O
5	an	_	an	_	DT	160	_	_	_	_	_	_	_	O
6	ophthalmologist	_	UNK	_	NN	160	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	160	_	_	_	_	_	_	_	O
8	new	_	new	_	JJ	160	_	_	_	_	_	_	_	O
9	vessel	_	vessel	_	NN	160	_	_	_	_	_	_	_	S-Created_entity
10	formation	_	formation	_	NN	160	_	_	_	_	_	formation.n	Creating	O
11	.	_	.	_	.	160	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	161	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	161	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	161	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	161	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	161	_	_	_	_	_	_	_	O
6	:	_	:	_	:	161	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	161	_	_	_	_	_	_	_	O
8	(	_	(	_	(	161	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	161	_	_	_	_	_	_	_	O
10	)	_	)	_	)	161	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	161	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	161	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	161	_	_	_	_	_	_	_	O
14	)	_	)	_	)	161	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	161	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	161	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	161	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	161	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	161	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	161	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	161	_	_	_	_	_	_	_	O
8	(	_	(	_	(	161	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	161	_	_	_	_	_	_	_	O
10	)	_	)	_	)	161	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	161	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	161	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	161	_	_	_	_	_	_	_	O
14	)	_	)	_	)	161	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	162	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	162	_	_	_	_	_	aware.a	Awareness	O
3	that	_	that	_	IN	162	_	_	_	_	_	_	_	O
4	,	_	,	_	,	162	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	162	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	162	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	162	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	162	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	162	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	162	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	162	_	_	_	_	_	_	_	O
12	,	_	,	_	,	162	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	162	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	162	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	162	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	162	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	162	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	162	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	162	_	_	_	_	_	_	_	O
20	effective	_	effective	_	JJ	162	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	162	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	162	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	162	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	162	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	162	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	162	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	162	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	162	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	162	_	_	_	_	_	_	_	O
4	,	_	,	_	,	162	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	162	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	162	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	162	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	162	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	162	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	162	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	162	_	_	_	_	_	_	_	O
12	,	_	,	_	,	162	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	162	_	_	_	_	_	_	_	S-Entity
14	is	_	be	_	VBZ	162	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	162	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	162	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	162	_	_	_	_	_	effective.a	Usefulness	O
18	and	_	and	_	CC	162	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	162	_	_	_	_	_	_	_	O
20	effective	_	effective	_	JJ	162	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	162	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	162	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	162	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	162	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	162	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	162	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	162	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	162	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	162	_	_	_	_	_	_	_	O
4	,	_	,	_	,	162	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	162	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	162	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	162	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	162	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	162	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	162	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	162	_	_	_	_	_	_	_	O
12	,	_	,	_	,	162	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	162	_	_	_	_	_	_	_	S-Goods
14	is	_	be	_	VBZ	162	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	162	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	162	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	162	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	162	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	162	_	_	_	_	_	cost.n	Expensiveness	O
20	effective	_	effective	_	JJ	162	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	162	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	162	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	162	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	162	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	162	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	162	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	162	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	162	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	162	_	_	_	_	_	_	_	O
4	,	_	,	_	,	162	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	162	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	162	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	162	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	162	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	162	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	162	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	162	_	_	_	_	_	_	_	O
12	,	_	,	_	,	162	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	162	_	_	_	_	_	_	_	S-Entity
14	is	_	be	_	VBZ	162	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	162	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	162	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	162	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	162	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	162	_	_	_	_	_	_	_	O
20	effective	_	effective	_	JJ	162	_	_	_	_	_	effective.a	Usefulness	O
21	in	_	in	_	IN	162	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	162	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	162	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	162	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	162	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	162	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	162	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	162	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	162	_	_	_	_	_	_	_	O
4	,	_	,	_	,	162	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	162	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	162	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	162	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	162	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	162	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	162	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	162	_	_	_	_	_	_	_	O
12	,	_	,	_	,	162	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	162	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	162	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	162	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	162	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	162	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	162	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	162	_	_	_	_	_	_	_	O
20	effective	_	effective	_	JJ	162	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	162	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	162	_	_	_	_	_	adult.n	People_by_age	S-Person
23	with	_	with	_	IN	162	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	162	_	_	_	_	_	_	_	O
25	2	_	2	_	CD	162	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	162	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	162	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	162	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	162	_	_	_	_	_	_	_	O
4	,	_	,	_	,	162	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	162	_	_	_	_	_	_	_	O
6	metformin	_	UNK	_	VBN	162	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	162	_	_	_	_	_	_	_	O
8	contraindicated	_	UNK	_	VBN	162	_	_	_	_	_	_	_	O
9	or	_	or	_	CC	162	_	_	_	_	_	_	_	O
10	not	_	not	_	RB	162	_	_	_	_	_	_	_	O
11	tolerated	_	UNK	_	VBN	162	_	_	_	_	_	_	_	O
12	,	_	,	_	,	162	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NN	162	_	_	_	_	_	_	_	O
14	is	_	be	_	VBZ	162	_	_	_	_	_	_	_	O
15	both	_	both	_	DT	162	_	_	_	_	_	_	_	O
16	clinically	_	UNK	_	RB	162	_	_	_	_	_	_	_	O
17	effective	_	effective	_	JJ	162	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	162	_	_	_	_	_	_	_	O
19	cost	_	cost	_	NN	162	_	_	_	_	_	_	_	O
20	effective	_	effective	_	JJ	162	_	_	_	_	_	_	_	O
21	in	_	in	_	IN	162	_	_	_	_	_	_	_	O
22	adults	_	adult	_	NNS	162	_	_	_	_	_	_	_	O
23	with	_	with	_	IN	162	_	_	_	_	_	_	_	O
24	type	_	type	_	JJ	162	_	_	_	_	_	type.n	Type	S-Subtype
25	2	_	2	_	CD	162	_	_	_	_	_	_	_	O
26	diabetes	_	UNK	_	NNS	162	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	163	_	_	_	_	_	_	_	O
2	,	_	,	_	,	163	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	163	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	163	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	163	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	163	_	_	_	_	_	person.n	People	S-Person
7	for	_	for	_	IN	163	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	163	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	163	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	163	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	163	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	163	_	_	_	_	_	_	_	O
13	,	_	,	_	,	163	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	163	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	163	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	163	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	163	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	163	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	163	_	_	_	_	_	_	_	O
20	combination	_	combination	_	NN	163	_	_	_	_	_	_	_	O
21	containing	_	contain	_	VBG	163	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	163	_	_	_	_	_	_	_	O
23	that	_	that	_	WDT	163	_	_	_	_	_	_	_	O
24	can	_	can	_	MD	163	_	_	_	_	_	_	_	O
25	be	_	be	_	VB	163	_	_	_	_	_	_	_	O
26	offered	_	offer	_	VBN	163	_	_	_	_	_	_	_	O
27	at	_	at	_	IN	163	_	_	_	_	_	_	_	O
28	first	_	first	_	JJ	163	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	163	_	_	_	_	_	_	_	O
30	.	_	.	_	.	163	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	163	_	_	_	_	_	_	_	O
2	,	_	,	_	,	163	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	163	_	_	_	_	_	_	_	B-Item
4	with	_	with	_	IN	163	_	_	_	_	_	_	_	I-Item
5	any	_	any	_	DT	163	_	_	_	_	_	_	_	I-Item
6	person	_	person	_	NN	163	_	_	_	_	_	_	_	I-Item
7	for	_	for	_	IN	163	_	_	_	_	_	_	_	I-Item
8	whom	_	whom	_	WP	163	_	_	_	_	_	_	_	I-Item
9	unk	_	UNK	_	NN	163	_	_	_	_	_	_	_	I-Item
10	is	_	be	_	VBZ	163	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	163	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	163	_	_	_	_	_	consider.v	Categorization	O
13	,	_	,	_	,	163	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	163	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	163	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	163	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	163	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	163	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	163	_	_	_	_	_	_	_	O
20	combination	_	combination	_	NN	163	_	_	_	_	_	_	_	O
21	containing	_	contain	_	VBG	163	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	163	_	_	_	_	_	_	_	O
23	that	_	that	_	WDT	163	_	_	_	_	_	_	_	O
24	can	_	can	_	MD	163	_	_	_	_	_	_	_	O
25	be	_	be	_	VB	163	_	_	_	_	_	_	_	O
26	offered	_	offer	_	VBN	163	_	_	_	_	_	_	_	O
27	at	_	at	_	IN	163	_	_	_	_	_	_	_	O
28	first	_	first	_	JJ	163	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	163	_	_	_	_	_	_	_	O
30	.	_	.	_	.	163	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	163	_	_	_	_	_	_	_	O
2	,	_	,	_	,	163	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	163	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	163	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	163	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	163	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	163	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	163	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	163	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	163	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	163	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	163	_	_	_	_	_	_	_	O
13	,	_	,	_	,	163	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	163	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	163	_	_	_	_	_	there.adv	Locative_relation	S-Ground
16	is	_	be	_	VBZ	163	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	163	_	_	_	_	_	_	_	B-Ground
18	licensed	_	UNK	_	JJ	163	_	_	_	_	_	_	_	I-Ground
19	unk	_	UNK	_	JJ	163	_	_	_	_	_	_	_	I-Ground
20	combination	_	combination	_	NN	163	_	_	_	_	_	_	_	I-Ground
21	containing	_	contain	_	VBG	163	_	_	_	_	_	_	_	I-Ground
22	unk	_	UNK	_	NN	163	_	_	_	_	_	_	_	I-Ground
23	that	_	that	_	WDT	163	_	_	_	_	_	_	_	I-Ground
24	can	_	can	_	MD	163	_	_	_	_	_	_	_	I-Ground
25	be	_	be	_	VB	163	_	_	_	_	_	_	_	I-Ground
26	offered	_	offer	_	VBN	163	_	_	_	_	_	_	_	I-Ground
27	at	_	at	_	IN	163	_	_	_	_	_	_	_	I-Ground
28	first	_	first	_	JJ	163	_	_	_	_	_	_	_	I-Ground
29	intensification	_	UNK	_	NN	163	_	_	_	_	_	_	_	I-Ground
30	.	_	.	_	.	163	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	163	_	_	_	_	_	_	_	O
2	,	_	,	_	,	163	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	163	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	163	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	163	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	163	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	163	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	163	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	163	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	163	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	163	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	163	_	_	_	_	_	_	_	O
13	,	_	,	_	,	163	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	163	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	163	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	163	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	163	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	163	_	_	_	_	_	_	_	B-Aggregate_property
19	unk	_	UNK	_	JJ	163	_	_	_	_	_	_	_	I-Aggregate_property
20	combination	_	combination	_	NN	163	_	_	_	_	_	combination.n	Aggregate	S-Aggregate
21	containing	_	contain	_	VBG	163	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	163	_	_	_	_	_	_	_	O
23	that	_	that	_	WDT	163	_	_	_	_	_	_	_	O
24	can	_	can	_	MD	163	_	_	_	_	_	_	_	O
25	be	_	be	_	VB	163	_	_	_	_	_	_	_	O
26	offered	_	offer	_	VBN	163	_	_	_	_	_	_	_	O
27	at	_	at	_	IN	163	_	_	_	_	_	_	_	O
28	first	_	first	_	JJ	163	_	_	_	_	_	_	_	O
29	intensification	_	UNK	_	NN	163	_	_	_	_	_	_	_	O
30	.	_	.	_	.	163	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	163	_	_	_	_	_	_	_	O
2	,	_	,	_	,	163	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	163	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	163	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	163	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	163	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	163	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	163	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	163	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	163	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	163	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	163	_	_	_	_	_	_	_	O
13	,	_	,	_	,	163	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	163	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	163	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	163	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	163	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	163	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	163	_	_	_	_	_	_	_	O
20	combination	_	combination	_	NN	163	_	_	_	_	_	_	_	O
21	containing	_	contain	_	VBG	163	_	_	_	_	_	contain.v	Containing	O
22	unk	_	UNK	_	NN	163	_	_	_	_	_	_	_	B-Contents
23	that	_	that	_	WDT	163	_	_	_	_	_	_	_	I-Contents
24	can	_	can	_	MD	163	_	_	_	_	_	_	_	I-Contents
25	be	_	be	_	VB	163	_	_	_	_	_	_	_	I-Contents
26	offered	_	offer	_	VBN	163	_	_	_	_	_	_	_	I-Contents
27	at	_	at	_	IN	163	_	_	_	_	_	_	_	I-Contents
28	first	_	first	_	JJ	163	_	_	_	_	_	_	_	I-Contents
29	intensification	_	UNK	_	NN	163	_	_	_	_	_	_	_	I-Contents
30	.	_	.	_	.	163	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	163	_	_	_	_	_	_	_	O
2	,	_	,	_	,	163	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	163	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	163	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	163	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	163	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	163	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	163	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	163	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	163	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	163	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	163	_	_	_	_	_	_	_	O
13	,	_	,	_	,	163	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	163	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	163	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	163	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	163	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	163	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	163	_	_	_	_	_	_	_	O
20	combination	_	combination	_	NN	163	_	_	_	_	_	_	_	O
21	containing	_	contain	_	VBG	163	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	163	_	_	_	_	_	_	_	B-Entity
23	that	_	that	_	WDT	163	_	_	_	_	_	_	_	I-Entity
24	can	_	can	_	MD	163	_	_	_	_	_	can.v	Capability	O
25	be	_	be	_	VB	163	_	_	_	_	_	_	_	B-Event
26	offered	_	offer	_	VBN	163	_	_	_	_	_	_	_	I-Event
27	at	_	at	_	IN	163	_	_	_	_	_	_	_	I-Event
28	first	_	first	_	JJ	163	_	_	_	_	_	_	_	I-Event
29	intensification	_	UNK	_	NN	163	_	_	_	_	_	_	_	I-Event
30	.	_	.	_	.	163	_	_	_	_	_	_	_	O

1	however	_	However	_	RB	163	_	_	_	_	_	_	_	O
2	,	_	,	_	,	163	_	_	_	_	_	_	_	O
3	discuss	_	discus	_	NNS	163	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	163	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	163	_	_	_	_	_	_	_	O
6	person	_	person	_	NN	163	_	_	_	_	_	_	_	O
7	for	_	for	_	IN	163	_	_	_	_	_	_	_	O
8	whom	_	whom	_	WP	163	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	163	_	_	_	_	_	_	_	O
10	is	_	be	_	VBZ	163	_	_	_	_	_	_	_	O
11	being	_	be	_	VBG	163	_	_	_	_	_	_	_	O
12	considered	_	consider	_	VBN	163	_	_	_	_	_	_	_	O
13	,	_	,	_	,	163	_	_	_	_	_	_	_	O
14	that	_	that	_	IN	163	_	_	_	_	_	_	_	O
15	there	_	there	_	EX	163	_	_	_	_	_	_	_	O
16	is	_	be	_	VBZ	163	_	_	_	_	_	_	_	O
17	no	_	no	_	DT	163	_	_	_	_	_	_	_	O
18	licensed	_	UNK	_	JJ	163	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	163	_	_	_	_	_	_	_	O
20	combination	_	combination	_	NN	163	_	_	_	_	_	_	_	O
21	containing	_	contain	_	VBG	163	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	163	_	_	_	_	_	_	_	O
23	that	_	that	_	WDT	163	_	_	_	_	_	_	_	O
24	can	_	can	_	MD	163	_	_	_	_	_	_	_	O
25	be	_	be	_	VB	163	_	_	_	_	_	_	_	O
26	offered	_	offer	_	VBN	163	_	_	_	_	_	_	_	O
27	at	_	at	_	IN	163	_	_	_	_	_	_	_	O
28	first	_	first	_	JJ	163	_	_	_	_	_	first.a	Ordinal_numbers	O
29	intensification	_	UNK	_	NN	163	_	_	_	_	_	_	_	S-Type
30	.	_	.	_	.	163	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	164	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	164	_	_	_	_	_	risk.n	Run_risk	O
3	factors	_	factor	_	NNS	164	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	164	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	164	_	_	_	_	_	_	_	O
6	conditions	_	condition	_	NNS	164	_	_	_	_	_	_	_	O
7	,	_	,	_	,	164	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	164	_	_	_	_	_	_	_	O
9	increased	_	increase	_	VBN	164	_	_	_	_	_	_	_	O
10	age	_	age	_	NN	164	_	_	_	_	_	_	_	O
11	,	_	,	_	,	164	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	164	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	164	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	164	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	164	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	164	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	164	_	_	_	_	_	_	_	O
18	:	_	:	_	:	164	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	164	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	164	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	164	_	_	_	_	_	_	_	O
22	'	_	'	_	POS	164	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	164	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	164	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	164	_	_	_	_	_	_	_	O
26	characteristics	_	characteristic	_	NNS	164	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	164	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	164	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	164	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	164	_	_	_	_	_	_	_	O
3	factors	_	factor	_	NNS	164	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	164	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	164	_	_	_	_	_	_	_	B-Total
6	conditions	_	condition	_	NNS	164	_	_	_	_	_	_	_	I-Total
7	,	_	,	_	,	164	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	164	_	_	_	_	_	include.v	Inclusion	O
9	increased	_	increase	_	VBN	164	_	_	_	_	_	_	_	B-Part
10	age	_	age	_	NN	164	_	_	_	_	_	_	_	I-Part
11	,	_	,	_	,	164	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	164	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	164	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	164	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	164	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	164	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	164	_	_	_	_	_	_	_	O
18	:	_	:	_	:	164	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	164	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	164	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	164	_	_	_	_	_	_	_	O
22	'	_	'	_	POS	164	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	164	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	164	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	164	_	_	_	_	_	_	_	O
26	characteristics	_	characteristic	_	NNS	164	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	164	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	164	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	164	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	164	_	_	_	_	_	_	_	O
3	factors	_	factor	_	NNS	164	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	164	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	164	_	_	_	_	_	_	_	O
6	conditions	_	condition	_	NNS	164	_	_	_	_	_	_	_	O
7	,	_	,	_	,	164	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	164	_	_	_	_	_	_	_	O
9	increased	_	increase	_	VBN	164	_	_	_	_	_	increase.v	Change_position_on_a_scale	O
10	age	_	age	_	NN	164	_	_	_	_	_	_	_	S-Item
11	,	_	,	_	,	164	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	164	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	164	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	164	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	164	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	164	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	164	_	_	_	_	_	_	_	O
18	:	_	:	_	:	164	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	164	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	164	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	164	_	_	_	_	_	_	_	O
22	'	_	'	_	POS	164	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	164	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	164	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	164	_	_	_	_	_	_	_	O
26	characteristics	_	characteristic	_	NNS	164	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	164	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	164	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	164	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	164	_	_	_	_	_	_	_	O
3	factors	_	factor	_	NNS	164	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	164	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	164	_	_	_	_	_	_	_	O
6	conditions	_	condition	_	NNS	164	_	_	_	_	_	_	_	O
7	,	_	,	_	,	164	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	164	_	_	_	_	_	_	_	O
9	increased	_	increase	_	VBN	164	_	_	_	_	_	_	_	S-Relative_time
10	age	_	age	_	NN	164	_	_	_	_	_	age.n	Calendric_unit	S-Unit
11	,	_	,	_	,	164	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	164	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	164	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	164	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	164	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	164	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	164	_	_	_	_	_	_	_	O
18	:	_	:	_	:	164	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	164	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	164	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	164	_	_	_	_	_	_	_	O
22	'	_	'	_	POS	164	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	164	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	164	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	164	_	_	_	_	_	_	_	O
26	characteristics	_	characteristic	_	NNS	164	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	164	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	164	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	164	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	164	_	_	_	_	_	_	_	O
3	factors	_	factor	_	NNS	164	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	164	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	164	_	_	_	_	_	_	_	O
6	conditions	_	condition	_	NNS	164	_	_	_	_	_	_	_	O
7	,	_	,	_	,	164	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	164	_	_	_	_	_	_	_	O
9	increased	_	increase	_	VBN	164	_	_	_	_	_	_	_	O
10	age	_	age	_	NN	164	_	_	_	_	_	_	_	O
11	,	_	,	_	,	164	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	164	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	164	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	164	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	164	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	164	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	164	_	_	_	_	_	_	_	O
18	:	_	:	_	:	164	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	164	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	164	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	164	_	_	_	_	_	manufacturer.n	Manufacturing	S-Producer
22	'	_	'	_	POS	164	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	164	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	164	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	164	_	_	_	_	_	_	_	O
26	characteristics	_	characteristic	_	NNS	164	_	_	_	_	_	_	_	O
27	for	_	for	_	IN	164	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	164	_	_	_	_	_	_	_	O

1	known	_	UNK	_	VBN	164	_	_	_	_	_	_	_	O
2	risk	_	risk	_	NN	164	_	_	_	_	_	_	_	O
3	factors	_	factor	_	NNS	164	_	_	_	_	_	_	_	O
4	for	_	for	_	IN	164	_	_	_	_	_	_	_	O
5	these	_	these	_	DT	164	_	_	_	_	_	_	_	O
6	conditions	_	condition	_	NNS	164	_	_	_	_	_	_	_	O
7	,	_	,	_	,	164	_	_	_	_	_	_	_	O
8	including	_	include	_	VBG	164	_	_	_	_	_	_	_	O
9	increased	_	increase	_	VBN	164	_	_	_	_	_	_	_	O
10	age	_	age	_	NN	164	_	_	_	_	_	_	_	O
11	,	_	,	_	,	164	_	_	_	_	_	_	_	O
12	should	_	should	_	MD	164	_	_	_	_	_	_	_	O
13	be	_	be	_	VB	164	_	_	_	_	_	_	_	O
14	carefully	_	carefully	_	RB	164	_	_	_	_	_	_	_	O
15	evaluated	_	UNK	_	VBN	164	_	_	_	_	_	_	_	O
16	before	_	before	_	IN	164	_	_	_	_	_	_	_	O
17	treatment	_	treatment	_	NN	164	_	_	_	_	_	_	_	O
18	:	_	:	_	:	164	_	_	_	_	_	_	_	O
19	see	_	see	_	VB	164	_	_	_	_	_	_	_	O
20	the	_	the	_	DT	164	_	_	_	_	_	_	_	O
21	manufacturers	_	manufacturer	_	NNS	164	_	_	_	_	_	_	_	O
22	'	_	'	_	POS	164	_	_	_	_	_	_	_	O
23	summaries	_	summary	_	NNS	164	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	164	_	_	_	_	_	_	_	O
25	product	_	product	_	NN	164	_	_	_	_	_	_	_	S-Entity
26	characteristics	_	characteristic	_	NNS	164	_	_	_	_	_	characteristic.n	Distinctiveness	O
27	for	_	for	_	IN	164	_	_	_	_	_	_	_	O
28	details	_	detail	_	NNS	164	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	165	_	_	_	_	_	_	_	B-Speaker
2	and	_	and	_	CC	165	_	_	_	_	_	_	_	I-Speaker
3	healthcare	_	UNK	_	NNP	165	_	_	_	_	_	_	_	I-Speaker
4	products	_	product	_	NNS	165	_	_	_	_	_	_	_	I-Speaker
5	regulatory	_	Regulatory	_	NNP	165	_	_	_	_	_	_	_	I-Speaker
6	agency	_	Agency	_	NNP	165	_	_	_	_	_	_	_	I-Speaker
7	(	_	(	_	(	165	_	_	_	_	_	_	_	I-Speaker
8	mhra	_	UNK	_	NNP	165	_	_	_	_	_	_	_	I-Speaker
9	)	_	)	_	)	165	_	_	_	_	_	_	_	I-Speaker
10	guidance	_	guidance	_	NN	165	_	_	_	_	_	_	_	I-Speaker
11	(	_	(	_	(	165	_	_	_	_	_	_	_	I-Speaker
12	2011	_	2011	_	CD	165	_	_	_	_	_	_	_	I-Speaker
13	)	_	)	_	)	165	_	_	_	_	_	_	_	I-Speaker
14	advises	_	advise	_	VBZ	165	_	_	_	_	_	advise.v	Telling	O
15	that	_	that	_	IN	165	_	_	_	_	_	_	_	B-Message
16	unk	_	UNK	_	NNS	165	_	_	_	_	_	_	_	I-Message
17	should	_	should	_	MD	165	_	_	_	_	_	_	_	I-Message
18	review	_	review	_	VB	165	_	_	_	_	_	_	_	I-Message
19	the	_	the	_	DT	165	_	_	_	_	_	_	_	I-Message
20	safety	_	safety	_	NN	165	_	_	_	_	_	_	_	I-Message
21	and	_	and	_	CC	165	_	_	_	_	_	_	_	I-Message
22	efficacy	_	UNK	_	NN	165	_	_	_	_	_	_	_	I-Message
23	of	_	of	_	IN	165	_	_	_	_	_	_	_	I-Message
24	pioglitazone	_	UNK	_	NN	165	_	_	_	_	_	_	_	I-Message
25	in	_	in	_	IN	165	_	_	_	_	_	_	_	I-Message
26	individuals	_	individual	_	NNS	165	_	_	_	_	_	_	_	I-Message
27	after	_	after	_	IN	165	_	_	_	_	_	_	_	I-Message
28	unk	_	UNK	_	CD	165	_	_	_	_	_	_	_	I-Message
29	months	_	month	_	NNS	165	_	_	_	_	_	_	_	I-Message
30	of	_	of	_	IN	165	_	_	_	_	_	_	_	I-Message
31	treatment	_	treatment	_	NN	165	_	_	_	_	_	_	_	I-Message
32	to	_	to	_	TO	165	_	_	_	_	_	_	_	I-Message
33	ensure	_	ensure	_	VB	165	_	_	_	_	_	_	_	I-Message
34	that	_	that	_	IN	165	_	_	_	_	_	_	_	I-Message
35	only	_	only	_	JJ	165	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	165	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	165	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	165	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	165	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	165	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	165	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	165	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	165	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	165	_	_	_	_	_	_	_	O
45	'	_	'	_	POS	165	_	_	_	_	_	_	_	O
46	.	_	.	_	.	165	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	165	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	165	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	165	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	165	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	165	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	165	_	_	_	_	_	_	_	O
7	(	_	(	_	(	165	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	165	_	_	_	_	_	_	_	O
9	)	_	)	_	)	165	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	165	_	_	_	_	_	_	_	O
11	(	_	(	_	(	165	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	165	_	_	_	_	_	_	_	O
13	)	_	)	_	)	165	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	165	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	165	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	165	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	165	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	165	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	165	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	165	_	_	_	_	_	safety.n	Being_at_risk	O
21	and	_	and	_	CC	165	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	165	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	165	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	165	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	165	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	165	_	_	_	_	_	_	_	O
27	after	_	after	_	IN	165	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	165	_	_	_	_	_	_	_	O
29	months	_	month	_	NNS	165	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	165	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	165	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	165	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	165	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	165	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	165	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	165	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	165	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	165	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	165	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	165	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	165	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	165	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	165	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	165	_	_	_	_	_	_	_	O
45	'	_	'	_	POS	165	_	_	_	_	_	_	_	O
46	.	_	.	_	.	165	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	165	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	165	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	165	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	165	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	165	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	165	_	_	_	_	_	_	_	O
7	(	_	(	_	(	165	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	165	_	_	_	_	_	_	_	O
9	)	_	)	_	)	165	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	165	_	_	_	_	_	_	_	O
11	(	_	(	_	(	165	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	165	_	_	_	_	_	_	_	O
13	)	_	)	_	)	165	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	165	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	165	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	165	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	165	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	165	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	165	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	165	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	165	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	165	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	165	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	165	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	165	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	165	_	_	_	_	_	individual.n	People	S-Person
27	after	_	after	_	IN	165	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	165	_	_	_	_	_	_	_	O
29	months	_	month	_	NNS	165	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	165	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	165	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	165	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	165	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	165	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	165	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	165	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	165	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	165	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	165	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	165	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	165	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	165	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	165	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	165	_	_	_	_	_	_	_	O
45	'	_	'	_	POS	165	_	_	_	_	_	_	_	O
46	.	_	.	_	.	165	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	165	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	165	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	165	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	165	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	165	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	165	_	_	_	_	_	_	_	O
7	(	_	(	_	(	165	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	165	_	_	_	_	_	_	_	O
9	)	_	)	_	)	165	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	165	_	_	_	_	_	_	_	O
11	(	_	(	_	(	165	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	165	_	_	_	_	_	_	_	O
13	)	_	)	_	)	165	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	165	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	165	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	165	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	165	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	165	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	165	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	165	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	165	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	165	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	165	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	165	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	165	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	165	_	_	_	_	_	_	_	O
27	after	_	after	_	IN	165	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	165	_	_	_	_	_	_	_	S-Count
29	months	_	month	_	NNS	165	_	_	_	_	_	month.n	Calendric_unit	S-Unit
30	of	_	of	_	IN	165	_	_	_	_	_	_	_	B-Whole
31	treatment	_	treatment	_	NN	165	_	_	_	_	_	_	_	I-Whole
32	to	_	to	_	TO	165	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	165	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	165	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	165	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	165	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	165	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	165	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	165	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	165	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	165	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	165	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	165	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	165	_	_	_	_	_	_	_	O
45	'	_	'	_	POS	165	_	_	_	_	_	_	_	O
46	.	_	.	_	.	165	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	165	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	165	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	165	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	165	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	165	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	165	_	_	_	_	_	_	_	O
7	(	_	(	_	(	165	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	165	_	_	_	_	_	_	_	O
9	)	_	)	_	)	165	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	165	_	_	_	_	_	_	_	O
11	(	_	(	_	(	165	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	165	_	_	_	_	_	_	_	O
13	)	_	)	_	)	165	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	165	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	165	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	165	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	165	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	165	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	165	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	165	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	165	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	165	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	165	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	165	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	165	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	165	_	_	_	_	_	_	_	O
27	after	_	after	_	IN	165	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	165	_	_	_	_	_	_	_	O
29	months	_	month	_	NNS	165	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	165	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	165	_	_	_	_	_	treatment.n	Cure	S-Patient
32	to	_	to	_	TO	165	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	165	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	165	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	165	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	165	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	165	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	165	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	165	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	165	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	165	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	165	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	165	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	165	_	_	_	_	_	_	_	O
45	'	_	'	_	POS	165	_	_	_	_	_	_	_	O
46	.	_	.	_	.	165	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	165	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	165	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	165	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	165	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	165	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	165	_	_	_	_	_	_	_	O
7	(	_	(	_	(	165	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	165	_	_	_	_	_	_	_	O
9	)	_	)	_	)	165	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	165	_	_	_	_	_	_	_	O
11	(	_	(	_	(	165	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	165	_	_	_	_	_	_	_	O
13	)	_	)	_	)	165	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	165	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	165	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	165	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	165	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	165	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	165	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	165	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	165	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	165	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	165	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	165	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	165	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	165	_	_	_	_	_	_	_	O
27	after	_	after	_	IN	165	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	165	_	_	_	_	_	_	_	O
29	months	_	month	_	NNS	165	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	165	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	165	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	165	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	165	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	165	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	165	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	165	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	165	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	165	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	165	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	165	_	_	_	_	_	_	_	S-Manner
41	continue	_	continue	_	NN	165	_	_	_	_	_	continue.v	Process_continue	O
42	to	_	to	_	TO	165	_	_	_	_	_	_	_	B-Event
43	be	_	be	_	VB	165	_	_	_	_	_	_	_	I-Event
44	treated	_	treat	_	VBN	165	_	_	_	_	_	_	_	I-Event
45	'	_	'	_	POS	165	_	_	_	_	_	_	_	I-Event
46	.	_	.	_	.	165	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	165	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	165	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	165	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	165	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	165	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	165	_	_	_	_	_	_	_	O
7	(	_	(	_	(	165	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	165	_	_	_	_	_	_	_	O
9	)	_	)	_	)	165	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	165	_	_	_	_	_	_	_	O
11	(	_	(	_	(	165	_	_	_	_	_	_	_	O
12	2011	_	2011	_	CD	165	_	_	_	_	_	_	_	O
13	)	_	)	_	)	165	_	_	_	_	_	_	_	O
14	advises	_	advise	_	VBZ	165	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	165	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	165	_	_	_	_	_	_	_	O
17	should	_	should	_	MD	165	_	_	_	_	_	_	_	O
18	review	_	review	_	VB	165	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	165	_	_	_	_	_	_	_	O
20	safety	_	safety	_	NN	165	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	165	_	_	_	_	_	_	_	O
22	efficacy	_	UNK	_	NN	165	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	165	_	_	_	_	_	_	_	O
24	pioglitazone	_	UNK	_	NN	165	_	_	_	_	_	_	_	O
25	in	_	in	_	IN	165	_	_	_	_	_	_	_	O
26	individuals	_	individual	_	NNS	165	_	_	_	_	_	_	_	O
27	after	_	after	_	IN	165	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	CD	165	_	_	_	_	_	_	_	O
29	months	_	month	_	NNS	165	_	_	_	_	_	_	_	O
30	of	_	of	_	IN	165	_	_	_	_	_	_	_	O
31	treatment	_	treatment	_	NN	165	_	_	_	_	_	_	_	O
32	to	_	to	_	TO	165	_	_	_	_	_	_	_	O
33	ensure	_	ensure	_	VB	165	_	_	_	_	_	_	_	O
34	that	_	that	_	IN	165	_	_	_	_	_	_	_	O
35	only	_	only	_	JJ	165	_	_	_	_	_	_	_	O
36	patients	_	patient	_	NNS	165	_	_	_	_	_	_	_	O
37	who	_	who	_	WP	165	_	_	_	_	_	_	_	O
38	are	_	be	_	VBP	165	_	_	_	_	_	_	_	O
39	deriving	_	derive	_	VBG	165	_	_	_	_	_	_	_	O
40	benefit	_	benefit	_	NN	165	_	_	_	_	_	_	_	O
41	continue	_	continue	_	NN	165	_	_	_	_	_	_	_	O
42	to	_	to	_	TO	165	_	_	_	_	_	_	_	O
43	be	_	be	_	VB	165	_	_	_	_	_	_	_	O
44	treated	_	treat	_	VBN	165	_	_	_	_	_	treat.v	Medical_intervention	O
45	'	_	'	_	POS	165	_	_	_	_	_	_	_	S-Patient
46	.	_	.	_	.	165	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	166	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	166	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	166	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	166	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	166	_	_	_	_	_	_	_	O
6	:	_	:	_	:	166	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	166	_	_	_	_	_	_	_	O
8	(	_	(	_	(	166	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	166	_	_	_	_	_	_	_	O
10	)	_	)	_	)	166	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	166	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	166	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	166	_	_	_	_	_	_	_	O
14	)	_	)	_	)	166	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	166	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	166	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	166	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	166	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	166	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	166	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	166	_	_	_	_	_	_	_	O
8	(	_	(	_	(	166	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	166	_	_	_	_	_	_	_	O
10	)	_	)	_	)	166	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	166	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	166	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	166	_	_	_	_	_	_	_	O
14	)	_	)	_	)	166	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	167	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	167	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	167	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	167	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	167	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	167	_	_	_	_	_	_	_	O
7	(	_	(	_	(	167	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	167	_	_	_	_	_	_	_	O
9	)	_	)	_	)	167	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	167	_	_	_	_	_	_	_	O
11	(	_	(	_	(	167	_	_	_	_	_	_	_	O
12	2016	_	UNK	_	CD	167	_	_	_	_	_	_	_	O
13	)	_	)	_	)	167	_	_	_	_	_	_	_	O
14	warned	_	warn	_	VBD	167	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	167	_	_	_	_	_	_	_	O
16	serious	_	serious	_	JJ	167	_	_	_	_	_	_	_	O
17	,	_	,	_	,	167	_	_	_	_	_	_	_	O
18	life-threatening	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
19	,	_	,	_	,	167	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	167	_	_	_	_	_	_	_	O
21	fatal	_	fatal	_	JJ	167	_	_	_	_	_	fatal.a	Killing	O
22	cases	_	case	_	NNS	167	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	167	_	_	_	_	_	_	_	O
24	diabetic	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
25	ketoacidosis	_	UNK	_	NN	167	_	_	_	_	_	_	_	O
26	have	_	have	_	VBP	167	_	_	_	_	_	_	_	O
27	been	_	be	_	VBN	167	_	_	_	_	_	_	_	O
28	reported	_	report	_	VBN	167	_	_	_	_	_	_	_	O
29	rarely	_	UNK	_	RB	167	_	_	_	_	_	_	_	O
30	in	_	in	_	IN	167	_	_	_	_	_	_	_	O
31	people	_	people	_	NNS	167	_	_	_	_	_	_	_	O
32	taking	_	take	_	VBG	167	_	_	_	_	_	_	_	O
33	an	_	an	_	DT	167	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
35	inhibitor	_	UNK	_	NN	167	_	_	_	_	_	_	_	O
36	(	_	(	_	(	167	_	_	_	_	_	_	_	O
37	a	_	a	_	DT	167	_	_	_	_	_	_	_	O
38	substantial	_	substantial	_	JJ	167	_	_	_	_	_	_	_	O
39	proportion	_	proportion	_	NN	167	_	_	_	_	_	_	_	O
40	of	_	of	_	IN	167	_	_	_	_	_	_	_	O
41	the	_	the	_	DT	167	_	_	_	_	_	_	_	O
42	cases	_	case	_	NNS	167	_	_	_	_	_	_	_	O
43	concerned	_	concerned	_	JJ	167	_	_	_	_	_	_	_	O
44	off-label	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
45	use	_	use	_	NN	167	_	_	_	_	_	_	_	O
46	in	_	in	_	IN	167	_	_	_	_	_	_	_	O
47	people	_	people	_	NNS	167	_	_	_	_	_	_	_	O
48	with	_	with	_	IN	167	_	_	_	_	_	_	_	O
49	type	_	type	_	JJ	167	_	_	_	_	_	_	_	O
50	1	_	1	_	CD	167	_	_	_	_	_	_	_	O
51	diabetes	_	UNK	_	NNS	167	_	_	_	_	_	_	_	O
52	,	_	,	_	,	167	_	_	_	_	_	_	_	O
53	which	_	which	_	WDT	167	_	_	_	_	_	_	_	O
54	is	_	be	_	VBZ	167	_	_	_	_	_	_	_	O
55	not	_	not	_	RB	167	_	_	_	_	_	_	_	O
56	recommended	_	recommend	_	VBN	167	_	_	_	_	_	_	_	O
57	)	_	)	_	)	167	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	167	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	167	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	167	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	167	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	167	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	167	_	_	_	_	_	_	_	O
7	(	_	(	_	(	167	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	167	_	_	_	_	_	_	_	O
9	)	_	)	_	)	167	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	167	_	_	_	_	_	_	_	O
11	(	_	(	_	(	167	_	_	_	_	_	_	_	O
12	2016	_	UNK	_	CD	167	_	_	_	_	_	_	_	O
13	)	_	)	_	)	167	_	_	_	_	_	_	_	O
14	warned	_	warn	_	VBD	167	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	167	_	_	_	_	_	_	_	O
16	serious	_	serious	_	JJ	167	_	_	_	_	_	_	_	O
17	,	_	,	_	,	167	_	_	_	_	_	_	_	O
18	life-threatening	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
19	,	_	,	_	,	167	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	167	_	_	_	_	_	_	_	O
21	fatal	_	fatal	_	JJ	167	_	_	_	_	_	_	_	S-Incident
22	cases	_	case	_	NNS	167	_	_	_	_	_	case.n	Criminal_investigation	O
23	of	_	of	_	IN	167	_	_	_	_	_	_	_	B-Suspect
24	diabetic	_	UNK	_	JJ	167	_	_	_	_	_	_	_	I-Suspect
25	ketoacidosis	_	UNK	_	NN	167	_	_	_	_	_	_	_	I-Suspect
26	have	_	have	_	VBP	167	_	_	_	_	_	_	_	O
27	been	_	be	_	VBN	167	_	_	_	_	_	_	_	O
28	reported	_	report	_	VBN	167	_	_	_	_	_	_	_	O
29	rarely	_	UNK	_	RB	167	_	_	_	_	_	_	_	O
30	in	_	in	_	IN	167	_	_	_	_	_	_	_	O
31	people	_	people	_	NNS	167	_	_	_	_	_	_	_	O
32	taking	_	take	_	VBG	167	_	_	_	_	_	_	_	O
33	an	_	an	_	DT	167	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
35	inhibitor	_	UNK	_	NN	167	_	_	_	_	_	_	_	O
36	(	_	(	_	(	167	_	_	_	_	_	_	_	O
37	a	_	a	_	DT	167	_	_	_	_	_	_	_	O
38	substantial	_	substantial	_	JJ	167	_	_	_	_	_	_	_	O
39	proportion	_	proportion	_	NN	167	_	_	_	_	_	_	_	O
40	of	_	of	_	IN	167	_	_	_	_	_	_	_	O
41	the	_	the	_	DT	167	_	_	_	_	_	_	_	O
42	cases	_	case	_	NNS	167	_	_	_	_	_	_	_	O
43	concerned	_	concerned	_	JJ	167	_	_	_	_	_	_	_	O
44	off-label	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
45	use	_	use	_	NN	167	_	_	_	_	_	_	_	O
46	in	_	in	_	IN	167	_	_	_	_	_	_	_	O
47	people	_	people	_	NNS	167	_	_	_	_	_	_	_	O
48	with	_	with	_	IN	167	_	_	_	_	_	_	_	O
49	type	_	type	_	JJ	167	_	_	_	_	_	_	_	O
50	1	_	1	_	CD	167	_	_	_	_	_	_	_	O
51	diabetes	_	UNK	_	NNS	167	_	_	_	_	_	_	_	O
52	,	_	,	_	,	167	_	_	_	_	_	_	_	O
53	which	_	which	_	WDT	167	_	_	_	_	_	_	_	O
54	is	_	be	_	VBZ	167	_	_	_	_	_	_	_	O
55	not	_	not	_	RB	167	_	_	_	_	_	_	_	O
56	recommended	_	recommend	_	VBN	167	_	_	_	_	_	_	_	O
57	)	_	)	_	)	167	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	167	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	167	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	167	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	167	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	167	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	167	_	_	_	_	_	_	_	O
7	(	_	(	_	(	167	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	167	_	_	_	_	_	_	_	O
9	)	_	)	_	)	167	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	167	_	_	_	_	_	_	_	O
11	(	_	(	_	(	167	_	_	_	_	_	_	_	O
12	2016	_	UNK	_	CD	167	_	_	_	_	_	_	_	O
13	)	_	)	_	)	167	_	_	_	_	_	_	_	O
14	warned	_	warn	_	VBD	167	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	167	_	_	_	_	_	_	_	O
16	serious	_	serious	_	JJ	167	_	_	_	_	_	_	_	O
17	,	_	,	_	,	167	_	_	_	_	_	_	_	O
18	life-threatening	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
19	,	_	,	_	,	167	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	167	_	_	_	_	_	_	_	O
21	fatal	_	fatal	_	JJ	167	_	_	_	_	_	_	_	B-Message
22	cases	_	case	_	NNS	167	_	_	_	_	_	_	_	I-Message
23	of	_	of	_	IN	167	_	_	_	_	_	_	_	I-Message
24	diabetic	_	UNK	_	JJ	167	_	_	_	_	_	_	_	I-Message
25	ketoacidosis	_	UNK	_	NN	167	_	_	_	_	_	_	_	I-Message
26	have	_	have	_	VBP	167	_	_	_	_	_	_	_	O
27	been	_	be	_	VBN	167	_	_	_	_	_	_	_	O
28	reported	_	report	_	VBN	167	_	_	_	_	_	report.v	Statement	O
29	rarely	_	UNK	_	RB	167	_	_	_	_	_	_	_	B-Message
30	in	_	in	_	IN	167	_	_	_	_	_	_	_	I-Message
31	people	_	people	_	NNS	167	_	_	_	_	_	_	_	I-Message
32	taking	_	take	_	VBG	167	_	_	_	_	_	_	_	I-Message
33	an	_	an	_	DT	167	_	_	_	_	_	_	_	I-Message
34	unk	_	UNK	_	JJ	167	_	_	_	_	_	_	_	I-Message
35	inhibitor	_	UNK	_	NN	167	_	_	_	_	_	_	_	I-Message
36	(	_	(	_	(	167	_	_	_	_	_	_	_	I-Message
37	a	_	a	_	DT	167	_	_	_	_	_	_	_	I-Message
38	substantial	_	substantial	_	JJ	167	_	_	_	_	_	_	_	I-Message
39	proportion	_	proportion	_	NN	167	_	_	_	_	_	_	_	I-Message
40	of	_	of	_	IN	167	_	_	_	_	_	_	_	I-Message
41	the	_	the	_	DT	167	_	_	_	_	_	_	_	I-Message
42	cases	_	case	_	NNS	167	_	_	_	_	_	_	_	I-Message
43	concerned	_	concerned	_	JJ	167	_	_	_	_	_	_	_	I-Message
44	off-label	_	UNK	_	JJ	167	_	_	_	_	_	_	_	I-Message
45	use	_	use	_	NN	167	_	_	_	_	_	_	_	I-Message
46	in	_	in	_	IN	167	_	_	_	_	_	_	_	I-Message
47	people	_	people	_	NNS	167	_	_	_	_	_	_	_	I-Message
48	with	_	with	_	IN	167	_	_	_	_	_	_	_	I-Message
49	type	_	type	_	JJ	167	_	_	_	_	_	_	_	O
50	1	_	1	_	CD	167	_	_	_	_	_	_	_	O
51	diabetes	_	UNK	_	NNS	167	_	_	_	_	_	_	_	O
52	,	_	,	_	,	167	_	_	_	_	_	_	_	O
53	which	_	which	_	WDT	167	_	_	_	_	_	_	_	O
54	is	_	be	_	VBZ	167	_	_	_	_	_	_	_	O
55	not	_	not	_	RB	167	_	_	_	_	_	_	_	O
56	recommended	_	recommend	_	VBN	167	_	_	_	_	_	_	_	O
57	)	_	)	_	)	167	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	167	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	167	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	167	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	167	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	167	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	167	_	_	_	_	_	_	_	O
7	(	_	(	_	(	167	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	167	_	_	_	_	_	_	_	O
9	)	_	)	_	)	167	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	167	_	_	_	_	_	_	_	O
11	(	_	(	_	(	167	_	_	_	_	_	_	_	O
12	2016	_	UNK	_	CD	167	_	_	_	_	_	_	_	O
13	)	_	)	_	)	167	_	_	_	_	_	_	_	O
14	warned	_	warn	_	VBD	167	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	167	_	_	_	_	_	_	_	O
16	serious	_	serious	_	JJ	167	_	_	_	_	_	_	_	O
17	,	_	,	_	,	167	_	_	_	_	_	_	_	O
18	life-threatening	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
19	,	_	,	_	,	167	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	167	_	_	_	_	_	_	_	O
21	fatal	_	fatal	_	JJ	167	_	_	_	_	_	_	_	O
22	cases	_	case	_	NNS	167	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	167	_	_	_	_	_	_	_	O
24	diabetic	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
25	ketoacidosis	_	UNK	_	NN	167	_	_	_	_	_	_	_	O
26	have	_	have	_	VBP	167	_	_	_	_	_	_	_	O
27	been	_	be	_	VBN	167	_	_	_	_	_	_	_	O
28	reported	_	report	_	VBN	167	_	_	_	_	_	_	_	O
29	rarely	_	UNK	_	RB	167	_	_	_	_	_	_	_	O
30	in	_	in	_	IN	167	_	_	_	_	_	_	_	O
31	people	_	people	_	NNS	167	_	_	_	_	_	people.n	People	S-Person
32	taking	_	take	_	VBG	167	_	_	_	_	_	_	_	O
33	an	_	an	_	DT	167	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
35	inhibitor	_	UNK	_	NN	167	_	_	_	_	_	_	_	O
36	(	_	(	_	(	167	_	_	_	_	_	_	_	O
37	a	_	a	_	DT	167	_	_	_	_	_	_	_	O
38	substantial	_	substantial	_	JJ	167	_	_	_	_	_	_	_	O
39	proportion	_	proportion	_	NN	167	_	_	_	_	_	_	_	O
40	of	_	of	_	IN	167	_	_	_	_	_	_	_	O
41	the	_	the	_	DT	167	_	_	_	_	_	_	_	O
42	cases	_	case	_	NNS	167	_	_	_	_	_	_	_	O
43	concerned	_	concerned	_	JJ	167	_	_	_	_	_	_	_	O
44	off-label	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
45	use	_	use	_	NN	167	_	_	_	_	_	_	_	O
46	in	_	in	_	IN	167	_	_	_	_	_	_	_	O
47	people	_	people	_	NNS	167	_	_	_	_	_	_	_	O
48	with	_	with	_	IN	167	_	_	_	_	_	_	_	O
49	type	_	type	_	JJ	167	_	_	_	_	_	_	_	O
50	1	_	1	_	CD	167	_	_	_	_	_	_	_	O
51	diabetes	_	UNK	_	NNS	167	_	_	_	_	_	_	_	O
52	,	_	,	_	,	167	_	_	_	_	_	_	_	O
53	which	_	which	_	WDT	167	_	_	_	_	_	_	_	O
54	is	_	be	_	VBZ	167	_	_	_	_	_	_	_	O
55	not	_	not	_	RB	167	_	_	_	_	_	_	_	O
56	recommended	_	recommend	_	VBN	167	_	_	_	_	_	_	_	O
57	)	_	)	_	)	167	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	167	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	167	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	167	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	167	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	167	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	167	_	_	_	_	_	_	_	O
7	(	_	(	_	(	167	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	167	_	_	_	_	_	_	_	O
9	)	_	)	_	)	167	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	167	_	_	_	_	_	_	_	O
11	(	_	(	_	(	167	_	_	_	_	_	_	_	O
12	2016	_	UNK	_	CD	167	_	_	_	_	_	_	_	O
13	)	_	)	_	)	167	_	_	_	_	_	_	_	O
14	warned	_	warn	_	VBD	167	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	167	_	_	_	_	_	_	_	O
16	serious	_	serious	_	JJ	167	_	_	_	_	_	_	_	O
17	,	_	,	_	,	167	_	_	_	_	_	_	_	O
18	life-threatening	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
19	,	_	,	_	,	167	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	167	_	_	_	_	_	_	_	O
21	fatal	_	fatal	_	JJ	167	_	_	_	_	_	_	_	O
22	cases	_	case	_	NNS	167	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	167	_	_	_	_	_	_	_	O
24	diabetic	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
25	ketoacidosis	_	UNK	_	NN	167	_	_	_	_	_	_	_	O
26	have	_	have	_	VBP	167	_	_	_	_	_	_	_	O
27	been	_	be	_	VBN	167	_	_	_	_	_	_	_	O
28	reported	_	report	_	VBN	167	_	_	_	_	_	_	_	O
29	rarely	_	UNK	_	RB	167	_	_	_	_	_	_	_	O
30	in	_	in	_	IN	167	_	_	_	_	_	_	_	O
31	people	_	people	_	NNS	167	_	_	_	_	_	_	_	O
32	taking	_	take	_	VBG	167	_	_	_	_	_	_	_	O
33	an	_	an	_	DT	167	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
35	inhibitor	_	UNK	_	NN	167	_	_	_	_	_	_	_	O
36	(	_	(	_	(	167	_	_	_	_	_	_	_	O
37	a	_	a	_	DT	167	_	_	_	_	_	_	_	O
38	substantial	_	substantial	_	JJ	167	_	_	_	_	_	_	_	O
39	proportion	_	proportion	_	NN	167	_	_	_	_	_	_	_	O
40	of	_	of	_	IN	167	_	_	_	_	_	_	_	O
41	the	_	the	_	DT	167	_	_	_	_	_	_	_	O
42	cases	_	case	_	NNS	167	_	_	_	_	_	case.n	Instance	S-Instance
43	concerned	_	concerned	_	JJ	167	_	_	_	_	_	_	_	O
44	off-label	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
45	use	_	use	_	NN	167	_	_	_	_	_	_	_	O
46	in	_	in	_	IN	167	_	_	_	_	_	_	_	O
47	people	_	people	_	NNS	167	_	_	_	_	_	_	_	O
48	with	_	with	_	IN	167	_	_	_	_	_	_	_	O
49	type	_	type	_	JJ	167	_	_	_	_	_	_	_	O
50	1	_	1	_	CD	167	_	_	_	_	_	_	_	O
51	diabetes	_	UNK	_	NNS	167	_	_	_	_	_	_	_	O
52	,	_	,	_	,	167	_	_	_	_	_	_	_	O
53	which	_	which	_	WDT	167	_	_	_	_	_	_	_	O
54	is	_	be	_	VBZ	167	_	_	_	_	_	_	_	O
55	not	_	not	_	RB	167	_	_	_	_	_	_	_	O
56	recommended	_	recommend	_	VBN	167	_	_	_	_	_	_	_	O
57	)	_	)	_	)	167	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	167	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	167	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	167	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	167	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	167	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	167	_	_	_	_	_	_	_	O
7	(	_	(	_	(	167	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	167	_	_	_	_	_	_	_	O
9	)	_	)	_	)	167	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	167	_	_	_	_	_	_	_	O
11	(	_	(	_	(	167	_	_	_	_	_	_	_	O
12	2016	_	UNK	_	CD	167	_	_	_	_	_	_	_	O
13	)	_	)	_	)	167	_	_	_	_	_	_	_	O
14	warned	_	warn	_	VBD	167	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	167	_	_	_	_	_	_	_	O
16	serious	_	serious	_	JJ	167	_	_	_	_	_	_	_	O
17	,	_	,	_	,	167	_	_	_	_	_	_	_	O
18	life-threatening	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
19	,	_	,	_	,	167	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	167	_	_	_	_	_	_	_	O
21	fatal	_	fatal	_	JJ	167	_	_	_	_	_	_	_	O
22	cases	_	case	_	NNS	167	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	167	_	_	_	_	_	_	_	O
24	diabetic	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
25	ketoacidosis	_	UNK	_	NN	167	_	_	_	_	_	_	_	O
26	have	_	have	_	VBP	167	_	_	_	_	_	_	_	O
27	been	_	be	_	VBN	167	_	_	_	_	_	_	_	O
28	reported	_	report	_	VBN	167	_	_	_	_	_	_	_	O
29	rarely	_	UNK	_	RB	167	_	_	_	_	_	_	_	O
30	in	_	in	_	IN	167	_	_	_	_	_	_	_	O
31	people	_	people	_	NNS	167	_	_	_	_	_	_	_	O
32	taking	_	take	_	VBG	167	_	_	_	_	_	_	_	O
33	an	_	an	_	DT	167	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
35	inhibitor	_	UNK	_	NN	167	_	_	_	_	_	_	_	O
36	(	_	(	_	(	167	_	_	_	_	_	_	_	O
37	a	_	a	_	DT	167	_	_	_	_	_	_	_	O
38	substantial	_	substantial	_	JJ	167	_	_	_	_	_	_	_	O
39	proportion	_	proportion	_	NN	167	_	_	_	_	_	_	_	O
40	of	_	of	_	IN	167	_	_	_	_	_	_	_	O
41	the	_	the	_	DT	167	_	_	_	_	_	_	_	B-Experiencer
42	cases	_	case	_	NNS	167	_	_	_	_	_	_	_	I-Experiencer
43	concerned	_	concerned	_	JJ	167	_	_	_	_	_	concerned.a	Emotion_directed	O
44	off-label	_	UNK	_	JJ	167	_	_	_	_	_	_	_	B-Stimulus
45	use	_	use	_	NN	167	_	_	_	_	_	_	_	I-Stimulus
46	in	_	in	_	IN	167	_	_	_	_	_	_	_	I-Stimulus
47	people	_	people	_	NNS	167	_	_	_	_	_	_	_	I-Stimulus
48	with	_	with	_	IN	167	_	_	_	_	_	_	_	I-Stimulus
49	type	_	type	_	JJ	167	_	_	_	_	_	_	_	I-Stimulus
50	1	_	1	_	CD	167	_	_	_	_	_	_	_	I-Stimulus
51	diabetes	_	UNK	_	NNS	167	_	_	_	_	_	_	_	I-Stimulus
52	,	_	,	_	,	167	_	_	_	_	_	_	_	O
53	which	_	which	_	WDT	167	_	_	_	_	_	_	_	O
54	is	_	be	_	VBZ	167	_	_	_	_	_	_	_	O
55	not	_	not	_	RB	167	_	_	_	_	_	_	_	O
56	recommended	_	recommend	_	VBN	167	_	_	_	_	_	_	_	O
57	)	_	)	_	)	167	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	167	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	167	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	167	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	167	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	167	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	167	_	_	_	_	_	_	_	O
7	(	_	(	_	(	167	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	167	_	_	_	_	_	_	_	O
9	)	_	)	_	)	167	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	167	_	_	_	_	_	_	_	O
11	(	_	(	_	(	167	_	_	_	_	_	_	_	O
12	2016	_	UNK	_	CD	167	_	_	_	_	_	_	_	O
13	)	_	)	_	)	167	_	_	_	_	_	_	_	O
14	warned	_	warn	_	VBD	167	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	167	_	_	_	_	_	_	_	O
16	serious	_	serious	_	JJ	167	_	_	_	_	_	_	_	O
17	,	_	,	_	,	167	_	_	_	_	_	_	_	O
18	life-threatening	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
19	,	_	,	_	,	167	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	167	_	_	_	_	_	_	_	O
21	fatal	_	fatal	_	JJ	167	_	_	_	_	_	_	_	O
22	cases	_	case	_	NNS	167	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	167	_	_	_	_	_	_	_	O
24	diabetic	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
25	ketoacidosis	_	UNK	_	NN	167	_	_	_	_	_	_	_	O
26	have	_	have	_	VBP	167	_	_	_	_	_	_	_	O
27	been	_	be	_	VBN	167	_	_	_	_	_	_	_	O
28	reported	_	report	_	VBN	167	_	_	_	_	_	_	_	O
29	rarely	_	UNK	_	RB	167	_	_	_	_	_	_	_	O
30	in	_	in	_	IN	167	_	_	_	_	_	_	_	O
31	people	_	people	_	NNS	167	_	_	_	_	_	_	_	O
32	taking	_	take	_	VBG	167	_	_	_	_	_	_	_	O
33	an	_	an	_	DT	167	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
35	inhibitor	_	UNK	_	NN	167	_	_	_	_	_	_	_	O
36	(	_	(	_	(	167	_	_	_	_	_	_	_	O
37	a	_	a	_	DT	167	_	_	_	_	_	_	_	O
38	substantial	_	substantial	_	JJ	167	_	_	_	_	_	_	_	O
39	proportion	_	proportion	_	NN	167	_	_	_	_	_	_	_	O
40	of	_	of	_	IN	167	_	_	_	_	_	_	_	O
41	the	_	the	_	DT	167	_	_	_	_	_	_	_	O
42	cases	_	case	_	NNS	167	_	_	_	_	_	_	_	O
43	concerned	_	concerned	_	JJ	167	_	_	_	_	_	_	_	O
44	off-label	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
45	use	_	use	_	NN	167	_	_	_	_	_	use.n	Using	O
46	in	_	in	_	IN	167	_	_	_	_	_	_	_	O
47	people	_	people	_	NNS	167	_	_	_	_	_	_	_	O
48	with	_	with	_	IN	167	_	_	_	_	_	_	_	O
49	type	_	type	_	JJ	167	_	_	_	_	_	_	_	O
50	1	_	1	_	CD	167	_	_	_	_	_	_	_	O
51	diabetes	_	UNK	_	NNS	167	_	_	_	_	_	_	_	O
52	,	_	,	_	,	167	_	_	_	_	_	_	_	O
53	which	_	which	_	WDT	167	_	_	_	_	_	_	_	O
54	is	_	be	_	VBZ	167	_	_	_	_	_	_	_	O
55	not	_	not	_	RB	167	_	_	_	_	_	_	_	O
56	recommended	_	recommend	_	VBN	167	_	_	_	_	_	_	_	O
57	)	_	)	_	)	167	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	167	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	167	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	167	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	167	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	167	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	167	_	_	_	_	_	_	_	O
7	(	_	(	_	(	167	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	167	_	_	_	_	_	_	_	O
9	)	_	)	_	)	167	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	167	_	_	_	_	_	_	_	O
11	(	_	(	_	(	167	_	_	_	_	_	_	_	O
12	2016	_	UNK	_	CD	167	_	_	_	_	_	_	_	O
13	)	_	)	_	)	167	_	_	_	_	_	_	_	O
14	warned	_	warn	_	VBD	167	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	167	_	_	_	_	_	_	_	O
16	serious	_	serious	_	JJ	167	_	_	_	_	_	_	_	O
17	,	_	,	_	,	167	_	_	_	_	_	_	_	O
18	life-threatening	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
19	,	_	,	_	,	167	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	167	_	_	_	_	_	_	_	O
21	fatal	_	fatal	_	JJ	167	_	_	_	_	_	_	_	O
22	cases	_	case	_	NNS	167	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	167	_	_	_	_	_	_	_	O
24	diabetic	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
25	ketoacidosis	_	UNK	_	NN	167	_	_	_	_	_	_	_	O
26	have	_	have	_	VBP	167	_	_	_	_	_	_	_	O
27	been	_	be	_	VBN	167	_	_	_	_	_	_	_	O
28	reported	_	report	_	VBN	167	_	_	_	_	_	_	_	O
29	rarely	_	UNK	_	RB	167	_	_	_	_	_	_	_	O
30	in	_	in	_	IN	167	_	_	_	_	_	_	_	O
31	people	_	people	_	NNS	167	_	_	_	_	_	_	_	O
32	taking	_	take	_	VBG	167	_	_	_	_	_	_	_	O
33	an	_	an	_	DT	167	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
35	inhibitor	_	UNK	_	NN	167	_	_	_	_	_	_	_	O
36	(	_	(	_	(	167	_	_	_	_	_	_	_	O
37	a	_	a	_	DT	167	_	_	_	_	_	_	_	O
38	substantial	_	substantial	_	JJ	167	_	_	_	_	_	_	_	O
39	proportion	_	proportion	_	NN	167	_	_	_	_	_	_	_	O
40	of	_	of	_	IN	167	_	_	_	_	_	_	_	O
41	the	_	the	_	DT	167	_	_	_	_	_	_	_	O
42	cases	_	case	_	NNS	167	_	_	_	_	_	_	_	O
43	concerned	_	concerned	_	JJ	167	_	_	_	_	_	_	_	O
44	off-label	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
45	use	_	use	_	NN	167	_	_	_	_	_	_	_	O
46	in	_	in	_	IN	167	_	_	_	_	_	_	_	O
47	people	_	people	_	NNS	167	_	_	_	_	_	people.n	People	S-Person
48	with	_	with	_	IN	167	_	_	_	_	_	_	_	O
49	type	_	type	_	JJ	167	_	_	_	_	_	_	_	O
50	1	_	1	_	CD	167	_	_	_	_	_	_	_	O
51	diabetes	_	UNK	_	NNS	167	_	_	_	_	_	_	_	O
52	,	_	,	_	,	167	_	_	_	_	_	_	_	O
53	which	_	which	_	WDT	167	_	_	_	_	_	_	_	O
54	is	_	be	_	VBZ	167	_	_	_	_	_	_	_	O
55	not	_	not	_	RB	167	_	_	_	_	_	_	_	O
56	recommended	_	recommend	_	VBN	167	_	_	_	_	_	_	_	O
57	)	_	)	_	)	167	_	_	_	_	_	_	_	O

1	medicines	_	UNK	_	NNS	167	_	_	_	_	_	_	_	O
2	and	_	and	_	CC	167	_	_	_	_	_	_	_	O
3	healthcare	_	UNK	_	NNP	167	_	_	_	_	_	_	_	O
4	products	_	product	_	NNS	167	_	_	_	_	_	_	_	O
5	regulatory	_	Regulatory	_	NNP	167	_	_	_	_	_	_	_	O
6	agency	_	Agency	_	NNP	167	_	_	_	_	_	_	_	O
7	(	_	(	_	(	167	_	_	_	_	_	_	_	O
8	mhra	_	UNK	_	NNP	167	_	_	_	_	_	_	_	O
9	)	_	)	_	)	167	_	_	_	_	_	_	_	O
10	guidance	_	guidance	_	NN	167	_	_	_	_	_	_	_	O
11	(	_	(	_	(	167	_	_	_	_	_	_	_	O
12	2016	_	UNK	_	CD	167	_	_	_	_	_	_	_	O
13	)	_	)	_	)	167	_	_	_	_	_	_	_	O
14	warned	_	warn	_	VBD	167	_	_	_	_	_	_	_	O
15	that	_	that	_	IN	167	_	_	_	_	_	_	_	O
16	serious	_	serious	_	JJ	167	_	_	_	_	_	_	_	O
17	,	_	,	_	,	167	_	_	_	_	_	_	_	O
18	life-threatening	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
19	,	_	,	_	,	167	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	167	_	_	_	_	_	_	_	O
21	fatal	_	fatal	_	JJ	167	_	_	_	_	_	_	_	O
22	cases	_	case	_	NNS	167	_	_	_	_	_	_	_	O
23	of	_	of	_	IN	167	_	_	_	_	_	_	_	O
24	diabetic	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
25	ketoacidosis	_	UNK	_	NN	167	_	_	_	_	_	_	_	O
26	have	_	have	_	VBP	167	_	_	_	_	_	_	_	O
27	been	_	be	_	VBN	167	_	_	_	_	_	_	_	O
28	reported	_	report	_	VBN	167	_	_	_	_	_	_	_	O
29	rarely	_	UNK	_	RB	167	_	_	_	_	_	_	_	O
30	in	_	in	_	IN	167	_	_	_	_	_	_	_	O
31	people	_	people	_	NNS	167	_	_	_	_	_	_	_	O
32	taking	_	take	_	VBG	167	_	_	_	_	_	_	_	O
33	an	_	an	_	DT	167	_	_	_	_	_	_	_	O
34	unk	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
35	inhibitor	_	UNK	_	NN	167	_	_	_	_	_	_	_	O
36	(	_	(	_	(	167	_	_	_	_	_	_	_	O
37	a	_	a	_	DT	167	_	_	_	_	_	_	_	O
38	substantial	_	substantial	_	JJ	167	_	_	_	_	_	_	_	O
39	proportion	_	proportion	_	NN	167	_	_	_	_	_	_	_	O
40	of	_	of	_	IN	167	_	_	_	_	_	_	_	O
41	the	_	the	_	DT	167	_	_	_	_	_	_	_	O
42	cases	_	case	_	NNS	167	_	_	_	_	_	_	_	O
43	concerned	_	concerned	_	JJ	167	_	_	_	_	_	_	_	O
44	off-label	_	UNK	_	JJ	167	_	_	_	_	_	_	_	O
45	use	_	use	_	NN	167	_	_	_	_	_	_	_	O
46	in	_	in	_	IN	167	_	_	_	_	_	_	_	O
47	people	_	people	_	NNS	167	_	_	_	_	_	_	_	O
48	with	_	with	_	IN	167	_	_	_	_	_	_	_	O
49	type	_	type	_	JJ	167	_	_	_	_	_	type.n	Type	S-Subtype
50	1	_	1	_	CD	167	_	_	_	_	_	_	_	B-Category
51	diabetes	_	UNK	_	NNS	167	_	_	_	_	_	_	_	I-Category
52	,	_	,	_	,	167	_	_	_	_	_	_	_	O
53	which	_	which	_	WDT	167	_	_	_	_	_	_	_	O
54	is	_	be	_	VBZ	167	_	_	_	_	_	_	_	O
55	not	_	not	_	RB	167	_	_	_	_	_	_	_	O
56	recommended	_	recommend	_	VBN	167	_	_	_	_	_	_	_	O
57	)	_	)	_	)	167	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	168	_	_	_	_	_	_	_	B-Speaker
2	mhra	_	UNK	_	NNP	168	_	_	_	_	_	_	_	I-Speaker
3	advised	_	advise	_	VBD	168	_	_	_	_	_	advise.v	Telling	O
4	that	_	that	_	IN	168	_	_	_	_	_	_	_	B-Message
5	healthcare	_	healthcare	_	NN	168	_	_	_	_	_	_	_	I-Message
6	professionals	_	professional	_	NNS	168	_	_	_	_	_	_	_	I-Message
7	should	_	should	_	MD	168	_	_	_	_	_	_	_	I-Message
8	test	_	test	_	VB	168	_	_	_	_	_	_	_	I-Message
9	for	_	for	_	IN	168	_	_	_	_	_	_	_	I-Message
10	raised	_	raise	_	VBN	168	_	_	_	_	_	_	_	I-Message
11	ketones	_	UNK	_	NNS	168	_	_	_	_	_	_	_	I-Message
12	in	_	in	_	IN	168	_	_	_	_	_	_	_	I-Message
13	people	_	people	_	NNS	168	_	_	_	_	_	_	_	I-Message
14	with	_	with	_	IN	168	_	_	_	_	_	_	_	I-Message
15	ketoacidosis	_	UNK	_	NN	168	_	_	_	_	_	_	_	I-Message
16	symptoms	_	symptom	_	NNS	168	_	_	_	_	_	_	_	I-Message
17	who	_	who	_	WP	168	_	_	_	_	_	_	_	I-Message
18	are	_	be	_	VBP	168	_	_	_	_	_	_	_	I-Message
19	receiving	_	receive	_	VBG	168	_	_	_	_	_	_	_	I-Message
20	an	_	an	_	DT	168	_	_	_	_	_	_	_	I-Message
21	unk	_	UNK	_	JJ	168	_	_	_	_	_	_	_	I-Message
22	inhibitor	_	UNK	_	NN	168	_	_	_	_	_	_	_	I-Message
23	,	_	,	_	,	168	_	_	_	_	_	_	_	O
24	even	_	even	_	RB	168	_	_	_	_	_	_	_	O
25	if	_	if	_	IN	168	_	_	_	_	_	_	_	O
26	their	_	their	_	PRP$	168	_	_	_	_	_	_	_	O
27	plasma	_	UNK	_	NN	168	_	_	_	_	_	_	_	O
28	glucose	_	UNK	_	NN	168	_	_	_	_	_	_	_	O
29	levels	_	level	_	NNS	168	_	_	_	_	_	_	_	O
30	are	_	be	_	VBP	168	_	_	_	_	_	_	_	O
31	near-normal	_	UNK	_	JJ	168	_	_	_	_	_	_	_	O
32	.	_	.	_	.	168	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	168	_	_	_	_	_	_	_	O
2	mhra	_	UNK	_	NNP	168	_	_	_	_	_	_	_	O
3	advised	_	advise	_	VBD	168	_	_	_	_	_	_	_	O
4	that	_	that	_	IN	168	_	_	_	_	_	_	_	O
5	healthcare	_	healthcare	_	NN	168	_	_	_	_	_	_	_	B-Tester
6	professionals	_	professional	_	NNS	168	_	_	_	_	_	_	_	I-Tester
7	should	_	should	_	MD	168	_	_	_	_	_	_	_	O
8	test	_	test	_	VB	168	_	_	_	_	_	test.v	Operational_testing	O
9	for	_	for	_	IN	168	_	_	_	_	_	_	_	B-Product
10	raised	_	raise	_	VBN	168	_	_	_	_	_	_	_	I-Product
11	ketones	_	UNK	_	NNS	168	_	_	_	_	_	_	_	I-Product
12	in	_	in	_	IN	168	_	_	_	_	_	_	_	I-Product
13	people	_	people	_	NNS	168	_	_	_	_	_	_	_	I-Product
14	with	_	with	_	IN	168	_	_	_	_	_	_	_	I-Product
15	ketoacidosis	_	UNK	_	NN	168	_	_	_	_	_	_	_	I-Product
16	symptoms	_	symptom	_	NNS	168	_	_	_	_	_	_	_	I-Product
17	who	_	who	_	WP	168	_	_	_	_	_	_	_	I-Product
18	are	_	be	_	VBP	168	_	_	_	_	_	_	_	I-Product
19	receiving	_	receive	_	VBG	168	_	_	_	_	_	_	_	I-Product
20	an	_	an	_	DT	168	_	_	_	_	_	_	_	I-Product
21	unk	_	UNK	_	JJ	168	_	_	_	_	_	_	_	I-Product
22	inhibitor	_	UNK	_	NN	168	_	_	_	_	_	_	_	I-Product
23	,	_	,	_	,	168	_	_	_	_	_	_	_	O
24	even	_	even	_	RB	168	_	_	_	_	_	_	_	O
25	if	_	if	_	IN	168	_	_	_	_	_	_	_	O
26	their	_	their	_	PRP$	168	_	_	_	_	_	_	_	O
27	plasma	_	UNK	_	NN	168	_	_	_	_	_	_	_	O
28	glucose	_	UNK	_	NN	168	_	_	_	_	_	_	_	O
29	levels	_	level	_	NNS	168	_	_	_	_	_	_	_	O
30	are	_	be	_	VBP	168	_	_	_	_	_	_	_	O
31	near-normal	_	UNK	_	JJ	168	_	_	_	_	_	_	_	O
32	.	_	.	_	.	168	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	168	_	_	_	_	_	_	_	O
2	mhra	_	UNK	_	NNP	168	_	_	_	_	_	_	_	O
3	advised	_	advise	_	VBD	168	_	_	_	_	_	_	_	O
4	that	_	that	_	IN	168	_	_	_	_	_	_	_	O
5	healthcare	_	healthcare	_	NN	168	_	_	_	_	_	_	_	O
6	professionals	_	professional	_	NNS	168	_	_	_	_	_	_	_	O
7	should	_	should	_	MD	168	_	_	_	_	_	_	_	O
8	test	_	test	_	VB	168	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	168	_	_	_	_	_	_	_	O
10	raised	_	raise	_	VBN	168	_	_	_	_	_	_	_	O
11	ketones	_	UNK	_	NNS	168	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	168	_	_	_	_	_	_	_	O
13	people	_	people	_	NNS	168	_	_	_	_	_	people.n	People	S-Person
14	with	_	with	_	IN	168	_	_	_	_	_	_	_	O
15	ketoacidosis	_	UNK	_	NN	168	_	_	_	_	_	_	_	O
16	symptoms	_	symptom	_	NNS	168	_	_	_	_	_	_	_	O
17	who	_	who	_	WP	168	_	_	_	_	_	_	_	O
18	are	_	be	_	VBP	168	_	_	_	_	_	_	_	O
19	receiving	_	receive	_	VBG	168	_	_	_	_	_	_	_	O
20	an	_	an	_	DT	168	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	JJ	168	_	_	_	_	_	_	_	O
22	inhibitor	_	UNK	_	NN	168	_	_	_	_	_	_	_	O
23	,	_	,	_	,	168	_	_	_	_	_	_	_	O
24	even	_	even	_	RB	168	_	_	_	_	_	_	_	O
25	if	_	if	_	IN	168	_	_	_	_	_	_	_	O
26	their	_	their	_	PRP$	168	_	_	_	_	_	_	_	O
27	plasma	_	UNK	_	NN	168	_	_	_	_	_	_	_	O
28	glucose	_	UNK	_	NN	168	_	_	_	_	_	_	_	O
29	levels	_	level	_	NNS	168	_	_	_	_	_	_	_	O
30	are	_	be	_	VBP	168	_	_	_	_	_	_	_	O
31	near-normal	_	UNK	_	JJ	168	_	_	_	_	_	_	_	O
32	.	_	.	_	.	168	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	168	_	_	_	_	_	_	_	O
2	mhra	_	UNK	_	NNP	168	_	_	_	_	_	_	_	O
3	advised	_	advise	_	VBD	168	_	_	_	_	_	_	_	O
4	that	_	that	_	IN	168	_	_	_	_	_	_	_	O
5	healthcare	_	healthcare	_	NN	168	_	_	_	_	_	_	_	O
6	professionals	_	professional	_	NNS	168	_	_	_	_	_	_	_	O
7	should	_	should	_	MD	168	_	_	_	_	_	_	_	O
8	test	_	test	_	VB	168	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	168	_	_	_	_	_	_	_	O
10	raised	_	raise	_	VBN	168	_	_	_	_	_	_	_	O
11	ketones	_	UNK	_	NNS	168	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	168	_	_	_	_	_	_	_	O
13	people	_	people	_	NNS	168	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	168	_	_	_	_	_	_	_	O
15	ketoacidosis	_	UNK	_	NN	168	_	_	_	_	_	_	_	S-Indicated
16	symptoms	_	symptom	_	NNS	168	_	_	_	_	_	symptom.n	Sign	O
17	who	_	who	_	WP	168	_	_	_	_	_	_	_	O
18	are	_	be	_	VBP	168	_	_	_	_	_	_	_	O
19	receiving	_	receive	_	VBG	168	_	_	_	_	_	_	_	O
20	an	_	an	_	DT	168	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	JJ	168	_	_	_	_	_	_	_	O
22	inhibitor	_	UNK	_	NN	168	_	_	_	_	_	_	_	O
23	,	_	,	_	,	168	_	_	_	_	_	_	_	O
24	even	_	even	_	RB	168	_	_	_	_	_	_	_	O
25	if	_	if	_	IN	168	_	_	_	_	_	_	_	O
26	their	_	their	_	PRP$	168	_	_	_	_	_	_	_	O
27	plasma	_	UNK	_	NN	168	_	_	_	_	_	_	_	O
28	glucose	_	UNK	_	NN	168	_	_	_	_	_	_	_	O
29	levels	_	level	_	NNS	168	_	_	_	_	_	_	_	O
30	are	_	be	_	VBP	168	_	_	_	_	_	_	_	O
31	near-normal	_	UNK	_	JJ	168	_	_	_	_	_	_	_	O
32	.	_	.	_	.	168	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	168	_	_	_	_	_	_	_	O
2	mhra	_	UNK	_	NNP	168	_	_	_	_	_	_	_	O
3	advised	_	advise	_	VBD	168	_	_	_	_	_	_	_	O
4	that	_	that	_	IN	168	_	_	_	_	_	_	_	O
5	healthcare	_	healthcare	_	NN	168	_	_	_	_	_	_	_	O
6	professionals	_	professional	_	NNS	168	_	_	_	_	_	_	_	O
7	should	_	should	_	MD	168	_	_	_	_	_	_	_	O
8	test	_	test	_	VB	168	_	_	_	_	_	_	_	O
9	for	_	for	_	IN	168	_	_	_	_	_	_	_	O
10	raised	_	raise	_	VBN	168	_	_	_	_	_	_	_	O
11	ketones	_	UNK	_	NNS	168	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	168	_	_	_	_	_	_	_	O
13	people	_	people	_	NNS	168	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	168	_	_	_	_	_	_	_	O
15	ketoacidosis	_	UNK	_	NN	168	_	_	_	_	_	_	_	B-Recipient
16	symptoms	_	symptom	_	NNS	168	_	_	_	_	_	_	_	I-Recipient
17	who	_	who	_	WP	168	_	_	_	_	_	_	_	I-Recipient
18	are	_	be	_	VBP	168	_	_	_	_	_	_	_	O
19	receiving	_	receive	_	VBG	168	_	_	_	_	_	receive.v	Receiving	O
20	an	_	an	_	DT	168	_	_	_	_	_	_	_	B-Theme
21	unk	_	UNK	_	JJ	168	_	_	_	_	_	_	_	I-Theme
22	inhibitor	_	UNK	_	NN	168	_	_	_	_	_	_	_	I-Theme
23	,	_	,	_	,	168	_	_	_	_	_	_	_	O
24	even	_	even	_	RB	168	_	_	_	_	_	_	_	O
25	if	_	if	_	IN	168	_	_	_	_	_	_	_	O
26	their	_	their	_	PRP$	168	_	_	_	_	_	_	_	O
27	plasma	_	UNK	_	NN	168	_	_	_	_	_	_	_	O
28	glucose	_	UNK	_	NN	168	_	_	_	_	_	_	_	O
29	levels	_	level	_	NNS	168	_	_	_	_	_	_	_	O
30	are	_	be	_	VBP	168	_	_	_	_	_	_	_	O
31	near-normal	_	UNK	_	JJ	168	_	_	_	_	_	_	_	O
32	.	_	.	_	.	168	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	169	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	169	_	_	_	_	_	aware.a	Awareness	O
3	that	_	that	_	IN	169	_	_	_	_	_	_	_	B-Content
4	the	_	the	_	DT	169	_	_	_	_	_	_	_	I-Content
5	drugs	_	drug	_	NNS	169	_	_	_	_	_	_	_	I-Content
6	in	_	in	_	IN	169	_	_	_	_	_	_	_	I-Content
7	dual	_	dual	_	JJ	169	_	_	_	_	_	_	_	I-Content
8	therapy	_	therapy	_	NN	169	_	_	_	_	_	_	_	I-Content
9	should	_	should	_	MD	169	_	_	_	_	_	_	_	O
10	be	_	be	_	VB	169	_	_	_	_	_	_	_	O
11	introduced	_	introduce	_	VBN	169	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	169	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	169	_	_	_	_	_	_	_	O
14	stepwise	_	UNK	_	NN	169	_	_	_	_	_	_	_	O
15	manner	_	manner	_	NN	169	_	_	_	_	_	_	_	O
16	,	_	,	_	,	169	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	169	_	_	_	_	_	_	_	O
18	for	_	for	_	IN	169	_	_	_	_	_	_	_	O
19	tolerability	_	UNK	_	NN	169	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	169	_	_	_	_	_	_	_	O
21	effectiveness	_	UNK	_	NN	169	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	169	_	_	_	_	_	_	_	O
23	each	_	each	_	DT	169	_	_	_	_	_	_	_	O
24	drug	_	drug	_	NN	169	_	_	_	_	_	_	_	O
25	.	_	.	_	.	169	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	169	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	169	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	169	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	169	_	_	_	_	_	_	_	O
5	drugs	_	drug	_	NNS	169	_	_	_	_	_	drug.n	Intoxicants	S-Intoxicant
6	in	_	in	_	IN	169	_	_	_	_	_	_	_	O
7	dual	_	dual	_	JJ	169	_	_	_	_	_	_	_	O
8	therapy	_	therapy	_	NN	169	_	_	_	_	_	_	_	O
9	should	_	should	_	MD	169	_	_	_	_	_	_	_	O
10	be	_	be	_	VB	169	_	_	_	_	_	_	_	O
11	introduced	_	introduce	_	VBN	169	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	169	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	169	_	_	_	_	_	_	_	O
14	stepwise	_	UNK	_	NN	169	_	_	_	_	_	_	_	O
15	manner	_	manner	_	NN	169	_	_	_	_	_	_	_	O
16	,	_	,	_	,	169	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	169	_	_	_	_	_	_	_	O
18	for	_	for	_	IN	169	_	_	_	_	_	_	_	O
19	tolerability	_	UNK	_	NN	169	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	169	_	_	_	_	_	_	_	O
21	effectiveness	_	UNK	_	NN	169	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	169	_	_	_	_	_	_	_	O
23	each	_	each	_	DT	169	_	_	_	_	_	_	_	O
24	drug	_	drug	_	NN	169	_	_	_	_	_	_	_	O
25	.	_	.	_	.	169	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	169	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	169	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	169	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	169	_	_	_	_	_	_	_	O
5	drugs	_	drug	_	NNS	169	_	_	_	_	_	_	_	O
6	in	_	in	_	IN	169	_	_	_	_	_	_	_	O
7	dual	_	dual	_	JJ	169	_	_	_	_	_	dual.a	Cardinal_numbers	S-Number
8	therapy	_	therapy	_	NN	169	_	_	_	_	_	_	_	S-Entity
9	should	_	should	_	MD	169	_	_	_	_	_	_	_	O
10	be	_	be	_	VB	169	_	_	_	_	_	_	_	O
11	introduced	_	introduce	_	VBN	169	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	169	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	169	_	_	_	_	_	_	_	O
14	stepwise	_	UNK	_	NN	169	_	_	_	_	_	_	_	O
15	manner	_	manner	_	NN	169	_	_	_	_	_	_	_	O
16	,	_	,	_	,	169	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	169	_	_	_	_	_	_	_	O
18	for	_	for	_	IN	169	_	_	_	_	_	_	_	O
19	tolerability	_	UNK	_	NN	169	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	169	_	_	_	_	_	_	_	O
21	effectiveness	_	UNK	_	NN	169	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	169	_	_	_	_	_	_	_	O
23	each	_	each	_	DT	169	_	_	_	_	_	_	_	O
24	drug	_	drug	_	NN	169	_	_	_	_	_	_	_	O
25	.	_	.	_	.	169	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	169	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	169	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	169	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	169	_	_	_	_	_	_	_	O
5	drugs	_	drug	_	NNS	169	_	_	_	_	_	_	_	O
6	in	_	in	_	IN	169	_	_	_	_	_	_	_	O
7	dual	_	dual	_	JJ	169	_	_	_	_	_	_	_	O
8	therapy	_	therapy	_	NN	169	_	_	_	_	_	_	_	O
9	should	_	should	_	MD	169	_	_	_	_	_	_	_	O
10	be	_	be	_	VB	169	_	_	_	_	_	_	_	O
11	introduced	_	introduce	_	VBN	169	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	169	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	169	_	_	_	_	_	_	_	O
14	stepwise	_	UNK	_	NN	169	_	_	_	_	_	_	_	S-Manner
15	manner	_	manner	_	NN	169	_	_	_	_	_	manner.n	Conduct	O
16	,	_	,	_	,	169	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	169	_	_	_	_	_	_	_	O
18	for	_	for	_	IN	169	_	_	_	_	_	_	_	O
19	tolerability	_	UNK	_	NN	169	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	169	_	_	_	_	_	_	_	O
21	effectiveness	_	UNK	_	NN	169	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	169	_	_	_	_	_	_	_	O
23	each	_	each	_	DT	169	_	_	_	_	_	_	_	O
24	drug	_	drug	_	NN	169	_	_	_	_	_	_	_	O
25	.	_	.	_	.	169	_	_	_	_	_	_	_	O

1	be	_	UNK	_	NNP	169	_	_	_	_	_	_	_	O
2	aware	_	aware	_	JJ	169	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	169	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	169	_	_	_	_	_	_	_	O
5	drugs	_	drug	_	NNS	169	_	_	_	_	_	_	_	O
6	in	_	in	_	IN	169	_	_	_	_	_	_	_	O
7	dual	_	dual	_	JJ	169	_	_	_	_	_	_	_	O
8	therapy	_	therapy	_	NN	169	_	_	_	_	_	_	_	O
9	should	_	should	_	MD	169	_	_	_	_	_	_	_	O
10	be	_	be	_	VB	169	_	_	_	_	_	_	_	O
11	introduced	_	introduce	_	VBN	169	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	169	_	_	_	_	_	_	_	O
13	a	_	a	_	DT	169	_	_	_	_	_	_	_	O
14	stepwise	_	UNK	_	NN	169	_	_	_	_	_	_	_	O
15	manner	_	manner	_	NN	169	_	_	_	_	_	_	_	O
16	,	_	,	_	,	169	_	_	_	_	_	_	_	O
17	checking	_	check	_	VBG	169	_	_	_	_	_	check.v	Inspecting	O
18	for	_	for	_	IN	169	_	_	_	_	_	_	_	B-Ground
19	tolerability	_	UNK	_	NN	169	_	_	_	_	_	_	_	I-Ground
20	and	_	and	_	CC	169	_	_	_	_	_	_	_	I-Ground
21	effectiveness	_	UNK	_	NN	169	_	_	_	_	_	_	_	I-Ground
22	of	_	of	_	IN	169	_	_	_	_	_	_	_	I-Ground
23	each	_	each	_	DT	169	_	_	_	_	_	_	_	I-Ground
24	drug	_	drug	_	NN	169	_	_	_	_	_	_	_	I-Ground
25	.	_	.	_	.	169	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	170	_	_	_	_	_	_	_	S-Speaker
2	advises	_	advise	_	VBZ	170	_	_	_	_	_	advise.v	Telling	O
3	that	_	that	_	IN	170	_	_	_	_	_	_	_	B-Message
4	if	_	if	_	IN	170	_	_	_	_	_	_	_	I-Message
5	the	_	the	_	DT	170	_	_	_	_	_	_	_	I-Message
6	combination	_	combination	_	NN	170	_	_	_	_	_	_	_	I-Message
7	is	_	be	_	VBZ	170	_	_	_	_	_	_	_	I-Message
8	used	_	use	_	VBN	170	_	_	_	_	_	_	_	I-Message
9	,	_	,	_	,	170	_	_	_	_	_	_	_	I-Message
10	people	_	people	_	NNS	170	_	_	_	_	_	_	_	I-Message
11	should	_	should	_	MD	170	_	_	_	_	_	_	_	I-Message
12	be	_	be	_	VB	170	_	_	_	_	_	_	_	I-Message
13	observed	_	observe	_	VBN	170	_	_	_	_	_	_	_	I-Message
14	for	_	for	_	IN	170	_	_	_	_	_	_	_	I-Message
15	signs	_	sign	_	NNS	170	_	_	_	_	_	_	_	I-Message
16	and	_	and	_	CC	170	_	_	_	_	_	_	_	I-Message
17	symptoms	_	symptom	_	NNS	170	_	_	_	_	_	_	_	I-Message
18	of	_	of	_	IN	170	_	_	_	_	_	_	_	I-Message
19	heart	_	heart	_	NN	170	_	_	_	_	_	_	_	I-Message
20	failure	_	failure	_	NN	170	_	_	_	_	_	_	_	I-Message
21	,	_	,	_	,	170	_	_	_	_	_	_	_	I-Message
22	weight	_	weight	_	NN	170	_	_	_	_	_	_	_	I-Message
23	gain	_	gain	_	NN	170	_	_	_	_	_	_	_	O
24	,	_	,	_	,	170	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	170	_	_	_	_	_	_	_	O
26	oedema	_	UNK	_	NN	170	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	170	_	_	_	_	_	_	_	O
2	advises	_	advise	_	VBZ	170	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	170	_	_	_	_	_	_	_	O
4	if	_	if	_	IN	170	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	170	_	_	_	_	_	_	_	O
6	combination	_	combination	_	NN	170	_	_	_	_	_	combination.n	Aggregate	S-Aggregate
7	is	_	be	_	VBZ	170	_	_	_	_	_	_	_	O
8	used	_	use	_	VBN	170	_	_	_	_	_	_	_	O
9	,	_	,	_	,	170	_	_	_	_	_	_	_	O
10	people	_	people	_	NNS	170	_	_	_	_	_	_	_	O
11	should	_	should	_	MD	170	_	_	_	_	_	_	_	O
12	be	_	be	_	VB	170	_	_	_	_	_	_	_	O
13	observed	_	observe	_	VBN	170	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	170	_	_	_	_	_	_	_	O
15	signs	_	sign	_	NNS	170	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	170	_	_	_	_	_	_	_	O
17	symptoms	_	symptom	_	NNS	170	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	170	_	_	_	_	_	_	_	O
19	heart	_	heart	_	NN	170	_	_	_	_	_	_	_	O
20	failure	_	failure	_	NN	170	_	_	_	_	_	_	_	O
21	,	_	,	_	,	170	_	_	_	_	_	_	_	O
22	weight	_	weight	_	NN	170	_	_	_	_	_	_	_	O
23	gain	_	gain	_	NN	170	_	_	_	_	_	_	_	O
24	,	_	,	_	,	170	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	170	_	_	_	_	_	_	_	O
26	oedema	_	UNK	_	NN	170	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	170	_	_	_	_	_	_	_	O
2	advises	_	advise	_	VBZ	170	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	170	_	_	_	_	_	_	_	O
4	if	_	if	_	IN	170	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	170	_	_	_	_	_	_	_	B-Instrument
6	combination	_	combination	_	NN	170	_	_	_	_	_	_	_	I-Instrument
7	is	_	be	_	VBZ	170	_	_	_	_	_	_	_	O
8	used	_	use	_	VBN	170	_	_	_	_	_	use.v	Using	O
9	,	_	,	_	,	170	_	_	_	_	_	_	_	O
10	people	_	people	_	NNS	170	_	_	_	_	_	_	_	O
11	should	_	should	_	MD	170	_	_	_	_	_	_	_	O
12	be	_	be	_	VB	170	_	_	_	_	_	_	_	O
13	observed	_	observe	_	VBN	170	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	170	_	_	_	_	_	_	_	O
15	signs	_	sign	_	NNS	170	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	170	_	_	_	_	_	_	_	O
17	symptoms	_	symptom	_	NNS	170	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	170	_	_	_	_	_	_	_	O
19	heart	_	heart	_	NN	170	_	_	_	_	_	_	_	O
20	failure	_	failure	_	NN	170	_	_	_	_	_	_	_	O
21	,	_	,	_	,	170	_	_	_	_	_	_	_	O
22	weight	_	weight	_	NN	170	_	_	_	_	_	_	_	O
23	gain	_	gain	_	NN	170	_	_	_	_	_	_	_	O
24	,	_	,	_	,	170	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	170	_	_	_	_	_	_	_	O
26	oedema	_	UNK	_	NN	170	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	170	_	_	_	_	_	_	_	O
2	advises	_	advise	_	VBZ	170	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	170	_	_	_	_	_	_	_	O
4	if	_	if	_	IN	170	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	170	_	_	_	_	_	_	_	O
6	combination	_	combination	_	NN	170	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	170	_	_	_	_	_	_	_	O
8	used	_	use	_	VBN	170	_	_	_	_	_	_	_	O
9	,	_	,	_	,	170	_	_	_	_	_	_	_	O
10	people	_	people	_	NNS	170	_	_	_	_	_	people.n	People	S-Person
11	should	_	should	_	MD	170	_	_	_	_	_	_	_	O
12	be	_	be	_	VB	170	_	_	_	_	_	_	_	O
13	observed	_	observe	_	VBN	170	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	170	_	_	_	_	_	_	_	O
15	signs	_	sign	_	NNS	170	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	170	_	_	_	_	_	_	_	O
17	symptoms	_	symptom	_	NNS	170	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	170	_	_	_	_	_	_	_	O
19	heart	_	heart	_	NN	170	_	_	_	_	_	_	_	O
20	failure	_	failure	_	NN	170	_	_	_	_	_	_	_	O
21	,	_	,	_	,	170	_	_	_	_	_	_	_	O
22	weight	_	weight	_	NN	170	_	_	_	_	_	_	_	O
23	gain	_	gain	_	NN	170	_	_	_	_	_	_	_	O
24	,	_	,	_	,	170	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	170	_	_	_	_	_	_	_	O
26	oedema	_	UNK	_	NN	170	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	170	_	_	_	_	_	_	_	O
2	advises	_	advise	_	VBZ	170	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	170	_	_	_	_	_	_	_	O
4	if	_	if	_	IN	170	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	170	_	_	_	_	_	_	_	O
6	combination	_	combination	_	NN	170	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	170	_	_	_	_	_	_	_	O
8	used	_	use	_	VBN	170	_	_	_	_	_	_	_	O
9	,	_	,	_	,	170	_	_	_	_	_	_	_	O
10	people	_	people	_	NNS	170	_	_	_	_	_	_	_	S-Protagonist
11	should	_	should	_	MD	170	_	_	_	_	_	_	_	O
12	be	_	be	_	VB	170	_	_	_	_	_	_	_	O
13	observed	_	observe	_	VBN	170	_	_	_	_	_	observe.v	Compliance	O
14	for	_	for	_	IN	170	_	_	_	_	_	_	_	B-Norm
15	signs	_	sign	_	NNS	170	_	_	_	_	_	_	_	I-Norm
16	and	_	and	_	CC	170	_	_	_	_	_	_	_	I-Norm
17	symptoms	_	symptom	_	NNS	170	_	_	_	_	_	_	_	I-Norm
18	of	_	of	_	IN	170	_	_	_	_	_	_	_	I-Norm
19	heart	_	heart	_	NN	170	_	_	_	_	_	_	_	I-Norm
20	failure	_	failure	_	NN	170	_	_	_	_	_	_	_	I-Norm
21	,	_	,	_	,	170	_	_	_	_	_	_	_	I-Norm
22	weight	_	weight	_	NN	170	_	_	_	_	_	_	_	I-Norm
23	gain	_	gain	_	NN	170	_	_	_	_	_	_	_	I-Norm
24	,	_	,	_	,	170	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	170	_	_	_	_	_	_	_	O
26	oedema	_	UNK	_	NN	170	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	170	_	_	_	_	_	_	_	O
2	advises	_	advise	_	VBZ	170	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	170	_	_	_	_	_	_	_	O
4	if	_	if	_	IN	170	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	170	_	_	_	_	_	_	_	O
6	combination	_	combination	_	NN	170	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	170	_	_	_	_	_	_	_	O
8	used	_	use	_	VBN	170	_	_	_	_	_	_	_	O
9	,	_	,	_	,	170	_	_	_	_	_	_	_	O
10	people	_	people	_	NNS	170	_	_	_	_	_	_	_	O
11	should	_	should	_	MD	170	_	_	_	_	_	_	_	O
12	be	_	be	_	VB	170	_	_	_	_	_	_	_	O
13	observed	_	observe	_	VBN	170	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	170	_	_	_	_	_	_	_	O
15	signs	_	sign	_	NNS	170	_	_	_	_	_	sign.n	Sign	S-Indicator
16	and	_	and	_	CC	170	_	_	_	_	_	_	_	O
17	symptoms	_	symptom	_	NNS	170	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	170	_	_	_	_	_	_	_	O
19	heart	_	heart	_	NN	170	_	_	_	_	_	_	_	O
20	failure	_	failure	_	NN	170	_	_	_	_	_	_	_	O
21	,	_	,	_	,	170	_	_	_	_	_	_	_	O
22	weight	_	weight	_	NN	170	_	_	_	_	_	_	_	O
23	gain	_	gain	_	NN	170	_	_	_	_	_	_	_	O
24	,	_	,	_	,	170	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	170	_	_	_	_	_	_	_	O
26	oedema	_	UNK	_	NN	170	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	170	_	_	_	_	_	_	_	O
2	advises	_	advise	_	VBZ	170	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	170	_	_	_	_	_	_	_	O
4	if	_	if	_	IN	170	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	170	_	_	_	_	_	_	_	O
6	combination	_	combination	_	NN	170	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	170	_	_	_	_	_	_	_	O
8	used	_	use	_	VBN	170	_	_	_	_	_	_	_	O
9	,	_	,	_	,	170	_	_	_	_	_	_	_	O
10	people	_	people	_	NNS	170	_	_	_	_	_	_	_	O
11	should	_	should	_	MD	170	_	_	_	_	_	_	_	O
12	be	_	be	_	VB	170	_	_	_	_	_	_	_	O
13	observed	_	observe	_	VBN	170	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	170	_	_	_	_	_	_	_	O
15	signs	_	sign	_	NNS	170	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	170	_	_	_	_	_	_	_	O
17	symptoms	_	symptom	_	NNS	170	_	_	_	_	_	symptom.n	Sign	O
18	of	_	of	_	IN	170	_	_	_	_	_	_	_	B-Indicated
19	heart	_	heart	_	NN	170	_	_	_	_	_	_	_	I-Indicated
20	failure	_	failure	_	NN	170	_	_	_	_	_	_	_	I-Indicated
21	,	_	,	_	,	170	_	_	_	_	_	_	_	I-Indicated
22	weight	_	weight	_	NN	170	_	_	_	_	_	_	_	I-Indicated
23	gain	_	gain	_	NN	170	_	_	_	_	_	_	_	I-Indicated
24	,	_	,	_	,	170	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	170	_	_	_	_	_	_	_	O
26	oedema	_	UNK	_	NN	170	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	170	_	_	_	_	_	_	_	O
2	advises	_	advise	_	VBZ	170	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	170	_	_	_	_	_	_	_	O
4	if	_	if	_	IN	170	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	170	_	_	_	_	_	_	_	O
6	combination	_	combination	_	NN	170	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	170	_	_	_	_	_	_	_	O
8	used	_	use	_	VBN	170	_	_	_	_	_	_	_	O
9	,	_	,	_	,	170	_	_	_	_	_	_	_	O
10	people	_	people	_	NNS	170	_	_	_	_	_	_	_	O
11	should	_	should	_	MD	170	_	_	_	_	_	_	_	O
12	be	_	be	_	VB	170	_	_	_	_	_	_	_	O
13	observed	_	observe	_	VBN	170	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	170	_	_	_	_	_	_	_	O
15	signs	_	sign	_	NNS	170	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	170	_	_	_	_	_	_	_	O
17	symptoms	_	symptom	_	NNS	170	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	170	_	_	_	_	_	_	_	O
19	heart	_	heart	_	NN	170	_	_	_	_	_	_	_	S-Agent
20	failure	_	failure	_	NN	170	_	_	_	_	_	failure.n	Success_or_failure	O
21	,	_	,	_	,	170	_	_	_	_	_	_	_	O
22	weight	_	weight	_	NN	170	_	_	_	_	_	_	_	O
23	gain	_	gain	_	NN	170	_	_	_	_	_	_	_	O
24	,	_	,	_	,	170	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	170	_	_	_	_	_	_	_	O
26	oedema	_	UNK	_	NN	170	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	170	_	_	_	_	_	_	_	O
2	advises	_	advise	_	VBZ	170	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	170	_	_	_	_	_	_	_	O
4	if	_	if	_	IN	170	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	170	_	_	_	_	_	_	_	O
6	combination	_	combination	_	NN	170	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	170	_	_	_	_	_	_	_	O
8	used	_	use	_	VBN	170	_	_	_	_	_	_	_	O
9	,	_	,	_	,	170	_	_	_	_	_	_	_	O
10	people	_	people	_	NNS	170	_	_	_	_	_	_	_	O
11	should	_	should	_	MD	170	_	_	_	_	_	_	_	O
12	be	_	be	_	VB	170	_	_	_	_	_	_	_	O
13	observed	_	observe	_	VBN	170	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	170	_	_	_	_	_	_	_	O
15	signs	_	sign	_	NNS	170	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	170	_	_	_	_	_	_	_	O
17	symptoms	_	symptom	_	NNS	170	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	170	_	_	_	_	_	_	_	O
19	heart	_	heart	_	NN	170	_	_	_	_	_	_	_	O
20	failure	_	failure	_	NN	170	_	_	_	_	_	_	_	O
21	,	_	,	_	,	170	_	_	_	_	_	_	_	O
22	weight	_	weight	_	NN	170	_	_	_	_	_	weight.n	Dimension	S-Dimension
23	gain	_	gain	_	NN	170	_	_	_	_	_	_	_	S-Object
24	,	_	,	_	,	170	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	170	_	_	_	_	_	_	_	O
26	oedema	_	UNK	_	NN	170	_	_	_	_	_	_	_	O

1	it	_	It	_	PRP	170	_	_	_	_	_	_	_	O
2	advises	_	advise	_	VBZ	170	_	_	_	_	_	_	_	O
3	that	_	that	_	IN	170	_	_	_	_	_	_	_	O
4	if	_	if	_	IN	170	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	170	_	_	_	_	_	_	_	O
6	combination	_	combination	_	NN	170	_	_	_	_	_	_	_	O
7	is	_	be	_	VBZ	170	_	_	_	_	_	_	_	O
8	used	_	use	_	VBN	170	_	_	_	_	_	_	_	O
9	,	_	,	_	,	170	_	_	_	_	_	_	_	O
10	people	_	people	_	NNS	170	_	_	_	_	_	_	_	O
11	should	_	should	_	MD	170	_	_	_	_	_	_	_	O
12	be	_	be	_	VB	170	_	_	_	_	_	_	_	O
13	observed	_	observe	_	VBN	170	_	_	_	_	_	_	_	O
14	for	_	for	_	IN	170	_	_	_	_	_	_	_	O
15	signs	_	sign	_	NNS	170	_	_	_	_	_	_	_	O
16	and	_	and	_	CC	170	_	_	_	_	_	_	_	O
17	symptoms	_	symptom	_	NNS	170	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	170	_	_	_	_	_	_	_	O
19	heart	_	heart	_	NN	170	_	_	_	_	_	_	_	O
20	failure	_	failure	_	NN	170	_	_	_	_	_	_	_	O
21	,	_	,	_	,	170	_	_	_	_	_	_	_	O
22	weight	_	weight	_	NN	170	_	_	_	_	_	_	_	S-Theme
23	gain	_	gain	_	NN	170	_	_	_	_	_	gain.n	Getting	O
24	,	_	,	_	,	170	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	170	_	_	_	_	_	_	_	O
26	oedema	_	UNK	_	NN	170	_	_	_	_	_	_	_	O

1	pioglitazone	_	UNK	_	NN	171	_	_	_	_	_	_	_	S-State_of_affairs
2	should	_	should	_	MD	171	_	_	_	_	_	should.v	Desirable_event	O
3	be	_	be	_	VB	171	_	_	_	_	_	_	_	B-State_of_affairs
4	discontinued	_	discontinue	_	VBN	171	_	_	_	_	_	_	_	I-State_of_affairs
5	if	_	if	_	IN	171	_	_	_	_	_	_	_	I-State_of_affairs
6	any	_	any	_	DT	171	_	_	_	_	_	_	_	I-State_of_affairs
7	deterioration	_	UNK	_	NN	171	_	_	_	_	_	_	_	I-State_of_affairs
8	in	_	in	_	IN	171	_	_	_	_	_	_	_	I-State_of_affairs
9	cardiac	_	UNK	_	JJ	171	_	_	_	_	_	_	_	I-State_of_affairs
10	status	_	status	_	NN	171	_	_	_	_	_	_	_	I-State_of_affairs
11	occurs	_	occur	_	VBZ	171	_	_	_	_	_	_	_	I-State_of_affairs
12	.	_	.	_	.	171	_	_	_	_	_	_	_	O

1	pioglitazone	_	UNK	_	NN	171	_	_	_	_	_	_	_	S-Activity
2	should	_	should	_	MD	171	_	_	_	_	_	_	_	O
3	be	_	be	_	VB	171	_	_	_	_	_	_	_	O
4	discontinued	_	discontinue	_	VBN	171	_	_	_	_	_	discontinue.v	Activity_stop	O
5	if	_	if	_	IN	171	_	_	_	_	_	_	_	O
6	any	_	any	_	DT	171	_	_	_	_	_	_	_	O
7	deterioration	_	UNK	_	NN	171	_	_	_	_	_	_	_	O
8	in	_	in	_	IN	171	_	_	_	_	_	_	_	O
9	cardiac	_	UNK	_	JJ	171	_	_	_	_	_	_	_	O
10	status	_	status	_	NN	171	_	_	_	_	_	_	_	O
11	occurs	_	occur	_	VBZ	171	_	_	_	_	_	_	_	O
12	.	_	.	_	.	171	_	_	_	_	_	_	_	O

1	pioglitazone	_	UNK	_	NN	171	_	_	_	_	_	_	_	O
2	should	_	should	_	MD	171	_	_	_	_	_	_	_	O
3	be	_	be	_	VB	171	_	_	_	_	_	_	_	O
4	discontinued	_	discontinue	_	VBN	171	_	_	_	_	_	_	_	O
5	if	_	if	_	IN	171	_	_	_	_	_	_	_	O
6	any	_	any	_	DT	171	_	_	_	_	_	_	_	B-Event
7	deterioration	_	UNK	_	NN	171	_	_	_	_	_	_	_	I-Event
8	in	_	in	_	IN	171	_	_	_	_	_	_	_	I-Event
9	cardiac	_	UNK	_	JJ	171	_	_	_	_	_	_	_	I-Event
10	status	_	status	_	NN	171	_	_	_	_	_	_	_	I-Event
11	occurs	_	occur	_	VBZ	171	_	_	_	_	_	occur.v	Event	O
12	.	_	.	_	.	171	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	172	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	172	_	_	_	_	_	_	_	O
3	in	_	in	_	IN	172	_	_	_	_	_	_	_	O
4	this	_	this	_	DT	172	_	_	_	_	_	_	_	O
5	guideline	_	guideline	_	NN	172	_	_	_	_	_	_	_	O
6	also	_	also	_	RB	172	_	_	_	_	_	_	_	O
7	apply	_	apply	_	VB	172	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	172	_	_	_	_	_	_	_	O
9	any	_	any	_	DT	172	_	_	_	_	_	_	_	O
10	current	_	current	_	JJ	172	_	_	_	_	_	current.a	Temporal_collocation	O
11	and	_	and	_	CC	172	_	_	_	_	_	_	_	O
12	future	_	future	_	JJ	172	_	_	_	_	_	_	_	O
13	biosimilar	_	UNK	_	JJ	172	_	_	_	_	_	_	_	B-Trajector_event
14	product	_	product	_	NN	172	_	_	_	_	_	_	_	I-Trajector_event
15	(	_	(	_	(	172	_	_	_	_	_	_	_	I-Trajector_event
16	s	_	s	_	JJ	172	_	_	_	_	_	_	_	I-Trajector_event
17	)	_	)	_	)	172	_	_	_	_	_	_	_	I-Trajector_event
18	of	_	of	_	IN	172	_	_	_	_	_	_	_	I-Trajector_event
19	insulin	_	UNK	_	NN	172	_	_	_	_	_	_	_	I-Trajector_event
20	unk	_	UNK	_	NN	172	_	_	_	_	_	_	_	I-Trajector_event
21	that	_	that	_	WDT	172	_	_	_	_	_	_	_	I-Trajector_event
22	have	_	have	_	VBP	172	_	_	_	_	_	_	_	I-Trajector_event
23	an	_	an	_	DT	172	_	_	_	_	_	_	_	I-Trajector_event
24	appropriate	_	appropriate	_	JJ	172	_	_	_	_	_	_	_	I-Trajector_event
25	marketing	_	UNK	_	NN	172	_	_	_	_	_	_	_	I-Trajector_event
26	authorisation	_	UNK	_	NN	172	_	_	_	_	_	_	_	I-Trajector_event
27	that	_	that	_	WDT	172	_	_	_	_	_	_	_	I-Trajector_event
28	allows	_	allow	_	VBZ	172	_	_	_	_	_	_	_	I-Trajector_event
29	the	_	the	_	DT	172	_	_	_	_	_	_	_	I-Trajector_event
30	use	_	use	_	NN	172	_	_	_	_	_	_	_	I-Trajector_event
31	of	_	of	_	IN	172	_	_	_	_	_	_	_	I-Trajector_event
32	the	_	the	_	DT	172	_	_	_	_	_	_	_	I-Trajector_event
33	biosimilar	_	UNK	_	NN	172	_	_	_	_	_	_	_	O
34	(	_	(	_	(	172	_	_	_	_	_	_	_	O
35	s	_	s	_	NN	172	_	_	_	_	_	_	_	O
36	)	_	)	_	)	172	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	172	_	_	_	_	_	_	_	O
38	the	_	the	_	DT	172	_	_	_	_	_	_	_	O
39	same	_	same	_	JJ	172	_	_	_	_	_	_	_	O
40	indication	_	indication	_	NN	172	_	_	_	_	_	_	_	O
41	.	_	.	_	.	172	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	172	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	172	_	_	_	_	_	_	_	O
3	in	_	in	_	IN	172	_	_	_	_	_	_	_	O
4	this	_	this	_	DT	172	_	_	_	_	_	_	_	O
5	guideline	_	guideline	_	NN	172	_	_	_	_	_	_	_	O
6	also	_	also	_	RB	172	_	_	_	_	_	_	_	O
7	apply	_	apply	_	VB	172	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	172	_	_	_	_	_	_	_	O
9	any	_	any	_	DT	172	_	_	_	_	_	_	_	O
10	current	_	current	_	JJ	172	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	172	_	_	_	_	_	_	_	O
12	future	_	future	_	JJ	172	_	_	_	_	_	_	_	O
13	biosimilar	_	UNK	_	JJ	172	_	_	_	_	_	_	_	O
14	product	_	product	_	NN	172	_	_	_	_	_	_	_	O
15	(	_	(	_	(	172	_	_	_	_	_	_	_	O
16	s	_	s	_	JJ	172	_	_	_	_	_	_	_	O
17	)	_	)	_	)	172	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	172	_	_	_	_	_	_	_	O
19	insulin	_	UNK	_	NN	172	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NN	172	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	172	_	_	_	_	_	_	_	B-Event
22	have	_	have	_	VBP	172	_	_	_	_	_	_	_	I-Event
23	an	_	an	_	DT	172	_	_	_	_	_	_	_	I-Event
24	appropriate	_	appropriate	_	JJ	172	_	_	_	_	_	_	_	I-Event
25	marketing	_	UNK	_	NN	172	_	_	_	_	_	_	_	I-Event
26	authorisation	_	UNK	_	NN	172	_	_	_	_	_	_	_	I-Event
27	that	_	that	_	WDT	172	_	_	_	_	_	_	_	S-Agent
28	allows	_	allow	_	VBZ	172	_	_	_	_	_	allow.v	Preventing_or_letting	O
29	the	_	the	_	DT	172	_	_	_	_	_	_	_	B-Event
30	use	_	use	_	NN	172	_	_	_	_	_	_	_	I-Event
31	of	_	of	_	IN	172	_	_	_	_	_	_	_	I-Event
32	the	_	the	_	DT	172	_	_	_	_	_	_	_	I-Event
33	biosimilar	_	UNK	_	NN	172	_	_	_	_	_	_	_	I-Event
34	(	_	(	_	(	172	_	_	_	_	_	_	_	I-Event
35	s	_	s	_	NN	172	_	_	_	_	_	_	_	I-Event
36	)	_	)	_	)	172	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	172	_	_	_	_	_	_	_	O
38	the	_	the	_	DT	172	_	_	_	_	_	_	_	O
39	same	_	same	_	JJ	172	_	_	_	_	_	_	_	O
40	indication	_	indication	_	NN	172	_	_	_	_	_	_	_	O
41	.	_	.	_	.	172	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	172	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	172	_	_	_	_	_	_	_	O
3	in	_	in	_	IN	172	_	_	_	_	_	_	_	O
4	this	_	this	_	DT	172	_	_	_	_	_	_	_	O
5	guideline	_	guideline	_	NN	172	_	_	_	_	_	_	_	O
6	also	_	also	_	RB	172	_	_	_	_	_	_	_	O
7	apply	_	apply	_	VB	172	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	172	_	_	_	_	_	_	_	O
9	any	_	any	_	DT	172	_	_	_	_	_	_	_	O
10	current	_	current	_	JJ	172	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	172	_	_	_	_	_	_	_	O
12	future	_	future	_	JJ	172	_	_	_	_	_	_	_	O
13	biosimilar	_	UNK	_	JJ	172	_	_	_	_	_	_	_	O
14	product	_	product	_	NN	172	_	_	_	_	_	_	_	O
15	(	_	(	_	(	172	_	_	_	_	_	_	_	O
16	s	_	s	_	JJ	172	_	_	_	_	_	_	_	O
17	)	_	)	_	)	172	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	172	_	_	_	_	_	_	_	O
19	insulin	_	UNK	_	NN	172	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NN	172	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	172	_	_	_	_	_	_	_	O
22	have	_	have	_	VBP	172	_	_	_	_	_	_	_	O
23	an	_	an	_	DT	172	_	_	_	_	_	_	_	O
24	appropriate	_	appropriate	_	JJ	172	_	_	_	_	_	_	_	O
25	marketing	_	UNK	_	NN	172	_	_	_	_	_	_	_	O
26	authorisation	_	UNK	_	NN	172	_	_	_	_	_	_	_	O
27	that	_	that	_	WDT	172	_	_	_	_	_	_	_	O
28	allows	_	allow	_	VBZ	172	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	172	_	_	_	_	_	_	_	O
30	use	_	use	_	NN	172	_	_	_	_	_	use.n	Using	O
31	of	_	of	_	IN	172	_	_	_	_	_	_	_	B-Instrument
32	the	_	the	_	DT	172	_	_	_	_	_	_	_	I-Instrument
33	biosimilar	_	UNK	_	NN	172	_	_	_	_	_	_	_	I-Instrument
34	(	_	(	_	(	172	_	_	_	_	_	_	_	O
35	s	_	s	_	NN	172	_	_	_	_	_	_	_	O
36	)	_	)	_	)	172	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	172	_	_	_	_	_	_	_	O
38	the	_	the	_	DT	172	_	_	_	_	_	_	_	O
39	same	_	same	_	JJ	172	_	_	_	_	_	_	_	O
40	indication	_	indication	_	NN	172	_	_	_	_	_	_	_	O
41	.	_	.	_	.	172	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	172	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	172	_	_	_	_	_	_	_	O
3	in	_	in	_	IN	172	_	_	_	_	_	_	_	O
4	this	_	this	_	DT	172	_	_	_	_	_	_	_	O
5	guideline	_	guideline	_	NN	172	_	_	_	_	_	_	_	O
6	also	_	also	_	RB	172	_	_	_	_	_	_	_	O
7	apply	_	apply	_	VB	172	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	172	_	_	_	_	_	_	_	O
9	any	_	any	_	DT	172	_	_	_	_	_	_	_	O
10	current	_	current	_	JJ	172	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	172	_	_	_	_	_	_	_	O
12	future	_	future	_	JJ	172	_	_	_	_	_	_	_	O
13	biosimilar	_	UNK	_	JJ	172	_	_	_	_	_	_	_	O
14	product	_	product	_	NN	172	_	_	_	_	_	_	_	O
15	(	_	(	_	(	172	_	_	_	_	_	_	_	O
16	s	_	s	_	JJ	172	_	_	_	_	_	_	_	O
17	)	_	)	_	)	172	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	172	_	_	_	_	_	_	_	O
19	insulin	_	UNK	_	NN	172	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NN	172	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	172	_	_	_	_	_	_	_	O
22	have	_	have	_	VBP	172	_	_	_	_	_	_	_	O
23	an	_	an	_	DT	172	_	_	_	_	_	_	_	O
24	appropriate	_	appropriate	_	JJ	172	_	_	_	_	_	_	_	O
25	marketing	_	UNK	_	NN	172	_	_	_	_	_	_	_	O
26	authorisation	_	UNK	_	NN	172	_	_	_	_	_	_	_	O
27	that	_	that	_	WDT	172	_	_	_	_	_	_	_	O
28	allows	_	allow	_	VBZ	172	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	172	_	_	_	_	_	_	_	O
30	use	_	use	_	NN	172	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	172	_	_	_	_	_	_	_	O
32	the	_	the	_	DT	172	_	_	_	_	_	_	_	O
33	biosimilar	_	UNK	_	NN	172	_	_	_	_	_	_	_	O
34	(	_	(	_	(	172	_	_	_	_	_	_	_	O
35	s	_	s	_	NN	172	_	_	_	_	_	_	_	O
36	)	_	)	_	)	172	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	172	_	_	_	_	_	_	_	O
38	the	_	the	_	DT	172	_	_	_	_	_	_	_	O
39	same	_	same	_	JJ	172	_	_	_	_	_	same.a	Identicality	O
40	indication	_	indication	_	NN	172	_	_	_	_	_	_	_	S-Type
41	.	_	.	_	.	172	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	172	_	_	_	_	_	_	_	O
2	recommendations	_	UNK	_	NNS	172	_	_	_	_	_	_	_	O
3	in	_	in	_	IN	172	_	_	_	_	_	_	_	O
4	this	_	this	_	DT	172	_	_	_	_	_	_	_	O
5	guideline	_	guideline	_	NN	172	_	_	_	_	_	_	_	O
6	also	_	also	_	RB	172	_	_	_	_	_	_	_	O
7	apply	_	apply	_	VB	172	_	_	_	_	_	_	_	O
8	to	_	to	_	TO	172	_	_	_	_	_	_	_	O
9	any	_	any	_	DT	172	_	_	_	_	_	_	_	O
10	current	_	current	_	JJ	172	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	172	_	_	_	_	_	_	_	O
12	future	_	future	_	JJ	172	_	_	_	_	_	_	_	O
13	biosimilar	_	UNK	_	JJ	172	_	_	_	_	_	_	_	O
14	product	_	product	_	NN	172	_	_	_	_	_	_	_	O
15	(	_	(	_	(	172	_	_	_	_	_	_	_	O
16	s	_	s	_	JJ	172	_	_	_	_	_	_	_	O
17	)	_	)	_	)	172	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	172	_	_	_	_	_	_	_	O
19	insulin	_	UNK	_	NN	172	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NN	172	_	_	_	_	_	_	_	O
21	that	_	that	_	WDT	172	_	_	_	_	_	_	_	O
22	have	_	have	_	VBP	172	_	_	_	_	_	_	_	O
23	an	_	an	_	DT	172	_	_	_	_	_	_	_	O
24	appropriate	_	appropriate	_	JJ	172	_	_	_	_	_	_	_	O
25	marketing	_	UNK	_	NN	172	_	_	_	_	_	_	_	O
26	authorisation	_	UNK	_	NN	172	_	_	_	_	_	_	_	O
27	that	_	that	_	WDT	172	_	_	_	_	_	_	_	O
28	allows	_	allow	_	VBZ	172	_	_	_	_	_	_	_	O
29	the	_	the	_	DT	172	_	_	_	_	_	_	_	O
30	use	_	use	_	NN	172	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	172	_	_	_	_	_	_	_	O
32	the	_	the	_	DT	172	_	_	_	_	_	_	_	O
33	biosimilar	_	UNK	_	NN	172	_	_	_	_	_	_	_	O
34	(	_	(	_	(	172	_	_	_	_	_	_	_	O
35	s	_	s	_	NN	172	_	_	_	_	_	_	_	O
36	)	_	)	_	)	172	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	172	_	_	_	_	_	_	_	O
38	the	_	the	_	DT	172	_	_	_	_	_	_	_	O
39	same	_	same	_	JJ	172	_	_	_	_	_	_	_	S-Descriptor
40	indication	_	indication	_	NN	172	_	_	_	_	_	indication.n	Sign	S-Indicator
41	.	_	.	_	.	172	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	173	_	_	_	_	_	_	_	B-Speaker
2	mhra	_	UNK	_	NNP	173	_	_	_	_	_	_	_	I-Speaker
3	advises	_	advise	_	VBZ	173	_	_	_	_	_	advise.v	Telling	O
4	that	_	that	_	IN	173	_	_	_	_	_	_	_	B-Message
5	prescribers	_	UNK	_	NNS	173	_	_	_	_	_	_	_	I-Message
6	should	_	should	_	MD	173	_	_	_	_	_	_	_	I-Message
7	take	_	take	_	VB	173	_	_	_	_	_	_	_	I-Message
8	into	_	into	_	IN	173	_	_	_	_	_	_	_	I-Message
9	account	_	account	_	NN	173	_	_	_	_	_	_	_	I-Message
10	the	_	the	_	DT	173	_	_	_	_	_	_	_	I-Message
11	overall	_	overall	_	JJ	173	_	_	_	_	_	_	_	I-Message
12	safety	_	safety	_	NN	173	_	_	_	_	_	_	_	I-Message
13	profile	_	profile	_	NN	173	_	_	_	_	_	_	_	I-Message
14	of	_	of	_	IN	173	_	_	_	_	_	_	_	I-Message
15	unk	_	UNK	_	NN	173	_	_	_	_	_	_	_	I-Message
16	,	_	,	_	,	173	_	_	_	_	_	_	_	I-Message
17	and	_	and	_	CC	173	_	_	_	_	_	_	_	I-Message
18	in	_	in	_	IN	173	_	_	_	_	_	_	_	I-Message
19	particular	_	particular	_	JJ	173	_	_	_	_	_	_	_	I-Message
20	its	_	it	_	PRP$	173	_	_	_	_	_	_	_	I-Message
21	cardiac	_	UNK	_	JJ	173	_	_	_	_	_	_	_	I-Message
22	risk	_	risk	_	NN	173	_	_	_	_	_	_	_	I-Message
23	and	_	and	_	CC	173	_	_	_	_	_	_	_	I-Message
24	potential	_	potential	_	JJ	173	_	_	_	_	_	_	_	I-Message
25	interactions	_	UNK	_	NNS	173	_	_	_	_	_	_	_	I-Message
26	with	_	with	_	IN	173	_	_	_	_	_	_	_	I-Message
27	other	_	other	_	JJ	173	_	_	_	_	_	_	_	I-Message
28	medicines	_	medicine	_	NNS	173	_	_	_	_	_	_	_	I-Message
29	(	_	(	_	(	173	_	_	_	_	_	_	_	I-Message
30	such	_	such	_	JJ	173	_	_	_	_	_	_	_	I-Message
31	as	_	a	_	IN	173	_	_	_	_	_	_	_	I-Message
32	erythromycin	_	UNK	_	NN	173	_	_	_	_	_	_	_	I-Message
33	)	_	)	_	)	173	_	_	_	_	_	_	_	I-Message
34	,	_	,	_	,	173	_	_	_	_	_	_	_	I-Message
35	if	_	if	_	IN	173	_	_	_	_	_	_	_	I-Message
36	there	_	there	_	EX	173	_	_	_	_	_	_	_	I-Message
37	is	_	be	_	VBZ	173	_	_	_	_	_	_	_	I-Message
38	a	_	a	_	DT	173	_	_	_	_	_	_	_	I-Message
39	clinical	_	UNK	_	JJ	173	_	_	_	_	_	_	_	I-Message
40	need	_	need	_	NN	173	_	_	_	_	_	_	_	I-Message
41	to	_	to	_	TO	173	_	_	_	_	_	_	_	I-Message
42	use	_	use	_	VB	173	_	_	_	_	_	_	_	I-Message
43	it	_	it	_	PRP	173	_	_	_	_	_	_	_	I-Message
44	at	_	at	_	IN	173	_	_	_	_	_	_	_	O
45	doses	_	dos	_	NNS	173	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	173	_	_	_	_	_	_	_	O
47	durations	_	UNK	_	NNS	173	_	_	_	_	_	_	_	O
48	greater	_	greater	_	JJR	173	_	_	_	_	_	_	_	O
49	than	_	than	_	IN	173	_	_	_	_	_	_	_	O
50	those	_	those	_	DT	173	_	_	_	_	_	_	_	O
51	authorised	_	UNK	_	JJ	173	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	173	_	_	_	_	_	_	_	O
2	mhra	_	UNK	_	NNP	173	_	_	_	_	_	_	_	O
3	advises	_	advise	_	VBZ	173	_	_	_	_	_	_	_	O
4	that	_	that	_	IN	173	_	_	_	_	_	_	_	O
5	prescribers	_	UNK	_	NNS	173	_	_	_	_	_	_	_	S-State_of_affairs
6	should	_	should	_	MD	173	_	_	_	_	_	should.v	Desirable_event	O
7	take	_	take	_	VB	173	_	_	_	_	_	_	_	B-State_of_affairs
8	into	_	into	_	IN	173	_	_	_	_	_	_	_	I-State_of_affairs
9	account	_	account	_	NN	173	_	_	_	_	_	_	_	I-State_of_affairs
10	the	_	the	_	DT	173	_	_	_	_	_	_	_	I-State_of_affairs
11	overall	_	overall	_	JJ	173	_	_	_	_	_	_	_	I-State_of_affairs
12	safety	_	safety	_	NN	173	_	_	_	_	_	_	_	I-State_of_affairs
13	profile	_	profile	_	NN	173	_	_	_	_	_	_	_	I-State_of_affairs
14	of	_	of	_	IN	173	_	_	_	_	_	_	_	I-State_of_affairs
15	unk	_	UNK	_	NN	173	_	_	_	_	_	_	_	I-State_of_affairs
16	,	_	,	_	,	173	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	173	_	_	_	_	_	_	_	O
18	in	_	in	_	IN	173	_	_	_	_	_	_	_	O
19	particular	_	particular	_	JJ	173	_	_	_	_	_	_	_	O
20	its	_	it	_	PRP$	173	_	_	_	_	_	_	_	O
21	cardiac	_	UNK	_	JJ	173	_	_	_	_	_	_	_	O
22	risk	_	risk	_	NN	173	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	173	_	_	_	_	_	_	_	O
24	potential	_	potential	_	JJ	173	_	_	_	_	_	_	_	O
25	interactions	_	UNK	_	NNS	173	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	173	_	_	_	_	_	_	_	O
27	other	_	other	_	JJ	173	_	_	_	_	_	_	_	O
28	medicines	_	medicine	_	NNS	173	_	_	_	_	_	_	_	O
29	(	_	(	_	(	173	_	_	_	_	_	_	_	O
30	such	_	such	_	JJ	173	_	_	_	_	_	_	_	O
31	as	_	a	_	IN	173	_	_	_	_	_	_	_	O
32	erythromycin	_	UNK	_	NN	173	_	_	_	_	_	_	_	O
33	)	_	)	_	)	173	_	_	_	_	_	_	_	O
34	,	_	,	_	,	173	_	_	_	_	_	_	_	O
35	if	_	if	_	IN	173	_	_	_	_	_	_	_	O
36	there	_	there	_	EX	173	_	_	_	_	_	_	_	O
37	is	_	be	_	VBZ	173	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	173	_	_	_	_	_	_	_	O
39	clinical	_	UNK	_	JJ	173	_	_	_	_	_	_	_	O
40	need	_	need	_	NN	173	_	_	_	_	_	_	_	O
41	to	_	to	_	TO	173	_	_	_	_	_	_	_	O
42	use	_	use	_	VB	173	_	_	_	_	_	_	_	O
43	it	_	it	_	PRP	173	_	_	_	_	_	_	_	O
44	at	_	at	_	IN	173	_	_	_	_	_	_	_	O
45	doses	_	dos	_	NNS	173	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	173	_	_	_	_	_	_	_	O
47	durations	_	UNK	_	NNS	173	_	_	_	_	_	_	_	O
48	greater	_	greater	_	JJR	173	_	_	_	_	_	_	_	O
49	than	_	than	_	IN	173	_	_	_	_	_	_	_	O
50	those	_	those	_	DT	173	_	_	_	_	_	_	_	O
51	authorised	_	UNK	_	JJ	173	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	173	_	_	_	_	_	_	_	O
2	mhra	_	UNK	_	NNP	173	_	_	_	_	_	_	_	O
3	advises	_	advise	_	VBZ	173	_	_	_	_	_	_	_	O
4	that	_	that	_	IN	173	_	_	_	_	_	_	_	O
5	prescribers	_	UNK	_	NNS	173	_	_	_	_	_	_	_	S-Author
6	should	_	should	_	MD	173	_	_	_	_	_	_	_	O
7	take	_	take	_	VB	173	_	_	_	_	_	_	_	O
8	into	_	into	_	IN	173	_	_	_	_	_	_	_	O
9	account	_	account	_	NN	173	_	_	_	_	_	account.n	Text	O
10	the	_	the	_	DT	173	_	_	_	_	_	_	_	O
11	overall	_	overall	_	JJ	173	_	_	_	_	_	_	_	O
12	safety	_	safety	_	NN	173	_	_	_	_	_	_	_	O
13	profile	_	profile	_	NN	173	_	_	_	_	_	_	_	O
14	of	_	of	_	IN	173	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	173	_	_	_	_	_	_	_	O
16	,	_	,	_	,	173	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	173	_	_	_	_	_	_	_	O
18	in	_	in	_	IN	173	_	_	_	_	_	_	_	O
19	particular	_	particular	_	JJ	173	_	_	_	_	_	_	_	O
20	its	_	it	_	PRP$	173	_	_	_	_	_	_	_	O
21	cardiac	_	UNK	_	JJ	173	_	_	_	_	_	_	_	O
22	risk	_	risk	_	NN	173	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	173	_	_	_	_	_	_	_	O
24	potential	_	potential	_	JJ	173	_	_	_	_	_	_	_	O
25	interactions	_	UNK	_	NNS	173	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	173	_	_	_	_	_	_	_	O
27	other	_	other	_	JJ	173	_	_	_	_	_	_	_	O
28	medicines	_	medicine	_	NNS	173	_	_	_	_	_	_	_	O
29	(	_	(	_	(	173	_	_	_	_	_	_	_	O
30	such	_	such	_	JJ	173	_	_	_	_	_	_	_	O
31	as	_	a	_	IN	173	_	_	_	_	_	_	_	O
32	erythromycin	_	UNK	_	NN	173	_	_	_	_	_	_	_	O
33	)	_	)	_	)	173	_	_	_	_	_	_	_	O
34	,	_	,	_	,	173	_	_	_	_	_	_	_	O
35	if	_	if	_	IN	173	_	_	_	_	_	_	_	O
36	there	_	there	_	EX	173	_	_	_	_	_	_	_	O
37	is	_	be	_	VBZ	173	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	173	_	_	_	_	_	_	_	O
39	clinical	_	UNK	_	JJ	173	_	_	_	_	_	_	_	O
40	need	_	need	_	NN	173	_	_	_	_	_	_	_	O
41	to	_	to	_	TO	173	_	_	_	_	_	_	_	O
42	use	_	use	_	VB	173	_	_	_	_	_	_	_	O
43	it	_	it	_	PRP	173	_	_	_	_	_	_	_	O
44	at	_	at	_	IN	173	_	_	_	_	_	_	_	O
45	doses	_	dos	_	NNS	173	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	173	_	_	_	_	_	_	_	O
47	durations	_	UNK	_	NNS	173	_	_	_	_	_	_	_	O
48	greater	_	greater	_	JJR	173	_	_	_	_	_	_	_	O
49	than	_	than	_	IN	173	_	_	_	_	_	_	_	O
50	those	_	those	_	DT	173	_	_	_	_	_	_	_	O
51	authorised	_	UNK	_	JJ	173	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	173	_	_	_	_	_	_	_	O
2	mhra	_	UNK	_	NNP	173	_	_	_	_	_	_	_	O
3	advises	_	advise	_	VBZ	173	_	_	_	_	_	_	_	O
4	that	_	that	_	IN	173	_	_	_	_	_	_	_	O
5	prescribers	_	UNK	_	NNS	173	_	_	_	_	_	_	_	O
6	should	_	should	_	MD	173	_	_	_	_	_	_	_	O
7	take	_	take	_	VB	173	_	_	_	_	_	_	_	O
8	into	_	into	_	IN	173	_	_	_	_	_	_	_	O
9	account	_	account	_	NN	173	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	173	_	_	_	_	_	_	_	O
11	overall	_	overall	_	JJ	173	_	_	_	_	_	_	_	O
12	safety	_	safety	_	NN	173	_	_	_	_	_	safety.n	Being_at_risk	O
13	profile	_	profile	_	NN	173	_	_	_	_	_	_	_	O
14	of	_	of	_	IN	173	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	173	_	_	_	_	_	_	_	O
16	,	_	,	_	,	173	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	173	_	_	_	_	_	_	_	O
18	in	_	in	_	IN	173	_	_	_	_	_	_	_	O
19	particular	_	particular	_	JJ	173	_	_	_	_	_	_	_	O
20	its	_	it	_	PRP$	173	_	_	_	_	_	_	_	O
21	cardiac	_	UNK	_	JJ	173	_	_	_	_	_	_	_	O
22	risk	_	risk	_	NN	173	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	173	_	_	_	_	_	_	_	O
24	potential	_	potential	_	JJ	173	_	_	_	_	_	_	_	O
25	interactions	_	UNK	_	NNS	173	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	173	_	_	_	_	_	_	_	O
27	other	_	other	_	JJ	173	_	_	_	_	_	_	_	O
28	medicines	_	medicine	_	NNS	173	_	_	_	_	_	_	_	O
29	(	_	(	_	(	173	_	_	_	_	_	_	_	O
30	such	_	such	_	JJ	173	_	_	_	_	_	_	_	O
31	as	_	a	_	IN	173	_	_	_	_	_	_	_	O
32	erythromycin	_	UNK	_	NN	173	_	_	_	_	_	_	_	O
33	)	_	)	_	)	173	_	_	_	_	_	_	_	O
34	,	_	,	_	,	173	_	_	_	_	_	_	_	O
35	if	_	if	_	IN	173	_	_	_	_	_	_	_	O
36	there	_	there	_	EX	173	_	_	_	_	_	_	_	O
37	is	_	be	_	VBZ	173	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	173	_	_	_	_	_	_	_	O
39	clinical	_	UNK	_	JJ	173	_	_	_	_	_	_	_	O
40	need	_	need	_	NN	173	_	_	_	_	_	_	_	O
41	to	_	to	_	TO	173	_	_	_	_	_	_	_	O
42	use	_	use	_	VB	173	_	_	_	_	_	_	_	O
43	it	_	it	_	PRP	173	_	_	_	_	_	_	_	O
44	at	_	at	_	IN	173	_	_	_	_	_	_	_	O
45	doses	_	dos	_	NNS	173	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	173	_	_	_	_	_	_	_	O
47	durations	_	UNK	_	NNS	173	_	_	_	_	_	_	_	O
48	greater	_	greater	_	JJR	173	_	_	_	_	_	_	_	O
49	than	_	than	_	IN	173	_	_	_	_	_	_	_	O
50	those	_	those	_	DT	173	_	_	_	_	_	_	_	O
51	authorised	_	UNK	_	JJ	173	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	173	_	_	_	_	_	_	_	O
2	mhra	_	UNK	_	NNP	173	_	_	_	_	_	_	_	O
3	advises	_	advise	_	VBZ	173	_	_	_	_	_	_	_	O
4	that	_	that	_	IN	173	_	_	_	_	_	_	_	O
5	prescribers	_	UNK	_	NNS	173	_	_	_	_	_	_	_	O
6	should	_	should	_	MD	173	_	_	_	_	_	_	_	O
7	take	_	take	_	VB	173	_	_	_	_	_	_	_	O
8	into	_	into	_	IN	173	_	_	_	_	_	_	_	O
9	account	_	account	_	NN	173	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	173	_	_	_	_	_	_	_	O
11	overall	_	overall	_	JJ	173	_	_	_	_	_	_	_	O
12	safety	_	safety	_	NN	173	_	_	_	_	_	_	_	O
13	profile	_	profile	_	NN	173	_	_	_	_	_	_	_	O
14	of	_	of	_	IN	173	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	173	_	_	_	_	_	_	_	O
16	,	_	,	_	,	173	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	173	_	_	_	_	_	_	_	O
18	in	_	in	_	IN	173	_	_	_	_	_	_	_	O
19	particular	_	particular	_	JJ	173	_	_	_	_	_	_	_	O
20	its	_	it	_	PRP$	173	_	_	_	_	_	_	_	S-Protagonist
21	cardiac	_	UNK	_	JJ	173	_	_	_	_	_	_	_	S-Asset
22	risk	_	risk	_	NN	173	_	_	_	_	_	risk.n	Run_risk	O
23	and	_	and	_	CC	173	_	_	_	_	_	_	_	O
24	potential	_	potential	_	JJ	173	_	_	_	_	_	_	_	O
25	interactions	_	UNK	_	NNS	173	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	173	_	_	_	_	_	_	_	O
27	other	_	other	_	JJ	173	_	_	_	_	_	_	_	O
28	medicines	_	medicine	_	NNS	173	_	_	_	_	_	_	_	O
29	(	_	(	_	(	173	_	_	_	_	_	_	_	O
30	such	_	such	_	JJ	173	_	_	_	_	_	_	_	O
31	as	_	a	_	IN	173	_	_	_	_	_	_	_	O
32	erythromycin	_	UNK	_	NN	173	_	_	_	_	_	_	_	O
33	)	_	)	_	)	173	_	_	_	_	_	_	_	O
34	,	_	,	_	,	173	_	_	_	_	_	_	_	O
35	if	_	if	_	IN	173	_	_	_	_	_	_	_	O
36	there	_	there	_	EX	173	_	_	_	_	_	_	_	O
37	is	_	be	_	VBZ	173	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	173	_	_	_	_	_	_	_	O
39	clinical	_	UNK	_	JJ	173	_	_	_	_	_	_	_	O
40	need	_	need	_	NN	173	_	_	_	_	_	_	_	O
41	to	_	to	_	TO	173	_	_	_	_	_	_	_	O
42	use	_	use	_	VB	173	_	_	_	_	_	_	_	O
43	it	_	it	_	PRP	173	_	_	_	_	_	_	_	O
44	at	_	at	_	IN	173	_	_	_	_	_	_	_	O
45	doses	_	dos	_	NNS	173	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	173	_	_	_	_	_	_	_	O
47	durations	_	UNK	_	NNS	173	_	_	_	_	_	_	_	O
48	greater	_	greater	_	JJR	173	_	_	_	_	_	_	_	O
49	than	_	than	_	IN	173	_	_	_	_	_	_	_	O
50	those	_	those	_	DT	173	_	_	_	_	_	_	_	O
51	authorised	_	UNK	_	JJ	173	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	173	_	_	_	_	_	_	_	O
2	mhra	_	UNK	_	NNP	173	_	_	_	_	_	_	_	O
3	advises	_	advise	_	VBZ	173	_	_	_	_	_	_	_	O
4	that	_	that	_	IN	173	_	_	_	_	_	_	_	O
5	prescribers	_	UNK	_	NNS	173	_	_	_	_	_	_	_	O
6	should	_	should	_	MD	173	_	_	_	_	_	_	_	O
7	take	_	take	_	VB	173	_	_	_	_	_	_	_	O
8	into	_	into	_	IN	173	_	_	_	_	_	_	_	O
9	account	_	account	_	NN	173	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	173	_	_	_	_	_	_	_	O
11	overall	_	overall	_	JJ	173	_	_	_	_	_	_	_	O
12	safety	_	safety	_	NN	173	_	_	_	_	_	_	_	O
13	profile	_	profile	_	NN	173	_	_	_	_	_	_	_	O
14	of	_	of	_	IN	173	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	173	_	_	_	_	_	_	_	O
16	,	_	,	_	,	173	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	173	_	_	_	_	_	_	_	O
18	in	_	in	_	IN	173	_	_	_	_	_	_	_	O
19	particular	_	particular	_	JJ	173	_	_	_	_	_	_	_	O
20	its	_	it	_	PRP$	173	_	_	_	_	_	_	_	S-Entity
21	cardiac	_	UNK	_	JJ	173	_	_	_	_	_	_	_	O
22	risk	_	risk	_	NN	173	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	173	_	_	_	_	_	_	_	O
24	potential	_	potential	_	JJ	173	_	_	_	_	_	potential.a	Capability	O
25	interactions	_	UNK	_	NNS	173	_	_	_	_	_	_	_	B-Event
26	with	_	with	_	IN	173	_	_	_	_	_	_	_	I-Event
27	other	_	other	_	JJ	173	_	_	_	_	_	_	_	I-Event
28	medicines	_	medicine	_	NNS	173	_	_	_	_	_	_	_	I-Event
29	(	_	(	_	(	173	_	_	_	_	_	_	_	O
30	such	_	such	_	JJ	173	_	_	_	_	_	_	_	O
31	as	_	a	_	IN	173	_	_	_	_	_	_	_	O
32	erythromycin	_	UNK	_	NN	173	_	_	_	_	_	_	_	O
33	)	_	)	_	)	173	_	_	_	_	_	_	_	O
34	,	_	,	_	,	173	_	_	_	_	_	_	_	O
35	if	_	if	_	IN	173	_	_	_	_	_	_	_	O
36	there	_	there	_	EX	173	_	_	_	_	_	_	_	O
37	is	_	be	_	VBZ	173	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	173	_	_	_	_	_	_	_	O
39	clinical	_	UNK	_	JJ	173	_	_	_	_	_	_	_	O
40	need	_	need	_	NN	173	_	_	_	_	_	_	_	O
41	to	_	to	_	TO	173	_	_	_	_	_	_	_	O
42	use	_	use	_	VB	173	_	_	_	_	_	_	_	O
43	it	_	it	_	PRP	173	_	_	_	_	_	_	_	O
44	at	_	at	_	IN	173	_	_	_	_	_	_	_	O
45	doses	_	dos	_	NNS	173	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	173	_	_	_	_	_	_	_	O
47	durations	_	UNK	_	NNS	173	_	_	_	_	_	_	_	O
48	greater	_	greater	_	JJR	173	_	_	_	_	_	_	_	O
49	than	_	than	_	IN	173	_	_	_	_	_	_	_	O
50	those	_	those	_	DT	173	_	_	_	_	_	_	_	O
51	authorised	_	UNK	_	JJ	173	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	173	_	_	_	_	_	_	_	O
2	mhra	_	UNK	_	NNP	173	_	_	_	_	_	_	_	O
3	advises	_	advise	_	VBZ	173	_	_	_	_	_	_	_	O
4	that	_	that	_	IN	173	_	_	_	_	_	_	_	O
5	prescribers	_	UNK	_	NNS	173	_	_	_	_	_	_	_	O
6	should	_	should	_	MD	173	_	_	_	_	_	_	_	O
7	take	_	take	_	VB	173	_	_	_	_	_	_	_	O
8	into	_	into	_	IN	173	_	_	_	_	_	_	_	O
9	account	_	account	_	NN	173	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	173	_	_	_	_	_	_	_	O
11	overall	_	overall	_	JJ	173	_	_	_	_	_	_	_	O
12	safety	_	safety	_	NN	173	_	_	_	_	_	_	_	O
13	profile	_	profile	_	NN	173	_	_	_	_	_	_	_	O
14	of	_	of	_	IN	173	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	173	_	_	_	_	_	_	_	O
16	,	_	,	_	,	173	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	173	_	_	_	_	_	_	_	O
18	in	_	in	_	IN	173	_	_	_	_	_	_	_	O
19	particular	_	particular	_	JJ	173	_	_	_	_	_	_	_	O
20	its	_	it	_	PRP$	173	_	_	_	_	_	_	_	O
21	cardiac	_	UNK	_	JJ	173	_	_	_	_	_	_	_	O
22	risk	_	risk	_	NN	173	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	173	_	_	_	_	_	_	_	O
24	potential	_	potential	_	JJ	173	_	_	_	_	_	_	_	O
25	interactions	_	UNK	_	NNS	173	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	173	_	_	_	_	_	_	_	O
27	other	_	other	_	JJ	173	_	_	_	_	_	other.a	Increment	O
28	medicines	_	medicine	_	NNS	173	_	_	_	_	_	_	_	S-Class
29	(	_	(	_	(	173	_	_	_	_	_	_	_	O
30	such	_	such	_	JJ	173	_	_	_	_	_	_	_	O
31	as	_	a	_	IN	173	_	_	_	_	_	_	_	O
32	erythromycin	_	UNK	_	NN	173	_	_	_	_	_	_	_	O
33	)	_	)	_	)	173	_	_	_	_	_	_	_	O
34	,	_	,	_	,	173	_	_	_	_	_	_	_	O
35	if	_	if	_	IN	173	_	_	_	_	_	_	_	O
36	there	_	there	_	EX	173	_	_	_	_	_	_	_	O
37	is	_	be	_	VBZ	173	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	173	_	_	_	_	_	_	_	O
39	clinical	_	UNK	_	JJ	173	_	_	_	_	_	_	_	O
40	need	_	need	_	NN	173	_	_	_	_	_	_	_	O
41	to	_	to	_	TO	173	_	_	_	_	_	_	_	O
42	use	_	use	_	VB	173	_	_	_	_	_	_	_	O
43	it	_	it	_	PRP	173	_	_	_	_	_	_	_	O
44	at	_	at	_	IN	173	_	_	_	_	_	_	_	O
45	doses	_	dos	_	NNS	173	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	173	_	_	_	_	_	_	_	O
47	durations	_	UNK	_	NNS	173	_	_	_	_	_	_	_	O
48	greater	_	greater	_	JJR	173	_	_	_	_	_	_	_	O
49	than	_	than	_	IN	173	_	_	_	_	_	_	_	O
50	those	_	those	_	DT	173	_	_	_	_	_	_	_	O
51	authorised	_	UNK	_	JJ	173	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	173	_	_	_	_	_	_	_	O
2	mhra	_	UNK	_	NNP	173	_	_	_	_	_	_	_	O
3	advises	_	advise	_	VBZ	173	_	_	_	_	_	_	_	O
4	that	_	that	_	IN	173	_	_	_	_	_	_	_	O
5	prescribers	_	UNK	_	NNS	173	_	_	_	_	_	_	_	O
6	should	_	should	_	MD	173	_	_	_	_	_	_	_	O
7	take	_	take	_	VB	173	_	_	_	_	_	_	_	O
8	into	_	into	_	IN	173	_	_	_	_	_	_	_	O
9	account	_	account	_	NN	173	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	173	_	_	_	_	_	_	_	O
11	overall	_	overall	_	JJ	173	_	_	_	_	_	_	_	O
12	safety	_	safety	_	NN	173	_	_	_	_	_	_	_	O
13	profile	_	profile	_	NN	173	_	_	_	_	_	_	_	O
14	of	_	of	_	IN	173	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	173	_	_	_	_	_	_	_	O
16	,	_	,	_	,	173	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	173	_	_	_	_	_	_	_	O
18	in	_	in	_	IN	173	_	_	_	_	_	_	_	O
19	particular	_	particular	_	JJ	173	_	_	_	_	_	_	_	O
20	its	_	it	_	PRP$	173	_	_	_	_	_	_	_	O
21	cardiac	_	UNK	_	JJ	173	_	_	_	_	_	_	_	O
22	risk	_	risk	_	NN	173	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	173	_	_	_	_	_	_	_	O
24	potential	_	potential	_	JJ	173	_	_	_	_	_	_	_	O
25	interactions	_	UNK	_	NNS	173	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	173	_	_	_	_	_	_	_	O
27	other	_	other	_	JJ	173	_	_	_	_	_	_	_	O
28	medicines	_	medicine	_	NNS	173	_	_	_	_	_	_	_	O
29	(	_	(	_	(	173	_	_	_	_	_	_	_	O
30	such	_	such	_	JJ	173	_	_	_	_	_	_	_	O
31	as	_	a	_	IN	173	_	_	_	_	_	_	_	O
32	erythromycin	_	UNK	_	NN	173	_	_	_	_	_	_	_	O
33	)	_	)	_	)	173	_	_	_	_	_	_	_	O
34	,	_	,	_	,	173	_	_	_	_	_	_	_	O
35	if	_	if	_	IN	173	_	_	_	_	_	_	_	O
36	there	_	there	_	EX	173	_	_	_	_	_	there.adv	Locative_relation	S-Ground
37	is	_	be	_	VBZ	173	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	173	_	_	_	_	_	_	_	O
39	clinical	_	UNK	_	JJ	173	_	_	_	_	_	_	_	O
40	need	_	need	_	NN	173	_	_	_	_	_	_	_	O
41	to	_	to	_	TO	173	_	_	_	_	_	_	_	O
42	use	_	use	_	VB	173	_	_	_	_	_	_	_	O
43	it	_	it	_	PRP	173	_	_	_	_	_	_	_	O
44	at	_	at	_	IN	173	_	_	_	_	_	_	_	O
45	doses	_	dos	_	NNS	173	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	173	_	_	_	_	_	_	_	O
47	durations	_	UNK	_	NNS	173	_	_	_	_	_	_	_	O
48	greater	_	greater	_	JJR	173	_	_	_	_	_	_	_	O
49	than	_	than	_	IN	173	_	_	_	_	_	_	_	O
50	those	_	those	_	DT	173	_	_	_	_	_	_	_	O
51	authorised	_	UNK	_	JJ	173	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	173	_	_	_	_	_	_	_	O
2	mhra	_	UNK	_	NNP	173	_	_	_	_	_	_	_	O
3	advises	_	advise	_	VBZ	173	_	_	_	_	_	_	_	O
4	that	_	that	_	IN	173	_	_	_	_	_	_	_	O
5	prescribers	_	UNK	_	NNS	173	_	_	_	_	_	_	_	O
6	should	_	should	_	MD	173	_	_	_	_	_	_	_	O
7	take	_	take	_	VB	173	_	_	_	_	_	_	_	O
8	into	_	into	_	IN	173	_	_	_	_	_	_	_	O
9	account	_	account	_	NN	173	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	173	_	_	_	_	_	_	_	O
11	overall	_	overall	_	JJ	173	_	_	_	_	_	_	_	O
12	safety	_	safety	_	NN	173	_	_	_	_	_	_	_	O
13	profile	_	profile	_	NN	173	_	_	_	_	_	_	_	O
14	of	_	of	_	IN	173	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	173	_	_	_	_	_	_	_	O
16	,	_	,	_	,	173	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	173	_	_	_	_	_	_	_	O
18	in	_	in	_	IN	173	_	_	_	_	_	_	_	O
19	particular	_	particular	_	JJ	173	_	_	_	_	_	_	_	O
20	its	_	it	_	PRP$	173	_	_	_	_	_	_	_	O
21	cardiac	_	UNK	_	JJ	173	_	_	_	_	_	_	_	O
22	risk	_	risk	_	NN	173	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	173	_	_	_	_	_	_	_	O
24	potential	_	potential	_	JJ	173	_	_	_	_	_	_	_	O
25	interactions	_	UNK	_	NNS	173	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	173	_	_	_	_	_	_	_	O
27	other	_	other	_	JJ	173	_	_	_	_	_	_	_	O
28	medicines	_	medicine	_	NNS	173	_	_	_	_	_	_	_	O
29	(	_	(	_	(	173	_	_	_	_	_	_	_	O
30	such	_	such	_	JJ	173	_	_	_	_	_	_	_	O
31	as	_	a	_	IN	173	_	_	_	_	_	_	_	O
32	erythromycin	_	UNK	_	NN	173	_	_	_	_	_	_	_	O
33	)	_	)	_	)	173	_	_	_	_	_	_	_	O
34	,	_	,	_	,	173	_	_	_	_	_	_	_	O
35	if	_	if	_	IN	173	_	_	_	_	_	_	_	O
36	there	_	there	_	EX	173	_	_	_	_	_	_	_	O
37	is	_	be	_	VBZ	173	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	173	_	_	_	_	_	_	_	O
39	clinical	_	UNK	_	JJ	173	_	_	_	_	_	_	_	S-Requirement
40	need	_	need	_	NN	173	_	_	_	_	_	need.n	Needing	O
41	to	_	to	_	TO	173	_	_	_	_	_	_	_	O
42	use	_	use	_	VB	173	_	_	_	_	_	_	_	O
43	it	_	it	_	PRP	173	_	_	_	_	_	_	_	O
44	at	_	at	_	IN	173	_	_	_	_	_	_	_	O
45	doses	_	dos	_	NNS	173	_	_	_	_	_	_	_	O
46	or	_	or	_	CC	173	_	_	_	_	_	_	_	O
47	durations	_	UNK	_	NNS	173	_	_	_	_	_	_	_	O
48	greater	_	greater	_	JJR	173	_	_	_	_	_	_	_	O
49	than	_	than	_	IN	173	_	_	_	_	_	_	_	O
50	those	_	those	_	DT	173	_	_	_	_	_	_	_	O
51	authorised	_	UNK	_	JJ	173	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	173	_	_	_	_	_	_	_	O
2	mhra	_	UNK	_	NNP	173	_	_	_	_	_	_	_	O
3	advises	_	advise	_	VBZ	173	_	_	_	_	_	_	_	O
4	that	_	that	_	IN	173	_	_	_	_	_	_	_	O
5	prescribers	_	UNK	_	NNS	173	_	_	_	_	_	_	_	O
6	should	_	should	_	MD	173	_	_	_	_	_	_	_	O
7	take	_	take	_	VB	173	_	_	_	_	_	_	_	O
8	into	_	into	_	IN	173	_	_	_	_	_	_	_	O
9	account	_	account	_	NN	173	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	173	_	_	_	_	_	_	_	O
11	overall	_	overall	_	JJ	173	_	_	_	_	_	_	_	O
12	safety	_	safety	_	NN	173	_	_	_	_	_	_	_	O
13	profile	_	profile	_	NN	173	_	_	_	_	_	_	_	O
14	of	_	of	_	IN	173	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NN	173	_	_	_	_	_	_	_	O
16	,	_	,	_	,	173	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	173	_	_	_	_	_	_	_	O
18	in	_	in	_	IN	173	_	_	_	_	_	_	_	O
19	particular	_	particular	_	JJ	173	_	_	_	_	_	_	_	O
20	its	_	it	_	PRP$	173	_	_	_	_	_	_	_	O
21	cardiac	_	UNK	_	JJ	173	_	_	_	_	_	_	_	O
22	risk	_	risk	_	NN	173	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	173	_	_	_	_	_	_	_	O
24	potential	_	potential	_	JJ	173	_	_	_	_	_	_	_	O
25	interactions	_	UNK	_	NNS	173	_	_	_	_	_	_	_	O
26	with	_	with	_	IN	173	_	_	_	_	_	_	_	O
27	other	_	other	_	JJ	173	_	_	_	_	_	_	_	O
28	medicines	_	medicine	_	NNS	173	_	_	_	_	_	_	_	O
29	(	_	(	_	(	173	_	_	_	_	_	_	_	O
30	such	_	such	_	JJ	173	_	_	_	_	_	_	_	O
31	as	_	a	_	IN	173	_	_	_	_	_	_	_	O
32	erythromycin	_	UNK	_	NN	173	_	_	_	_	_	_	_	O
33	)	_	)	_	)	173	_	_	_	_	_	_	_	O
34	,	_	,	_	,	173	_	_	_	_	_	_	_	O
35	if	_	if	_	IN	173	_	_	_	_	_	_	_	O
36	there	_	there	_	EX	173	_	_	_	_	_	_	_	O
37	is	_	be	_	VBZ	173	_	_	_	_	_	_	_	O
38	a	_	a	_	DT	173	_	_	_	_	_	_	_	O
39	clinical	_	UNK	_	JJ	173	_	_	_	_	_	_	_	O
40	need	_	need	_	NN	173	_	_	_	_	_	_	_	O
41	to	_	to	_	TO	173	_	_	_	_	_	_	_	O
42	use	_	use	_	VB	173	_	_	_	_	_	use.v	Using	O
43	it	_	it	_	PRP	173	_	_	_	_	_	_	_	S-Instrument
44	at	_	at	_	IN	173	_	_	_	_	_	_	_	B-Purpose
45	doses	_	dos	_	NNS	173	_	_	_	_	_	_	_	I-Purpose
46	or	_	or	_	CC	173	_	_	_	_	_	_	_	O
47	durations	_	UNK	_	NNS	173	_	_	_	_	_	_	_	O
48	greater	_	greater	_	JJR	173	_	_	_	_	_	_	_	O
49	than	_	than	_	IN	173	_	_	_	_	_	_	_	O
50	those	_	those	_	DT	173	_	_	_	_	_	_	_	O
51	authorised	_	UNK	_	JJ	173	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	174	_	_	_	_	_	_	_	B-Focal_occasion
2	prescriber	_	UNK	_	NN	174	_	_	_	_	_	_	_	I-Focal_occasion
3	should	_	should	_	MD	174	_	_	_	_	_	_	_	O
4	follow	_	follow	_	VB	174	_	_	_	_	_	follow.v	Relative_time	O
5	relevant	_	relevant	_	JJ	174	_	_	_	_	_	_	_	B-Landmark_occasion
6	professional	_	professional	_	JJ	174	_	_	_	_	_	_	_	I-Landmark_occasion
7	guidance	_	guidance	_	NN	174	_	_	_	_	_	_	_	I-Landmark_occasion
8	,	_	,	_	,	174	_	_	_	_	_	_	_	O
9	taking	_	take	_	VBG	174	_	_	_	_	_	_	_	O
10	full	_	full	_	JJ	174	_	_	_	_	_	_	_	O
11	responsibility	_	responsibility	_	NN	174	_	_	_	_	_	_	_	O
12	for	_	for	_	IN	174	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	174	_	_	_	_	_	_	_	O
14	decision	_	decision	_	NN	174	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	174	_	_	_	_	_	_	_	O
2	prescriber	_	UNK	_	NN	174	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	174	_	_	_	_	_	_	_	O
4	follow	_	follow	_	VB	174	_	_	_	_	_	_	_	O
5	relevant	_	relevant	_	JJ	174	_	_	_	_	_	_	_	O
6	professional	_	professional	_	JJ	174	_	_	_	_	_	_	_	O
7	guidance	_	guidance	_	NN	174	_	_	_	_	_	_	_	O
8	,	_	,	_	,	174	_	_	_	_	_	_	_	O
9	taking	_	take	_	VBG	174	_	_	_	_	_	_	_	O
10	full	_	full	_	JJ	174	_	_	_	_	_	full.a	Completeness	O
11	responsibility	_	responsibility	_	NN	174	_	_	_	_	_	_	_	S-Whole
12	for	_	for	_	IN	174	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	174	_	_	_	_	_	_	_	O
14	decision	_	decision	_	NN	174	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	174	_	_	_	_	_	_	_	O
2	prescriber	_	UNK	_	NN	174	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	174	_	_	_	_	_	_	_	O
4	follow	_	follow	_	VB	174	_	_	_	_	_	_	_	O
5	relevant	_	relevant	_	JJ	174	_	_	_	_	_	_	_	O
6	professional	_	professional	_	JJ	174	_	_	_	_	_	_	_	O
7	guidance	_	guidance	_	NN	174	_	_	_	_	_	_	_	O
8	,	_	,	_	,	174	_	_	_	_	_	_	_	O
9	taking	_	take	_	VBG	174	_	_	_	_	_	_	_	O
10	full	_	full	_	JJ	174	_	_	_	_	_	_	_	O
11	responsibility	_	responsibility	_	NN	174	_	_	_	_	_	responsibility.n	Being_obligated	S-Duty
12	for	_	for	_	IN	174	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	174	_	_	_	_	_	_	_	O
14	decision	_	decision	_	NN	174	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	174	_	_	_	_	_	_	_	O
2	prescriber	_	UNK	_	NN	174	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	174	_	_	_	_	_	_	_	O
4	follow	_	follow	_	VB	174	_	_	_	_	_	_	_	O
5	relevant	_	relevant	_	JJ	174	_	_	_	_	_	_	_	O
6	professional	_	professional	_	JJ	174	_	_	_	_	_	_	_	O
7	guidance	_	guidance	_	NN	174	_	_	_	_	_	_	_	O
8	,	_	,	_	,	174	_	_	_	_	_	_	_	O
9	taking	_	take	_	VBG	174	_	_	_	_	_	_	_	O
10	full	_	full	_	JJ	174	_	_	_	_	_	_	_	O
11	responsibility	_	responsibility	_	NN	174	_	_	_	_	_	_	_	O
12	for	_	for	_	IN	174	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	174	_	_	_	_	_	_	_	O
14	decision	_	decision	_	NN	174	_	_	_	_	_	decision.n	Deciding	O

1	informed	_	UNK	_	NNP	175	_	_	_	_	_	_	_	S-Speaker
2	consent	_	consent	_	NN	175	_	_	_	_	_	consent.v	Commitment	O
3	should	_	should	_	MD	175	_	_	_	_	_	_	_	O
4	be	_	be	_	VB	175	_	_	_	_	_	_	_	O
5	obtained	_	obtain	_	VBN	175	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	175	_	_	_	_	_	_	_	O
7	documented	_	document	_	VBN	175	_	_	_	_	_	_	_	O

1	informed	_	UNK	_	NNP	175	_	_	_	_	_	_	_	B-Theme
2	consent	_	consent	_	NN	175	_	_	_	_	_	_	_	I-Theme
3	should	_	should	_	MD	175	_	_	_	_	_	_	_	O
4	be	_	be	_	VB	175	_	_	_	_	_	_	_	O
5	obtained	_	obtain	_	VBN	175	_	_	_	_	_	obtain.v	Getting	O
6	and	_	and	_	CC	175	_	_	_	_	_	_	_	O
7	documented	_	document	_	VBN	175	_	_	_	_	_	_	_	O

1	informed	_	UNK	_	NNP	175	_	_	_	_	_	_	_	O
2	consent	_	consent	_	NN	175	_	_	_	_	_	_	_	O
3	should	_	should	_	MD	175	_	_	_	_	_	_	_	O
4	be	_	be	_	VB	175	_	_	_	_	_	_	_	O
5	obtained	_	obtain	_	VBN	175	_	_	_	_	_	_	_	O
6	and	_	and	_	CC	175	_	_	_	_	_	_	_	O
7	documented	_	document	_	VBN	175	_	_	_	_	_	document.v	Recording	O

1	type	_	Type	_	$	176	_	_	_	_	_	type.n	Type	S-Subtype
2	2	_	2	_	CD	176	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	176	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	176	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	176	_	_	_	_	_	_	_	O
6	:	_	:	_	:	176	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	176	_	_	_	_	_	_	_	O
8	(	_	(	_	(	176	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	176	_	_	_	_	_	_	_	O
10	)	_	)	_	)	176	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	176	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	176	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	176	_	_	_	_	_	_	_	O
14	)	_	)	_	)	176	_	_	_	_	_	_	_	O

1	type	_	Type	_	$	176	_	_	_	_	_	_	_	O
2	2	_	2	_	CD	176	_	_	_	_	_	_	_	O
3	diabetes	_	UNK	_	NNS	176	_	_	_	_	_	_	_	O
4	in	_	in	_	IN	176	_	_	_	_	_	_	_	O
5	adults	_	adult	_	NNS	176	_	_	_	_	_	adult.n	People_by_age	S-Person
6	:	_	:	_	:	176	_	_	_	_	_	_	_	O
7	management	_	management	_	NN	176	_	_	_	_	_	_	_	O
8	(	_	(	_	(	176	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NNP	176	_	_	_	_	_	_	_	O
10	)	_	)	_	)	176	_	_	_	_	_	_	_	O
11	conditions	_	condition	_	NNS	176	_	_	_	_	_	_	_	O
12	#	_	UNK	_	UNK	176	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	NNS	176	_	_	_	_	_	_	_	O
14	)	_	)	_	)	176	_	_	_	_	_	_	_	O

